{"originalText": "，患者3月前因“直肠癌”于在我院于全麻上行直肠癌根治术（DIXON术），手术过程顺利，术后给予抗感染及营养支持治疗，患者恢复好，切口愈合良好。，术后病理示：直肠腺癌（中低度分化），浸润溃疡型，面积3.5*2CM，侵达外膜。双端切线另送“近端”、“远端”及环周底部切除面未查见癌。肠壁一站（10个）、中间组（8个）淋巴结未查见癌。，免疫组化染色示：ERCC1弥漫（+）、TS少部分弱（+）、SYN（-）、CGA（-）。术后查无化疗禁忌后给予3周期化疗，，方案为：奥沙利铂150MG D1，亚叶酸钙0.3G+替加氟1.0G D2-D6，同时给与升白细胞、护肝、止吐、免疫增强治疗，患者副反应轻。院外期间患者一般情况好，无恶心，无腹痛腹胀胀不适，无现患者为行复查及化疗再次来院就诊，门诊以“直肠癌术后”收入院。   近期患者精神可，饮食可，大便正常，小便正常，近期体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 8, "end_pos": 11}, {"label_type": "手术", "overlap": 0, "start_pos": 21, "end_pos": 35}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 78, "end_pos": 95}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 139, "end_pos": 159}, {"end_pos": 234, "label_type": "药物", "overlap": 0, "start_pos": 230}, {"end_pos": 247, "label_type": "药物", "overlap": 0, "start_pos": 243}, {"end_pos": 255, "label_type": "药物", "overlap": 0, "start_pos": 252}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 276, "end_pos": 277}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 312, "end_pos": 313}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 314, "end_pos": 315}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 342, "end_pos": 347}]}
{"originalText": "，患者因罹患“胃癌”于2013-10-29在我院予行全麻上胃癌根治术，，术中见：腹腔内腹水，腹膜无转移，肝脏未触及明显转移性灶，肿瘤位于胃体、胃底部，小弯侧偏后壁，约5*4*2CM大小，肿瘤已侵达浆膜外，第1、3组淋巴结肿大，肿瘤尚能活动，经探查决定行全胃切除，空肠J字代胃术。手术顺利，术后积极予相关对症支持治疗；，后病理示：胃底、体小弯侧低分化腺癌，部分为印戒细胞癌图像，蕈伞型，面积5.2*3.5CM，局部侵达粘膜上层，并于少数腺管内查见癌栓。双端切线及另送“近端切线”未查见癌。呈三组（5/13个）淋巴结癌转移。一组（7个）、四组（13个）、五组（1个）、六组（4个）淋巴结未查见癌。，癌组织免疫组化染色示：ERCC1（+）、β-TUBULIN-III（+）、TS（-）、RRM1（-）、TOPOII阳性细胞数约20%、CERBB-2（2+） 。依据患者病情及肿瘤病理与分期继续术后辅助性化疗指征存在，患者及家属拒绝化疗。自术后出院以来，患者一般情况保持良好；无发热，偶有恶心，无呕吐，无反酸、嗳气，无明显进食不适，偶有进食后轻微腹胀，无腹痛。现患者为行进一步复查并必要时适当处理而再来我院就诊，门诊依情以“胃恶性肿瘤术后”收入院。目前患者精神及情绪状态良好，食欲较术前明显减少，饮食可，夜间睡眠后；今8个月体重减轻18KG。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 7, "end_pos": 9}, {"end_pos": 34, "label_type": "手术", "overlap": 0, "start_pos": 29}, {"end_pos": 42, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"end_pos": 44, "label_type": "解剖部位", "overlap": 0, "start_pos": 43}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 46, "end_pos": 47}, {"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 75, "end_pos": 78}, {"end_pos": 138, "label_type": "手术", "overlap": 0, "start_pos": 126}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 164, "end_pos": 191}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 244, "end_pos": 256}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 260, "end_pos": 291}, {"end_pos": 470, "label_type": "解剖部位", "overlap": 0, "start_pos": 469}, {"end_pos": 474, "label_type": "解剖部位", "overlap": 0, "start_pos": 473}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 508, "end_pos": 515}]}
{"originalText": "，患者3月余前于我院诊断为“直肠癌”，于2015-10-26在全麻上行腹腔镜直肠癌根治术，，术后病理示：，201518502：（直肠）腺癌（中度分化），浸润溃疡型，体积2.7*2*0.8CM，侵达浆膜。 双端切线及另送“近切线”、“远切线”未查见癌。 肠壁一站（6个）、中间组（3个）、中央组（3个）淋巴结未查见癌。低级别腺管状腺瘤。，免疫组化染色示：TS部分（+）、SYN（-）。，术后病理分期：PT3N0M0，II期，DUKES B。依情2015-11-08.2015-12-09给予奥沙利铂200MG D1+亚叶酸钙0.3G D2-6 +替加氟1G D2-6 静滴，同时辅以镇吐、升血、免疫调节等对症支持治疗。化疗过程总体顺利。现为复查化疗来我院，门诊以“直肠癌术后”收入院。目前患者精神好，食欲及饮食好，夜间睡眠良好，小便正常，大便4-5次/天，基本成形。否认近期明显体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"end_pos": 44, "label_type": "手术", "overlap": 0, "start_pos": 35}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 63, "end_pos": 81}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 126, "end_pos": 153}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 158, "end_pos": 166}, {"end_pos": 248, "label_type": "药物", "overlap": 0, "start_pos": 244}, {"end_pos": 261, "label_type": "药物", "overlap": 0, "start_pos": 257}, {"end_pos": 275, "label_type": "药物", "overlap": 0, "start_pos": 272}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 331, "end_pos": 336}]}
{"originalText": "，患者因“结肠癌”于2012-12-13在我院于全麻上行右半结肠切15除术，手术过程顺利，术后给予抗感染及营养支持治疗，患者恢复好，切口愈合良好，，术后病理：13862.2012结肠腺癌（中度分化），溃疡型，面积6.5*3.5，侵达浆膜脂肪组织。双端切线未查见癌。结肠腺管状腺瘤。呈肠壁一站（1/5个）淋巴结癌转移。肠壁二站（3个）淋巴结未查见癌。，免疫组化染色示癌组织：ERCC1(+)、TS少数细胞（+）。（PT4AN1M0，IIIA，DUCKS C）。后患者恢复好出院，术后给予化疗2周期。   院外期间患者一般情况好，无恶心，无腹痛腹胀胀不适，现患者为行复查及化疗再次来院就诊，门诊以“结肠癌术后”收入院。   近期患者精神可，饮食可，大便次数多，小便正常，近期体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 5, "end_pos": 8}, {"end_pos": 37, "label_type": "手术", "overlap": 0, "start_pos": 28}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 89, "end_pos": 103}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 132, "end_pos": 139}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 141, "end_pos": 154}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 158, "end_pos": 169}, {"end_pos": 269, "label_type": "解剖部位", "overlap": 0, "start_pos": 268}, {"end_pos": 271, "label_type": "解剖部位", "overlap": 0, "start_pos": 270}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 297, "end_pos": 302}]}
{"originalText": "，缘于入院前4月余因中下腹部闷痛不适伴排黑便于我院就诊，诊断为“胃癌”，于2014年06月06日在全麻上行“腹腔镜辅助上根治性远端胃大部切除术（ROUX-Y吻合术D2）”手术顺利。术后病理（201417771），：“（远端胃）胃体小弯早期（IIC型）低分化腺癌，部分为印戒细胞癌，侵及粘膜上层，手术标本下、上切端及另送（下切端）均未见癌浸润。找到小弯淋巴结5个，大弯淋巴结5个，幽门下淋巴结18个，幽门上淋巴结3个，及另送（第8P组）淋巴结2个，均未见癌转移。另送（胃右动脉根部淋巴结）为脂肪、脉管及神经组织。，免疫组化结果：CK(L)（+++），CD68（组织细胞+），KI67（50%+）”，术后给予对症、抗感染治疗，恢复良好,伤口愈合良好。分别于2014.07.16、2014.08.13、2014.09.17、2014.10.29予“奥沙利铂（齐沙）150MGIVGTTD1+替吉奥胶囊（艾奕）40MGPOBIDD2-15”方案行术后第1、2、3、4周期化疗，化疗过程顺利。今为第5周期化疗再次入院。自下次出院后饮食、睡眠可，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 32, "end_pos": 34}, {"end_pos": 71, "label_type": "手术", "overlap": 0, "start_pos": 54}, {"end_pos": 83, "label_type": "手术", "overlap": 0, "start_pos": 72}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 108, "end_pos": 139}, {"end_pos": 178, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"end_pos": 186, "label_type": "解剖部位", "overlap": 0, "start_pos": 181}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"end_pos": 205, "label_type": "解剖部位", "overlap": 0, "start_pos": 199}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"end_pos": 375, "label_type": "药物", "overlap": 0, "start_pos": 371}, {"end_pos": 378, "label_type": "药物", "overlap": 0, "start_pos": 376}, {"end_pos": 397, "label_type": "药物", "overlap": 0, "start_pos": 392}, {"end_pos": 400, "label_type": "药物", "overlap": 0, "start_pos": 398}, {"end_pos": 469, "label_type": "解剖部位", "overlap": 0, "start_pos": 468}, {"end_pos": 472, "label_type": "解剖部位", "overlap": 0, "start_pos": 471}]}
{"originalText": "，缘于入院前5月余因“反复返酸、嗳气7年”就诊我院，，行胃镜检查示：“1.胃窦癌2.慢性萎缩性胃炎”，，病理示：“胃管状腺癌II-III级”，下腹部平扫+，增强示：“胃肿瘤，伴腹腔、腹膜后多发淋巴结肿大”，考虑肿瘤局部较晚期，遂于2015.04.18、2015.05.11、2015.06.02、2015.06.29、2015.08.02予“安素泰210MGIVGTTD1+奥沙利铂（艾恒）150MGIVGTTD2+希罗达1000MGBIDPOD1-14”方案新辅助化疗，辅以止吐、制酸、保胃、保肝、营养支持等治疗。化疗后未见明显骨髓抑制，一般情况尚可。并于入院前1月余（2015.09.01）全麻上行“腹腔镜上根治性远端胃大部切除术”。术顺，术后恢复可，，术后病理：(远端胃)，：胃体及胃窦小弯侧早期隆起型（0-I型）低黏附性癌，印戒细胞癌为主，部分为低分化腺癌及未分化癌，浸润脉管及神经组织，脉管内见癌栓，侵及黏膜上层。标本下切端、上切端及另送(下切端)，均未见癌浸润。找到小弯侧淋巴结0/13个，大弯侧淋巴结2/10个，幽门下淋巴结1/4个，幽门上淋巴结5/6个，另送(胃右动脉根部）淋巴结2/8个，(胃壁)淋巴结0/4个，见癌转移。，免疫组化染色结果：CK(PAN)（+++），E-CADHERIN（+++），CDX-2（+++），CGA（+），CD56（-），SY（-），HER-2（-）。门诊拟“胃窦术后化疗”收入院。自发病以来，精神、睡眠可，食欲一般，大小便如常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 37, "end_pos": 40}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 42, "end_pos": 49}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 57, "end_pos": 69}, {"label_type": "影像检查", "overlap": 0, "start_pos": 71, "end_pos": 76}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 83, "end_pos": 86}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 99}, {"end_pos": 174, "label_type": "药物", "overlap": 0, "start_pos": 171}, {"end_pos": 191, "label_type": "药物", "overlap": 0, "start_pos": 187}, {"end_pos": 194, "label_type": "药物", "overlap": 0, "start_pos": 192}, {"end_pos": 211, "label_type": "药物", "overlap": 0, "start_pos": 208}, {"end_pos": 246, "label_type": "解剖部位", "overlap": 0, "start_pos": 245}, {"end_pos": 249, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 265, "end_pos": 269}, {"end_pos": 317, "label_type": "手术", "overlap": 0, "start_pos": 302}, {"end_pos": 338, "label_type": "解剖部位", "overlap": 0, "start_pos": 337}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 341, "end_pos": 387}, {"end_pos": 445, "label_type": "解剖部位", "overlap": 0, "start_pos": 439}, {"end_pos": 457, "label_type": "解剖部位", "overlap": 0, "start_pos": 451}, {"end_pos": 469, "label_type": "解剖部位", "overlap": 0, "start_pos": 463}, {"end_pos": 480, "label_type": "解剖部位", "overlap": 0, "start_pos": 474}, {"end_pos": 498, "label_type": "解剖部位", "overlap": 0, "start_pos": 487}, {"end_pos": 510, "label_type": "解剖部位", "overlap": 0, "start_pos": 503}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 604, "end_pos": 610}]}
{"originalText": "，入院前1月余因“进行性吞咽困难1年”就诊我院，，查胃镜示：，食管占位伴狭窄：癌不能排除，，活检病理示：“鳞状下皮呈乳头状增生，部分鳞状下皮呈低级别下皮内瘤变”，完善颈胸腹部，CT：食管下段部分管壁不规则增厚，考虑为食管癌，伴右侧锁骨下窝、食管旁沟及纵膈内多发淋巴结转移；另病变下缘一食管憩室。考虑食管癌伴纵隔淋巴结转移，为提高手术切除率，建议行术前新辅助化疗，告知患者家属，其表示理解，遂于2016.12.26、2017.01.16按氟尿嘧啶3000MG微量泵泵入+洛铂50MGIVGTTD2+多西他赛（泰索帝）120MGIVGTTD2”第1、2周期化疗，辅以保肝、止吐、制酸、营养支持等治疗，疗程较为顺利，未见明显化疗副反应。现为求进一步治疗，遂再次就诊我科，门诊拟“食管癌术前化疗”收住院。末次出院以来，精神、睡眠一般，大小便如常，体重无明显增减。", "entities": [{"end_pos": 33, "label_type": "解剖部位", "overlap": 0, "start_pos": 31}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 53, "end_pos": 79}, {"label_type": "影像检查", "overlap": 0, "start_pos": 83, "end_pos": 90}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 108, "end_pos": 135}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 142, "end_pos": 146}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 149, "end_pos": 160}, {"end_pos": 222, "label_type": "药物", "overlap": 0, "start_pos": 218}, {"end_pos": 236, "label_type": "药物", "overlap": 0, "start_pos": 234}, {"end_pos": 252, "label_type": "药物", "overlap": 0, "start_pos": 248}, {"end_pos": 256, "label_type": "药物", "overlap": 0, "start_pos": 253}, {"end_pos": 283, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 336, "end_pos": 339}]}
{"originalText": "患者4月余前因“下腹疼痛不适，伴反酸、嗳气”在我院完善相关检查后确诊“胃体胃窦癌”，于2015-10-10在全麻上行“胃癌根治术（远端胃大部分切除）”，术程顺利，术后预防感染支持对症等处理，恢复好，切口甲级愈合。术后病理示：“胃体胃窦癌 PT4AN3AM0 IIIC期。”于2015-11-05、2015-12-07、2016-01-14、2016-02-15、2016-03-18日在我院行SOX（奥沙利铂 100MG IVDRIP+替吉奥 60MG QN+替吉奥 40MG QM）方案化疗，化疗期间患者未诉特殊不适，未见明显副反应。现在为上一步治疗来我院门诊就诊，拟“胃癌综合治疗后”收入我科。术后出院至今患者精神尚可，食欲为半流为主，大小便正常，体重增加约2KG。", "entities": [{"end_pos": 10, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 35, "end_pos": 40}, {"label_type": "手术", "overlap": 0, "start_pos": 59, "end_pos": 74}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 113, "end_pos": 134}, {"end_pos": 204, "label_type": "药物", "overlap": 0, "start_pos": 200}, {"end_pos": 221, "label_type": "药物", "overlap": 0, "start_pos": 218}, {"end_pos": 233, "label_type": "药物", "overlap": 0, "start_pos": 230}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 286, "end_pos": 293}]}
{"originalText": "，患者因壶腹部占位于2016-07-22日在我科行胰十二指肠切除术+肝囊肿开窗引流+肝活检术，，术后病理示：壶腹部鳞状细胞癌（低度分化），体积4*2.8*2.5CM，侵达十二指肠粘膜层，侵及胰腺组织，于较多脉管内查见癌栓。胆总管、胃、十二指肠切线及胰腺切除面未查见癌；胆总管残端切线于少数脉管内查见癌栓。呈胰腺周围淋巴结（1/2个）癌转移。胃周围（2个）淋巴结未查见癌。慢性胆囊炎。（肝囊肿右、左）纤维性囊壁样结构，慢性发炎，局部衬覆单层立方下皮。（肝活检）肝组织一块，部分肝细胞淤胆，肝被膜及汇管区较多炎细胞浸润。，免疫组化染色示：CK5/6（+）、P63（+）、CK7（-）、CK20（-）、SYN（-）。患者术后恢复良好，无特殊不适，2016.10.6入院行静脉化疗治疗，2016.12.5入院行介入及静脉化疗，2017.2.16入院行静脉化疗，治疗结束后出院。患者出院后，自觉全身乏力，无明显腹胀、腹痛，无恶心、呕吐，无心慌、胸闷等不适。今患者为术后综合治疗，来我院就诊，门诊以“胰十二指肠术后”收入院。   患者自术后以来，神志清，精神好，饮食可，睡眠可，大小便无异常，体重略增加。", "entities": [{"end_pos": 7, "label_type": "解剖部位", "overlap": 0, "start_pos": 4}, {"end_pos": 33, "label_type": "手术", "overlap": 0, "start_pos": 25}, {"end_pos": 41, "label_type": "手术", "overlap": 0, "start_pos": 34}, {"end_pos": 46, "label_type": "手术", "overlap": 0, "start_pos": 42}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 54, "end_pos": 68}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 114, "label_type": "解剖部位", "overlap": 0, "start_pos": 111}, {"end_pos": 116, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"end_pos": 137, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"end_pos": 160, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"end_pos": 180, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 185, "end_pos": 190}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 192, "end_pos": 195}, {"label_type": "手术", "overlap": 0, "start_pos": 225, "end_pos": 228}, {"end_pos": 230, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"end_pos": 238, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 243, "end_pos": 244}, {"end_pos": 401, "label_type": "解剖部位", "overlap": 0, "start_pos": 400}, {"end_pos": 404, "label_type": "解剖部位", "overlap": 0, "start_pos": 403}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 414, "end_pos": 415}, {"end_pos": 418, "label_type": "解剖部位", "overlap": 0, "start_pos": 417}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 444, "end_pos": 451}]}
{"originalText": "，缘于入院前3年余于我院诊断为胃癌，于2012-04-11在全麻上行腹腔镜上根治性全胃切除术，术后病理示(201210103)，：食管胃交界溃疡型管状腺癌II－III级，侵出浆膜层，手术标本下、上切端及另送（下切端）均未见癌浸润。找到贲门左淋巴结1/15个，小弯淋巴结0/2个，大弯淋巴结0/1个，幽门下淋巴结0/5个，幽门上淋巴结0/5个，及另送（第8组）淋巴结0/4个见癌转移。，免疫组化：KI67（30%+），P53（-），CD56（-），SY（-），CGA（-），CK18（+++）。术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。术后再入院行洛铂50MG+表柔比星100MGD1+希罗达1500MGBIDD1-D14方案化疗6周期，未见明显化疗反应，2天前,自诉腹痛,脐周明显,呈阵发性,可自行缓解,伴肛门停止排气排便.现感症状加重,无明显缓解方式,为求进一步诊治遂来我院，门诊拟腹痛待查收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 15, "end_pos": 17}, {"end_pos": 46, "label_type": "手术", "overlap": 0, "start_pos": 34}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 65, "end_pos": 84}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"end_pos": 134, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"end_pos": 155, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"end_pos": 182, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}, {"end_pos": 283, "label_type": "药物", "overlap": 0, "start_pos": 281}, {"end_pos": 292, "label_type": "药物", "overlap": 0, "start_pos": 288}, {"end_pos": 303, "label_type": "药物", "overlap": 0, "start_pos": 300}, {"end_pos": 342, "label_type": "解剖部位", "overlap": 0, "start_pos": 341}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 344, "end_pos": 345}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 361, "end_pos": 363}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 400, "end_pos": 404}, {"end_pos": 426, "label_type": "解剖部位", "overlap": 0, "start_pos": 425}, {"end_pos": 429, "label_type": "解剖部位", "overlap": 0, "start_pos": 428}]}
{"originalText": "，缘于入院前3月因“直肠癌”就诊我院，于2016年11月10日在全麻上行腹腔镜上直肠根治术（DIXON手术）,探查腹腔内无明显出血，没有明显粘连，无明显腹水，肿瘤位于腹膜返折下5CM对系膜侧，侵及浆膜层，未形成肠梗阻，近端无扩张，周围未见明显肿大淋巴结。术顺,术后予预防感染、制酸、补液、营养支持、增强免疫力等处理，术后恢复可。术后病理（201641027），：（直肠），：直肠隆起型中分化管状腺癌，小灶区为黏液腺癌，侵犯肠壁全层，脉管见癌侵犯，未见明确神经侵犯，手术标本下、上切端及另送（下切端）、（上切端）未见癌浸润。找到肠周淋巴结3/14枚及另送（肠系膜上动脉根部）淋巴结0/4枚，（中间组）淋巴结1/9枚，见癌转移。，免疫组化：肿瘤细胞示CK7（-），CK20（+++），KI67（60%+）。MLH-1（++），MSH-2（+++），MSH-6（+++），PMS-2（+）提示该病例肿瘤微卫星稳定(MSS)，请结合临床。检测到KRAS基因存在G13D突变。未检测到NRAS基因热点突变。未检测到BRAF基因V600E突变。于2016-12-10予“奥沙利铂200MGIVGTTD1+卡培他滨1500MGBIDD1-D14”方案化疗，此次为化疗再次就诊我院，门诊拟直肠癌术后化疗收入院。自下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"label_type": "手术", "overlap": 0, "start_pos": 36, "end_pos": 54}, {"end_pos": 59, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 83, "end_pos": 84}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 105}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 187, "end_pos": 208}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 211, "end_pos": 212}, {"end_pos": 268, "label_type": "解剖部位", "overlap": 0, "start_pos": 263}, {"end_pos": 289, "label_type": "解剖部位", "overlap": 0, "start_pos": 276}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 294, "end_pos": 302}, {"end_pos": 483, "label_type": "药物", "overlap": 0, "start_pos": 479}, {"end_pos": 500, "label_type": "药物", "overlap": 0, "start_pos": 496}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 536, "end_pos": 541}, {"end_pos": 566, "label_type": "解剖部位", "overlap": 0, "start_pos": 565}, {"end_pos": 569, "label_type": "解剖部位", "overlap": 0, "start_pos": 568}]}
{"originalText": "，患者12天前因“子宫内膜复杂性增生”在我院行全子宫切除术+两侧输卵管切除术+盆腔粘连松解术。，术中探查: 部分大网膜粘连于左前腹壁，分离粘连后见肝脏表面光滑，大网膜及肠管表面未见明显异常。盆腹腔内少量血性积液。子宫前位，约2个月妊娠大小，表面光滑，局部质硬，呈腺肌病样改变，子宫后壁上段与部分肠系膜粘连，右侧卵巢粘连于子宫右后壁，左侧卵巢萎缩，粘连于子宫左后壁和侧腹膜。两侧输卵管外观正常。，术中腹腔冲洗液送快速病理检查结果提示：（腹腔冲洗液）离心涂片查见大量间皮细胞及少量淋巴细胞、中性粒细胞。子宫内膜呈孕激素类药物治疗后改变，冰冻切片局部查见少许复杂性增生的内膜。未累及子宫颈外口切线。手术顺利，，术后常规病理回示：子宫内膜复杂性增生，部分腺体呈高级别下皮内瘤变，部分区域为高分化子宫内膜样腺癌，位于粘膜内，未累及子宫颈颈管内口，未累及底部切除面及外口残端切线。慢性子宫颈炎。（两侧）输卵管组织。，免疫组化染色示：ER（+）、PR（+）、P53少量（+）。建议进一步治疗。患者现无腹痛及阴道流血，无其他不适。今日患者为行进一步治疗来院就诊，门诊以“子宫内膜病变术后”收入院。   患者自发病以来，一般情况可，精神、睡眠良好，饮食一般，大小便无异常，体重无明显改变。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 9, "end_pos": 18}, {"label_type": "手术", "overlap": 0, "start_pos": 23, "end_pos": 46}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 62, "end_pos": 65}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 86, "label_type": "解剖部位", "overlap": 0, "start_pos": 84}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 108, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 138, "end_pos": 140}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 147, "end_pos": 148}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 160, "end_pos": 162}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 176, "end_pos": 178}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 183, "end_pos": 184}, {"end_pos": 191, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 199}, {"end_pos": 219, "label_type": "解剖部位", "overlap": 0, "start_pos": 217}, {"end_pos": 253, "label_type": "解剖部位", "overlap": 0, "start_pos": 249}, {"end_pos": 293, "label_type": "解剖部位", "overlap": 0, "start_pos": 288}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 311, "end_pos": 350}, {"end_pos": 367, "label_type": "解剖部位", "overlap": 0, "start_pos": 360}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 384, "end_pos": 390}, {"end_pos": 398, "label_type": "解剖部位", "overlap": 0, "start_pos": 391}, {"end_pos": 444, "label_type": "解剖部位", "overlap": 0, "start_pos": 443}, {"end_pos": 448, "label_type": "解剖部位", "overlap": 0, "start_pos": 446}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 477, "end_pos": 485}]}
{"originalText": "，缘于入院前20余日于我院诊为乙状结肠癌，于2015-10-21在全麻上行乙状结肠癌根治术，，术中见：腹腔内无明显腹水，腹腔、盆腔、大网膜无明显转移结节，肝脏质地大小正常，未触及肿物，胆囊未触及结石。肿瘤位于乙状结肠上段，约6×5㎝，未形成肠梗阻，近端肠管无扩张，周围可见少许肿大淋巴结。诊断“乙状结肠癌”，遂决定行“乙状结肠癌根治术。术后病理示.(乙状结肠)，：肠溃疡型管状腺癌II级，侵犯肠壁全层及肠周脂肪组织，侵犯神经组织，未见肯定脉管侵犯，手术标本下、上切端及另送（下切端）（上切端）均未见癌浸润；找到肠周淋巴结9个，未见癌转移。2.该病例检测到KRAS基因12号密码子GLY12ASP突变。3.该病例未检测到BRAF基因V600E突变。，术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。2015-11-21行第1周期化疗，具体方案为“沙利铂140MGD1IVGTT+氟尿嘧啶700MGD1IVGTT+氟尿嘧啶4200MGD1-D2微量泵泵人+亚叶酸650MGD1-D2IVGTT”，此次为术后第2次化疗再次就诊我院，门诊拟乙状结肠癌术后化疗收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 15, "end_pos": 20}, {"end_pos": 45, "label_type": "手术", "overlap": 0, "start_pos": 37}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 51}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 62, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 63}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 92}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 126}, {"end_pos": 143, "label_type": "解剖部位", "overlap": 0, "start_pos": 140}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 147, "end_pos": 152}, {"end_pos": 167, "label_type": "手术", "overlap": 0, "start_pos": 159}, {"end_pos": 179, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 182, "end_pos": 193}, {"end_pos": 198, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 201, "end_pos": 202}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 255}, {"end_pos": 380, "label_type": "药物", "overlap": 0, "start_pos": 377}, {"end_pos": 397, "label_type": "药物", "overlap": 0, "start_pos": 393}, {"end_pos": 414, "label_type": "药物", "overlap": 0, "start_pos": 410}, {"end_pos": 434, "label_type": "药物", "overlap": 0, "start_pos": 431}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 471, "end_pos": 478}, {"end_pos": 502, "label_type": "解剖部位", "overlap": 0, "start_pos": 501}, {"end_pos": 505, "label_type": "解剖部位", "overlap": 0, "start_pos": 504}]}
{"originalText": "，缘于入院前2个月因诊断为“胃癌”，于2014年12月09日在我院全麻上行“根治性远端胃大部切除术，ROUX-Y吻合，D2，R0”，术顺，术后予以制酸、保肝、增强免疫力、抗肿瘤、抗感染、抑制消化液分泌及对症支持治疗。术后病理（201443329），：(远端胃)，：胃角溃疡型粘液腺癌，部分为印戒细胞癌，侵出浆膜外，手术标本下、上切端均未见癌浸润，找到小弯淋巴结2/14个，大弯淋巴结0/7个，幽门上淋巴结2/15个，见癌转移。（201443369），：找到(第7组)淋巴结0/1个、(第8组)淋巴结2/2个、(第9组)淋巴结0/1个，见癌转移。2015.01.09按“奥沙利铂150MGD1多柔比星脂质体（里葆多）40MGD2希罗达1000MGD1-14”行第1周期术后辅助化疗，辅以护胃，保肝，止呕吐等对症处理。1天前无明显诱因出现发热，无寒战，无肢体抽搐，遂来我院就诊，门诊拟“胃角溃疡型粘液腺癌（PT4AN2M0IIIB期）术后化疗，发热待查”收住入院。自发病以来，患者精神、饮食、睡眠尚可，大小便正常，体重未见明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"end_pos": 49, "label_type": "手术", "overlap": 0, "start_pos": 38}, {"end_pos": 58, "label_type": "手术", "overlap": 0, "start_pos": 50}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 129, "label_type": "解剖部位", "overlap": 0, "start_pos": 126}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 132, "end_pos": 150}, {"end_pos": 180, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 191, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 228, "end_pos": 236}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 241, "end_pos": 249}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 254, "end_pos": 262}, {"end_pos": 288, "label_type": "药物", "overlap": 0, "start_pos": 284}, {"end_pos": 302, "label_type": "药物", "overlap": 0, "start_pos": 295}, {"end_pos": 306, "label_type": "药物", "overlap": 0, "start_pos": 303}, {"end_pos": 316, "label_type": "药物", "overlap": 0, "start_pos": 313}, {"end_pos": 344, "label_type": "解剖部位", "overlap": 0, "start_pos": 343}, {"end_pos": 347, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 391, "end_pos": 417}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 420, "end_pos": 424}]}
{"originalText": "，入院前8天（2013.12.06）因“宫颈鳞癌IB1期”就诊我院全麻上行行腹腔粘连松解术+部分大网膜切除术+广泛全子宫+两侧卵巢移位术+盆腔淋巴结清扫术，术前查，CA125：18.42U/ML，术后病理回报（201338627），：1、（全子宫），：宫颈浸润型鳞状细胞癌II级，侵及肌层（浸润深度＜1/2宫颈全层），脉管内见癌栓，手术标本阴道切端及两侧宫旁组织均未见癌浸润。宫体肌间平滑肌瘤，宫内膜呈增生状态。2、找到（右髂总）淋巴结0/6个，（右盆腔）淋巴结2/40个，（右侧腹股沟）淋巴结0/2个，（左髂总）淋巴结0/9个，（左盆腔）淋巴结1/16个见癌转移。3、（大网膜），：送检网膜组织未见癌细胞种植转移。，免疫组化：KI67（40%+），CK5/6（+++），CK(H)（+++），P63（++++），CEA（++），CK18（-），术后予补液、营养支持等治疗，恢复良好，伤口愈合II/甲。今为行第1次化疗，再次就诊我院，门诊拟“宫颈鳞癌（IB1期，II级）术后”收入院。下次出院以来，精神、睡眠、饮食好，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 20, "end_pos": 28}, {"label_type": "手术", "overlap": 0, "start_pos": 38, "end_pos": 77}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 82, "end_pos": 87}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 126, "end_pos": 139}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 175, "end_pos": 179}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 188, "end_pos": 196}, {"end_pos": 200, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}, {"end_pos": 218, "label_type": "解剖部位", "overlap": 0, "start_pos": 210}, {"end_pos": 231, "label_type": "解剖部位", "overlap": 0, "start_pos": 223}, {"end_pos": 247, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 273, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 421, "end_pos": 437}, {"end_pos": 461, "label_type": "解剖部位", "overlap": 0, "start_pos": 460}, {"end_pos": 464, "label_type": "解剖部位", "overlap": 0, "start_pos": 463}]}
{"originalText": "，患者7月前因“下腹腹胀伴反酸”至我院就诊，完善相关检查，诊断“胃体胃窦癌(CT4N2M0,IIIB期)”，建议先行化疗，患者及家属表示理解同意，遂于2015-5-26、2015-06-19、2015-07-13分别予XELOX(希罗达 1250MG BID PO D1-14+奥沙利铂150MG IVDRIP Q3W)化疗三程,过程顺利，无明显副反应，后于2015-08-24在全麻上行胃癌根治术（远端胃大切），术程顺利，术后预防感染支持对症等处理。，术后病理示：胃中至低分化管状腺癌（LAUREN，分型：肠型），浸润至胃壁浆膜上层，可见神经束侵犯，未见明确脉管内癌栓；肿瘤消退分级（MANDARD），：TRG4；网膜组织未见癌；LN（-）；YPT3N0M0，IIA期。术后恢复可，于2015-10-10、开始采用XELOX化疗方案化疗（奥沙利铂150MG Q3W IVDRIP+卡培他滨1250MGBID*14天）一程，过程顺利。现为行上程化疗来我院就诊，拟“胃癌综合治疗后”收入我科。自下次出院以来，患者精神可，食欲尚可，大小便正常，体重无明显上降。", "entities": [{"end_pos": 10, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 32, "end_pos": 52}, {"end_pos": 118, "label_type": "药物", "overlap": 0, "start_pos": 115}, {"end_pos": 143, "label_type": "药物", "overlap": 0, "start_pos": 139}, {"label_type": "手术", "overlap": 0, "start_pos": 193, "end_pos": 206}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 233, "end_pos": 257}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 261, "end_pos": 262}, {"end_pos": 374, "label_type": "药物", "overlap": 0, "start_pos": 370}, {"end_pos": 395, "label_type": "药物", "overlap": 0, "start_pos": 391}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 432, "end_pos": 439}]}
{"originalText": "，2009年12月底出现黑便，，于当地行胃镜检查并行病理检查示: 胃体中下部溃疡， 病理示中分化腺癌， 无腹胀、泛酸、嗳气、恶心、呕吐、 无头晕、 心悸、乏力等症， 2010年1月13日于我院胃胰科行胃癌根治术， 2010年1月18日，我院病理：切缘未见癌， 胃体可见3X2X1CM3溃疡型肿物， 镜上为中分化腺癌侵及胃壁全层至浆膜层，网膜未见癌， 肝总动脉旁（0/1)、 胃大弯（0/1)淋巴结未见癌， 贲门左(3/3)、 胃小弯(8/9)、幽门上（2/2)淋巴结可见腺癌转移，，免疫组化：CEA(+)、 P53(+)、 PR(-)、 ER-B(+)、 ER(+++)、 共计，LN: 13/16转移， 术后于2010年2月-2010年8月行术后化疗6程， 具体用药为艾素100MG 静点+ 希罗达1500MG BID PO，2014年6月初出现右侧下上肢活动受限， 7月份症状逐渐加重， 7月10日就诊于*****， ，行MRI检查提示：胃癌术后多发脑转移， 行甘露醇及地塞米松、 洛赛克治疗后效果不佳。遂于我院就诊，2014-8-5行奥沙利铂150MG D1+ 替吉奥 50MG BID D1-14化疗一程，2014-08-18开始行三维适形全脑放疗，剂量30GY/10F。2014-09-19始行替吉奥 50MG BID D1-14单药化疗一程。本次为行上一程化疗收入我科， 我科以“胃癌术后脑转移 RTXNXM1 IV期”收入， 入科以来， 精神饮食尚可， 无恶心、 呕吐,二便正常，体重无明显减低。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 33, "end_pos": 40}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 45, "end_pos": 50}, {"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 53}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 74}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 96, "end_pos": 97}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 97, "end_pos": 98}, {"end_pos": 105, "label_type": "手术", "overlap": 0, "start_pos": 100}, {"end_pos": 132, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 152, "end_pos": 157}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 159, "end_pos": 160}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 174, "end_pos": 198}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 203, "end_pos": 233}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 235, "end_pos": 237}, {"end_pos": 337, "label_type": "药物", "overlap": 0, "start_pos": 335}, {"end_pos": 350, "label_type": "药物", "overlap": 0, "start_pos": 347}, {"end_pos": 379, "label_type": "解剖部位", "overlap": 0, "start_pos": 374}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 421, "end_pos": 430}, {"end_pos": 436, "label_type": "药物", "overlap": 0, "start_pos": 433}, {"end_pos": 441, "label_type": "药物", "overlap": 0, "start_pos": 437}, {"end_pos": 446, "label_type": "药物", "overlap": 0, "start_pos": 443}, {"end_pos": 474, "label_type": "药物", "overlap": 0, "start_pos": 470}, {"end_pos": 487, "label_type": "药物", "overlap": 0, "start_pos": 484}, {"end_pos": 526, "label_type": "解剖部位", "overlap": 0, "start_pos": 525}, {"end_pos": 555, "label_type": "药物", "overlap": 0, "start_pos": 552}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 596, "end_pos": 615}]}
{"originalText": "，患者因低位直肠癌于2014-08-27在全麻上行直肠癌根治术（DIXON）。，术中探查见：腹腔内无腹水，腹膜无转移，肝脏未触及转移结节，肿瘤位于腹膜返折处，手术顺利，术后给予抑酸、抗感染、营养支持等治疗。术后病理（201413291），：（直肠）腺癌(中度分化),浸润溃疡型,体积7.5*4.5*2CM,部分侵穿纤维膜达脂肪组织，距底部切除面甚近，局部侵达浆膜，浆膜面未查见癌。 双端切线及另送“近切线”、“远切线”未查见癌。 呈一站（6/10个）淋巴结癌转移。 中央组（7个）淋巴结未查见癌。 ，癌组织免疫组化染色示：TS（-）、SYN（-）。术后给予3周期化疗，，方案为：奥沙利铂200MG D1，亚叶酸钙0.3G+替加氟1.0G D2-D6，同时给与升白细胞、护肝、止吐、免疫增强治疗，过程顺利，自下次出院以来，患者一般情况保持良好；无发热，无恶心、呕吐，无反酸、嗳气，无明显进食不适；未现明显腹痛、腹胀。现患者为行复查并辅助化疗而再来我院就诊，门诊以“直肠癌术后”收入院。   患者精神好，食欲、饮食好，睡眠可；肛门排气排便存在。无体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 6, "end_pos": 9}, {"label_type": "手术", "overlap": 0, "start_pos": 25, "end_pos": 38}, {"end_pos": 48, "label_type": "解剖部位", "overlap": 0, "start_pos": 46}, {"end_pos": 51, "label_type": "解剖部位", "overlap": 0, "start_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 53, "end_pos": 54}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 73, "end_pos": 74}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 120, "end_pos": 138}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 216, "end_pos": 229}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 233, "end_pos": 243}, {"end_pos": 293, "label_type": "药物", "overlap": 0, "start_pos": 289}, {"end_pos": 306, "label_type": "药物", "overlap": 0, "start_pos": 302}, {"end_pos": 314, "label_type": "药物", "overlap": 0, "start_pos": 311}, {"end_pos": 336, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}, {"end_pos": 402, "label_type": "解剖部位", "overlap": 0, "start_pos": 401}, {"end_pos": 405, "label_type": "解剖部位", "overlap": 0, "start_pos": 404}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 431, "end_pos": 436}]}
{"originalText": "，缘于入院前6月余于我院诊为胃窦癌，于2016年02月26日在全麻上行腹腔镜上根治性远端胃切除术，术顺，，病理：（远端胃），：胃窦溃疡型低黏附性癌（印戒细胞癌为主，部分为未分化癌及黏液腺癌），侵犯脉管及神经组织，脉管内见癌栓，侵出浆膜层。手术标本下切端、上切端及另送（下切端）均未见癌浸润。找到小弯侧淋巴结0/8个，幽门下淋巴结0/1个，幽门上淋巴结4/9个，另送（第1组）淋巴结0/1个,（第7组）淋巴结0/1个，（第8组）淋巴结0/6个，（第9组）淋巴结0/1个，见癌转移。另送（第12组淋巴结）镜上为脂肪、纤维及脉管组织。（小肠），：送检小肠组织，未见癌浸润。，免疫组化染色结果：KI67（70%阳性），P53（-），P170（+++），GSTπ（-），EGFR（+++），5-FU（+），HER-2（-）。术后予制酸、营养支持等治疗好转后出院。术后予2016-04-12、2016.5.6、2016.5.30、2016.6.23、2016.8.9行“洛铂D150MGIVGTT+卡培他滨D2-141500MGPOBID”化疗6次，辅以保肝、保胃、止吐抗肿瘤治疗。此次入院前2天因无明显诱因出现中下腹绞痛，伴恶心，无呕吐，无畏冷、寒战，无腹胀、腹痛等其他不适，求诊我科，门诊拟胃窦癌术后化疗后，腹痛待查收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"end_pos": 48, "label_type": "手术", "overlap": 0, "start_pos": 35}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 63, "end_pos": 95}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 158}, {"end_pos": 175, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 182, "end_pos": 190}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 195, "end_pos": 203}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 208, "end_pos": 216}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 221, "end_pos": 229}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 242, "end_pos": 249}, {"end_pos": 267, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"end_pos": 274, "label_type": "解剖部位", "overlap": 0, "start_pos": 272}, {"end_pos": 431, "label_type": "药物", "overlap": 0, "start_pos": 429}, {"end_pos": 447, "label_type": "药物", "overlap": 0, "start_pos": 443}, {"end_pos": 473, "label_type": "解剖部位", "overlap": 0, "start_pos": 472}, {"end_pos": 476, "label_type": "解剖部位", "overlap": 0, "start_pos": 475}, {"end_pos": 503, "label_type": "解剖部位", "overlap": 0, "start_pos": 500}, {"end_pos": 523, "label_type": "解剖部位", "overlap": 0, "start_pos": 522}, {"end_pos": 526, "label_type": "解剖部位", "overlap": 0, "start_pos": 525}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 541, "end_pos": 546}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 550, "end_pos": 554}, {"end_pos": 576, "label_type": "解剖部位", "overlap": 0, "start_pos": 575}, {"end_pos": 579, "label_type": "解剖部位", "overlap": 0, "start_pos": 578}]}
{"originalText": "，患者于2015年5月26日在我院行腹腔镜检查+卵巢肿瘤活检术。，术后病理学检查报告：(左卵巢)破碎卵巢组织见部分异型性腺体和分化较低的片巢状细胞，局灶伴鳞状下皮化生，符合恶性肿瘤，考虑为腺癌。于5月30日给予TP方案化疗（紫杉醇（特素）240MG静脉滴注，顺铂90MG腹腔灌注）。于７月３日在全麻上经腹行全子宫切除术+两侧附件切除术+大网膜部分切除术+阑尾切除术。，术后病检示：1、（左卵巢）中-低分化浆液性乳头状腺癌，同侧输卵管未见癌累及。右卵巢见癌转移，右输卵管、子宫未见癌转移。阑尾未见癌转移。大网膜见癌转移。2、子宫平滑肌瘤。于７月１３日行紫杉醇（泰素）240MG静脉滴注＋顺铂90MG灌腹，8月14日行紫杉醇（泰素）240MG+顺铂100MG静脉滴注化疗，9月19日、10月21日、11月19日、12月19日行紫杉醇（泰素）240MG+奥沙利铂200MG化疗。化疗过程中，患者有恶心、呕吐、脱发等症状，化疗结束后缓解。入院前20天，患者于我科门诊复查，门诊给予“华蟾素片”治疗，自诉用药后患者感腹痛、腹胀，尚能忍受，无腹泻、恶心、呕吐等。因腹痛持续，患者遂于今日来院。门诊以“第六次化疗后、卵巢浆液性乳头状腺癌IIIC期”收住入院。\\U0004   患者本次发病以来，食欲正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，体重无明显变化。", "entities": [{"end_pos": 31, "label_type": "手术", "overlap": 0, "start_pos": 18}, {"end_pos": 47, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"end_pos": 52, "label_type": "解剖部位", "overlap": 0, "start_pos": 50}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 86, "end_pos": 90}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 94, "end_pos": 96}, {"end_pos": 115, "label_type": "药物", "overlap": 0, "start_pos": 112}, {"end_pos": 118, "label_type": "药物", "overlap": 0, "start_pos": 116}, {"end_pos": 131, "label_type": "药物", "overlap": 0, "start_pos": 129}, {"end_pos": 137, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"label_type": "手术", "overlap": 0, "start_pos": 150, "end_pos": 182}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 192, "end_pos": 210}, {"end_pos": 216, "label_type": "解剖部位", "overlap": 0, "start_pos": 213}, {"end_pos": 225, "label_type": "解剖部位", "overlap": 0, "start_pos": 222}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 230}, {"end_pos": 237, "label_type": "解剖部位", "overlap": 0, "start_pos": 235}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 243}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 261, "end_pos": 267}, {"end_pos": 278, "label_type": "药物", "overlap": 0, "start_pos": 275}, {"end_pos": 281, "label_type": "药物", "overlap": 0, "start_pos": 279}, {"end_pos": 294, "label_type": "药物", "overlap": 0, "start_pos": 292}, {"end_pos": 300, "label_type": "解剖部位", "overlap": 0, "start_pos": 299}, {"end_pos": 310, "label_type": "药物", "overlap": 0, "start_pos": 307}, {"end_pos": 313, "label_type": "药物", "overlap": 0, "start_pos": 311}, {"end_pos": 322, "label_type": "药物", "overlap": 0, "start_pos": 320}, {"end_pos": 364, "label_type": "药物", "overlap": 0, "start_pos": 361}, {"end_pos": 367, "label_type": "药物", "overlap": 0, "start_pos": 365}, {"end_pos": 378, "label_type": "药物", "overlap": 0, "start_pos": 374}, {"end_pos": 441, "label_type": "药物", "overlap": 0, "start_pos": 437}, {"end_pos": 454, "label_type": "解剖部位", "overlap": 0, "start_pos": 453}, {"end_pos": 457, "label_type": "解剖部位", "overlap": 0, "start_pos": 456}, {"end_pos": 466, "label_type": "解剖部位", "overlap": 0, "start_pos": 465}, {"end_pos": 477, "label_type": "解剖部位", "overlap": 0, "start_pos": 476}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 501, "end_pos": 516}]}
{"originalText": "，2016.1.29患者以“阴道不规则出血半年”为主诉首次入院，我院病理科会诊为浸润性低分化鳞状细胞癌，诊断宫颈鳞癌IIB期，，术前予TP化疗2周期：紫杉醇480MG、顺铂220MG，检查无手术禁忌症，2016-03-18在全麻上行III型全子宫及及两附件两附件切除及盆腔淋巴结清扫术及腹主动脉旁淋巴结活检术，术顺，，术后病理回报：盆腔及腹主动脉淋巴结未见转移癌。宫旁及子宫动脉未见癌。全子宫及两附件示宫颈及宫体上段肌层（均大于1/2肌层）中见异型细胞呈小巢团状排列，病变诊断为低分化癌，符合腺鳞癌，可见脉管癌栓，阴道穹窿可见个别散在的癌细胞，检查现为术后放疗入院。自起病以来，患者精神、睡眠可，食欲如常，大小便正常，体重无上降。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 40, "end_pos": 51}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 54, "end_pos": 62}, {"end_pos": 78, "label_type": "药物", "overlap": 0, "start_pos": 75}, {"end_pos": 86, "label_type": "药物", "overlap": 0, "start_pos": 84}, {"label_type": "手术", "overlap": 0, "start_pos": 116, "end_pos": 154}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"end_pos": 176, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"end_pos": 196, "label_type": "解剖部位", "overlap": 0, "start_pos": 194}, {"end_pos": 200, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}, {"end_pos": 203, "label_type": "解剖部位", "overlap": 0, "start_pos": 201}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 239, "end_pos": 243}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 246, "end_pos": 249}, {"end_pos": 261, "label_type": "解剖部位", "overlap": 0, "start_pos": 257}]}
{"originalText": "2014-08因食纳差，检查发现下腹包块，2014-09-03在全麻上行剖腹探查术，术中见肿瘤位于十二指肠，约10*11*10CM，质硬，与周围组织粘连致密无法切除，行胃空肠吻合术（未见手术记录）。术后病理：（十二指肠肿物）梭形细胞肿瘤，瘤细胞细胞增生活跃，核分裂多见，大于10/10HPF，CD117(3+),CD34(-),DOG-1(3+),CK(-),S-100(-),SMA(-),KI67(+25%)。术后口服伊马替尼（**产）治疗至今。患者目前乏力，近1月出现黑便，一般情况尚可。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"end_pos": 41, "label_type": "手术", "overlap": 0, "start_pos": 36}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 49}, {"end_pos": 90, "label_type": "手术", "overlap": 0, "start_pos": 84}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 104, "end_pos": 118}, {"end_pos": 215, "label_type": "药物", "overlap": 0, "start_pos": 211}]}
{"originalText": "，者约于1个月前因“结肠恶性肿瘤”于2013-04-28日在全麻上行左半结肠切除术。手术过程顺利，术后给予抗感染及营养支持治疗，患者恢复好。，术后病理：4976.2013 结肠腺癌（中低分化），浸润溃疡型，面积5.5*5.5CM，局部粘液腺癌图像，侵达浆膜脂肪组织。双端切线未查见癌，呈肠壁一站（2/8个）淋巴癌转移。肠壁二站（2个）、中间组（4个）淋巴结未查见癌。，免疫组化染色示癌组织：ERCC1(+),TS（-）。术后分期 PT4N1M0 III期，术后给予化疗治疗，，方案为：奥沙利铂200MG D1+右亚叶酸钙50 MGD2-6 +氟尿苷1000MG D2-6 静滴。    院外期间，患者无发热，无腹痛腹胀不适，大便通畅。现患者为行复查化疗来我科就诊，以“结肠癌术后”收入院。    病人自下次出院以来，神志清，精神可，饮食可，大、小便正常，体重未见明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 16}, {"end_pos": 41, "label_type": "手术", "overlap": 0, "start_pos": 34}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 85, "end_pos": 102}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 117, "end_pos": 121}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 143, "end_pos": 144}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 159, "end_pos": 178}, {"end_pos": 246, "label_type": "药物", "overlap": 0, "start_pos": 242}, {"end_pos": 260, "label_type": "药物", "overlap": 0, "start_pos": 255}, {"end_pos": 274, "label_type": "药物", "overlap": 0, "start_pos": 271}, {"end_pos": 306, "label_type": "解剖部位", "overlap": 0, "start_pos": 305}, {"end_pos": 308, "label_type": "解剖部位", "overlap": 0, "start_pos": 307}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 334, "end_pos": 339}]}
{"originalText": "，患者2015-09-15因“腹痛伴大便性状习惯改变1月”就诊于我院结直肠科，外院肠镜检查提示结肠肝曲环周肿物，肠镜不能通过，活检病理提示腺癌，遂2015-09-18行全麻上“左半结肠切除术”，过程顺利，，术后病理示：镜检为中分化腺癌，癌组织浸润至肠壁浆膜上层；未见明确脉管内癌栓及神经束侵犯；各切缘未见癌；淋巴结2/10见腺癌转移，，免疫组化：ER（-），ERCC1（+），MSH2（+），MSH6（+），MLH1（+），PMS2（+），KI67（40%+），，分期为：PT3N1BM0IIIB期，术后恢复可。2015-10-15于我科行第1程XELOX方案术后辅助化疗，过程顺利，现患者为行进一步治疗入我科。患者3周来，无发热，胃纳可，睡眠一般，大小便正常，体重无明显上降。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 15}, {"end_pos": 37, "label_type": "解剖部位", "overlap": 0, "start_pos": 34}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 47, "end_pos": 51}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 69, "end_pos": 71}, {"end_pos": 95, "label_type": "手术", "overlap": 0, "start_pos": 88}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 112, "end_pos": 117}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 124, "end_pos": 125}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 162, "end_pos": 164}, {"end_pos": 317, "label_type": "解剖部位", "overlap": 0, "start_pos": 316}]}
{"originalText": "，缘于入院前半个月前我院行胃镜检查提示：食管炎（A级），贲门息肉样隆起，共双枚，大小分别为1.0CM、1.5CM，慢性萎缩性胃炎，十二指肠球部溃疡（S2期），十二指肠球部炎症。，胃镜病理：（十二指肠降部）间质中量慢性炎症细胞及少量急性炎症细胞浸润，灶性腺体呈腺瘤样增生。（贲门）腺下皮轻度肠化，其上见胃固有腺，间质大量急、慢性炎症细胞浸润。，肠镜检查示：结肠多发息肉，直径0.6CM-1CM。予内镜上切除部分小息肉。，病理：（肝曲）肠管状腺瘤，伴腺下皮低级别下皮内瘤变，（横结肠）肠管状腺瘤，伴腺下皮低级别下皮内瘤变（中度不典型增生）。无腹痛、腹胀、腹泻、呕血、排黑便、排血便、里急后重，无恶心、呕吐，无反酸、嗳气、胸骨后烧灼感，无消瘦、食欲减退等。今为求进一步诊治求诊我院，门诊拟“胃肠息肉”收住院。近半个月以来，精神、睡眠、食欲尚可，大小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 20, "end_pos": 27}, {"end_pos": 30, "label_type": "解剖部位", "overlap": 0, "start_pos": 28}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 57, "end_pos": 64}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 65, "end_pos": 78}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 79, "end_pos": 87}, {"end_pos": 101, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 136}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 150}, {"end_pos": 179, "label_type": "解剖部位", "overlap": 0, "start_pos": 177}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 212, "end_pos": 221}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 223, "end_pos": 234}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 235, "end_pos": 245}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 247, "end_pos": 267}, {"end_pos": 270, "label_type": "解剖部位", "overlap": 0, "start_pos": 269}, {"end_pos": 273, "label_type": "解剖部位", "overlap": 0, "start_pos": 272}, {"end_pos": 276, "label_type": "解剖部位", "overlap": 0, "start_pos": 275}, {"end_pos": 311, "label_type": "解剖部位", "overlap": 0, "start_pos": 308}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 342, "end_pos": 346}]}
{"originalText": "，缘于入院前39个月因反复左上腹痛于我院行腹部B超示：回盲部壁增厚,癌可能。并于2010.11.1于我院肿瘤外科在全麻上行左半结肠切除术,盲肠部可及一大约3CM*4CM肿物，侵及浆膜层。术后病理（201026573），示：(左半结肠)大肠回盲部结外粘膜相关淋巴组织边缘区B细胞淋巴瘤(MALT),侵犯浆膜层，手术标本双切端未见肿瘤。找到肠周淋巴结1/19个见淋巴瘤细胞浸润。，免疫组化：CD3（-），CD5（-），CD10（-），CD20（+++），CD21（-），CD23（-），CD30（-），CYCLIND1（-），KI67（10%），BCL-2（+++），CD56（-）。术后恢复可，切口II/甲愈合。术后进一步查胸部+全腹CT未见明显复发转移征象，术后先后予CHOP（环磷酰胺1100MGIV，D1+表柔比星90MGIV，D1+长春新碱2MG，IV，D1+泼尼松10MGTID，D1-D14）3周方案全身化疗4周期，辅以保肝、止吐、调节免疫力等处理，化疗过程较顺利。最后一次化疗2011年1月27日。此后定期（3个月）复查胸部+全腹CT增强未见复发转移征象，血清β2微球蛋白阴性。今无腹痛、腹胀、腹泻，无恶心、呕吐等不适，今为求复查再次就诊我院，门诊拟回盲部淋巴瘤术后收住院。本次发病以来，精神、睡眠、食欲可，大小便如常，体重无骤变。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "影像检查", "overlap": 0, "start_pos": 21, "end_pos": 25}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 27, "end_pos": 30}, {"end_pos": 68, "label_type": "手术", "overlap": 0, "start_pos": 61}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 69}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 111, "end_pos": 147}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"label_type": "影像检查", "overlap": 0, "start_pos": 311, "end_pos": 318}, {"end_pos": 343, "label_type": "药物", "overlap": 0, "start_pos": 339}, {"end_pos": 359, "label_type": "药物", "overlap": 0, "start_pos": 355}, {"end_pos": 373, "label_type": "药物", "overlap": 0, "start_pos": 369}, {"end_pos": 386, "label_type": "药物", "overlap": 0, "start_pos": 383}, {"end_pos": 417, "label_type": "解剖部位", "overlap": 0, "start_pos": 416}, {"label_type": "影像检查", "overlap": 0, "start_pos": 466, "end_pos": 473}, {"end_pos": 498, "label_type": "解剖部位", "overlap": 0, "start_pos": 497}, {"end_pos": 501, "label_type": "解剖部位", "overlap": 0, "start_pos": 500}, {"end_pos": 504, "label_type": "解剖部位", "overlap": 0, "start_pos": 503}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 531, "end_pos": 539}]}
{"originalText": "，缘于入院前3月余前于我院诊为胃癌，于2014-12-12在全麻上行腹腔镜上根治性远端胃大部切除术，术顺。术后病理示（胃大部），：胃体大弯侧溃疡型低分化腺癌，侵及浆膜层，侵犯神经，手术标本下、上双切端及另送（下切端）、（上切端）均未见癌浸润。找到小弯淋巴结0/10个，大弯淋巴结2/8个，幽门下淋巴结0/2个，幽门上淋巴结0/2个，及另送的（第一组）淋巴结0/1个，（第七组）淋巴结0/5个，（第八组）淋巴结0/1个，（第十二组）淋巴结0/3个，见癌转移。（第九组），：送检脂肪、纤维及神经组织。术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。患者于2015-01-05行“奥沙利铂（齐沙）200MGIVGTT+替吉奥60MGPOD1-14。”化疗方案治疗1周期，辅以止吐、制酸、保肝等对症支持治疗，患者口服替吉奥时出现皮肤瘙痒、皮疹等不适，2015-01-24行“替加氟3.6G泵入+奥沙利铂130MGIVGTT+亚叶酸钙300MGIVGTT”方案化疗，2015-02-11，2015-02-28予“替加氟3.6G泵入+奥沙利铂130MGIVGTT+亚叶酸钙300MGIVGTT”方案化疗辅以止吐、保肝、制酸等处理。今为行第5周期化疗治疗，再次就诊我院，门诊拟胃癌术后收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 15, "end_pos": 17}, {"end_pos": 49, "label_type": "手术", "overlap": 0, "start_pos": 34}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 65, "end_pos": 78}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"end_pos": 150, "label_type": "解剖部位", "overlap": 0, "start_pos": 144}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 170, "end_pos": 178}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 183, "end_pos": 191}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 196, "end_pos": 204}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 209, "end_pos": 218}, {"end_pos": 296, "label_type": "药物", "overlap": 0, "start_pos": 292}, {"end_pos": 299, "label_type": "药物", "overlap": 0, "start_pos": 297}, {"end_pos": 314, "label_type": "药物", "overlap": 0, "start_pos": 311}, {"end_pos": 362, "label_type": "药物", "overlap": 0, "start_pos": 359}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 370, "end_pos": 372}, {"end_pos": 391, "label_type": "药物", "overlap": 0, "start_pos": 388}, {"end_pos": 402, "label_type": "药物", "overlap": 0, "start_pos": 398}, {"end_pos": 417, "label_type": "药物", "overlap": 0, "start_pos": 413}, {"end_pos": 459, "label_type": "药物", "overlap": 0, "start_pos": 456}, {"end_pos": 470, "label_type": "药物", "overlap": 0, "start_pos": 466}, {"end_pos": 485, "label_type": "药物", "overlap": 0, "start_pos": 481}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 506, "end_pos": 507}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 536, "end_pos": 540}, {"end_pos": 562, "label_type": "解剖部位", "overlap": 0, "start_pos": 561}, {"end_pos": 565, "label_type": "解剖部位", "overlap": 0, "start_pos": 564}]}
{"originalText": "，患者2014年3月无明显诱因上出现中下腹疼痛，较剧烈，每次持续2-3分钟，不伴放射痛，有反酸嗳气，患者食欲欠佳，进食油腻食物后即感恶心，无腹胀腹泻，无呕血黑便。于2014-4-1行PET-CT考虑为胃窦部MT伴胃周淋巴结转移；脂肪肝；肝左后叶上段及两肾囊肿；左肾小结石；2014-04-02在我院全麻上行胃癌根治术，毕II式远端胃。术中见腹腔无腹水，肝脏、腹盆腔大网膜无异常。胃窦部小弯侧直径2CM增厚区，未浸润浆膜，胃周围可见肝动脉旁3CM肿瘤结节，淋巴结明显肿大。，病理：(远端胃)下皮性恶性肿瘤，部分区为神经内分泌癌(G3，约占肿瘤体积40%)；部分为肉瘤样癌(约占肿瘤体积40%)；部分为管状腺癌，分化II级(LAUREN分型肠型，约占肿瘤组织20%)。癌组织浸润胃壁肌层。双切缘未见癌累及。检出大弯侧淋巴结8枚，均未见癌转移(0/8)；检出小弯侧淋巴结19枚，其中5枚见癌转移(5/19)，另见癌结节1枚；检出幽门上淋巴结12枚，其中3枚见癌转移(3/12)。免疫组化(2014-N3491)，:TP(60%+),TS(20%+),B-TUBULIN(30%+),KI67(60%+),TOPII-A(40%+),ERCC-1(-),C-MET(-),HER-2(0),CK广(神经内分泌癌及肠型腺癌区域100%++,肉瘤样癌区域约10%+),SYN(30%++),CHG(30%++),CD56(部分+)。 手术过程顺利。术后恢复良好。患者术后分期PT2N3M0 IIIA期，有术后辅助化疗指征，考虑患者术后病理提示部分神经内分泌癌、部分肉瘤样癌、部分管状腺癌，拟三药联合方案，于2014.5.12、2014.6.2、2014.6.23、2014.7.15行第1-4次EOX方案术后辅助化疗，，计划用药：表柔比星 50MG/M2，奥沙利铂 130MG/M2，希罗达 1000MG/M2 BID D1-14，，计算用药：表柔比星 76.605MG D1，奥沙利铂 199.173MG D1，希罗达 1532.1MG/M2 BID D1-14，，实际用药：表柔比星100MG D1，奥沙利铂 150MG D1，希罗达 1500MG BID D1-14 Q3W，期间于2014.7.15复查腹部CT未见明确复发转移灶。患者化疗耐受可，今日为行第5次辅助化疗治疗入院。患者患病以来，精神可，夜眠可，二便无殊，近期体重稳定。", "entities": [{"end_pos": 21, "label_type": "解剖部位", "overlap": 0, "start_pos": 18}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"label_type": "影像检查", "overlap": 0, "start_pos": 91, "end_pos": 97}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 100, "end_pos": 113}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 114, "end_pos": 117}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 118, "end_pos": 129}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 130, "end_pos": 135}, {"label_type": "手术", "overlap": 0, "start_pos": 153, "end_pos": 166}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"end_pos": 178, "label_type": "解剖部位", "overlap": 0, "start_pos": 176}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 179, "end_pos": 182}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 210}, {"end_pos": 218, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 239, "end_pos": 331}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 337, "end_pos": 338}, {"end_pos": 359, "label_type": "解剖部位", "overlap": 0, "start_pos": 353}, {"end_pos": 382, "label_type": "解剖部位", "overlap": 0, "start_pos": 376}, {"end_pos": 417, "label_type": "解剖部位", "overlap": 0, "start_pos": 411}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 667, "end_pos": 673}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 674, "end_pos": 680}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 681, "end_pos": 687}, {"end_pos": 763, "label_type": "药物", "overlap": 0, "start_pos": 759}, {"end_pos": 776, "label_type": "药物", "overlap": 0, "start_pos": 772}, {"end_pos": 789, "label_type": "药物", "overlap": 0, "start_pos": 786}, {"end_pos": 820, "label_type": "药物", "overlap": 0, "start_pos": 816}, {"end_pos": 837, "label_type": "药物", "overlap": 0, "start_pos": 833}, {"end_pos": 854, "label_type": "药物", "overlap": 0, "start_pos": 851}, {"end_pos": 887, "label_type": "药物", "overlap": 0, "start_pos": 883}, {"end_pos": 900, "label_type": "药物", "overlap": 0, "start_pos": 896}, {"end_pos": 913, "label_type": "药物", "overlap": 0, "start_pos": 910}, {"label_type": "影像检查", "overlap": 0, "start_pos": 949, "end_pos": 953}]}
{"originalText": "，缘于入院前6月余于我院诊为胃窦癌，于2016-6-14在全麻上行腹腔镜上根治性远端胃大部切除术。，术中见：腹腔镜探查见腹腔内无明显腹水，盆腔、腹壁、大网膜未见明显转移结节，肝脏质地大小正常，未见明显肿物，胆囊无肿大。胃窦幽门管可见病灶，侵及浆膜层，侵及部分肝脏，侵及部分胰腺及横结肠系膜，周围可见大量肿大淋巴结，最大约1.5×1㎝，考虑为“胃窦癌伴出血伴肝脏、胰腺受侵”。术后病理（201620266）示（远端胃），：胃窦浸润型管状腺癌II-III级，侵出浆膜层，侵犯肝被膜至肝实质。手术标本下、上切端及另送（下切端）均未见癌浸润。找到小弯淋巴结0/7个，幽门下淋巴结1/4个，幽门上淋巴结2/8个，见癌转移。，免疫组化：KI67（50%+），CK8（++），CK7（-），CK20（++），CD56（-），HER-2（-），术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。术后分别于2016-09-04、2016-10-12、2016-11-07行乐沙定150MGIVGTTD1+替吉奥40MGPOBIDD1-14方案化疗，此次为行第4次化疗就诊我院，门诊拟胃窦癌术后化疗收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"end_pos": 48, "label_type": "手术", "overlap": 0, "start_pos": 33}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 62, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 67, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 69}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 72, "end_pos": 73}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 105, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"end_pos": 114, "label_type": "解剖部位", "overlap": 0, "start_pos": 109}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 136}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 139, "end_pos": 142}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 171, "end_pos": 185}, {"end_pos": 207, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 210, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 235, "end_pos": 236}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 239, "end_pos": 242}, {"end_pos": 274, "label_type": "解剖部位", "overlap": 0, "start_pos": 269}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 279}, {"end_pos": 296, "label_type": "解剖部位", "overlap": 0, "start_pos": 290}, {"end_pos": 434, "label_type": "药物", "overlap": 0, "start_pos": 430}, {"end_pos": 450, "label_type": "药物", "overlap": 0, "start_pos": 447}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 486, "end_pos": 491}, {"end_pos": 515, "label_type": "解剖部位", "overlap": 0, "start_pos": 514}, {"end_pos": 518, "label_type": "解剖部位", "overlap": 0, "start_pos": 517}]}
{"originalText": "，患者于2016-10-12在全麻上行\\\"胃癌根治术\\\"（远端胃切除术），，术后病理回报:“（胃大体）镜检为胃低粘附性癌，符合低分化腺癌，LAUREN，分型：弥漫型，癌组织浸润至胃壁浆膜上层，可见脉管内癌栓及神经束侵犯；网膜组织未见癌。淋巴结46枚，4枚见癌。（远、近切缘）未见癌”。2016-11-11，2016-12-05，2016-12-28已行SOX方案化疗3程，现为行上一程术后辅助化疗收入我科。患者目前无恶心、呕吐，无腹泻、腹胀，精神尚可，食欲一般，大小便正常，身体减轻4KG。", "entities": [{"end_pos": 26, "label_type": "手术", "overlap": 0, "start_pos": 21}, {"end_pos": 35, "label_type": "手术", "overlap": 0, "start_pos": 29}, {"end_pos": 48, "label_type": "解剖部位", "overlap": 0, "start_pos": 47}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 54, "end_pos": 60}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 63, "end_pos": 68}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 89, "end_pos": 90}, {"end_pos": 216, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"end_pos": 219, "label_type": "解剖部位", "overlap": 0, "start_pos": 218}]}
{"originalText": "，患者于2015年初患者出现呕吐、呕吐血性胃内容物，，外院查胃镜示：胃窦癌伴胃潴留，考虑胃癌，于2015-02-09于外院行“胃癌根治术”，病理提示低分化腺癌，，术后病理诊断：PT4N1M0（我院会诊病理切片示（胃窦）镜检为低分化腺癌，浸润胃壁全层至浆膜外脂肪组织。送检双切缘未见癌。送检癌结节一枚，淋巴结4枚，1/4见癌转移。）。术后于我院复查CT示未见复发转移。于2015-03及04月、2015-5-4给予SOX方案化疗3程顺利，无不适。今为求进一步诊治来我院。患者发病以来,有呕吐等症状。精神不佳,饮食睡眠佳,大小便正常，体重无减轻。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 21, "end_pos": 22}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 34, "end_pos": 41}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 44, "end_pos": 46}, {"end_pos": 68, "label_type": "手术", "overlap": 0, "start_pos": 63}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 74, "end_pos": 79}, {"end_pos": 108, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 112, "end_pos": 117}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 120, "end_pos": 121}, {"label_type": "影像检查", "overlap": 0, "start_pos": 173, "end_pos": 175}]}
{"originalText": "，缘于入院前1月余于我院诊为肝曲结肠粘液腺癌侵犯十二指肠及肝门区，于2016-08-03在全麻上行剖腹探查+胃空肠吻合+升结肠-横结肠侧侧吻合术，，术中见:腹腔内无明显腹水，肝脏表面光滑，盆腔、肠系膜、网膜表面未见明显结节，升结肠肠管略扩张，结肠肝曲可触及一大小约8*7CM肿物，质硬，侵出浆膜层，并向后侵犯包绕十二指肠降部、水平部，向下侵犯肝十二指肠韧带上方，肿物部分与后腹膜粘连致密固定无法分离。遂行下术，术顺，术后予补液、抗感染、营养支持等治疗。，术后病理：(左结肠动脉旁淋巴结)，：送检淋巴结1个见粘液腺癌转移，结合免疫组化结果，考虑消化系统来源。，免疫组化结果：CK7（-），CK20（+++），PAX-8（-），CDX2（+++）。并于2016-08-24予“乐沙定100MGIVGTTQDD1+卡培他滨1500MGPOBID×14天”方案行第1周期化疗，辅以保胃、保护粘膜、止吐及营养支持处理。今为行上一周期化疗，就诊我院门诊，门诊拟“升结肠癌术后化疗”收住入院，病程中精神、饮食、睡眠尚可，大小便正常，体重较前上降2KG。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 32}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 49, "end_pos": 72}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 96, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 97, "end_pos": 98}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 112}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 156, "end_pos": 166}, {"end_pos": 178, "label_type": "解剖部位", "overlap": 0, "start_pos": 171}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 187, "end_pos": 188}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 255, "end_pos": 257}, {"end_pos": 339, "label_type": "药物", "overlap": 0, "start_pos": 336}, {"end_pos": 358, "label_type": "药物", "overlap": 0, "start_pos": 354}, {"end_pos": 388, "label_type": "解剖部位", "overlap": 0, "start_pos": 387}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 425, "end_pos": 433}]}
{"originalText": "，患者因“反复餐后腹胀、恶心1月余”于2015-07-03入住我院，外院未经提示胃癌，于2015-07-16在全麻上行胃癌姑息切除术（远端胃大切），，术中探查见：小网膜囊可见少量硬结，盆底、横结肠、肝脏、胰腺、脾脏等未见种植转移结节，肿物位于胃窦，大小约6*8CM，突破浆膜，侵犯周围结缔组织，遂行胃癌姑息切除术，术后预防感染支持对症等处理，恢复好，切口甲级愈合。术后病理示1（胃大体）镜检为中至低分化腺癌，部分为粘液腺癌（LAUREN，分型：混合型），癌组织浸润至胃壁浆膜层；可见脉管内癌栓及神经束侵犯；网膜组织中见淋巴结2枚，2/2见腺癌转移。2（第1组淋巴结）5枚，4/5见腺癌转移。3（第3组淋巴结）4枚，3/4见腺癌转移。4（第4组淋巴结）11枚，7/11见腺癌转移。5（第5组淋巴结）3枚，3/3见腺癌转移。6（第6组淋巴结）镜上为脂肪结缔组织，未见癌。7（第7组淋巴结）3枚，3/3见腺癌转移。8（第8组淋巴结）2枚，2/2见腺癌转移。9（第12A组淋巴结）镜上为脂肪结缔组织，未见癌。10（近切缘）未见癌。11（远切缘）未见癌。，免疫组化：VEGF（+），HER-2（0）。，原位杂交：EBERS（-）。术后于2015-09-17、2015-10-15、2015-11-12予以SOX（S-1 60MG，BID×D1-14+OXA190MG×D1）方案化疗3程。今为求进一步诊治来我院。患者发病以来,无腹痛、恶心、呕吐、反酸、嗳气。精神佳,饮食睡眠佳,大小便正常，体重无减轻。", "entities": [{"end_pos": 10, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 40, "end_pos": 42}, {"label_type": "手术", "overlap": 0, "start_pos": 59, "end_pos": 73}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 92}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 101, "label_type": "解剖部位", "overlap": 0, "start_pos": 99}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 102}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 105}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 156, "label_type": "手术", "overlap": 0, "start_pos": 149}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 196, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 233, "end_pos": 234}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 269, "end_pos": 271}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 276, "end_pos": 282}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 290, "end_pos": 292}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 297, "end_pos": 303}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 311, "end_pos": 313}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 318, "end_pos": 324}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 334, "end_pos": 336}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 341, "end_pos": 347}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 355, "end_pos": 357}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 362, "end_pos": 368}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 385, "end_pos": 391}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 399, "end_pos": 401}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 406, "end_pos": 412}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 420, "end_pos": 422}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 427, "end_pos": 435}, {"end_pos": 554, "label_type": "药物", "overlap": 0, "start_pos": 551}, {"end_pos": 573, "label_type": "药物", "overlap": 0, "start_pos": 570}, {"end_pos": 610, "label_type": "解剖部位", "overlap": 0, "start_pos": 609}]}
{"originalText": "，缘于入院前20个月因“中下腹闷痛”就诊于我院，查胃镜提示胃窦溃疡，恶性待排，住胸外科于2012.05.21在全麻上行根治性远端胃大部切除＋毕Ｉ式吻合术，术中探查未见腹水，盆底、肝脏表面无转移性结节，肿瘤位于胃窦小弯侧，呈溃疡型，范围约4CMX3CM，侵及浆膜，另见小弯侧胃壁3枚米粒大小结节，，切除结节送术中冰冻示：平滑肌和小淋巴结2个，送检淋巴结呈反应性增生。手术顺利，术后病理（201214740），：(胃)，：胃窦小弯侧溃疡型管状腺癌II级，侵及浆膜层，侵犯神经组织，脉管内见癌栓。手术标本下、上切端及另送（下切端）均未见癌浸润。找到小弯淋巴结1/14个、大弯淋巴结1/18个、幽门下淋巴结1/2个、幽门上淋巴结1/9个及另送(贲门右)淋巴结0/3个、(胃右动脉旁)淋巴结0/7个、(脾动脉旁)淋巴结0/2个、(肝总动脉旁)淋巴结0/4个见癌转移，（201214606），：(胃壁结节)送检少量平滑肌组织及淋巴结二个，淋巴结反应性增生。术后予“5-FU7500MG泵入+CF300MG静滴D1-5+顺铂30MG静滴D1-5Q3W”化疗3周期及口服希罗达化疗2周期（具体不详），末次化疗时间2012.10。术后定期复查未见肿瘤复发转移。12，周前复查腹部B超：肝左叶实质性占位性病变，大小约27MM×26MM，，下消化道钡餐：吻合口区钡剂通过顺畅，两肺纹理增多增粗。遂就诊我科，查下腹部，CT：1、肝右内叶占位性病变，与2012-05-15旧片对比为新增病灶，考虑肝转移瘤，另肝内数个小囊肿，2、两肾多发囊肿，两肾小结石或钙化；CEA24.8NG/ML；CA199149.1U/ML。于2013.11.2、2013.11.16、2013.11.30予FOLFOX两周方案“奥沙利铂(艾恒)120MG静滴D1+亚叶酸钙300MG静滴D1、2+替加氟3G持续泵入44HD1Q2W”姑息性化疗3周期，过程顺利。后复查腹部CT平扫+，增强：1、胃大部切除术后，残胃充盈欠佳，吻合口区未见明显占位性病变。2、肝右内叶占位性病变，考虑肝转移瘤，与2013-10-31旧片对比较前明显减小，另肝内数个小囊肿。3、所摄入右侧肾下腺内侧肢增粗，部分略呈结节状，转移不能排除。4、两肾多发囊肿；两肾小结石或钙化。CER13.97NG/ML，CA12510.95U/ML。疗效评价为PR。于2013.12.16在基础麻醉上行超声引导上右肝肿块射频消融术，术顺，术后无腹痛、恶心、呕吐等不适。于2013.12.21、2013.01.04予原方案（FOLFOX两周方案）化疗第4、第5周期。目前患者无腹痛、恶心、呕吐，无纳差、乏力，无眼黄、尿黄、皮肤黄，今为进一步诊治，门诊拟“胃癌术后肝转移”收入我科。术后精神、睡眠、食欲尚可，大小便正常，体重无明显变化。", "entities": [{"end_pos": 15, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 29, "end_pos": 33}, {"end_pos": 41, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"label_type": "手术", "overlap": 0, "start_pos": 59, "end_pos": 76}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 83}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 133, "end_pos": 137}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 205, "end_pos": 206}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 209, "end_pos": 224}, {"end_pos": 276, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"end_pos": 287, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"end_pos": 299, "label_type": "解剖部位", "overlap": 0, "start_pos": 293}, {"end_pos": 310, "label_type": "解剖部位", "overlap": 0, "start_pos": 304}, {"end_pos": 325, "label_type": "解剖部位", "overlap": 0, "start_pos": 317}, {"end_pos": 340, "label_type": "解剖部位", "overlap": 0, "start_pos": 330}, {"end_pos": 354, "label_type": "解剖部位", "overlap": 0, "start_pos": 345}, {"end_pos": 369, "label_type": "解剖部位", "overlap": 0, "start_pos": 359}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 392, "end_pos": 393}, {"end_pos": 430, "label_type": "药物", "overlap": 0, "start_pos": 426}, {"end_pos": 441, "label_type": "药物", "overlap": 0, "start_pos": 439}, {"end_pos": 455, "label_type": "药物", "overlap": 0, "start_pos": 453}, {"end_pos": 480, "label_type": "药物", "overlap": 0, "start_pos": 477}, {"label_type": "影像检查", "overlap": 0, "start_pos": 528, "end_pos": 532}, {"end_pos": 536, "label_type": "解剖部位", "overlap": 0, "start_pos": 533}, {"label_type": "影像检查", "overlap": 0, "start_pos": 559, "end_pos": 565}, {"end_pos": 579, "label_type": "解剖部位", "overlap": 0, "start_pos": 577}, {"label_type": "影像检查", "overlap": 0, "start_pos": 593, "end_pos": 599}, {"end_pos": 606, "label_type": "解剖部位", "overlap": 0, "start_pos": 602}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 635, "end_pos": 639}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 651, "end_pos": 657}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 667, "end_pos": 670}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 680, "end_pos": 685}, {"end_pos": 743, "label_type": "药物", "overlap": 0, "start_pos": 739}, {"end_pos": 746, "label_type": "药物", "overlap": 0, "start_pos": 744}, {"end_pos": 761, "label_type": "药物", "overlap": 0, "start_pos": 757}, {"end_pos": 776, "label_type": "药物", "overlap": 0, "start_pos": 773}, {"label_type": "影像检查", "overlap": 0, "start_pos": 808, "end_pos": 818}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 821, "end_pos": 828}, {"end_pos": 831, "label_type": "解剖部位", "overlap": 0, "start_pos": 830}, {"end_pos": 856, "label_type": "解剖部位", "overlap": 0, "start_pos": 852}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 864, "end_pos": 868}, {"end_pos": 893, "label_type": "解剖部位", "overlap": 0, "start_pos": 892}, {"end_pos": 913, "label_type": "解剖部位", "overlap": 0, "start_pos": 905}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 933, "end_pos": 939}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 940, "end_pos": 948}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 949, "end_pos": 952}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 963, "end_pos": 968}, {"label_type": "手术", "overlap": 0, "start_pos": 1004, "end_pos": 1018}, {"end_pos": 1026, "label_type": "解剖部位", "overlap": 0, "start_pos": 1025}, {"end_pos": 1091, "label_type": "解剖部位", "overlap": 0, "start_pos": 1090}, {"end_pos": 1108, "label_type": "解剖部位", "overlap": 0, "start_pos": 1107}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 1129, "end_pos": 1136}]}
{"originalText": "，患者因“进食阻挡感1月余”于2017.10.23第1次入住我院，入院后完善相关辅助检查，CT检查示“考虑食管上段贲门CA可能性大，请结合内镜检查；肝多发囊肿；肝内钙化灶”，给予抑酸、保护胃黏膜、抗氧化等对症支持治疗，结合患者病史、胃镜检查、活检病理，诊断贲门腺癌明确，为行手术治疗于2017.10.25由消化科转入胸外1科。转科后完善相关术前检查，排除手术禁忌后，于2017.10.27全麻上行贲门癌根治术，术后病理（2017.10.31，病理号201725281），示：贲门腺癌（中度分化），浸润溃疡型，体积4*3.5*0.6CM，侵达浆膜；双端切线未查见癌；一组（1个）、二组（1个）、三组（4个）、“上段食管旁”（3个）、“贲门周围”（4个）、“胃右动脉旁”（8个）淋巴结未查见癌。，免疫组化染色示：CERBB-2（3+）、SYN（-）、β-TUBULIN-III少数（+）、 RRM1少数（+）、TOPOII多数（+）。术后给予雾化、化痰、抗感染、抑酸、止疼、补液、营养支持等治疗，患者术后恢复良好，经口进食未诉明显不适、病情平稳后出院。   患者自出院以来半流质饮食，偶有进食哽噎感，伴胸骨后烧灼感，无进食疼痛，无嗳气、呃逆，无声音嘶哑、饮食呛咳，无咳嗽、咳痰，无咯血，无胸痛、胸闷，无心悸，无恶心、呕吐，无腹痛、腹泻，今患者为求进一步诊治，再次来我院就诊，拟行全身化疗为主的肿瘤综合治疗，门诊以“贲门癌”收入院。   患者神志清，精神、睡眠好，半流质饮食，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "影像检查", "overlap": 0, "start_pos": 45, "end_pos": 47}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 53, "end_pos": 61}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 74, "end_pos": 79}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 80, "end_pos": 81}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 94, "end_pos": 95}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 128, "end_pos": 132}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 158, "end_pos": 159}, {"end_pos": 204, "label_type": "手术", "overlap": 0, "start_pos": 198}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 237, "end_pos": 253}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 304, "end_pos": 340}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 499, "end_pos": 501}, {"end_pos": 543, "label_type": "解剖部位", "overlap": 0, "start_pos": 542}, {"end_pos": 546, "label_type": "解剖部位", "overlap": 0, "start_pos": 545}, {"end_pos": 550, "label_type": "解剖部位", "overlap": 0, "start_pos": 549}, {"end_pos": 561, "label_type": "解剖部位", "overlap": 0, "start_pos": 560}, {"end_pos": 564, "label_type": "解剖部位", "overlap": 0, "start_pos": 563}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 605, "end_pos": 608}]}
{"originalText": "，缘于1月余前因“进行性吞咽困难伴疼痛半年，加重半个月”就诊我院，查胃镜示“食管癌（距门齿22CM）”，病理（，病理号：201334934）示“食管鳞状细胞癌II级”；，胸腹部CT示：1、食管下段管壁不规则增厚，符合食管癌改变，肿块与气管后壁分界不清，邻近食管下段周围多发肿大淋巴结，下腹部贲门周围一淋巴结轻度增大，2、两上肺少许慢性炎症；两侧胸腔少量积液，3、左侧甲状腺甲状腺占位性病变。考虑肿瘤较大，尚不适手术，予排除化疗禁忌症，于2013.11.15按“顺铂40MGD1-3+安素泰240MGD2”行新辅助化疗，辅以止吐、制酸、保胃、抗过敏等治疗，化疗过程顺利，无诉特殊不适。今为行化疗再次入院。近来，精神、睡眠、饮食一般，大小便如常，体重无明显增减。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 38, "end_pos": 41}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 72, "end_pos": 82}, {"label_type": "影像检查", "overlap": 0, "start_pos": 85, "end_pos": 90}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 94, "end_pos": 98}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 108, "end_pos": 111}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 117, "end_pos": 119}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 128, "end_pos": 141}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 142, "end_pos": 153}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"end_pos": 186, "label_type": "解剖部位", "overlap": 0, "start_pos": 181}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"end_pos": 232, "label_type": "药物", "overlap": 0, "start_pos": 230}, {"end_pos": 244, "label_type": "药物", "overlap": 0, "start_pos": 241}, {"end_pos": 269, "label_type": "解剖部位", "overlap": 0, "start_pos": 268}]}
{"originalText": "，缘于入院前2月于我院查胃镜示：1.食管癌；2.慢性萎缩性胃炎；3.胃角溃疡(S2期)，，胃镜病理：(门齿30CM)，：送检食管粘膜，鳞状下皮高级别下皮内瘤变，部分癌变为鳞状。胸部CT平扫+，增强示：主动脉弓上缘水平至右上上肺静脉水平食管壁不规则明显增厚，考虑食管癌，侵犯外膜可能，伴纵膈及所摄入右锁骨窝区、肝胃间隙多发肿大淋巴结，遂门诊拟食管癌收入院，患者食管中上段鳞癌诊断明确，据其肿瘤分期需行术前新辅助化疗，2016-05-29、2016-06-25予以TP方案“紫杉醇（泰素）210MGIVGTTD2+顺铂40MGIVGTTD1-3”方案化疗，辅以保肝、保胃、抗肿瘤等治疗。发病以来，精神、睡眠可，食欲欠佳，大小便如常，体重减轻6公斤。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 18, "end_pos": 21}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 24, "end_pos": 31}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 34, "end_pos": 43}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 51}, {"end_pos": 64, "label_type": "解剖部位", "overlap": 0, "start_pos": 62}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 67, "end_pos": 79}, {"label_type": "影像检查", "overlap": 0, "start_pos": 88, "end_pos": 98}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 100, "end_pos": 104}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 109, "end_pos": 113}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 117, "end_pos": 119}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 130, "end_pos": 133}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 142, "end_pos": 165}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 170, "end_pos": 173}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 179, "end_pos": 186}, {"end_pos": 238, "label_type": "药物", "overlap": 0, "start_pos": 235}, {"end_pos": 241, "label_type": "药物", "overlap": 0, "start_pos": 239}, {"end_pos": 257, "label_type": "药物", "overlap": 0, "start_pos": 255}, {"end_pos": 280, "label_type": "解剖部位", "overlap": 0, "start_pos": 279}, {"end_pos": 283, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}]}
{"originalText": "，缘于入院前4月余因胸闷、气促就诊我院，，查全腹部CT提示：1、胃体部大弯、小弯壁不规则增厚，伴肝胃间隙、腹膜后多发淋巴结肿大，网膜增厚，为胃CA侵出浆膜层并网膜种植转移。2、腹腔、盆腔见大量积液。3、脾内类圆形低密度影，可能为转移瘤。4、两附件区多发囊实性病灶，为种植转移可能性大。5、所摄入两肺少许炎症，两侧胸腔少量积液。6、所摄入右房、右室增大。，我院麻醉胃镜：胃体癌慢性萎缩性胃炎。，病理示：（胃体）送检炎性肉芽组织中见多灶粘液湖，其内漂浮个别印戒样细胞，高度可疑癌。2014.03.03行“腹腔置管引流术”，于2014.03.05、2014.04.10予“乐沙定100MG+里葆多40MG”方案化疗，辅以保肝、止吐、补液等处理。过程顺利，无诉不适。03.14予腹腔腔内注射替加氟1G*3天+肿瘤坏死因子200万IU。于2014.05.14按“奥沙利铂(艾恒)150MG静滴D1+里葆多40MGD2”方案化疗，05.19、05.22、05.26予腹腔内注射“肿瘤坏死因子300万IU”。2014.06.23按“紫杉醇（安素泰）180MG+替吉奥60MGBID*14D”方案化疗，辅予止吐、保肝、营养等治疗,于2014.06.25予肿瘤坏死因子300万IU腹腔滴注。此次为化疗再次就诊我院，门诊拟胃体癌伴腹腔种植转移收入院。下次出院以来精神、睡眠、饮食尚可，诉偶有下腹胀痛不适，无发热，大小便正常，体重较前无明显变化。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"label_type": "影像检查", "overlap": 0, "start_pos": 22, "end_pos": 27}, {"end_pos": 41, "label_type": "解剖部位", "overlap": 0, "start_pos": 32}, {"end_pos": 52, "label_type": "解剖部位", "overlap": 0, "start_pos": 48}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 53}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 58, "end_pos": 61}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 70, "end_pos": 85}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"end_pos": 102, "label_type": "解剖部位", "overlap": 0, "start_pos": 101}, {"end_pos": 124, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 154}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 171}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 184, "end_pos": 194}, {"end_pos": 203, "label_type": "解剖部位", "overlap": 0, "start_pos": 201}, {"end_pos": 257, "label_type": "手术", "overlap": 0, "start_pos": 250}, {"end_pos": 286, "label_type": "药物", "overlap": 0, "start_pos": 283}, {"end_pos": 295, "label_type": "药物", "overlap": 0, "start_pos": 292}, {"end_pos": 309, "label_type": "解剖部位", "overlap": 0, "start_pos": 308}, {"end_pos": 337, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}, {"end_pos": 344, "label_type": "药物", "overlap": 0, "start_pos": 341}, {"end_pos": 356, "label_type": "药物", "overlap": 0, "start_pos": 350}, {"end_pos": 380, "label_type": "药物", "overlap": 0, "start_pos": 376}, {"end_pos": 383, "label_type": "药物", "overlap": 0, "start_pos": 381}, {"end_pos": 397, "label_type": "药物", "overlap": 0, "start_pos": 394}, {"end_pos": 429, "label_type": "解剖部位", "overlap": 0, "start_pos": 427}, {"end_pos": 439, "label_type": "药物", "overlap": 0, "start_pos": 433}, {"end_pos": 462, "label_type": "药物", "overlap": 0, "start_pos": 459}, {"end_pos": 466, "label_type": "药物", "overlap": 0, "start_pos": 463}, {"end_pos": 476, "label_type": "药物", "overlap": 0, "start_pos": 473}, {"end_pos": 500, "label_type": "解剖部位", "overlap": 0, "start_pos": 499}, {"end_pos": 525, "label_type": "药物", "overlap": 0, "start_pos": 519}, {"end_pos": 533, "label_type": "解剖部位", "overlap": 0, "start_pos": 531}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 551, "end_pos": 561}, {"end_pos": 587, "label_type": "解剖部位", "overlap": 0, "start_pos": 585}]}
{"originalText": "，患者因“下腹部隐痛不适3月”于2014年4月就诊我院门诊，行胃镜病理示低分化腺癌，后入住我院胃肠外科于2014年5月6日在全麻上予行根治性远端胃大部切除、毕II式吻合术，术后病理（201406646），：胃窦部腺癌(中、低度分化)，体积4.6*4.5*0.3CM，侵达粘膜上层。双端切线未查见癌。呈四组（2/5个）、五组（1/3个）淋巴结癌转移。六组（4个）、“1、3、7组”（10个）淋巴结未查见癌。（腹膜后）脂肪坏死结节。，免疫组化染色示：ERCC1少量（+）、β-TUBULIN-III少量（+）、TS少量（+）、RRM1（-）、TOPOII多量（+）、CERBB-2（-）、SYN（-）、CGA（-） 。术后患者恢复顺利，并行辅助化疗5周期，，化疗方案为：奥沙利铂200MG D1，希罗达2.0G BID D1-D14；化疗期间患者无明显副反应。末次化疗时间2014年10月8日。患者为行复查于2014年12月入住我科复查，CT：胃贲门癌术后CT所见，建议结合临床，左肺结节灶，较前无明显变化。肝脏多发低密度，符合囊肿CT表现，较前无明显变化，建议复查。复查腹部彩超示；肝内钙化灶，肝囊肿，胆囊息肉，右上腹皮上脂肪层强回声团，考虑脂肪瘤。此次为行复查入院。     目前患者精神及情绪状态可，饮食好，夜间睡眠可，大小便正常，近期无明显体重变化。", "entities": [{"end_pos": 8, "label_type": "解剖部位", "overlap": 0, "start_pos": 5}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 36, "end_pos": 41}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 47, "end_pos": 48}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 48, "end_pos": 49}, {"label_type": "手术", "overlap": 0, "start_pos": 67, "end_pos": 85}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 103, "end_pos": 116}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 150, "end_pos": 171}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 174, "end_pos": 197}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 203, "end_pos": 204}, {"end_pos": 337, "label_type": "药物", "overlap": 0, "start_pos": 333}, {"end_pos": 349, "label_type": "药物", "overlap": 0, "start_pos": 346}, {"label_type": "影像检查", "overlap": 0, "start_pos": 417, "end_pos": 419}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 420, "end_pos": 426}, {"end_pos": 440, "label_type": "解剖部位", "overlap": 0, "start_pos": 438}, {"end_pos": 454, "label_type": "解剖部位", "overlap": 0, "start_pos": 452}, {"label_type": "影像检查", "overlap": 0, "start_pos": 464, "end_pos": 466}, {"label_type": "影像检查", "overlap": 0, "start_pos": 484, "end_pos": 488}, {"end_pos": 491, "label_type": "解剖部位", "overlap": 0, "start_pos": 490}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 496, "end_pos": 499}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 500, "end_pos": 504}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 505, "end_pos": 508}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 520, "end_pos": 523}]}
{"originalText": "，患者因患“胃癌”于2006-8-9于我院在全麻上予行“姑息性近端胃大部切除、幽门成形术”，，术后病理回示：贲门腺癌（中度分化），浸润溃疡型，面积6*3CM，侵穿浆膜，周围淋巴结未查见癌。术后行6周期化疗，化疗期间病人无明显不适，适应性良好。自出院后，患者每年复查1次，一般情况保持良好,近来感下腹部隐痛不适，无发热、腹泻、腹胀，无反酸、嗳气等不适。３月前患者再次来院复查，查CEA明显增高，为83.96NG/ML,，行胃镜检查示：食管上端近原手术吻合口见菜花样病变，胃食管食管吻合口以远至胃体，见大面积的菜花样隆起，，病理示：（胃体）高级别下皮内瘤变（重度异型增生及原位癌）。考虑胃癌术后复发可能性大，已给予序贯化疗３次，方案为奥沙利铂200MG D1+亚叶酸钙0.3G D2-6 +替加氟1000MG D2-6 静滴。经化疗后CEA指标呈上降趋势，最近１次CEA为50.12NG/ML化疗期间患者消化道反应较重、白细胞降低，均给予对症处理。出院后一般情况良好，进食、大小便恢复正常。现患者为行进一步复查治疗就诊，门诊以“胃癌术后”收入院。   目前患者精神及情绪状态可，食欲、饮食可，夜间睡眠正常，大小便正常，近期无明显体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 6, "end_pos": 8}, {"label_type": "手术", "overlap": 0, "start_pos": 28, "end_pos": 44}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 54, "end_pos": 70}, {"end_pos": 150, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 160, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 162}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 188, "end_pos": 191}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 216}, {"end_pos": 237, "label_type": "解剖部位", "overlap": 0, "start_pos": 234}, {"end_pos": 239, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"end_pos": 247, "label_type": "解剖部位", "overlap": 0, "start_pos": 245}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 264, "end_pos": 288}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 291, "end_pos": 295}, {"end_pos": 319, "label_type": "药物", "overlap": 0, "start_pos": 315}, {"end_pos": 332, "label_type": "药物", "overlap": 0, "start_pos": 328}, {"end_pos": 346, "label_type": "药物", "overlap": 0, "start_pos": 343}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 365, "end_pos": 368}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 380, "end_pos": 383}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 462, "end_pos": 466}]}
{"originalText": "，患者2010年8月无明显诱因上出现下腹部疼痛，呈阵发性，隐痛，不剧烈，不伴恶心、呕吐、腹泻、便血、黑便、呕血等，外院查肠镜检查，未见明显异常,于2011年3月8日外院胃镜示胃体肿瘤？胃窦多发息肉（I型），，我院会诊病理示：（胃底）粘膜固有层内见异型细胞，部分呈印戒细胞样，肿瘤性病变不能除外，免疫组化考虑非霍奇金淋巴瘤，，弥漫大B细胞型：CK广（-）、CK8（-）、LCA（+++）、CD79A（+++100%）、CD20（+++100%）、CD3（少数小淋巴细胞+）、CD10（部分+）、BCL-2（+）、MUC-1（部分+）、KI-67（++90%）、CD30（++）、CD15（-）、CD56（-）、GRANB（-）。，外院腹部B超：脾稍大、肝胆囊胰体肾未见明显异常、腹腔未见明显积液。2011年3月21，外院行腹部CT示：下腹部CT增强未见明显异常。遂于2011/3/25收入我科。，入院后血常规：，红细胞计数: 4.65X10^12/L；，血红蛋白: 132G/L；，血小板计数: 168X10^9/L；，白细胞计数: 4.53X10^9/L；，中性粒细胞百分比: 66.7%；，淋巴细胞百分比: 22.7%；PET/，CT：淋巴瘤病例；胃体、胃窦局部胃壁增厚伴糖代谢异常增高，符合淋巴瘤图像表现。，骨髓穿刺涂片：骨髓增生欠活跃，髓象中红系增生尚可，粒、巨二系增生欠活跃，形态、比例均无明显异常。，骨髓活检：（骨髓）镜上为骨髓滴，免疫组化结果示，造血组织三系细胞均可见到，各系细胞形态未见明显异常，未见到淋巴瘤累及骨髓证据，请结合临床。免疫组化(11-N1436)，：MPO(粒系+) CD61(巨核+) CD68(组织细胞+) CD34(-) CD20(少数淋巴+) CD79A(少数淋巴+) CD3(少数淋巴+) CD56(-) KI-67(50%+) CYCLIND1(-) VS38C(少数+) BCL-2(少数淋巴+) CD10(-) TDT(-) 网染示网状纤维不增生。患者于2011-3-29/2011-4-29行R-CHOP方案化疗（美罗华 0.6 D0+CTX1.2 D1+盖诺40MG D1+EADM120MG D1+DEX15MG D1-D5），化疗过程中无明显不适。，患者出院后随访血常规：5/11，红细胞计数: 4.02X10^12/L；，血红蛋白:112G/L；，血小板计数:140X10^9/L；，白细胞计数:1.2X10^9/L；，中性粒细胞百分比:24.0%；，淋巴细胞百分比: 0.7%；5-18，随访血常规: 红细胞计数 4.57X10^12/L；，血红蛋白:125G/L；，血小板计数:292X10^9/L；，白细胞计数:6.3X10^9/L；，中性粒细胞百分比:83.9%；，淋巴细胞百分比: 14.6%。患者出院后无明显不适，现为行第3次化疗收入病房。患者发病以来，神清，精神可，胃纳可，二便可，体重无明显上降。", "entities": [{"end_pos": 20, "label_type": "解剖部位", "overlap": 0, "start_pos": 18}, {"end_pos": 45, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 87, "end_pos": 89}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 92, "end_pos": 102}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 153, "end_pos": 169}, {"label_type": "影像检查", "overlap": 0, "start_pos": 316, "end_pos": 320}, {"end_pos": 322, "label_type": "解剖部位", "overlap": 0, "start_pos": 321}, {"end_pos": 326, "label_type": "解剖部位", "overlap": 0, "start_pos": 325}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 326, "end_pos": 328}, {"end_pos": 330, "label_type": "解剖部位", "overlap": 0, "start_pos": 328}, {"end_pos": 331, "label_type": "解剖部位", "overlap": 0, "start_pos": 330}, {"end_pos": 340, "label_type": "解剖部位", "overlap": 0, "start_pos": 338}, {"label_type": "影像检查", "overlap": 0, "start_pos": 360, "end_pos": 364}, {"label_type": "影像检查", "overlap": 0, "start_pos": 366, "end_pos": 371}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 405, "end_pos": 410}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 426, "end_pos": 430}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 440, "end_pos": 445}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 459, "end_pos": 464}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 479, "end_pos": 487}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 496, "end_pos": 503}, {"label_type": "影像检查", "overlap": 0, "start_pos": 511, "end_pos": 518}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 519, "end_pos": 522}, {"end_pos": 527, "label_type": "解剖部位", "overlap": 0, "start_pos": 525}, {"end_pos": 530, "label_type": "解剖部位", "overlap": 0, "start_pos": 528}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 532, "end_pos": 533}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 547, "end_pos": 550}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 658, "end_pos": 661}, {"end_pos": 884, "label_type": "药物", "overlap": 0, "start_pos": 881}, {"end_pos": 895, "label_type": "药物", "overlap": 0, "start_pos": 892}, {"end_pos": 904, "label_type": "药物", "overlap": 0, "start_pos": 902}, {"end_pos": 915, "label_type": "药物", "overlap": 0, "start_pos": 912}, {"end_pos": 928, "label_type": "药物", "overlap": 0, "start_pos": 925}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 968, "end_pos": 973}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 989, "end_pos": 993}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 1002, "end_pos": 1007}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 1020, "end_pos": 1025}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 1038, "end_pos": 1046}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 1054, "end_pos": 1061}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 1080, "end_pos": 1085}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 1100, "end_pos": 1104}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 1113, "end_pos": 1118}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 1131, "end_pos": 1136}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 1149, "end_pos": 1157}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 1165, "end_pos": 1172}, {"end_pos": 1219, "label_type": "解剖部位", "overlap": 0, "start_pos": 1218}]}
{"originalText": "，缘于入院前1年余患者因“体检发现“血PSA”升高1个月”为主诉入院，，入院后查免疫:T--PSA5.05NG/ML、F--PSA0.463NG/ML、F/T9.2。行“B超引导上经直肠前列腺穿刺活检”，恢复好，病理报告（201231203），：1.（右外侧中部），:前列腺癌GLEANSON分级III级（评分2＋3＝5分）。，免疫组化染色：灶性CK(H)、P63示腺体基底细胞消失，P504S腺体阳性。2.（右、左外侧基底部）、（左外侧中部）、（右、左外侧尖部），:前列腺增生症，伴PINI级。，免疫组化染色：CK(H)（基底细胞+），P63（基底细胞+），P504S（－）。，全身骨ECT示：未见明显异常。当时予拟手术治疗，因患者暂不想手术并要求出院，故未经手术治疗，予口服‘氟他安’治疗，并嘱其出院后定期复查。1年患者定期复查PSA均无异常。今为进一步诊疗求诊我院。门诊拟“前列腺癌”收入院。患者自发病来体重无明显变化，体力情况良好，小便如前所述，大便正常，睡眠良好，食欲一般，精神状态一般。", "entities": [{"label_type": "实验室检验", "overlap": 0, "start_pos": 19, "end_pos": 22}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 43, "end_pos": 49}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 59, "end_pos": 65}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 76, "end_pos": 79}, {"end_pos": 100, "label_type": "手术", "overlap": 0, "start_pos": 85}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 134, "end_pos": 152}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 234, "end_pos": 247}, {"label_type": "影像检查", "overlap": 0, "start_pos": 290, "end_pos": 296}, {"end_pos": 343, "label_type": "药物", "overlap": 0, "start_pos": 340}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 366, "end_pos": 369}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 390, "end_pos": 394}]}
{"originalText": "入院前2+月，因诊断结肠肿瘤于我科住院治疗，于2015年09月24日在全麻上行腹腔镜上腹腔探查术、中转开腹，右半结肠癌根治术、小肠系膜结节活检、开腹肿瘤特殊治疗、肠粘连松解术。术后病检示（病理号1508031）：右半结肠粘液性腺癌（中分化），侵及浆膜层外脂肪组织、肠系膜及网膜癌转移、肠系膜淋巴结未见癌转移（0/14），两侧切缘未见癌累及。术后予以止血、镇痛、补液、抑酸、雾化祛痰、抗感染等对症治疗。目前患者无恶心、呕吐、腹痛、腹胀、便血等表现，今日前来我院，拟行第2次化疗，故以\\\"右半结肠癌术后 第2次化疗\\\"收入我科住院治疗。   近期患者精神、食欲、睡眠可，大小便正常，体重无明显改变。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 14}, {"label_type": "手术", "overlap": 0, "start_pos": 39, "end_pos": 87}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 106, "end_pos": 120}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 132, "end_pos": 141}, {"end_pos": 148, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 215, "label_type": "解剖部位", "overlap": 0, "start_pos": 214}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 242, "end_pos": 249}]}
{"originalText": "，2016.2.17行“胃癌切除术”，具体术式不详，术后病理示（远端胃及大网膜），切除：溃疡型低分化腺癌，伴印戒细胞癌，LAUREN，分型：弥漫型；癌侵及浆膜；可见脉管癌栓及神经侵犯（免疫组化CD34、D2-40证实）；十二指肠残端及胃残端未见癌；网膜组织未见癌；淋巴结可见癌转移（第1组6/12，第3组1/1，第4SB组0/0，第4D组0/1，第5组1/1，第6组6/8，第7组1/1，第8组1/3，第9组0/3，第11P组0/0，第12A组0/0，第14V组1/1）；（第1组淋巴结）其中一枚淋巴结内见异位胰腺组织；- ，肿瘤病理分期：PT4AN3B。，免疫组化结果显示肿瘤:AFP(－),CMET(1+),EBER(－),EGFR(2+),HER2(0),KI-67(+25～50%),MLH1(+＞75%),MSH2(+＞75%),MSH6(+＞75%),PDL-1(－),PMS2(+＞75%),SALL4(－),CK(+)。，淋巴结转移癌：CK（+）。入组RESOLVE A组 已行XELOX方案化疗3周期，末次化疗2016.04.11，化疗后出现恶心2度，影响进食，目前患者大小便基本正常，化疗后体重上降3KG。", "entities": [{"end_pos": 17, "label_type": "手术", "overlap": 0, "start_pos": 12}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 34, "end_pos": 35}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 44, "end_pos": 73}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 110, "end_pos": 114}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 237, "end_pos": 243}, {"end_pos": 257, "label_type": "解剖部位", "overlap": 0, "start_pos": 255}]}
{"originalText": "，患者因卵巢癌于2016-04-12行“经腹筋膜外子宫+两附件切除+大网膜切除+阑尾切除+盆腔转移病灶清除+肿瘤细胞减灭术”，手术过程顺利，术后输液抗炎治疗。，常规病理结果示：（两侧附件）高级别浆液性乳头状癌，右卵巢肿物切面积2.8*1.5CM，左卵巢肿物切面积6*3.5CM，两侧输卵管查见癌。阑尾、“盆腔转移灶”查见癌，另送大网膜组织中查见癌。（子宫）萎缩的子宫内膜；慢性宫颈炎。右宫旁查见癌，左宫旁未查见癌。，免疫组化：ER(2+,20%),PR(1+,2%),WT-1(+),P53(-),KI67阳性率约50%。于2016-01-22给予多西他赛（多帕菲）100MG+卡铂400MG方案化疗，患者住院期间化疗毒副反应轻。今日入院，拟行第2次化疗。患者自出院后，无发热，无咳嗽咳痰，恶心呕吐轻，无腹痛腹胀，无阴道流血及排液，饮食睡眠可，大小便无异常，体重增加1KG。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 4, "end_pos": 7}, {"label_type": "手术", "overlap": 0, "start_pos": 20, "end_pos": 61}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 88, "end_pos": 104}, {"end_pos": 108, "label_type": "解剖部位", "overlap": 0, "start_pos": 105}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"end_pos": 150, "label_type": "解剖部位", "overlap": 0, "start_pos": 148}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 181}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 186, "end_pos": 191}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 192, "end_pos": 194}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 199, "end_pos": 201}, {"end_pos": 278, "label_type": "药物", "overlap": 0, "start_pos": 274}, {"end_pos": 282, "label_type": "药物", "overlap": 0, "start_pos": 279}, {"end_pos": 291, "label_type": "药物", "overlap": 0, "start_pos": 289}, {"end_pos": 353, "label_type": "解剖部位", "overlap": 0, "start_pos": 352}, {"end_pos": 355, "label_type": "解剖部位", "overlap": 0, "start_pos": 354}, {"end_pos": 360, "label_type": "解剖部位", "overlap": 0, "start_pos": 358}]}
{"originalText": "患者因“腹痛1月余”于2011-11-17入我院，查CA125为1349U/ML，CA153为189.7U/ML，NSE为25.15NG/ML。B超提示“左侧卵巢实性占位伴中至大量腹水”，考虑“卵巢癌”，于2011-11-24行“肿瘤细胞减灭术（全子宫+两附件切除术+大网膜切除术+DIXON术+回盲部切除术）”。术程顺利，减瘤满意，残存肿瘤直径小于1CM。术后病理示：两侧卵巢见低分化浆液性腺癌浸润，脉管内见癌栓；子宫底壁外膜层、右输卵管外膜层、直肠外膜层及肌层见浆液性腺癌浸润；回盲部肠管肠壁浆膜层、肌层、粘膜上层及粘膜层均见低分化浆液性腺癌浸润，脉管内见癌栓，另见2枚淋巴结有腺癌转移；余送检、大网膜、结肠表面肿物均见低分化腺癌浸润。术后诊断“卵巢浆液性腺癌IIIC期”。术后出现肠瘘，保守治疗效果欠佳，遂于2011-12-09行“腹腔清创引流+回肠造瘘术”，术后予加强营养等治疗。一般情况恢复、腹壁切口愈合良好后于2012-01-18、2012-02-23、2012-5-17予TP（北华素180MG，波贝500MG）方案化疗3程，化疗后无明显恶心、呕吐反应，出现两脚底麻木感，予营养神经治疗后好转。今遵原主诊教授意见为行化疗入院。下次出院至今，患者精神、食欲、睡眠可，大便正常，小便顺畅，体重稍有增加。", "entities": [{"end_pos": 5, "label_type": "解剖部位", "overlap": 0, "start_pos": 4}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 26, "end_pos": 31}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 41, "end_pos": 46}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 57, "end_pos": 60}, {"label_type": "影像检查", "overlap": 0, "start_pos": 72, "end_pos": 74}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 97, "end_pos": 100}, {"label_type": "手术", "overlap": 0, "start_pos": 115, "end_pos": 155}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 185, "end_pos": 200}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 208, "end_pos": 211}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 216, "end_pos": 220}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 224, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 241, "end_pos": 244}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 244, "end_pos": 246}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 246, "end_pos": 247}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 265, "end_pos": 273}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 291, "end_pos": 293}, {"end_pos": 306, "label_type": "解剖部位", "overlap": 0, "start_pos": 304}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 312, "end_pos": 317}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 325, "end_pos": 337}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 343, "end_pos": 345}, {"label_type": "手术", "overlap": 0, "start_pos": 369, "end_pos": 381}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 401, "end_pos": 402}, {"end_pos": 449, "label_type": "药物", "overlap": 0, "start_pos": 446}, {"end_pos": 457, "label_type": "药物", "overlap": 0, "start_pos": 455}, {"end_pos": 489, "label_type": "解剖部位", "overlap": 0, "start_pos": 486}]}
{"originalText": "，患者3余月前因“胃癌”于我院在全麻上行“胃大部切除术”。，术中探查：未见腹水，P0H0，肿瘤位于胃窦小弯明显浸透浆膜外，浆膜呈皱缩上凹状部分网膜覆盖其下。，术后病理：，病理诊断：，进行期胃窦癌：BORRMANN3型 浸润深度（SE）　浸润溃疡型，低－中分化腺癌 断端无癌 ，静脉癌栓：，无　淋巴管癌栓：无　伴淋巴结转移(1/38枚) 。（，病理号：199546）。患者术后恢复良好。今为求进一步治疗，遂来我院。病来，患者饮食睡眠可，大小便正常，体重无明显减轻。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 9, "end_pos": 11}, {"end_pos": 27, "label_type": "手术", "overlap": 0, "start_pos": 21}, {"end_pos": 38, "label_type": "解剖部位", "overlap": 0, "start_pos": 37}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 49}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 94, "end_pos": 131}]}
{"originalText": "缘于入院前1余年前于我院诊为胃癌，于2012-08-07在全麻上行根治术全胃切除术。术后病理（201223223）示全胃：食管胃交界溃疡型管状腺癌，II-III级，侵出浆膜层，侵犯脉管和神经。手术标本下切端见癌浸润，手术标本上切端和另送（下切端）未见癌浸润。镜上找到贲门周淋巴结3/8个、小弯淋巴结3/4个、大弯淋巴结0/1个、幽门下淋巴结0/4个和幽门上淋巴结0/1个见癌转移。术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲，并顺利出院，2012.09.24行“伊立替康280MG+替吉奥60MGBID×14D”方案化疗1周期，2012.10.23按“伊立替康280MG+替吉奥40MGBID×14D”方案化疗1周期，2012.11.20按“伊立替康240MG+替吉奥80MGBID×7D”化疗1次,2012.12.22按““安素泰210MG+艾奕40MGBID×14D”化疗1次，2013.1.18予“安素泰240MG+替吉奥40MGBID×14D”方案化疗1次，2013.02.23按T“安素泰240MG”方案化疗1周期。2014.08.28予“表柔比星70MGIVGTTD1+替吉奥40MGBID×10D”方案化疗1次，2014.09.22予“表柔比星70MGIVGTTD1+安素泰210MGIVGTTD1+替吉奥40MGBID×14D”。今为再次化疗就诊我院，门诊拟胃癌术后化疗后收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"end_pos": 41, "label_type": "手术", "overlap": 0, "start_pos": 33}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 61, "end_pos": 81}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 144}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 154}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 241, "label_type": "药物", "overlap": 0, "start_pos": 237}, {"end_pos": 250, "label_type": "药物", "overlap": 0, "start_pos": 247}, {"end_pos": 286, "label_type": "药物", "overlap": 0, "start_pos": 282}, {"end_pos": 295, "label_type": "药物", "overlap": 0, "start_pos": 292}, {"end_pos": 331, "label_type": "药物", "overlap": 0, "start_pos": 327}, {"end_pos": 340, "label_type": "药物", "overlap": 0, "start_pos": 337}, {"end_pos": 372, "label_type": "药物", "overlap": 0, "start_pos": 369}, {"end_pos": 380, "label_type": "药物", "overlap": 0, "start_pos": 378}, {"end_pos": 411, "label_type": "药物", "overlap": 0, "start_pos": 408}, {"end_pos": 420, "label_type": "药物", "overlap": 0, "start_pos": 417}, {"end_pos": 455, "label_type": "药物", "overlap": 0, "start_pos": 452}, {"end_pos": 485, "label_type": "药物", "overlap": 0, "start_pos": 481}, {"end_pos": 500, "label_type": "药物", "overlap": 0, "start_pos": 497}, {"end_pos": 535, "label_type": "药物", "overlap": 0, "start_pos": 531}, {"end_pos": 550, "label_type": "药物", "overlap": 0, "start_pos": 547}, {"end_pos": 566, "label_type": "药物", "overlap": 0, "start_pos": 563}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 593, "end_pos": 597}, {"end_pos": 622, "label_type": "解剖部位", "overlap": 0, "start_pos": 621}, {"end_pos": 625, "label_type": "解剖部位", "overlap": 0, "start_pos": 624}]}
{"originalText": "，患者4年前因\\\"胸中段段食管中-低分化鳞癌\\\"于我院行“经右胸食管癌根治+胃食管主动脉弓下吻合术”，，术后复查：2015年2月25日，我院CT检查示：食道癌术后改变，纵隔胃代食管未见明显软组织肿物。气管右侧旁淋巴结转移。，超声检查示：右侧颈部VI区及IV区小淋巴结，其中VI区最大淋巴结较前次检查（2014-11-04）增大，考虑恶性可能性大。2015年02月27日，右颈肿大淋巴结穿刺活检病理考虑：增生的纤维组织中见高至中分化鳞状细胞癌浸润，考虑为食管癌转移。现患者出现声嘶20天，考虑右颈转移淋巴结侵犯喉返神经。今为进一步诊治收入我科。起病以来，患者无发热、咳嗽，无胸闷、胸痛，无恶心、呕吐，胃纳、睡眠、精神可，大小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 9, "end_pos": 22}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 29, "end_pos": 49}, {"label_type": "影像检查", "overlap": 0, "start_pos": 70, "end_pos": 72}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 76, "end_pos": 81}, {"end_pos": 86, "label_type": "解剖部位", "overlap": 0, "start_pos": 84}, {"end_pos": 87, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"end_pos": 108, "label_type": "解剖部位", "overlap": 0, "start_pos": 100}, {"end_pos": 133, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 136, "end_pos": 144}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 185, "end_pos": 192}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 210, "end_pos": 220}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 226, "end_pos": 229}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 245, "end_pos": 252}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 254, "end_pos": 255}, {"end_pos": 287, "label_type": "解剖部位", "overlap": 0, "start_pos": 286}, {"end_pos": 290, "label_type": "解剖部位", "overlap": 0, "start_pos": 289}, {"end_pos": 300, "label_type": "解剖部位", "overlap": 0, "start_pos": 299}]}
{"originalText": "，缘于4个月前因食管胃交界腺癌于我院行（2015.10.19）正中开腹根治性全胃切除+食管-空肠ROUX-EN-Y吻合+空肠造瘘+脾切除术，术后病理（201537413），：(全胃)，：食管-胃交界处溃疡型混合型腺神经内分泌癌【腺癌为管状腺癌II-III级，神经内分泌肿瘤为G3型（神经内分泌癌）】，浸润脉管及神经组织，脉管内见癌栓，侵出浆膜层。手术标本下切端、上切端，及另送(最下切端)均未见癌浸润。找到贲门周淋巴结1/4个，小弯侧淋巴结1/11个，大弯侧淋巴结0/6个，幽门上淋巴结0/2个。脾脏组织。，免疫组化染色结果：KI67（30%阳性），P53（++），MLH1（++），MSH-6（+++），CGA（+++），CD56（++），SY（++）。（MM2051901）该病例未检测到KRAS基因12、13号密码子热点突变。（MM20151902）该病例未检测到BRAF基因V600E突变。术后恢复良好，目前进食半流质膳食，无不适。分别于2015.11.25、2015.12.25、2016.01.21日行3周期化疗，“顺铂40MG静滴D1-3+紫杉醇180MG静滴D2”方案，今为求术后第4周期化疗再诊我院，门诊拟食管胃交界腺癌术后化疗收住我科。近来，精神、睡眠、饮食一般，大小便如常，体重无明显增减。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 8, "end_pos": 15}, {"label_type": "手术", "overlap": 0, "start_pos": 31, "end_pos": 69}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 93, "end_pos": 149}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 203}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 214}, {"end_pos": 232, "label_type": "解剖部位", "overlap": 0, "start_pos": 226}, {"end_pos": 243, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"end_pos": 250, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"end_pos": 466, "label_type": "药物", "overlap": 0, "start_pos": 464}, {"end_pos": 480, "label_type": "药物", "overlap": 0, "start_pos": 477}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 512, "end_pos": 521}]}
{"originalText": "，患者5年余前因\\\"升结肠癌\\\"在外院手术治疗，术后规律完成辅助化疗（XELOX方案化疗8程），但未规律复查。近1年偶有大便带血，量少，大便不成形，1-3次/天，无腹痛、腹胀，无黑便、恶心等，未予重视。于2015-01月至外院复查肠镜发现距肛40CM结肠肿物，肠镜不能通过，活检病理提示腺癌。 于2015-01-22至我院全麻上行\\\"右半结肠切除术\\\"，，术后病理示：（乙状结肠大体）镜检为肠低分化腺癌（印戒细胞癌），浸润至肠壁浆膜上层，未见脉管内癌栓及神经束侵犯；网膜组织未见癌。区域淋巴结15/22（+），，免疫组化：ER（-），ERCC1（+），MLH1（+），MSH2（-），MSH6（-），PMS2（+），KI67（40%+），CK（+）。，术后分期：PT3N2BM0 IIIC期。于2015-03-25、2015-04-11、2015-04-28、2015-05-12及2015-05-26;2015-6-9、2015-06-23给予 FOLFOX 方案化疗7程顺利，化疗耐受性可，今为进一步治疗入院。近期患者精神胃纳睡眠尚可，大小便正常，体重无明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 14}, {"end_pos": 83, "label_type": "解剖部位", "overlap": 0, "start_pos": 82}, {"end_pos": 86, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 143, "end_pos": 145}, {"end_pos": 174, "label_type": "手术", "overlap": 0, "start_pos": 167}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 195, "end_pos": 208}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 212, "end_pos": 213}, {"end_pos": 464, "label_type": "解剖部位", "overlap": 0, "start_pos": 463}]}
{"originalText": "入院前1月，患者因确诊“食管下段鳞癌”于2016年04月11日在全麻+两腔上行经颈胸腹下段食管癌切除术、术后标本送病检（1603183）：食管鳞状细胞癌侵及全层，远近切缘均未见癌累及，贲门上淋巴结见癌转移（1/1）,胃右动脉旁、隆突上淋巴结未见癌转移，术后予以心电监护、禁食、水、胃肠减压、静脉高营养、抗感染、祛痰、解痉、护胃、止血、降血压等对症支持治疗后，好转出院。今患者为行第一次化疗来我院就诊，门诊以“食管癌”收入我科住院治疗。   自患病以来，患者精神、食欲、睡眠尚可，二便正常，体征无明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 12, "end_pos": 18}, {"end_pos": 51, "label_type": "手术", "overlap": 0, "start_pos": 35}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 69, "end_pos": 76}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 92}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 108, "end_pos": 120}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 140, "end_pos": 141}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 141, "end_pos": 142}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 162}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 204, "end_pos": 207}]}
{"originalText": "，患者于69天前于我院因“，盆腔包块：卵巢CA?”行“腹腔镜上腹膜活检术+右侧卵巢切除术”，术中切除右侧卵巢及2.0CM*1.0CM大小腹膜送冰冻病理切片，2013-4-27 ，冰冻切片报告单检查报告：1、（右卵巢）卵巢组织中见腺癌。2、（腹膜）纤维脂肪组织中见腺癌。检查无活动性出血后，手术顺利，麻醉满意，术中出血约50ML，术毕安返病房。2013-4-28 ，组织病理检查报告：1、（右卵巢）送检组织中见腺癌组织，待免疫组化进一步明确类型。2、（腹膜）送检纤维脂肪组织中可见少许腺癌组织。2013-05-03（右卵巢）中-低分化宫内膜样腺癌伴腹膜转移。，术后给予：补液、抗炎对症治疗。术后给予紫杉醇静滴+顺铂腹腔灌注化疗双次，化疗过程中病员有恶心、呕吐等不适。现患者来我院要求行第3次化疗。\\U0004   患者本次发病以来，食欲减退， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，体重无明显变化。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 19, "end_pos": 23}, {"label_type": "手术", "overlap": 0, "start_pos": 27, "end_pos": 44}, {"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 108}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 114, "end_pos": 116}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 120, "end_pos": 121}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 131, "end_pos": 133}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 194}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 204, "end_pos": 206}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 226}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 241, "end_pos": 243}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 256, "end_pos": 277}, {"end_pos": 301, "label_type": "药物", "overlap": 0, "start_pos": 298}, {"end_pos": 306, "label_type": "药物", "overlap": 0, "start_pos": 304}, {"end_pos": 308, "label_type": "解剖部位", "overlap": 0, "start_pos": 306}]}
{"originalText": "缘于入院1年前于我院诊为“直肠癌伴肝转移”，于2015年12月07日在全麻上行“腹腔镜上直肠姑息性切除术+末段回肠造瘘术”，术顺，术后病理示：（直肠）大肠溃疡型管状腺癌II级，部分为筛状粉刺型，侵出外膜层，手术标本双切端及另送(下切端)(上切端)均未见癌浸润，找到肠周淋巴结2/21个，及另送(肠系膜上动脉根部)淋巴结0/1个，见癌转移。术后恢复良好。于2015.12.30、2016.01.21、2016.02.13、2016.03.06、2016.03.30、2016.04.22、2016.05.12、2016.06.03、2016.06.27、2016.07.21、2016.08.11、2016.9.02、2016.10.27、2016.11.18、2016.12.23行“伊立替康240MGIVGTTD1+卡培他滨1500MGPOBIDD1-D14”化疗，辅以止吐、制酸、保肝、增强免疫等，化疗过程顺利，未见明显不适。出院后无头晕、乏力，无口腔溃疡、手足麻木无力等不适。此次为行第16次化疗就诊我院，门诊拟“直肠癌术后化疗”收入院。下次出院以来精神、睡眠、饮食可，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 13, "end_pos": 20}, {"label_type": "手术", "overlap": 0, "start_pos": 40, "end_pos": 60}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 75, "end_pos": 87}, {"end_pos": 137, "label_type": "解剖部位", "overlap": 0, "start_pos": 132}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 146}, {"end_pos": 346, "label_type": "药物", "overlap": 0, "start_pos": 342}, {"end_pos": 363, "label_type": "药物", "overlap": 0, "start_pos": 359}, {"end_pos": 394, "label_type": "解剖部位", "overlap": 0, "start_pos": 393}, {"end_pos": 420, "label_type": "解剖部位", "overlap": 0, "start_pos": 419}, {"end_pos": 428, "label_type": "解剖部位", "overlap": 0, "start_pos": 426}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 431, "end_pos": 432}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 432, "end_pos": 433}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 460, "end_pos": 465}]}
{"originalText": "缘于1个多月前因食管下段癌于我院行胸腹腔镜联合全胸段食管切除+食管-胃底右颈部吻合术。手术顺利。术后病理（病理号：201607041）示食管髓质型高分化鳞状细胞癌，侵及外膜层，手术标本双切端未见癌浸润，找到食管周淋巴结1个，未见癌转移。现患者一般情况尚可，无明显恶心、呕吐，无头晕、头痛，无咳嗽、咳痰，无胸闷、胸痛，无腹痛、腹胀，无周身骨骼疼痛等不适。今为求入院第1周期化疗再诊我院，门诊拟食管癌（T3N2M0IIIB期）收住我科。近来，精神、睡眠、饮食一般，大小便如常，体重无明显增减。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 8, "end_pos": 13}, {"label_type": "手术", "overlap": 0, "start_pos": 17, "end_pos": 42}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 68, "end_pos": 81}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"end_pos": 142, "label_type": "解剖部位", "overlap": 0, "start_pos": 141}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"end_pos": 156, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"end_pos": 160, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 162}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 195, "end_pos": 211}]}
{"originalText": "，患者2月余前因“反复剑突上痛3年余，加重2月。”入院，入院完善辅助检查后于2015.12.09在OR于全麻上行“远端胃切除+B-II重建+空肠BRAUN吻合”术，术后予以预防感染，对症支持治疗，恢复顺利，，术后病理:（胃大体）镜检为胃粘液腺癌，LAUREN，分型：肠型，浸润至胃壁浆膜层，可见脉管及神经束侵犯；网膜组织未见癌。切缘未见癌。淋巴结6/44见粘液腺癌转移。，免疫组化：癌细胞 HER-2（0），VEGF（+）。，原位杂交：EBERS（-）。术后于2016-01-20行SOX（奥沙利铂 150MG + 替吉奥 50MG BID）第1疗程化疗，无明显不良反应。现为行术后第二次化疗返院。自下次出院，患者无发热，无头痛、头晕，无咳嗽、咳痰，无心悸、胸闷、胸痛，无尿频、尿急。精神、睡眠可，胃纳一般，二便正常，患者体重上降2KG。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 11, "end_pos": 13}, {"label_type": "影像检查", "overlap": 0, "start_pos": 49, "end_pos": 51}, {"label_type": "手术", "overlap": 0, "start_pos": 57, "end_pos": 79}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 110, "end_pos": 111}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 117, "end_pos": 135}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 139, "end_pos": 140}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 178, "end_pos": 182}, {"end_pos": 249, "label_type": "药物", "overlap": 0, "start_pos": 245}, {"end_pos": 262, "label_type": "药物", "overlap": 0, "start_pos": 258}, {"end_pos": 313, "label_type": "解剖部位", "overlap": 0, "start_pos": 312}, {"end_pos": 316, "label_type": "解剖部位", "overlap": 0, "start_pos": 315}, {"end_pos": 327, "label_type": "解剖部位", "overlap": 0, "start_pos": 326}, {"end_pos": 330, "label_type": "解剖部位", "overlap": 0, "start_pos": 329}, {"end_pos": 333, "label_type": "解剖部位", "overlap": 0, "start_pos": 332}]}
{"originalText": "，缘于入院前28个月因结肠息肉行腹部CT示肝脏数个低、稍低密度灶，部分为小囊肿，部分转移瘤不能排除，并于2012.03.06行腹腔镜上乙状结肠病损切除术，术后病理(201206355)，示：(降结肠肿瘤及肠管系膜)，：肠溃疡型管状腺癌II级，侵出外膜层。手术标本双切口及另送(下切端)、(上切端)均未见癌浸润。找到肿物周淋巴结4/10个，肠周淋巴结2/8个见癌转移，术后患者恢复顺利出院。于2012-4-25在B超引导上行“左肝转移灶射频消融术”，并于2012-5-8及2012-5-30行2次“艾恒150MG+希罗达1000MGBID*14天”化疗。于2012-06-22、2012-08-24、2012-10-11、2013-01-18、2013-03-11、2013-04-08行肝动脉置管(5-FU+亚叶酸钙+艾恒)化疗，此后不定期复查。今为进一步治疗就诊于我院，门诊拟结肠癌肝转移术后介入术后收入院。目前患者精神、睡眠、饮食尚可，大小便无明显异常，体重未见明显减轻。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 11, "end_pos": 15}, {"label_type": "影像检查", "overlap": 0, "start_pos": 16, "end_pos": 20}, {"end_pos": 23, "label_type": "解剖部位", "overlap": 0, "start_pos": 21}, {"end_pos": 76, "label_type": "手术", "overlap": 0, "start_pos": 63}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 96, "end_pos": 101}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 102}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 109, "end_pos": 120}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 222, "label_type": "手术", "overlap": 0, "start_pos": 212}, {"end_pos": 250, "label_type": "药物", "overlap": 0, "start_pos": 248}, {"end_pos": 259, "label_type": "药物", "overlap": 0, "start_pos": 256}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 343, "end_pos": 344}, {"end_pos": 353, "label_type": "药物", "overlap": 0, "start_pos": 349}, {"end_pos": 358, "label_type": "药物", "overlap": 0, "start_pos": 354}, {"end_pos": 361, "label_type": "药物", "overlap": 0, "start_pos": 359}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 389, "end_pos": 397}]}
{"originalText": "，患者5月余前因“发作性胸闷、憋气半年余，加重1月余”入院，，行肠镜检查提示：结肠癌、结肠多发息肉。查无手术禁忌后于2016-11-03日在全身麻醉上行左半结肠切除术。，术后病理示：结肠腺癌（中-低度分化），浸润溃疡型，体积7.5*4*1.7CM，侵穿浆膜，未累及底部切除面及双端切线。 “一站”（7个）、“二站”（5个）、“三站”（12个）淋巴结未查见癌。慢性阑尾炎，外膜有较多中性粒细胞浸润。，癌组织免疫组化染色示：SYN（-）、BRAF（-）、MLH1（+）、MSH2（+）、MSH6（+）、PMS2（±）。院外期间患者一般情况好，无恶心，无腹痛腹胀胀不适，现患者为行复查及化疗来院就诊，门诊以“结肠癌术后”收入院。   近期患者精神可，饮食可，大便次数多，小便正常，近期体重无明显变化。", "entities": [{"end_pos": 13, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 39, "end_pos": 42}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 43, "end_pos": 49}, {"end_pos": 83, "label_type": "手术", "overlap": 0, "start_pos": 76}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 91, "end_pos": 109}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 179, "end_pos": 184}, {"end_pos": 275, "label_type": "解剖部位", "overlap": 0, "start_pos": 274}, {"end_pos": 277, "label_type": "解剖部位", "overlap": 0, "start_pos": 276}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 301, "end_pos": 306}]}
{"originalText": "，患者2016年2月因“反复下腹痛4月余。”入院，入院完善辅助检查，，明确诊断：胃癌。后于2016-02-17在OR于全麻上行“腹腔镜辅助胃癌根治术（远端胃切除+B-II重建+空肠空肠Ｂｒａｕｎ吻合）”，术后予以预防感染，对症支持治疗，恢复顺利，，术后病理回报：（胃大体）镜检为中-低分化腺癌，部分为印戒细胞癌，LAUREN，分型：混合型，癌组织浸润至胃壁浆膜上层，可见脉管内癌栓及神经束侵犯。切缘未见癌。淋巴结）2/46见腺癌转移。，免疫组化：CK（+），VEGF（+），HER-2（-）。，原位杂交：EBERS（-）。 术后于2016-03-21、2016-04-11、2016-05-03、2016-05-23、2016-06-13、2016-07-05在我院行(奥沙利铂 150MG Q3W IVDRIP D1 + 替吉奥 60MG BID PO D1-14)化疗6疗程，过程顺利。现为行术后第7疗程化疗返院治疗。自下次出院以来，患者体重无明显变化。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"end_pos": 41, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"end_pos": 74, "label_type": "手术", "overlap": 0, "start_pos": 64}, {"end_pos": 80, "label_type": "手术", "overlap": 0, "start_pos": 75}, {"end_pos": 87, "label_type": "手术", "overlap": 0, "start_pos": 81}, {"end_pos": 99, "label_type": "手术", "overlap": 0, "start_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 132, "end_pos": 135}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 139, "end_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 176, "end_pos": 177}, {"end_pos": 339, "label_type": "药物", "overlap": 0, "start_pos": 335}, {"end_pos": 366, "label_type": "药物", "overlap": 0, "start_pos": 362}]}
{"originalText": "，患者约于1个月前因“胃癌”于2014-10-23在全麻上行根治性胃大部切除、毕I式吻合术，手术顺利，术后给予输液、抗生素及营养支持等治疗。，术后病理示：（9302.2012）胃窦大弯侧腺癌（中度分化），浸润溃疡型，面积2.5*2CM，厚2.8CM，侵达浆膜。双端切线未查见癌。四组（5个）、六组（9个）、“1、3、7组”（8个）淋巴结，未查见癌。，术后病理分期：PT4AN0M0，IIB期。院外期间，患者无发热，无腹痛腹胀不适，大便通畅。现患者为行复查化疗来我科就诊，以“胃癌术后”收入院。    病人自下次出院以来，神志清，精神可，饮食可，大、小便正常，体重未见明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 11, "end_pos": 13}, {"label_type": "手术", "overlap": 0, "start_pos": 30, "end_pos": 45}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 88, "end_pos": 107}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 139, "end_pos": 168}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 208}, {"end_pos": 211, "label_type": "解剖部位", "overlap": 0, "start_pos": 210}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 237, "end_pos": 241}]}
{"originalText": "患者因“下腹部疼痛不适，以进食后尤甚，伴返酸、嗳气”，在我院确诊胃癌，遂于2015.3.13在我院手术室全麻上行\\\"胃癌根治术（远端胃大部切除+ROUX-EN-Y重建）\\\"，术程顺利，术后恢复可。术后病理提示：T3N3M0，IIIB。 已于2015.4.3、2015.4.22、2015-05-14、2015-6-4,2015-6-26行5程化疗，方案为奥沙利铂+替吉奥，化疗期间无明显副反应，现复查血常规、肝肾功能结果基本正常。现为行上一程化疗收入我科。起病以来，患者精神尚可，食欲一般，大小便正常，身体无明显消瘦。", "entities": [{"end_pos": 7, "label_type": "解剖部位", "overlap": 0, "start_pos": 4}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 32, "end_pos": 34}, {"end_pos": 63, "label_type": "手术", "overlap": 0, "start_pos": 58}, {"label_type": "手术", "overlap": 0, "start_pos": 64, "end_pos": 83}, {"end_pos": 181, "label_type": "药物", "overlap": 0, "start_pos": 177}, {"end_pos": 185, "label_type": "药物", "overlap": 0, "start_pos": 182}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 204, "end_pos": 205}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 205, "end_pos": 206}]}
{"originalText": "，患者2015年9月9日于全麻上经腹腔镜直肠癌DIXON术，，术后病理：直肠癌（浆膜上层），扁平隆起型，高分化腺癌，I级，断端无癌，淋巴结可见癌转移（5/13枚），，浸润深度：浆膜上层，周围神经节侵犯（+)，脉管癌栓（-），结外肿瘤种植（-)，PTNM，分期：T3N2AM0，IIIB期，，免疫组化：KI67（50-70%+），P53(>90%+)，CDX2(>90%+)，CA199(+)，CEA(+++)，GSTP1(+++)，EGFR(+++)，VEGF(++)，MLH1(>90%+)，MSH2(>90%+)，MSH6(>90%+)，PMS2(>90%+)。血管内皮细胞CD34（+）其内未见癌栓，淋巴管内皮细胞D2-40(+)其内未见癌栓,周围神经S100（+）可见癌侵犯，，病理号：1806。术后患者恢复良好，术后行腹腔穿刺化疗一次，今为求进一步治疗收入我科。近日无发热，饮食睡眠可，大小便正常，无腹痛，无便血，近来体重未见明显变化。ECOG，评分：1分。", "entities": [{"end_pos": 29, "label_type": "手术", "overlap": 0, "start_pos": 16}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 36, "end_pos": 60}, {"end_pos": 366, "label_type": "解剖部位", "overlap": 0, "start_pos": 364}, {"end_pos": 406, "label_type": "解剖部位", "overlap": 0, "start_pos": 405}]}
{"originalText": "，患者3月前因“下腹部疼痛不适半年余，加重伴进食后呕吐2月余”入院,于2016-9-7在全麻上行胃癌根治术（毕-II式吻合），手术过程顺利，术后患者恢复好，切口愈合好，按期拆线。，术后病理：胃窦低分化腺癌，体积3.5*3.5*1.6CM，浸润溃疡型，侵穿浆膜。双端切线未查见癌。呈“第六组”（6/13个）、“胃第六组”（1/1）淋巴结癌转移。第三组（4个）、第四组（4个）、“胃第七组”（1个）淋巴结未查见癌。第五组查见癌结节一个。，癌组织免疫组化染色示：CERBB-2（1+）、SYN（-）、β-TUBULIN-III（-）、 RRM1个别（+）、TOPOII（+）。根据患者病情具有化疗指征，于2016-09-25开始第一周期化疗，，方案为：奥沙利铂200MG D1，亚叶酸钙0.3G+氟尿嘧啶0.75G D2-D6，同时给与升白细胞、护肝、止吐、免疫增强治疗，患者化疗耐受可，无明显化疗副反应。现患者为求明确诊疗来我院就诊，门诊以“胃癌术后”收入我科。   患者自发病以来，精神可，饮食欠佳，睡眠可，二便正常，体重减轻约14KG。体力无明显改变。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"end_pos": 53, "label_type": "手术", "overlap": 0, "start_pos": 48}, {"end_pos": 61, "label_type": "手术", "overlap": 0, "start_pos": 54}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 95, "end_pos": 102}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 154, "end_pos": 167}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 171, "end_pos": 200}, {"end_pos": 327, "label_type": "药物", "overlap": 0, "start_pos": 323}, {"end_pos": 340, "label_type": "药物", "overlap": 0, "start_pos": 336}, {"end_pos": 349, "label_type": "药物", "overlap": 0, "start_pos": 345}, {"end_pos": 372, "label_type": "解剖部位", "overlap": 0, "start_pos": 371}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 419, "end_pos": 423}]}
{"originalText": "，患者4月前因“下腹部疼痛不适10余年，加重1月余”入院，2016-06-02在全麻上行胃癌根治+幽门成形术，手术过程顺利，术后患者恢复好，切口愈合好，按期拆线。，术后病理：（201611546），：胃体小弯腺癌（中度分化），局部伴神经内分泌分化，体积2*1*0.5CM，溃疡型，侵达浅肌层。双端切线及另送“近切线”未查见癌。 呈“三组”淋巴结（8/13个）淋巴结癌转移。“四组”（5个）淋巴结未查见癌。 ，癌组织免疫组化染色示：TS部分（+）、TOPOII多数（+）、β-TUBULIN-III少数（+）、 RRM1（-）、SYN部分（-）、CERBB-2（-）。术后给予辅助化疗，，方案为：奥沙利铂150MG D1+亚叶酸钙0.3G D2-6 +氟尿嘧啶750MG D2-6 静滴。现患者为求复查化疗来我院就诊，为行进一步治疗，门诊以\\\"胃癌术后\\\"收入我科。   患者自发病以来，精神可，饮食可，睡眠可，二便正常，体重体力无明显改变。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"label_type": "手术", "overlap": 0, "start_pos": 44, "end_pos": 54}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 100, "end_pos": 112}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 166, "end_pos": 172}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 187, "end_pos": 197}, {"end_pos": 301, "label_type": "药物", "overlap": 0, "start_pos": 297}, {"end_pos": 314, "label_type": "药物", "overlap": 0, "start_pos": 310}, {"end_pos": 329, "label_type": "药物", "overlap": 0, "start_pos": 325}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 371, "end_pos": 375}]}
{"originalText": "，患者于1月前因“反复中下腹闷痛不适3月”入院，诊为胃癌，于2013年12月10日在全麻上行根治性全胃切除术+食管空肠ROUX-Y吻合术（D2），手术顺利。术中见腹腔内无明显粘连，无明显腹水，盆腔、腹壁、大网膜无明显转移结节，肝脏表面光滑，未见明显转移灶，肿瘤位于贲门胃体下段小弯侧，侵出浆膜层，活动度可，周围可及明显肿大淋巴结，主要位于胃小弯侧及胃右动脉旁。术后病理（201339038），：（全胃），：食管胃交界溃疡型低分化腺癌，侵出浆膜层，侵犯神经，脉管内见癌栓，手术标本下、上切端及另送（下切端）均未见癌浸润，找到贲门左淋巴结1/2个，小弯淋巴结5/11个，大弯淋巴结0/1个，幽门上淋巴结0/3个，及另送的（胃右动脉根部）淋巴结2/5个见癌转移。另送（脾门淋巴结）为纤维、脂肪组织。术后给予对症、抗感染治疗，恢复良好,伤口愈合II/甲。此次为术后第1次化疗入院。患者出院后饮食、夜休可，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 26, "end_pos": 28}, {"label_type": "手术", "overlap": 0, "start_pos": 46, "end_pos": 72}, {"end_pos": 83, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 99, "end_pos": 100}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"end_pos": 141, "label_type": "解剖部位", "overlap": 0, "start_pos": 132}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 174, "end_pos": 175}, {"end_pos": 200, "label_type": "解剖部位", "overlap": 0, "start_pos": 199}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 203, "end_pos": 216}, {"end_pos": 267, "label_type": "解剖部位", "overlap": 0, "start_pos": 261}, {"end_pos": 277, "label_type": "解剖部位", "overlap": 0, "start_pos": 272}, {"end_pos": 288, "label_type": "解剖部位", "overlap": 0, "start_pos": 283}, {"end_pos": 299, "label_type": "解剖部位", "overlap": 0, "start_pos": 293}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 308, "end_pos": 319}, {"end_pos": 336, "label_type": "解剖部位", "overlap": 0, "start_pos": 331}, {"end_pos": 400, "label_type": "解剖部位", "overlap": 0, "start_pos": 399}, {"end_pos": 403, "label_type": "解剖部位", "overlap": 0, "start_pos": 402}]}
{"originalText": "，患者约于5月前因“乙状结肠癌”于2017-02-07在全麻上行乙状结肠癌根治术，手术过程顺利，术后患者恢复好，切口愈合好，按期拆线。，术后病理:（乙状结肠）腺癌，中、低度分化，浸润溃疡型，体积5*3*1.3CM，侵穿浆膜， 双端切线及另送“近切线”、“远切线”未查见癌。 呈肠壁一站（4/10个）淋巴结癌转移。 中间组淋巴结（1个）未查见癌。，免疫组化染色示：SYN（-）、BRAF（-）、MLH1（+）、MSH2（+）、 MSH6（+）、PMS2（+）。查无化疗禁忌后于2017-03-05开始给予规律化疗5周期，，方案为：奥沙利铂200MG D1，亚叶酸钙0.3G+氟尿嘧啶0.75G D2-D6，同时给与升白细胞、护肝、止吐、免疫增强治疗，患者副反应轻。院外期间患者一般情况好，无恶心，无腹痛腹胀不适，1天前患者发现白细胞低，现患者为行复查及化疗再次来院就诊，门诊以“乙状结肠癌术后”收入院。          发病以来，患者精神好，饮食好，睡眠好，小便正常，体重无明显改变。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"end_pos": 40, "label_type": "手术", "overlap": 0, "start_pos": 32}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 73, "end_pos": 81}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 138, "end_pos": 152}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 157, "end_pos": 163}, {"end_pos": 268, "label_type": "药物", "overlap": 0, "start_pos": 264}, {"end_pos": 281, "label_type": "药物", "overlap": 0, "start_pos": 277}, {"end_pos": 290, "label_type": "药物", "overlap": 0, "start_pos": 286}, {"end_pos": 313, "label_type": "解剖部位", "overlap": 0, "start_pos": 312}, {"end_pos": 349, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"end_pos": 351, "label_type": "解剖部位", "overlap": 0, "start_pos": 350}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 388, "end_pos": 395}]}
{"originalText": "，患者6月余前因“直肠癌”在我院行直肠癌DIXON手术，手术过程顺利，术后给予抗感染、营养支持并补液治疗，患者2017-02-15因“直肠癌术后吻合口瘘”行“横结肠造口术”，手术过程顺利，术后给予抗感染、营养支持、补液及对症治疗，，术后病理检查结果回示：（直肠）腺癌（中、低度分化，局部伴神经内分泌分化；部分为粘液腺癌，约占30%）， 隆起型，体积2*2*1.5CM，局部侵达深肌层，并肠壁外脂肪组织内查见癌转移 灶（1处），长径约0.7CM，双端切线及另送“近切线”、“远切线”未查见癌。 多发性增生性（锯齿状）息肉。 一站淋巴结（8个）未查见癌。，癌组织免疫组化染色示：SYN局部（+）、BRAF（-）、MSH2（+）、MSH6（+）、 MLH1（+）、PMS2（+）。病情稳定后出院.患者于2017-6-2、2017-7-2及2017-7-30来我院入住我科，排除化疗禁忌后给予奥沙利铂200MGD1+氟尿嘧啶0.75G D2-D6+亚叶酸钙0.3G D2-D6，辅以保肝、护胃、止吐等对症支持治疗，过程顺利，患者耐受可，化疗结束后出院。   出院后患者病情稳定，无发热畏寒，无恶心呕吐，无咳嗽胸闷，无腹胀腹泻以及腹痛，精神好，饮食好，睡眠好，小便正常，体重无明显改变。现患者为求进一步治疗入院，门诊以“直肠癌术后”收入院。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 9, "end_pos": 12}, {"end_pos": 27, "label_type": "手术", "overlap": 0, "start_pos": 17}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 67, "end_pos": 76}, {"end_pos": 85, "label_type": "手术", "overlap": 0, "start_pos": 79}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 127, "end_pos": 171}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 193, "end_pos": 194}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 246, "end_pos": 259}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 260, "end_pos": 266}, {"end_pos": 396, "label_type": "药物", "overlap": 0, "start_pos": 392}, {"end_pos": 408, "label_type": "药物", "overlap": 0, "start_pos": 404}, {"end_pos": 424, "label_type": "药物", "overlap": 0, "start_pos": 420}, {"end_pos": 439, "label_type": "解剖部位", "overlap": 0, "start_pos": 438}, {"end_pos": 442, "label_type": "解剖部位", "overlap": 0, "start_pos": 441}, {"end_pos": 501, "label_type": "解剖部位", "overlap": 0, "start_pos": 500}, {"end_pos": 505, "label_type": "解剖部位", "overlap": 0, "start_pos": 504}, {"end_pos": 507, "label_type": "解剖部位", "overlap": 0, "start_pos": 506}, {"end_pos": 511, "label_type": "解剖部位", "overlap": 0, "start_pos": 510}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 555, "end_pos": 560}]}
{"originalText": "，患者于2012-11无明显诱因出现下腹不适，轻度腹痛，与饮食无关，伴嗳气，无反酸、腹胀、恶心、呕吐及黑便。2012-11-9，就诊*********行电子胃镜检查：胃窦小弯侧见一巨大溃疡，大小约4.0X4.0CM,周围粘膜红肿，累及胃角，，胃窦活检病理为：粘膜慢性炎伴溃疡形成，局部腺体排列紊乱，不排外恶变可能.2012-11-22，入**三院行电子胃镜检查示：胃角结构破坏，可见一3X3CM巨大溃疡，底部凹凸不平，，胃角粘膜活检病理为：低分化腺癌。后转我院就诊，于2012-12-14日在全麻上行“胃癌根治术”术程顺利，术后病理为胃低分化腺癌，浸润至浆膜层，淋巴结7(+)/34，后遵原主诊医师意见2013-01-06、2013-01-25、2-25、3-15予多西他赛＋S-1”化疗3程，过程顺利。现为上一程化疗入院，起病以来，精神、饮食、睡眠尚可，大小便正常，体重无明显上降。", "entities": [{"end_pos": 20, "label_type": "解剖部位", "overlap": 0, "start_pos": 18}, {"end_pos": 26, "label_type": "解剖部位", "overlap": 0, "start_pos": 25}, {"end_pos": 43, "label_type": "解剖部位", "overlap": 0, "start_pos": 42}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 83}, {"end_pos": 119, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 210}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 220, "end_pos": 225}, {"end_pos": 256, "label_type": "手术", "overlap": 0, "start_pos": 251}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 267, "end_pos": 273}, {"end_pos": 337, "label_type": "药物", "overlap": 0, "start_pos": 333}, {"end_pos": 341, "label_type": "药物", "overlap": 0, "start_pos": 338}]}
{"originalText": "患者3个多月前因“大便习性改变4个月。”到我院就诊，经肠镜、MR等检查考虑为直肠肿物，侵犯粘膜上层，经多次表面活检及穿刺病理均未见癌。2016-3-11全麻上行TEM术，术中见肿物巨大，并与固有肌层粘连，予粘膜上层分离并分块切除。术中冰冻病理报告未见癌。术后石蜡病理提示腺癌，侵犯粘膜肌层并有中断。术后诊断为腺癌PT1N0M0。考虑肿物基底为下次肠镜息肉切除后疤痕，可能有残留，2016-5-21全麻上行腹腔镜DIXON+回肠造瘘术，术后病理：肠壁及淋巴结未见癌残留。术后恢复较慢。出院后造口排液较稀，无腹痛、发热等其他不适。现为造口回纳收入院。自下次出院以来，患者无恶心、呕吐等，无发热、咳嗽、身目黄染，无骶部痛等，精神可，纳眠可，小便无异常，体重上降月8KG。", "entities": [{"label_type": "影像检查", "overlap": 0, "start_pos": 30, "end_pos": 32}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 38, "end_pos": 40}, {"end_pos": 84, "label_type": "手术", "overlap": 0, "start_pos": 80}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 135, "end_pos": 137}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 154, "end_pos": 163}, {"label_type": "手术", "overlap": 0, "start_pos": 202, "end_pos": 216}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 222, "end_pos": 228}, {"end_pos": 253, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 306, "label_type": "解剖部位", "overlap": 0, "start_pos": 304}]}
{"originalText": "缘于入院前9月于我院诊为胃癌，于2014-02-24在全麻上行腹腔镜上根治性远端胃大部切除术，术后病理示（远端胃）胃窦小弯侧溃疡型管状腺癌II-III级，侵出浆膜层，侵犯神经，脉管内见癌栓，手术标本下、上切端及另送（下切端）均未见癌浸润。找到小弯淋巴结3/9个，大弯淋巴结4/6个，幽门下淋巴结0/5个，幽门上淋巴结0/3个，及另送（第8组）淋巴结1/2个，（第15组）淋巴结0/1个见癌转移。另送（第14V组淋巴结）为脂肪、纤维及脉管组织。免疫组化结果：CK7（+++），CK20（-），VILLIN（+++），CEA（+++），CDX-2（灶+），CGA（-），CD56（-），SY（-），KI67（30%+），HER-2（++）。术后恢复情况良好，术后已予“奥沙利铂200MGD1+多柔比星60MGD1+替吉奥60MGBIDD1-D14”方案化疗6周期，过程顺利，效果良好，未见明显化疗副反应。此次为复查就诊我院，门诊拟胃癌术后化疗收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 12, "end_pos": 14}, {"end_pos": 46, "label_type": "手术", "overlap": 0, "start_pos": 31}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 53}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 57, "end_pos": 76}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 131}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 141}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 166, "end_pos": 174}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 179, "end_pos": 188}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 200, "end_pos": 208}, {"end_pos": 336, "label_type": "药物", "overlap": 0, "start_pos": 332}, {"end_pos": 348, "label_type": "药物", "overlap": 0, "start_pos": 344}, {"end_pos": 358, "label_type": "药物", "overlap": 0, "start_pos": 355}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 413, "end_pos": 417}, {"end_pos": 441, "label_type": "解剖部位", "overlap": 0, "start_pos": 440}, {"end_pos": 444, "label_type": "解剖部位", "overlap": 0, "start_pos": 443}]}
{"originalText": "，患者因“直肠癌”于2017-02-17在全麻上行直肠癌根治术(DIXON)，术后给予抗感染、营养支持、抑酸治疗，患者恢复好，切口愈合良好。，术后病理：直肠腺癌（中、低度分化），部分呈粘液腺癌分化，隆起型，体积9*9*2.5CM，侵穿浆膜，于外膜脂肪组织内查见一处癌转移灶。双端切线及另送“近切线”、“远切线”未查见癌。呈“一站”（1/12个）淋巴结癌转移。 “中央组”（2个）、“中间组”（1个）未查见癌。，免疫组化染色示：SYN（-）、BRAF（-）、MLH1（+）、MSH2（+）、MSH6（+）、PMS2（+）。 2017-03-17开始化疗，方案为奥沙利铂200MGD1，亚叶酸钙300MG+氟尿嘧啶750MG D2-D6，化疗期间有恶心、无呕吐，院外期间患者一般情况好，无恶心，无腹痛腹胀不适，现患者为行复查及化疗再次来院就诊，门诊以“直肠癌术后”收入院。   近期患者精神可，饮食可，大便次数多，小便正常，近期体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 5, "end_pos": 8}, {"label_type": "手术", "overlap": 0, "start_pos": 25, "end_pos": 38}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 76, "end_pos": 102}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 162, "end_pos": 175}, {"end_pos": 283, "label_type": "药物", "overlap": 0, "start_pos": 279}, {"end_pos": 295, "label_type": "药物", "overlap": 0, "start_pos": 291}, {"end_pos": 305, "label_type": "药物", "overlap": 0, "start_pos": 301}, {"end_pos": 347, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"end_pos": 349, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 374, "end_pos": 379}]}
{"originalText": "，缘于入院前4月余在我院诊为“胃窦癌”，于2015年07月21日在全麻上行根治性远端胃切除、胃空肠ROUX-Y吻合术（D2）。，术中见：腹腔内无明显腹水，腹腔内未见转移结节，肝脏质地大小正常，未见明显肿物，胆囊无肿大。病灶位于胃角处向下侵犯胃体中段，明显侵出浆膜面，胃右动脉附近可见一肿大淋巴结，大小约3.0×3.0右左。手术顺利。术后病理（201526673），示:1.(远端胃)，：胃体前壁及胃窦溃疡型管状腺癌II-III级，伴坏死，侵出浆膜层。手术标本下切端、上切端及另送(下切端)均未见癌浸润。找到小弯侧淋巴结1/10个，大弯侧淋巴结0/4个，幽门下淋巴结0/1个，幽门上淋巴结1/6个，及另送(胃右动脉根部)淋巴结0/2个，见癌转移。，免疫组化染色结果：CGA（-），CD56（-），SY（-），KI67（60%阳性），CK(PAN)（+++），HER-2（-）；术后预防性抗感染、补液、营养等对症治疗，恢复良好后出院。术后分别于2015.09.21、2015.10.26予“奥沙利铂（乐沙定）200MGIVGGTD1+希罗达1500MGPOBIDD1-14”方案化疗2个周期。化疗过程顺利，无特殊不适。今为行第3次化疗，再次就诊于我院，门诊拟“胃管状腺癌术后（PT4AN1M0IIIA期）化疗”收入住院。自下次出院以来，精神可，睡眠可，饮食稍差，大、小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手术", "overlap": 0, "start_pos": 37, "end_pos": 58}, {"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 105, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 120, "end_pos": 122}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 133, "end_pos": 134}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 187}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 193, "end_pos": 214}, {"end_pos": 259, "label_type": "解剖部位", "overlap": 0, "start_pos": 253}, {"end_pos": 271, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"end_pos": 282, "label_type": "解剖部位", "overlap": 0, "start_pos": 276}, {"end_pos": 293, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"end_pos": 312, "label_type": "解剖部位", "overlap": 0, "start_pos": 301}, {"end_pos": 447, "label_type": "药物", "overlap": 0, "start_pos": 443}, {"end_pos": 451, "label_type": "药物", "overlap": 0, "start_pos": 448}, {"end_pos": 468, "label_type": "药物", "overlap": 0, "start_pos": 465}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 528, "end_pos": 550}]}
{"originalText": "入院前３月，患者因直肠癌于本院行腹腔镜辅助上直肠癌根治术（MILES），手术顺利。术后组织病理检查报告示直肠溃疡型中分化管状腺癌，浸及肠壁全层，可见神经侵犯及癌栓。切端未见癌累及。肠壁淋巴结可见癌转移（1/2）。术后患者恢复好，无畏寒发热，无恶心呕吐，无腹胀腹痛，造瘘口排便排气通畅，已行FOLFOX方案化疗2次，为求术后第３次化疗于今日入院。\\U0004   患者自起病以来，精神可，胃纳可，大便如常，小便如常，体重未见明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 9, "end_pos": 12}, {"label_type": "手术", "overlap": 0, "start_pos": 16, "end_pos": 35}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 52, "end_pos": 64}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 67, "end_pos": 68}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"end_pos": 130, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"end_pos": 194, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}]}
{"originalText": "，2012-11-30行右乳癌根治术，术后病理示（右）乳腺浸润性导管癌，II级，大小1.8×XXX1.7×XXX1.5CM，未见脉管癌栓；乳头及皮肤未见特殊。，肿瘤病理分期：PT1C。（右腋窝前哨）淋巴结未见癌转移（0/1）；（右腋窝前哨及导丝定位）淋巴结未见癌转移（0/2）。，免疫组化染色结果：CK(-)。，免疫组化：ER(+>75%),PR(+约20%），HER-2（1+）。术后CEF方案化疗6周期，现口服来曲唑（芙瑞）内分泌治疗。 5-20本院胃镜检查提示慢性胃炎，HP(-)。现恶心未吐，进食少，大便可，睡眠差。", "entities": [{"end_pos": 18, "label_type": "手术", "overlap": 0, "start_pos": 12}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 24, "end_pos": 39}, {"end_pos": 102, "label_type": "解剖部位", "overlap": 0, "start_pos": 92}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 113, "end_pos": 128}, {"end_pos": 210, "label_type": "药物", "overlap": 0, "start_pos": 207}, {"end_pos": 213, "label_type": "药物", "overlap": 0, "start_pos": 211}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 233, "end_pos": 237}]}
{"originalText": "缘于入院前4年余因“乙状结肠癌”于我院行“腹腔镜辅助上乙状结肠癌根治术”，术后病理(201131862)回报“(乙状)结肠蕈伞型管状腺癌II级，侵及浆膜层，手术标本下、上切端及另送(下、上切端)未见癌浸润，找到肠周淋巴结11个均未见癌转移，另送(肠系膜上动脉根部淋巴结)为脂肪脉管结缔组织”，术后恢复良好出院，出院后于门诊定期复查期间发现肝、肺、骨多发转移。3年前开始口服希罗达及中药治疗（具体不详），治疗期间未诉不适。入院前2天患者无明显诱因出现纳差，并逐渐出现乏力感，无恶心、呕吐，无腹痛、腹胀、腹泻，无发热、畏寒等不适，今为求进一步诊治，就诊我院，门诊拟“乙状结肠癌术后伴肝、骨、肺多发转移”收治入院，自发病以来，饮食较差，睡眠可，二便正常，体重较前无明显改变。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 15}, {"end_pos": 35, "label_type": "手术", "overlap": 0, "start_pos": 21}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 55, "end_pos": 71}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 105}, {"end_pos": 134, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 171}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"end_pos": 189, "label_type": "药物", "overlap": 0, "start_pos": 186}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"end_pos": 248, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"end_pos": 251, "label_type": "解剖部位", "overlap": 0, "start_pos": 250}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 281, "end_pos": 298}]}
{"originalText": "，缘于入院前[主诉单一时间1年于我院诊断“降结肠癌”，查无禁忌后，于2014年04月28日在全麻上行腹腔镜上右半结肠切除术。，术中见：无腹水，肝表面光滑，胃及空肠未见明显病变。降结肠可见一大约2*3CM隆起型肿物，质硬，侵出浆膜层，肠系膜根部未见明显肿大淋巴结，术顺，术后予抗炎、制酸、补液等对症治疗，，术后病理示：（结肠），：肠隆起型管状腺癌II级，侵及粘膜上层，手术标本双切端及另送（下切端）、（上切端）均未见癌浸润；找到肠周淋巴结14个，及另送（肠系膜动脉根部）淋巴结2个，均未见癌转移。，免疫组化结果：KI67（40%阳性），P53（-），P170（+），GSTπ（+），EGFR（-），5-FU（++），MLH1（++），MSH6（++），MGMT（++）。该病例未检测到BRAF基因V600E突变、未检测到KRAS基因12、13号密码子热点突变。术后恢复良好。1周前患者于我院行PET-CT提示肝转移，无寒战、发热，无恶心、呕吐，无反酸、嗳气、腹胀、消瘦、头晕、乏力、皮肤巩膜黄染再次。就诊于我院，遂门诊拟降结肠癌术后收入院。自发病以来，精神、睡眠、食欲尚可，大便如下述，小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 21, "end_pos": 25}, {"end_pos": 61, "label_type": "手术", "overlap": 0, "start_pos": 50}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 116, "end_pos": 117}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 164, "end_pos": 175}, {"end_pos": 218, "label_type": "解剖部位", "overlap": 0, "start_pos": 213}, {"end_pos": 237, "label_type": "解剖部位", "overlap": 0, "start_pos": 225}, {"label_type": "影像检查", "overlap": 0, "start_pos": 395, "end_pos": 401}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 403, "end_pos": 404}, {"end_pos": 429, "label_type": "解剖部位", "overlap": 0, "start_pos": 428}, {"end_pos": 435, "label_type": "解剖部位", "overlap": 0, "start_pos": 434}, {"end_pos": 442, "label_type": "解剖部位", "overlap": 0, "start_pos": 440}, {"end_pos": 444, "label_type": "解剖部位", "overlap": 0, "start_pos": 442}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 459, "end_pos": 465}]}
{"originalText": "患者1月余前因“胃恶性肿瘤”于我院就诊，于2016-10-25在全麻上行“胃癌根治术”，手术顺利，术后恢复良好，术后病理胃窦小弯腺癌（中度分化），体积4*3.5*1.4CM，浸润溃疡型，侵达浆膜，累及十二指肠，于部分脉管中查见癌栓，未累及近端切线。距远端切线甚近。呈“五组”（1/1个）、“第六组”（2/2个）淋巴结癌转移。四组（7个）、六组（7个）、“一三七组”（10个）淋巴结未查见癌。免疫组化染色示癌组织：CERBB-2（2+）、SYN（-）、β-TUBULIN-III（-）、RRM1少数（+）、TOPOII多数（+）、CD34血管（+）、D2-40淋巴结（+）。结合患者病情及肿瘤病理与分期继续予行术后化疗，给予“奥沙利铂200MG D1+亚叶酸钙0.3G D2-6 +替加氟1000MG D2-6 静滴”方案化疗，同时辅以镇吐、升血、免疫调节等对症支持治疗，恢复良好出院。今为行第二次化疗于我科就诊，门诊以“胃癌术后”收入院。  患者自发病以来，精神情绪及体力良好，食欲、饮食、睡眠好，小便正常。体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 8, "end_pos": 13}, {"end_pos": 42, "label_type": "手术", "overlap": 0, "start_pos": 37}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 60, "end_pos": 72}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 100}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 134, "end_pos": 158}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 162, "end_pos": 190}, {"end_pos": 316, "label_type": "药物", "overlap": 0, "start_pos": 312}, {"end_pos": 329, "label_type": "药物", "overlap": 0, "start_pos": 325}, {"end_pos": 343, "label_type": "药物", "overlap": 0, "start_pos": 340}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 410, "end_pos": 414}]}
{"originalText": "，缘于入院前1+个月（2014.05.30）因“卵巢浆液性乳头状囊腺癌”就诊我科在全麻上行“全子宫+两附件切除+腹盆腔粘连松解术”，术前查，CA125：144.50U/ML（2014.05.27）；，术中见：腹水300ML，色黄，子宫略小，子宫右前侧壁上段见结节状增生约0.8CM，右卵巢萎缩状，右输卵管未见占位病变，左附件区一囊实性包块约7*9*12CM，表面不规则，包膜尚完整，与肠管及左侧腹壁广泛粘连，松解粘连后见肠系膜及陶氏腔少许乳头状结节。术中满意减瘤（无肉眼残留）。术后恢复可，腹部切口愈合良好，术后病理回报（201416906），：左卵巢高级别浆液性乳头状囊腺癌，伴坏死；另见输卵管下皮呈中度不典型增生；（201416919），：送检(肠系膜结节)中见腺癌浸润；（C1401074）腹水涂片未见肿瘤细胞。入院前31天（2014.06.13）查CA12581.07U/ML，遂于入院前27天（2014.06.17）予以“‘紫杉醇240MGIVGTTD1+洛铂50MGIPD1’”方案行术后第1次辅助化疗，化疗过程顺利，停药第5天出现骨髓抑制I度、药物性肝损害，予升白、保肝对症治疗后好转出院。出院后一般情况可，现拟行术后第2次化疗，就诊我院门诊，门诊拟“卵巢浆液性乳头状囊腺癌（IIIB期，G1）术后”收住入院。自下次出院以来，饮食、睡眠可，二便正常，体重无明显减轻。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 24, "end_pos": 35}, {"label_type": "手术", "overlap": 0, "start_pos": 46, "end_pos": 64}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 70, "end_pos": 75}, {"end_pos": 105, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 141}, {"end_pos": 152, "label_type": "解剖部位", "overlap": 0, "start_pos": 148}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 194, "label_type": "解剖部位", "overlap": 0, "start_pos": 192}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 197, "end_pos": 198}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 210, "end_pos": 211}, {"end_pos": 217, "label_type": "解剖部位", "overlap": 0, "start_pos": 214}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"end_pos": 235, "label_type": "解剖部位", "overlap": 0, "start_pos": 234}, {"end_pos": 247, "label_type": "解剖部位", "overlap": 0, "start_pos": 245}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 273, "end_pos": 288}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 295, "end_pos": 298}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 325, "end_pos": 326}, {"end_pos": 349, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"end_pos": 420, "label_type": "药物", "overlap": 0, "start_pos": 417}, {"end_pos": 435, "label_type": "药物", "overlap": 0, "start_pos": 433}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 472, "end_pos": 478}, {"end_pos": 483, "label_type": "解剖部位", "overlap": 0, "start_pos": 482}, {"end_pos": 492, "label_type": "解剖部位", "overlap": 0, "start_pos": 491}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 533, "end_pos": 556}]}
{"originalText": "缘于入院前8日于我院诊为“宫颈鳞癌”，于2015年04月22日在全麻上行“广泛全子宫两附件切除术+盆腔淋巴结清扫术+阔韧带肌瘤剥除术+阴道顶悬吊术”，术中见“腹腔内未见明显腹水；子宫萎缩，表面凹凸不平，活动可；左侧阔韧带见一肌瘤，大小约3×4CM；两侧输卵管结扎术后改变；两侧卵巢外观正常，肝、脾、膈上、肠管、肠系膜、腹膜等未见明显异常”。术后病理（201514785）示：“(全子宫+两附件)1.宫颈内生浸润性鳞状细胞癌II级，肿瘤垂直浸润＞1/2肌层，水平浸润25MM，组织学内口、阴道切端、右宫旁组织及左宫旁组织均未肿瘤侵犯；找到(右盆腔）淋巴结5个，(左盆腔）淋巴结8个，(右髂总）淋巴结2个，(左髂总）淋巴结6个，均未见癌转移；2.子宫肌间多发性平滑肌瘤，伴玻璃样变性，宫内膜呈萎缩改变；3.右、左卵巢组织；4.右、左输卵管组织”。术后给予对症、营养支持等治疗，恢复良好，伤口愈合II/甲，予办理出院。此次为化疗就诊我院，门诊拟“宫颈鳞癌术后”收入院。自病以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 13, "end_pos": 17}, {"label_type": "手术", "overlap": 0, "start_pos": 37, "end_pos": 73}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"end_pos": 87, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 105}, {"end_pos": 132, "label_type": "手术", "overlap": 0, "start_pos": 124}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 136}, {"end_pos": 146, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"end_pos": 148, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 155, "end_pos": 156}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 159, "end_pos": 160}, {"end_pos": 192, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"end_pos": 196, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 199, "end_pos": 214}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 243}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 248, "end_pos": 250}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 254, "end_pos": 256}, {"end_pos": 276, "label_type": "解剖部位", "overlap": 0, "start_pos": 268}, {"end_pos": 287, "label_type": "解剖部位", "overlap": 0, "start_pos": 279}, {"end_pos": 298, "label_type": "解剖部位", "overlap": 0, "start_pos": 290}, {"end_pos": 309, "label_type": "解剖部位", "overlap": 0, "start_pos": 301}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 321, "end_pos": 332}, {"end_pos": 343, "label_type": "解剖部位", "overlap": 0, "start_pos": 340}, {"end_pos": 356, "label_type": "解剖部位", "overlap": 0, "start_pos": 351}, {"end_pos": 367, "label_type": "解剖部位", "overlap": 0, "start_pos": 361}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 420, "end_pos": 426}, {"end_pos": 447, "label_type": "解剖部位", "overlap": 0, "start_pos": 446}, {"end_pos": 450, "label_type": "解剖部位", "overlap": 0, "start_pos": 449}]}
{"originalText": "，患者1个月余前因“吞咽困难1月余。”就诊我院我科，完善相关检查后诊断残胃癌，排除手术禁忌症后于2016.5.23在全麻上行残胃癌切除术+复杂肠粘连松解术+ROUX-EN-Y吻合术，术程顺利，术后预防感染支持对症等处理，恢复好，切口甲级愈合。，术后病理示：中至低分化腺癌（LAUREN，分型：肠型），癌组织浸润至胃壁浆膜层并侵犯邻近的肝组织被膜，并累及食管壁深肌层，可见脉管内癌栓及神经束侵犯；PT4N3M0 IIIC期。患者术后恢复可，出院后生活质量可，于2016.6.24于我院经随机分组纳入CAPITAL临床试验行术后辅助化疗，签署知情同意书后行 SOX （奥沙利铂150ｍｇ+替吉奥60MG BID）方案化疗一程，化疗过程顺利，出现I°骨髓抑制，无其他明显不适。现为行上一程化疗来我院门诊就诊，拟“残胃癌综合治疗后”收入我科。起病以来，患者精神尚可，食欲尚可，大小便正常，体重稍减轻。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 35, "end_pos": 38}, {"label_type": "手术", "overlap": 0, "start_pos": 62, "end_pos": 90}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 128, "end_pos": 149}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 167, "end_pos": 168}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 176, "end_pos": 178}, {"end_pos": 286, "label_type": "药物", "overlap": 0, "start_pos": 282}, {"end_pos": 295, "label_type": "药物", "overlap": 0, "start_pos": 292}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 320, "end_pos": 326}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 353, "end_pos": 361}]}
{"originalText": "入院前4+月，患者因“大便习惯改变伴大便带血6月，加重2月。”于我科住院治疗，完善相关检查，诊断为“直肠腺癌（PT2N0M0）”，于2016年2月6日在全麻上行腹腔镜上直肠癌根治术（DIXON）。术后病理报告（1601061）：（直肠）中分化腺癌，侵及深肌层。远、近端切缘及环周切缘未见癌累及。肠周淋巴结未见癌转移（0/11）。术后予以补液、止血、抗感染、对症支持、伤口换药等处理，恢复较好，无特殊不适，好转出院。术后分别于2016-02-27日、3月25日、4月19日,5月13日于我科行化疗4次，方案均为奥沙利铂+雷替曲塞，化疗后患者偶有肢体麻木，无明显恶心、呕吐、腹痛、腹胀、便血等表现，遵医嘱于今日至我院行直肠癌术后第5次化疗。故以\\\"直肠癌术后第5次化疗\\\"收入我科住院治疗。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 50, "end_pos": 63}, {"label_type": "手术", "overlap": 0, "start_pos": 80, "end_pos": 97}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 114, "end_pos": 123}, {"end_pos": 152, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 258, "label_type": "药物", "overlap": 0, "start_pos": 254}, {"end_pos": 263, "label_type": "药物", "overlap": 0, "start_pos": 259}, {"end_pos": 286, "label_type": "解剖部位", "overlap": 0, "start_pos": 285}, {"end_pos": 289, "label_type": "解剖部位", "overlap": 0, "start_pos": 288}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 307, "end_pos": 312}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 322, "end_pos": 327}]}
{"originalText": "，缘于入院前1月于我院诊为小肠癌，于2015-11-09在全麻上行小肠癌根治术，，术中见：腹腔内无明显腹水，大网膜、盆腹腔未见转移结节，距TREITZ韧带约6CM处空肠可触及肿物，大小约7×5×4CM，侵出浆膜层，环周生长，系膜侧可触及多个肿大淋巴结，最大直径约0.8CM，近端肠管无明显扩张。术后病理（201540286）示(小肠)，：溃疡型乳头状-管状腺癌II级，侵及浆膜层，手术标本双切端及另送（近切端）（远切端）均未见癌浸润。找到肠周淋巴结19个及另送（系膜）淋巴结1个，(肠系膜根部)淋巴结1个，均未见癌转移。术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。此次为化疗再次就诊我院，门诊拟小肠管状腺癌（PT4AN0M0IIB期）术后收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 13, "end_pos": 16}, {"end_pos": 39, "label_type": "手术", "overlap": 0, "start_pos": 33}, {"end_pos": 47, "label_type": "解剖部位", "overlap": 0, "start_pos": 45}, {"end_pos": 52, "label_type": "解剖部位", "overlap": 0, "start_pos": 51}, {"end_pos": 57, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 69}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 82}, {"end_pos": 141, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 169, "end_pos": 183}, {"end_pos": 224, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"end_pos": 237, "label_type": "解剖部位", "overlap": 0, "start_pos": 230}, {"end_pos": 250, "label_type": "解剖部位", "overlap": 0, "start_pos": 240}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 304, "end_pos": 326}, {"end_pos": 348, "label_type": "解剖部位", "overlap": 0, "start_pos": 347}, {"end_pos": 351, "label_type": "解剖部位", "overlap": 0, "start_pos": 350}]}
{"originalText": "，患者因“便血伴便细近2月，加重5天”进一步确诊为直肠癌于2016-4-11在我院予行全麻上直肠肿瘤DIXON切除术，，术中探查见：腹腔内无腹水，腹膜无转移，肝脏未触及转移病灶，肿瘤位于直肠上段，腹腔内无法触及，病人肥胖，系膜未触及肿大淋巴结。手术顺利，术后积极予相关对症支持治疗并恢复总体平稳；相关手术病理示直肠腺癌（中、低度分化）,隆起型,体积3.5*3*0.8CM,侵达浅肌层,未累及底部切除面。双端切线及另送“近切线”、“远切线”未查见癌。肠壁一站（13个）、二站（10个）淋巴结未查见癌。，免疫组化染色示：SYN（-）、TS较多（+）。患者于术后20天康复出院；依据患者病情及肿瘤病理与分期继续术后辅助性化疗指征存在，依情于2016-4-26给予术后首周期辅助化疗，，具体用药为：奥沙利铂200MG D1+亚叶酸钙0.3G D2-6 +替加氟1000MG D2-6 静滴，同时辅以镇吐、升血、免疫调节等对症支持治疗（化疗过程总体顺利）。其后给予原方案化疗3周期。自下次出院以来，患者一般情况保持良好；无发热，无恶心、呕吐，无反酸、嗳气，无明显进食不适；持续未现明显腹痛、腹胀。现患者为行复查并辅助化疗而再来我院就诊，门诊依情以“直肠癌术后”收入院。目前患者精神及情绪状态良好，食欲、饮食好，夜间睡眠后；肛门排气排便存在（排便次数偏多）。述近期无明显体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 25, "end_pos": 28}, {"end_pos": 58, "label_type": "手术", "overlap": 0, "start_pos": 46}, {"end_pos": 68, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 73, "end_pos": 74}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 93, "end_pos": 95}, {"end_pos": 100, "label_type": "解剖部位", "overlap": 0, "start_pos": 98}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 155, "end_pos": 171}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 224, "end_pos": 244}, {"end_pos": 349, "label_type": "药物", "overlap": 0, "start_pos": 345}, {"end_pos": 362, "label_type": "药物", "overlap": 0, "start_pos": 358}, {"end_pos": 376, "label_type": "药物", "overlap": 0, "start_pos": 373}, {"end_pos": 488, "label_type": "解剖部位", "overlap": 0, "start_pos": 487}, {"end_pos": 491, "label_type": "解剖部位", "overlap": 0, "start_pos": 490}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 519, "end_pos": 524}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 556, "end_pos": 558}]}
{"originalText": "，患者2015-06因“无明显诱因出现大便带鲜血，量少，伴大便次数增加至2-3次/天5月”，外院肠镜检查提示乙状结肠距肛门18-20CM肿物，大小2×1CM，肠镜能通过，活检病理提示腺癌，大肠多发息肉。转诊我院2015-06-20在全麻上行DIXON术，，术后病理示：（乙状结肠大体）镜检为结肠中分化腺癌，浸润至肠壁浆膜上层，癌组织侵犯神经束，脉管内见癌栓；经多取材另见淋巴结2枚，未见癌。2（近切缘）未见癌。3（远切缘）未见癌。4（中央组淋巴结）1枚，未见癌。5（中间组淋巴结）2枚，1/2见腺癌转移。6（肠旁淋巴结）2枚，未见癌。，免疫组化：ER（-），ERCC1（+），MLH1（+），MSH2（+），MSH6（+），PMS2（+），KI67（70%+），分期PT3N1AM0,IIIB期。术顺，术后切口愈合佳。于2015-07-18、2015-08-07、2015-08-28行XELOX方案辅助化疗3程，过程顺利。3程化疗后于2015-09-17行胸片及彩超复查未见肿瘤复发转移征象。现患者为行上程化疗入院。近3周来，患者精神睡眠可，胃纳可，二便正常，体重无明显上降。", "entities": [{"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 91, "end_pos": 93}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 94, "end_pos": 100}, {"end_pos": 126, "label_type": "手术", "overlap": 0, "start_pos": 120}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 145, "end_pos": 152}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 156, "end_pos": 157}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 217}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 233, "end_pos": 239}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 247, "end_pos": 249}, {"end_pos": 259, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}, {"label_type": "影像检查", "overlap": 0, "start_pos": 429, "end_pos": 431}, {"label_type": "影像检查", "overlap": 0, "start_pos": 432, "end_pos": 434}, {"end_pos": 473, "label_type": "解剖部位", "overlap": 0, "start_pos": 472}]}
{"originalText": "，入院前5个月余诊断为“贲门-胃体癌”，于2013.12.25在我科行“腹腔镜辅助上根治性全胃切除（D2）+食管空肠ROUX-EN-Y吻合术”，术顺，术后病理（201341015），：(全胃)，：食管胃交界溃疡型管状腺癌III级，伴神经内分泌分化，侵出浆膜层，手术标本下、上切端和另送（下切端）均未见癌浸润。找到贲门周淋巴结11个，小弯淋巴结13个、大弯淋巴结11个、幽门下淋巴结4个、幽门上淋巴结14个和另送(胃右动脉根部)淋巴结4个、(脾门)淋巴结4个均未见癌转移。另送(脾动脉旁淋巴结)为纤维脉管脂肪组织。，免疫组化结果：KI67（60%），P53（+++），P170（++），GSTπ（++），EGFR（-），5-FU（++），HER-2（-），SY（+）。术后予预防感染、补液、营养支持、调节免疫等治疗，恢复良好后出院。于2014.01.28,2014.02.21，2014.3.18，2014.04.16按“奥沙利铂100MGIVGTTD1+替吉奥40MGBIDPOD2-15”方案行术后化疗，辅以保肝、止吐、增强免疫等治疗，过程顺利。现为行术后第4周期化疗就诊我院，门诊拟“胃癌术后化疗”收入院。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 12, "end_pos": 18}, {"label_type": "手术", "overlap": 0, "start_pos": 36, "end_pos": 70}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 98, "end_pos": 123}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"end_pos": 171, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"end_pos": 180, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"end_pos": 216, "label_type": "解剖部位", "overlap": 0, "start_pos": 205}, {"end_pos": 226, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 238}, {"end_pos": 414, "label_type": "药物", "overlap": 0, "start_pos": 410}, {"end_pos": 430, "label_type": "药物", "overlap": 0, "start_pos": 427}, {"end_pos": 457, "label_type": "解剖部位", "overlap": 0, "start_pos": 456}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 494, "end_pos": 498}]}
{"originalText": "，患者因“大便带血”并进一步确诊为直肠癌于2015-2-9在全麻上行腹会阴联合直肠癌根治术（MILES手术）。，术中探查见：腹腔内无腹水，腹膜无转移，肝脏未触及转移结节，肿瘤位于直肠上段，腹腔内无法探及。直肠系膜内可触及肿大淋巴结。手术顺利，患者术后积极予相关对症支持治疗并恢复总体平稳。相关手术病理(201502427），回示：（直肠）腺癌（中度分化），浸润型，体积5*4.5*1CM，侵达外膜。 双端切线未查见癌； 一站（12个）、二站（4个）、中间组（5个）及中央组（1个）淋巴结未查见癌；，免疫组化染色示癌组织：TS少量（+）、SYN（-）。患者术后于相关化疗治疗。现患者1月前出现阴道内流出少量液体，于2016-10-13日行腹盆部CT示盆腔内占位性病变，考虑局部复发并侵及局部阴道壁可能性大，门诊依情以“直肠癌术后复发”收入院。目前患者精神及情绪状态良好，食欲、饮食好，夜间睡眠好；间断性结肠造口排气排便顺畅并性状良好。述近期无明显体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 17, "end_pos": 20}, {"label_type": "手术", "overlap": 0, "start_pos": 34, "end_pos": 54}, {"end_pos": 64, "label_type": "解剖部位", "overlap": 0, "start_pos": 62}, {"end_pos": 67, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 70}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"end_pos": 96, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 102, "end_pos": 104}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 169, "end_pos": 181}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 210, "end_pos": 243}, {"end_pos": 297, "label_type": "解剖部位", "overlap": 0, "start_pos": 295}, {"label_type": "影像检查", "overlap": 0, "start_pos": 318, "end_pos": 323}, {"end_pos": 326, "label_type": "解剖部位", "overlap": 0, "start_pos": 324}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 344, "end_pos": 346}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 358, "end_pos": 363}, {"end_pos": 402, "label_type": "解剖部位", "overlap": 0, "start_pos": 400}]}
{"originalText": "，因“进食后胸骨不适半年”，当地胃镜提示：胃窦溃疡型隆起性病变。诊断胃癌。体重较前稍有上降。我院行胃癌根治术，，术后病理：胃隆起型高分化腺癌，伴粘液分泌，大小10.5×XXX6.5CM，LAUREN，分型：肠型；癌侵及浆膜上纤维脂肪组织；可见脉管癌栓；胃残端、（十二指肠残端）及网膜组织均未见癌；淋巴结未见癌转移（第1组0/2、第3组0/0、第4SB组0/7、第4D组0/2、第5组0/3、第6组0/21、第7组0/11、第8A组0/4、第8P组0/1、第9组0/9、第11P组0/1、第12A组0/0、第12P组0/1)；，肿瘤病理分期：PT3N0。，免疫组化结果显示:B-CATENIN(+),CD147(+),CD44(－),CMET(1+),EGFR(3+),HER2(0),KI67(+90%),MLH1(+＜25%),MSH2(+＞75%),MSH6(+＞75%),P-CADHERIN(+＞75%),PMS2(+25～50%),TTF-1(－)。术后恢复可，拟行术后化疗。2015-6-11开始行SOX术后辅助化疗，无明显不良反应。", "entities": [{"end_pos": 8, "label_type": "解剖部位", "overlap": 0, "start_pos": 6}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 21, "end_pos": 31}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 34, "end_pos": 36}, {"end_pos": 54, "label_type": "手术", "overlap": 0, "start_pos": 49}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 61, "end_pos": 70}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 126}, {"end_pos": 135, "label_type": "解剖部位", "overlap": 0, "start_pos": 131}]}
{"originalText": "，患者因“直肠癌”于2016-11-08于我院在全麻上予行直肠HARTMANN手术，术后病理（3766.2013），回示：病理诊断 ，:直肠腺癌（中度分化），浸润溃疡型，体积8*6*0.6CM，侵达外膜脂肪组织，未累及切除面。双端切线未查见癌。呈肠壁一站（1/22个）淋巴结癌转移。肠壁二站（2个）淋巴结未查见癌。低级别腺管状腺瘤。，免疫组化染色示癌组织：SYN（-）、BRAF（-）、MLH1（+）、MSH2（+）、MSH6（+）、PMS2（+）。患者术后恢复好。根据患者病情，除外化疗禁忌症，于2016-12-8、201-01-08给予化疗双周期，，方案为：奥沙利铂200MG DL+亚叶酸钙0.3GD2-6+替加氟1000MG D2-6静滴，同时给予升白细胞、护肝、止吐、免疫增强治疗，无明显化疗副反应。自下次出院后，患者一般情况保持良好， 无乏力感，无发热，无恶心、呕吐，无反酸、嗳气，无明显进食不适，未现明显 腹痛、腹胀；大小便情况良好。现患者为行复查来我院就诊，门诊以“直肠癌术后”收入院。目前患者精神及情绪状态可，食欲、饮食好，夜间睡眠可，大便出现便秘，不规律，不成形，小便正常，近期无明显体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 5, "end_pos": 8}, {"end_pos": 41, "label_type": "手术", "overlap": 0, "start_pos": 29}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 68, "end_pos": 84}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 123, "end_pos": 137}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 141, "end_pos": 152}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 157, "end_pos": 165}, {"end_pos": 285, "label_type": "药物", "overlap": 0, "start_pos": 281}, {"end_pos": 298, "label_type": "药物", "overlap": 0, "start_pos": 294}, {"end_pos": 310, "label_type": "药物", "overlap": 0, "start_pos": 307}, {"end_pos": 335, "label_type": "解剖部位", "overlap": 0, "start_pos": 334}, {"end_pos": 411, "label_type": "解剖部位", "overlap": 0, "start_pos": 410}, {"end_pos": 414, "label_type": "解剖部位", "overlap": 0, "start_pos": 413}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 441, "end_pos": 446}]}
{"originalText": "缘于入院前9天（2013.12.24）因“卵巢癌”于我院行“全子宫+两附件切除术+阑尾+大网膜切除术+盆腔淋巴结清扫术”。术中见腹腔内淡黄色腹水约200ML，取腹水30ML送细胞学检查，子宫体前位，常大，右卵巢囊实性增大约10*10*10CM大小，色灰白，表面光滑，包膜完整，组织脆烂，与周围组织无粘连，内见淡黄色粘稠样液体流出，右输卵管及左附件外观正常，肝、脾、膈上、肠管、肠系膜、腹膜等未见明显异常。切除右附件送冰冻，病理回报（201340780）：卵巢恶性下皮性肿瘤，考虑为粘液性囊腺癌，输卵管未见肿瘤细胞浸润。遂行下术，术顺，术后恢复好，术后病理（201340902）（左侧）卵巢及输卵管组织；盆腔淋巴结均未见癌转移；(大网膜)送检网膜组织未见癌细胞种植转移；（阑尾）阑尾组织未见癌细胞种植转移，呈阑尾周围炎改变。（C132334）腹水涂片未见肿瘤细胞。余病理未报。现患者无畏冷、发热，无咳嗽、咳痰，无腹痛、腹胀，无头晕、眼花，胸闷、心悸等不适，要求入院化疗，门诊拟“右卵巢粘液性囊腺癌IA期术后”收入院。发病以来，精神、睡眠、食欲一般，大小便正常，体重无明显增减。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 21, "end_pos": 24}, {"label_type": "手术", "overlap": 0, "start_pos": 30, "end_pos": 59}, {"end_pos": 66, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 96, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"end_pos": 105, "label_type": "解剖部位", "overlap": 0, "start_pos": 102}, {"end_pos": 169, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"end_pos": 179, "label_type": "解剖部位", "overlap": 0, "start_pos": 178}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 188, "end_pos": 189}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 192, "end_pos": 193}, {"end_pos": 207, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 227, "end_pos": 236}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 240, "end_pos": 246}, {"end_pos": 250, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"end_pos": 294, "label_type": "解剖部位", "overlap": 0, "start_pos": 288}, {"end_pos": 298, "label_type": "解剖部位", "overlap": 0, "start_pos": 295}, {"end_pos": 306, "label_type": "解剖部位", "overlap": 0, "start_pos": 301}, {"end_pos": 337, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}, {"end_pos": 340, "label_type": "解剖部位", "overlap": 0, "start_pos": 338}, {"end_pos": 355, "label_type": "解剖部位", "overlap": 0, "start_pos": 353}, {"end_pos": 371, "label_type": "解剖部位", "overlap": 0, "start_pos": 370}, {"end_pos": 406, "label_type": "解剖部位", "overlap": 0, "start_pos": 405}, {"end_pos": 409, "label_type": "解剖部位", "overlap": 0, "start_pos": 408}, {"end_pos": 413, "label_type": "解剖部位", "overlap": 0, "start_pos": 412}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 415, "end_pos": 416}, {"end_pos": 419, "label_type": "解剖部位", "overlap": 0, "start_pos": 418}, {"end_pos": 422, "label_type": "解剖部位", "overlap": 0, "start_pos": 421}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 438, "end_pos": 452}]}
{"originalText": "患者于2014年7月7日因“卵巢癌”在全麻上行剖腹探查+卵巢癌细胞减灭术（全子宫、两侧附件、大网膜、阑尾、盆腔转移灶、直肠转移灶切除+盆腔淋巴结清扫术），术后病检结果为：左卵巢浆液性乳头状腺癌； (直肠表面转移灶、腹腔转移灶)见癌组织。（大网膜）未见癌累及。（右盆腔淋巴结、左盆腔淋巴结）未见癌转移（0/6、0/6）。于7月20日行术后第一次TP方案（紫杉醇静脉滴入+顺铂腹腔灌注）联合化疗，于2014年8月12日第二次行TP（紫杉醇静脉滴入+顺铂腹腔灌注）方案化疗，于2014年9月2日行第三次化疗，化疗方案为TP方案（紫杉醇+奈达铂）静脉化疗，于2014年9月22日行第四次化疗，化疗方案为TP方案（紫杉醇+奈达铂）静脉化疗，化疗后无明显毒副反应。于2014年10月13日行第五次化疗，化疗方案为TP方案（紫杉醇+奈达铂）静脉化疗，化疗后无明显毒副反应。于2014年11月04日第六次化疗，化疗方案为TP方案（紫杉醇+奈达铂）静脉化疗，化疗后无明显毒副反应，出院后定期复查电解质及血常规。今患者为行第7次化疗再入院，门诊拟以“卵巢浆液性乳头状腺癌IIIC期术后，拟行第7次化疗”收治入院。   患者自患病以来，精神、食欲尚可，睡眠可，大小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"label_type": "手术", "overlap": 0, "start_pos": 23, "end_pos": 76}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 85, "end_pos": 96}, {"end_pos": 101, "label_type": "解剖部位", "overlap": 0, "start_pos": 99}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 107}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"end_pos": 143, "label_type": "解剖部位", "overlap": 0, "start_pos": 137}, {"end_pos": 179, "label_type": "药物", "overlap": 0, "start_pos": 176}, {"end_pos": 186, "label_type": "药物", "overlap": 0, "start_pos": 184}, {"end_pos": 188, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"end_pos": 217, "label_type": "药物", "overlap": 0, "start_pos": 214}, {"end_pos": 224, "label_type": "药物", "overlap": 0, "start_pos": 222}, {"end_pos": 226, "label_type": "解剖部位", "overlap": 0, "start_pos": 224}, {"end_pos": 264, "label_type": "药物", "overlap": 0, "start_pos": 261}, {"end_pos": 268, "label_type": "药物", "overlap": 0, "start_pos": 265}, {"end_pos": 305, "label_type": "药物", "overlap": 0, "start_pos": 302}, {"end_pos": 309, "label_type": "药物", "overlap": 0, "start_pos": 306}, {"end_pos": 358, "label_type": "药物", "overlap": 0, "start_pos": 355}, {"end_pos": 362, "label_type": "药物", "overlap": 0, "start_pos": 359}, {"end_pos": 410, "label_type": "药物", "overlap": 0, "start_pos": 407}, {"end_pos": 414, "label_type": "药物", "overlap": 0, "start_pos": 411}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 465, "end_pos": 482}]}
{"originalText": "，缘于入院前6个月“进行性眼黄、尿黄、皮肤黄染30天”为主诉入我科住院，考虑十二指肠乳头占位，并于全麻上行“胰十二指肠切除术”，术中见腹腔内无腹水，腹壁及盆底未触及种植结节。肝脏表面张力高，呈淤胆改变，形态、大小正常，未触及肿物，胆囊约8×5×4CM3，表面张力高，无充血、水肿，未触及结石，肝脏及胆囊与大网膜粘连明显，予松解。胆总管扩张，直径约1.5CM。十二指肠降部触及一肿物，质硬。，术后病理回报：1、（胰十二指肠），：十二指肠乳头部浸润型管状腺癌II-III级，侵犯神经，侵及深肌层，未侵犯胆总管及胰腺，手术标本胃切端、小肠切端、胰腺切端及胆总管切端均未见癌浸润。找到胃周淋巴结1个、胰腺周淋巴结2个，及另送（肝十二指肠韧带）淋巴结1个和（肝总动脉旁）淋巴结4个均未见癌转移。2、，胆囊：慢性胆囊炎，胆石症。术后患者恢复好，皮肤黄染逐渐消退，无发热、呕吐、腹泻、血便等。近1个月患者偶有下腹部闷痛，行走时明显，无发热、呕吐、腹胀、黑便、皮肤黄染等不适。为进一步复查，再次求诊我院，门诊拟“十二指肠癌术后”收住入院。本病以来患者精神睡眠食欲大致可，二便无明显异常，体重无明显改变。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"end_pos": 44, "label_type": "解剖部位", "overlap": 0, "start_pos": 38}, {"end_pos": 62, "label_type": "手术", "overlap": 0, "start_pos": 54}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 74, "end_pos": 75}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 148, "label_type": "解剖部位", "overlap": 0, "start_pos": 146}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 205}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 213, "end_pos": 234}, {"end_pos": 252, "label_type": "解剖部位", "overlap": 0, "start_pos": 249}, {"end_pos": 255, "label_type": "解剖部位", "overlap": 0, "start_pos": 253}, {"end_pos": 261, "label_type": "解剖部位", "overlap": 0, "start_pos": 260}, {"end_pos": 266, "label_type": "解剖部位", "overlap": 0, "start_pos": 264}, {"end_pos": 271, "label_type": "解剖部位", "overlap": 0, "start_pos": 269}, {"end_pos": 277, "label_type": "解剖部位", "overlap": 0, "start_pos": 274}, {"end_pos": 293, "label_type": "解剖部位", "overlap": 0, "start_pos": 288}, {"end_pos": 302, "label_type": "解剖部位", "overlap": 0, "start_pos": 296}, {"end_pos": 320, "label_type": "解剖部位", "overlap": 0, "start_pos": 308}, {"end_pos": 333, "label_type": "解剖部位", "overlap": 0, "start_pos": 323}, {"end_pos": 347, "label_type": "解剖部位", "overlap": 0, "start_pos": 345}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 348, "end_pos": 353}, {"end_pos": 383, "label_type": "解剖部位", "overlap": 0, "start_pos": 382}, {"end_pos": 400, "label_type": "解剖部位", "overlap": 0, "start_pos": 397}, {"end_pos": 417, "label_type": "解剖部位", "overlap": 0, "start_pos": 416}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 448, "end_pos": 455}]}
{"originalText": "缘于入院前1+月,于我院诊断“子宫内膜癌”，在全麻上行“全子宫切除术+两侧附件切除术+肿瘤细胞减灭术+骶韧带悬吊术+大网膜肿物切除术”，术后予以预防感染、补液、营养支持等治疗，术后病理（201340184）（全子宫）：恶性苗勒氏管混合瘤，侵及宫体浆膜层(浸润深度&GT;1/2肌层)，宫颈组织学内口见肿瘤浸润。宫体肌间多发平滑肌瘤。慢性宫颈炎。术后诊断“子宫恶性苗勒氏管混合瘤IIIA期”，于2013.12.30及2014.01.21行化疗，化疗方案为“异环磷酰胺2G静滴D1-3+洛铂40MG腹腔注射”，并辅以止吐、保肝、抗过敏、补液等支持治疗，2次化疗过程中均出现骨髓抑制II度，予“惠尔血”升白处理。今为化疗再次就诊我院，门诊拟“子宫恶性苗勒氏管混合瘤IIIA期”收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 15, "end_pos": 20}, {"label_type": "手术", "overlap": 0, "start_pos": 28, "end_pos": 66}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 109, "end_pos": 118}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 123}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 142, "end_pos": 144}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 166, "end_pos": 171}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 177, "end_pos": 193}, {"label_type": "药物", "overlap": 0, "start_pos": 227, "end_pos": 232}, {"end_pos": 243, "label_type": "药物", "overlap": 0, "start_pos": 241}, {"end_pos": 249, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"end_pos": 261, "label_type": "解剖部位", "overlap": 0, "start_pos": 260}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 284, "end_pos": 291}, {"end_pos": 297, "label_type": "药物", "overlap": 0, "start_pos": 294}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 318, "end_pos": 334}, {"end_pos": 357, "label_type": "解剖部位", "overlap": 0, "start_pos": 356}, {"end_pos": 360, "label_type": "解剖部位", "overlap": 0, "start_pos": 359}]}
{"originalText": "术前化疗XELOX方案2周期，行根治性远端胃大部切除，术后病理：胃窦小弯侧溃疡型中-低分化腺癌，大小1.6×1.6CM，侵至胃壁深肌层（约4/5固有肌层），部分肿瘤细胞变性坏死（30％），未见脉管癌栓，淋巴结未见癌转移（第3组0/4、4D组0/2、第6组0/5、第7+9组0/6、第8组0/2、第11P组0/1、第12A、第1组0/0、第4SB组0/0、第5组0/0、第8P组0/0），胃断端及十二指肠断端未见癌，网膜组织未见特殊。目前进食可。", "entities": [{"end_pos": 26, "label_type": "手术", "overlap": 0, "start_pos": 16}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 32, "end_pos": 47}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 62, "end_pos": 63}, {"end_pos": 194, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}]}
{"originalText": "，患者于2017-5-22在全麻上行3D腹腔镜上直肠癌根治术（DIXON）。手术过程顺利，术后患者恢复良好。术后病理（201711714），：直肠管状粘液腺癌（低分化），浸润溃疡型，体积3*2.5*1CM，浸润浆膜上层。未侵犯切线（近切线12CM、远切线甚近）。 呈一站（11/11个）、二站（3/3个）淋巴结癌转移。，免疫组化染色示癌组织：SYN（-）、BRAF（-）、MLH1（+）、MSH2（+）、MSH6（+）、PMS2（+）。术后恢复顺利，先后给予2次辅助化疗（具体用药为），今日为行术后复查及再次化疗治疗来院，门诊以“直肠癌术后”收入。患者无发热，无头痛、头晕，无胸闷、心慌，无恶心、呕吐，无腹胀、腹痛，无黑便、便血；自下次出院以来病情稳定，精神可，食欲及饮食正常，夜间睡眠好，大便约2次/日，质软成形，小便次数有所增多，量及性状无明显异常，体重无明显改变。", "entities": [{"label_type": "手术", "overlap": 0, "start_pos": 24, "end_pos": 37}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 71, "end_pos": 90}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 133, "end_pos": 155}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 265, "end_pos": 270}, {"end_pos": 282, "label_type": "解剖部位", "overlap": 0, "start_pos": 281}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 284}, {"end_pos": 289, "label_type": "解剖部位", "overlap": 0, "start_pos": 288}, {"end_pos": 303, "label_type": "解剖部位", "overlap": 0, "start_pos": 302}, {"end_pos": 306, "label_type": "解剖部位", "overlap": 0, "start_pos": 305}]}
{"originalText": "，缘于入院前3个月于我院诊为胃癌，于2015-12-29在全麻上行根治性全胃切除术（食管空肠ROUX-Y吻合、D2+、R0)，术后病理（201547566），示：(全胃)，:胃体－胃窦溃疡型管状腺癌II级，侵及浆膜层，侵犯神经及脉管组织。手术标本下切端、上切端及另送（下切端）均未见癌浸润。找到贲门周淋巴结2/14个，小弯侧淋巴结0/1个，大弯侧淋巴结0/1个，幽门下淋巴结0/1个，幽门上淋巴结0/5个及另送(第8组)淋巴结0/1个、(第9组）淋巴结0/4个、(第11D组)淋巴结0/2个、(第11P组)淋巴结0/6个、(第14V组)淋巴结0/2个见癌转移。另送(第12组淋巴结)镜上为纤维脂肪组织。，免疫组化结果：肿瘤细胞示CK7（+），CK20（+），VILLIN（+），CDX-2（+），CEA（+），HER-2（2+），KI67（40%+）。术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。于2016.01.27、2016.02.17、2016.03.07予“奥沙利铂（艾恒）200MG静滴D1+氟尿嘧啶4000MG持续48H泵入”方案化疗，辅以止吐、保胃、护肝等支持治疗，化疗过程顺利，未见明显化疗副反应。此次为第4次化疗再次就诊我院，门诊拟胃癌术后化疗收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"label_type": "手术", "overlap": 0, "start_pos": 33, "end_pos": 62}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 83}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 87, "end_pos": 102}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 165, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 176, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 181}, {"end_pos": 198, "label_type": "解剖部位", "overlap": 0, "start_pos": 192}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 205, "end_pos": 213}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 218, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 231, "end_pos": 241}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 246, "end_pos": 256}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 261, "end_pos": 271}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 283, "end_pos": 290}, {"end_pos": 444, "label_type": "药物", "overlap": 0, "start_pos": 440}, {"end_pos": 447, "label_type": "药物", "overlap": 0, "start_pos": 445}, {"end_pos": 462, "label_type": "药物", "overlap": 0, "start_pos": 458}, {"end_pos": 488, "label_type": "解剖部位", "overlap": 0, "start_pos": 487}, {"end_pos": 491, "label_type": "解剖部位", "overlap": 0, "start_pos": 490}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 532, "end_pos": 536}, {"end_pos": 560, "label_type": "解剖部位", "overlap": 0, "start_pos": 559}, {"end_pos": 563, "label_type": "解剖部位", "overlap": 0, "start_pos": 562}]}
{"originalText": "，缘于入院前1月于我院诊为“胃窦癌”，于2016年10月27日在全麻上行腹腔镜上根治性远端胃大部切除术（D2,ROUX-EN-Y吻合）。，手术经过如上:腹腔镜探查见腹腔内无明显腹水，盆腔、腹壁、大网膜无转移结节，肝脏质地大小正常，未见明显转移病灶。腹腔镜上探查肿瘤位于胃窦小弯侧，未侵及浆膜层，周围未及明显肿大淋巴结，遂决定行“腹腔镜辅助上根治性远端胃大部切除+残胃空肠ROUX-Y吻合术（D2）”。术后予预防性抗感染、制酸、免疫调节及营养支持等治疗，恢复良好,伤口愈合II/甲。，术后病理：1、（远端胃），：胃体胃窦交界前壁早期（0-I型）管状腺癌II级，部分为黏液腺癌，侵及黏膜上层。手术标本下、上切端及另送（下切端）均未见癌浸润。找到另送（第1组）淋巴结0/4个，（第3组）淋巴结0/2个，（第4SB组）淋巴结0/4个，（第4D组）淋巴结0/4个，（第6组）淋巴结0/5个，（第7组）淋巴结0/8个，（第8A组）淋巴结0/1个，（第9组）淋巴结0/1个，（第11P组）淋巴结0/1个，（第12A组）淋巴结1/1个，见癌转移。2、（第5组淋巴结），：送检为纤维、脂肪和脉管组织。，免疫组化：KI67（50%+），CK7（+++），CK20（个别细胞阳性），VILLIN（+++），CD56（-）。此次为化疗再次就诊我院，门诊拟“胃窦癌术后”收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"label_type": "手术", "overlap": 0, "start_pos": 36, "end_pos": 67}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 76, "end_pos": 78}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 82}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"end_pos": 96, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"end_pos": 108, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"label_type": "手术", "overlap": 0, "start_pos": 164, "end_pos": 198}, {"end_pos": 252, "label_type": "解剖部位", "overlap": 0, "start_pos": 251}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 255, "end_pos": 286}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 322, "end_pos": 330}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 335, "end_pos": 343}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 348, "end_pos": 358}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 363, "end_pos": 372}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 377, "end_pos": 385}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 390, "end_pos": 398}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 403, "end_pos": 412}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 417, "end_pos": 425}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 430, "end_pos": 440}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 445, "end_pos": 455}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 468, "end_pos": 474}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 566, "end_pos": 571}, {"end_pos": 594, "label_type": "解剖部位", "overlap": 0, "start_pos": 593}, {"end_pos": 597, "label_type": "解剖部位", "overlap": 0, "start_pos": 596}]}
{"originalText": "，患者3月余前因“便血1年加重1天”入住我院，入院后完善相关检查，，结肠镜结果示：直肠癌，取病理送检。，病理示：（直肠）腺癌（201709974）。查无手术禁忌，于2017-05-15日行“直肠MILES术”，手术顺利，术后恢复可，，术后病理：（，病理号：201710980）（直肠）腺癌（中度分化），浸润溃疡型，体积5*3.5*0.8CM，浸润非腹膜覆盖的结直肠周围组织，双端切线未查见癌。呈“中间组”（2/10个）淋巴结转移。一站(4个）淋巴结未查见癌。，免疫组化染色示癌组织：SYN（-）、BRAF（-）、MLH1（+）、MSH2（+）、MSH6（+）、PMS2（+）。术后给予3程化疗，，具体用药为：奥沙利铂200MGD1+亚叶酸钙0.3G D2-6 +替加氟（方克）1G D2-6 静脉滴注；同时予镇吐、升血及免疫调节等对症支持治疗。过程顺利，患者出院。出院后病情稳定，现为求进一步复查治疗入院，门诊以“直肠癌术后”收入院。患者自发病以来神志清，精神、饮食可，夜间睡眠可，无发热，大小便正常，体重无明显改变。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 41, "end_pos": 44}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 56, "end_pos": 62}, {"end_pos": 103, "label_type": "手术", "overlap": 0, "start_pos": 95}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 138, "end_pos": 156}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 174, "end_pos": 175}, {"end_pos": 182, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 197, "end_pos": 212}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 215, "end_pos": 224}, {"end_pos": 308, "label_type": "药物", "overlap": 0, "start_pos": 304}, {"end_pos": 320, "label_type": "药物", "overlap": 0, "start_pos": 316}, {"end_pos": 334, "label_type": "药物", "overlap": 0, "start_pos": 331}, {"end_pos": 337, "label_type": "药物", "overlap": 0, "start_pos": 335}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 407, "end_pos": 412}]}
{"originalText": "，患者4个月前因“便秘2月余”入住我院消化内科，行胸、腹、，盆腔CT示：两肺上叶纤维灶，肝多发囊肿、肾囊肿，直肠壁增厚、符合直肠CA表现。为行手术治疗，转我科。完善相关术前检查后，于2016-02-15行直肠癌根治术，，术后病理：直肠腺癌（中低度分化），部分呈粘液腺癌图像，浸润溃疡型，体积6.5*5*0.6CM。 侵达被膜。 双端切线及另送“直肠近切线”、“直肠远切线”未查见癌。 呈肠壁一站（2/11个）淋巴结癌转移。 符合炎性增生性息肉。 ，免疫组化染色示：TS部分（+）、SYN（-）。术后给予补液，换药及对症支持治疗并口服希罗达行化学治疗。   院外期间患者一般情况可，无发热，无腹痛腹胀胀不适，现患者为行复查及本周期化疗再次来我院就诊，门诊以“直肠术后”收住入院。   患者自下次出院来，神志清，精神可，饮食尚可，大小便正常，体重无明显变化。", "entities": [{"label_type": "影像检查", "overlap": 0, "start_pos": 25, "end_pos": 34}, {"end_pos": 40, "label_type": "解剖部位", "overlap": 0, "start_pos": 36}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 44, "end_pos": 49}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 50, "end_pos": 53}, {"end_pos": 57, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 62, "end_pos": 66}, {"end_pos": 108, "label_type": "手术", "overlap": 0, "start_pos": 102}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 115, "end_pos": 142}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 172}, {"end_pos": 182, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 193, "end_pos": 194}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 214, "end_pos": 221}, {"end_pos": 269, "label_type": "药物", "overlap": 0, "start_pos": 266}, {"end_pos": 296, "label_type": "解剖部位", "overlap": 0, "start_pos": 295}, {"end_pos": 298, "label_type": "解剖部位", "overlap": 0, "start_pos": 297}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 328, "end_pos": 332}]}
{"originalText": "，患者入院完善相关检查，诊断\\\"乙状结肠癌 右肾下腺转移？ \\\"，未见手术禁忌，2015-07-31全麻上行乙状结肠切除+右肾下腺切除术，术中见肿瘤侵犯浆膜，近端结肠不全梗阻，，术后病理回报：1（乙状结肠大体）镜检为中分化腺癌，浸润至肠壁浆膜上层，未见明确脉管及神经束侵犯，并可见脓肿形成。2（近切缘）未见癌。3（远切缘）未见癌。4（中央淋巴结）镜上为脂肪结缔组织，未见癌。5（中间淋巴结）5枚，未见癌。6（肠旁淋巴结）10枚，未见癌。7（右肾下腺肿物）镜上为肾下腺组织，未见癌。，免疫组化：ER（-），ERCC1（+），MSH2（-），MSH6（+），PMS2（+），MLH1（+），KI67（60%+）。患者术后恢复可。并于今日来诊入院行术后辅助治疗。患者发病以来，精神饮食睡眠一般,大小便正常，体重无减轻。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 16, "end_pos": 28}, {"label_type": "手术", "overlap": 0, "start_pos": 54, "end_pos": 68}, {"end_pos": 83, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"end_pos": 102, "label_type": "解剖部位", "overlap": 0, "start_pos": 98}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 108, "end_pos": 113}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 117, "end_pos": 118}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 167, "end_pos": 172}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 189, "end_pos": 194}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"end_pos": 224, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"end_pos": 233, "label_type": "解剖部位", "overlap": 0, "start_pos": 230}]}
{"originalText": "，患者2012年底开始出现接触性出血，2013年4月曾行宫颈细胞学检查及HPV检查未发现异常（未见单），2014年8月我院门诊就诊，，TCT:镜上见异型腺细胞，考虑为腺癌。遂行（宫颈肿物）活检术，，术后病理：镜检为低分化癌。妇科检查可见宫颈下唇可见结节状肿物约3X2.5CM，考虑“宫颈癌IB1期”，于2014-09-16在行“宫颈癌根治术(II型子宫切除+两侧附件切除+盆腔淋巴结清扫术+腹主动脉旁淋巴结活检术）”。，术后病检结果示：（全子宫+两附件）镜检为宫颈低分化癌，结合免疫组化结果，符合低分化腺鳞癌，浸润宫颈及宫颈管浅肌层（&LT;1/2肌层），未累及阴道穹窿及子宫体上段；未见明确脉管内癌栓及神经束侵犯。淋巴结未见肿瘤转移。术后于2014-09-25、2014-10-21予TP方案（紫杉醇+顺铂）化疗2程，下次化疗结束后白细胞最低达2.1×109/L，予瑞白升白治疗后血常规恢复正常。今再次返院化疗入院。患者起病以来，精神可，无呕吐，入睡好，阴道无流血，二便正常，体重无明显改变。", "entities": [{"label_type": "实验室检验", "overlap": 0, "start_pos": 36, "end_pos": 39}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 83, "end_pos": 85}, {"end_pos": 97, "label_type": "手术", "overlap": 0, "start_pos": 88}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 107, "end_pos": 111}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 141, "end_pos": 148}, {"label_type": "手术", "overlap": 0, "start_pos": 164, "end_pos": 207}, {"end_pos": 222, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"end_pos": 226, "label_type": "解剖部位", "overlap": 0, "start_pos": 223}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 230, "end_pos": 236}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 248, "end_pos": 254}, {"end_pos": 259, "label_type": "解剖部位", "overlap": 0, "start_pos": 257}, {"end_pos": 263, "label_type": "解剖部位", "overlap": 0, "start_pos": 260}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 281}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 286, "end_pos": 289}, {"end_pos": 351, "label_type": "药物", "overlap": 0, "start_pos": 348}, {"end_pos": 354, "label_type": "药物", "overlap": 0, "start_pos": 352}, {"end_pos": 386, "label_type": "药物", "overlap": 0, "start_pos": 384}, {"end_pos": 430, "label_type": "解剖部位", "overlap": 0, "start_pos": 428}]}
{"originalText": "，缘于入院前1月因门诊胃镜检查示：“贲门溃疡型胃癌”，，病理：腺癌，门诊拟“贲门癌”收住入院，入院后完善相关检查未见明显手术禁忌症，2014年07月07日在全麻上行“根治性全胃切除术（食道空肠ROUX-Y吻合、D2、R0）”，术顺，术后予换药、止血、补液、营养心肌、维持电解质平衡等治疗。，术后病理结果：1、，全胃：食管胃交界溃疡型管状腺癌II，侵出浆膜层，侵犯神经，脉管内见癌栓，手术标本上切端未见癌浸润。找到贲门周淋巴结1/7个，小弯淋巴结2/6个，大弯淋巴结0/4个，幽门下淋巴结0/1个，幽门上淋巴结0/4个，及另送的（第8组）淋巴结0/3个，（第9组）淋巴结0/5个，（第十一组）淋巴结0/1个，（腹主动脉旁）淋巴结0/1个，（空肠系膜）淋巴结0/1个见癌转移。2、（食管上段旁）、（第十组），：送检脉管、纤维及脂肪组织。3、（大网膜结节），：送检纤维脂肪组织中见癌浸润。此次为化疗再次就诊我院，门诊拟胃癌术后化疗收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 18, "end_pos": 25}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 31, "end_pos": 33}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 38, "end_pos": 41}, {"label_type": "手术", "overlap": 0, "start_pos": 83, "end_pos": 111}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 130, "end_pos": 131}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 158, "end_pos": 172}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"end_pos": 222, "label_type": "解剖部位", "overlap": 0, "start_pos": 217}, {"end_pos": 232, "label_type": "解剖部位", "overlap": 0, "start_pos": 227}, {"end_pos": 243, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"end_pos": 254, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 263, "end_pos": 271}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 276, "end_pos": 284}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 289, "end_pos": 298}, {"end_pos": 313, "label_type": "解剖部位", "overlap": 0, "start_pos": 303}, {"end_pos": 327, "label_type": "解剖部位", "overlap": 0, "start_pos": 318}, {"end_pos": 343, "label_type": "解剖部位", "overlap": 0, "start_pos": 339}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 406, "end_pos": 410}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 433, "end_pos": 434}, {"end_pos": 437, "label_type": "解剖部位", "overlap": 0, "start_pos": 436}]}
{"originalText": "患者于约4月前无明显诱因上开始出现阴道出血，于******健院行宫颈活检提示中分化鳞癌，后至我院行病理会诊提示低分化癌，考虑为低分化鳞状细胞癌。临床考虑宫颈癌IIA2期。2016-01-18、2016-2-15于我院行力朴素+顺铂方案2程。2016-03-15全麻上行III型子宫切除、两附件切除、盆腔淋巴结清扫。术后病理：（子宫）镜检为宫颈低分化鳞状细胞癌，浸润宫颈及宫颈管深肌层；累及阴道穹窿；可见脉管内癌栓，未见明确神经束侵犯；萎缩性子宫内膜；平滑肌瘤。送检（左髂内淋巴结）1枚，见癌转移，其余多组淋巴结送检均未见癌。术后恢复好，现患者按主诊教授意见入院行术后辅助化疗，2016-04-07给予TC（力扑素240MGD1+顺铂50MGD1）方案化疗1程顺利，无不适。查体无特殊。患者发病以来,精神、饮食、睡眠尚可,大小便无明显异常。体重无明显减轻。", "entities": [{"end_pos": 19, "label_type": "解剖部位", "overlap": 0, "start_pos": 17}, {"end_pos": 34, "label_type": "解剖部位", "overlap": 0, "start_pos": 32}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 38, "end_pos": 43}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 55, "end_pos": 59}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 63, "end_pos": 71}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 76, "end_pos": 84}, {"end_pos": 112, "label_type": "药物", "overlap": 0, "start_pos": 109}, {"end_pos": 115, "label_type": "药物", "overlap": 0, "start_pos": 113}, {"label_type": "手术", "overlap": 0, "start_pos": 134, "end_pos": 156}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 169, "end_pos": 179}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"end_pos": 188, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"end_pos": 198, "label_type": "解剖部位", "overlap": 0, "start_pos": 194}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 220, "end_pos": 224}, {"end_pos": 239, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"end_pos": 306, "label_type": "药物", "overlap": 0, "start_pos": 303}, {"end_pos": 316, "label_type": "药物", "overlap": 0, "start_pos": 314}]}
{"originalText": "，患者2个月前因下腹部不适于我院就诊，，入院后行胃镜检查示：于胃体上部、胃角后壁处可见较深凹陷性病变，占胃腔1/2周，中央可见巨大溃疡，表面覆污苔，周围粘膜不规则，有明显浸润并周边呈堤形隆起；病变部位胃腔狭小，内镜尚能通过；贲门部未受侵犯。胃镜病理（201600649），示：（胃角、胃体后壁）低分化腺癌。于2016-01-14在全麻上行根治性胃癌根治术+毕I式吻合，，术后病理示：（201600925）胃体、胃窦低分化腺癌，浸润溃疡型，体积14*9*1.6CM，侵穿浆膜，并于部分脉管内查见癌栓。累及近端切线，远端切线及另送“远端切线”未查见癌。呈三组（3/3个）、四组（11/17个）、六组（9/11个）、“胃1、3、7组”（2/5个）淋巴结癌转移。 “胃第六组”（1个）淋巴结未查见癌。，癌组织免疫组化染色示：RRM1（-）、TS局灶（+）、TOPOII部分（+）、 β-TUBULIN-III（-）、SYN（-）、CERBB-2（-）。术后给予静脉营养、抑酸、补液、补充白蛋白、抗感染等对症治疗。患者恢复良好出院，现患者为进一步行化疗来我院，门诊以“胃癌术后”收入我科。   患者自发病以来，精神可，饮食欠佳，睡眠可，二便正常，体重体力无明显改变。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 31, "end_pos": 32}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 36, "end_pos": 37}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 101, "label_type": "解剖部位", "overlap": 0, "start_pos": 100}, {"end_pos": 114, "label_type": "解剖部位", "overlap": 0, "start_pos": 112}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 138, "end_pos": 152}, {"label_type": "手术", "overlap": 0, "start_pos": 169, "end_pos": 183}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 202, "end_pos": 212}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 275, "end_pos": 323}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 329, "end_pos": 341}, {"end_pos": 442, "label_type": "药物", "overlap": 0, "start_pos": 439}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 479, "end_pos": 483}]}
{"originalText": "入院前3月，患者因结肠镜发现左半结肠肿瘤就诊于我院我科，于2015-09-23我院在全麻上行“剖腹探查、结肠癌根治术、肠粘连松解术”，手术顺利，术后予止血、预防性抗感染、补液、对症等治疗。术后病检（1508028）：（升结肠）粘液性腺癌，侵及全层，远、近切缘未见癌累及，肠周脂肪组织中淋巴结未见癌转移（0/8），（肠系膜结节）见癌组织（2枚），（腹膜结节）未见癌组织。术后恢复可，病情好转出院。于2015-10-20及2015-11-10在我科行化疗，目前患者无畏寒、发热，无咳嗽、咳痰，无恶心、呕吐，无腹痛、腹泻，无胸闷、胸痛、心悸等不适。患者为求第三次化疗，以“左半结肠癌术后3月，拟行第四次化疗”收入我科住院治疗。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 20}, {"label_type": "手术", "overlap": 0, "start_pos": 47, "end_pos": 65}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 108, "end_pos": 118}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 135, "end_pos": 136}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 157, "end_pos": 158}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 173, "end_pos": 174}, {"end_pos": 253, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 255}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"end_pos": 263, "label_type": "解剖部位", "overlap": 0, "start_pos": 262}, {"end_pos": 266, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 283, "end_pos": 290}]}
{"originalText": "患者7月前于我院行剖腹探查+胃癌根治（D2，R1）+放射性粒子植入术，手术顺利，术后安返病房，术后给予补液、消肿、营养支持等对症处理，术后患者恢复顺利，术后病理检查结果：（胃窦）低分化腺癌。胃第八组淋巴结）可见癌转移（1/1）。（胃窦）溃疡型低分化腺癌，浸及胃壁全层，神经见癌侵犯，脉管中见癌栓，上切端见癌累及，下切端食管复鳞下皮轻度不典型增生，胃小弯、大弯淋巴结见癌转移（各为7/8、7/8），网膜中未见癌转移，患者出院后无特处不适。1周前无明显诱因出现全身乏力，且食欲减退，无畏寒、发热，无腹痛，无恶心呕吐等症状，为弄清病情并及时治疗，今入我院我科。\\U0004   患者自起病以来，精神略差，胃纳较差，大便如常，小便如常，体重未见明显上降。", "entities": [{"label_type": "手术", "overlap": 0, "start_pos": 9, "end_pos": 34}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 85, "end_pos": 94}, {"end_pos": 102, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 114, "end_pos": 126}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 129, "end_pos": 130}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 173, "end_pos": 182}, {"end_pos": 248, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}]}
{"originalText": "患者6月余前（2015-7-16）因结肠癌于我院行左半结肠切除术+淋巴结清扫术，术后常规病理示：（25232.15）（左半结肠）中低分化腺癌，溃疡型，切面积6*4.5CM，侵达外膜，下上切缘、阑尾及另送吻合器切缘均未查见癌。肠周淋巴结14枚，其中7枚查见转移（7/14）；另送肠系膜根部淋巴结1枚，未查见转移癌（0/1）。术后给予消炎营养支持治疗，病情好转后出院。后患者因“术后肠梗阻”再次入院，行保守治疗好转后出院。后患者再次返院行奥沙利铂+CF+替加氟方案化疗5周期，耐受好。现患者为行上一周期化疗治疗再次来我院，门诊以“结肠癌术后化疗”收入院。自发病来，患者饮食睡眠尚可，二便无明显异常，体重较前无明显改变。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 18, "end_pos": 21}, {"label_type": "手术", "overlap": 0, "start_pos": 25, "end_pos": 39}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 58, "end_pos": 70}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 112}, {"end_pos": 146, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 187, "end_pos": 192}, {"end_pos": 221, "label_type": "药物", "overlap": 0, "start_pos": 217}, {"end_pos": 224, "label_type": "药物", "overlap": 0, "start_pos": 222}, {"end_pos": 228, "label_type": "药物", "overlap": 0, "start_pos": 225}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 263, "end_pos": 268}]}
{"originalText": "，缘于入院前4月余于我院诊断为直肠癌，于2016-01-21在全麻上行腹腔镜上直肠癌姑息性切除术DIXON，，术后病理：（201602459）1、（直肠），：肠溃疡型管状腺癌II级，侵及外膜层。手术标本下、上切端及另送（下切端）、（上切端）均未见癌浸润。找到肠周淋巴结0/6个，未见癌转移。肠周脂肪组织中找到12枚癌结节。2、（肠系膜上动脉根部淋巴结），：送检为纤维、脂肪及脉管组织。3、（盆壁结节），：送检为癌结节。，免疫组化：KI67（50%+），CK7（-），CK20（+++），VILLIN（++++），CDX-2（+++），CD56（-），MLH1（+），MSH2（+），PMS2（-），MSH-6（+）。，微卫星稳定性：MSI-L。，病理：（MM20160170）该病例检测到KRAS基因12号密码子G12D突变。，病理：(MM20160171)该病例未检测到BRAF基因V600E突变。术后给予对症、营养支持等治疗，恢复可。于2016.03.19,2016.5.4予“伊立替康240MGD1+卡培他滨片1500MGBIDD1-14”方案化疗，辅以保胃、保肝、增强免疫等，未见明显化疗副反应。出院后无腹痛、腹胀，无呕血、黑便，无发热、寒战等。此次为行上一周期化疗再次就诊我院，门诊拟直肠癌术后化疗收入院。下次出院以来精神、睡眠、饮食可，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手术", "overlap": 0, "start_pos": 35, "end_pos": 53}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 74, "end_pos": 76}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 79, "end_pos": 90}, {"end_pos": 134, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 145, "end_pos": 146}, {"end_pos": 175, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 445, "label_type": "药物", "overlap": 0, "start_pos": 441}, {"end_pos": 458, "label_type": "药物", "overlap": 0, "start_pos": 453}, {"end_pos": 482, "label_type": "解剖部位", "overlap": 0, "start_pos": 481}, {"end_pos": 485, "label_type": "解剖部位", "overlap": 0, "start_pos": 484}, {"end_pos": 507, "label_type": "解剖部位", "overlap": 0, "start_pos": 506}, {"end_pos": 510, "label_type": "解剖部位", "overlap": 0, "start_pos": 509}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 547, "end_pos": 552}]}
{"originalText": "缘于入院前4月余于我院诊为“胃癌、直肠癌”，于2016.6.11在全麻上行“全腹腔镜上根治性远端胃大部切除术+直肠癌根治术”。术后病理示“（远端胃)胃角溃疡型低黏附性癌(低分化腺癌，部分为印戒细胞癌)，侵出浆膜层，侵犯神经及脉管组织，手术标本下、上切端及另送(胃下切端)均未见癌浸润；找到胃小弯淋巴结0/18个，大弯及网膜淋巴结0/9个，幽门下淋巴结1/1个，幽门上淋巴结0/8个，见癌转移。小弯侧脂肪组织见少量胰腺组织”，术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。术后分别于2016.7.13、2016.8.3、2016.8.23予“乐沙定200MGIVGTTQDD1+卡培他滨片1500MGPOBIDD1-14”方案化疗。于2016.09.21行回肠造口还纳术，术后恢复可，此次为行再次化疗就诊我院，门诊拟胃癌、直肠癌术后收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 17, "end_pos": 20}, {"label_type": "手术", "overlap": 0, "start_pos": 38, "end_pos": 61}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 74, "end_pos": 100}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"end_pos": 150, "label_type": "解剖部位", "overlap": 0, "start_pos": 144}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 156, "end_pos": 164}, {"end_pos": 175, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 186, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 196, "end_pos": 198}, {"end_pos": 208, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"end_pos": 279, "label_type": "药物", "overlap": 0, "start_pos": 276}, {"end_pos": 298, "label_type": "药物", "overlap": 0, "start_pos": 294}, {"end_pos": 340, "label_type": "手术", "overlap": 0, "start_pos": 333}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 363, "end_pos": 365}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 366, "end_pos": 371}, {"end_pos": 393, "label_type": "解剖部位", "overlap": 0, "start_pos": 392}, {"end_pos": 396, "label_type": "解剖部位", "overlap": 0, "start_pos": 395}]}
{"originalText": "，缘于入院前2月余因“胃癌”于2015.11.27全麻上行“腹腔镜辅助上根治性全胃切除术（D2）”，术后病理回报（201543270），：（全胃），：胃体小弯侧浸润型管状腺癌II-III级，部分为粘液腺癌和低粘附性癌，侵及浆膜层，脉管内见癌栓。手术标本下、上切端及另送（下切端）未见癌浸润。找到贲门左淋巴结0/21个，小弯淋巴结11/13个，大弯淋巴结1/7个，幽门下淋巴结0/2个，幽门上淋巴结1/8个，另送（第7组）淋巴结3/4个，（第8组）淋巴结1/3个，（第9组）淋巴结7/7个，（第11组）淋巴结3/5个，（第12A组）淋巴结0/1个，（第12P组）淋巴结0/1个，见癌转移。，免疫组化：KI67（60%肿瘤细胞阳性），CK7（+），CK20（-），VILLIN（+++），CK18（+++），HER-2（-），CEA（+++），E-CADHERIN（+++），CD68（+++），CD163（-），CD34（+++），D2-40（+），CD31（+++），CD56（-），SYN（-），CGA（-）。于2015.12.23、2016.01.14日行“伊立替康240MGIVGTTD1+替吉奥60MGPOBIDD1-14”方案化疗。为求再次术后化疗就诊我院，门诊拟胃癌术后化疗收入院，下次出院以来，精神、睡眠、食欲差，大便，小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 11, "end_pos": 13}, {"end_pos": 44, "label_type": "手术", "overlap": 0, "start_pos": 30}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 75, "end_pos": 108}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 176, "label_type": "解剖部位", "overlap": 0, "start_pos": 171}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 181}, {"end_pos": 198, "label_type": "解剖部位", "overlap": 0, "start_pos": 192}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 205, "end_pos": 213}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 218, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 231, "end_pos": 239}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 244, "end_pos": 253}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 258, "end_pos": 268}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 273, "end_pos": 283}, {"end_pos": 485, "label_type": "药物", "overlap": 0, "start_pos": 481}, {"end_pos": 501, "label_type": "药物", "overlap": 0, "start_pos": 498}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 537, "end_pos": 541}]}
{"originalText": "患者2-月前因诊断为升结肠恶性肿瘤及肝内外胆管结石行根治性左半结肠切除术+胆总管探查术。升结肠肿瘤病理类型：左半结肠溃疡型中分化管状乳头状腺癌，免疫组化 CK7（－） CK20（+++） CEA（++） VILLIN（+++） CDX－2（++） KI-67（+++）＞90% P53（+） CERBB-2（－） EGFR（+） GST－π（+） TOPOII（++） PGP（+） SYN（－） CGA（－） NSE（－） CD56（－） MLH－1（++） MSH－2（+++） MSH－6（+++） PMS－2（++）；分期T3N1M0。今可按照FOXFOL方案行第二次化疗。遂以“升结肠肿瘤根治术后2-月，拟行第2次化疗”收治入院。\\U0004   患者自起病以来，精神可，胃纳可，大便如常，小便如常，体重未见明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 17}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 18, "end_pos": 25}, {"label_type": "手术", "overlap": 0, "start_pos": 26, "end_pos": 43}, {"end_pos": 47, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 54, "end_pos": 71}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 294, "end_pos": 303}, {"end_pos": 342, "label_type": "解剖部位", "overlap": 0, "start_pos": 341}]}
{"originalText": "缘于入院前4年因“乙状结肠癌”就诊我院，于我院行“腹腔镜辅助上乙状结肠癌根治术”，术中见“肿瘤位于乙状结肠中段，约3*2.5CM，对系膜侧侵出浆膜层，未侵犯周围组织，周围无明显肿大淋巴结”，术后病理(201131862)回报“(乙状)结肠蕈伞型管状腺癌II级，侵及浆膜层，手术标本下、上切端及另送(下、上切端)未见癌浸润，找到肠周淋巴结11个均未见癌转移，另送(肠系膜上动脉根部淋巴结)为脂肪脉管结缔组织”，术后病情恢复良好出院，后门诊定期复查发现肝、肺、骨多发转移。入院前2年前开始给予口服希罗达及中药治疗，无诉腹痛、腹胀，无畏冷、发热等不适。今为再次治疗，门诊拟“乙状结肠癌术后伴肝、肺骨多发转移”收治入院，自发病以来，饮食较差，睡眠可，二便正常，无消瘦乏力，体重较前无明显改变。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 9, "end_pos": 14}, {"end_pos": 39, "label_type": "手术", "overlap": 0, "start_pos": 25}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 49, "end_pos": 55}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 113, "end_pos": 129}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 163}, {"end_pos": 192, "label_type": "解剖部位", "overlap": 0, "start_pos": 181}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 224, "end_pos": 233}, {"end_pos": 249, "label_type": "药物", "overlap": 0, "start_pos": 246}, {"end_pos": 258, "label_type": "解剖部位", "overlap": 0, "start_pos": 257}, {"end_pos": 261, "label_type": "解剖部位", "overlap": 0, "start_pos": 260}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 284, "end_pos": 300}]}
{"originalText": "，缘于入院前4月余诊为直肠癌，于2014年11月19日在全麻上行“腹腔镜上直肠癌根治术（MILES）”，手术顺利。术后病理(201440195），：“（直肠）直肠溃疡型管状腺癌II级并坏死，侵出外膜层，未侵及齿状线，侵犯神经组织，下、上切端及环周切缘均未见癌浸润。肿物周围淋巴结6个、肠周淋巴结14个未见癌转移。，病理分期：PT4AN0M0，IIB期。”术后给予对症、抗感染治疗，恢复良好,伤口愈合II/甲。于2015年1月7日、2015年2月4日、2015年3月4日行“奥沙利铂（齐沙）250MGIVGTTD1+希罗达1500MGPOBIDD1-14”方案3次化疗，未见明显化疗副反应，今返院行第4周期化疗，门诊拟“直肠癌术后化疗”收入院。出院后饮食、睡眠可，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 11, "end_pos": 14}, {"label_type": "手术", "overlap": 0, "start_pos": 33, "end_pos": 50}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 79, "end_pos": 91}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"end_pos": 240, "label_type": "药物", "overlap": 0, "start_pos": 236}, {"end_pos": 243, "label_type": "药物", "overlap": 0, "start_pos": 241}, {"end_pos": 260, "label_type": "药物", "overlap": 0, "start_pos": 257}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 309, "end_pos": 314}, {"end_pos": 333, "label_type": "解剖部位", "overlap": 0, "start_pos": 332}, {"end_pos": 336, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}]}
{"originalText": "，缘于入院前5月余，以“排便次数增多伴血便1个月。”为主诉入院，诊断直肠癌，遂于2013-5-7在全麻上行腹腔镜上直肠癌根治术+预防性回肠造瘘，术顺，术后予防感染、补液等治疗。，病理示：1、大肠溃疡型管状腺癌II级，侵及深肌层，手术标本吻合切端见少量癌浸润，手术标本另一切端及另送（下切端）、（上切端）均未见癌浸润。找到肿物周淋巴结6个，肠周淋巴结9个均未见癌转移。另送（肠系膜上动脉根部淋巴结）为脂肪、脉管及神经组织。2、大肠管状腺瘤，伴低级别下皮内瘤变。，免疫组化结果：CK7（-），CK20（++），VILLIN（+++），CEA（+++），CDX-2（+++），CD56（-），KI67（50%+）。今患者再次入院，要求关闭造瘘口，门诊拟“直肠癌术后，回肠造瘘术后”收入院，自发病以来，精神、睡眠、食欲尚可，大便经造瘘口排出可，小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 34, "end_pos": 37}, {"label_type": "手术", "overlap": 0, "start_pos": 53, "end_pos": 71}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 95, "end_pos": 107}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 160, "end_pos": 166}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 212, "end_pos": 218}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 324, "end_pos": 336}]}
{"originalText": "患者于1月余前因“直肠癌”在我科行“腹腔镜上直肠癌根治术（MILES）+放射性粒子植入术”，手术顺利，术后病理结果为：（直肠）溃疡型中分化管状腺癌浸及肠壁深肌层，双切端未见癌累及，肠壁淋巴结见癌转移（1/10）。术后患者恢复较好，出院后患者无腹痛、腹胀，无畏寒发热，会阴部切口逐步愈合，现已明显变浅变小，肉芽组织生长良好，今患者为求术后第1次全身静脉化疗来我院就诊，门诊以“直肠癌（MILES）术后”收入我科。\\U0004   患者发病以来，神志 清晰，精神可，胃纳可，大便如常，小便如常，体重未见明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 9, "end_pos": 12}, {"label_type": "手术", "overlap": 0, "start_pos": 18, "end_pos": 44}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 59, "end_pos": 73}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 75, "end_pos": 76}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 187, "end_pos": 199}]}
{"originalText": "，患者于4月前（2015-09-07）因“1.盆腔包块（卵巢CA？）；2.糖尿病”在全麻上行剖腹探查+全子宫两附件切除+大网膜切除+阑尾切除+放射性粒子置入术。，术中见：右侧附件失去正常形态，大小约10X9X8CM，实性，表面充血水肿，呈紫蓝色，可见烂鱼肉样组织，质脆，易触血，侵及后盆壁，与宫底、乙状结肠形成粘连。钝性分离粘连后，见子宫常大，子宫底、前壁见转移癌灶。左侧输卵管见少量转移灶，左卵巢形态正常。大网膜增厚、盆腔腹膜见散状结节病灶，最大约3CM。术中切除右附件交家属过目后送病理行冰冻切片示“（右附件）卵巢浆液性乳头状囊腺癌浸及输卵管”，遂行子宫、左侧附件、大网膜、阑尾切除术后标本送病检，，术后病检示：1、（肿瘤组织）送检物为浆液性乳头状囊腺癌。2、子宫表面见癌组织累及，宫腔、宫颈及右附件均未见癌累及。3、大网膜及阑尾均未见癌转移。并于09-11行顺铂100MG腹腔灌注、09-15行紫杉醇210MG静滴第一次化疗。分别于2015-10-20、2015-12-01予患者行紫杉醇（特素)210MG+奥沙利铂180MG化疗2个疗程，化疗过程较为顺利，患者恶心、呕吐等不适症状较轻。现患者无特殊不适，要求行第四次化疗。\\U0004   患者本次发病以来，食欲正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，体重无明显变化。", "entities": [{"end_pos": 25, "label_type": "解剖部位", "overlap": 0, "start_pos": 23}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 28, "end_pos": 32}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 37, "end_pos": 40}, {"label_type": "手术", "overlap": 0, "start_pos": 46, "end_pos": 79}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"end_pos": 148, "label_type": "解剖部位", "overlap": 0, "start_pos": 146}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"end_pos": 169, "label_type": "解剖部位", "overlap": 0, "start_pos": 167}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 172, "end_pos": 178}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 210, "end_pos": 212}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 212, "end_pos": 213}, {"end_pos": 236, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 252, "end_pos": 268}, {"end_pos": 273, "label_type": "解剖部位", "overlap": 0, "start_pos": 270}, {"end_pos": 279, "label_type": "解剖部位", "overlap": 0, "start_pos": 277}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 280}, {"end_pos": 288, "label_type": "解剖部位", "overlap": 0, "start_pos": 285}, {"end_pos": 294, "label_type": "手术", "overlap": 0, "start_pos": 289}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 320, "end_pos": 329}, {"end_pos": 334, "label_type": "解剖部位", "overlap": 0, "start_pos": 332}, {"end_pos": 345, "label_type": "解剖部位", "overlap": 0, "start_pos": 343}, {"end_pos": 348, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"end_pos": 352, "label_type": "解剖部位", "overlap": 0, "start_pos": 349}, {"end_pos": 367, "label_type": "解剖部位", "overlap": 0, "start_pos": 365}, {"end_pos": 384, "label_type": "药物", "overlap": 0, "start_pos": 382}, {"end_pos": 391, "label_type": "解剖部位", "overlap": 0, "start_pos": 389}, {"end_pos": 403, "label_type": "药物", "overlap": 0, "start_pos": 400}, {"end_pos": 447, "label_type": "药物", "overlap": 0, "start_pos": 444}, {"end_pos": 450, "label_type": "药物", "overlap": 0, "start_pos": 448}, {"end_pos": 461, "label_type": "药物", "overlap": 0, "start_pos": 457}]}
{"originalText": "，患者3月前因“反复腹痛、腹泻10余天，加重3天”入院，于2016-03-18在全麻上行乙状结肠部分切除+乙状结肠单腔造瘘术，手术过程顺利。，术后病理：结肠腺癌（中度分化），浸润溃疡型，体积5*4*0.9CM，侵达浆膜脂肪组织。双端切线及环周底部切除面未查见癌。肠壁一站（8/14个）淋巴结癌转移。符合结肠炎性息肉。，免疫组化染色示癌组织：SYN（-）、TS弱（+）。2月前患者造口旁出现可复性肿物，站立和用力后增大，平卧后可以回纳消失，伴造口脱垂及肠粘膜渗血，现患者为求进一步诊治，门诊以“造口旁疝”收入我科。   患者精神欠佳，普通饮食，大小便正常，体重较前无明显变化。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "手术", "overlap": 0, "start_pos": 44, "end_pos": 62}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 76, "end_pos": 86}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 131, "end_pos": 145}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 151, "end_pos": 157}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 226}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 246, "end_pos": 250}]}
{"originalText": "，缘于入院前1月余于我院诊为回盲部肿瘤，于2013-12-10在全麻上行根治性左半结肠切除术，术后病理（201339034）示回盲部浸润型粘液腺癌，侵犯浆膜外，手术标本回肠切端、结肠切端均未见癌浸润，送检淋巴结未见癌转移，术后给予对症、营养支持等治疗，术后恢复良好,伤口愈合II/甲，术后于2014.01.02，行化疗治疗：FOLFOX，方案：替加氟3.4持续泵入/CF0.3D1-2+奥沙利铂200MGD1，辅以保肝、制酸、止吐、提高免疫力，化疗过程顺利，无明显化疗不良反应，今为再次化疗入院，门诊拟回盲部腺癌术后化疗收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 19}, {"end_pos": 46, "label_type": "手术", "overlap": 0, "start_pos": 36}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 63, "end_pos": 73}, {"end_pos": 86, "label_type": "解剖部位", "overlap": 0, "start_pos": 84}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"end_pos": 175, "label_type": "药物", "overlap": 0, "start_pos": 172}, {"end_pos": 185, "label_type": "药物", "overlap": 0, "start_pos": 183}, {"end_pos": 197, "label_type": "药物", "overlap": 0, "start_pos": 193}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 208}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 251, "end_pos": 258}, {"end_pos": 282, "label_type": "解剖部位", "overlap": 0, "start_pos": 281}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 284}]}
{"originalText": "，患者因患“乙状结肠癌”于2014-02-25于我院在全麻上予行乙状结肠癌根治术；术后病理(201402452），示：（乙状结肠）腺癌（中、低度分化），隆起型，面积3.5*2CM，侵达浆膜脂肪组织，双端切线及另送“近端切线”、“远端切线”未查见癌。一站（13个）、中间组（3个）、中央组（5个）淋巴结未查见癌。，免疫组化染色示癌组织：ERCC1少数（+）、TS（-）。，病理分期为：PT3N0M0 IIA期 DUKESB。依情行术后辅助化疗指证存在，排除化疗禁忌后，先后给予6个周期辅助化疗，，具体化疗方案为：奥沙利铂150MG D1，亚叶酸钙0.3G+替加氟1.0G D2-D6，同时给予升白细胞、保肝、护胃、止吐、免疫增强治疗。自下次出院后，患者一般情况保持良好，无乏力感，无发热，无恶心、呕吐，无胸闷、心慌，无头晕、头痛，无反酸、嗳气，无明显进食不适，未现明显腹痛、腹胀；大小便情况良好。现患者为行复查来我院就诊，门诊以“乙状结肠癌术后”收入院。目前患者精神及情绪状态可，食欲、饮食好，夜间睡眠可，大小便正常，近期无明显体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 6, "end_pos": 11}, {"end_pos": 40, "label_type": "手术", "overlap": 0, "start_pos": 32}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 59, "end_pos": 75}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 124, "end_pos": 150}, {"end_pos": 259, "label_type": "药物", "overlap": 0, "start_pos": 255}, {"end_pos": 272, "label_type": "药物", "overlap": 0, "start_pos": 268}, {"end_pos": 280, "label_type": "药物", "overlap": 0, "start_pos": 277}, {"end_pos": 302, "label_type": "解剖部位", "overlap": 0, "start_pos": 301}, {"end_pos": 305, "label_type": "解剖部位", "overlap": 0, "start_pos": 304}, {"end_pos": 352, "label_type": "解剖部位", "overlap": 0, "start_pos": 351}, {"end_pos": 359, "label_type": "解剖部位", "overlap": 0, "start_pos": 358}, {"end_pos": 362, "label_type": "解剖部位", "overlap": 0, "start_pos": 361}, {"end_pos": 384, "label_type": "解剖部位", "overlap": 0, "start_pos": 383}, {"end_pos": 387, "label_type": "解剖部位", "overlap": 0, "start_pos": 386}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 414, "end_pos": 421}]}
{"originalText": "缘于3月前因残胃癌在我院于2014年01月02日在全麻上行根治性残胃癌切除术手术顺利。术后病理示（残胃）胃近贲门处溃疡型管状腺癌II-III级，部分为粘液腺癌，侵及浆膜层，侵犯神经，脉管内见癌栓，未见侵犯食管胃交界区。手术标本下切端、吻合肠管双切端及另送（下切端）均未见癌浸润，找到贲门**/8个，小弯侧淋巴结0/6个，大弯侧淋巴结0/2个，见癌转移。术后恢复良好，顺利出院。出院后于术后2周出现“腹痛伴肛门停止排气、排便”再次就诊我院，考虑“粘连性小肠梗阻”予禁食、胃肠减压、灌肠、抑制消化液分泌、营养支持等积极保守治疗后，患者腹痛一度好转后再次呈持续性腹痛伴阵发性加剧，遂于2014.1.25全麻上行“剖腹探查+小肠粘连松解术”，术顺，术后恢复良好，出院后无腹痛、腹胀、恶心、呕吐等不适，2014.02.17、2014.3.3、2014.4.1于我院行“奥沙利铂100MGD1IVGTT+亚叶酸钙200MGD1-2IVGTT+替加氟3.0GCIV”方案术后3周期化疗，化疗过程顺利，无特殊不适，此次为化疗再次入院。患者出院后饮食、夜休可，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 6, "end_pos": 9}, {"end_pos": 38, "label_type": "手术", "overlap": 0, "start_pos": 29}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 48, "end_pos": 71}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 75, "end_pos": 79}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 102, "end_pos": 104}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 104, "end_pos": 105}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 119, "end_pos": 120}, {"end_pos": 143, "label_type": "解剖部位", "overlap": 0, "start_pos": 141}, {"end_pos": 155, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"end_pos": 200, "label_type": "解剖部位", "overlap": 0, "start_pos": 199}, {"end_pos": 204, "label_type": "解剖部位", "overlap": 0, "start_pos": 202}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 222, "end_pos": 229}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 234, "end_pos": 235}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 235, "end_pos": 236}, {"end_pos": 241, "label_type": "解剖部位", "overlap": 0, "start_pos": 240}, {"end_pos": 266, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"end_pos": 279, "label_type": "解剖部位", "overlap": 0, "start_pos": 278}, {"label_type": "手术", "overlap": 0, "start_pos": 303, "end_pos": 315}, {"end_pos": 332, "label_type": "解剖部位", "overlap": 0, "start_pos": 331}, {"end_pos": 335, "label_type": "解剖部位", "overlap": 0, "start_pos": 334}, {"end_pos": 383, "label_type": "药物", "overlap": 0, "start_pos": 379}, {"end_pos": 400, "label_type": "药物", "overlap": 0, "start_pos": 396}, {"end_pos": 418, "label_type": "药物", "overlap": 0, "start_pos": 415}, {"end_pos": 473, "label_type": "解剖部位", "overlap": 0, "start_pos": 472}, {"end_pos": 476, "label_type": "解剖部位", "overlap": 0, "start_pos": 475}]}
{"originalText": "，缘于入院前1月于我院诊为胃角癌，2015年09月07日在全麻上行腹腔镜辅助上根治性远端胃大部切除术（毕II式，D2），术后予预防性抗感染、制酸、补液支持等治疗。术后病理（201532192），：(远端胃大部分)，:胃角溃疡型管状腺癌II级，侵及浆膜层，手术标本双切端及另送(下切端)均未见癌浸润。找到小弯淋巴结2/21个、大弯淋巴结0/2个、幽门下淋巴结0/2个、幽门上淋巴结1/11个，及另送(胃右A根部）淋巴结0/3个、(第8P）淋巴结1/6个，见癌转移。术后恢复良好,伤口愈合II/甲。此次为化疗再次就诊我院，门诊拟胃角癌术后收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 13, "end_pos": 16}, {"label_type": "手术", "overlap": 0, "start_pos": 33, "end_pos": 59}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 101, "end_pos": 102}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 108, "end_pos": 120}, {"end_pos": 156, "label_type": "解剖部位", "overlap": 0, "start_pos": 151}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 162}, {"end_pos": 178, "label_type": "解剖部位", "overlap": 0, "start_pos": 172}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 198, "end_pos": 208}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 213, "end_pos": 221}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 262, "end_pos": 267}, {"end_pos": 289, "label_type": "解剖部位", "overlap": 0, "start_pos": 288}, {"end_pos": 292, "label_type": "解剖部位", "overlap": 0, "start_pos": 291}]}
{"originalText": "，缘于入院前5月余于我院诊断为“直肠癌伴两肺多发转移瘤”，予2016-07-08行“腹腔镜上直肠部分切除术（姑息性）+乙状结肠造瘘术”，，术中见：腹腔内无明显出血，没有明显粘连，无腹水，肿瘤下缘位于腹膜反折下2CM右左，明显累及浆膜面，侵犯左侧盆壁，肿瘤上缘于腹腔内不可探及，术中诊断“直肠癌伴肺转移”，考虑肿瘤晚期，外侵明显，遂决定行“腹腔镜上姑息性直肠癌切除术（HARTMANN）+乙状结肠造瘘术”。术顺，术后予止血、止痛，抑酸保胃、保肝，增强免疫，加强营养支持等治疗，恢复良好。，术后病理示：(直肠)，：肠溃疡型管状腺癌II级，部分为筛状粉刺型，伴坏死，侵犯神经及脉管，见脉管内癌栓，侵及浆膜层。手术标本下、上切端均未见癌浸润。找到肠周淋巴结2/12个，见癌转移，找到癌结节3个。另送(肠系膜上动脉根部淋巴结)镜上为脂肪、血管及纤维结缔组织。，免疫组化染色结果：KI67（80%阳性），EGFR（+），P53（+），P16（+）。于2016.07.30、2016.8.20、2016.09.10、2016.10.14行“伊立替康240MGIVGTTD1+卡培他滨1500MGPOBIDD1-14+洛铂40MG腹腔灌注D1”方案化疗。于2016.11.12予“伊立替康240MGIVGTTD1+卡培他滨1500MGPOBIDD1-14”方案化疗，今为第6次化疗，就诊我院，门诊拟“直肠癌术后化疗”收入院。自下次发病以来，精神、睡眠、食欲尚可，大便如下述，小便如常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 16, "end_pos": 27}, {"label_type": "手术", "overlap": 0, "start_pos": 42, "end_pos": 66}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 99, "end_pos": 100}, {"end_pos": 132, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 143, "end_pos": 150}, {"label_type": "手术", "overlap": 0, "start_pos": 169, "end_pos": 200}, {"end_pos": 218, "label_type": "解剖部位", "overlap": 0, "start_pos": 217}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 250, "end_pos": 252}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 255, "end_pos": 266}, {"end_pos": 324, "label_type": "解剖部位", "overlap": 0, "start_pos": 319}, {"end_pos": 357, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"end_pos": 467, "label_type": "药物", "overlap": 0, "start_pos": 463}, {"end_pos": 484, "label_type": "药物", "overlap": 0, "start_pos": 480}, {"end_pos": 503, "label_type": "药物", "overlap": 0, "start_pos": 501}, {"end_pos": 509, "label_type": "解剖部位", "overlap": 0, "start_pos": 507}, {"end_pos": 536, "label_type": "药物", "overlap": 0, "start_pos": 532}, {"end_pos": 553, "label_type": "药物", "overlap": 0, "start_pos": 549}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 592, "end_pos": 597}]}
{"originalText": "，患者5个半月前(2014-12-23)因“直肠癌”，在我院全麻上上行直肠高位前切除术。术中探查H0P0，病灶大小约3*2.5*1.0CM，位于直肠下段，左前壁，浆膜为脂肪遮盖。余腹膜内未见异常。，术后病理：，进展期直肠癌：隆起型　中分化管状腺癌　断端无癌。淋巴结见转移癌（1/15枚）DUKES分期C期（，病理号：178036），术后3周（4个半月前）因胆囊炎、胆囊结石，在我院普外科行急诊胆囊切除术。恢复顺利，2015-5-4于我科行希罗达、艾恒化疗一次，现为再次行化疗而入我科，患者病来食欲佳，睡眠良好，大便不成形，小便正常，近半年自觉体重上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 22, "end_pos": 25}, {"end_pos": 43, "label_type": "手术", "overlap": 0, "start_pos": 35}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 72, "end_pos": 76}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 91}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 108, "end_pos": 123}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 178, "end_pos": 186}, {"label_type": "手术", "overlap": 0, "start_pos": 196, "end_pos": 201}, {"end_pos": 222, "label_type": "药物", "overlap": 0, "start_pos": 219}, {"end_pos": 225, "label_type": "药物", "overlap": 0, "start_pos": 223}]}
{"originalText": "，罹患残胃癌于2013-9-6在我院予行全麻上全胃切除术（空肠J字代胃）；，术中探查见：腹腔内严重粘连，腹腔内无腹水，肝脏无法探查，盆底腹膜无异常；肿瘤位于残胃后壁，溃疡性肿块，约10 X 8CM。肿瘤侵出浆膜层。患者术后积极予相关对症支持治疗并恢复顺利良好。相关手术病理(2013 11248），示：残胃低分化腺癌，体积7.5*7*3.2CM，蕈伞型，侵达浆膜。双端切线及另送“胃远端切线”未查见癌。贲门周围（10个）淋巴结未查见癌。，免疫组化染色示癌组织：ERCC1（+）、β-TUBULIN-III（+）、TS（-）、RRM1（-）、TOPOII（阳性数60%）、CERBB-2（-）。合患者病情及肿瘤病理与分期继续予行术后化疗相关辅助治疗指征存在；依情先后予2013-9、2013-10予行术后辅助化疗2周期，，具体用药为：奥沙利铂200MG D1+亚叶酸钙0.3G D2-6 +替加氟1000MG D2-6 静滴，同时辅以镇吐、升血、免疫调节等对症支持治疗（化疗期间患者总体耐受性良好；复查血像示外周血白细胞减少，予瑞白升血处理）。自下次出院（2013-10-23）以来，患者一般情况保持良好；无发热，无恶心、呕吐，无明显反酸、嗳气，无明显进食不适，未现明显腹痛、腹胀。现患者为行规律性复查并完善相关后续辅助治疗而再至我科就诊，遂依情以“胃恶性肿瘤术后”收入院。目前患者精神及情绪状态良好，食欲、饮食好，夜间睡眠后；近期无明显体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 3, "end_pos": 6}, {"label_type": "手术", "overlap": 0, "start_pos": 23, "end_pos": 36}, {"end_pos": 46, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 57, "label_type": "解剖部位", "overlap": 0, "start_pos": 56}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"end_pos": 68, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 79, "end_pos": 80}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 151, "end_pos": 158}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 190, "end_pos": 191}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 201, "end_pos": 213}, {"end_pos": 370, "label_type": "药物", "overlap": 0, "start_pos": 366}, {"end_pos": 383, "label_type": "药物", "overlap": 0, "start_pos": 379}, {"end_pos": 397, "label_type": "药物", "overlap": 0, "start_pos": 394}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 453, "end_pos": 459}, {"end_pos": 465, "label_type": "药物", "overlap": 0, "start_pos": 463}, {"end_pos": 535, "label_type": "解剖部位", "overlap": 0, "start_pos": 534}, {"end_pos": 538, "label_type": "解剖部位", "overlap": 0, "start_pos": 537}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 574, "end_pos": 581}]}
{"originalText": "，患者于2016-11-04在全麻上行\\\"胃癌根治术(全胃）\\\"，，术后病理回报:“（胃大体）镜检为中至低分化腺癌，LAUREN，分型：肠型，癌组织侵犯至胃壁浆膜上层，并累及食管壁外膜层；未见明确脉管内癌栓，可见神经束侵犯；网膜组织未见癌。淋巴结41枚，2枚见癌。（远、近切缘）未见癌”。术后预防感染、抑制分泌、静脉营养等对症支持处理，恢复好，2016-12-05已予行一程术后辅助化疗，以现为行上一程化疗收住我科，起病以来，患者精神尚可，食欲欠佳，大小便正常，体重上降3KG。", "entities": [{"label_type": "手术", "overlap": 0, "start_pos": 21, "end_pos": 30}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 43, "end_pos": 44}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 50, "end_pos": 64}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 77, "end_pos": 78}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 87, "end_pos": 89}]}
{"originalText": "缘于入院前1余年前于我院诊为胃癌，于2012-08-07在全麻上行根治术全胃切除术。术后病理（201223223）示全胃：食管胃交界溃疡型管状腺癌，II-III级，侵出浆膜层，侵犯脉管和神经。手术标本下切端见癌浸润，手术标本上切端和另送（下切端）未见癌浸润。镜上找到贲门周淋巴结3/8个、小弯淋巴结3/4个、大弯淋巴结0/1个、幽门下淋巴结0/4个和幽门上淋巴结0/1个见癌转移。术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲，并顺利出院，2012.09.24行“伊立替康280MG+替吉奥60MGBID×14D”方案化疗1周期，2012.10.23按“伊立替康280MG+替吉奥40MGBID×14D”方案化疗1周期，2012.11.20按“伊立替康240MG+替吉奥80MGBID×7D”化疗1次,2012.12.22按““安素泰210MG+艾奕40MGBID×14D”化疗1次，2013.1.18予“安素泰240MG+替吉奥40MGBID×14D”方案化疗1次，2013.02.23按T“安素泰240MG”方案化疗1周期。2014.08.28予“表柔比星70MGIVGTTD1+替吉奥40MGBID×10D”方案化疗1次。今为再次化疗就诊我院，门诊拟胃癌术后化疗后收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"end_pos": 41, "label_type": "手术", "overlap": 0, "start_pos": 33}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 61, "end_pos": 81}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 144}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 154}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 241, "label_type": "药物", "overlap": 0, "start_pos": 237}, {"end_pos": 250, "label_type": "药物", "overlap": 0, "start_pos": 247}, {"end_pos": 286, "label_type": "药物", "overlap": 0, "start_pos": 282}, {"end_pos": 295, "label_type": "药物", "overlap": 0, "start_pos": 292}, {"end_pos": 331, "label_type": "药物", "overlap": 0, "start_pos": 327}, {"end_pos": 340, "label_type": "药物", "overlap": 0, "start_pos": 337}, {"end_pos": 372, "label_type": "药物", "overlap": 0, "start_pos": 369}, {"end_pos": 380, "label_type": "药物", "overlap": 0, "start_pos": 378}, {"end_pos": 411, "label_type": "药物", "overlap": 0, "start_pos": 408}, {"end_pos": 420, "label_type": "药物", "overlap": 0, "start_pos": 417}, {"end_pos": 455, "label_type": "药物", "overlap": 0, "start_pos": 452}, {"end_pos": 485, "label_type": "药物", "overlap": 0, "start_pos": 481}, {"end_pos": 500, "label_type": "药物", "overlap": 0, "start_pos": 497}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 533, "end_pos": 537}, {"end_pos": 562, "label_type": "解剖部位", "overlap": 0, "start_pos": 561}, {"end_pos": 565, "label_type": "解剖部位", "overlap": 0, "start_pos": 564}]}
{"originalText": "，缘于入院前1月于我院诊为直肠癌，于2014-03-03在全麻上行腹腔镜上直肠癌根治术DIXON，，术中见：腹腔网膜及盆底光滑无结节，无腹水，肝表面光滑，胃及空肠未见明显病变。直肠腹膜返折距离肛门约10CM可触及一肿物，大小约3CM*2CM，质硬，未侵犯浆膜层，肠系膜上动脉根部可触及多枚肿大，与腹壁明显粘连，予分离，见肠管周围数个肿大淋巴结，大者直径约1CM，决定行“腹腔镜直肠癌根治切除术”。。术后病理(201405649)示1.大肠溃疡型管状腺癌II级，侵犯浅肌层。周围肠管粘膜及粘膜上层淋巴组织增生活跃。手术标本双切端及另送（下切端）、（上切端）均未见癌浸润。找到肠周淋巴结1/18个，及另送（肠系膜上血管旁）淋巴结0/7个见癌转移。，免疫组化结果：CK7（-），CK20（+），VILLIN（+++），CEA（+++），CDX-2（+++），CGA（-），CD56（-），SY（-），KI67（60%+）。2.大肠管状腺瘤，伴低级别下皮内瘤变。，术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。于2014.3.25、2014.4.9、2014.4.24、2014.5.14予“奥沙利铂150MGIVGTTD1+替加氟3.6GCIVD1+亚叶酸钙300MGIVGTTD1-2”方案行4次化疗，此次为术后第5次化疗再次就诊我院，门诊拟直肠癌术后收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 13, "end_pos": 16}, {"label_type": "手术", "overlap": 0, "start_pos": 33, "end_pos": 48}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 54, "end_pos": 55}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 91}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 131, "end_pos": 132}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 148, "end_pos": 149}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 160, "end_pos": 161}, {"end_pos": 171, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"end_pos": 196, "label_type": "手术", "overlap": 0, "start_pos": 185}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 217, "end_pos": 229}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 238, "end_pos": 239}, {"end_pos": 291, "label_type": "解剖部位", "overlap": 0, "start_pos": 286}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 300, "end_pos": 312}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 410, "end_pos": 416}, {"end_pos": 502, "label_type": "药物", "overlap": 0, "start_pos": 498}, {"end_pos": 518, "label_type": "药物", "overlap": 0, "start_pos": 515}, {"end_pos": 532, "label_type": "药物", "overlap": 0, "start_pos": 528}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 575, "end_pos": 580}, {"end_pos": 602, "label_type": "解剖部位", "overlap": 0, "start_pos": 601}, {"end_pos": 605, "label_type": "解剖部位", "overlap": 0, "start_pos": 604}]}
{"originalText": "，患者20余天月前行姑息性乙状结肠部分切除术，术后病理（201413928），：乙状结肠粘液腺癌，体积10*8*2.5CM，浸润溃疡型，侵达浆膜并侵穿纤维膜达脂肪组织。双端切线及另送“近切线”、“远切线”未查见癌。肠壁一站（7个）、中间组（6个）淋巴结未查见癌。，免疫组化染色示癌组织：TS大部分（+）、SYN（-）。患者于1天前开始出现腹胀、呕吐胃内容物，未排气、排便。急来我院门诊就诊，为行进一步诊治门诊依情以“结肠术后”收入院。患者自发病以来，无反复发热、畏寒，未现尿频、尿急、尿痛及排尿困难。目前精神差，不能进饮食。否认近期明显体重改变。", "entities": [{"end_pos": 22, "label_type": "手术", "overlap": 0, "start_pos": 10}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 40, "end_pos": 48}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 107, "end_pos": 126}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 175, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 208, "end_pos": 212}]}
{"originalText": "，缘于入院前5月余于我院诊断为“贲门癌”，于2015-12-21在全麻上行腹腔镜上根治性全胃切除术+胆囊切除术。术后病理示1、（全胃），：食管胃交界溃疡型管状腺癌II-III级，侵出浆膜层，侵犯神经组织。手术标本下切端见癌浸润。手术标本上切端及另送（下切端）均未见癌浸润。找到贲门左淋巴结4/9个，贲门右淋巴结0/1个，小弯淋巴结1/1个，大弯淋巴结0/0个，幽门下淋巴结0/3个，幽门上淋巴结0/1个，及另送（第7组）淋巴结1/1个，（第8组）淋巴结0/1个，（第11组）淋巴结2/3个，（第12组）淋巴结0/6个，见癌转移。，免疫组化：KI67（80%肿瘤细胞阳性），CK7（++），CK20（-），VILLIN（+++），CEA（+++），CD56（-），CGA（-），SYN（-），HER-2（-）。2、（第9组淋巴结），：送检脂肪及脉管组织。3、（胆囊），：胆囊组织。术后恢复可，于2016.01.21、2016.02.14、2016.03.08、2016.04.01、2016.04.28予“伊立替康240MGIVGTTD1+替吉奥40MGPOBIDD1-14”方案化疗，辅以止吐、增强免疫、营养支持等治疗，化疗过程顺利，无化疗副反应。今为行第6周期化疗，求诊于我院门诊，门诊拟“贲门腺癌（PT4AN3M0，IIIC期）术后化疗”收入院。自下次出院以来精神、睡眠、饮食可，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 16, "end_pos": 19}, {"label_type": "手术", "overlap": 0, "start_pos": 37, "end_pos": 55}, {"end_pos": 66, "label_type": "解剖部位", "overlap": 0, "start_pos": 65}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 69, "end_pos": 88}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"end_pos": 155, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"end_pos": 165, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"end_pos": 175, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"end_pos": 186, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 191}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 205, "end_pos": 213}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 218, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 231, "end_pos": 240}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 245, "end_pos": 254}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 356, "end_pos": 364}, {"end_pos": 381, "label_type": "解剖部位", "overlap": 0, "start_pos": 379}, {"end_pos": 386, "label_type": "解剖部位", "overlap": 0, "start_pos": 384}, {"end_pos": 456, "label_type": "药物", "overlap": 0, "start_pos": 452}, {"end_pos": 472, "label_type": "药物", "overlap": 0, "start_pos": 469}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 546, "end_pos": 550}]}
{"originalText": "，患者约于3年前因“乙状结肠癌”于2014-02-19日在全麻上行乙状结肠部分切除、乙状结肠单腔造瘘，阑尾切除术。手术过程顺利，术后给予抗感染及营养支持治疗，患者恢复好。，术后病理：结肠腺癌(中低度分化),浸润溃疡型,面积2.2*1.2CM，侵达浆膜，少数脉管内查见癌栓。双端切线未查见癌。结肠肠壁部分坏死、穿孔，肠系膜及肠壁周围脂肪组织化脓、坏死。肠壁一站（3个）淋巴结未查见癌。慢性阑尾炎。，免疫组化染色示癌组织：ERCC1（+）、TS（+）。术后给予患者化疗4周期，，方案为：奥沙利铂200MG D1+亚叶酸钙0.3G D2-6 +替加氟1000MG D2-6 静滴，同时给与升白细胞、护肝、止吐、免疫增强治疗，患者化疗过程平稳。后患者拒绝继续化疗，未规律复查。院外期间，患者无发热，无腹痛腹胀不适，大便通畅。现患者为行复查来我科就诊，以“乙状结肠癌术后、乙状结肠造瘘术后”收入院。   病人自下次出院以来，神志清，精神可，饮食可，大、小便正常，体重未见明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 15}, {"label_type": "手术", "overlap": 0, "start_pos": 33, "end_pos": 56}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 91, "end_pos": 102}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 145, "end_pos": 147}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 147, "end_pos": 148}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 157, "end_pos": 158}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 161, "end_pos": 162}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 175, "end_pos": 186}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 191, "end_pos": 196}, {"end_pos": 245, "label_type": "药物", "overlap": 0, "start_pos": 241}, {"end_pos": 258, "label_type": "药物", "overlap": 0, "start_pos": 254}, {"end_pos": 272, "label_type": "药物", "overlap": 0, "start_pos": 269}, {"end_pos": 298, "label_type": "解剖部位", "overlap": 0, "start_pos": 297}, {"end_pos": 347, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"end_pos": 349, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 373, "end_pos": 380}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 381, "end_pos": 389}]}
{"originalText": "，患者1月前因“腹部不适伴黑便1月余”入院，，腰骶部平扫示：腰1压缩性骨折，，腰椎退行性变：腰2/3、3/4、4/5椎间盘突出并腰4/5水平双侧隐窝狭窄，骶1-3水平椎管局限性膨大，不除外骶管囊肿。，腹部CT示：胆囊结石，胃腔扩张、幽门部周围壁厚。，行胃镜示：胃癌伴幽门梗阻；，病理示：（胃窦、幽门）腺癌。 ，幽门螺旋杆菌染色示：阳性（1+）。于2016-04-12全麻上行根治性胃大部切除+毕I式吻合术。，术后病理示：（201607470）胃窦腺癌（中低度分化），浸润溃疡型，体积4*4*2CM，侵达浆膜脂肪组织，部分侵穿浆膜。双端切线及另送“远端”切线未查见癌。呈六组（2/9个）淋巴结癌转移。三组（2个）、四组（3个）、另送“1、3、7组”（6个）淋巴结未查见癌。，免疫组化染色示癌组织：CERBB-2（-）、SYN（-）、β-TUBULIN-III部分（+）、TS部分弱（+）、RRM1部分（+）、TOPOII部分（+）。患者为求进一步诊治，来我院就诊，门诊以“胃癌术后”收入院。   发病以来，食欲差，睡眠可，大小便正常，体重较前无明显变化。", "entities": [{"end_pos": 10, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"label_type": "影像检查", "overlap": 0, "start_pos": 23, "end_pos": 28}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 30, "end_pos": 37}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 39, "end_pos": 45}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 46, "end_pos": 63}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 64, "end_pos": 76}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 77, "end_pos": 90}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 91, "end_pos": 98}, {"label_type": "影像检查", "overlap": 0, "start_pos": 100, "end_pos": 104}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 106, "end_pos": 110}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 111}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 116}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 130, "end_pos": 137}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 143, "end_pos": 152}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 155, "end_pos": 163}, {"label_type": "手术", "overlap": 0, "start_pos": 187, "end_pos": 202}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 221, "end_pos": 232}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 284, "end_pos": 295}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 299, "end_pos": 330}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 435, "end_pos": 439}]}
{"originalText": "患者6周前因“血便伴大便习惯改变1月余”,确诊为“1、乙状结肠腺癌并肝转移2、两肺结节 转移瘤？”后，完善检查，无手术禁忌症，于2013-12-27全麻上行姑息性“乙状结肠切除”，术顺，术后恢复可，术后病理结果回示：1（乙状结肠） 镜检为结肠中至低分化管状腺癌，癌组织浸润至肠壁浆膜层外脂肪结缔组织，可见神经束侵犯及脉管内癌栓。2（近切缘）未见癌。3（远切缘）未见癌。4（中央组淋巴结）4枚，未见癌。5（中间组淋巴结）2枚，未见癌，另见2枚肿瘤种植结节。6（肠周淋巴结）6枚，1/6见腺癌转移。术后预防感染、对症、支持治疗，术后诊断1.乙状结肠腺癌并肝转移 PT4AN1M1 IV期;2.两肺结节 转移瘤？3.子宫肌瘤4.慢性胆囊炎 5.左肾囊肿。现术后第6周，今为进一步治疗遂入我科。患者现无发热、乏力、咳嗽、气促、身目黄染等，精神睡眠可，胃纳一般，大小便可，体重无明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 27, "end_pos": 37}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 39, "end_pos": 47}, {"end_pos": 88, "label_type": "手术", "overlap": 0, "start_pos": 78}, {"end_pos": 114, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 119, "end_pos": 130}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 137, "end_pos": 138}, {"end_pos": 192, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"end_pos": 208, "label_type": "解剖部位", "overlap": 0, "start_pos": 202}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 242, "end_pos": 244}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 268, "end_pos": 278}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 294, "end_pos": 302}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 305, "end_pos": 309}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 311, "end_pos": 316}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 319, "end_pos": 323}, {"end_pos": 372, "label_type": "解剖部位", "overlap": 0, "start_pos": 371}]}
{"originalText": "患者因\\\"体检发现肝占位10天\\\"于2012年1月到我院就诊，经完善检查诊断为结肠腺癌并肝多发转移,无手术禁忌症，于2012-02-06日全麻上行“DIXON'S+肠粘连松解术”，术顺，术后恢复顺利。术后病理示中分化腺癌，浸润至浆膜上，淋巴结3/9转移。于术后3周始返院行FOLFIRI（开普拓+5-FU/CF）化疗8周期，加安维汀7周期。2012-6-20查CT示肝脏各叶可见多发异常密度影，病变较前缩小（最大者由20×31MM缩至15×28MM），病变数目大致同前。多学科讨论决定暂停开普拓及安维汀，继续予5FU/CF维持化疗，结合射频治疗。后患者于2012年7月11日行肝转移瘤射频消融术，术程顺利。现为进一步治疗入住我科，患者精神、饮食、睡眠可，大小便正常，无腹痛、腹胀、恶心、呕吐，体重无明显减轻。", "entities": [{"end_pos": 10, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 39, "end_pos": 49}, {"label_type": "手术", "overlap": 0, "start_pos": 74, "end_pos": 88}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 105, "end_pos": 110}, {"end_pos": 147, "label_type": "药物", "overlap": 0, "start_pos": 144}, {"end_pos": 152, "label_type": "药物", "overlap": 0, "start_pos": 148}, {"end_pos": 155, "label_type": "药物", "overlap": 0, "start_pos": 153}, {"end_pos": 166, "label_type": "药物", "overlap": 0, "start_pos": 163}, {"label_type": "影像检查", "overlap": 0, "start_pos": 180, "end_pos": 182}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}, {"end_pos": 247, "label_type": "药物", "overlap": 0, "start_pos": 244}, {"end_pos": 251, "label_type": "药物", "overlap": 0, "start_pos": 248}, {"end_pos": 258, "label_type": "药物", "overlap": 0, "start_pos": 255}, {"end_pos": 261, "label_type": "药物", "overlap": 0, "start_pos": 259}, {"end_pos": 297, "label_type": "手术", "overlap": 0, "start_pos": 288}, {"end_pos": 335, "label_type": "解剖部位", "overlap": 0, "start_pos": 334}, {"end_pos": 338, "label_type": "解剖部位", "overlap": 0, "start_pos": 337}]}
{"originalText": "，缘于3月前因“反复进食受阻2月余。”为主诉入院，诊断食管占位，排除手术禁忌症后于2016-01-20在全麻上行胸腔镜上全胸段食管切除+食管-胃底右颈部吻合术，术顺，术后恢复可，术后病理（201602316），：(食管及胃底)，：食管溃疡型鳞状细胞癌II级，侵及外膜层，手术标本下、上切端均未见癌浸润，找到胃周淋巴结1/17个，另送(隆突上)淋巴结0/2个、(右喉返喉返神经旁)淋巴结0/8个、(左喉返喉返神经旁)淋巴结个0/5、(右锁骨下)淋巴结0/4个、(下段食管旁)淋巴结0/1个、(颈段食管旁)淋巴结0/2个、(上段食管旁)个淋巴结0/1个，见癌转移。排除化疗禁忌症后于2016.02.19、2016.03.13、2016.04.08以“顺铂40MGD1-2，紫杉醇（泰素）180MGD2”行化疗，辅以保肝、护胃、提高免疫力等处理，未见明显化疗副反应，现为求第4期化疗，就诊我院，门诊拟“食管癌术后化疗后”收住入院，自出院以来，精神、睡眠、饮食一般，大小便如常，体重无明显增减。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 27, "end_pos": 31}, {"label_type": "手术", "overlap": 0, "start_pos": 56, "end_pos": 79}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 107}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 115, "end_pos": 128}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"end_pos": 192, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}, {"end_pos": 224, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"end_pos": 239, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"end_pos": 254, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"end_pos": 270, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"end_pos": 325, "label_type": "药物", "overlap": 0, "start_pos": 323}, {"end_pos": 337, "label_type": "药物", "overlap": 0, "start_pos": 334}, {"end_pos": 340, "label_type": "药物", "overlap": 0, "start_pos": 338}, {"end_pos": 357, "label_type": "解剖部位", "overlap": 0, "start_pos": 356}, {"end_pos": 360, "label_type": "解剖部位", "overlap": 0, "start_pos": 359}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 398, "end_pos": 403}]}
{"originalText": "入院前5+月，患者因胃癌于2014.5.21全麻上行腹腔镜胃癌根治术中转开腹全胃切除空肠食管ROUX-ENY吻合术+横结肠部分切除术。术后抗感染补液及营养支持治疗。术后病检：（1404047）&LT;胃&GT;低分化腺癌，部分为印戒细胞癌，侵及全层，双侧切缘未见癌累及，大弯淋巴结未见癌转移(0/3),小弯淋巴结见癌转移(10/15),&LT;7、8、9组&GT;淋巴结见癌转移(8/9)，大网膜组织未见癌累及，经科内讨论于6月2日行奥沙利铂+氟尿嘧啶化疗及对症治疗。2014年07月03日患者行术后第二次化疗，2014年08月18日患者行术后第三次化疗，2014年09月25日患者行术后四次化疗，患者化疗副反应较轻，化疗后精神、食欲、睡眠尚可，未有发热，未明显见脱发，无咳嗽、咳痰，今日患者为拟行第5次化疗，到我院门诊就诊，门诊以“胃癌术后第5次化疗”收入我科住院治疗。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 12}, {"label_type": "手术", "overlap": 0, "start_pos": 26, "end_pos": 66}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 105, "end_pos": 119}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"end_pos": 156, "label_type": "解剖部位", "overlap": 0, "start_pos": 151}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 172, "end_pos": 185}, {"end_pos": 221, "label_type": "药物", "overlap": 0, "start_pos": 217}, {"end_pos": 226, "label_type": "药物", "overlap": 0, "start_pos": 222}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 367, "end_pos": 371}]}
{"originalText": "，缘于3个月前于我院查腹部CT示：1、横结肠近脾区肠壁增厚，伴邻近脂肪间隙内数个淋巴结，考虑新生物可能，建议进一步肠镜检查。2、肝内多发占位性病变，考虑多发转移瘤。，行肠镜示：结肠癌，病理回报为（降结肠）大肠管状腺癌II级。于2013年11月21日在全麻上行“腹腔镜辅助上姑息性右半结肠切除术”，手术顺利。术后给予对症、抗感染治疗，恢复良好,伤口愈合II/甲。术后病理示“（右半结肠）大肠隆起型管状腺癌II级，侵出浆膜层，浆膜面见癌结节形成，脉管内见癌栓，手术标本双切端均未见癌浸润。找到肠周淋巴结4/18个见癌转移。，免疫组化结果：CK20（++），CK7（-），VILLIN（+++），CEA（+++），CDX-2（+++），CGA（-），SY（-），CD56（-），KI67（40%+）。”根据术后病理，肿瘤分期为PT4BN2AM1IV期。据其肿瘤分期有化疗指征，于2013-12-06以“伊立替康280MGIVGTTD1+替吉奥60MGPOBIDD1-14”方案化疗，化疗过程顺利，无明显化疗副作用。此次为化疗再次入院。自出院后饮食、夜休可，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"label_type": "影像检查", "overlap": 0, "start_pos": 11, "end_pos": 15}, {"end_pos": 27, "label_type": "解剖部位", "overlap": 0, "start_pos": 19}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 88, "end_pos": 91}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 97, "end_pos": 111}, {"end_pos": 146, "label_type": "手术", "overlap": 0, "start_pos": 130}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 186, "end_pos": 204}, {"end_pos": 249, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"end_pos": 402, "label_type": "药物", "overlap": 0, "start_pos": 398}, {"end_pos": 418, "label_type": "药物", "overlap": 0, "start_pos": 415}, {"end_pos": 477, "label_type": "解剖部位", "overlap": 0, "start_pos": 476}, {"end_pos": 480, "label_type": "解剖部位", "overlap": 0, "start_pos": 479}]}
{"originalText": "胃癌术后2年，外院检查提示左上腹包块，肾积水外院2014-4-17胃镜提示胃底体粘膜水肿，僵硬（BORRMANNIV）。活检病理为低分化腺癌，部分印戒。2014.4.30行胃癌根治术，术中不详，术后病理：胃小弯弥漫浸润性低分化腺癌，部分为印戒，3X3CM，侵润胃壁全层，切缘、大网膜无癌累及，小弯侧大弯侧淋巴结10枚无癌转移。HER-2( 0) 。现术后恢复可，可进少量半流食，进食后无明显不适，体重较术前上降约5KG近期检查发现左上腹肿块，左肾积水。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 0, "end_pos": 4}, {"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 19, "end_pos": 22}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 37, "end_pos": 39}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 65, "end_pos": 70}, {"end_pos": 91, "label_type": "手术", "overlap": 0, "start_pos": 86}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 102, "end_pos": 115}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 130, "end_pos": 131}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 146, "end_pos": 155}, {"end_pos": 218, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 221, "end_pos": 225}]}
{"originalText": "，患者于4年余前在我科行剖腹探查+乙状结肠肿瘤切除＋近端造口、远端封闭+结肠减压，3年余前行乙状结肠造口还纳术，已于2012年8月完成FOLFRI化疗方案五次，2014年3月入院复查发现卵巢转移，遂行经腹全子宫+两附件切除术+阑尾切除术+大网膜切除+左侧淋巴结清扫术+盆腔粘连松解，术中冰冻病理结果示左卵巢腺癌；手术顺利，术后患者恢复可，半年前*****行CT检查后发现发现网膜及系膜多发肿瘤转移，遂行规范XELOX化疗4次。1月前，患者因“乙状结肠癌术后3年余，肛门停止排气排便7天”入院。，入院后全腹部增强CT提示：结肠CA伴卵巢转移术后改变，小肠梗阻，考虑末端回肠粘连狭窄所致可能。遂于2015-12-03在全麻上行剖腹探查+肠粘连松解+左半结肠切除术，手术顺利，，术中冰冻切片提示：（左半结肠）腺癌，双切端未见癌累及。，术后病理诊断：左半结肠中分化管状腺癌，浸及肠壁全层，脉管内见癌栓。双切端未见癌累及。肠壁下淋巴结未见癌转移（0/10）。患者入院前无发热、寒战，无恶心、呕吐，无反酸、嗳气，今为行第5次化疗前来我院，门诊拟“乙状结肠癌、卵巢转移”收入我科。\\U0004   患者自起病以来，精神可，胃纳可，大便如常，小便如常，体重未见明显上降。", "entities": [{"label_type": "手术", "overlap": 0, "start_pos": 12, "end_pos": 40}, {"end_pos": 55, "label_type": "手术", "overlap": 0, "start_pos": 46}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 93, "end_pos": 97}, {"label_type": "手术", "overlap": 0, "start_pos": 100, "end_pos": 140}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 150, "end_pos": 155}, {"label_type": "影像检查", "overlap": 0, "start_pos": 178, "end_pos": 180}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 187, "end_pos": 198}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 221, "end_pos": 228}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 232}, {"label_type": "影像检查", "overlap": 0, "start_pos": 250, "end_pos": 257}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 260, "end_pos": 271}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 274, "end_pos": 278}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 281}, {"label_type": "手术", "overlap": 0, "start_pos": 311, "end_pos": 329}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 345, "end_pos": 353}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 371, "end_pos": 382}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 385, "end_pos": 386}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 406, "end_pos": 412}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 467, "end_pos": 477}, {"end_pos": 505, "label_type": "解剖部位", "overlap": 0, "start_pos": 504}]}
{"originalText": "，缘于入院前1月于我院诊为回盲部癌，于2015-06-23在全麻上行腹腔镜上左半结肠切除术，，术中见：腹腔内无明显出血，无明显腹水，于回盲部见肿瘤，大小约6×5×4CM，累及回肠末端约3.0CM，侵出浆膜层，与周围组织无明显粘连，未形成梗阻，近端肠管无扩张，周围及肠系膜根部未见明显肿大淋巴结。术后病理（201523144）示(左半结肠)，：肠浸润性管状腺癌II级，侵犯回盲瓣及回肠，侵及浆膜层，见神经侵犯，手术标本双切端及另送（下切端）（上切端）均未见癌浸润，找到阑尾根部淋巴结3个，回肠周淋巴结7个，结肠周围淋巴结26个，另送(回结肠动脉根部）淋巴结4个，(结肠中动脉根部）淋巴结4个，均未见癌转移；慢性阑尾炎。该病例未检测到KRAS基因12、13号密码子热点突变。该病例未检测到BRAF基因V600E突变。，术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。此次为行第1次化疗再次就诊我院，门诊拟回盲部癌术后收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 13, "end_pos": 17}, {"end_pos": 45, "label_type": "手术", "overlap": 0, "start_pos": 34}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 51}, {"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 137, "label_type": "解剖部位", "overlap": 0, "start_pos": 132}, {"end_pos": 146, "label_type": "解剖部位", "overlap": 0, "start_pos": 143}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 171, "end_pos": 182}, {"end_pos": 188, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"end_pos": 191, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"end_pos": 240, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"end_pos": 249, "label_type": "解剖部位", "overlap": 0, "start_pos": 243}, {"end_pos": 259, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 277, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"end_pos": 292, "label_type": "解剖部位", "overlap": 0, "start_pos": 280}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 302, "end_pos": 307}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 405, "end_pos": 411}, {"end_pos": 433, "label_type": "解剖部位", "overlap": 0, "start_pos": 432}, {"end_pos": 436, "label_type": "解剖部位", "overlap": 0, "start_pos": 435}]}
{"originalText": "，患者4月前因“胃癌”于2017-05-04在我院于全麻上行胃癌癌根治术（远端胃大部切除+毕I式吻合术），手术过程顺利，术后给予抗感染及营养支持治疗，患者恢复好，切口愈合良好，病愈出院。，术后病理示：（201710017）胃窦前壁腺癌（低分化）粘液性印戒，面积5*4.5CM，厚1.2CM，侵达浆膜。双端切线未查见癌。三组（5个）、四组（4个）、七组（1个）、“1、3、7组”（12个）淋巴结，未查见癌。，免疫组化染色示：CERB-2（-）、SYN少量（+）、β-TUBULIN-III部分（+）、RRM1（-）、TOPO II少量（+），于我院行化疗，，化疗方案为：奥沙利铂200MG D1+亚叶酸钙0.3D2-6 +氟尿嘧啶750MG D2-6 静滴，同时予以升白细胞、止吐、抑酸、保肝、免疫增强治疗。   院外期间患者一般情况好，无恶心，无腹痛腹胀胀不适，现患者为行复查及化疗再次来院就诊，门诊以“胃癌术后”收入院。   近期患者一般情况良好，神志清，精神良好，饮食、睡眠良好，大便次数多，小便正常，近期体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 8, "end_pos": 10}, {"label_type": "手术", "overlap": 0, "start_pos": 30, "end_pos": 52}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 111, "end_pos": 127}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 159, "end_pos": 196}, {"end_pos": 288, "label_type": "药物", "overlap": 0, "start_pos": 284}, {"end_pos": 301, "label_type": "药物", "overlap": 0, "start_pos": 297}, {"end_pos": 314, "label_type": "药物", "overlap": 0, "start_pos": 310}, {"end_pos": 345, "label_type": "解剖部位", "overlap": 0, "start_pos": 344}, {"end_pos": 374, "label_type": "解剖部位", "overlap": 0, "start_pos": 373}, {"end_pos": 376, "label_type": "解剖部位", "overlap": 0, "start_pos": 375}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 402, "end_pos": 406}]}
{"originalText": "，患者3月余前无明显诱因出现下腹部疼隐痛，程度轻微，可自行忍受，予抑酸等处理后疼痛可缓解，腹痛无向腰背部放射，无腹胀、腹泻，无恶心、呕吐，无便血、黑便。遂就诊于我院，，查胃镜示：胃窦幽门前见一溃疡型肿物，胃窦腔变形，狭窄。，活检提示：（胃窦幽门前溃疡型肿物活检）镜检为中至低分化腺癌，LAUREN，分型：考虑混合型。入院后完善相关检查，未见明显手术禁忌，有手术适应症，于2017-04-07在我院行“腹腔镜胃癌根治术”，术程顺利，术后恢复良好。，病理检查：（胃大体）镜检为胃中至低分化腺癌，LAUREN，分型：混合型，癌组织浸润至胃壁浆膜层，可见脉管内癌栓及神经束侵犯；网膜组织未见癌。（近切缘）（远切缘），镜上：粘膜慢性炎，局灶腺体伴轻度不典型增生及肠下皮化生。（淋巴结）6/52见腺癌转移；，免疫组化：VEGF（局灶弱+），HER-2（0），CK（+）。，原位杂交：EBERS（-）。术后分期为T4N2M0 IIIB期，术后恢复可，双便正常，体重上降20+斤。术后于2017-05-04行XELOX方案化疗1程，现按主诊教授意见收入我科。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"end_pos": 46, "label_type": "解剖部位", "overlap": 0, "start_pos": 45}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 49, "end_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 50, "end_pos": 51}, {"end_pos": 57, "label_type": "解剖部位", "overlap": 0, "start_pos": 56}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 89, "end_pos": 91}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 93}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 102, "end_pos": 104}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 118, "end_pos": 120}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 120, "end_pos": 122}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 134, "end_pos": 141}, {"end_pos": 208, "label_type": "手术", "overlap": 0, "start_pos": 200}, {"end_pos": 230, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 236, "end_pos": 251}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 265, "end_pos": 266}, {"end_pos": 327, "label_type": "解剖部位", "overlap": 0, "start_pos": 326}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 342, "end_pos": 344}]}
{"originalText": "，患者因“胃癌”于2015-5-19于我院行“胃癌根治术”，术后恢复良好，，术后病理示：胃窦腺癌，中度分化，浸润溃疡型，体积8*5*2.2CM，侵穿浆膜，部分脉管内查见癌栓，并大弯侧、小弯侧脂肪组织内及大网膜内多灶性癌转移，双端切线未查见癌。呈四组（3/9个）、六组（1/6个）淋巴结癌转移及“肝圆韧带”癌转移。三组（2个）、五组（1个）、“1、3、7组”（13个）淋巴结未查见癌。，癌组织免疫组化染色示：β-TUBULIN-III局灶（+）、TS（-）、RRM1局灶（+）、TOPOII少数（+）、CERBB-2（-）、SYN（-）。，依情予行术后2疗程化疗：奥沙利铂150MG D1+亚叶酸钙0.3G D2-6+替加氟1GD2-6,化疗过程顺利，无明显不适，现为进一步治疗至我科就诊，遂依情以“胃恶性肿瘤术后”收入院。发病来，患者目前患者精神好，食欲一般，夜间睡眠可，小便正常，大便未诉异常，近期体重无明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 5, "end_pos": 7}, {"end_pos": 28, "label_type": "手术", "overlap": 0, "start_pos": 23}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 44, "end_pos": 48}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 88, "end_pos": 90}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 92, "end_pos": 94}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 122, "end_pos": 142}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 156, "end_pos": 186}, {"end_pos": 285, "label_type": "药物", "overlap": 0, "start_pos": 281}, {"end_pos": 298, "label_type": "药物", "overlap": 0, "start_pos": 294}, {"end_pos": 311, "label_type": "药物", "overlap": 0, "start_pos": 308}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 349, "end_pos": 356}]}
{"originalText": "，患者因“乙状结肠癌”于2012-11-30在我院于全麻上行乙状结肠癌根治术，手术过程顺利，术后给予抗感染及营养支持治疗，患者恢复好，切口愈合良好。，术后病理示：（13304.2012）(乙状结肠）腺癌（中度分化，部分为粘液腺癌图像），符合绒毛状管状腺瘤癌变，面积为4*3.5CM，侵穿浆膜，双侧切线及另送“近端”、“远端”切线未查见癌。一站淋巴结（9个）、中间组淋巴结（7个）未查见癌。查无化疗禁忌后，分别于2012-12-20、2013-1-21、2013-2-16行3次化疗治疗，，化疗方案为：奥沙利铂150MG D1，亚叶酸钙0.3G+替加氟1.0G D2-D6，同时给与升白细胞、护肝、止吐、免疫增强治疗，患者副反应轻。   院外期间患者一般情况好，无恶心，无腹痛腹胀胀不适，现患者为行复查及化疗再次来院就诊，门诊以“乙状结肠癌术后”收入院。   近期患者精神可，饮食可，大便次数多，小便正常，近期体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 5, "end_pos": 10}, {"end_pos": 38, "label_type": "手术", "overlap": 0, "start_pos": 30}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 93, "end_pos": 129}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 169, "end_pos": 174}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 179, "end_pos": 185}, {"end_pos": 254, "label_type": "药物", "overlap": 0, "start_pos": 250}, {"end_pos": 267, "label_type": "药物", "overlap": 0, "start_pos": 263}, {"end_pos": 275, "label_type": "药物", "overlap": 0, "start_pos": 272}, {"end_pos": 297, "label_type": "解剖部位", "overlap": 0, "start_pos": 296}, {"end_pos": 336, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}, {"end_pos": 338, "label_type": "解剖部位", "overlap": 0, "start_pos": 337}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 364, "end_pos": 371}]}
{"originalText": "，缘于入院1月余前于我院诊为降结肠中分化管状腺癌，于2016年03月04日在全麻上行“腹腔镜上根治性右半结肠切除术”，术后病理（N201601905），：（右半结肠），：结肠溃疡型中分化管状腺癌，侵犯肠壁全层及肠周脂肪组织，侵犯神经、脉管组织，手术标本双切端及另送(上切端)均未见癌浸润,另送(下切端)浆膜外纤维脂肪组织中见癌浸润。找到肠周淋巴结5/15个见癌转移。另送(右结肠根部淋巴结)、(结肠中血管右支根部淋巴结)镜上为纤维、血管、脂肪组织。（MN20160037），：该病例未检测到BRAF基因V600E突变。（MN20160037），：该病例检测到KRAS基因12号密码子G12S突变。术顺安返，予预防性抗感染、制酸、提高免疫力、营养支持等治疗好转后出院。于2016.04.12予“安维汀200MGIVGTTD1+奥沙利铂120MGIVGTTD2+氟尿嘧啶3400MGCIV48H+亚叶酸钙300MGIVGTTD1-2”方案化疗1个周期，化疗过程顺利，化疗后未见明显不良反应。此次为化疗再次就诊我院，门诊拟结肠癌术后收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 24}, {"end_pos": 57, "label_type": "手术", "overlap": 0, "start_pos": 43}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 85, "end_pos": 97}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 100, "end_pos": 101}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 105, "end_pos": 106}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"end_pos": 194, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}, {"end_pos": 349, "label_type": "药物", "overlap": 0, "start_pos": 346}, {"end_pos": 366, "label_type": "药物", "overlap": 0, "start_pos": 362}, {"end_pos": 383, "label_type": "药物", "overlap": 0, "start_pos": 379}, {"end_pos": 400, "label_type": "药物", "overlap": 0, "start_pos": 396}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 458, "end_pos": 463}, {"end_pos": 485, "label_type": "解剖部位", "overlap": 0, "start_pos": 484}, {"end_pos": 488, "label_type": "解剖部位", "overlap": 0, "start_pos": 487}]}
{"originalText": "患者于2015.10.28在我院因“绝经2年后阴道不规则流血2月”行经腹广泛性子宫+两附件切除术+盆腔淋巴结清扫术，手术顺利，术后病理示：（38711.15）（宫颈）中低分化鳞状细胞癌，肿瘤切面积4.8×2.6CM，侵及宫颈全层及宫颈内口；阴道壁、右左宫旁组织未查见癌；右闭孔淋巴结4枚（0/4）、左闭孔淋巴结5枚（0/5）均未查见转移癌；右髂血管淋巴结9枚，其中8枚查见转移癌（8/9），左髂血管淋巴结7枚，其中1枚查见转移癌（1/7）；萎缩性子宫内膜，两侧输卵管大致正常，两侧卵巢白体。于2015.11.13行紫杉醇+顺铂化疗1周期，化疗过程中出现紫杉醇过敏，后于2015.12.09改为力朴素270MG+顺铂120MG化疗1周期，未诉明显不适。后为行进一步治疗转入我科，排除放化疗禁忌后，给予局部放疗计划，计划量DT=4500CGY/25F，同时顺铂40MG D1-3+力扑素270MG D1化疗1周期，过程顺利，无明显不适。后为行进一步诊治，就诊我院。排除化疗禁忌后于2016.2.16给予力扑素270MG D1+顺铂40MG D1-3化疗1周期，过程顺利，无明显不适。现为行上周期化疗再次收入我科。患者自下次出院以来，饮食睡眠可，大小便正常，体重无明显改变。", "entities": [{"end_pos": 25, "label_type": "解剖部位", "overlap": 0, "start_pos": 23}, {"label_type": "手术", "overlap": 0, "start_pos": 34, "end_pos": 57}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 79, "end_pos": 92}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 115, "end_pos": 117}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 141, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"end_pos": 155, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 195}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 223, "end_pos": 225}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 228, "end_pos": 233}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 238, "end_pos": 244}, {"end_pos": 260, "label_type": "药物", "overlap": 0, "start_pos": 257}, {"end_pos": 263, "label_type": "药物", "overlap": 0, "start_pos": 261}, {"end_pos": 279, "label_type": "药物", "overlap": 0, "start_pos": 276}, {"end_pos": 299, "label_type": "药物", "overlap": 0, "start_pos": 296}, {"end_pos": 307, "label_type": "药物", "overlap": 0, "start_pos": 305}, {"end_pos": 378, "label_type": "药物", "overlap": 0, "start_pos": 376}, {"end_pos": 391, "label_type": "药物", "overlap": 0, "start_pos": 388}, {"end_pos": 452, "label_type": "药物", "overlap": 0, "start_pos": 449}, {"end_pos": 463, "label_type": "药物", "overlap": 0, "start_pos": 461}]}
{"originalText": "，2017年02月17日在全麻上行腹腔镜探查，根治性全胃切除术。，术后病理：（全胃和大网膜），切除： - 溃疡型低分化腺癌，LAUREN，分型：混合型； - 位于粘膜层； - 未见脉管癌栓； - （食管断端）、（十二指肠残端）未见癌； - 大网膜未见癌； - 淋巴结未见癌转移（第1组0/3、第2组0/2、第3组0/0、第4D组0/1、第4SA组0/0、第5组0/2、第7组0/3、第8A组0/1、第8P组0/2、第9组0/2、第11D组0/3、第12A组0/0、第6组0/3、第11P组0/4、第4SB组0/0）； - ，肿瘤病理分期：PT1AN0。，免疫组化结果显示:CD56(－),CGA(－),CK(+),KI-67(+40%),SYN(－)。术后恢复可。，术后基线：胸CT（-),腹盆，CT：盆腔少量积液，较前增多。2017-3-15 C125 76.84。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 17, "end_pos": 31}, {"end_pos": 41, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 53, "end_pos": 61}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 99, "end_pos": 101}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"label_type": "影像检查", "overlap": 0, "start_pos": 338, "end_pos": 341}, {"label_type": "影像检查", "overlap": 0, "start_pos": 345, "end_pos": 350}, {"end_pos": 353, "label_type": "解剖部位", "overlap": 0, "start_pos": 351}]}
{"originalText": "，缘于入院前44天因“盲肠癌”于2016.05.30在全麻上行“腹腔镜上左半结肠根治性切除术”，，术中见：腹腔内无明显出血，无明显腹水，肿瘤位于盲肠，肿瘤侵犯左外侧腹壁，未形成梗阻，近端肠管无扩张，周围可见数个肿大淋巴结。术后病理（201618360），示：(左半结肠)，：结肠溃疡型管状腺癌II级，伴坏死，侵出外膜层；回肠末端淋巴组织增生。手术标本回肠切端、结肠切端及另送（近切端）、（远切端）均未见癌浸润。找到回肠周淋巴结1/5个、结肠周淋巴结3/10个，及另送(回结肠动脉根部)淋巴结2/2，见癌转移。，免疫组化：13号KI67（60%+），CK8（+++），CEA（+++），P53（-）；22号KI67（生发中心80%+，滤泡间区2%+），CD3（T细胞+++），CD20（B细胞+++），BCL-2（+++）。术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。并于2016.06.23予“奥沙利铂150MGIVGTTD1+卡培他滨片1000MGPOBIDD1-14”方案化疗1周期，辅以制酸、保肝、止吐等预处理，化疗过程顺利，无明显不适。此次为化疗再次就诊我院，门诊拟“盲肠癌术后化疗”收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 11, "end_pos": 14}, {"end_pos": 46, "label_type": "手术", "overlap": 0, "start_pos": 32}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 53}, {"end_pos": 66, "label_type": "解剖部位", "overlap": 0, "start_pos": 65}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 82, "end_pos": 83}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 93, "end_pos": 94}, {"end_pos": 134, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 137, "end_pos": 149}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 160, "end_pos": 162}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 182, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"end_pos": 213, "label_type": "解剖部位", "overlap": 0, "start_pos": 207}, {"end_pos": 224, "label_type": "解剖部位", "overlap": 0, "start_pos": 218}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"end_pos": 408, "label_type": "药物", "overlap": 0, "start_pos": 404}, {"end_pos": 425, "label_type": "药物", "overlap": 0, "start_pos": 421}, {"end_pos": 458, "label_type": "解剖部位", "overlap": 0, "start_pos": 457}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 495, "end_pos": 500}, {"end_pos": 525, "label_type": "解剖部位", "overlap": 0, "start_pos": 524}, {"end_pos": 528, "label_type": "解剖部位", "overlap": 0, "start_pos": 527}]}
{"originalText": "，患者于入院前4个月因“反复血便6个月”住我院查腹部，CT:1、乙状结肠管壁不规则增厚，符合乙状结肠CA（浸润型）改变，侵犯浆膜层，伴周围少许淋巴结。2、阑尾切除术后改变。遂于2013.11.14全麻上“腹腔镜上乙状结肠癌根治术”，术顺，术后予预防感染、营养支持、补液等治疗。，术后病理：(乙状结肠)，:肠溃疡型管状腺癌II级，侵及深肌层，侵犯神经组织，手术标本下、上切端及另送(下切端)、(上切端)均未见癌浸润，找到肠周淋巴结17个，及另送(直肠下动脉旁染色淋巴结1)淋巴结1个，(直肠下动脉旁染色淋巴结2)淋巴结1个，(肠系膜上动脉)淋巴结2个均未见癌浸润。术后恢复可，进食半流质饮食无腹痛、腹胀等不适，创口愈合良好，于2013.12.23、2014.01.12、2014.02.05、2014.02.27予以“奥沙利铂200MGIVGTTD1+希罗达1500MGPOBIDD1-14”方案化疗，化疗期间辅以预防性制酸、止吐等治疗，化疗期间未见明显不适。今为第5次化疗就诊我院，门诊拟“结肠癌术后”收住入院，自患病以来患者精神、睡眠、饮食一般，大小便正常，体重无明显改变。", "entities": [{"label_type": "影像检查", "overlap": 0, "start_pos": 24, "end_pos": 29}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 32, "end_pos": 36}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 46, "end_pos": 57}, {"label_type": "手术", "overlap": 0, "start_pos": 77, "end_pos": 82}, {"end_pos": 114, "label_type": "手术", "overlap": 0, "start_pos": 102}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 152, "end_pos": 163}, {"end_pos": 214, "label_type": "解剖部位", "overlap": 0, "start_pos": 209}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 222, "end_pos": 234}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 242, "end_pos": 254}, {"end_pos": 272, "label_type": "解剖部位", "overlap": 0, "start_pos": 261}, {"end_pos": 296, "label_type": "解剖部位", "overlap": 0, "start_pos": 295}, {"end_pos": 299, "label_type": "解剖部位", "overlap": 0, "start_pos": 298}, {"end_pos": 362, "label_type": "药物", "overlap": 0, "start_pos": 358}, {"end_pos": 378, "label_type": "药物", "overlap": 0, "start_pos": 375}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 445, "end_pos": 450}]}
{"originalText": "，缘于入院前4个月因“乙转结肠癌”于2014年01月09日行“腹腔镜上乙状结肠癌根治术”。术后病理（201400845），：1、（乙状结肠），：大肠溃疡型乳头状-管状腺癌II级，侵及浆膜，手术标本双切端及另送（下切端）、（上切端）均未见癌浸润。找到肿物周淋巴结9个，肠周淋巴结8个，均未见癌转移。2、（肠系膜上动脉根部）送检脉管、纤维及脂肪组织。，术后给予对症、抗感染治疗，恢复良好,伤口愈合II/甲。于2014.02.04、2014.02.24、2014.03.17、2014.04.10、2014.4.30予“奥沙利铂(艾恒)200MG静滴D1+卡培他滨片(希罗达)1500MG口服BIDD1-14”方案化疗5周期，化疗过程顺利，辅以制酸、止吐等处理。此次为化疗再次入院。患者出院后饮食、夜休可，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"end_pos": 43, "label_type": "手术", "overlap": 0, "start_pos": 31}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 65}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 72, "end_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 124, "end_pos": 130}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 151, "end_pos": 152}, {"end_pos": 261, "label_type": "药物", "overlap": 0, "start_pos": 257}, {"end_pos": 264, "label_type": "药物", "overlap": 0, "start_pos": 262}, {"end_pos": 279, "label_type": "药物", "overlap": 0, "start_pos": 275}, {"end_pos": 284, "label_type": "药物", "overlap": 0, "start_pos": 281}, {"end_pos": 352, "label_type": "解剖部位", "overlap": 0, "start_pos": 351}, {"end_pos": 355, "label_type": "解剖部位", "overlap": 0, "start_pos": 354}]}
{"originalText": "，患者因“，盆腔包块：卵巢癌？”于2013-12-30我可行肿瘤细胞减灭术（全子宫切除+两附件切除+盆腔淋巴结切除+腹主动脉淋巴结切除+大网膜切除+肠粘连松解术），术程顺利，术后恢复良好。，术后病理提示：两侧卵巢见低分化腺癌浸润，形态较符合高级别浆液性腺癌，子宫体后壁外膜层及肌层见腺癌浸润，宫颈管后壁外膜层见腺癌浸润，大网膜纤维组织中见低分化腺癌浸润，两侧输卵管、宫颈及盆腔淋巴结均未见癌。结合术后病理诊断为“卵巢低分化腺癌IIIC期”，今为术后辅助化疗收入院，患者近1月以来精神可，大小便无异常，体重无明显减轻。", "entities": [{"end_pos": 8, "label_type": "解剖部位", "overlap": 0, "start_pos": 6}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 11, "end_pos": 14}, {"label_type": "手术", "overlap": 0, "start_pos": 38, "end_pos": 80}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 102, "end_pos": 106}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 107, "end_pos": 112}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 120, "end_pos": 128}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 129, "end_pos": 132}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 141, "end_pos": 143}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 146, "end_pos": 149}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 155, "end_pos": 157}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 167, "end_pos": 174}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 177, "end_pos": 182}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 183, "end_pos": 185}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 186, "end_pos": 191}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 206, "end_pos": 218}]}
{"originalText": "，患者于3月余前因胰腺肿物于我科行胰十二指肠切除、联合胰腺体颈部切除、胃造瘘、空肠造瘘术”，，术后病理示:胰腺导管内乳头状粘连性肿瘤伴下皮重度不典型增生.术后予保肝、制酸、输白蛋白、对症等治疗。术后恢复可，予带T管、胃、空肠造瘘管、左腹腔引流管出院。2月余前T管管周出现明显渗液，呈浓稠状，，入院查下腹部CT示:腹腔积液.予行B超引导上腹腔穿刺置管引流后予抗感染、补液、保肝等处理后腹腔管、胃空肠造瘘管、T管均拔除后出院，现患者无腹痛、腹胀，无畏寒、发热，无眼黄、尿黄、皮肤黄等不适，今为进一步复查，来我院，门诊以胰十二指肠切除术后收入院。患者自发病以来饮食少，大小便无异常，体重无明显增减。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"label_type": "手术", "overlap": 0, "start_pos": 17, "end_pos": 44}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 53, "end_pos": 55}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 58, "end_pos": 76}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 108}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"end_pos": 119, "label_type": "解剖部位", "overlap": 0, "start_pos": 116}, {"label_type": "影像检查", "overlap": 0, "start_pos": 150, "end_pos": 154}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 156, "end_pos": 160}, {"end_pos": 176, "label_type": "手术", "overlap": 0, "start_pos": 163}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"end_pos": 193, "label_type": "解剖部位", "overlap": 0, "start_pos": 191}, {"end_pos": 198, "label_type": "解剖部位", "overlap": 0, "start_pos": 195}, {"end_pos": 216, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"end_pos": 219, "label_type": "解剖部位", "overlap": 0, "start_pos": 218}, {"end_pos": 230, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"end_pos": 237, "label_type": "解剖部位", "overlap": 0, "start_pos": 235}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 257, "end_pos": 266}]}
{"originalText": "，缘于入院前1年余因“食管中段癌（PT2N0M0）II期”就诊我院2013.08.12在全麻上行食管中段癌切除+食管-胃底弓下吻合术，，术中探查：胸腔无粘连，无淡黄色积液；肿物位于主动脉弓后，局部增厚约2.5CM，未累及外膜，食管旁多发淋巴结肿大。，术后病理示：（201324854）(食管)，：食管溃疡型鳞状细胞癌II级，侵及深肌层（1/2肌层），手术标本下上切端均未见癌浸润，找到食管周淋巴结3个及另送(中段食管旁）淋巴结11个，(胃右动脉旁）淋巴结14个，均未见癌转移，(贲门旁淋巴结）为血管、脂肪、纤维结缔组织及横纹肌组织。，免疫组化结果：KI67（50%），P53（+++），P170（-），GSTπ（+++），EGFR（+++）。现为术后复查再次就诊我院。下次出院至今患者无胸闷、憋气；无胸背痛；无腹痛、腹胀；无呕血、黑便；偶有返酸。饮食睡眠较好。大小便正常。体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 11, "end_pos": 16}, {"label_type": "手术", "overlap": 0, "start_pos": 48, "end_pos": 66}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 113, "end_pos": 121}, {"end_pos": 145, "label_type": "解剖部位", "overlap": 0, "start_pos": 143}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 148, "end_pos": 161}, {"end_pos": 198, "label_type": "解剖部位", "overlap": 0, "start_pos": 192}, {"end_pos": 213, "label_type": "解剖部位", "overlap": 0, "start_pos": 203}, {"end_pos": 227, "label_type": "解剖部位", "overlap": 0, "start_pos": 217}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 239}, {"end_pos": 344, "label_type": "解剖部位", "overlap": 0, "start_pos": 343}, {"end_pos": 352, "label_type": "解剖部位", "overlap": 0, "start_pos": 350}, {"end_pos": 356, "label_type": "解剖部位", "overlap": 0, "start_pos": 355}, {"end_pos": 359, "label_type": "解剖部位", "overlap": 0, "start_pos": 358}]}
{"originalText": "患者因\\\"子宫肌瘤\\\"于2013年9月10日行全子宫切除术+右侧附件切除术，术后外院病理结果示子宫内膜样腺癌（中-低分化），浸润深肌层，累及宫颈管，诊断为子宫内膜癌。术后恢复可。2013-10-30、2013-11-22行TP方案化疗（多帕菲、伯尔定）2程。2013-12-12行“力朴素+伯尔定”化疗1程。现按主诊教授意见入院行上一程化疗。患者近期精神、睡眠、胃纳可，大小便无异常，体重未见明显减轻。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 5, "end_pos": 9}, {"label_type": "手术", "overlap": 0, "start_pos": 23, "end_pos": 37}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 47, "end_pos": 61}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 77, "end_pos": 82}, {"end_pos": 121, "label_type": "药物", "overlap": 0, "start_pos": 118}, {"end_pos": 125, "label_type": "药物", "overlap": 0, "start_pos": 122}, {"end_pos": 144, "label_type": "药物", "overlap": 0, "start_pos": 141}, {"end_pos": 148, "label_type": "药物", "overlap": 0, "start_pos": 145}, {"end_pos": 182, "label_type": "解剖部位", "overlap": 0, "start_pos": 181}]}
{"originalText": "，患者约于6个月前因“乙状结肠癌”于2017-01-23在全麻上行“乙状结肠根治术”，手术过程顺利，术后患者恢复好，切口愈合好，按期拆线。术后病理( 201701617)，：乙状结肠粘液腺癌，浸润溃疡型，体积6.5*4*1.3CM，局部侵穿浆膜。双端切线及另送“近切线”、“远切线”未查见癌。呈一站（3/8个）、中间组（1/8个）淋巴结癌转移。，免疫组化染色示癌组织：SYN（-）、BRAF（-）、MLH1（+）、MSH2（+）、MSH6（+）、PMS2（+）。患者术后出现发热，尿培养+药敏(20170204)，: 铜绿假单胞菌，给予抗炎、退热等药物治疗后，症状逐渐缓解后出院。患者出院后规律至我院复查，给予6周期化疗，，方案为：奥沙利铂200MG D1，亚叶酸钙0.3G+氟尿嘧啶0.75G D2-D6，同时给与升白细胞、护肝、止吐、免疫增强治疗，患者副反应轻。   院外期间，患者无发热，无腹痛腹胀不适，大便通畅。现患者为行复查化疗来我科就诊，以“乙状结肠癌术后”收入院。   病人自下次出院以来，神志清，精神可，饮食可，大、小便正常，体重未见明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 11, "end_pos": 16}, {"end_pos": 41, "label_type": "手术", "overlap": 0, "start_pos": 34}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 87, "end_pos": 95}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 147, "end_pos": 168}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 240, "end_pos": 243}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 244, "end_pos": 246}, {"end_pos": 320, "label_type": "药物", "overlap": 0, "start_pos": 316}, {"end_pos": 333, "label_type": "药物", "overlap": 0, "start_pos": 329}, {"end_pos": 342, "label_type": "药物", "overlap": 0, "start_pos": 338}, {"end_pos": 365, "label_type": "解剖部位", "overlap": 0, "start_pos": 364}, {"end_pos": 399, "label_type": "解剖部位", "overlap": 0, "start_pos": 398}, {"end_pos": 401, "label_type": "解剖部位", "overlap": 0, "start_pos": 400}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 427, "end_pos": 434}]}
{"originalText": "，患者因患“胃癌”于2017-07-10日在全麻上行全胃切除术+空肠J字代胃术，手术顺利，术后给予抗炎、抑酸、营养支持及对症支持治疗，术后病理示术后病理（201715979），示：胃体腺癌（低分化），浸润溃疡型，体积2.5*1*1.3CM，侵达浆膜。双端切线及另送“食管切线”未查见癌。一组（7个）、三组（2个）、四组（4个）、五组（1个）及六组（2个）淋巴结未查见癌。，免疫组化染色示：CERBB-2（-）、SYN（-）、β-TUBULIN-III少数（+）、RRM1（-）、TOPOII部分（+）。术后给予化疗1疗程，，方案：奥沙利铂200MG D1+亚叶酸钙0.3G D2-6 +替加氟1000MG D2-6 静滴，现患者为行复查化疗来我院就诊，门诊以“胃癌术后”收入院。自下次出院后，患者一般情况保持良好， 无乏力感，无发热，无恶心、呕吐，无反酸、嗳气，无明显进食不适，未现明显 腹痛、腹胀；大小便情况良好。目前患者精神及情绪状态可，食欲、饮食好，夜间睡眠可，大小便正常，近期无明显体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 6, "end_pos": 8}, {"label_type": "手术", "overlap": 0, "start_pos": 26, "end_pos": 39}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 90, "end_pos": 99}, {"end_pos": 135, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 142, "end_pos": 180}, {"end_pos": 269, "label_type": "药物", "overlap": 0, "start_pos": 265}, {"end_pos": 282, "label_type": "药物", "overlap": 0, "start_pos": 278}, {"end_pos": 296, "label_type": "药物", "overlap": 0, "start_pos": 293}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 330, "end_pos": 334}, {"end_pos": 395, "label_type": "解剖部位", "overlap": 0, "start_pos": 394}, {"end_pos": 398, "label_type": "解剖部位", "overlap": 0, "start_pos": 397}]}
{"originalText": "患者1年余前（2014-9-30）因“胃癌”于我院行胃癌根治术（毕I），术后给予消炎营养支持治疗，患者出现肠梗阻症状，于2014-10-15在全麻上行肠粘连松解术+空肠造瘘术，术后给予消炎、营养支持治疗，病情好转后出院。术中常规病理示：（胃）中分化腺癌，溃疡型，肿物切面积4.5*1CM，侵达浆膜脂肪组织，双端切缘及吻合器切缘未查见癌。小弯侧淋巴结22枚，其中2枚（2/22）查见转移；大弯侧淋巴结12枚，其中4枚（4/12）查见转移。另送网膜组织内未查见癌。后患者再次入院行奥沙利铂+CF+替加氟方案化疗8个周期，耐受良好。后患者反复腹痛，给予对症后症状均可缓解。现患者为进一步诊疗，再次来我院，门诊以“胃癌术后肠粘连”收入院。自发病以来，患者神志清，精神可，睡眠尚可，昨日排便一次，小便无明显异常，体重较下次入院无明显改变。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 19, "end_pos": 21}, {"end_pos": 35, "label_type": "手术", "overlap": 0, "start_pos": 26}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 53, "end_pos": 56}, {"label_type": "手术", "overlap": 0, "start_pos": 75, "end_pos": 87}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 118, "end_pos": 126}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"end_pos": 242, "label_type": "药物", "overlap": 0, "start_pos": 238}, {"end_pos": 245, "label_type": "药物", "overlap": 0, "start_pos": 243}, {"end_pos": 249, "label_type": "药物", "overlap": 0, "start_pos": 246}, {"end_pos": 269, "label_type": "解剖部位", "overlap": 0, "start_pos": 268}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 303, "end_pos": 307}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 307, "end_pos": 310}]}
{"originalText": "，缘于入院3月余前我院诊断为贲门癌，于2015.11.06在气管插管全麻上行“腹腔镜辅助上根治性全胃切除术”，，术中见：腹腔内无腹水，腹腔内未见明显转移结节，肿瘤位于贲门，大小约5.0×5.0CM，呈浸润溃疡型，侵及浆膜层，周围有肿大淋巴结.术中诊断“贲门癌”。，术后病理示：食管胃交界处溃疡型中－低分化腺癌,侵犯浆膜层，侵犯脉管及神经组织，间质见多量淋巴细胞浸润。手术标本下切端粘膜上层可见脉管癌栓，标本上切端均未见癌浸润。找到贲门周淋巴结9/20个，小弯淋巴结0/29个，大弯淋巴结0/8个，幽门下淋巴结0/3个，幽门上淋巴结0/4个，网膜淋巴结0/1个及另送（胃右动脉根部）淋巴结1/9个见癌转移。（胃右动脉根部）淋巴结见多发下皮样结节，呈肉芽肿性炎改变。术后给予对症、营养支持等处理，恢复良好，切口愈合为II/甲。术后于2015.12.5、2015.12.27、2016.01.23予以“伊立替康240MGIVGTTD1+替吉奥60MGPOBIDD1-D14”方案化疗，辅以保胃、保肝、增强免疫、营养补液治疗。今为术后4次化疗，再次入院，门诊拟“贲门癌术后化疗”收入住院，自下次出院以来饮食、夜休可，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"end_pos": 32, "label_type": "解剖部位", "overlap": 0, "start_pos": 30}, {"end_pos": 53, "label_type": "手术", "overlap": 0, "start_pos": 39}, {"end_pos": 62, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"end_pos": 85, "label_type": "解剖部位", "overlap": 0, "start_pos": 83}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 126, "end_pos": 129}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 138, "end_pos": 154}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"end_pos": 232, "label_type": "解剖部位", "overlap": 0, "start_pos": 227}, {"end_pos": 243, "label_type": "解剖部位", "overlap": 0, "start_pos": 238}, {"end_pos": 254, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"end_pos": 265, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"end_pos": 275, "label_type": "解剖部位", "overlap": 0, "start_pos": 270}, {"end_pos": 293, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"end_pos": 313, "label_type": "解剖部位", "overlap": 0, "start_pos": 302}, {"end_pos": 402, "label_type": "药物", "overlap": 0, "start_pos": 398}, {"end_pos": 418, "label_type": "药物", "overlap": 0, "start_pos": 415}, {"end_pos": 443, "label_type": "解剖部位", "overlap": 0, "start_pos": 442}, {"end_pos": 446, "label_type": "解剖部位", "overlap": 0, "start_pos": 445}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 477, "end_pos": 482}, {"end_pos": 506, "label_type": "解剖部位", "overlap": 0, "start_pos": 505}, {"end_pos": 509, "label_type": "解剖部位", "overlap": 0, "start_pos": 508}]}
{"originalText": "，患者因“直肠癌”于2015-06-16在我院在全麻上行根治性DIXON手术，手术过程顺利，术后患者恢复好，切口愈合好，按期拆线。，术后病理：（直肠）腺癌（中度分化），隆起型，体积8.5*7*1.5CM，侵达深肌层，底部切除面 未查见癌。 双端切线及另送“近切线”、“远切线”未查见癌。 一站（5个）、中央组（11个）、中间组（1个）淋巴结未查见癌。 ，免疫组化染色示：TS少量（+）、SYN（-）。后患者出现发热及左下腹痛，行CT检查示胆总管结石并以下水平胆系扩张，请肝胆外科会诊后给予抗生素及保肝治疗，患者症状明显好转。   院外期间患者一般情况好，无恶心，无腹痛腹胀不适，2015年9月21日门诊行结肠镜检查发现结肠多发息肉，并行内镜上结肠息肉电切术，术后恢复好，现患者为行复查再次来院就诊，为行进一步治疗，门诊以“直肠癌术后、结肠多发息肉”收入院。   近期患者精神可，饮食可，大便次数多，小便正常，近期体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 5, "end_pos": 8}, {"end_pos": 38, "label_type": "手术", "overlap": 0, "start_pos": 28}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 71, "end_pos": 83}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 143, "end_pos": 170}, {"end_pos": 211, "label_type": "解剖部位", "overlap": 0, "start_pos": 208}, {"label_type": "影像检查", "overlap": 0, "start_pos": 214, "end_pos": 216}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 219, "end_pos": 224}, {"end_pos": 250, "label_type": "解剖部位", "overlap": 0, "start_pos": 249}, {"end_pos": 283, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 284}, {"end_pos": 311, "label_type": "解剖部位", "overlap": 0, "start_pos": 309}, {"end_pos": 328, "label_type": "手术", "overlap": 0, "start_pos": 318}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 361, "end_pos": 366}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 367, "end_pos": 373}]}
{"originalText": "，缘于入院前2个月在我院诊为“降结肠癌”，并于2014.04.28在全麻上行“腹腔镜辅助上根治性右半结肠切除术+小肠肿物切除术”，术顺，术后病理（201412664），：（右半结肠），：1.肠隆起型绒毛状-管状腺癌II级，癌组织侵犯脉管组织，侵及浅肌层。手术标本双切端及另送（下切端）、（上切端）均未见癌浸润；找到肠周淋巴结23个，均未见癌转移。肠周见癌结节1个。2.肠绒毛状-管状腺瘤，伴腺下皮低级别下皮内瘤变。（小肠），：送检组织镜上为梭形细胞增生结节（最大径0.5CM），细胞核呈短梭形，可见核仁，胞浆嗜碱性，排列呈束状，核分裂像少见（&LT;2个/50HPF），结合免疫组化结果，考虑危险度低的胃肠道间质瘤，因送检组织均为肿瘤组织，未见肠粘膜，无法判断切缘情况，请结合临床诊断。建议随访。，免疫组化结果：CK(PAN)（-），CD117（+++），CD34（++），DOG1（+++），DESMIN（-），H-CALDESMON（-），ACTIN(SM)（-），S100（个别细胞阳性），NF(PAN)（-），CD57（-），KI67（2%阳性）。术后予营养支持治疗，恢复良好。术后按“奥沙利铂(齐沙)150MGIVGTTD1+希罗达1000.00MGPOBIDD2-15”方案化疗，于2014-05-28行第1周期化疗。今入院行术后第2周期化疗，门诊拟“降结肠癌术后化疗”收住入院。自术后出院以来，精神、睡眠、食欲尚可，大小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 15, "end_pos": 19}, {"label_type": "手术", "overlap": 0, "start_pos": 39, "end_pos": 63}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 95, "end_pos": 110}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 157}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 184, "end_pos": 193}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 208}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 301, "end_pos": 307}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 322, "end_pos": 323}, {"end_pos": 501, "label_type": "药物", "overlap": 0, "start_pos": 497}, {"end_pos": 504, "label_type": "药物", "overlap": 0, "start_pos": 502}, {"end_pos": 521, "label_type": "药物", "overlap": 0, "start_pos": 518}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 582, "end_pos": 588}]}
{"originalText": "，缘于入院前1月于我院诊为乙状结肠癌，于2015-05-03在全麻上行腹腔镜上乙状结肠根治性切除术，术后病理（201614352），示：“乙状结肠浸润性管状腺癌I-II级，侵及浆膜上层。手术标本下、上切端及另送（下切端）、（上切端）均未见癌浸润。找到肠周淋巴结10个，及另送的（直肠下动脉根部）淋巴结3个，均未见癌转移。，免疫组化：KI-67（20%+），CK7（+），CK20（+++），VILLIN（++++），CDX2（+++），β-CATENIN（膜+++）。该病例未检测到KRAS基因12、13号密码子热点突变。，病理：该病例未检测到BRAF基因V600E突变”，术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。2016.06.03予“奥沙利铂200MGIVGTTD1+卡培他滨1500MGPOBIDD2-14”方案化疗1个疗程，辅以止吐、保肝、制酸、增强免疫等治疗，无明显化疗毒副反应。此次为行上一周期化疗，门诊拟乙状结肠癌术后化疗收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 13, "end_pos": 18}, {"end_pos": 49, "label_type": "手术", "overlap": 0, "start_pos": 35}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 69, "end_pos": 85}, {"end_pos": 130, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"end_pos": 150, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"end_pos": 332, "label_type": "药物", "overlap": 0, "start_pos": 328}, {"end_pos": 349, "label_type": "药物", "overlap": 0, "start_pos": 345}, {"end_pos": 382, "label_type": "解剖部位", "overlap": 0, "start_pos": 381}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 418, "end_pos": 425}, {"end_pos": 449, "label_type": "解剖部位", "overlap": 0, "start_pos": 448}, {"end_pos": 452, "label_type": "解剖部位", "overlap": 0, "start_pos": 451}]}
{"originalText": "，缘于入院前25天因胃体癌于2015年11月24日在我院全麻上行“腹腔镜辅助上根治性全胃切除术”，，术中探查见：腹腔内无明显腹水，盆腔、腹壁、大网膜无转移结节，肝脏质地大小正常，胆囊无肿大。胃体病灶不能探及，周围无明显肿大淋巴结，手术顺利，术后予抗感染、营养支持、免疫等治疗，术后恢复良好，术后病理（201541588），：（全胃)，:胃窦小弯侧溃疡型管状腺癌II级，侵犯肌层。手术标本下、上切端及另送（下切端）均未见癌浸润。找到贲门周淋巴结0/7个，幽门上淋巴结0/13个，及另送(第1组）淋巴结0/1个、（第7组）淋巴结1/7个、（第8组）淋巴结2/9个、（第9组）淋巴结0/2个，见癌转移。另送（第11组淋巴结）、（第12组淋巴结）镜上为纤维、血管、脂肪组织。小弯侧、幽门下、大弯侧脂肪组织未找见淋巴结；，免疫组化：肿瘤细胞示KI67（20％阳性），P53（-），P170（++），GSTπ（-），EGFR（-），5-FU（+），HER-2（+），CK(L)（++）。此次为术后第1周期化疗再次入院。患者出院后饮食、夜休可，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"end_pos": 47, "label_type": "手术", "overlap": 0, "start_pos": 33}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 56}, {"end_pos": 63, "label_type": "解剖部位", "overlap": 0, "start_pos": 62}, {"end_pos": 67, "label_type": "解剖部位", "overlap": 0, "start_pos": 65}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 165, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 168, "end_pos": 183}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"end_pos": 232, "label_type": "解剖部位", "overlap": 0, "start_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 241, "end_pos": 249}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 255, "end_pos": 262}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 267, "end_pos": 275}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 280, "end_pos": 288}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 300, "end_pos": 319}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 333, "end_pos": 335}, {"end_pos": 339, "label_type": "解剖部位", "overlap": 0, "start_pos": 337}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 341, "end_pos": 343}, {"end_pos": 414, "label_type": "药物", "overlap": 0, "start_pos": 410}, {"end_pos": 467, "label_type": "解剖部位", "overlap": 0, "start_pos": 466}, {"end_pos": 470, "label_type": "解剖部位", "overlap": 0, "start_pos": 469}]}
{"originalText": "，缘于入院前2月余于我院诊为“直肠癌”，于2015-10-12在全麻上行腹腔镜上直肠根治术（DIXON手术）中转开腹+膀胱病损修补术，，术中见：腹腔内无明显出血，肿瘤位于直乙交界处，与膀胱分界不清，形成肠梗阻，近端稍扩张，周围见数个明显肿大淋巴结。，术后病理：（201541031）（直肠），：肠外生型管状腺癌II级，侵犯肠壁全层及肠周脂肪组织，间质见多量急慢性炎症细胞及组织细胞浸润。手术标本双切端及另送(下切端)、(上切端)均未见癌浸润。找到肠周淋巴结68个未见癌转移。于2015.12.18予“奥沙利铂(艾恒)200MG静滴D1+卡培他滨片(希罗达)1500MG口服BIDD1-14方案”化疗，辅予止吐、保胃、护肝等相关治疗。化疗过程顺利，无化疗副反应。此次为第2次化疗，再次就诊我院，门诊拟“直肠癌术后化疗”收入我科。自下次出院后饮食、夜休可，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手术", "overlap": 0, "start_pos": 36, "end_pos": 66}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 92}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 101, "end_pos": 104}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 147, "end_pos": 158}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 161, "end_pos": 162}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 166, "end_pos": 167}, {"end_pos": 228, "label_type": "解剖部位", "overlap": 0, "start_pos": 223}, {"end_pos": 254, "label_type": "药物", "overlap": 0, "start_pos": 250}, {"end_pos": 257, "label_type": "药物", "overlap": 0, "start_pos": 255}, {"label_type": "药物", "overlap": 0, "start_pos": 268, "end_pos": 272}, {"end_pos": 277, "label_type": "药物", "overlap": 0, "start_pos": 274}, {"end_pos": 307, "label_type": "解剖部位", "overlap": 0, "start_pos": 306}, {"end_pos": 310, "label_type": "解剖部位", "overlap": 0, "start_pos": 309}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 350, "end_pos": 355}, {"end_pos": 378, "label_type": "解剖部位", "overlap": 0, "start_pos": 377}, {"end_pos": 381, "label_type": "解剖部位", "overlap": 0, "start_pos": 380}]}
{"originalText": "患者8个月前因“进行性吞咽困难1个月”就诊于我院，完善术前准备后，于2013-10-08行“胸段段食管食管切除+食管-胃左胸顶吻合术+左侧第5肋骨固定术”，术顺，术后恢复良好后出院。术后病理示：胸段食管多中心鳞状下皮癌，其一为溃疡性鳞状细胞癌I-II级，侵犯神经，侵出外膜，其二为浸润型鳞状细胞癌I-II级，侵犯神经及齿状线。找到贲门淋巴结1/7，左喉返神经旁淋巴结1/3，见癌转移。于2013.12.01、2013.12.26按“洛铂50MGD1+多帕菲120MGIVGTT”方案化疗2个周期，并于2014.01.19、2014.02.13按“洛铂50MGD1+安素泰180MGD2IVGTT”方案化疗第3、4周期，辅以制酸、保胃、保肝、止吐等治疗，化疗过程顺利，现为化疗4周期后复查就诊我院，门诊拟“食管癌术后化疗后”收住入院。下次出院至今无胸闷、憋气、胸背痛，无腹痛、腹胀，无呕血、黑便。精神、睡眠、饮食较好，大小便正常，体重无明显变化。", "entities": [{"label_type": "手术", "overlap": 0, "start_pos": 46, "end_pos": 76}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 97, "end_pos": 109}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 113, "end_pos": 126}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 140, "end_pos": 153}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 174, "end_pos": 183}, {"end_pos": 218, "label_type": "药物", "overlap": 0, "start_pos": 216}, {"end_pos": 228, "label_type": "药物", "overlap": 0, "start_pos": 225}, {"end_pos": 275, "label_type": "药物", "overlap": 0, "start_pos": 273}, {"end_pos": 285, "label_type": "药物", "overlap": 0, "start_pos": 282}, {"end_pos": 316, "label_type": "解剖部位", "overlap": 0, "start_pos": 315}, {"end_pos": 319, "label_type": "解剖部位", "overlap": 0, "start_pos": 318}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 352, "end_pos": 357}, {"end_pos": 374, "label_type": "解剖部位", "overlap": 0, "start_pos": 373}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 379, "end_pos": 380}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 380, "end_pos": 381}, {"end_pos": 385, "label_type": "解剖部位", "overlap": 0, "start_pos": 384}, {"end_pos": 388, "label_type": "解剖部位", "overlap": 0, "start_pos": 387}]}
{"originalText": "患者2008.2.1因“大便性状改变，发现结肠肿块10天”入我院全科，2.5行乙状结肠癌根治术（应用吻合器），术中探查：腹腔及其他脏器未及异常，乙状结肠近直肠处可及4×4CM肿块，术中病理“溃疡性腺癌，分化II－III级，侵及全层，切缘未见癌累及，肠旁淋巴结19枚，均未及癌转移”。分别1.28（乐沙定，君瑞清），2.23（乐沙定，替加氟）行介入化疗。今为再次行介入化疗入院。病程中，患者精神可，胃纳差，睡眠可，双便正常。", "entities": [{"end_pos": 23, "label_type": "解剖部位", "overlap": 0, "start_pos": 21}, {"end_pos": 47, "label_type": "手术", "overlap": 0, "start_pos": 39}, {"end_pos": 62, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 95, "end_pos": 100}, {"end_pos": 129, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"end_pos": 151, "label_type": "药物", "overlap": 0, "start_pos": 148}, {"end_pos": 155, "label_type": "药物", "overlap": 0, "start_pos": 152}, {"end_pos": 165, "label_type": "药物", "overlap": 0, "start_pos": 162}, {"end_pos": 169, "label_type": "药物", "overlap": 0, "start_pos": 166}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 198}]}
{"originalText": "，缘于入院前1月于我院诊断为结肠肝曲癌，于2014-10-20在全麻上行腹腔镜上扩大根治性左半结肠切除术，，术中见：腹腔内无明显出血，无明显粘连，无明显腹水，肝脏无明显转移结节，肿瘤位于结肠肝曲，大小约5*3CM，侵出浆膜层，未明显侵及十二指肠，周围可及多发肿大淋巴结。术后病理（病理号201435395）示（左半结肠），：大肠隆起型管状腺癌II级，侵及浆膜，侵犯神经，手术标本双切端及另送（近切端）、（远切端）均未见癌浸润。找到回肠周淋巴结1个，结肠周淋巴结50个，另送（回结肠动脉根部）淋巴结5个，（结肠中动脉根部）淋巴结5个均未见癌转移。另见阑尾组织，术后给予对症、营养支持等治疗，恢复良好，伤口愈合II/甲，出院后无发热、畏冷，无咳嗽、咳痰，无胸闷、心悸，无腹痛、腹胀、腹泻等不适，今为行术后第1次化疗就诊我院，门诊拟结肠肝曲癌术后收入院。下次出院以来，精神、睡眠、饮食可，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 19}, {"end_pos": 52, "label_type": "手术", "overlap": 0, "start_pos": 36}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 162, "end_pos": 174}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"end_pos": 230, "label_type": "解剖部位", "overlap": 0, "start_pos": 224}, {"end_pos": 248, "label_type": "解剖部位", "overlap": 0, "start_pos": 236}, {"end_pos": 263, "label_type": "解剖部位", "overlap": 0, "start_pos": 251}, {"end_pos": 276, "label_type": "解剖部位", "overlap": 0, "start_pos": 274}, {"end_pos": 327, "label_type": "解剖部位", "overlap": 0, "start_pos": 326}, {"end_pos": 330, "label_type": "解剖部位", "overlap": 0, "start_pos": 329}, {"end_pos": 334, "label_type": "解剖部位", "overlap": 0, "start_pos": 333}, {"end_pos": 337, "label_type": "解剖部位", "overlap": 0, "start_pos": 336}, {"end_pos": 340, "label_type": "解剖部位", "overlap": 0, "start_pos": 339}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 363, "end_pos": 370}]}
{"originalText": "，患者2月前于我院在全麻上行手术，探查腹腔内无腹水，腹膜无转移，肝脏未触及转移结节，肿瘤位于结肠肝曲，约5×4×4CM，已侵出浆膜，侵犯十二指肠和胰头，并造成肿瘤与盲肠之间闭袢性梗阻，梗阻肠腔明显扩张，肠腔内大量稀薄粪便，结肠系膜未见明显肿大淋巴结，探查后决定行姑息性左半结肠切除术。手术过程顺利。，术后病理结果示：（左半结肠）腺癌（中度分化），结合免疫组化考虑来自结肠，部分细胞伴神经内分泌分化。浸润溃疡型，体积4.5*3.5*1.2CM，侵穿浆膜及纤维膜。，术后病理结果示：（左半结肠）腺癌（中度分化），结合免疫组化考虑来自结肠，部分细胞伴神经内分泌分化。浸润溃疡型，体积4.5*3.5*1.2CM，侵穿浆膜及纤维膜。 双端切线及底部切除面未查见癌。 肠壁一站(8个)、二站(4个)、三站(3个)、中间组(5个)淋巴结未查见癌。 ，免疫组化染色示：CK7(-)、CK20(+)、VILLIN(+)、CDX-2(+)、TS部分(+)、 SYN（少数细胞阳性）。现患者为行进一步诊治，门诊以“结肠癌术后”收入我科。患者术后精神、饮食可，小便正常，大便排便费力，体重无明显变化。", "entities": [{"end_pos": 21, "label_type": "解剖部位", "overlap": 0, "start_pos": 19}, {"end_pos": 24, "label_type": "解剖部位", "overlap": 0, "start_pos": 23}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 26, "end_pos": 27}, {"end_pos": 34, "label_type": "解剖部位", "overlap": 0, "start_pos": 32}, {"end_pos": 50, "label_type": "解剖部位", "overlap": 0, "start_pos": 46}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 82}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 94, "end_pos": 95}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 101, "end_pos": 102}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 111, "end_pos": 113}, {"end_pos": 141, "label_type": "手术", "overlap": 0, "start_pos": 131}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 158, "end_pos": 166}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 239, "end_pos": 247}, {"end_pos": 266, "label_type": "解剖部位", "overlap": 0, "start_pos": 264}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 327, "end_pos": 361}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 446, "end_pos": 451}]}
{"originalText": "，患者因“宫颈癌”于2015-09-02在我院于全麻上行腹腔镜上盆腔淋巴结清扫+腹主动脉旁淋巴结取样+广泛子宫+两侧输卵管切除术+左侧卵巢切除+右侧卵巢悬吊术。，术后病理检查示：宫颈腺癌，符合中肾管癌，侵犯宫颈壁全层及宫颈管内口。右盆腔淋巴结12枚，其中一枚查见转移癌（31622.15)。，免疫组化：ER(-) PR(-) CR(-) CK(-) P16(-) NAPSINA(-)PAX-8个别腺体弱阳性，P53(-) CEA(+) WT-1(-)KI-67阳性率50%。术后一般情况可，2015-09-14给予紫杉醇240MG+顺铂110MG化疗，化疗过程顺利，副反应不重。2015-10-9予紫杉醇240MG+顺铂110MG方案化疗，予心电监护，水极化，化疗过程顺利，无明显化疗反应。2015-11-9 在我院放疗二科予紫杉醇240MG D1 +顺铂40MG D1-3方案化疗，盆腔适形放疗中，放化疗过程顺利，情况好转出院。于2015-12-25日、2016-1-17日给予紫杉醇240MG+顺铂110MG药物化疗2次。现患者无腹痛，无发热，无腰骶疼痛。为求第6次化疗，门诊以“宫颈癌术后化疗”收入院。患者一般情况可，睡眠饮食可，大小便无明显异常，体重无明显减轻。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 5, "end_pos": 8}, {"label_type": "手术", "overlap": 0, "start_pos": 28, "end_pos": 79}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 89, "end_pos": 93}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 96, "end_pos": 100}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 103, "end_pos": 105}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 109, "end_pos": 112}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 261, "label_type": "药物", "overlap": 0, "start_pos": 258}, {"end_pos": 269, "label_type": "药物", "overlap": 0, "start_pos": 267}, {"end_pos": 303, "label_type": "药物", "overlap": 0, "start_pos": 300}, {"end_pos": 311, "label_type": "药物", "overlap": 0, "start_pos": 309}, {"end_pos": 367, "label_type": "药物", "overlap": 0, "start_pos": 364}, {"end_pos": 379, "label_type": "药物", "overlap": 0, "start_pos": 377}, {"end_pos": 395, "label_type": "解剖部位", "overlap": 0, "start_pos": 393}, {"end_pos": 444, "label_type": "药物", "overlap": 0, "start_pos": 441}, {"end_pos": 452, "label_type": "药物", "overlap": 0, "start_pos": 450}, {"end_pos": 469, "label_type": "解剖部位", "overlap": 0, "start_pos": 468}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 476, "end_pos": 477}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 477, "end_pos": 478}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 493, "end_pos": 498}]}
{"originalText": "，患者于2015年11月26日因“宫颈癌IAI”在全麻上行腹腔镜上广泛子宫+两附件切除术+盆腔淋巴结清扫术。，术中见：子宫表面光滑，正常大小，两侧输卵管、卵巢均未见明显异常。两侧骶、主韧带无明显增厚。两侧盆腔未见明显肿大淋巴结。窥器扩开宫颈口，宫颈后唇可见活检创面，阴道壁粘膜光滑，无异常，术毕安返病房。，术后常规病理回示：（942790.15）（子宫）低分化鳞状细胞癌，4处癌灶，，切面积分别是：0.8*0.3CM、0.4*0.2CM、0.3*0.2CM、0.2*0.1CM，侵及宫颈管深度小于1/3，并查见鳞状下皮高级别下皮内瘤变累及腺体。右、左宫宫旁组织及阴道断端未查见癌。萎缩的子宫内膜。（两侧）输卵管组织。（两侧卵巢）白体。另送检右盆腔淋巴结4枚，均未查见转移癌（0/4)，另送检“左盆腔淋巴结”为脂肪结缔组织，未查见癌。。今为术后第1次化疗就诊我院，门诊以“宫颈癌术后化疗”收入院，患者自发病以来，饮食睡眠可，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 17, "end_pos": 23}, {"label_type": "手术", "overlap": 0, "start_pos": 29, "end_pos": 53}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 71, "end_pos": 80}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 87, "end_pos": 94}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 100, "end_pos": 104}, {"end_pos": 113, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 122}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 133, "end_pos": 135}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 173, "end_pos": 185}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 241}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 256, "end_pos": 267}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 272, "end_pos": 276}, {"end_pos": 283, "label_type": "解剖部位", "overlap": 0, "start_pos": 281}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 293, "end_pos": 295}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 298, "end_pos": 305}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 308, "end_pos": 316}, {"end_pos": 326, "label_type": "解剖部位", "overlap": 0, "start_pos": 320}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 346, "end_pos": 352}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 385, "end_pos": 390}]}
{"originalText": "，患者6个月前（2014-5）无明显诱因出现排便习惯改变，大便2-4次/日，呈稀糊状，伴里急后重感，无脓血，无腹痛腹胀，无恶心呕吐，无发热，自诉口服中药（具体不详）效果不明显。遂就诊于我院消化内科，2014年7月9日，行肠镜检查示：，直肠：肛缘至距肛缘约7CM见约环2/3管腔不规则隆起病变，表面糜烂结节状。，诊断意见：直肠CARCINOMA。2014年7月16日于我院胃肠外科在全麻上行腹会阴直肠癌根治术（MILES手术），术中见肿瘤位于腹膜返折上方，巨大充满小骨盆腔，，术后病理示：距肛门侧切缘4CM处，肠粘膜面见8*7*2.5CM灰白溃疡型肿物，，诊断意见：A(直肠肿瘤)，:黏液腺癌(中低分化)，侵及外膜；L251(14/14)、L252(3/8)，：淋巴结转移癌；L253(0/1)，：淋巴结淋巴组织增生（，病理号：Z0480550）。，免疫组化：，A2：C-ERBB-2(1+) D2-40(-) CEA(+) CK20(+) CK7(-) KI-67(约50%+) CD34(-)。术后恢复可，于我科行XELOX方案化疗3周期，，具体用药：艾恒 200MG D1 静点，希罗达 1500MG 日二次口服。末次化疗后出现I°粒细胞上降，未治疗。现为行进一步治疗收入我科。患者目前一般状况可，无发热，无腹痛、腹泻及便血，饮食睡眠可，二便正常，周身无疼痛，病来体重无明显减轻，ECOG评分1分。", "entities": [{"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 119, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 160, "end_pos": 171}, {"label_type": "手术", "overlap": 0, "start_pos": 194, "end_pos": 212}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 220, "end_pos": 221}, {"end_pos": 235, "label_type": "解剖部位", "overlap": 0, "start_pos": 231}, {"end_pos": 246, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 254, "end_pos": 255}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 284, "end_pos": 288}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 291, "end_pos": 295}, {"end_pos": 479, "label_type": "药物", "overlap": 0, "start_pos": 477}, {"end_pos": 496, "label_type": "药物", "overlap": 0, "start_pos": 492}, {"end_pos": 557, "label_type": "解剖部位", "overlap": 0, "start_pos": 556}, {"end_pos": 560, "label_type": "解剖部位", "overlap": 0, "start_pos": 559}]}
{"originalText": "2年前，患者因“反复腹胀1年”入我院，考虑“胃底贲门恶性肿瘤可能”，2014-09-19在我院于全麻上行“剖腹探查、根治性全胃切除术、食管-空肠ROUX-EN-Y吻合术”，手术顺利，术后病理诊断示“（胃）中分化腺癌，侵及肠壁全层至浆膜外，双切端未见癌累及，胃大、小弯淋巴结未见癌转移（分别为0/5、0/9），网膜未见癌累及”。术后积极予以抗感染、营养支持、对症和支持治疗，患者好转出院。术后已行6次全身静脉化疗（FOLFOX方案）。现嘱医嘱，为例行术后复查收入我科。\\U0004   患者起病以来，精神尚可，胃纳可，睡眠可，大小便正常，体重未见明显改变。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 22, "end_pos": 30}, {"label_type": "手术", "overlap": 0, "start_pos": 53, "end_pos": 84}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 99, "end_pos": 107}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 110, "end_pos": 111}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 128}, {"end_pos": 255, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}]}
{"originalText": "患者2016年8月因“发现上腹包块4个月”就诊我院，考虑卵巢恶性肿瘤，于2016-09-13于全麻上行肿瘤细胞减灭术（I型全子宫切除+两侧附件切除+大网膜切除+盆腔及腹主动脉旁淋巴结清扫+肠修补术），术中冰冻提示为高级别浆液性癌，手术为满意减灭术。因患者术前贫血，术中输注红细胞400ML及新鲜冰冻血浆400ML，无明显输血反应，手术过程顺利，术后予心电监护、吸氧、抗炎、补液等对症支持治疗。并于2016-09-20行TC方案（进口紫杉醇210MG D1，伯尔定550MG D1）化疗第一程、2016-10-12行TC方案（紫杉醇210MG D1+卡铂700MG D1）化疗第二程、2016-11-07行TC方案（紫杉醇210MG D1+卡铂700MG D1）化疗第三程，现为行上一程化疗入院。患者近期精神、睡眠稍差，食欲欠佳，二便如常，体重近期无明显改变。既往化疗及肿瘤标志物情况：。", "entities": [{"end_pos": 15, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 28, "end_pos": 34}, {"label_type": "手术", "overlap": 0, "start_pos": 51, "end_pos": 99}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 107, "end_pos": 114}, {"end_pos": 219, "label_type": "药物", "overlap": 0, "start_pos": 216}, {"end_pos": 231, "label_type": "药物", "overlap": 0, "start_pos": 228}, {"end_pos": 265, "label_type": "药物", "overlap": 0, "start_pos": 262}, {"end_pos": 276, "label_type": "药物", "overlap": 0, "start_pos": 274}, {"end_pos": 310, "label_type": "药物", "overlap": 0, "start_pos": 307}, {"end_pos": 321, "label_type": "药物", "overlap": 0, "start_pos": 319}]}
{"originalText": "，根治性全胃切除术后2月余复查。，术后病理：胃体小弯侧溃疡型低分化腺癌（LAUREN，分型：弥漫型），大小5×3.5CM；侵至浆膜层，见神经侵犯，免疫组化CD34(+),D2-40(+)示脉管癌栓；食道残端及十二指肠残端均未见癌；淋巴结见癌转移【共44枚，21，枚转移：第1组0/5、第2组0/0、第3组8/13、第4SA组0/2、第4SB组0/0、第4D组5/7、第5组1/1、第6组5/5、（第7、9组）0/6、第8组1/1、第11P组0/1、12A组0/2、 14V1/1】；，肿瘤病理学分期：PT4N3B。，免疫组化结果显示:CD34(+),CD44(+),CMET(+),D2-40(+),EGFR(+),HER2(－),KI-67(+25～50%),P170(+),P27(+25～50%),P53(+25～50%),TOPOII(+＜25%)。术后化疗1周期SOX（2013-8-8，乐沙定200MG D1，爱斯万 60MG BID1-14，Q3WKS），骨髓毒性II度，升白治疗，胃肠道反应0度，外周神经毒性I度。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 1, "end_pos": 10}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 22, "end_pos": 50}, {"end_pos": 101, "label_type": "解剖部位", "overlap": 0, "start_pos": 99}, {"end_pos": 108, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 115, "end_pos": 240}, {"end_pos": 402, "label_type": "药物", "overlap": 0, "start_pos": 399}, {"end_pos": 414, "label_type": "药物", "overlap": 0, "start_pos": 411}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 448, "end_pos": 449}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 449, "end_pos": 450}]}
{"originalText": "，缘于入院前4月余于我院诊为结肠肝曲管状腺癌，于2014-10-20在全麻上行腹腔镜上扩大根治性左半结肠癌切除，，术中见：腹腔内无明显出血，无明显粘连，无明显腹水，肝脏无明显转移结节，肿瘤位于结肠肝曲，大小约5*5CM，侵出浆膜层，未明显侵及十二指肠，周围可及多发肿大淋巴结。术后病理（病理号201435397、201433427），：（左半结肠），：大肠溃疡型管状腺癌II-III级，部分为粘液腺癌，侵出浆膜，侵犯神经，脉管内见癌栓，手术标本回肠切端、结肠切端及另送（近切端）、（远切端）均未见癌浸润。找到回肠周淋巴结0/5个，结肠周淋巴结7/27个，及另送（结肠中动脉根部）淋巴结3/11个，（回结肠动脉根部）淋巴结0/6个，见癌转移。另见阑尾组织。该病例未检测到KRAS基因12、13号密码子热点突变、BRAF基因V600E突变。，术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。于2014-11-29、2014-12-20、2015-01-10、2015-02-03予“奥沙利铂150MG静滴D1+希罗达1000MG口服D2-15”行第1、2、3、4次化疗方案，化疗过程顺利，无明显化疗副作用。此次为拟行第5次化疗方案再次就诊我院，门诊拟结肠肝曲管状腺癌术后化疗收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 22}, {"end_pos": 55, "label_type": "手术", "overlap": 0, "start_pos": 39}, {"end_pos": 63, "label_type": "解剖部位", "overlap": 0, "start_pos": 61}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 82}, {"end_pos": 100, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 176, "end_pos": 192}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 196, "end_pos": 200}, {"end_pos": 224, "label_type": "解剖部位", "overlap": 0, "start_pos": 222}, {"end_pos": 229, "label_type": "解剖部位", "overlap": 0, "start_pos": 227}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}, {"end_pos": 271, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"end_pos": 292, "label_type": "解剖部位", "overlap": 0, "start_pos": 280}, {"end_pos": 310, "label_type": "解剖部位", "overlap": 0, "start_pos": 298}, {"end_pos": 324, "label_type": "解剖部位", "overlap": 0, "start_pos": 322}, {"end_pos": 448, "label_type": "药物", "overlap": 0, "start_pos": 444}, {"end_pos": 461, "label_type": "药物", "overlap": 0, "start_pos": 458}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 528, "end_pos": 538}, {"end_pos": 562, "label_type": "解剖部位", "overlap": 0, "start_pos": 561}, {"end_pos": 565, "label_type": "解剖部位", "overlap": 0, "start_pos": 564}]}
{"originalText": "缘于1年前因左肝原发性肝癌于我院行左半肝切除术+胆囊切除术,术顺,术后病理(201237164)示:左半肝肝脏原发性巨块型中分化肝癌,侵及肝被膜,脉管内见癌栓,周边组织呈空泡性及脂肪性变.术后恢复可。无腹胀、腹痛。无恶心、呕吐，无发热、寒战及黄疸。无畏冷、寒战、发热。现患者返院复查，门诊拟“肝癌术后”收住入院，自发病以来，患者食欲尚可，精神可，体重无明显上降，大、小便正常。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 6, "end_pos": 13}, {"label_type": "手术", "overlap": 0, "start_pos": 17, "end_pos": 29}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 50, "end_pos": 66}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 70}, {"end_pos": 102, "label_type": "解剖部位", "overlap": 0, "start_pos": 101}, {"end_pos": 105, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 146, "end_pos": 150}]}
{"originalText": "缘于入院前4月余于我院诊为直肠癌，于2014-07-07在全麻上行腹腔镜上直肠癌根治术。术后病理示（直肠）：大肠隆起型管状-绒毛状腺癌II级，侵及外膜，侵犯神经，脉管内见癌栓，手术标本双切端及另送（下切端）、（上切端）均未见癌浸润。找到肠周淋巴结5/16个见癌转移。未检测到BRAF基因V600E突变。检测到KRAS基因12号密码子GLY12ASP和13号密码子GLY13ASP突变。，术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。术后于我院以乐沙定200MGD1+希罗达1500MGD1-D14方案行4周期化疗,化疗过程顺利，化疗期间复查CT，效果良好。此次为化疗再次就诊我院，门诊拟直肠管状-绒毛状腺癌术后收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 13, "end_pos": 16}, {"end_pos": 43, "label_type": "手术", "overlap": 0, "start_pos": 33}, {"end_pos": 52, "label_type": "解剖部位", "overlap": 0, "start_pos": 50}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 54, "end_pos": 70}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 231, "label_type": "药物", "overlap": 0, "start_pos": 228}, {"end_pos": 242, "label_type": "药物", "overlap": 0, "start_pos": 239}, {"label_type": "影像检查", "overlap": 0, "start_pos": 276, "end_pos": 278}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 299, "end_pos": 311}, {"end_pos": 333, "label_type": "解剖部位", "overlap": 0, "start_pos": 332}, {"end_pos": 336, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}]}
{"originalText": "，缘于2个月余前入院，诊断为直肠隆起型管状腺癌，于2014.01.16在我科行“腹腔镜上直肠癌根治术（DIXON）”。术后病理示（201401611），：(直肠)，：肠隆起型绒毛状-管状腺癌II级，侵犯脉管组织，脉管内见癌栓，侵及深肌层（&GT;1/2肌层），手术标本双切端、环周切缘及另送(下切端)、(上切端)均未见癌浸润。找到肠周淋巴结2/18个，见癌转移。另送(肠系膜上动脉根部)镜上为脂肪、脉管及纤维结缔组织。，免疫组化结果：KI67（80%阳性），P53（+++），P170（++），GSTπ（个别细胞阳性），EGFR（-），5-FU（-），MLH1（+++），MSH6（个别细胞阳性），MGMT（++）。术后给予对症、抗感染治疗，恢复良好,伤口愈合II/甲。并于2014.02.16开始予“奥沙利铂150MGIVGTTD1+希罗达1000MGPOBIDD2-15”方案行术后第1周期化疗，患者耐受良好，此次为第2次化疗再次入院。出院后饮食、夜休可，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 23}, {"label_type": "手术", "overlap": 0, "start_pos": 40, "end_pos": 57}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 83, "end_pos": 98}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"end_pos": 192, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 272, "label_type": "药物", "overlap": 0, "start_pos": 268}, {"end_pos": 355, "label_type": "药物", "overlap": 0, "start_pos": 351}, {"end_pos": 371, "label_type": "药物", "overlap": 0, "start_pos": 368}, {"end_pos": 432, "label_type": "解剖部位", "overlap": 0, "start_pos": 431}, {"end_pos": 435, "label_type": "解剖部位", "overlap": 0, "start_pos": 434}]}
{"originalText": "，外院肠镜示：乙状结肠距肛门20CM可见环周样结节状粘膜不规则隆起。，病理：乙状结肠高分化腺癌。2017-8-22行乙状结肠癌手术，（直肠下段），切除：- 中分化腺癌，伴钙化，最大径4.5CM；- 可见脉管癌栓及神经侵犯；- 癌组织侵达浆膜上，浆膜上另见癌结节；- （近端）及（远端）切缘未见癌；- 淋巴结可见癌转移（肠周1/13，直肠下动脉旁0/1），未侵犯淋巴结被膜外；- ，肿瘤病理分期：PT3N1A。，免疫组化结果显示:BRAF(－),CMET(2+),EGFR(3+),HER2(1+),KI-67(70%),MLH1(+),MSH2(+),MSH6(+),PMS2(+)。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 7}, {"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 38, "end_pos": 47}, {"end_pos": 65, "label_type": "手术", "overlap": 0, "start_pos": 58}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 78, "end_pos": 83}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 150, "end_pos": 176}]}
{"originalText": "，缘于入院前3月余于我院诊断为“直肠癌”，于2014-10-09行“腹腔镜上直肠癌根治术”，术顺，术后病理示（直肠），：肠溃疡型管状腺癌II级，癌组织侵犯脉管及神经组织，侵及外膜层。手术标本双切端、环周切缘及另送（下切端）、（上切端）均未见癌浸润。找到肠周淋巴结2/9个见癌转移。另送(肠系膜上动脉根部淋巴结)镜上为脂肪、脉管、神经及纤维结缔组织。，免疫组化染色结果：KI67（50%阳性），P53（+++），P170（+++），GSTπ（+），EGFR（++），5-FU（+），MLH1（+++），MSH-6（+++），MGMT（-）。于2014.11.19、2014.12.24予按奥沙利铂(乐沙定)200MGIVGTTD1+希罗达1000MGPOBIDD1-D14方案化疗，辅以保肝、止吐、制酸等对症处理，化疗过程顺利，此次为行第3次化疗，门诊拟“直肠癌术后化疗”收入我科。自入院以来，精神、睡眠、饮食良好，体力情况良好，大小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 16, "end_pos": 19}, {"end_pos": 44, "label_type": "手术", "overlap": 0, "start_pos": 34}, {"end_pos": 57, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 60, "end_pos": 71}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 126}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 143}, {"end_pos": 236, "label_type": "药物", "overlap": 0, "start_pos": 232}, {"end_pos": 297, "label_type": "药物", "overlap": 0, "start_pos": 293}, {"end_pos": 301, "label_type": "药物", "overlap": 0, "start_pos": 298}, {"end_pos": 318, "label_type": "药物", "overlap": 0, "start_pos": 315}, {"end_pos": 344, "label_type": "解剖部位", "overlap": 0, "start_pos": 343}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 377, "end_pos": 382}]}
{"originalText": "，患者2016.1.28因左下腹疼痛4天入我院普外科。当时无恶心、呕吐，无反酸、嗳气，无呕血，腹部CT示结肠肝曲占位，考虑结肠癌并腹腔淋巴结转移，腹部B超示左侧腹部包块，考虑占位性病变，肠系膜及腹膜后淋巴结肿大。入院后给予完善各项检查，于2016-1-30在全麻上行腹腔镜扩大根治性左半结肠切除术，，术后病理：（结肠）中分化腺癌，部分为粘液腺癌（后者约占60%），溃疡型，肿瘤切面积9*2.5CM，侵透浆膜，回肠切缘、结肠切缘、阑尾及网膜组织未查见癌，肠周淋巴结36枚，其中1枚查见转移癌。患者术后恢复可，入我科后复查CT未见肿瘤复发及转移征象，2016-2-18起给予MFOLFOX6方案化疗5周期，，具体为：奥沙利铂130MG D1+右亚叶酸钙300MG D1+氟尿嘧啶0.625G D1，3.75G 输液泵维持46小时，耐受可。今为行上一周期化疗再次入院。患者自下次出院以来，神志清，精神可，大小便正常，体重无明显变化。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "影像检查", "overlap": 0, "start_pos": 47, "end_pos": 51}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 61, "end_pos": 72}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 92, "end_pos": 103}, {"end_pos": 148, "label_type": "手术", "overlap": 0, "start_pos": 133}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 155, "end_pos": 164}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 168, "end_pos": 172}, {"end_pos": 206, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"end_pos": 211, "label_type": "解剖部位", "overlap": 0, "start_pos": 209}, {"end_pos": 216, "label_type": "解剖部位", "overlap": 0, "start_pos": 214}, {"end_pos": 231, "label_type": "解剖部位", "overlap": 0, "start_pos": 226}, {"label_type": "影像检查", "overlap": 0, "start_pos": 259, "end_pos": 261}, {"end_pos": 310, "label_type": "药物", "overlap": 0, "start_pos": 306}, {"end_pos": 324, "label_type": "药物", "overlap": 0, "start_pos": 319}, {"end_pos": 337, "label_type": "药物", "overlap": 0, "start_pos": 333}]}
{"originalText": "，患者于2014-6外院检查发现AFP升高。2014-6-22，六院行CT检查：肝左叶巨大占位，肝癌可能大。2014-7-1来我院就诊，，行MRI检查示：肝左叶巨块型MT，大小约8.4X11.5CM。7/，15查AFP: 6428.0NG/ML；7/18行特殊肝段切除术（V、VI、VIII段）+胆囊切除术。，术后病理：（肝左叶）肝细胞肝癌，III级，伴出血、坏死，脉管内见癌栓。肝切缘未见癌组织累及。周围肝组织汇管区淋巴细胞浸润伴纤维组织增生（G1S2），部分区肝细胞大细胞变。（胆囊）慢性炎。检出胆囊旁淋巴结1枚，慢性炎。免疫组化(2014-N8731)2，号蜡块:AFP(++),HEPA(++),CK7(-),CK19(-),CD34(血窦丰富),KI67(50%阳性),GS(++),HSP70(++),GPC3(-),OPN(-)。术后手术区积液，予以置管引流。7/，25出院前查AFP: 1362.0NG/ML；出院后，随访腹部，CT：肝MT术后改变，术区积液、积气，随访；肝脏囊肿，8/，18随访AFP：113NG/ML。现为进一步介入治疗收入院。患者发病以来，胃纳可、夜寐可、二便正常、体重无明显减轻。", "entities": [{"label_type": "实验室检验", "overlap": 0, "start_pos": 16, "end_pos": 19}, {"label_type": "影像检查", "overlap": 0, "start_pos": 35, "end_pos": 37}, {"end_pos": 43, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 48, "end_pos": 50}, {"label_type": "影像检查", "overlap": 0, "start_pos": 70, "end_pos": 73}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 77, "end_pos": 85}, {"label_type": "手术", "overlap": 0, "start_pos": 128, "end_pos": 153}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 161}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 165, "end_pos": 175}, {"end_pos": 191, "label_type": "解剖部位", "overlap": 0, "start_pos": 190}, {"end_pos": 204, "label_type": "解剖部位", "overlap": 0, "start_pos": 203}, {"end_pos": 233, "label_type": "解剖部位", "overlap": 0, "start_pos": 232}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 240, "end_pos": 247}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 250}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 396, "end_pos": 399}, {"label_type": "影像检查", "overlap": 0, "start_pos": 419, "end_pos": 424}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 425, "end_pos": 430}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 444, "end_pos": 448}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 456, "end_pos": 459}, {"end_pos": 490, "label_type": "解剖部位", "overlap": 0, "start_pos": 489}]}
{"originalText": "患者于2016-01-08因“结肠癌”于我院行左半结肠切除+淋巴结清扫术，术后病理示：（01083.16）结合986.16（结肠）中分化腺癌，隆起型，肿瘤切面积8*5.5CM，侵达浆膜，下、上切线均未查见癌，肠周查见淋巴结17枚，其中2枚查见癌（2/17）。（膀胱）结缔组织急慢性炎，其内查见少许异型下皮，考虑为腺癌累及。术后给予抗炎、补液、营养及对症治疗，术后恢复可。现患者无恶心、呕吐，无腹痛、腹胀，大便通畅，为行化疗治疗，今日就诊于我院，门诊以“结肠癌术后化疗”收住入院。患者自发病以来，神志清，精神可，食欲、睡眠可，小便正常，体重变化不明显。高血压病史30余年，未规律服药，现血压正常。患乙型病毒性肝炎20年。尿频、排尿困难1年余，未行治疗。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手术", "overlap": 0, "start_pos": 23, "end_pos": 36}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 61, "end_pos": 70}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 104, "end_pos": 111}, {"end_pos": 132, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 156, "end_pos": 158}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"end_pos": 200, "label_type": "解剖部位", "overlap": 0, "start_pos": 199}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 226, "end_pos": 231}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 275, "end_pos": 278}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 298, "end_pos": 305}]}
{"originalText": "患者1月前因\\\"间断下腹痛1年，发现结肠占位2天\\\"于我院行左半结肠切除术，手术顺利，病理回报为（左半结肠）结肠隆起型高中分化腺癌，部分为粘液腺癌，大小10×5×4CM，癌侵及浆膜上纤维脂肪组织，距环周切缘约3MM，未见脉管癌栓，淋巴结未见癌转移（肠周0/13，结肠中血管旁0/2），（近端）及（远端）切缘未见特殊。免疫组化结果显示 CD44(+)，CMET(+)，COX2(+)，EGFR()，HER2(1+)，KI-67(+20%)，MLH1(+50～75%)，MMP7(弱+)，MSH2(+25～50%)，MSH6()，P170()，P27(+25～50%)，P53(+50～75%)，TOPOII(+＜10%)。现患者为求进一步治疗，以“结肠癌术后”收入院。患者自发病以来，精神饮食可，睡眠可，二便正常，体重无明显减轻。", "entities": [{"end_pos": 13, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"end_pos": 20, "label_type": "解剖部位", "overlap": 0, "start_pos": 18}, {"end_pos": 37, "label_type": "手术", "overlap": 0, "start_pos": 30}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 48, "end_pos": 65}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 69, "end_pos": 73}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 115, "end_pos": 141}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 323, "end_pos": 328}]}
{"originalText": "缘于入院前5月因诊为降结肠癌伴肝转移，于2016.01.15、2016.02.05在我院予“奥沙利铂200MGIVGTTD1+卡培他滨片(希罗达)1500MGBIDPOD1-14”方案行术前新辅助化疗，未见明显化疗后不良反应，于2016年02月29日于我院行腹腔镜上右半结肠切除术（姑息性），术顺，术后病理回报（201605763）：结肠隆起型黏液腺癌，侵及浆膜上层，侵犯脉管组织，未见肯定神经侵犯。手术标本远、近切端均未见癌浸润。找到肠周淋巴结4/22个，见癌转移。肠周脂肪中找到4枚癌结节。肠粘膜溃疡。另送（右结肠动脉根部）、（肠系膜上静脉根部）镜上为纤维、血管及脂肪组织。术后恢复可，无腹痛、腹胀，无恶心、呕吐等不适，术后予“盐酸伊立替康240MG静滴D1+卡培他滨片1500MGBIDPOD1-14”“盐酸伊立替康240MG静滴D1+安维汀400MG（自备）D1+替吉奥60MGBIDPOD1-14”方案化疗3次，化疗期间予制酸、补液、营养支持等对症处理。为进一步治疗，门诊拟“降结肠癌伴肝转移（PT1N2AM1AIVA期）”收入院，自下次出院以来，精神、睡眠、饮食可，大小便如常，体重未见明显减轻。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 18}, {"end_pos": 50, "label_type": "药物", "overlap": 0, "start_pos": 46}, {"end_pos": 68, "label_type": "药物", "overlap": 0, "start_pos": 63}, {"end_pos": 72, "label_type": "药物", "overlap": 0, "start_pos": 69}, {"end_pos": 140, "label_type": "手术", "overlap": 0, "start_pos": 129}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 167, "end_pos": 176}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 218}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 234, "end_pos": 235}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 247, "end_pos": 248}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 256, "end_pos": 259}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 266, "end_pos": 267}, {"end_pos": 297, "label_type": "解剖部位", "overlap": 0, "start_pos": 296}, {"end_pos": 300, "label_type": "解剖部位", "overlap": 0, "start_pos": 299}, {"end_pos": 322, "label_type": "药物", "overlap": 0, "start_pos": 316}, {"end_pos": 337, "label_type": "药物", "overlap": 0, "start_pos": 332}, {"end_pos": 361, "label_type": "药物", "overlap": 0, "start_pos": 355}, {"end_pos": 374, "label_type": "药物", "overlap": 0, "start_pos": 371}, {"end_pos": 389, "label_type": "药物", "overlap": 0, "start_pos": 386}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 443, "end_pos": 451}]}
{"originalText": "，患者2014年上半年无明显诱因出现大便带鲜血，量少，伴大便次数增加至8-10次/天，稀烂，偶有里急后重，2014年11他也前出现间歇性脐周隐痛，大便后可缓解。无恶心、发热等不适。到外院对症处理，便血症状无明显缓解。2015-1-9，外院肠镜检查提示:距肛门17-19CM乙状结肠肿物，肠镜能通过。活检病理提示高分化腺癌。后至我院就诊，完善检查后于2015年1月22日全麻上行腹腔镜上DIXON术，术程顺利，，术后病理结果回报：（乙状结肠大体）镜检为肠中分化腺癌，浸润至肠壁浆膜上层，未见明确脉管内癌栓及神经束侵犯。（中央淋巴结）1枚，未见癌。（中间淋巴结）2枚，未见癌。（肠旁淋巴结）6枚，未见癌。（系膜根部淋巴结）1枚，未见癌。，分期为：PT3N0M0 IIA期。，免疫组化：MLH1（+），MSH2（+），MSH6（+），PMS2（+）。于2015-03-23开始至今行希罗达7程口服化疗顺利,化疗后未出现明显副反应。现患者为进一步诊治入院遵主诊教授意见行本周期化疗。目前患者一般情况可，无发热、咳嗽、身目黄染，无骶部痛等，精神可，纳眠可，小便无异常，手术至今体重约上降15KG。", "entities": [{"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 155, "end_pos": 160}, {"end_pos": 198, "label_type": "手术", "overlap": 0, "start_pos": 188}, {"end_pos": 219, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 225, "end_pos": 231}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 235, "end_pos": 236}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 259, "end_pos": 264}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 273, "end_pos": 278}, {"end_pos": 292, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"end_pos": 308, "label_type": "解剖部位", "overlap": 0, "start_pos": 301}, {"end_pos": 391, "label_type": "药物", "overlap": 0, "start_pos": 388}, {"end_pos": 462, "label_type": "解剖部位", "overlap": 0, "start_pos": 460}]}
{"originalText": "患者因胃MT于2010年1月14日在我科行腹腔镜根治性全胃切除术，术后病理示：(全胃)平坦型低分化腺癌,侵及全层及周围脂肪组织,呈弥漫浸润性生长,侵及神经束,部分脉管可见癌栓,双切缘未见肿瘤累及. 检出小弯淋巴结13枚,其中9枚见癌转移; 检出大弯淋巴结3枚,均可见癌转移; 检出幽门下淋巴结2枚,均未见癌转移; 检出幽门上淋巴结13枚,均见癌转移; 另送14组淋巴结2枚,均可见癌转移; 另送切缘未见癌累及。患者术少量多餐，偶有腹泻，无发热、恶心、呕吐等。已行2次化疗，现为化疗收住入院。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 3, "end_pos": 6}, {"end_pos": 32, "label_type": "手术", "overlap": 0, "start_pos": 21}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 39, "end_pos": 51}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 101}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 122}, {"end_pos": 146, "label_type": "解剖部位", "overlap": 0, "start_pos": 140}, {"end_pos": 165, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 216, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}]}
{"originalText": "，患者近1月前（2016-02-23）前因“胃癌”于我院行胃癌姑息性切除术（远端胃大部切除+毕I式吻合），，术中探查见：肿瘤位于胃窦小弯侧，大小约5*4*3CM,侵透浆膜并侵及胰腺，胃周可见多组肿大淋巴结，其中7、8、9组淋巴结融合成团，并与胰腺浸润。，术后常规病理示：（胃）低分化腺癌，局灶伴印戒细胞癌分化，弥漫浸润型，肿瘤切面积5.5*0.8CM，侵及胃壁深肌层。双端切缘、吻合器切缘及网膜组织未查见癌。大弯侧淋巴结11枚，其中3枚（3/11）查见转移；第7、8组淋巴结9枚，其中1枚（1/9）查见转移；小弯侧淋巴结8枚，均未查见转移（0/8）。，免疫组化：CK（+）、HER-2（2+）、SYN（-）、E-CAD（+）。术后给予消炎、营养支持治疗，病情好转后出院。现患者无恶心、呕吐，无腹痛、腹胀，半流质饮食，二便正常。现为求进一步治疗，门诊以“胃癌术后”收入院。自下次出院来，神志清，精神可，饮食可，体重较前无明显改变。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 22, "end_pos": 24}, {"label_type": "手术", "overlap": 0, "start_pos": 29, "end_pos": 52}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 64, "end_pos": 68}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"end_pos": 92, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 105, "end_pos": 114}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 135, "end_pos": 143}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 147, "end_pos": 152}, {"end_pos": 183, "label_type": "解剖部位", "overlap": 0, "start_pos": 178}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 229, "end_pos": 237}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}, {"end_pos": 347, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"end_pos": 350, "label_type": "解剖部位", "overlap": 0, "start_pos": 349}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 376, "end_pos": 380}]}
{"originalText": "，缘于入院前1月余于我院诊为直肠癌，于2016.01.12在全麻上行腹腔镜上直肠癌根治术DIXON，，术中见：上腹部粘连，腹腔内无明显出血，无明显腹水，盆腔、腹壁、大网膜、肝脏未见明显转移结节，腹腔位于直肠下段，大小约3*2.5CM，可疑侵及浆膜层。术后病理（201601067），：(直肠)，：肠隆起型绒毛状-管状腺癌II级，局灶性浸润深肌层（&GT;1/2肌层），并见淋巴管内癌栓。手术标本双切端及另送（下切端）、(上切端)均未见癌浸润。找到肠周淋巴结9个（经本组下级医师复核淋巴结），另送(肠系膜上动脉根部）淋巴结1个，均未见癌转移。，免疫组化染色结果：KI67（60%阳性），P53（+++），P170（+++），5-FU（++），MLH1（+++），MSH2（+++），PMS2（+++），MSH-6（+++）。DNA错配修复的MMR蛋白（PMS2、MSH6、MLH1和MSH2）免疫组化染色提示本例肿瘤微卫星稳定（MSS）。术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲出院。于2016.01.30行“奥沙利铂(乐沙定)150MGIVGTTD1+卡培他滨片(希罗达)1000MGPOBIDD1-14”方案化疗，辅以保胃、保肝、止吐等治疗，未见明显化疗副反应。今为行第2次化疗再次就诊我院，门诊拟“直肠癌术后化疗”收住入院。自下次出院以来，。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"label_type": "手术", "overlap": 0, "start_pos": 34, "end_pos": 49}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"end_pos": 63, "label_type": "解剖部位", "overlap": 0, "start_pos": 61}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 79, "end_pos": 80}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"end_pos": 99, "label_type": "解剖部位", "overlap": 0, "start_pos": 97}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 101, "end_pos": 105}, {"end_pos": 145, "label_type": "解剖部位", "overlap": 0, "start_pos": 143}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 148, "end_pos": 163}, {"end_pos": 228, "label_type": "解剖部位", "overlap": 0, "start_pos": 223}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"end_pos": 315, "label_type": "药物", "overlap": 0, "start_pos": 311}, {"end_pos": 466, "label_type": "药物", "overlap": 0, "start_pos": 462}, {"end_pos": 470, "label_type": "药物", "overlap": 0, "start_pos": 467}, {"end_pos": 489, "label_type": "药物", "overlap": 0, "start_pos": 484}, {"end_pos": 493, "label_type": "药物", "overlap": 0, "start_pos": 490}, {"end_pos": 520, "label_type": "解剖部位", "overlap": 0, "start_pos": 519}, {"end_pos": 523, "label_type": "解剖部位", "overlap": 0, "start_pos": 522}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 559, "end_pos": 564}]}
{"originalText": "，缘于4月前因反复进食阻塞3个月就诊于我院，完善术前准备后，于20160106行胸腹腔镜联合全胸段食管切除+食管-胃底右颈部吻合+右甲状腺结节切除术。手术顺利，术后恢复良好后出院，，术后病理示：（食管及胃底）食管多中心性蕈伞型鳞状细胞癌II级，侵及外膜层，侵犯神经及脉管组织，手术标本下、上切端及另送(最下切端)均未见癌浸润。找到食管周淋巴结0/2个，胃周淋巴结0/5个，及另送(右喉返喉返神经旁)淋巴结0/16个，（左喉返喉返神经神经旁）淋巴结0/5个，(颈部右喉返喉返神经旁)淋巴结1/1个，(隆突上)淋巴结0/2个，(上段食管旁)淋巴结0/5个，（贲门旁）淋巴结0/4个见癌转移。，免疫组化：肿瘤细胞示KI67（60%阳性），CK(H)（+），P63（+），P53（个别细胞阳性），P170（++），GSTπ（-），EGFR（++）。排除化疗禁忌症后于2016-02-03，2016-02-28，2016-03-22以“顺铂40MGD1-3，紫杉醇210MGD2”方案行3周期次化疗，辅以保肝，护胃，提高免疫力等处理，未见明显化疗副反应。现为求第4次化疗，就诊我科，拟“食管癌术后”入我科。下次出院至今无胸闷、憋气；无胸背痛；无腹痛、腹胀；无呕血、黑便；偶有返酸。饮食睡眠较好。大小便正常。体重无明显变化。", "entities": [{"label_type": "手术", "overlap": 0, "start_pos": 40, "end_pos": 74}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 97, "end_pos": 121}, {"end_pos": 171, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 176}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 208}, {"end_pos": 243, "label_type": "解剖部位", "overlap": 0, "start_pos": 228}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"end_pos": 271, "label_type": "解剖部位", "overlap": 0, "start_pos": 261}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 276}, {"end_pos": 415, "label_type": "药物", "overlap": 0, "start_pos": 413}, {"end_pos": 427, "label_type": "药物", "overlap": 0, "start_pos": 424}, {"end_pos": 449, "label_type": "解剖部位", "overlap": 0, "start_pos": 448}, {"end_pos": 452, "label_type": "解剖部位", "overlap": 0, "start_pos": 451}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 488, "end_pos": 493}, {"end_pos": 506, "label_type": "解剖部位", "overlap": 0, "start_pos": 505}, {"end_pos": 514, "label_type": "解剖部位", "overlap": 0, "start_pos": 512}, {"end_pos": 518, "label_type": "解剖部位", "overlap": 0, "start_pos": 517}, {"end_pos": 521, "label_type": "解剖部位", "overlap": 0, "start_pos": 520}]}
{"originalText": "，缘于入院前1月于我院诊为胃癌，于2013-11-29在全麻上行根治性远端胃大部切除术，，术中见：腹腔内无明显腹水，盆腔、腹壁、大网膜无转移结节，肝脏质地大小正常，未及明显转移结节。胃腔扩张明显，胃壁水肿增厚，肿瘤位于幽门管大弯侧偏前壁，活动度可，侵出浆膜层，未侵犯胰腺，周围可及肿大淋巴结。术后病理示（201337693）(远端胃)，：胃窦溃疡型管状腺癌II-III级，少部分为低粘附性癌（主要为印戒细胞癌），脉管内见癌栓，侵出浆膜层，手术标本下切端、上切端及另送(下切端)均未见癌浸润。找到大弯侧淋巴结0/1个，小弯侧淋巴结4/6个，幽门下淋巴结4/6个，幽门上淋巴结4/7个另送(胃右动脉根部)淋巴结1/9个，见癌转移。找到小弯侧癌结节1个，幽门下癌结节1个，幽门上癌结节1个，另送(第14V组淋巴结)镜上为脉管、脂肪、纤维结缔组织。，免疫组化结果：KI67（75%阳性），P53（+++），P170（-），GSTπ（+），EGFR（-），5-FU（++），HER-2（-）。术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。此次为化疗就诊我院，门诊拟胃癌术后收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 13, "end_pos": 15}, {"end_pos": 43, "label_type": "手术", "overlap": 0, "start_pos": 32}, {"end_pos": 51, "label_type": "解剖部位", "overlap": 0, "start_pos": 49}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 61, "end_pos": 62}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"end_pos": 100, "label_type": "解剖部位", "overlap": 0, "start_pos": 98}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 109, "end_pos": 114}, {"end_pos": 135, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 165, "end_pos": 166}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 169, "end_pos": 205}, {"end_pos": 253, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"end_pos": 264, "label_type": "解剖部位", "overlap": 0, "start_pos": 258}, {"end_pos": 275, "label_type": "解剖部位", "overlap": 0, "start_pos": 269}, {"end_pos": 286, "label_type": "解剖部位", "overlap": 0, "start_pos": 280}, {"end_pos": 303, "label_type": "解剖部位", "overlap": 0, "start_pos": 292}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 315, "end_pos": 317}, {"end_pos": 326, "label_type": "解剖部位", "overlap": 0, "start_pos": 324}, {"end_pos": 335, "label_type": "解剖部位", "overlap": 0, "start_pos": 333}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 345, "end_pos": 353}, {"end_pos": 427, "label_type": "药物", "overlap": 0, "start_pos": 423}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 483, "end_pos": 487}, {"end_pos": 509, "label_type": "解剖部位", "overlap": 0, "start_pos": 508}, {"end_pos": 512, "label_type": "解剖部位", "overlap": 0, "start_pos": 511}]}
{"originalText": "患者于2014年05月因“子宫内膜癌”于******健院行“腹腔镜上广泛切除术+两附件切除术+盆腔LN及腹主动脉旁淋巴结清扫术”术后病理为“子宫内膜样腺鳞癌II级伴鳞状生化”。2014年5月至7月行TC方案化疗3程。2015年11月复查CT提示“盆腔以及两侧髂血管旁多发肿大淋巴结，考虑M”。2015年12月PET/CT示“两髂及两闭孔多个淋巴结代谢活跃，考虑M”。遂至我院就诊，当时因患者拒绝化疗未及时治疗。现患者诉阴道口瘙痒严重，里急后重感，于2016-03-07给予TC（进口）方案化疗1程。今再次来我院就诊。患者发病以来,精神一般,饮食睡眠不佳,大小便不正常：里急后重感，体重有减轻。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 13, "end_pos": 18}, {"label_type": "手术", "overlap": 0, "start_pos": 30, "end_pos": 63}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 70, "end_pos": 86}, {"label_type": "影像检查", "overlap": 0, "start_pos": 118, "end_pos": 120}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 127, "end_pos": 130}, {"label_type": "影像检查", "overlap": 0, "start_pos": 154, "end_pos": 160}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 162}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 209}]}
{"originalText": "，患者约于7年前因“结肠癌”于2009-09-08日在全麻上行左半结肠切除术。手术过程顺利，术后给予抗感染及营养支持治疗，患者恢复好。，术后病理：（7282.2009）结肠腺癌（中低度分化），浸润溃疡型，面积4*3CM，侵达浆膜脂肪组织。累及阑尾浆膜面。双端切线未查见癌。呈一站（1/22）个淋巴结癌转移。术后给予患者化疗6周期，，方案为：奥沙利铂200MG D1（1-3期）奥沙利铂150MG D1（4-6期），亚叶酸钙0.3G+替加氟1.0G D2-D6。现患者腹胀，食欲差，就诊于我院门诊。    患者院外就诊期间，神志清，精神可，大、小便正常，体重未见明显变化。门诊以“左半结肠切除术后7年余”收入我院。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"end_pos": 38, "label_type": "手术", "overlap": 0, "start_pos": 31}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 84, "end_pos": 95}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 123}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 137, "end_pos": 149}, {"end_pos": 174, "label_type": "药物", "overlap": 0, "start_pos": 170}, {"end_pos": 192, "label_type": "药物", "overlap": 0, "start_pos": 188}, {"end_pos": 211, "label_type": "药物", "overlap": 0, "start_pos": 207}, {"end_pos": 219, "label_type": "药物", "overlap": 0, "start_pos": 216}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 289, "end_pos": 297}]}
{"originalText": "，缘于4月前因“下腹部闷痛不适”腹部CT提示肝占位，进一步于我院行“腹腔镜上右肝肿物切除术+胆囊切除术”。，术后病理报告示：1.（右肝脏肿物），：肝脏原发性中分化肝细胞-胆管细胞混合型癌，伴坏死，侵及肝被膜及周边肝组织。癌周肝脏组织，肝细胞水肿变性，汇管区小胆管增生，伴中量慢性炎症细胞浸润。2（胆囊），：慢性胆囊炎。，免疫组化：CK7(-),CK20（+++），VILLIN(+++)，CDX-2(-),CK19(+++),CA19-9(-),GLYPICAN-3（+），CEA（-），KI67(70%),TTF-1(-),NSE(-),SY(-),PAS(灶性区域少量阳性)，AB染色（-）。术后患者无不适。无畏寒、寒战、发热，无恶心、呕吐、纳差，无皮肤黄、眼黄、尿黄。无腹痛、腹胀、腹泻，无返酸，嗳气。定期我院门诊随访，评估病情稳定。今为复查来我院，门诊拟“肝癌术后”收入院。自发病以来，食欲正常，睡眠、精神可，体重无明显上降，大、小便正常。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 16, "end_pos": 20}, {"end_pos": 23, "label_type": "解剖部位", "overlap": 0, "start_pos": 22}, {"label_type": "手术", "overlap": 0, "start_pos": 34, "end_pos": 51}, {"end_pos": 68, "label_type": "解剖部位", "overlap": 0, "start_pos": 65}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 73, "end_pos": 93}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 100, "end_pos": 101}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"end_pos": 114, "label_type": "解剖部位", "overlap": 0, "start_pos": 112}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 125, "end_pos": 131}, {"end_pos": 150, "label_type": "解剖部位", "overlap": 0, "start_pos": 148}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 153, "end_pos": 158}, {"end_pos": 339, "label_type": "解剖部位", "overlap": 0, "start_pos": 338}, {"end_pos": 342, "label_type": "解剖部位", "overlap": 0, "start_pos": 341}, {"end_pos": 345, "label_type": "解剖部位", "overlap": 0, "start_pos": 344}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 382, "end_pos": 386}]}
{"originalText": "患者于2011.8.3在全麻上行剖腹探查+肠减压+根治性左半结肠切除术，术后恢复可，病理类型为结肠溃疡型中分化管状腺癌，浸及肠壁全层，脉管内见癌栓。双切端及阑尾均未见癌累及。肠壁下淋巴结未见癌转移（0/12），另送（系膜）组织未见癌转移，分期(T4N0M0) 。术后已行6次FOLFOX方案全身化疗，化疗期间患者无恶心、呕吐、腹泻等不适，化疗过程顺利，本次为术后复查入院。\\U0004   患者本次发病以来，食欲正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，体重无明显变化。", "entities": [{"label_type": "手术", "overlap": 0, "start_pos": 16, "end_pos": 35}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 47, "end_pos": 59}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 163}]}
{"originalText": "，入院前3个月余于我院诊为胃癌，于2015年04月06日在全麻上行“腔镜上根治性全胃切除术+食管空肠ROUX-Y吻合术（D2）+脾切除术”。术后病理（201512223），：(全胃)，：食管胃交界溃疡型管状腺癌II-III级，侵及浆膜层，累及神经。手术标本下、上切端及另送(下切端)均未见癌浸润。找到贲门周淋巴结1/3个，小弯淋巴结1/11个，大弯淋巴结1/1个，幽门上0/5个，另送(第7组）淋巴结0/1个，(第8组）淋巴结0/1个，(第9组）淋巴结1/4个，(第10组）淋巴结1/3个，(第11组）淋巴结1/2个，(第15组）淋巴结0/1个，见癌转移。幽门下淋巴结及另送(第12组淋巴结)未查见淋巴结。另送脾脏组织，未见癌浸润。术后给予对症、抗感染治疗，恢复良好,伤口愈合II/甲。于2015.05.04、2015.06.23、2015.06.13行“奥沙利铂200MGIVGTTD1+替吉奥60MGPOBIDD1-14”方案化疗3次，辅予保胃、制酸、止吐、补液等，无明显药物毒性反应。今为术后第4次辅助化疗,门诊以“胃贲门管状腺癌（PT4AN2M0IIIB期）术后”收入院。自出院后饮食、夜休可，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 13, "end_pos": 15}, {"label_type": "手术", "overlap": 0, "start_pos": 34, "end_pos": 68}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 93, "end_pos": 112}, {"end_pos": 156, "label_type": "解剖部位", "overlap": 0, "start_pos": 150}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 161}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 172}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 192, "end_pos": 200}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 205, "end_pos": 213}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 218, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 231, "end_pos": 240}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 245, "end_pos": 254}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 259, "end_pos": 268}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 278}, {"end_pos": 307, "label_type": "解剖部位", "overlap": 0, "start_pos": 305}, {"end_pos": 382, "label_type": "药物", "overlap": 0, "start_pos": 378}, {"end_pos": 398, "label_type": "药物", "overlap": 0, "start_pos": 395}, {"end_pos": 424, "label_type": "解剖部位", "overlap": 0, "start_pos": 423}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 461, "end_pos": 483}, {"end_pos": 503, "label_type": "解剖部位", "overlap": 0, "start_pos": 502}, {"end_pos": 506, "label_type": "解剖部位", "overlap": 0, "start_pos": 505}]}
{"originalText": "，缘于入院前2月余前于我院确诊为“直肠癌”，2015.07.11日行腹腔镜上直肠部分切除术,术后予以制酸,抗炎,护胃等对症处理,术后病理示(201525467)，:，：(直肠)，：肠隆起型管状腺癌II级，伴坏死，侵及外膜层，手术标本双切端及另送（下切端）、（上切端）均未见癌浸润。找到肠周淋巴结13个均未见癌转移。(MM20151216)，:该病例未检测到KRAS基因12、13号密码子热点突变。该病例未检测到BRAF基因V600E突变，术后于2015.07.29、2015.08.25予以“卡培他滨1500MGPOBIDD1-D14+奥沙利铂200MGD1IVGTT”方案化疗,期间辅以保胃,保肝止呕吐等对症处理。此次为行第3周期化疗再次就诊我院，门诊拟直肠癌术后收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 17, "end_pos": 20}, {"end_pos": 45, "label_type": "手术", "overlap": 0, "start_pos": 34}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 87, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 90, "end_pos": 101}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"end_pos": 250, "label_type": "药物", "overlap": 0, "start_pos": 246}, {"end_pos": 272, "label_type": "药物", "overlap": 0, "start_pos": 268}, {"end_pos": 296, "label_type": "解剖部位", "overlap": 0, "start_pos": 295}, {"end_pos": 299, "label_type": "解剖部位", "overlap": 0, "start_pos": 298}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 328, "end_pos": 333}, {"end_pos": 355, "label_type": "解剖部位", "overlap": 0, "start_pos": 354}, {"end_pos": 358, "label_type": "解剖部位", "overlap": 0, "start_pos": 357}]}
{"originalText": "，其于1月前因结肠占位性病变于2013.06.13下午在全麻上行遂行结肠癌根治术+放射性粒子置入术，术中冰冻提示乙状结肠腺癌，侵及肠壁深肌层，双切缘阴性。手术顺利，，术后病检提示：乙状结肠溃疡型中分化管状乳头状腺癌，浸及肠壁全层，脉管、神经未见癌侵犯，双切端未见癌累及，淋巴结见癌转移（1/5），，肿瘤分期：T3NXM1 。术后予以预防感染、抗肿瘤等对症支持治疗，恢复良好，并于2013.06.24治愈出院。出院后食欲较好，体重增加约6KG，未诉特殊不适，今患者为行第1次全身静脉化疗入院。\\U0004   患者发病以来，神志 清晰，精神可，胃纳可，大便如常，小便如常，体重未见明显上降。", "entities": [{"end_pos": 9, "label_type": "解剖部位", "overlap": 0, "start_pos": 7}, {"label_type": "手术", "overlap": 0, "start_pos": 34, "end_pos": 49}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 56, "end_pos": 62}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 65, "end_pos": 66}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 90, "end_pos": 107}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 110, "end_pos": 111}, {"end_pos": 272, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}]}
{"originalText": "，缘于5月余前因“直肠癌”就诊我院,于2016.06.29行“腔镜上直肠根治术（DIXON手术）”，探查腹腔内无明显出血，无明显腹水，无明显粘连，无明显腹腔肿瘤种植转移，肿瘤位于腹膜返折下7CM，侵出前壁浆膜层，未形成肠梗阻，近端无扩张，周围少许肿大淋巴结。术顺，术后予预防感染、制酸、补液、营养支持等治疗，，术后病理示：（直肠）大肠溃疡型管状腺癌II级，侵出外膜层，可见脉管内癌栓，未见明确神经侵犯。，病理：手术标本双切端及另送（下切端）、（上切端）均未见癌浸润，另送（上切端）灶性腺下皮呈低级别下皮内瘤变。找到肠周淋巴结1/24个，及另送（肠系膜上动脉根部）淋巴结0/1个，见癌转移。，免疫组化：KI67（60%+），P53（+++），CK7（-），CK20（+++），CEA（++）。术后恢复可，无恶心、呕吐、腹痛、腹胀、发热、畏寒等不适。术后于2016.07.26、2016.08.17、2016.09.12、2016.10.08、2016.10.30、2016.11.21予以“奥沙利铂150MGIVGTTD1+卡培他滨1500MGBIDD1-D14”方案化疗，为行上一周期化疗，就诊我院,门诊拟直肠癌术后化疗收治入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 9, "end_pos": 12}, {"label_type": "手术", "overlap": 0, "start_pos": 31, "end_pos": 47}, {"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 89, "end_pos": 90}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 109, "end_pos": 112}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 161, "end_pos": 177}, {"end_pos": 262, "label_type": "解剖部位", "overlap": 0, "start_pos": 257}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"end_pos": 359, "label_type": "解剖部位", "overlap": 0, "start_pos": 358}, {"end_pos": 362, "label_type": "解剖部位", "overlap": 0, "start_pos": 361}, {"end_pos": 448, "label_type": "药物", "overlap": 0, "start_pos": 444}, {"end_pos": 465, "label_type": "药物", "overlap": 0, "start_pos": 461}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 503, "end_pos": 508}, {"end_pos": 533, "label_type": "解剖部位", "overlap": 0, "start_pos": 532}, {"end_pos": 536, "label_type": "解剖部位", "overlap": 0, "start_pos": 535}]}
{"originalText": "，患者因直肠癌于2014年12月05日行直肠前切除术，，术后病理：直肠（切除），：溃疡型中分化腺癌，肿物最大径6CM；侵及周围脂肪组织及浆膜上层；可见脉管癌栓； 淋巴结可见癌转移（19/24）； - 环周切缘、（近端）及（远端）均未见癌；另送肠管未见癌； ，肿瘤病理分期：PT3N2B。现为行术后辅助化疗入院，患者自发病以来精神睡眠食欲尚好，小便如常，大便如下述，体重无明显改变。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 4, "end_pos": 7}, {"end_pos": 26, "label_type": "手术", "overlap": 0, "start_pos": 20}, {"end_pos": 35, "label_type": "解剖部位", "overlap": 0, "start_pos": 33}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 41, "end_pos": 49}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 122}]}
{"originalText": "患者1月余前于我院诊断为“乙状结肠肿物，恶性待排”完善术前检查，排除手术禁忌症后于2013-01-31行乙状结肠切除术，术后恢复可，有排气排便，术后病理示：乙状结肠中分化腺癌，浸润至肠壁粘膜上层，未见神经束侵犯，未见脉管内癌栓，中间淋巴结转移一枚（1/7），中央淋巴结（0/5），肠旁淋巴结（0/2），患者术后于2013年2月26日开始行XELOX方案化疗5程，过程顺利，现为进一步治疗入住本科。患者自下次出院以来，食欲、睡眠及精神良好，小便正常，体力无上降，体重无明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 13, "end_pos": 24}, {"end_pos": 59, "label_type": "手术", "overlap": 0, "start_pos": 52}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 78, "end_pos": 87}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 92}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 114, "end_pos": 119}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 129, "end_pos": 134}, {"end_pos": 145, "label_type": "解剖部位", "overlap": 0, "start_pos": 140}]}
{"originalText": "，缘于入院前4个月(2015-09-14)，于我院查肠镜：升结肠肠乳头状管状腺癌II级，遂于3个月前(2015年09月21日)全麻上行腹腔镜上左半结肠根治性切除术，，术中探查见：探查腹腔内无明显出血，无明显腹水，升结肠可见肿瘤，近端几达回盲部，远端近肝曲，明显侵出浆膜层，与周围组织稍明显粘连，未形成梗阻，近端肠管无扩张，周围及肠系膜根部可见数个肿大淋巴结；术后病理(N201503896)，：左半结肠回盲部隆起型管状腺癌II级，伴神经内分泌分化及坏死，侵及浆膜层，脉管内见癌栓，手术标本结肠切端、回肠切端及另送（下切端）、（上切端）均未见癌浸润。找到回肠周淋巴结2个，结肠周淋巴结29个均未见癌转移。术顺，术后分别于2015-10-22、2015-11-13、2015-12-05、2015-12-27行“奥沙利铂D1200MGIVGTT+希罗达D2-141500MGPOBID”方案化疗4次，化疗过程顺利，今为进一步化疗，门诊拟“结肠癌术后”收住入院。自下次出院以来，精神、食欲、睡眠尚可，大小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 29, "end_pos": 43}, {"end_pos": 81, "label_type": "手术", "overlap": 0, "start_pos": 67}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 164, "end_pos": 165}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 197, "end_pos": 214}, {"end_pos": 246, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"end_pos": 251, "label_type": "解剖部位", "overlap": 0, "start_pos": 249}, {"end_pos": 282, "label_type": "解剖部位", "overlap": 0, "start_pos": 276}, {"end_pos": 291, "label_type": "解剖部位", "overlap": 0, "start_pos": 285}, {"end_pos": 358, "label_type": "药物", "overlap": 0, "start_pos": 354}, {"end_pos": 374, "label_type": "药物", "overlap": 0, "start_pos": 371}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 417, "end_pos": 422}]}
{"originalText": "，患者2016年4月初无明显诱因出现腹部绞痛，伴恶心、呕吐，无呕血、黄疸等不适，在院外考虑“肠套叠”，遂转至**一院就诊，入院后行CT检查提示全身多发性淋巴结肿大，考虑淋巴瘤；左上腹回-回肠套叠，考虑小肠淋巴瘤；脾大，脾内多发结节，考虑淋巴瘤。完善相关检查后于2016-04-08在**一院行腹腔镜探查、左半结肠切除术，，术后病理回报：送检肠管见一息肉样肿物，病变符合套细胞淋巴瘤，，免疫组化：CYCLIND1、CD5、CD20、CD79A、BCL-2、SOX11均为（+），CD23、CD3、CD10、BCL-6均为（-），KI67(30%+)。术后恢复可。2016-04-20查PET/CT，提示：全身多发淋巴结肿大，最大者约1.4*1.0CM(右颈部V区)、4.6*3.2CM(左髂血管旁)、5.9*2.6CM(左侧腹股沟区，SUVMAX 4.2)；脾大，代谢不均匀增高，符合淋巴瘤；中轴骨、骨盆骨髓弥漫性代谢轻度增高，考虑反应性改变与淋巴瘤累及鉴别。现为进一步治疗，来我院就诊，门诊拟“套细胞淋巴瘤”收入我科。起病以来，患者未诉发热、偶有盗汗，术后近一月体重上降5KG。精神稍差，食欲、睡眠可，大小便正常。", "entities": [{"end_pos": 20, "label_type": "解剖部位", "overlap": 0, "start_pos": 18}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 46, "end_pos": 49}, {"label_type": "影像检查", "overlap": 0, "start_pos": 65, "end_pos": 67}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 84, "end_pos": 87}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 88, "end_pos": 97}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 100, "end_pos": 105}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 109}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 118, "end_pos": 121}, {"label_type": "手术", "overlap": 0, "start_pos": 146, "end_pos": 159}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 170, "end_pos": 171}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 184, "end_pos": 190}, {"label_type": "影像检查", "overlap": 0, "start_pos": 291, "end_pos": 297}, {"end_pos": 330, "label_type": "解剖部位", "overlap": 0, "start_pos": 325}, {"end_pos": 346, "label_type": "解剖部位", "overlap": 0, "start_pos": 342}, {"end_pos": 365, "label_type": "解剖部位", "overlap": 0, "start_pos": 359}, {"end_pos": 379, "label_type": "解剖部位", "overlap": 0, "start_pos": 378}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 391, "end_pos": 394}, {"end_pos": 398, "label_type": "解剖部位", "overlap": 0, "start_pos": 395}, {"end_pos": 401, "label_type": "解剖部位", "overlap": 0, "start_pos": 399}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 421, "end_pos": 424}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 447, "end_pos": 453}]}
{"originalText": "，患者2015.11.27因“卵巢癌”于我院全麻上行经腹子宫+两侧附件切除+大网膜切除+部分肠壁转移病灶切除术。，术中探查见：盆腹腔可见淡黄色腹水，量约500ML，子宫前位，萎缩，前壁可见菜花样结节，右侧卵巢约3*2CM大小，表面不规则菜花状突起，质脆，左侧卵巢约2*2CM大小，形态似右侧卵巢，大网膜挛缩呈厚饼状，质硬，与肠管形成致密粘连，结肠、升结肠、横结肠、直肠前前壁肿物与肠管致密粘连，直肠前壁、结肠肝区及肝上极均可见不规则菜花样突起，腹盆壁、小肠表面可见大量结节样突起，质脆，易脱落。，术中切除右侧附件送快速病理回示：（右附件）图像符合高级别浆液性乳头状癌。，术后常规病理示：（两附件区）卵巢高级别浆液性乳头状癌，两侧输卵管查见癌，肿瘤自子宫浆膜面侵达宫壁肌层，送检（肠壁转移灶）和大网膜组织均查见癌；右、左宫宫旁组织未查见癌。（子宫）萎缩状态子宫内膜。慢性宫颈炎。，免疫组化：ER（80%+），PR（-），WT-1（+），P53（+）。术后恢复可，根据术后病理，于2015.12.06、2015.12.30、2016.01.21、2016.2.14、2016.3.10给予顺铂120MG+多帕菲120MG方案化疗5疗程，现患者欲行第6次化疗来院就诊，门诊以“卵巢癌术后化疗”收入院，患者者饮食睡眠正常，大小便无异常，体重无明显增减。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手术", "overlap": 0, "start_pos": 26, "end_pos": 55}, {"end_pos": 66, "label_type": "解剖部位", "overlap": 0, "start_pos": 63}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"end_pos": 84, "label_type": "解剖部位", "overlap": 0, "start_pos": 82}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 100}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 143}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 162, "end_pos": 163}, {"end_pos": 173, "label_type": "解剖部位", "overlap": 0, "start_pos": 171}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 178}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 190, "end_pos": 191}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}, {"end_pos": 206, "label_type": "解剖部位", "overlap": 0, "start_pos": 202}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 207}, {"end_pos": 225, "label_type": "解剖部位", "overlap": 0, "start_pos": 222}, {"end_pos": 228, "label_type": "解剖部位", "overlap": 0, "start_pos": 226}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 268, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 273, "end_pos": 283}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 293, "end_pos": 311}, {"end_pos": 317, "label_type": "解剖部位", "overlap": 0, "start_pos": 312}, {"end_pos": 328, "label_type": "解剖部位", "overlap": 0, "start_pos": 324}, {"end_pos": 335, "label_type": "解剖部位", "overlap": 0, "start_pos": 331}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 339, "end_pos": 340}, {"end_pos": 364, "label_type": "解剖部位", "overlap": 0, "start_pos": 356}, {"end_pos": 372, "label_type": "解剖部位", "overlap": 0, "start_pos": 370}, {"end_pos": 381, "label_type": "解剖部位", "overlap": 0, "start_pos": 377}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 382, "end_pos": 387}, {"end_pos": 494, "label_type": "药物", "overlap": 0, "start_pos": 492}, {"end_pos": 503, "label_type": "药物", "overlap": 0, "start_pos": 500}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 535, "end_pos": 540}]}
{"originalText": "患者入院3-月前，因直肠癌于2015-11-17行腹腔镜上直肠癌根治术，术后病检：（直肠）印戒细胞癌，侵及肠周脂肪组织，两侧切缘未见癌累及，肠周围脂肪组织中淋巴结见癌转移（9/13）。术后恢复良好，好转后出院。院外未诉特殊不适，无畏寒、发热、腹痛、腹泻、腹胀、恶心、呕吐等不适。于2015-12-19遵医嘱行第一次化疗，方案为FOLFOX4（奥沙利铂+5-氟尿嘧啶），化疗期间无化疗副反应，复查血常规未见明显异常后出院。院外无特殊不适，无腹痛、腹胀、腹泻、恶心、呕吐等不适。今为行第二次化疗就诊我院，门诊以“直肠癌术后，拟行第二次化疗”收入我科住院治疗。。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"end_pos": 35, "label_type": "手术", "overlap": 0, "start_pos": 25}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 41, "end_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 53, "end_pos": 54}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"end_pos": 175, "label_type": "药物", "overlap": 0, "start_pos": 171}, {"end_pos": 182, "label_type": "药物", "overlap": 0, "start_pos": 178}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 222}, {"end_pos": 226, "label_type": "解剖部位", "overlap": 0, "start_pos": 225}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 254, "end_pos": 259}]}
{"originalText": "，缘于入院前23天因“反复中下腹闷痛2周于外院”，行胃镜检查示：糜烂性胃炎（II级），胃角溃疡性质待定。病理（S201439361），：（胃角，活检）粘膜腺癌。遂于2014.11.28于我院行在全麻上行根治性远端胃大部切除术（毕II式，D2)。术顺，术后恢复良好，，术后病理：（201441656），：(远端胃大部)，:胃角溃疡癌变，为管状腺癌II级，其中部分为黏液腺癌，侵及肌层，间质纤维母细胞增生，并多量嗜酸性粒细胞浸浸润，未见明确的脉管内癌栓及神经侵犯，标本双切端均未见癌浸润。找到小弯侧淋巴结12个，大弯侧淋巴结1个，幽门上淋巴结3个，及另送(幽门下）淋巴结1个，(肝总动脉旁）淋巴结3个，(腹腔动脉旁）淋巴结4个，均未见癌转移。，免疫组化：肿瘤细胞示KI67（70%+），P53（+），P170（++），GSTπ（+），EGFR（+），5-FU（+），HER-2（-）。下次出院至今，进食流质膳食可，无恶心、呕吐，无腹痛、腹胀、腹泻，无呕血、黑便等不适，今为进一步复查就诊我院，门诊拟“胃癌术后”收住入院。自发病以来，患者精神、饮食、睡眠可，大小便正常，体重无明显增减。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 32, "end_pos": 42}, {"end_pos": 45, "label_type": "解剖部位", "overlap": 0, "start_pos": 43}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 69}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 75, "end_pos": 79}, {"label_type": "手术", "overlap": 0, "start_pos": 101, "end_pos": 121}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 181, "end_pos": 185}, {"end_pos": 250, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"end_pos": 260, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}, {"end_pos": 269, "label_type": "解剖部位", "overlap": 0, "start_pos": 263}, {"end_pos": 283, "label_type": "解剖部位", "overlap": 0, "start_pos": 275}, {"end_pos": 296, "label_type": "解剖部位", "overlap": 0, "start_pos": 286}, {"end_pos": 309, "label_type": "解剖部位", "overlap": 0, "start_pos": 299}, {"end_pos": 414, "label_type": "解剖部位", "overlap": 0, "start_pos": 413}, {"end_pos": 417, "label_type": "解剖部位", "overlap": 0, "start_pos": 416}, {"end_pos": 420, "label_type": "解剖部位", "overlap": 0, "start_pos": 419}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 448, "end_pos": 452}]}
{"originalText": "，缘于入院1年半前无明显诱因感下腹闷痛不适，就诊我院查腹部CT示“，胰头占位:考虑假乳头状”，于2013.04.11在全麻上行“胰头肿物切除、肝肿物切除、小肠憩室切除、胰肠吻合、空肠造瘘术”，术顺，术后病理（201310448），示：肝转移胰腺实性-假乳头状瘤。1.（胰头肿物）胰腺实性-假乳头状瘤，伴出血坏死，侵犯胰腺被摸。另送（肝结节）组织见肿瘤细胞浸润；2.（小肠）送检小肠组织，小肠全层见异位胰腺组织；3.（肝结节）肝转移性胰腺实性-假乳头状瘤。，免疫组化结果：CK(PAN)(++),KI67(6%),SY(+),CD56(+++),CGA(-),CD10(++),CD99(-),E-CADHERIN(-)。今为复查就诊我院，门诊拟胰腺实性假乳头状瘤伴肝转移术后收入院。自发病以来，精神、饮食、睡眠尚可，大小便正常，体重无明显改变。", "entities": [{"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 15}, {"label_type": "影像检查", "overlap": 0, "start_pos": 27, "end_pos": 31}, {"end_pos": 36, "label_type": "解剖部位", "overlap": 0, "start_pos": 34}, {"end_pos": 44, "label_type": "解剖部位", "overlap": 0, "start_pos": 42}, {"label_type": "手术", "overlap": 0, "start_pos": 64, "end_pos": 94}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 117, "end_pos": 130}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 133, "end_pos": 149}, {"end_pos": 160, "label_type": "解剖部位", "overlap": 0, "start_pos": 158}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 188}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 200}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 207, "end_pos": 226}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 322, "end_pos": 331}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 332, "end_pos": 337}]}
{"originalText": "，患者2016.1.26因“腹水原因待查”于我院在全麻上行经腹腹膜外子宫切除+两附件切除+全盆腹膜切除+盆腔淋巴结清扫+腹主动脉旁淋巴结清扫+阑尾切除术，，术后常规病理回示：（两侧卵巢）高级别浆液性乳头状癌，，右侧肿瘤体积：12*9.5*5CM，左侧肿瘤体积11*10*5.5CM，肿瘤侵及两侧输卵管壁外膜，右侧输卵管粘膜查见癌。子宫浆膜面、腹膜、大网膜、阑尾浆膜面均查见癌。右髂血管淋巴结4枚，其中1枚（1/4）查见转移；左髂血骨淋巴结3枚，其中1枚（1/3）查见转移；右闭孔淋巴结2枚，其中1枚（1/2）查见转移，左闭孔淋巴结3枚，其中2枚（2/3）查见转移；上腔静脉旁淋巴结1枚，其内（1/1）查见转移；髂前淋巴结1枚，其内（1/1）查见转移；腹主动脉旁淋巴结3枚，均（3/3）查见转移；“腹膜外肿瘤”内查见淋巴结1枚，其内（1/1）查见转移癌。另送“右髂血管淋巴结”3枚及“左髂血管淋巴结”1枚，均未查见转移。，免疫组化：CK（+）、CK7（+）、P53（+）、KI67阳性率约60%，ER（约30%，+）、PR（约90%，++）、WT-1（+）、CR局灶(+)。（，病理号：03351.16）。今日拟行卵巢癌术后第一次化疗入院，门诊以“卵巢癌术后化疗 ”收入院。患者自下次出院后，食欲欠佳，睡眠好，大小便正常，无明显恶心、呕吐，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 20}, {"label_type": "手术", "overlap": 0, "start_pos": 29, "end_pos": 76}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 87, "end_pos": 103}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 154}, {"end_pos": 169, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 171, "end_pos": 172}, {"end_pos": 183, "label_type": "解剖部位", "overlap": 0, "start_pos": 178}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 188}, {"end_pos": 219, "label_type": "解剖部位", "overlap": 0, "start_pos": 212}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 236}, {"end_pos": 265, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"end_pos": 290, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"end_pos": 310, "label_type": "解剖部位", "overlap": 0, "start_pos": 305}, {"end_pos": 333, "label_type": "解剖部位", "overlap": 0, "start_pos": 325}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 348, "end_pos": 353}, {"end_pos": 360, "label_type": "解剖部位", "overlap": 0, "start_pos": 357}, {"end_pos": 386, "label_type": "解剖部位", "overlap": 0, "start_pos": 379}, {"end_pos": 398, "label_type": "解剖部位", "overlap": 0, "start_pos": 391}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 506, "end_pos": 511}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 523, "end_pos": 528}]}
{"originalText": "，患者半个月前无明显诱因出现阵发性腹部绞痛，脐周为主，伴腹胀，恶心、呕吐，停止排气排便。无头晕、乏力、发热等不适。就诊外院，予胃肠减压、抑制消化液、抗炎、补液、灌肠等治疗，现腹痛缓解，今晨排不成形大便1次。2014-12-01外院肠镜检查提示结肠肝曲肿物，肠镜不能通过，活检病理提示腺癌。2014-12-16日于全麻上行“左半结肠切除+开腹恶性肿瘤特殊治疗”术，，术后病理：1（结肠大体）镜检为中分化腺癌，部分为黏液腺癌，浸润至浆膜上层，可见脉管内癌栓，未见神经束侵犯；阑尾粘膜慢性炎；另送检16枚淋巴结均未见癌。2（近切缘）未见癌。3（远切缘）未见癌。4（中央淋巴结）镜上为脂肪结缔组织，未见癌。5（中间淋巴结）镜上为脂肪结缔组织，未见癌。6（肠旁淋巴结）4枚，未见癌。7（阑尾）镜上为粘膜慢性炎。，免疫组化：ER（-），ERCC1（+），PMS2（+），MLH1（+），MSH2（+），MSH6（+），KI67（70%+）。 术后恢复顺利。起病以来无发热，睡眠一般，小便正常，体重上降8KG。", "entities": [{"end_pos": 19, "label_type": "解剖部位", "overlap": 0, "start_pos": 17}, {"end_pos": 24, "label_type": "解剖部位", "overlap": 0, "start_pos": 22}, {"end_pos": 29, "label_type": "解剖部位", "overlap": 0, "start_pos": 28}, {"end_pos": 46, "label_type": "解剖部位", "overlap": 0, "start_pos": 45}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 63}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 141, "end_pos": 143}, {"label_type": "手术", "overlap": 0, "start_pos": 161, "end_pos": 178}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 188, "end_pos": 202}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 206, "end_pos": 210}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 235, "end_pos": 242}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 279, "end_pos": 284}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 301, "end_pos": 306}, {"end_pos": 328, "label_type": "解剖部位", "overlap": 0, "start_pos": 323}, {"end_pos": 340, "label_type": "解剖部位", "overlap": 0, "start_pos": 338}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 344, "end_pos": 349}]}
{"originalText": "，患者因“胃恶性肿瘤”于2017-07-04在全麻上予行胃空肠吻合+空肠侧侧吻合术；，术中探查见：腹腔内少量腹水，肝脏正常，肿瘤位于胃窦小弯侧为主，远端绕胃近1周，已累及十二指肠第1段，约8*7*5CM大小，造成幽门梗阻，近端胃腔明显扩张，胃壁水肿增厚。肿瘤已侵出浆膜，与胰腺被膜及胰头浸润粘连，第3、4、5、6、7、8及12组淋巴结明显肿大，其中5、8、12组淋巴结与胰腺融合成团，探查发现原发肿瘤无法切除。术中遂行胃空肠吻合+空肠侧侧吻合术。病理学检查回示（201715397），：（大网膜）纤维脂肪组织内浸润的低分化腺癌。 胃型粘膜充血、水肿，轻度急慢性发炎。结合患者病情及肿瘤病理与分期继续予行术后化疗相关辅助治疗指征存在；依情于2017-7-19开始予行术后首周期辅助化疗，同时辅以镇吐、升血、免疫调节等对症支持治疗（化疗期间患者总体耐受性良好），患者现为求进一步治疗来院就诊，门诊依情以“胃恶性肿瘤术后”收入院。目前患者精神及情绪状态良好，食欲、饮食好，夜间睡眠后；近期无明显体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 5, "end_pos": 10}, {"label_type": "手术", "overlap": 0, "start_pos": 28, "end_pos": 41}, {"end_pos": 51, "label_type": "解剖部位", "overlap": 0, "start_pos": 49}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 59, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 92, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 106, "end_pos": 110}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 111}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 120, "end_pos": 121}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 136}, {"end_pos": 143, "label_type": "解剖部位", "overlap": 0, "start_pos": 141}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 174, "end_pos": 184}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"label_type": "手术", "overlap": 0, "start_pos": 209, "end_pos": 222}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 243, "end_pos": 263}, {"end_pos": 269, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 400, "end_pos": 407}]}
{"originalText": "，缘于入院前7月余因“食管胃交界区癌”于我科行根治性全胃及食管上段切除+食管-空肠ROUX-EN-Y吻合术（2015-09-17），术后病理（201533702）示“（食管上段+全胃），：食管胃交界浸润型管状腺癌II级，侵及浆膜层，侵犯神经，手术标本下、上切端均未见癌浸润，找到大弯淋巴结6个，幽门下淋巴结3个，幽门上淋巴结6个均未见癌转移。，201534030：1.(下切端)，：送检切端组织未见癌浸润。2.找到(贲门旁)淋巴结4/9个，(胃右动脉旁)淋巴结1/12个，(腹腔动脉旁)淋巴结0/1个，(肝总动脉旁)淋巴结0/1个，见癌转移”。术后恢复良好，并按“安素泰210MGD1+顺铂40MGD1-3”方案行术后辅助化疗1周期（2015-10-21），因第1次化疗消化道反应剧烈，故于2015.11.13、2015.12.05、2015-12-28以“洛铂50MG静滴D1+紫杉醇注射液(安素泰)210MG静滴D1”方案行第2、3、4周期化疗，辅以保肝、止吐、制酸、营养支持等治疗，疗程较为顺利。今为行术后复查再诊我院，门诊拟“食管胃交界区癌术后化疗后”收住入院。近来，精神、饮食、睡眠可，大小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 11, "end_pos": 18}, {"label_type": "手术", "overlap": 0, "start_pos": 23, "end_pos": 53}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 83, "end_pos": 109}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"end_pos": 215, "label_type": "解剖部位", "overlap": 0, "start_pos": 207}, {"end_pos": 230, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"end_pos": 246, "label_type": "解剖部位", "overlap": 0, "start_pos": 236}, {"end_pos": 261, "label_type": "解剖部位", "overlap": 0, "start_pos": 251}, {"end_pos": 285, "label_type": "药物", "overlap": 0, "start_pos": 282}, {"end_pos": 295, "label_type": "药物", "overlap": 0, "start_pos": 293}, {"end_pos": 338, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}, {"end_pos": 381, "label_type": "药物", "overlap": 0, "start_pos": 379}, {"end_pos": 393, "label_type": "药物", "overlap": 0, "start_pos": 390}, {"end_pos": 400, "label_type": "药物", "overlap": 0, "start_pos": 397}, {"end_pos": 429, "label_type": "解剖部位", "overlap": 0, "start_pos": 428}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 467, "end_pos": 476}]}
{"originalText": "，缘于1月前因进行性吞咽困难1个月就诊于我院，完善术前准备后于2014-08-07在全麻上行经左胸三切口食管下段癌切除+食管胃底左颈部吻合+左侧第5肋骨固定术，，术中所见：全胸腔少量粘连，探查肿瘤位于食管下段，奇静脉弓上，局部增厚长约6CM，累及外膜，局部侵出外膜，下段食管旁及纵隔多发淋巴结肿大。切除全胸段食管，并将胃底引线送至颈部，行食管-胃底手工吻合。术顺，术后安返病房，术后给予预防感染、营养支持、制酸、雾化祛痰等治疗，患者恢复良好。术后病理（201425956），：(食管)，：食管溃疡型鳞状细胞癌II级，侵出外膜层，手术标本双切端及另送(上切端)均未见癌转移。找到食管周淋巴结1/2个，另送(上切端)周淋巴结0/2个，(颈部食管旁)淋巴结0/2个，(下段食管旁)淋巴结0/1个，(胸部入口处)淋巴结1/1个，(胃右动脉旁)淋巴结0/5个，(肝总动脉旁)淋巴结0/2个见癌转移。今为入院化疗，遂就诊我院。门诊拟“食管癌术后”收入我科，下次出院至今患者无胸闷、憋气；无胸背痛；无腹痛、腹胀；无呕血、黑便；偶有返酸。饮食睡眠较好。大小便正常，体重无明显变化。", "entities": [{"label_type": "手术", "overlap": 0, "start_pos": 46, "end_pos": 79}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 100}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 105}, {"end_pos": 137, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"end_pos": 141, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"end_pos": 156, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"label_type": "手术", "overlap": 0, "start_pos": 169, "end_pos": 178}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 238, "end_pos": 257}, {"end_pos": 294, "label_type": "解剖部位", "overlap": 0, "start_pos": 288}, {"end_pos": 325, "label_type": "解剖部位", "overlap": 0, "start_pos": 315}, {"end_pos": 340, "label_type": "解剖部位", "overlap": 0, "start_pos": 330}, {"end_pos": 355, "label_type": "解剖部位", "overlap": 0, "start_pos": 345}, {"end_pos": 370, "label_type": "解剖部位", "overlap": 0, "start_pos": 360}, {"end_pos": 385, "label_type": "解剖部位", "overlap": 0, "start_pos": 375}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 411, "end_pos": 416}, {"end_pos": 432, "label_type": "解剖部位", "overlap": 0, "start_pos": 431}, {"end_pos": 440, "label_type": "解剖部位", "overlap": 0, "start_pos": 438}, {"end_pos": 444, "label_type": "解剖部位", "overlap": 0, "start_pos": 443}, {"end_pos": 447, "label_type": "解剖部位", "overlap": 0, "start_pos": 446}]}
{"originalText": "，缘于3月前（2014-11-18）因食管癌于我院行“胸腹腔镜联合翻身三切口全胸段食管切除+食管-胃底右颈吻合+空肠造瘘术”。手术顺利，术后恢复良好后出院。术后病理（201441090），：（食管及胃底），：食管隆起型鳞状细胞癌II级，伴坏死，癌组织侵犯脉管及神经组织，脉管内见癌栓，侵及外膜层。手术标本下切端、上切端均未见癌浸润。找到食管周淋巴结1/2个，胃周淋巴结0/2个，及另送（下段食管旁）淋巴结0/1个，（上段食管旁）淋巴结0/3个，（左喉返旁神经）淋巴结0/4个，（第7组）淋巴结0/8个，（第8组）淋巴结0/2个见癌转移。，免疫组化染色结果：KI67（40%阳性），P53（++），P170（-），GSTπ（++），EGFR（+++）。于2014.12.24、2015.01.14按“洛铂50MGD1+氟尿嘧啶4000MGCIV44H”方案行术后2周期化疗，并辅予保肝、止呕、制酸、增强免疫等辅助治疗。现为求化疗求诊我科，门诊拟“食管上段鳞癌术后”收入院。术后至今偶有返酸，进食半流质尚顺畅。饮食睡眠较好。大小便正常。体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 19, "end_pos": 22}, {"label_type": "手术", "overlap": 0, "start_pos": 27, "end_pos": 61}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 95, "end_pos": 117}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 192}, {"end_pos": 217, "label_type": "解剖部位", "overlap": 0, "start_pos": 207}, {"end_pos": 233, "label_type": "解剖部位", "overlap": 0, "start_pos": 222}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 238, "end_pos": 246}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 251, "end_pos": 259}, {"end_pos": 351, "label_type": "药物", "overlap": 0, "start_pos": 349}, {"end_pos": 362, "label_type": "药物", "overlap": 0, "start_pos": 358}, {"end_pos": 391, "label_type": "解剖部位", "overlap": 0, "start_pos": 390}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 422, "end_pos": 430}]}
{"originalText": "1+月前，患者因“大便习惯改变、便血”于我院胃肠外科住院治疗，行钡剂灌肠提示乙状结肠占位性病变；上腹部CT提示乙状结肠壁占位性病变；于2015.08.21在全麻上行腹腔镜上腹腔探查术+中转开腹+术中冰冻活检+乙状结肠癌根治术+小肠部分切除术、肠吻合术，术中见肿瘤位于右上腹，与右侧盆壁粘连紧密，同时与部分小肠、膀胱壁粘连，腹腔少量清亮腹水，肿瘤与盆壁粘连分离困难，升结肠、横结肠未见异常，于乙状结肠靠近降结肠处扪及一直径约5X4CM质硬肿块，肿瘤浸透肠壁，与右侧盆壁广泛粘连且紧密，与右侧膀胱壁部分粘连，小肠距回盲部约180CM处与肿瘤粘连，乙状结肠系膜间及根部可扪及肿大淋巴结。手术过程顺利，术后伤口出现感染，予以头孢替安抗感染等治疗，伤口逐渐愈合。术后病检：乙状结肠低分化腺癌侵及浆膜层，肠系膜淋巴结见癌转移（5/6），送检右侧盆壁见癌累及；于2015.09.04予以FOLFOX4（奥沙利铂150MG D1+亚叶酸钙0.3G D1~2+5-FU 0.625G D1~2静脉注射+5-FU 1G D1~2静脉滴入）、2015.09.23予以FOLFOX4（奥沙利铂150MG D1+亚叶酸钙0.3G D1~2+5-FU 0.7G D1~2静脉注射+5-FU 1G D1~2静脉滴入）化疗，化疗过程中无恶心、呕吐等不适，化疗结束后复查血常规未见骨髓抑制；患者今为行进一步治疗于我科住院治疗。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 22, "end_pos": 23}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 23, "end_pos": 24}, {"end_pos": 36, "label_type": "解剖部位", "overlap": 0, "start_pos": 35}, {"end_pos": 42, "label_type": "解剖部位", "overlap": 0, "start_pos": 38}, {"label_type": "影像检查", "overlap": 0, "start_pos": 48, "end_pos": 53}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"label_type": "手术", "overlap": 0, "start_pos": 82, "end_pos": 125}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"end_pos": 142, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 161, "end_pos": 162}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 167}, {"end_pos": 175, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 182}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 186}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 195}, {"end_pos": 204, "label_type": "解剖部位", "overlap": 0, "start_pos": 201}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 226}, {"end_pos": 233, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"end_pos": 247, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 254, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 258, "label_type": "解剖部位", "overlap": 0, "start_pos": 255}, {"end_pos": 281, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"end_pos": 312, "label_type": "药物", "overlap": 0, "start_pos": 308}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 331, "end_pos": 340}, {"end_pos": 352, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"end_pos": 368, "label_type": "解剖部位", "overlap": 0, "start_pos": 364}, {"end_pos": 398, "label_type": "药物", "overlap": 0, "start_pos": 394}, {"end_pos": 411, "label_type": "药物", "overlap": 0, "start_pos": 407}, {"end_pos": 425, "label_type": "药物", "overlap": 0, "start_pos": 421}, {"end_pos": 446, "label_type": "药物", "overlap": 0, "start_pos": 442}, {"end_pos": 484, "label_type": "药物", "overlap": 0, "start_pos": 480}, {"end_pos": 497, "label_type": "药物", "overlap": 0, "start_pos": 493}, {"end_pos": 511, "label_type": "药物", "overlap": 0, "start_pos": 507}, {"end_pos": 530, "label_type": "药物", "overlap": 0, "start_pos": 526}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 573, "end_pos": 577}]}
{"originalText": "，患者2015-03无明显诱因出现大便带暗红血，量少，伴大便次数增加至2-3次/天，稀烂，偶有里急后重，外院肠镜检查提示升结肠近肝曲环形肿物，肠镜能通过，活检病理提示腺癌；升结肠、乙状结肠、直肠多发小息肉。后就诊我院，完善检查后诊断为升结肠癌，未见远处转移，遂于2015-07-06全麻上行“左半结肠切除术”，，术后病理结果回示：1（近切缘）未见癌。2（远切缘）未见癌。3（根部淋巴结）5枚，未见癌。4（中间组淋巴结）4枚，未见癌。5（肠旁淋巴结）15枚，未见癌；另见癌结节一枚。6（肠大体）镜检为中至低分化腺癌，浸润至肠壁浆膜上层，未见明确脉管及神经束侵犯；阑尾及小肠粘膜慢性炎。，免疫组化：MSH2（+），MSH6（+），PMS2（+），MLH1（+），ER（-），ERCC1（+），KI67（60%+）。诊断分期PT3N1CM0IIIB期。患者术后恢复良好，现为进一步治疗收入我科。自下次出院以来，胃纳可，睡眠一般，小便正常，体重无上降。", "entities": [{"end_pos": 66, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 83, "end_pos": 85}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 117, "end_pos": 121}, {"end_pos": 153, "label_type": "手术", "overlap": 0, "start_pos": 146}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 218}, {"end_pos": 243, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 249, "end_pos": 256}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 260, "end_pos": 261}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 280, "end_pos": 290}, {"end_pos": 403, "label_type": "解剖部位", "overlap": 0, "start_pos": 402}]}
{"originalText": "患者1月余前因“大便带血3月余。”入院，诊断为“直肠癌”，患者入院后完善相关辅助检查，排除禁忌后于2016-01-17日在全麻上行腹腔镜直肠癌根治术，术后病理检查结果:（直肠）中分化腺癌，溃疡型，肿物切面积3.5*0.5CM，侵透外膜达周围脂肪组织，手术下上切线及环周切线均未查见癌，肠周淋巴结13枚中均未查见转移。现患者为求化疗治疗再次就诊于我科。患者近日来饮食、睡眠可，小便正常，大便同下，体重正常。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 24, "end_pos": 27}, {"end_pos": 74, "label_type": "手术", "overlap": 0, "start_pos": 65}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 84, "end_pos": 97}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}]}
{"originalText": "，患者2013年8月16日于我科全麻上行乙状结肠癌根治术，，术后病理：进展期乙状结肠癌，溃疡浸润型，中分化腺癌，，浸润深度：透浆膜，，生长方式：浸润型生长，肌间神经节侵犯（+），II级，断端无癌，淋巴结未见癌转移（0/19枚），DUKES，分期：B2期。，免疫组化结果：KI67>80%,P53>70%,CDX2 >50%,CA199(+),NM23(+),MLH1>70%,MSH2>70%,MSH6>60%,，病理号：517。患者术后行腹腔化疗2次，XELOX辅助化疗4次，无明显不良反应，今为求进一步辅助化疗收入我科。患者近日无发热，饮食睡眠可，小便正常，大便日一次，无腹泻，无便血，近来体重未见明显减轻。ECOG，评分：1分。", "entities": [{"end_pos": 28, "label_type": "手术", "overlap": 0, "start_pos": 20}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 35, "end_pos": 55}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 220, "end_pos": 221}, {"end_pos": 289, "label_type": "解剖部位", "overlap": 0, "start_pos": 288}]}
{"originalText": "患者1月余前因“嗳气、剑突上隐痛5月余。”于我院就诊后，完善辅助检查后于2015.04.29行“胃癌根治术（D2全胃+ROUX-EN-Y重建）”，术后病理提示：胃食管结合部腺癌II型，PT3N3AM0，IIIB期。术后恢复可，无腹痛、腹胀、恶心、呕吐等不适。于2015.05.27行SOX方案（奥沙利铂150MG IVDRIP D1+S-1 60MG PO BID D1-14）化疗。现按主诊教授建议来我院住院化疗。患者起病以来，食欲可，睡眠、精神可，大小便无明显异常，体重无明显变化。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 11, "end_pos": 13}, {"label_type": "手术", "overlap": 0, "start_pos": 48, "end_pos": 71}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 80, "end_pos": 106}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 114}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"end_pos": 151, "label_type": "药物", "overlap": 0, "start_pos": 147}, {"end_pos": 170, "label_type": "药物", "overlap": 0, "start_pos": 167}]}
{"originalText": "患者因“胃窦癌”于2015-7-8在我院全麻上行\\\"远端胃癌姑息切除癌姑息切除术\\\"，术程顺利，术后病理提示胃窦癌（PT4AN3BM1，IV期)。患者术后恢复可，于2015-8-12行SOX（维康达40MG BID PO D1-14+奥沙利铂 150MG IVDRIP Q3W）方案一程，过程顺利，偶感疲乏，余无恶心、呕吐、发热等不适，今为行上程术后辅助化疗收入我科。自下次出院以来，患者精神、睡眠可，食欲可，大小便正常，体重无明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 4, "end_pos": 7}, {"end_pos": 40, "label_type": "手术", "overlap": 0, "start_pos": 26}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 54, "end_pos": 72}, {"end_pos": 99, "label_type": "药物", "overlap": 0, "start_pos": 96}, {"end_pos": 121, "label_type": "药物", "overlap": 0, "start_pos": 117}]}
{"originalText": "，患者因“胃窦癌”入我院于2014-12-24在全麻上行\\\"（远端）胃癌根治术\\\"，术程顺利，，术后病理回报:“（胃肿物大体）镜检为胃中至低分化腺癌，LAUREN，分型：肠型，浸润胃壁浆膜层，可见脉管内癌栓及神经束侵犯；网膜组织未见癌。淋巴结4/61枚见腺癌转移。（近、远切缘）未见癌。，免疫组化：VEGF（+），HER-2（1+）。PT4AN2M0，IIIB期。”患者术后恢复可，现为行术后辅助化疗来我院就诊，拟“胃窦癌术后”入我科。自下次出院以来，患者一般情况可，大小便正常，进食量一般，睡眠正常，体重无明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 5, "end_pos": 8}, {"label_type": "手术", "overlap": 0, "start_pos": 30, "end_pos": 39}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 57, "end_pos": 58}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 66, "end_pos": 74}, {"end_pos": 86, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 91}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 127, "end_pos": 129}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 208, "end_pos": 213}]}
{"originalText": "，患者约于4个月前因“胃恶性肿瘤”在我院全麻上行姑息性胃大部切除术+毕II式吻合，手术过程顺利，术后患者恢复好，切口愈合好，，术后病理：胃窦部低分化腺癌，局部呈粘液腺癌图像，浸润溃疡型，体积7.5*3.7*2.2CM，侵穿浆膜，累及底部切除面。双端切线未查见癌。呈三组（3/3个）、五组（2/4个）、六组（5/7个）淋巴结癌转移。四组（2个）淋巴结未查见癌。，免疫组化染色示：CERBB-2（1+）、SYN（-）、ERCC1弥漫（+）、β-TUBULIN-III少量（+）、TS较多（+）、RRM1少量（+）、TOPOII少量（+）。根据患者病情具有化疗指征，于2014-08-06开始第一周期化疗，，方案为：奥沙利铂200MG D1+亚叶酸钙0.3G D2-6 +替加氟1000MG D2-6 静滴，同时给与升白细胞、护肝、止吐、免疫增强治疗，注意观察患者病情变化,给予升白、止吐等药物，患者化疗耐受可，无明显化疗副反应。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 11, "end_pos": 16}, {"label_type": "手术", "overlap": 0, "start_pos": 24, "end_pos": 40}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 68, "end_pos": 76}, {"end_pos": 309, "label_type": "药物", "overlap": 0, "start_pos": 305}, {"end_pos": 322, "label_type": "药物", "overlap": 0, "start_pos": 318}, {"end_pos": 336, "label_type": "药物", "overlap": 0, "start_pos": 333}, {"end_pos": 362, "label_type": "解剖部位", "overlap": 0, "start_pos": 361}]}
{"originalText": "缘于入院前3个月月于我院诊为“卵巢癌”，于2013-10-16在我科行“全麻上行盆腔粘连松解+阔韧带肿物切除术+全子宫切除术”，术后病理回报示：卵巢子宫内膜样腺癌I级，术后恢复良好，伤口愈合II/甲。术后于2013-11-03及2013-11-27予“多西他赛70MG/M2IVGTTD1+洛铂30MG/M2IVGTTD1”方案化疗2次，化疗过程顺利，第2次化疗出现II度骨髓抑制,予升白治疗后好转出院。2013-12-26予“紫杉醇240MGIVGTTD1+洛铂50MGIVGTTD1”方案第3次化疗，化疗过程顺利，化疗后出现II度骨髓抑制,予升白治疗后好转出院。现化疗间期已满，患者无畏冷、发热，无恶心、呕吐，无腹痛、腹泻等不适，今为求进一步诊治，门诊拟“卵巢子宫内膜样腺癌(II期，I级)术后”收入院。下次出院以来，精神、睡眠、饮食可，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手术", "overlap": 0, "start_pos": 36, "end_pos": 62}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 72, "end_pos": 83}, {"end_pos": 130, "label_type": "药物", "overlap": 0, "start_pos": 126}, {"end_pos": 147, "label_type": "药物", "overlap": 0, "start_pos": 145}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 183, "end_pos": 190}, {"end_pos": 217, "label_type": "药物", "overlap": 0, "start_pos": 214}, {"end_pos": 232, "label_type": "药物", "overlap": 0, "start_pos": 230}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 264, "end_pos": 271}, {"end_pos": 309, "label_type": "解剖部位", "overlap": 0, "start_pos": 308}, {"end_pos": 312, "label_type": "解剖部位", "overlap": 0, "start_pos": 311}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 330, "end_pos": 349}]}
{"originalText": "，患者3月前“结肠癌”于2015-10-14 在全麻上行姑息性乙状结肠癌切除+横结肠造瘘术，手术过程顺利，术后患者恢复好，切口愈合好，按期拆线。，术后病理：201517712（乙状结肠）粘液腺癌，浸润溃疡型，体积12*6*3CM，侵穿浆膜。 双端切线未查见癌。 肠壁一站（10个）淋巴结未查见癌。，免疫组化染色示癌组织：SYN（-）、TS（-）、BRAF（-）、MLH1（+）、 MSH2（+）、MSH6（+）、PMS2（+）。根据患者病情具有化疗指征，于2015-10-27、2015-11-24、2015-12-20行化疗3次，，方案为：奥沙利铂150MG D1，亚叶酸钙0.3G+替加氟0.8G D2-D6，同时给与升白细胞、护肝、止吐、免疫增强治疗，为进一步治疗，门诊以“乙状结肠癌术后”收入院。患者自发病以来，精神、睡眠可，体重近2月上降5千克。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 7, "end_pos": 10}, {"label_type": "手术", "overlap": 0, "start_pos": 28, "end_pos": 45}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 87, "end_pos": 103}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 130, "end_pos": 143}, {"end_pos": 275, "label_type": "药物", "overlap": 0, "start_pos": 271}, {"end_pos": 288, "label_type": "药物", "overlap": 0, "start_pos": 284}, {"end_pos": 296, "label_type": "药物", "overlap": 0, "start_pos": 293}, {"end_pos": 318, "label_type": "解剖部位", "overlap": 0, "start_pos": 317}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 340, "end_pos": 347}]}
{"originalText": "患者因家族性结肠息肉病于2010-9-8在我院于全麻上行全结肠切除术+远端直肠息肉电切术，手术过程顺利，术后给予抗感染、营养支持及对症治疗，恢复好，好转出院。病理回示：结肠多发绒毛状管状腺瘤，部分腺体呈轻－中度不典型增生；双端切线未见明显病变；肠壁一站（19个）、二站（13个）、三站（69个）；“结肠中动脉”（1个）淋巴结，呈反应性增生；慢性阑尾炎。   院外期间患者坚持口服易蒙停等药物治疗，大便成型，约5-6次/日，定期入院复查并行肠镜检查及直肠息肉电切治疗。现患者为行复查及进一步诊疗再次来我院就诊，门诊以\\\"结肠全切除术后、肠息肉\\\"收入院。   患者自下次出院后一般情况可，精神可，饮食、睡眠可，小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 6, "end_pos": 10}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 28, "end_pos": 44}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 84, "end_pos": 95}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 122, "end_pos": 162}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 170, "end_pos": 175}, {"end_pos": 192, "label_type": "药物", "overlap": 0, "start_pos": 189}, {"end_pos": 230, "label_type": "手术", "overlap": 0, "start_pos": 224}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 259, "end_pos": 266}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 267, "end_pos": 270}]}
{"originalText": "，患者2015.11.03在我院于全麻上行“经腹子宫切除+两附件切除+大网膜切除+肠壁转移瘤切除术”。2015.11.09，术后常规病理回示：（右附件）高级别浆液性乳头状癌，肿瘤体积约4*2.5*2CM。子宫内膜及肌层、宫颈、左附件及大网膜均未查见癌。另送“肠壁转移瘤”组织内查见癌。，免疫组化：ER（约60%）PR（约10%）P53（+）WT-1（+），NAPSINA(-),KI67阳性率约50%；分泌状态子宫内膜；慢性宫颈炎；左卵巢黄体囊肿。评估患者病情后，于2015.11.12、2015.12.12、2016.1.6给予紫杉醇（力朴素）270MG+卡铂（波贝）600MG方案静脉化疗3周期，并给予止吐、补液等对症治疗。化疗过程顺利，副反应轻，好转出院，现患者为行第4次化疗来我院就诊，门诊以“恶性肿瘤术后化疗”收入院。患者自发病以来，饮食及睡眠可，大小便正常，阴道无流血流液，体重无明显变化。", "entities": [{"label_type": "手术", "overlap": 0, "start_pos": 22, "end_pos": 49}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 71, "end_pos": 86}, {"end_pos": 109, "label_type": "解剖部位", "overlap": 0, "start_pos": 102}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 129, "end_pos": 134}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 205}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 210, "end_pos": 215}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 216, "end_pos": 223}, {"end_pos": 268, "label_type": "药物", "overlap": 0, "start_pos": 265}, {"end_pos": 272, "label_type": "药物", "overlap": 0, "start_pos": 269}, {"end_pos": 281, "label_type": "药物", "overlap": 0, "start_pos": 279}, {"end_pos": 284, "label_type": "药物", "overlap": 0, "start_pos": 282}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 351, "end_pos": 359}, {"end_pos": 387, "label_type": "解剖部位", "overlap": 0, "start_pos": 385}]}
{"originalText": "，缘于入院前1月于我院诊为结肠癌，于2016年10月20日在全麻上行腹腔镜辅助上乙状结肠癌根治术。，手术经过如上:探查腹腔内无明显粘连，无明显出血，无明显腹水，未及种植结节，肝脏未见明显转移灶，乙状结肠上段可探及肿瘤，侵出浆膜层，活动度可，周围未及明显肿大淋巴结，术后予预防性抗感染、制酸、免疫调节及营养支持等治疗。术后恢复可，病理回报（，病理号：20163776），：（乙状结肠），：大肠溃疡型管状腺癌II级，侵出外膜层，手术标本双切端及另送（下切端）（上切端），均未见癌浸润。找到肠周淋巴结1/17个，及另送（中间组）淋巴结0/6个、（肠系膜上动脉根部）淋巴结0/3个，见癌转移。此次为化疗再次就诊我院，门诊拟结肠癌术后化疗收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 13, "end_pos": 16}, {"end_pos": 48, "label_type": "手术", "overlap": 0, "start_pos": 34}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 59, "end_pos": 60}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 103, "label_type": "解剖部位", "overlap": 0, "start_pos": 97}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 185, "end_pos": 205}, {"end_pos": 247, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 282, "label_type": "解剖部位", "overlap": 0, "start_pos": 269}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 307, "end_pos": 312}, {"end_pos": 336, "label_type": "解剖部位", "overlap": 0, "start_pos": 335}, {"end_pos": 339, "label_type": "解剖部位", "overlap": 0, "start_pos": 338}]}
{"originalText": "，缘于入院前16月于我院诊断为直肠癌，于2014年12月01日在全麻上行“腹腔镜上根治性直肠癌切除术+回肠造瘘术”，术中见腹腔内无明显出血，小肠与小肠多节段肠间粘连，盆腔少量黄色腹水，肿瘤位于腹膜返折下3CM，侵出浆膜，周围可探及多发肿大淋巴结，肿瘤左侧盆腔可疑种植结节。手术顺利。术后病理回报（201441985），:（直乙交界），：大肠溃疡型管状腺癌II级，伴坏死，部分为筛状粉刺型，侵出浆膜层，癌组织侵犯脉管及神经组织，脉管内见癌栓；手术标本下切端、上切端及另送（下切端）、（上切端）均未见癌浸润。找到肠周淋巴结1/14个及另送（肠系膜上动脉根部）淋巴结0/4个见癌转移。（腹壁结节）送检纤维、脂肪组织中见腺癌组织浸润。于2015.01.21，2015.02.13，2015.03.25,2015.04.29行“奥沙利铂(齐沙)200MG静滴D1+希罗达1000MG口服BIDD1-14”方案化疗，辅以增强免疫、保胃、营养等处理，化疗过程中无肝肾功能损害、骨髓抑制等不良反应。入院1月前无明显诱因出现肛门疼痛，呈阵发性隐痛，无腹痛、腹胀，无发热、寒战等，无便血、腹泻，今为进一步诊治再次入院。门诊拟“直肠癌术后化疗后（PT4AN1M1IV期）”收入我院我科。下次出院后饮食、睡眠可，无腹痛、腹胀、发热，二便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手术", "overlap": 0, "start_pos": 37, "end_pos": 56}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 61, "end_pos": 62}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"end_pos": 85, "label_type": "解剖部位", "overlap": 0, "start_pos": 83}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"end_pos": 100, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"end_pos": 129, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 160, "end_pos": 180}, {"end_pos": 259, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}, {"end_pos": 280, "label_type": "解剖部位", "overlap": 0, "start_pos": 267}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 290, "end_pos": 291}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 306, "end_pos": 308}, {"end_pos": 363, "label_type": "药物", "overlap": 0, "start_pos": 359}, {"end_pos": 366, "label_type": "药物", "overlap": 0, "start_pos": 364}, {"end_pos": 380, "label_type": "药物", "overlap": 0, "start_pos": 377}, {"end_pos": 411, "label_type": "解剖部位", "overlap": 0, "start_pos": 410}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 424, "end_pos": 430}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 431, "end_pos": 435}, {"end_pos": 455, "label_type": "解剖部位", "overlap": 0, "start_pos": 453}, {"end_pos": 467, "label_type": "解剖部位", "overlap": 0, "start_pos": 466}, {"end_pos": 470, "label_type": "解剖部位", "overlap": 0, "start_pos": 469}, {"end_pos": 485, "label_type": "解剖部位", "overlap": 0, "start_pos": 484}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 503, "end_pos": 508}, {"end_pos": 546, "label_type": "解剖部位", "overlap": 0, "start_pos": 545}, {"end_pos": 549, "label_type": "解剖部位", "overlap": 0, "start_pos": 548}]}
{"originalText": "，缘于入院前5月余（2015.08）因“排便异常”就诊我院，查全腹CT（2015.08），：1、乙状结肠病变，多考虑结肠癌，部分侵及浆膜面可能，伴周围多发小淋巴结，于2015.08.14行“腹腔镜上直肠癌根治术（DIXON）”，术后病理示（201529660），：（直肠下段），：肠溃疡型管状腺癌II级，大部分为筛状粉刺型腺癌，伴坏死及钙化，侵出外膜层，手术标本双切端、环周切缘及另送(下切端)、(上切端)，均未见癌残余，找到肠管周围淋巴结2/24个，另送(肠系膜上动脉根部）淋巴结0/4个，见癌转移，，免疫组化染色结果：KI67（60%阳性），P53（+），P170（+++），GSTπ（-），EGFR（-），5-FU（-），MLH1（+++），MSH-6（+++），基因检测（20151492），：KRAS和BRAF无突变，术后恢复好，于2015.09.09、2015.09.23、2015.10.7予FOLFOX方案“奥沙利铂140MGD1+氟尿嘧啶3500MGCIV44HD1+亚叶酸钙300MGD1-2Q2W”术后辅助化疗3个周期，于2015.10.20开始行同步放化疗，放疗采用IMRT技术，以瘤床为GTVTB，PGTVTBDT50GY/25F，以包括瘤床、骶前、闭孔、髂内、骶3下缘以下髂外淋巴引流区为CTV1，PCTV1DT45GY/25F，予“氟尿嘧啶225MG/M2.D每周5天”方案同步化疗，配合腹部热疗。于2015.12.23、2016.01.06行4、5周期FOLFOX方案术后辅助化疗，现为继续治疗，门诊拟“直肠癌根治术后”收入住院。下次出院后，精神、睡眠、食欲欠佳，大小便正常，体重无明显变化。", "entities": [{"label_type": "影像检查", "overlap": 0, "start_pos": 31, "end_pos": 35}, {"end_pos": 52, "label_type": "解剖部位", "overlap": 0, "start_pos": 48}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 58, "end_pos": 61}, {"label_type": "手术", "overlap": 0, "start_pos": 95, "end_pos": 112}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 132, "end_pos": 151}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 156, "end_pos": 163}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 213}, {"end_pos": 241, "label_type": "解剖部位", "overlap": 0, "start_pos": 228}, {"end_pos": 416, "label_type": "药物", "overlap": 0, "start_pos": 412}, {"end_pos": 428, "label_type": "药物", "overlap": 0, "start_pos": 424}, {"end_pos": 447, "label_type": "药物", "overlap": 0, "start_pos": 443}, {"end_pos": 537, "label_type": "解剖部位", "overlap": 0, "start_pos": 535}, {"end_pos": 540, "label_type": "解剖部位", "overlap": 0, "start_pos": 538}, {"end_pos": 543, "label_type": "解剖部位", "overlap": 0, "start_pos": 541}, {"end_pos": 548, "label_type": "解剖部位", "overlap": 0, "start_pos": 544}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 550, "end_pos": 554}, {"end_pos": 585, "label_type": "药物", "overlap": 0, "start_pos": 581}, {"end_pos": 611, "label_type": "解剖部位", "overlap": 0, "start_pos": 609}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 668, "end_pos": 675}]}
{"originalText": "，患者近1个月前（2015-11-6）因“胃癌”于我科行胃癌根治术（毕I式吻合），手术过程顺利，，术后常规病理示：（胃）中分化腺癌伴粘液腺癌（后者约占15%），溃疡型，切面积4*1.0CM，侵透浆膜达周围脂肪组织。下上切线及吻合器切线均未查见癌。小弯侧淋巴结27枚，其中7枚查见转移癌（7/27）；大弯侧淋巴结10枚（0/10）及网膜组织未查见转移癌。，免疫组化：CK（+），E-CAD（+），HER-2（2+）。40092.15，术后给予抗炎补液营养支持治疗，好转后出院，现为求化疗治疗，门诊以“胃癌术后化疗”收入院。患者自下次出院以来，饮食睡眠可，二便无明显异常，体重较下次入院无明显改变。高血压病史1年余，最高达150/90MMHG，未治疗。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 21, "end_pos": 23}, {"label_type": "手术", "overlap": 0, "start_pos": 28, "end_pos": 40}, {"end_pos": 129, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 155, "label_type": "解剖部位", "overlap": 0, "start_pos": 149}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 249, "end_pos": 253}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 297, "end_pos": 300}]}
{"originalText": "，患者3个月余前因“反复嗳气半年余，解黑便3周。”就诊我院，完善相关检查后诊断胃窦癌，排除手术禁忌症后于2015-09-06在全麻上行胃癌根治术（远端胃大切），术程顺利，术后预防感染支持对症等处理，恢复好。，术后病理示：中-低分化腺癌，LAUREN，分型：混合型，浸润至胃壁浆膜层，脉管内见癌栓，可见神经束侵犯，LN 16/64（+）；PT4N3M0，IIIC期。出院后生活质量可，已于2015.10.8、2015-10-29、2015-11-25行SOX方案（奥沙利铂 150MG+替吉奥 60MG BID）化疗，化疗期间无明显毒副反应，有恶心感，耐受度尚可。现为行上一程化疗来我院门诊就诊，拟“胃癌综合治疗后”收入我科。起病以来，患者精神尚可，食欲尚可，大小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 39, "end_pos": 42}, {"label_type": "手术", "overlap": 0, "start_pos": 67, "end_pos": 79}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 110, "end_pos": 124}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"end_pos": 235, "label_type": "药物", "overlap": 0, "start_pos": 231}, {"end_pos": 246, "label_type": "药物", "overlap": 0, "start_pos": 242}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 299, "end_pos": 306}]}
{"originalText": "，入院前20+天，患者无明显原因出现大便干结，次数增多，平均每天3-4次，量少，不成形，伴大便中带血，伴肛门坠胀、里急后重，无腹胀、腹痛，无呕血、黑便，无头晕、头痛、发热等症状。遂于我院门诊就诊，，行乙状结肠镜并取活检提示：，电子乙状结肠镜：直肠新生物（性质？）；，病理活检：&LT;直肠&GT;腺癌。以“直肠癌”收入我科。于2016-02-24日在全麻上行腹腔镜上直肠癌根治术（MILES术式）。术中送病检（，病理号：1601483），：直肠中等分化腺癌侵及全层，远近切端均未见癌累及，肠系膜淋巴结未见癌转移（0/7）。术后予以抗感染，止血、抑酸护胃等对症支持治疗，术后恢复良好，造瘘口通畅，今日前来我院，拟行第一次化疗，故以“直肠癌术后第一次化疗”收入我科。", "entities": [{"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 64, "label_type": "解剖部位", "overlap": 0, "start_pos": 63}, {"end_pos": 67, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 153, "end_pos": 156}, {"label_type": "手术", "overlap": 0, "start_pos": 183, "end_pos": 198}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 220, "end_pos": 228}, {"end_pos": 250, "label_type": "解剖部位", "overlap": 0, "start_pos": 244}, {"end_pos": 276, "label_type": "解剖部位", "overlap": 0, "start_pos": 275}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 315, "end_pos": 320}]}
{"originalText": "，缘于入院前1月，我院诊为“胃癌,于2013年11月07日在全麻上行“腹腔镜上胃癌根治术”，手术顺利。，术后病理：（远端胃大部），：胃体小弯浸润型印戒细胞癌，侵及浆膜层，侵犯神经。手术标本下端、上端及另送（胃下端切口）均为浸润。找到小弯淋巴结1个吗，大弯淋巴结7个，幽门上淋巴结3个，及另送（第1组淋巴结1个），（第7组）淋巴结5个，（第8组）淋巴结1个，（第9组）淋巴结3个，（第12组）淋巴结1个均未见癌转移。，免疫组化：KI67(30%+),P53(个别细胞阳性)，CK7(+++),CK20（-），VILLIN（++++），CDX-2（++），CEA（++）,CD56(-),SYN（-），CGA（-），HER-2（-），E-CADHERIN（+）。术后给予制酸、抑酶、提高免疫力、营养、补液等支持对症治疗，恢复良好,伤口愈合II/甲。今为化疗再次入院。门诊拟“胃印戒细胞癌”收入院。下次出院以来精神、睡眠、饮食可，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"end_pos": 44, "label_type": "手术", "overlap": 0, "start_pos": 35}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 57, "end_pos": 78}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 116}, {"end_pos": 130, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 385, "end_pos": 391}]}
{"originalText": "，缘于入院前1月余，于我院诊为结肠脾曲癌，于2016-04-11在全麻上行腹腔镜辅助右半结肠根治性切除术、胃部分切除术，，术中见：探查肿物位于结肠脾曲，大小约10X5X5CM，侵出肠管前壁浆膜层，与前腹膜明显粘连，侵犯胃大弯后壁，未侵及胰腺、脾脏、肾脏。术后病理示（右半结肠+部分胃壁），：结肠溃疡型中分化腺癌，大部分为筛状粉刺型腺癌，侵出浆膜层，未见肯定脉管及神经侵犯，侵及胃浆膜层及浆膜上层，手术标本近切端、远切端及另送(近切端）、（远切端)均未见癌浸润；找到肠周淋巴结31个，均未见癌转移。送检胃体粘膜，呈中度慢性浅表性胃炎改变，术后给予对症、营养支持等治疗，恢复良好，伤口愈合II/甲。于2015.05.06在我院按“奥沙利铂250MGD1+卡培他滨1750MGD1-14”方案化疗一周期。此次为化疗再次就诊我院，门诊拟结肠癌术后收入院。下次出院以来精神、睡眠、饮食可，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 15, "end_pos": 20}, {"label_type": "手术", "overlap": 0, "start_pos": 37, "end_pos": 59}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 100, "end_pos": 101}, {"end_pos": 114, "label_type": "解剖部位", "overlap": 0, "start_pos": 109}, {"end_pos": 120, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 132, "end_pos": 155}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 160, "end_pos": 167}, {"end_pos": 237, "label_type": "解剖部位", "overlap": 0, "start_pos": 232}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 250, "end_pos": 252}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 256, "end_pos": 265}, {"end_pos": 317, "label_type": "药物", "overlap": 0, "start_pos": 313}, {"end_pos": 329, "label_type": "药物", "overlap": 0, "start_pos": 325}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 364, "end_pos": 369}]}
{"originalText": "，患者3月前主因“腹痛3月”入院，入院后完善相关检查，排除手术禁忌症，于2016.04.26在全麻上行胃癌根治术（全胃切除+ ROUX-EN-Y重建），术程顺利，术后安返病房，术后经抗感染、抑酸、止血、化痰、静脉营养支持等治疗，，术后病理示：（胃大体）镜检为胃中至低分化腺癌，LAUREN，分型：混合型，浸润至胃壁浆膜层，并累及食管壁至外膜层；可见脉管内癌栓及神经束侵犯；网膜组织未见癌。远近切缘未见癌。15/31LN(+)。分期PT4AN3MO,IIIC期。 现患者术后恢复良好，为术后行第7程XELOX辅助化疗来我院就诊。起病以来，患者无头晕、头痛，无发热、咳嗽、咳痰、胸闷、胸痛，精神体力一般，食欲上降，睡眠一般，小便正常，体重较前上降2KG。", "entities": [{"end_pos": 10, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"label_type": "手术", "overlap": 0, "start_pos": 51, "end_pos": 75}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 121, "end_pos": 144}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 272, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"end_pos": 275, "label_type": "解剖部位", "overlap": 0, "start_pos": 274}, {"end_pos": 288, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"end_pos": 291, "label_type": "解剖部位", "overlap": 0, "start_pos": 290}]}
{"originalText": "，缘于入院前2+个月于我院诊为“宫颈腺癌”，于2013年11月27日于我院在全麻上行广泛全子宫切除+两附件切除术+盆腔淋巴结清扫术。，术中见：盆腔无腹水，子宫增大如孕2个月大，表面光滑，右侧卵巢一囊肿，大小约3*3CM，与子宫及盆底粘连，分离过程见巧克力样液体流产，两侧骶韧带增粗，子宫后壁见紫蓝色结节，直肠子宫陷凹变浅，左侧附件及右输卵管未见明显异常。术后病理回报（201337408），示：（全子宫+两附件）子宫颈内生浸润型中分化粘液腺癌（宫颈管亚型），侵犯肌层（浸润最深处深度约1.0CM），未侵及宫内膜组织，（右、左）宫旁组织及手术标本阴道残端未见癌浸润。盆腔淋巴结未见癌转移，宫体肌间多发性平滑肌瘤，宫内膜呈增生状态，两侧输卵管及卵巢未见癌转移。术后恢复良好，伤口愈合II/甲。术后于2013.12.10及2014.1.8予PT方案“紫杉醇注射液(安素泰)210MGIVGTTD1+注射用洛铂43MGIVGTTD1”行第1，2次化疗。化疗后出现I度骨髓抑制,予特尔津升白治疗后出院。现患者无畏冷、发热，无腹痛、腹泻，无恶心、呕吐，无头晕、头痛等不适，遂就诊我院，门诊拟“宫颈腺癌(IB1期，II级)术后”收入院。下次出院以来，精神、睡眠、饮食可，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 16, "end_pos": 20}, {"label_type": "手术", "overlap": 0, "start_pos": 42, "end_pos": 65}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 74}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"end_pos": 113, "label_type": "解剖部位", "overlap": 0, "start_pos": 111}, {"end_pos": 116, "label_type": "解剖部位", "overlap": 0, "start_pos": 114}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"end_pos": 145, "label_type": "解剖部位", "overlap": 0, "start_pos": 141}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"end_pos": 165, "label_type": "解剖部位", "overlap": 0, "start_pos": 161}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 197, "end_pos": 228}, {"end_pos": 255, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 274, "label_type": "解剖部位", "overlap": 0, "start_pos": 272}, {"end_pos": 287, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"end_pos": 295, "label_type": "解剖部位", "overlap": 0, "start_pos": 293}, {"end_pos": 319, "label_type": "解剖部位", "overlap": 0, "start_pos": 314}, {"end_pos": 322, "label_type": "解剖部位", "overlap": 0, "start_pos": 320}, {"end_pos": 375, "label_type": "药物", "overlap": 0, "start_pos": 372}, {"end_pos": 382, "label_type": "药物", "overlap": 0, "start_pos": 379}, {"end_pos": 401, "label_type": "药物", "overlap": 0, "start_pos": 399}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 427, "end_pos": 433}, {"end_pos": 458, "label_type": "解剖部位", "overlap": 0, "start_pos": 457}, {"end_pos": 461, "label_type": "解剖部位", "overlap": 0, "start_pos": 460}, {"end_pos": 472, "label_type": "解剖部位", "overlap": 0, "start_pos": 471}, {"end_pos": 475, "label_type": "解剖部位", "overlap": 0, "start_pos": 474}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 490, "end_pos": 506}]}
{"originalText": "，缘于入院前2月余因“下腹部闷痛2月”入院，于2016年12月09日在全麻上行“腹腔镜上根治性全胃切除术”，术顺，术后予制酸、保肝、营养支持、补液等处理，，术后病理示：(全胃)，：胃体小弯溃疡型低粘附性癌（低分化腺癌），侵犯浆膜层，侵犯脉管及神经组织，手术标本下、上切端及另送（下切端）均未见癌浸润；找到贲门周淋巴结3/13枚，小弯淋巴结9/9枚，大弯淋巴结0/3枚，幽门下淋巴结0/2枚，幽门上淋巴结0/3枚及另送(11D）淋巴结0/2枚，见癌转移。另送（第6组淋巴结）、（第10组淋巴结）为纤维脂肪及脉管组织。诊断为“胃低分化腺癌”，于2017.01.07行“乐沙定200MGIVGTTQDD1+希罗达1500MGPOBIDD1-14”方案化疗，感耳鸣、恶心、呕吐，予对症处理后好转出院。此次为行第2周期化疗再次入院，门诊拟“胃低分化腺癌术后化疗”收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"end_pos": 52, "label_type": "手术", "overlap": 0, "start_pos": 40}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 84, "end_pos": 109}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 152}, {"end_pos": 169, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 179, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 195}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 261, "end_pos": 267}, {"end_pos": 285, "label_type": "药物", "overlap": 0, "start_pos": 282}, {"end_pos": 303, "label_type": "药物", "overlap": 0, "start_pos": 300}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 365, "end_pos": 373}, {"end_pos": 398, "label_type": "解剖部位", "overlap": 0, "start_pos": 397}, {"end_pos": 401, "label_type": "解剖部位", "overlap": 0, "start_pos": 400}]}
{"originalText": "，患者因诊为直肠癌2013-12-12就诊于我院，行放化疗，查无手术禁忌症，于2014-3-20全麻上行直肠癌低位前切除术，术后第六天出现吻合口瘘、腹膜炎，于2014-3-26急诊行剖腹探查术、腹盆腔冲洗、回肠造瘘术、腹盆腔置管引流术，术后予抗炎、营养支持治疗 ，恢复可。，术后病理：（近端18CM，直径3CM，距一断端2CM，距另一断端 12CM，可见一溃疡型肿物，大小3.5×XXX3CM， 溃疡深0.6CM，切面灰白、实性、质硬。直肠放化疗后（切除），： 肠溃疡型中分化腺癌伴粘液形成，大小3.5×XXX3×XXX0.6CM； - 侵至固有肌层； - 肿瘤缓解率约50％； 未见脉管癌栓； 双端切缘及环周切缘未见癌； 淋巴结未见癌转移0/21； - ，肿瘤病理分期：YPT2N0。，-免疫组化结果显示肿瘤细胞:CD44(－),CMET(－),COX2(局灶+),EGFR(+),HEP(－),HER2(1+),KI-67(+60%),MLH1(+＞75%),MSH2(+50～75%),MSH6(+＞75%),P170(+),P27(+),P53(－),TOPOII(+15%),TTF-1(－)。于2014-05-05日行术后第1周期化疗，化疗方案为“XELOX”，，具体为：奥沙利铂（乐沙定）240MG D1+卡陪他滨片3片 2/日 D1-14。2014-5-26、2014-6-16，2014-07-10,2014-7-30，2014-08-25，2014-9-19行第2、3、4、5、6、7周期化疗。目前恢复良好。为行造口还纳再次入院。患者自发病以来精神睡眠食欲尚好，小便如常，大便如下述，体重无明显改变。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 6, "end_pos": 9}, {"end_pos": 61, "label_type": "手术", "overlap": 0, "start_pos": 52}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 69, "end_pos": 73}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 74, "end_pos": 77}, {"label_type": "手术", "overlap": 0, "start_pos": 91, "end_pos": 117}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 218}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 230, "end_pos": 240}, {"end_pos": 546, "label_type": "药物", "overlap": 0, "start_pos": 542}, {"end_pos": 550, "label_type": "药物", "overlap": 0, "start_pos": 547}, {"end_pos": 565, "label_type": "药物", "overlap": 0, "start_pos": 560}]}
{"originalText": "，患者因罹患“胃窦小弯侧低分化腺癌”于2013-10-15在我院予行全麻上根治性胃大部切除，毕I式吻合。术后病理（ 201312957），示：胃窦小弯侧低分化腺癌，溃疡型，面积3*3CM，侵达外膜脂肪组织。双端切线及另送“远切线”未查见癌。三组（4个）、四组（4个）、五组（1个）、“1、3、7组”（11个）淋巴结未查见癌。，癌组织免疫组化染色示癌组织：β-TUBULIN-III（-）、TS（-）、RRM1（-）、TOPOII阳性细胞数约50%、CERBB-2（-）。，术后病理分期：PT4N0M0，IIIA期。依据患者病情及肿瘤病理与分期继续术后辅助性化疗指征存在。自下次手术出院（2013-10-25）以来，患者一般情况保持良好；无发热，无恶心、呕吐，无反酸、嗳气，无明显进食不适，未现明显腹痛、腹胀。现患者为行进一步复查并必要时适当处理而再来我院就诊，门诊依情以“胃术后”收入院。目前患者精神及情绪状态良好，食欲、饮食好，夜间睡眠后；近期无明显体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 7, "end_pos": 17}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 37, "end_pos": 51}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 71, "end_pos": 85}, {"end_pos": 349, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"end_pos": 352, "label_type": "解剖部位", "overlap": 0, "start_pos": 351}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 386, "end_pos": 389}]}
{"originalText": "，缘于入院前2年因食管髓质型鳞状细胞癌IIIA期（PT3N1M0）在全麻上行食管中段癌切除+食管-胃底弓下吻合术，术后予抗感染、抑酸、营养支持等治疗。，术后病理回报：食管髓质型鳞状细胞癌II级，侵及外膜层，手术标本下、上切端及另送（下切端）均未见癌浸润。找到（下段食管旁）淋巴结1/1个，（中段食管旁）淋巴结0/1个，（贲门旁）淋巴结0/3个，（胃右动脉旁）淋巴结0/1个，（降主动脉旁）淋巴结1/1个，（隆突上）淋巴结0/3个，（上肺韧带旁）淋巴结0/3个见癌转移。，免疫组化：KI67（40%+），P53（+++），P63（+++），CK5/6（++++），CK18（++），CD117（-）。术后予顺铂40MGD1-3+安素泰240MGD1方案化疗3周期，辅以保肝、止吐、制酸等治疗，患者疗程较为顺利。近2月来出现右胸肋骨疼痛，无胸闷、气促，无咳嗽、咳痰，无畏冷、发热等不适，今为求进一步诊治，求诊我院门诊，拟食管癌术后收入院。此次发病以来，精神、睡眠尚可，食欲如下述，大小便正常，体重无明显减轻。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 9, "end_pos": 33}, {"label_type": "手术", "overlap": 0, "start_pos": 38, "end_pos": 56}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 83, "end_pos": 96}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 144}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 182, "label_type": "解剖部位", "overlap": 0, "start_pos": 172}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 187}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 202}, {"end_pos": 225, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"end_pos": 304, "label_type": "药物", "overlap": 0, "start_pos": 302}, {"end_pos": 316, "label_type": "药物", "overlap": 0, "start_pos": 313}, {"end_pos": 335, "label_type": "解剖部位", "overlap": 0, "start_pos": 334}, {"end_pos": 364, "label_type": "解剖部位", "overlap": 0, "start_pos": 360}, {"end_pos": 369, "label_type": "解剖部位", "overlap": 0, "start_pos": 368}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 408, "end_pos": 413}]}
{"originalText": "，患者缘于入院前1年余于我院诊断为“胃间质瘤”，于2012.09.13在全麻上行腹腔镜辅助上胃体间质瘤楔形切除术。，术中见：肿物位于胃体前壁偏小弯侧，内生型，浆膜光滑无明显隆起，与周围组织无明显粘连，手术顺利。术后病理（291227160），：(胃间质瘤)，：胃间质瘤，危险程度低。术后予抗感染、补液、制酸、营养支持等治疗。恢复良好，伤口愈合II/甲。于1年余前开始口服“格列卫”治疗，服用后无诉不适。目前患者为复查，再次就诊我院，门诊拟“胃间质瘤术后”收入院。自下次出院以来饮食、睡眠正常，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 18, "end_pos": 22}, {"end_pos": 56, "label_type": "手术", "overlap": 0, "start_pos": 40}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 130, "end_pos": 134}, {"end_pos": 189, "label_type": "药物", "overlap": 0, "start_pos": 186}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 220, "end_pos": 226}, {"end_pos": 248, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"end_pos": 251, "label_type": "解剖部位", "overlap": 0, "start_pos": 250}]}
{"originalText": "，患者因罹患“结肠癌”于2013-08-06在我院予行全麻上姑息性右半结肠切除术，术后病理（9750.2013），：（横结肠）腺癌（中度分化），部分呈粘液腺癌图像，浸润溃疡型，面积7*6CM，侵穿浆膜，于肠壁脂肪组织内查见转移灶3处。呈肠壁一站（2/6个）、二站（1/1个）、“肠系膜根部”（1/1个）、“肠系膜中动脉根部”（2/2个）淋巴结癌转移。中间组（1个）淋巴结未查见癌。，术后病理分期：T4N2M0，IIIC期。术后已行6周期化疗，，化疗方案为：奥沙利铂200MG D1+亚叶酸钙0.3G D2-6 +替加氟1000MG D2-6 静滴，同时给予止吐、升血、增强免疫等治疗，因肿瘤指标仍有升高，依情于2014-03-31开始更改化疗方案，，具体用药为：伊利替康200MG D1、D8+亚叶酸钙0.3G D2-6 +替加氟1000MG D2-6 静滴，同时辅以镇吐、升血、免疫调节等对症支持治疗。化疗期间耐受良好。自下次出院以来，患者一般情况保持良好；无发热，无恶心、呕吐，无反酸、嗳气，无明显进食不适，未现明显腹痛、腹胀。现患者为行复查并辅助化疗而再来我院就诊，门诊依情以“结肠术后”收入院。目前患者精神及情绪状态良好，食欲、饮食好，夜间睡眠可；肛门排气排便好。近期无明显体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 7, "end_pos": 10}, {"end_pos": 40, "label_type": "手术", "overlap": 0, "start_pos": 30}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 58, "end_pos": 71}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 102, "end_pos": 103}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 118, "end_pos": 171}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 175, "end_pos": 185}, {"end_pos": 232, "label_type": "药物", "overlap": 0, "start_pos": 228}, {"end_pos": 245, "label_type": "药物", "overlap": 0, "start_pos": 241}, {"end_pos": 259, "label_type": "药物", "overlap": 0, "start_pos": 256}, {"end_pos": 335, "label_type": "药物", "overlap": 0, "start_pos": 331}, {"end_pos": 351, "label_type": "药物", "overlap": 0, "start_pos": 347}, {"end_pos": 365, "label_type": "药物", "overlap": 0, "start_pos": 362}, {"end_pos": 461, "label_type": "解剖部位", "overlap": 0, "start_pos": 460}, {"end_pos": 464, "label_type": "解剖部位", "overlap": 0, "start_pos": 463}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 492, "end_pos": 496}, {"end_pos": 530, "label_type": "解剖部位", "overlap": 0, "start_pos": 528}]}
{"originalText": "，缘于入院前3月余于我院诊为直肠癌，于2015-01-23在全麻上行直肠癌根治术（DIXON手术），术顺，术后病理示（201503026），：（直肠），：直肠溃疡型管状腺癌II级，侵出外膜层，侵犯神经组织，脉管内见癌栓，肠周纤维脂肪组织中见癌结节。手术标本下、上切端及另送（下切端）、（上切端）均未见癌浸润。找到肠周淋巴结1/12个，见癌转移。恢复良好,术后于2015.03.03予“替加氟2.5GCIV（46H）D1+奥沙利铂（艾恒）150MGIVGTTD1+替加氟2.5GCIV（46H）D3+亚叶酸钙300MGIVGTTD1-D5”方案化疗1次，2015.03.26予“替加氟2.5GCIV（46H）D1+奥沙利铂（艾恒）150MGIVGTTD2+亚叶酸钙300MGIVGTTD1-D3”化疗1次，过程顺利，此次为化疗再次就诊我院，门诊拟直肠癌术后化疗后收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"label_type": "手术", "overlap": 0, "start_pos": 34, "end_pos": 49}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 71, "end_pos": 89}, {"end_pos": 116, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"end_pos": 195, "label_type": "药物", "overlap": 0, "start_pos": 192}, {"end_pos": 214, "label_type": "药物", "overlap": 0, "start_pos": 210}, {"end_pos": 217, "label_type": "药物", "overlap": 0, "start_pos": 215}, {"end_pos": 234, "label_type": "药物", "overlap": 0, "start_pos": 231}, {"end_pos": 253, "label_type": "药物", "overlap": 0, "start_pos": 249}, {"end_pos": 291, "label_type": "药物", "overlap": 0, "start_pos": 288}, {"end_pos": 310, "label_type": "药物", "overlap": 0, "start_pos": 306}, {"end_pos": 313, "label_type": "药物", "overlap": 0, "start_pos": 311}, {"end_pos": 331, "label_type": "药物", "overlap": 0, "start_pos": 327}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 372, "end_pos": 377}, {"end_pos": 402, "label_type": "解剖部位", "overlap": 0, "start_pos": 401}, {"end_pos": 405, "label_type": "解剖部位", "overlap": 0, "start_pos": 404}]}
{"originalText": "，患者6月前因诊断为食管胸中段癌于我院行腹左胸食管癌切除术，术后患者出现左侧胸腔积液，留置胸腔穿刺引流可引出略浑浊液体，，术后病理提示：浸润性高分化鳞状细胞癌，大小3×XXX2×XXX1CM；癌侵透固有肌层达外膜层；淋巴结未见癌转移。，免疫组化结果显示:CD44(+++),CMET(+++),COX2(+),EGFR(+++),ERCC-1(+50～75%),HER2(－),KI-67(+25～50%),P170(+),P27(+＜25%),P53(－),TOPOII(+＜5%)。术后患者出现吻合口瘘，胸腔感染，给予通畅胸腔引流、胸腔冲洗、抗生素治疗、营养支持等治疗，复查造影以及胃镜，提示吻合口瘘愈合，患者胸腔感染治愈，患者可经口进食，主诉进食后返流呕吐，进食量少。今为进一步治疗而入我科。自发病以来，精神睡眠可，大小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 16}, {"end_pos": 29, "label_type": "手术", "overlap": 0, "start_pos": 20}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 36, "end_pos": 42}, {"end_pos": 47, "label_type": "解剖部位", "overlap": 0, "start_pos": 45}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 68, "end_pos": 79}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 254}, {"label_type": "手术", "overlap": 0, "start_pos": 263, "end_pos": 272}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 307, "end_pos": 311}]}
{"originalText": "患者2012年6月因“进行性吞咽困难”于外院确诊“贲门癌”，于2012年7月2日行贲门癌根治性近端胃切除+胃食管膈上吻合术，术中见贲门肿物约7*5大小，第1、2、3组淋巴结肿大，术后病理示贲门腺癌II级，浸润全层，LN 8/30 (+)，术后恢复可。遵主诊教授意见于2012-08-07至11-13行XELOX方案辅助化疗5程，现返院行上一程治疗。起病以来，患者精神睡眠一般，胃纳尚可，二便正常，近3周体重上降3KG。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 25, "end_pos": 28}, {"label_type": "手术", "overlap": 0, "start_pos": 41, "end_pos": 61}, {"end_pos": 67, "label_type": "解剖部位", "overlap": 0, "start_pos": 65}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 94, "end_pos": 101}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 188}]}
{"originalText": "，患者因“升结肠恶性肿瘤”于2014-09-12在我院予行全麻上行根治性左半结肠切除术。（201414180），：回盲部腺癌（中、低度分化），部分呈粘液腺癌图像，隆起型，体积7*6.5*4.5CM，侵达纤维膜，未累及浆膜。双端切线未查见癌。呈肠壁一站（1/17个）淋巴结癌转移。二站（4个）、三站（3个）、中间组（15个）、中央组（2个）淋巴结未查见癌。，免疫组化染色示癌组织：TS大部分（+）、SYN（-）。，术后病理分期：T3N1M0 IIIB期。依据患者病情及肿瘤病理与分期继续术后辅助性化疗指征存在，，查无化疗禁忌后术后行辅助化疗具体用药为：奥沙利铂200MGD1 +亚叶酸钙0.3G D2-6 +替加氟1G D2-6 静脉滴注；同时予镇吐、升血、免疫调节等对症支持治疗。患者化疗期间总体耐受性好。自下次化疗结束以来，患者一般情况保持良好；无发热，无恶心、呕吐，无反酸、嗳气，无明显进食不适，未现明显腹痛、腹胀。现患者为行进一步复查并必要时适当处理而再来我院就诊，门诊依情以“升结肠恶性肿瘤术后”收入院。目前患者精神及情绪状态良好，食欲、饮食好，夜间睡眠后；近期无明显体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 5, "end_pos": 12}, {"end_pos": 43, "label_type": "手术", "overlap": 0, "start_pos": 33}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 57, "end_pos": 70}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 74, "end_pos": 78}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 135}, {"end_pos": 279, "label_type": "药物", "overlap": 0, "start_pos": 275}, {"end_pos": 292, "label_type": "药物", "overlap": 0, "start_pos": 288}, {"end_pos": 306, "label_type": "药物", "overlap": 0, "start_pos": 303}, {"end_pos": 405, "label_type": "解剖部位", "overlap": 0, "start_pos": 404}, {"end_pos": 408, "label_type": "解剖部位", "overlap": 0, "start_pos": 407}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 442, "end_pos": 451}]}
{"originalText": "患者于2012年6月因“下腹不适2个月住我院”于2012年6月26日于我院行“根治性左半结肠切除术”。术程顺利，术后病理结果回报：升结肠镜检为结肠中至低分化腺癌，浸润至浆膜上层，肠周淋巴结（1/40）见腺癌转移。术后恢复可，术后诊断升结肠中-低分化腺癌术后 PT3N1M0IIIB期。术后恢复可，后于2012-7-23和2012-8-13行XELOX方案化疗2程,耐受可,现患者如期行上程化疗，患者一般情况可，饮食、睡眠正常，大小便如常，体重无明显减轻。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"end_pos": 49, "label_type": "手术", "overlap": 0, "start_pos": 39}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 71, "end_pos": 80}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 116, "end_pos": 141}]}
{"originalText": "，缘于入院3个月前因胃癌就诊我院，于2015.4.17全麻上行“腹腔镜中转-根治性全胃切除术”，，术中见：腹腔内无腹水，脾脏呈切除术后改变，腹腔、盆地、网膜未见结节，肿瘤位于胃体下段至胃底贲门部，浸润溃疡型，大小约7*5CM，侵出浆膜层，侵犯后壁胰体尾并与粘连，中转开腹再探查，胰体尾后方多发大小约1*1.5CM肿大腹膜后淋巴结，贲门右一1.5CM大小淋巴结，胃右动脉及肝总动脉、肝固有动脉表面见数个1CM大小淋巴结。术后病理（201514107），回报示：食管胃交界处溃疡型低分化腺癌，侵及将磨层，脉管内见瘤栓，手术下上切端均未见癌转移。术后于2015.5.13、2015.6.5、2015.6.29予奥沙利铂（齐沙200MG）IVGTTD1+希罗达1500MGPOBIDD1-14方案行术后3次化疗，辅助以制酸保肝补液等对症治疗。今为求术后第4次化疗，求诊我科，门诊拟“胃癌术后化疗”收住院。患者出院后饮食、夜休可，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 12}, {"end_pos": 46, "label_type": "手术", "overlap": 0, "start_pos": 32}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 53}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 62, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 142, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 158}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 190}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 229, "end_pos": 243}, {"end_pos": 306, "label_type": "药物", "overlap": 0, "start_pos": 302}, {"end_pos": 309, "label_type": "药物", "overlap": 0, "start_pos": 307}, {"end_pos": 326, "label_type": "药物", "overlap": 0, "start_pos": 323}, {"end_pos": 359, "label_type": "解剖部位", "overlap": 0, "start_pos": 358}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 387, "end_pos": 391}, {"end_pos": 412, "label_type": "解剖部位", "overlap": 0, "start_pos": 411}, {"end_pos": 415, "label_type": "解剖部位", "overlap": 0, "start_pos": 414}]}
{"originalText": "缘于入院前5月余前因食管腹段癌于我科行“右进胸食管腹段癌切除+食管-胃底弓上吻合术”（2014-06-25），术后病理(201420098)示“（腹段食管及近端胃）食管蕈伞型鳞状细胞癌II-III级，侵及外膜层，手术标本下、上切端及另送（下切端）均未见癌浸润。找到食管周淋巴结2个，及另送（右上肺门）淋巴结2个，（隆突上）淋巴结6个，（胃右动脉旁）淋巴结4个，（贲门旁）淋巴结2个，均未见癌转移。胃呈轻度慢性浅表性胃炎”。2个多月前因反复进食阻塞，考虑为“吻合口狭窄”并入院行“胃镜上吻合口狭窄扩张术”，按“顺铂40MGD1-3+安素泰240MGD1”方案行术后辅助化疗3周期（2014.09.17，2014.10.07，2014.11.06）。疗程较为顺利，无明显恶心、呕吐，无头痛、头痛，无呕血、黑便，无胸闷、胸痛，无气促、心悸，无腹痛、腹胀等不适。今为求术后第4周期辅助化疗再诊我院，门诊拟“食管上段癌”收住我科。近来，精神、睡眠、饮食一般，大小便如常，体重无明显增减。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 15}, {"label_type": "手术", "overlap": 0, "start_pos": 20, "end_pos": 41}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 72, "end_pos": 99}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 132}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 144}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 167}, {"end_pos": 188, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 198}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 200, "end_pos": 209}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 228, "end_pos": 233}, {"end_pos": 250, "label_type": "手术", "overlap": 0, "start_pos": 239}, {"end_pos": 256, "label_type": "药物", "overlap": 0, "start_pos": 254}, {"end_pos": 268, "label_type": "药物", "overlap": 0, "start_pos": 265}, {"end_pos": 341, "label_type": "解剖部位", "overlap": 0, "start_pos": 340}, {"end_pos": 344, "label_type": "解剖部位", "overlap": 0, "start_pos": 343}, {"end_pos": 355, "label_type": "解剖部位", "overlap": 0, "start_pos": 354}, {"end_pos": 358, "label_type": "解剖部位", "overlap": 0, "start_pos": 357}, {"end_pos": 365, "label_type": "解剖部位", "overlap": 0, "start_pos": 364}, {"end_pos": 369, "label_type": "解剖部位", "overlap": 0, "start_pos": 368}, {"end_pos": 372, "label_type": "解剖部位", "overlap": 0, "start_pos": 371}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 399, "end_pos": 404}]}
{"originalText": "，缘于半月余前因食管下段鳞癌于我院行（2014-2-14）翻身三切口食管下段癌切除+食管-胃底右颈部吻合+第6后肋内固定+空肠造瘘术，术后病理（201403696），：食管溃疡型鳞状细胞癌II级，侵出外膜层，手术标本下切端、上切端及另送(食管下切端)均未见癌浸润；找到食管周淋巴结7个及另送(喉返旁)淋巴结6个、(上段食管旁)淋巴结7个、(隆突上)淋巴结8个、(胃右动脉旁)淋巴结19个、(贲门旁)淋巴结7个、(胃大弯)淋巴结1个，均未见癌转移。，免疫组化结果：KI67（65%阳性），P53（-），P170（-），GSTπ（++），EGFR（-）。（201403588），：(颈段食管（缝线处为下切端）)，：送检食管切端组织，未见癌浸润。术后给予抗感染、营养支持、制酸、雾化祛痰等治疗，病情恢复顺利，已进食半流质，无明显恶心、呕吐，无头晕、头痛，无咳嗽、咳痰，无胸闷、胸痛，无腹痛、腹胀，无周身骨骼疼痛等不适。今为求入院术后第1周期化疗再诊我院，门诊拟食管下段癌术后化疗收住我科。近来，精神、睡眠、饮食一般，大小便如常，体重无明显增减。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 8, "end_pos": 14}, {"label_type": "手术", "overlap": 0, "start_pos": 29, "end_pos": 66}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 84, "end_pos": 97}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 119}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"end_pos": 153, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 180}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 194}, {"end_pos": 213, "label_type": "解剖部位", "overlap": 0, "start_pos": 205}, {"end_pos": 293, "label_type": "解剖部位", "overlap": 0, "start_pos": 289}, {"end_pos": 309, "label_type": "解剖部位", "overlap": 0, "start_pos": 307}, {"end_pos": 369, "label_type": "解剖部位", "overlap": 0, "start_pos": 368}, {"end_pos": 372, "label_type": "解剖部位", "overlap": 0, "start_pos": 371}, {"end_pos": 383, "label_type": "解剖部位", "overlap": 0, "start_pos": 382}, {"end_pos": 386, "label_type": "解剖部位", "overlap": 0, "start_pos": 385}, {"end_pos": 390, "label_type": "解剖部位", "overlap": 0, "start_pos": 389}, {"end_pos": 393, "label_type": "解剖部位", "overlap": 0, "start_pos": 392}, {"end_pos": 400, "label_type": "解剖部位", "overlap": 0, "start_pos": 396}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 427, "end_pos": 434}]}
{"originalText": "患者自诉近10年来大便秘结，排便困难，伴进食后腹胀，无血便、黑便、恶心等，无头晕、乏力、发热等不适。2015-03外院体检肠镜检查提示距肛16CM肿物，肠镜能通过，活检病理提示高分化腺癌。外院腹部CT、胸片未见远处转移。门诊以“结肠癌”收入我院。2015-04-08全麻上行乙状结肠切除术（DIXONS’术式），术后病理：中分化腺癌，癌组织浸润至肠壁外膜层；未见明确脉管及神经束侵犯，切缘未见癌，LN 1/11(+)。术后分期为PT4AN1M0 IIIB期。术后恢复可，2015-04-29、2015-05-20行XELOX方案辅助化疗2程，过程顺利。现为行上一程化疗入院。自下次出院以来，精神可，纳眠可，胃纳一般，二便正常，体重较前无明显变化。", "entities": [{"end_pos": 24, "label_type": "解剖部位", "overlap": 0, "start_pos": 23}, {"end_pos": 39, "label_type": "解剖部位", "overlap": 0, "start_pos": 38}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 88, "end_pos": 93}, {"label_type": "影像检查", "overlap": 0, "start_pos": 96, "end_pos": 100}, {"label_type": "影像检查", "overlap": 0, "start_pos": 101, "end_pos": 103}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 114, "end_pos": 117}, {"label_type": "手术", "overlap": 0, "start_pos": 137, "end_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 173, "end_pos": 174}, {"end_pos": 304, "label_type": "解剖部位", "overlap": 0, "start_pos": 303}]}
{"originalText": "患者1周余前在我院诊断为胃癌，于2013-3-20在全麻上行腹腔镜辅助远端胃癌根治术，手术过程顺利，术后病理结果回报远端胃局部残留粘膜内低分化腺癌（LAUREN分型：混合型；大小1毫米），未见脉管癌栓，淋巴结0/11未见癌转移，胃残端及十二指肠残端未见癌。术后患者出现胃排空障碍，为求进一步治疗入院。患者自发病以来精神、睡眠、食欲尚好，大小便正常，体重无明显改变。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 12, "end_pos": 14}, {"end_pos": 42, "label_type": "手术", "overlap": 0, "start_pos": 30}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 114}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 135, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}]}
{"originalText": "，缘于入院前1月余诊断“直乙交界处结肠癌”，于2013.11.11在我科行“腹腔镜上直乙交界处结肠癌根治术”，术中见腹腔内无明显腹水，未见明显转移结节，乙状结肠稍迂曲，肿瘤位于直肠-乙状结肠交界处，上缘距腹膜返折约7CM，约5×4CM，侵及浆膜层，未侵犯周围组织，未形成明显梗阻，周围未见明显肿大淋巴结。术顺，术毕安返病房，予补液及营养对症支持等治疗。术后病理（20335111），示：（直肠）大肠隆起型管状腺癌II级，侵犯外膜层，手术标本下、上切端及另送（下切端）、（上切端）均未见癌浸润。找到肿物周围淋巴结11个，肠周淋巴结21个，及另送（肠系膜上动脉根部）淋巴结5个，均未见癌转移。，免疫组化结果：CK20(+)，CK7(-)，VILLIN(+++)，CEA(++)，CDX-2(++)，CD56(-)，CGA（个别+），SY(个别+)，KI67(85%+)。术后恢复出院，后于2013.12.05开始予“奥沙利铂150MGIVGTTD1+希罗达1000MGPOBIDD2-15”方案行术后第1周期化疗，辅以保胃、保肝、止吐等治疗，过程顺利。现为求术后第2周期化疗再次就诊我院，门诊拟“直乙交界处结肠癌术后”收入院。自下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 12, "end_pos": 20}, {"end_pos": 53, "label_type": "手术", "overlap": 0, "start_pos": 38}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 102}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 193, "end_pos": 209}, {"end_pos": 264, "label_type": "解剖部位", "overlap": 0, "start_pos": 259}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"end_pos": 410, "label_type": "药物", "overlap": 0, "start_pos": 406}, {"end_pos": 426, "label_type": "药物", "overlap": 0, "start_pos": 423}, {"end_pos": 459, "label_type": "解剖部位", "overlap": 0, "start_pos": 458}, {"end_pos": 462, "label_type": "解剖部位", "overlap": 0, "start_pos": 461}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 496, "end_pos": 506}, {"end_pos": 530, "label_type": "解剖部位", "overlap": 0, "start_pos": 529}, {"end_pos": 533, "label_type": "解剖部位", "overlap": 0, "start_pos": 532}]}
{"originalText": "患者于2011年6月起前无明显诱因出现下腹部胀痛不适、纳差，无伴发热、黄疸、呕吐、黑便等，无处理，2011年9月再次出现右下腹痛，遂到**六院查CT示\\\"胰腺囊腺癌\\\"，9-30在气管麻上行“胰体尾切除+空肠近端切除+脾切除+结肠脾区切除+ROUX-EN-Y吻合术”，术程顺利，术后病理示胰腺粘液性囊腺癌；12月CT复查未见复发或转移征象。半月前患者突觉右下腹酸痛，伴腹胀，遂到外院复查肿瘤标记物CA199 164.1 U/L，CA125 49.6 U/L。2012-4-17**六院PET/CT示：胰腺提残端高代谢灶，考虑肿瘤复发；腹盆腔、肠旁、肠系膜、大网膜，肝周围膜、子宫子宫直肠窝多发高代谢病灶，考虑腹，盆腔广泛种植性转移。为进一步诊治至我院就诊，于2012-4-25/2012-5-24行健择方案（D1,D8,D15）化疗2程，过程顺利，化疗后II度白细胞上降。入院以来，无头晕头痛，无咳嗽咳痰，右下腹有按压痛，无腹胀，无呕吐、黑便，精神、胃纳、睡眠一般，体重无明显减轻。", "entities": [{"end_pos": 22, "label_type": "解剖部位", "overlap": 0, "start_pos": 19}, {"end_pos": 63, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"label_type": "影像检查", "overlap": 0, "start_pos": 72, "end_pos": 74}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 77, "end_pos": 82}, {"end_pos": 92, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"label_type": "手术", "overlap": 0, "start_pos": 96, "end_pos": 132}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 144, "end_pos": 152}, {"label_type": "影像检查", "overlap": 0, "start_pos": 156, "end_pos": 158}, {"end_pos": 180, "label_type": "解剖部位", "overlap": 0, "start_pos": 177}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 198, "end_pos": 204}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 214, "end_pos": 219}, {"label_type": "影像检查", "overlap": 0, "start_pos": 242, "end_pos": 248}, {"end_pos": 252, "label_type": "解剖部位", "overlap": 0, "start_pos": 250}, {"end_pos": 270, "label_type": "解剖部位", "overlap": 0, "start_pos": 267}, {"end_pos": 272, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 274, "end_pos": 275}, {"end_pos": 283, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"end_pos": 289, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"end_pos": 294, "label_type": "解剖部位", "overlap": 0, "start_pos": 289}, {"end_pos": 305, "label_type": "解剖部位", "overlap": 0, "start_pos": 304}, {"end_pos": 308, "label_type": "解剖部位", "overlap": 0, "start_pos": 306}, {"end_pos": 351, "label_type": "药物", "overlap": 0, "start_pos": 349}, {"end_pos": 393, "label_type": "解剖部位", "overlap": 0, "start_pos": 392}, {"end_pos": 395, "label_type": "解剖部位", "overlap": 0, "start_pos": 394}, {"end_pos": 406, "label_type": "解剖部位", "overlap": 0, "start_pos": 403}, {"end_pos": 413, "label_type": "解剖部位", "overlap": 0, "start_pos": 412}, {"end_pos": 426, "label_type": "解剖部位", "overlap": 0, "start_pos": 425}]}
{"originalText": "，缘于入院前2个月周于我院诊断为乙状结肠癌，于2014.01.03全麻上行“乙状结肠癌姑息切除+近端乙状结肠造瘘+小肠部分切除吻合术”，，术中见：乙状结肠一菜花样肿物,大约7.0*4.0*3.0CM，质硬，侵出浆膜，侵犯部分回肠及小肠系膜，侵及右髂部盆壁并与其粘连固定，右髂血管及右性腺血管受侵并被包绕，肠系膜上血管根部可见肿大淋巴结，肿物近端乙状结肠稍扩张，肠壁明显水肿增厚。术后予保肝、保胃、营养等治疗。术后病理（201400261），：1、（结肠），：大肠隆起型管状腺癌II级，伴坏死，侵及浆膜层，侵犯神经，手术标本下切端、上切端均未见癌浸润。找到肿物周淋巴结16个和肠周淋巴结7个均未见癌转移。2、（小肠），：送检小肠组织，肠壁全层急慢性炎症细胞浸润，病变以浆膜层最重，可见组织炎性坏死，伴大量急、慢性炎症细胞浸润，肉芽组织增生。该病例未检测到KRAS基因12、13号密码子热点突变。该病例未检测到BRAF基因V600E突变。术后恢复可，于2014.2.7、2014.2.21按“奥沙利铂150MGIVGTTD1+替加氟3.4GCIV+亚叶酸钙300MGIVGTTD1-2”方案予术后2期化疗，今为术后第3次化疗求诊我院，门诊拟“乙状结肠癌术后”收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 16, "end_pos": 21}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 38, "end_pos": 66}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 114, "label_type": "解剖部位", "overlap": 0, "start_pos": 112}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 115, "end_pos": 119}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 122}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"end_pos": 145, "label_type": "解剖部位", "overlap": 0, "start_pos": 140}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 152, "end_pos": 153}, {"end_pos": 176, "label_type": "解剖部位", "overlap": 0, "start_pos": 172}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 180, "end_pos": 181}, {"end_pos": 194, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 223, "end_pos": 241}, {"end_pos": 292, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"end_pos": 306, "label_type": "解剖部位", "overlap": 0, "start_pos": 304}, {"end_pos": 313, "label_type": "解剖部位", "overlap": 0, "start_pos": 311}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 316, "end_pos": 317}, {"end_pos": 448, "label_type": "药物", "overlap": 0, "start_pos": 444}, {"end_pos": 464, "label_type": "药物", "overlap": 0, "start_pos": 461}, {"end_pos": 476, "label_type": "药物", "overlap": 0, "start_pos": 472}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 519, "end_pos": 526}, {"end_pos": 549, "label_type": "解剖部位", "overlap": 0, "start_pos": 548}, {"end_pos": 552, "label_type": "解剖部位", "overlap": 0, "start_pos": 551}]}
{"originalText": "缘于入院前3个月于我院诊为“横结肠癌”，于2015.12.02在全麻上行“腹腔镜上横结肠癌根治性切除术”，术中见“探查腹腔内无明显出血、粘连、腹水，肿物位于横结肠中段偏左，可疑侵及浆膜层，未形成梗阻，周围可见数个肿大淋巴结”，术后病理（201543775）：“大肠隆起型管状腺癌II级，侵出浆膜层，手术标本下、上切端及另送（下切端）均未见癌浸润。找到肠周淋巴结14/42个，另送（结肠中动脉根部）淋巴结0/8个，见癌转移”，术后予对症、营养支持等治疗，恢复良好，伤口愈合II/甲出院。于2015.12.29、2016.01.19行“奥沙利铂（乐沙定）150MGIVGTTQDD1+希罗达1000MGPOBIDD1-14”方案化疗，未见明显化疗不良反应。今为行上一周期化疗就诊我院，门诊拟“横结肠癌术后化疗”收入院。自下次出院以来，精神、睡眠、饮食可，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 18}, {"end_pos": 51, "label_type": "手术", "overlap": 0, "start_pos": 37}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"end_pos": 85, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 130, "end_pos": 142}, {"end_pos": 180, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"end_pos": 270, "label_type": "药物", "overlap": 0, "start_pos": 266}, {"end_pos": 274, "label_type": "药物", "overlap": 0, "start_pos": 271}, {"end_pos": 293, "label_type": "药物", "overlap": 0, "start_pos": 290}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 344, "end_pos": 350}]}
{"originalText": "患者于2年前因“直肠吻合口漏”在我院于2012年09月04日在全麻上行剖腹探查+肠粘连松解术+回肠单腔造瘘术，手术过程顺利，术后给予抗感染及营养支持治疗。术后切口愈合较好。现患者一般情况可，造瘘口排气排便通畅，无腹胀、腹痛，无恶心、呕吐，无发热不适，为行小肠造口还纳术来我院就诊，门诊，以“小肠造漏术后”收入院。    发病以来，患者精神好，饮食可，睡眠尚可，小便正常，体重无明显改变。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 8, "end_pos": 14}, {"label_type": "手术", "overlap": 0, "start_pos": 35, "end_pos": 54}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 106}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 109}, {"end_pos": 134, "label_type": "手术", "overlap": 0, "start_pos": 127}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 145, "end_pos": 151}]}
{"originalText": "，缘于入院前2月余因“反复返酸、嗳气7年”就诊我院，，行胃镜检查示：“1.胃窦癌2.慢性萎缩性胃炎”，，病理示：“胃管状腺癌II-III级”，下腹部平扫+，增强示：“胃肿瘤，伴腹腔、腹膜后多发淋巴结肿大”，考虑肿瘤局部较晚期，遂于2015.04.18、2015.05.11、2015.06.02予“安素泰210MGIVGTTD1+奥沙利铂（艾恒）150MGIVGTTD2+希罗达1000MGPOBIDD1-14”方案新辅助化疗，辅以止吐、制酸、保胃、保肝、营养支持等治疗。化疗后未见明显骨髓抑制，一般情况尚可。今为求第4次化疗就诊我院，门诊拟“胃窦癌”收入院。自发病以来，精神、睡眠可，食欲一般，大小便如常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 37, "end_pos": 40}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 42, "end_pos": 49}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 57, "end_pos": 69}, {"label_type": "影像检查", "overlap": 0, "start_pos": 71, "end_pos": 77}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 83, "end_pos": 84}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 92}, {"end_pos": 152, "label_type": "药物", "overlap": 0, "start_pos": 149}, {"end_pos": 169, "label_type": "药物", "overlap": 0, "start_pos": 165}, {"end_pos": 172, "label_type": "药物", "overlap": 0, "start_pos": 170}, {"end_pos": 189, "label_type": "药物", "overlap": 0, "start_pos": 186}, {"end_pos": 224, "label_type": "解剖部位", "overlap": 0, "start_pos": 223}, {"end_pos": 227, "label_type": "解剖部位", "overlap": 0, "start_pos": 226}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 243, "end_pos": 247}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 272, "end_pos": 275}]}
{"originalText": "，患者2012年5月出现吞咽困难，伴下腹部不适，为隐痛，无明显放射，疼痛间断发作，患者无恶心、呕吐，无明显黑便，，患者行胃镜检查示：食管上段、贲门处占位，，病理示：低分化腺癌；，免疫组化结果显示:CK5/6(－),P63(－),CK8/18(+),CK7(+)。后行2次术前新辅助化疗，方案为奥沙利铂+替吉奥。患者于2012年11月29日在全麻上行经腹食管胃交界腺癌根治术，，术后病理回报：（食管胃交界腺癌化疗后）食管及胃交界部低分化腺癌，癌灶散在分布，直径0.2－0.5CM，侵及深肌层，癌细胞变性显著（约70％），肿瘤退缩分级（TRG），：1级，未见脉管癌栓；淋巴结未见癌转移（胃周0/2、胃小弯侧0/0、食管胃交界处0/3、大弯侧0/1)，食管和胃断端未见癌，网膜组织未见特殊；，肿瘤病理分期：YPT2NOM0G3 IIA期。患者自发病以来，饮食睡眠好，体重无减轻；患者体重无明显减轻。", "entities": [{"end_pos": 21, "label_type": "解剖部位", "overlap": 0, "start_pos": 18}, {"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"end_pos": 150, "label_type": "药物", "overlap": 0, "start_pos": 146}, {"end_pos": 154, "label_type": "药物", "overlap": 0, "start_pos": 151}, {"end_pos": 186, "label_type": "手术", "overlap": 0, "start_pos": 174}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 195, "end_pos": 219}, {"end_pos": 292, "label_type": "解剖部位", "overlap": 0, "start_pos": 291}, {"end_pos": 301, "label_type": "解剖部位", "overlap": 0, "start_pos": 297}, {"end_pos": 310, "label_type": "解剖部位", "overlap": 0, "start_pos": 305}, {"end_pos": 318, "label_type": "解剖部位", "overlap": 0, "start_pos": 315}, {"end_pos": 325, "label_type": "解剖部位", "overlap": 0, "start_pos": 323}, {"end_pos": 327, "label_type": "解剖部位", "overlap": 0, "start_pos": 326}]}
{"originalText": "，缘于入7月余于我院诊断为胃窦癌，于2016年04月08日在全麻上行腹腔镜辅助上根治性远端胃大部切除术，手术顺利，术后病理（201611241），：(远端胃)，：胃窦溃疡型黏液腺癌，部分为低黏附性癌（印戒细胞癌及未分化癌为主），侵犯脉管及神经组织，脉管内见癌栓，侵出浆膜层。手术标本下切端，上切端及另送(下切端)均未见癌浸润。找到小弯侧淋巴结10/19个，大弯侧淋巴结12/13个，幽门下淋巴结5/8个，幽门上淋巴结6/8个，及另送(胃右动脉根部）淋巴结1/6个，见癌转移。网膜结节为副脾组织。胃壁见异位胰腺组织，胰岛细胞增生。，免疫组化染色结果示：CK(PAN)（+++），HER-2（-），KI67（50%阳性），CD56（-），SY（-），CGA（-），E-CADHERIN（++）。术后给予对症、抗感染治疗，恢复良好,伤口愈合II/甲。分别于2016.05.05、2016.05.25、2016.06.17、2016.07.11、2016.08.07、2016.09.05、2016.10.04行“伊利替康200MGIVGTTD1+替吉奥60MGPOBIDD1-14”方案化疗，现为行第8次化疗再次就诊我院，门诊拟“胃窦癌（PT4AN3BM0IIIC期）术后化疗”收入院。自下次出院后饮食、睡眠可，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 13, "end_pos": 16}, {"end_pos": 51, "label_type": "手术", "overlap": 0, "start_pos": 34}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 74, "end_pos": 90}, {"end_pos": 171, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"end_pos": 184, "label_type": "解剖部位", "overlap": 0, "start_pos": 178}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 191}, {"end_pos": 208, "label_type": "解剖部位", "overlap": 0, "start_pos": 202}, {"end_pos": 227, "label_type": "解剖部位", "overlap": 0, "start_pos": 216}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 249, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"end_pos": 254, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 259, "label_type": "解剖部位", "overlap": 0, "start_pos": 257}, {"end_pos": 457, "label_type": "药物", "overlap": 0, "start_pos": 453}, {"end_pos": 473, "label_type": "药物", "overlap": 0, "start_pos": 470}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 512, "end_pos": 533}, {"end_pos": 555, "label_type": "解剖部位", "overlap": 0, "start_pos": 554}, {"end_pos": 558, "label_type": "解剖部位", "overlap": 0, "start_pos": 557}]}
{"originalText": "入院前2+月，患者因“乙状结肠肿瘤”于我科住院治疗，完善相关检查于2014年7月10日在全麻上行腹腔镜上乙状结肠癌根治术，术后病理诊断：乙状结肠粘液性腺癌（中分化）侵及粘膜上浅肌层，双侧切缘未见癌累及，肠系膜淋巴结见癌累及（1/7），术后给予止血、补液、抗感染、营养支持、护胃等治疗，术后恢复可，复查血常规、肝肾功、电解质未见明显异常。患者病情恢复顺利，无特殊不适，切口甲级愈合，好转出院。目前患者无恶心、呕吐、腹痛、腹胀、便血等表现，遵医嘱今日入我院，拟行第3次化疗，故以\\\"乙状结肠癌术后第3次化疗\\\"收入我科住院治疗。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 11, "end_pos": 17}, {"end_pos": 60, "label_type": "手术", "overlap": 0, "start_pos": 48}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 68, "end_pos": 82}, {"end_pos": 107, "label_type": "解剖部位", "overlap": 0, "start_pos": 101}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 137}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 154, "end_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 155, "end_pos": 156}, {"end_pos": 207, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 209}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 239, "end_pos": 246}]}
{"originalText": "，2017-10-25在手术室行开腹根治性乙状结肠切除术。，术后病理：（乙状结肠血管根部淋巴结乙状结肠）?XXXXXX结肠隆起型中分化腺癌，大小3×XXX2.5CM?XXXXXX侵及浆膜上纤维脂肪组织?XXXXXX未见脉管癌栓及神经侵犯?XXXXXX双断端未见癌?XXXXXX淋巴结可见癌转移（肠周1/14、乙状结肠血管根部0/0） ，肿瘤病理分期：PT3N1A； - ，免疫组化结果显示:BRAF(－),CMET(1+),EGFR(2+),HER2(0),KI-67(+＞75%),MLH1(+),MSH2(+),MSH6(+),PMS2(+)。", "entities": [{"end_pos": 28, "label_type": "手术", "overlap": 0, "start_pos": 16}, {"end_pos": 148, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 154}]}
{"originalText": "，患者因“结肠癌并肺转移”于2014-07-17在我院行姑息性左半结肠切除术，术中输血2U，切除标本送病理，输液、预防感染及静脉营养等对症支持治疗。病理诊断（201410878），:左半结肠腺癌（中度分化），浸润溃疡型，体积2.7*2.6*0.6CM，侵达外膜脂肪组织。双端切线未查见癌。肠壁一站（8个）、二站（7个）、中央组（1个）、中间组（11个）淋巴结未查见癌。，免疫组化染色示：ERCC1弥漫（+）、TS（-）。根据肿瘤病理分期（T3N0M1 IV期)。现患者为行进一步复查并必要时适当处理而再来我院就诊，门诊依情以“结肠术后”收入院。目前患者精神及情绪状态良好，食欲、饮食好，夜间睡眠后；近期无明显体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 5, "end_pos": 12}, {"end_pos": 38, "label_type": "手术", "overlap": 0, "start_pos": 28}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 91, "end_pos": 109}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 263, "end_pos": 267}]}
{"originalText": "缘于入院前1月于我院诊为“直肠癌”，于2013.12.11在我科行“腹腔镜上直肠癌根治术DIXON”，术中见腹腔内无明显腹水，肿物位于腹膜反折处，大小约2.5×2CM，可疑侵及浆膜层，周围见少许肿大淋巴结。术顺，术毕安返病房，予以预防感染、补液、营养支持、调节免疫等治疗。术后病理（201336679）示：（直肠）大肠溃疡型管状腺癌II级，部分为粘液腺癌，侵出外膜层，外膜面见癌结节形成，手术标本双切端及另送（下切端）、（上切端）均未见癌浸润。找到肿物周淋巴结1/7个，肠周淋巴结2/7个见癌转移。另送（肠系膜上动脉根部淋巴结）为脂肪、脉管及神经组织。术后恢复良好出院。此次为化疗再次就诊我院，门诊拟“直肠癌术后”收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 13, "end_pos": 16}, {"end_pos": 50, "label_type": "手术", "overlap": 0, "start_pos": 34}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 153, "end_pos": 169}, {"end_pos": 240, "label_type": "解剖部位", "overlap": 0, "start_pos": 235}, {"end_pos": 263, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 301, "end_pos": 306}, {"end_pos": 329, "label_type": "解剖部位", "overlap": 0, "start_pos": 328}, {"end_pos": 332, "label_type": "解剖部位", "overlap": 0, "start_pos": 331}]}
{"originalText": "，患者于患者于2月前于我院诊断为：结肠腺癌，在腹腔镜上结肠肿瘤切除术。，术后病理提示：左半结肠）溃疡型中分化腺癌，侵及肠壁全层，双切端未见癌累及，脉管内见癌栓，肠壁淋巴结见癌转移（2/15）。阑尾未见癌转移。1月前行第一次化疗，化疗后无发热，无恶心呕吐，无腹痛腹泻等不适。拟入院行第2次静脉化疗。\\U0004   患者发病以来，神志 清晰，精神可，胃纳可，大便如常，小便如常，体重未见明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 17, "end_pos": 21}, {"end_pos": 34, "label_type": "手术", "overlap": 0, "start_pos": 23}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 43, "end_pos": 56}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 59, "end_pos": 60}, {"end_pos": 85, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"end_pos": 129, "label_type": "解剖部位", "overlap": 0, "start_pos": 128}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"end_pos": 175, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}]}
{"originalText": "患者于2004年4月份在本院行右乳癌改良根治术,术后病理诊为:右乳腺浸润性导管癌,淋巴结10/11(+),PT3N3M0,IIIC期,ER(+),PR(-),HER-2(-),KI67(+++).术后以FEC方案化疗4程,之后行放疗.2004年9月份开始行TAM治疗,2004年12月加用雷诺得,2007年9月行卵巢去势手术,改瑞宁得治疗.2010年4月份发现骨转移(右股骨代谢活跃)行右股骨姑息性放疗.2011年初发现肺肝淋巴结等转移,行多西他赛化疗程4程后评价PD,改GX2程,肝病灶PD,行NP方案化疗6程,评价SD.后于2012年5月始使用替加氟治疗.复查CT示肝转移灶进展(2012年5月11日肝脏数个低密度灶4×4MM-9×9MM,2012年9月21肝数个低密度灶最大33×24MM).于2012-10-22以“泰素+顺铂”方案化疗一程。为进一步治疗入院.精神,睡眠,食欲欠佳,大小便正常.体重无明显变化.。", "entities": [{"end_pos": 23, "label_type": "手术", "overlap": 0, "start_pos": 15}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 31, "end_pos": 40}, {"end_pos": 147, "label_type": "药物", "overlap": 0, "start_pos": 144}, {"end_pos": 162, "label_type": "手术", "overlap": 0, "start_pos": 156}, {"end_pos": 167, "label_type": "药物", "overlap": 0, "start_pos": 164}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 180, "end_pos": 183}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 196, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"end_pos": 211, "label_type": "解剖部位", "overlap": 0, "start_pos": 210}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 224, "label_type": "药物", "overlap": 0, "start_pos": 220}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 241}, {"end_pos": 277, "label_type": "药物", "overlap": 0, "start_pos": 274}, {"label_type": "影像检查", "overlap": 0, "start_pos": 282, "end_pos": 284}, {"end_pos": 286, "label_type": "解剖部位", "overlap": 0, "start_pos": 285}, {"end_pos": 304, "label_type": "解剖部位", "overlap": 0, "start_pos": 302}, {"end_pos": 332, "label_type": "解剖部位", "overlap": 0, "start_pos": 331}, {"end_pos": 364, "label_type": "药物", "overlap": 0, "start_pos": 362}, {"end_pos": 367, "label_type": "药物", "overlap": 0, "start_pos": 365}]}
{"originalText": "，缘于入院前2月（2013.08.16）因“子宫内膜混合型腺癌”就诊我科行“盆腔粘连松解+筋膜外全子宫+两附件切除+盆腔淋巴结清扫术”。术顺，，术后病理回报：宫体混合型腺癌（80％为II型透明细胞腺癌，20％为I型子宫内膜样腺癌），侵及浅肌层，未侵犯宫颈组织学内口；余未示明显异常。，免疫组化表达：KI67（40%+），ER（-），PR（-）。术后恢复可，腹部切口II/甲愈合。术后于2013.8.29,2013.09.22予以“多西他赛140MGIVGTTDL+洛铂50MGIVGTTDL”方案行术后辅助化疗2次，化疗过程顺利，化疗后复查血常规、肝肾功能均未示明显异常，好转出院。出院期间未定期复查血常规、肝肾功能。现为进一步化疗，就诊我院，门诊拟“子宫内膜腺癌IA期术后”收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 22, "end_pos": 31}, {"label_type": "手术", "overlap": 0, "start_pos": 38, "end_pos": 66}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 79, "end_pos": 115}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"end_pos": 180, "label_type": "解剖部位", "overlap": 0, "start_pos": 178}, {"end_pos": 219, "label_type": "药物", "overlap": 0, "start_pos": 215}, {"end_pos": 234, "label_type": "药物", "overlap": 0, "start_pos": 232}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 274, "end_pos": 275}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 275, "end_pos": 276}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 304, "end_pos": 305}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 305, "end_pos": 306}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 326, "end_pos": 337}, {"end_pos": 360, "label_type": "解剖部位", "overlap": 0, "start_pos": 359}, {"end_pos": 363, "label_type": "解剖部位", "overlap": 0, "start_pos": 362}]}
{"originalText": "，患者因罹患“直肠腺癌”于2016-09-13在我院予行全麻上直肠肿瘤切除术，，术中见：腹腔内无腹水，腹膜无转移，肝脏正常。肿物位于腹膜返折下方，直肠与乙状结肠交界处，约2.5*2.5*1CM大小，肿瘤未侵出浆膜，直肠系膜根部未触及明显肿大淋巴结，肿瘤尚活动。决定行DIXON手术。手术病理(0400.2013），示：直肠腺癌（中度分化），浸润溃疡型，体积约5×4×1.2CM，侵达外膜。双端切线未查见癌。肠壁二站（4个）、中央组（2个）淋巴结未查见癌。免疫组化染色示ERCC（-）、TS(-)。术后行3周期辅助化疗，同时辅以镇吐、升血、免疫调节等对症支持治疗。化疗过程总体顺利,病情稳定出院。现患者为行复查并辅助化疗而再来我院就诊，门诊依情以“直肠癌术后”收入院。自下次出院以来，患者一般情况保持良好；无发热，无恶心、呕吐，无反酸、嗳气，无明显进食不适，未现明显腹痛、腹胀。目前患者精神及情绪状态良好，食欲、饮食好，夜间睡眠后；近期无明显体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 7, "end_pos": 11}, {"end_pos": 38, "label_type": "手术", "overlap": 0, "start_pos": 28}, {"end_pos": 46, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"end_pos": 49, "label_type": "解剖部位", "overlap": 0, "start_pos": 48}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 51, "end_pos": 52}, {"end_pos": 59, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"end_pos": 113, "label_type": "解剖部位", "overlap": 0, "start_pos": 107}, {"end_pos": 140, "label_type": "手术", "overlap": 0, "start_pos": 133}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 159, "end_pos": 175}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 203, "end_pos": 222}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 323, "end_pos": 328}, {"end_pos": 383, "label_type": "解剖部位", "overlap": 0, "start_pos": 382}, {"end_pos": 386, "label_type": "解剖部位", "overlap": 0, "start_pos": 385}]}
{"originalText": "，患者于今年8月初开始无明显诱因出现呕吐，伴嗳气，于外院行胃镜检查示“中段距门齿26-29㎝处后壁见一菜花状新生物，胃角见一3×2.5㎝溃疡”。病理“食管中段鳞状细胞癌；胃角低分化腺癌”。为进一步诊治来我院就诊。2016年8月25日行“贲门癌根治（全胃切除）+胰腺体尾部切除+脾切除术”，术中探查“肿瘤位于胃体小弯侧部，大小约8*7CM，向下侵犯胃底贲门及食管上段2CM，向后侵犯胰腺体部及尾部，脾门淋巴结多发肿大”。术后病理示“（胃大体）镜检为低分化腺癌，部分为印戒细胞癌，伴较多粘液分泌，LAUREN，分型：弥漫型，癌组织侵犯至胃壁浆膜层及食管外膜层，可见多量脉管内癌栓及神经束侵犯；另可见3枚淋巴结，其中2枚见腺癌转移，另1枚见鳞状细胞癌转移。（近切缘），镜上：食管粘膜组织中见一小团核异型的细胞，核偏位，胞浆有粘液，符合腺癌细胞浸润，经重新切片观察已未能找到该团细胞。56/69LN(+)”。分期PT4BN3BM0 IIIC期。然后转至我科，排除化疗禁忌症，于2016-09-30按“奥沙利铂200MG D1+替吉奥60MGBID D1-14”方案行第1程化疗，过程顺利。今患者按约回院继续化疗。入院时患者无呕吐、嗳气，睡眠、精神、食欲可，大小便正常，体重上降约1KG。", "entities": [{"end_pos": 40, "label_type": "解剖部位", "overlap": 0, "start_pos": 38}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 75, "end_pos": 84}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 85, "end_pos": 92}, {"label_type": "手术", "overlap": 0, "start_pos": 118, "end_pos": 142}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"end_pos": 182, "label_type": "解剖部位", "overlap": 0, "start_pos": 178}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 190}, {"end_pos": 203, "label_type": "解剖部位", "overlap": 0, "start_pos": 198}, {"end_pos": 217, "label_type": "解剖部位", "overlap": 0, "start_pos": 216}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 223, "end_pos": 228}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 232, "end_pos": 237}, {"end_pos": 271, "label_type": "解剖部位", "overlap": 0, "start_pos": 266}, {"end_pos": 274, "label_type": "解剖部位", "overlap": 0, "start_pos": 272}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 308, "end_pos": 310}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 317, "end_pos": 322}, {"end_pos": 338, "label_type": "解剖部位", "overlap": 0, "start_pos": 334}, {"end_pos": 450, "label_type": "药物", "overlap": 0, "start_pos": 446}, {"end_pos": 462, "label_type": "药物", "overlap": 0, "start_pos": 459}]}
{"originalText": "，患者因左侧结肠癌于2013-8-9在全麻上予行左半结肠切除术；相关手术病理（9929.2013），已回：结肠腺癌（中低度分化），部分呈粘液腺癌图像，侵润溃疡型，面积8*7CM，侵穿浆膜。少数脉管内查见癌栓，局部侵犯神经。双端切线未查见癌。呈肠壁一站（7/8个）、二站（1/3个）、中间组（1/2个）淋巴结癌转移。肠壁三站（2个）淋巴结未查见癌。，免疫组化染色示癌组织：ERCC1（+）、TS（-）。结合患者病情及肿瘤病理与分期继续予行术后化疗相关辅助治疗指征存在；依情已行4周期化疗，，具体用药为：奥沙利铂200MG D1+亚叶酸钙0.3G D2-6 +替加氟1000MG D2-6 静滴，同时辅以镇吐、升血、免疫调节等对症支持治疗（化疗期间患者总体耐受性良好）。自第下次化疗结束出院以来，患者未诉明显不适，一般情况保持良好；无发热，无恶心、呕吐，无反酸、嗳气，无明显进食不适，未现明显腹痛、腹胀。为行进一步复查并必要时适当处理而再来我院就诊，门诊依情以“结肠术后”收入院。目前患者精神及情绪状态良好，食欲、饮食好，夜间睡眠后；近期无明显体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 4, "end_pos": 9}, {"end_pos": 31, "label_type": "手术", "overlap": 0, "start_pos": 24}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 53, "end_pos": 64}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 68, "end_pos": 72}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 153}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 157, "end_pos": 168}, {"end_pos": 254, "label_type": "药物", "overlap": 0, "start_pos": 250}, {"end_pos": 267, "label_type": "药物", "overlap": 0, "start_pos": 263}, {"end_pos": 281, "label_type": "药物", "overlap": 0, "start_pos": 278}, {"end_pos": 395, "label_type": "解剖部位", "overlap": 0, "start_pos": 394}, {"end_pos": 398, "label_type": "解剖部位", "overlap": 0, "start_pos": 397}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 429, "end_pos": 433}]}
{"originalText": "，缘于入院前2月在我院确诊为胃癌，于2014年06月18日在全麻上行“剖腹探查+胃窦肿物活检术+胃空肠吻合术”，术顺，术后病理（201419201），提示：1、（胃壁）间质瘤，肿瘤最大径约0.8CM，镜上为梭形细胞为主型，未见显著异型性，核分裂像4/50HPF，危险程度极低。，免疫组化结果：CD34（+++），DOG1（+++），CD117（+++），P53（++），ACTIN(SM)（-），DESMIN（-），S100（-），KI67（8%+）。（瘤结周边仅见少量平滑肌组织，无法判断肿瘤浸润范围及切缘情况，请结合术中所见）2、（胃窦体）胃浸润型低分化腺癌，部分向神经内分泌方向分化，侵及浆膜层。，免疫组合结果：CK(L)（+++），CD68（-），CGA（-），CD56（+），SY（++），KI67（40%+）。术后给予对症、补液治疗，恢复良好,伤口愈合II/甲。2014-07-28以“奥沙利铂150MGD1+紫杉醇150MGD2+替吉奥胶囊(艾奕)40.00MGBID*7D”方案化疗1次，并辅以止吐、制酸、保胃保肝等对症处理，化疗过程顺利。此次为化疗再次入院。门诊拟“胃癌、胃空肠吻合术后”收入院。自下次出院后精神、饮食、睡眠可，无腹痛、腹胀、发热，二便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"label_type": "手术", "overlap": 0, "start_pos": 35, "end_pos": 54}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 80, "end_pos": 87}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 267, "end_pos": 281}, {"end_pos": 403, "label_type": "药物", "overlap": 0, "start_pos": 399}, {"end_pos": 414, "label_type": "药物", "overlap": 0, "start_pos": 411}, {"end_pos": 427, "label_type": "药物", "overlap": 0, "start_pos": 422}, {"end_pos": 430, "label_type": "药物", "overlap": 0, "start_pos": 428}, {"end_pos": 463, "label_type": "解剖部位", "overlap": 0, "start_pos": 462}, {"end_pos": 465, "label_type": "解剖部位", "overlap": 0, "start_pos": 464}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 492, "end_pos": 502}, {"end_pos": 525, "label_type": "解剖部位", "overlap": 0, "start_pos": 524}, {"end_pos": 528, "label_type": "解剖部位", "overlap": 0, "start_pos": 527}]}
{"originalText": "，缘于入院前5个月余因胃癌，于2015年02月15日在我院行“腹腔镜辅助上根治性远端胃大部切除术（D2）”，手术顺利。，术后病理：（远端胃），：胃窦隆起型粘液腺癌，侵及深肌层，脉管内见癌栓，手术标本下切端、上切端及另送（下切端）均未见癌浸润；找到小弯淋巴结1/22个，大弯淋巴结0/20个，幽门下淋巴结4/7个，幽门上淋巴结1/8个，及另送（胃右动脉根部）淋巴结0/10个见癌转移。于2015.05.15、2015.06.07行“奥沙利铂200MG静滴D1+卡培他滨片(希罗达)1500MG口服BIDD1-14”方案化疗第1、2周期，化疗过程顺利，此次为行第3周期化疗再次入院。患者出院后饮食、睡眠可，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 11, "end_pos": 13}, {"label_type": "手术", "overlap": 0, "start_pos": 31, "end_pos": 52}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 65, "end_pos": 81}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"end_pos": 162, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"end_pos": 219, "label_type": "药物", "overlap": 0, "start_pos": 215}, {"end_pos": 234, "label_type": "药物", "overlap": 0, "start_pos": 229}, {"end_pos": 238, "label_type": "药物", "overlap": 0, "start_pos": 235}, {"end_pos": 303, "label_type": "解剖部位", "overlap": 0, "start_pos": 302}, {"end_pos": 306, "label_type": "解剖部位", "overlap": 0, "start_pos": 305}]}
{"originalText": "，患者于4月余前入院，诊为结肠癌，于2015-08-11在全麻上行腹腔镜上左半结肠姑息性切除术，，术中见：腹腔内有淡黄色腹水约200ML，肿瘤位于升结肠中段，明显侵出浆膜面，形成不完全梗阻，近端肠管明显增厚扩张，周围可见数个肿大淋巴结，盆腔内可见多个绿豆大小的种植转移病灶，遂行下术，术顺。术后病理示(左半结肠)，：结肠溃疡型管状腺癌II级，侵出外膜层，侵犯神经组织，手术标本双切端及另送(近切端)、(远切端)均未见癌浸润。找到回肠周淋巴结0/5个、结肠周淋巴结5/22个，及另送(回结肠动脉根部）淋巴结0/3个，见癌转移。阑尾组织。，免疫组化：CK18（+++），CGA（-），CD56（-），SY（-），KI67（60%）。该病例未检测到KRAS基因12、13号密码子热点突变。该病例未检测到BRAF基因V600E突变，术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。2015.08.28、2015.09.23、2015.10.21、2015.11.12、2015.12.06行“奥沙利铂200MGIVGGTD1+希罗达1500MGPOBIDD1-14”方案化疗，辅以保胃、保肝、止吐、增强免疫、营养补液等治疗。过程顺利，未见明显化疗副反应。此次为化疗再次入院。门诊拟以“升结肠癌伴腹腔种植（PT4BN2AM1IV期)术后化疗”收入院，患者出院后饮食、夜休可，无腹痛、腹胀、发热，体重无明显改变。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 13, "end_pos": 16}, {"label_type": "手术", "overlap": 0, "start_pos": 33, "end_pos": 47}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 53}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 99, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 150, "end_pos": 170}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 214}, {"end_pos": 231, "label_type": "解剖部位", "overlap": 0, "start_pos": 225}, {"end_pos": 252, "label_type": "解剖部位", "overlap": 0, "start_pos": 240}, {"end_pos": 264, "label_type": "解剖部位", "overlap": 0, "start_pos": 262}, {"end_pos": 451, "label_type": "药物", "overlap": 0, "start_pos": 447}, {"end_pos": 467, "label_type": "药物", "overlap": 0, "start_pos": 464}, {"end_pos": 493, "label_type": "解剖部位", "overlap": 0, "start_pos": 492}, {"end_pos": 496, "label_type": "解剖部位", "overlap": 0, "start_pos": 495}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 543, "end_pos": 568}, {"end_pos": 589, "label_type": "解剖部位", "overlap": 0, "start_pos": 588}, {"end_pos": 592, "label_type": "解剖部位", "overlap": 0, "start_pos": 591}]}
{"originalText": "，患者因\\\"阴道不规则流血持续1月余，外院诊刮病理示宫颈癌10天\\\"入院，入院完善各项检查，无明显手术禁忌症，于2012.5.31在在全麻上行“II广泛性全子宫两附件切除术+盆腔淋巴结清扫术+腹主动脉旁淋巴结取样术”，，术中探查：无明显腹水。肝膈面、肝表面、胰、脾、胃、两肾、大小肠、大网膜未扪及明显异常，盆腔及腹主动脉旁可触及增大淋巴结，子宫增大，约10*8*7CM大小，水肿，宫颈膨大，约5*4*4CM大小，两附件外观正常。术后予以抗炎、对症等处理，患者恢复好。，术后病理结果示：中分化鳞状细胞癌，癌组织浸润宫颈至深肌层，并累及宫体上段至浅肌层，脉管内见癌栓，左闭孔淋巴结见鳞癌。有放化指征，经患者及家属充分知情同意，已入组5010计划，经随机抽签为序贯放化疗组（C组）。2012-06-08予以TP方案（紫杉醇240MG+DDP50MGD1-2）化疗一疗程。后于2012-7-24至2012-8-28行原发灶和转移灶放疗，45GY。今遵主诊教授意见前来化疗。患者发病以来饮食睡眠不佳,大小便正常，体重无减轻。", "entities": [{"end_pos": 8, "label_type": "解剖部位", "overlap": 0, "start_pos": 6}, {"end_pos": 28, "label_type": "解剖部位", "overlap": 0, "start_pos": 26}, {"end_pos": 86, "label_type": "手术", "overlap": 0, "start_pos": 72}, {"end_pos": 95, "label_type": "手术", "overlap": 0, "start_pos": 87}, {"end_pos": 107, "label_type": "手术", "overlap": 0, "start_pos": 96}, {"end_pos": 119, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 124, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"end_pos": 130, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"end_pos": 132, "label_type": "解剖部位", "overlap": 0, "start_pos": 131}, {"end_pos": 134, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"end_pos": 137, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"end_pos": 141, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"end_pos": 145, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"end_pos": 155, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"end_pos": 169, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 170}, {"end_pos": 192, "label_type": "解剖部位", "overlap": 0, "start_pos": 190}, {"end_pos": 209, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"end_pos": 258, "label_type": "解剖部位", "overlap": 0, "start_pos": 256}, {"end_pos": 268, "label_type": "解剖部位", "overlap": 0, "start_pos": 266}, {"end_pos": 277, "label_type": "解剖部位", "overlap": 0, "start_pos": 275}, {"end_pos": 288, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"end_pos": 358, "label_type": "药物", "overlap": 0, "start_pos": 355}, {"end_pos": 367, "label_type": "药物", "overlap": 0, "start_pos": 364}]}
{"originalText": "患者近双月前因“右下腹疼痛3日”入院，肠镜检查示结肠脾曲癌，胸部CT考虑肺部转移，于2010.09.15在联合麻醉上行姑息性右半结肠切除术，术后病理示“（结肠）溃疡型腺癌，分化II级，浸润全层及周围脂肪组织，双切缘未见癌累及。检出肠旁淋巴结14枚，均未见癌转移”。患者术后恢复可，10-6、11-3行双次化疗，方案为：乐沙定 200MG，同澳200MG，替加氟1G，D1；5% GW 140ML+替加氟 3.0，化疗泵，无特殊不适。现为行第三次化疗收治入院。发病以来患者神清精神可，胃纳二便睡眠正常，体重无明显改变。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 8}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 24, "end_pos": 29}, {"label_type": "影像检查", "overlap": 0, "start_pos": 30, "end_pos": 34}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 36, "end_pos": 40}, {"end_pos": 69, "label_type": "手术", "overlap": 0, "start_pos": 59}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 76, "end_pos": 91}, {"end_pos": 120, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 162, "label_type": "药物", "overlap": 0, "start_pos": 159}, {"end_pos": 171, "label_type": "药物", "overlap": 0, "start_pos": 169}, {"end_pos": 180, "label_type": "药物", "overlap": 0, "start_pos": 177}, {"end_pos": 192, "label_type": "药物", "overlap": 0, "start_pos": 186}, {"end_pos": 201, "label_type": "药物", "overlap": 0, "start_pos": 198}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 241}]}
{"originalText": "，缘于入院前2月因确诊为胃癌，于2014年04月28日在全麻上行腹腔镜辅助上姑息性全胃切除术（D2）。手术顺利。术后病理（病理号201412821），：(全胃)胃-食管交界溃疡型腺神经内分泌癌（G3），累及齿状线，脉管内见癌栓，侵出浆膜外，浆膜外见癌结节，手术标本下切端、上切端及另送(下切端)均未见癌浸润。找到手术标本小弯淋巴结8个，幽门上淋巴结6个，(第7组）淋巴结9个，(第8组）淋巴结1个，(第11组）淋巴结3个及(第12组）淋巴结1个均未见癌转移。手术标本贲门右、贲门左、大弯侧、幽门下均未查见淋巴结。送检(第9组淋巴结)镜上为脉管组织、纤维组织、平滑肌组织、神经组织、脂肪组织及脉管组织。，免疫组化：CD56（+），SY（++），CGA（+），CK18（+++），KI67（35%+），CDX-2（+）。术顺，术后恢复良好,排除化疗禁忌后，于2014.06.01予“奥沙利铂（艾恒）150MGD1+里葆多40MGD2+替吉奥40MGBIDD1-14_”方案化疗1次，过程中患者稍有恶心、呕吐，尚可耐受，予对症处理后症状明显好转出院，此次为化疗再次入院。门诊拟“胃癌术后化疗后”收住入院，出院后饮食、夜休可，大小便如常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 12, "end_pos": 14}, {"label_type": "手术", "overlap": 0, "start_pos": 32, "end_pos": 50}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 76, "end_pos": 100}, {"end_pos": 165, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"end_pos": 174, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"end_pos": 236, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"end_pos": 240, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 241}, {"end_pos": 247, "label_type": "解剖部位", "overlap": 0, "start_pos": 245}, {"end_pos": 393, "label_type": "药物", "overlap": 0, "start_pos": 389}, {"end_pos": 396, "label_type": "药物", "overlap": 0, "start_pos": 394}, {"end_pos": 408, "label_type": "药物", "overlap": 0, "start_pos": 405}, {"end_pos": 418, "label_type": "药物", "overlap": 0, "start_pos": 415}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 486, "end_pos": 490}]}
{"originalText": "，缘于入院前2年因“右肝内肝内胆管癌”于我院行“右半肝联合尾状叶切除+胆总管切除+左前、左后胆肠吻合+腹腔淋巴结清扫+腹腔粘连松解+腹壁肿物切除术”，术中输悬浮红细胞4U，血浆400ML，术后恢复尚可，定期复查腹部CT，，术后病理示：1.（右半肝），：肝中分化胆管细胞癌。2.（右门Ⅴ）送检脂肪、纤维组织中见胆管细胞癌浸润。，免疫组化:CK19(+++)、CK7(+++)、CK20(-)、CDX-2(++)、VILLIN(+++)。出院后无纳差、腹胀、腹泻，无返酸，嗳气，无恶心、呕吐，无发热、寒战及黄疸。20，余天前于我院门诊复查MRI示：肝左叶近膈面浸润性病变伴肝内胆管扩张，考虑为肝内胆管癌。13天前于我院行TACE，共灌注碘化油8ML＋表柔吡星40MG＋洛铂30MG＋栓塞微球(300-500UM)1支，术后出现发热，体温最高达38.9℃，伴畏冷、腹痛，考虑介入术后反应剧烈，治疗好转后出院。今为进一步治疗，门诊拟“右肝内肝内胆管癌术后复发”收住入院。自下次出院以来，精神、睡眠、食欲欠佳，大、小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 18}, {"label_type": "手术", "overlap": 0, "start_pos": 24, "end_pos": 73}, {"label_type": "影像检查", "overlap": 0, "start_pos": 105, "end_pos": 109}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 119, "end_pos": 135}, {"end_pos": 142, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 154, "end_pos": 159}, {"end_pos": 225, "label_type": "解剖部位", "overlap": 0, "start_pos": 224}, {"end_pos": 228, "label_type": "解剖部位", "overlap": 0, "start_pos": 227}, {"label_type": "影像检查", "overlap": 0, "start_pos": 267, "end_pos": 270}, {"end_pos": 278, "label_type": "解剖部位", "overlap": 0, "start_pos": 272}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 284, "end_pos": 290}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 294, "end_pos": 299}, {"end_pos": 312, "label_type": "手术", "overlap": 0, "start_pos": 308}, {"end_pos": 319, "label_type": "药物", "overlap": 0, "start_pos": 316}, {"end_pos": 327, "label_type": "药物", "overlap": 0, "start_pos": 323}, {"end_pos": 334, "label_type": "药物", "overlap": 0, "start_pos": 332}, {"end_pos": 343, "label_type": "药物", "overlap": 0, "start_pos": 339}, {"end_pos": 380, "label_type": "解剖部位", "overlap": 0, "start_pos": 379}, {"label_type": "手术", "overlap": 0, "start_pos": 384, "end_pos": 387}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 413, "end_pos": 423}]}
{"originalText": "，缘于5月余前因“胃癌”行“腹腔镜上根治性远端胃大部切除术”（2015-08-06），，术中见：腹腔内无明显腹水，盆腔、腹壁、大网膜未见明显转移结节，肝脏质地大小正常，未见明显肿物，胆囊无肿大。胃体小弯侧隐约可见病灶，可疑浸润型癌侵及浆膜层，周围见肿大淋巴结。术顺，术后恢复可。术后病理（201528816），：(远端胃)，：胃体小弯溃疡型低粘附性癌，部分为印戒细胞癌，侵及浆膜层。手术标本下、上切端及另送（下切端）均未见癌浸润。找到小弯淋巴结25/25个，大弯淋巴结3/9个，幽门下淋巴结2/2个，幽门上淋巴结6/6个，及另送(第8组)淋巴结1/1个，(第12组)淋巴结1/1个，见癌转移。，免疫组化：KI67（10%+），CK7（-），CK20（+++），VILLIN（+++），CDX-2（+++），CEA（+++），CD56（-），CGA（-），SYN（-），E-CADHERIN（++），HER-2（+），PT4AN3M0IIIC期。排除化疗前禁忌，于2015.09.23、2015.10.26按“卡培他滨片(希罗达)1500MG口服BID+多柔比星脂质体(里葆多)注40MG静滴(基)+奥沙利铂(乐沙定)200MG静滴”方案化疗，2015.12.23予“艾奕60MG口服D1-14+艾恒200MGD1+里葆多40MG静滴D1方案”化疗，并辅以止吐、制酸、保肝、增强免疫等治疗。化疗过程顺利，无明显化疗不良反应。今为返院行第4周期化疗就诊我院，门诊拟以“胃癌术后化疗”收入院。自发病以来，精神、睡眠、食欲尚可，大小便正常，体征无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 9, "end_pos": 11}, {"end_pos": 29, "label_type": "手术", "overlap": 0, "start_pos": 14}, {"end_pos": 50, "label_type": "解剖部位", "overlap": 0, "start_pos": 48}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 59, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 62, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"end_pos": 102, "label_type": "解剖部位", "overlap": 0, "start_pos": 97}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 156, "end_pos": 175}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 179, "end_pos": 184}, {"end_pos": 222, "label_type": "解剖部位", "overlap": 0, "start_pos": 217}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 239}, {"end_pos": 256, "label_type": "解剖部位", "overlap": 0, "start_pos": 250}, {"end_pos": 459, "label_type": "药物", "overlap": 0, "start_pos": 454}, {"end_pos": 463, "label_type": "药物", "overlap": 0, "start_pos": 460}, {"end_pos": 483, "label_type": "药物", "overlap": 0, "start_pos": 476}, {"end_pos": 487, "label_type": "药物", "overlap": 0, "start_pos": 484}, {"end_pos": 503, "label_type": "药物", "overlap": 0, "start_pos": 499}, {"end_pos": 507, "label_type": "药物", "overlap": 0, "start_pos": 504}, {"end_pos": 535, "label_type": "药物", "overlap": 0, "start_pos": 533}, {"end_pos": 549, "label_type": "药物", "overlap": 0, "start_pos": 547}, {"end_pos": 560, "label_type": "药物", "overlap": 0, "start_pos": 557}, {"end_pos": 585, "label_type": "解剖部位", "overlap": 0, "start_pos": 584}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 632, "end_pos": 636}]}
{"originalText": "患者因“直肠癌”于2014-06-05 在我院于全麻上行直肠癌根治术（DIXON术），手术过程顺利，术后给予抗感染及营养支持治疗，患者恢复好，切口愈合良好。现患者为术后复查来我院就诊。院外期间患者一般情况好，无恶心，无腹痛腹胀胀不适，现患者为行复查及化疗再次来院就诊，门诊以“直肠癌术后”收入院。近期患者精神可，饮食可，大便次数多，小便正常，近期体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 4, "end_pos": 7}, {"label_type": "手术", "overlap": 0, "start_pos": 28, "end_pos": 42}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 109}, {"end_pos": 112, "label_type": "解剖部位", "overlap": 0, "start_pos": 111}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 138, "end_pos": 143}]}
{"originalText": "患者23天前因“乙状结肠癌”在我院住院行开腹探查乙状结肠癌切除术，术中见腹膜及大网膜多发转移，手术顺利，术后恢复可，术后病检回示乙状结肠隆起型中分化腺癌，大小3.5×3.0CM，浸润肠壁全层，达周围纤维脂肪组织，可见脉管癌栓，肠周淋巴结可见癌转移（4/15），伴多个肠外癌结节，近肿物断端及远肿物断端未见癌；（肠系膜结节）纤维脂肪组织中可见中分化腺癌转移；（腹壁结节）中分化腺癌转移结节，大小0.5×0.5×0.3CM，病情平稳出院，为求第一次化疗，今来我院，门诊以“乙状结肠癌术后”收入院，患者自发病以来食欲可，食量稍少，精神、睡眠可，二便正常，体重近期无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 8, "end_pos": 13}, {"label_type": "手术", "overlap": 0, "start_pos": 20, "end_pos": 32}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 36, "end_pos": 37}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 64, "end_pos": 76}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 92}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"end_pos": 134, "label_type": "解剖部位", "overlap": 0, "start_pos": 133}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 155, "end_pos": 156}, {"end_pos": 181, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 234, "end_pos": 241}]}
{"originalText": "缘于入院前4月余于我院诊断“胃体癌”，遂于2015.03.05在全麻上行“腹腔镜上根治性全胃切除术”，术顺，术后病理（201507470）：胃体小弯溃疡型低分化腺癌，侵犯神经组织，侵出浆膜层，手术标本下切端、上切端及另送（下切端）均未见癌侵润。找到大弯侧淋巴结2/6个，小弯侧淋巴结6/7个，幽门上淋巴结9/15个，及另送(第7组)淋巴结0/8个，(第8组)淋巴结2/2个，(第9组)淋巴结0/3个，(第10组)淋巴结0/4个，(第11组)淋巴结2/3个，(第12组)淋巴结4/8个见癌转移。术后予抗感染、补液、营养支持等治疗，恢复可，切口II/甲愈合。于2015-03-31、2015-04-20予“伊立替康240MGIVGTTD1替吉奥胶囊(艾奕)60MGPOBIDD1-14”化疗2次，辅以止吐、制酸、保胃、营养支持等治疗，化疗过程顺利。今为第3次化疗就诊我院，门诊拟“胃癌术后化疗”收住入院，自下次出院以来，精神、食欲、睡眠尚可，大小便正常，体重无明显增减。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"end_pos": 49, "label_type": "手术", "overlap": 0, "start_pos": 37}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 70, "end_pos": 82}, {"end_pos": 130, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"end_pos": 141, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"end_pos": 152, "label_type": "解剖部位", "overlap": 0, "start_pos": 146}, {"end_pos": 305, "label_type": "药物", "overlap": 0, "start_pos": 301}, {"end_pos": 322, "label_type": "药物", "overlap": 0, "start_pos": 317}, {"end_pos": 325, "label_type": "药物", "overlap": 0, "start_pos": 323}, {"end_pos": 356, "label_type": "解剖部位", "overlap": 0, "start_pos": 355}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 388, "end_pos": 392}]}
{"originalText": "患者2015-04-21因“无明显诱因出现腹胀，伴便秘、里急后重，大便成形，偶有便血7月”，外院肠镜示距肛40CM息肉，0.8×1.2CM，活检病理腺瘤；2015-04-30行乙状结肠息肉电切术，病理腺癌，浸润深度达粘膜上层，无法评估蒂部情况。2015-06-03于我院结直肠科行乙状结肠切除术，术后病理：肠粘膜慢性炎，局灶粘膜缺损，可见炎性肉芽组织生长及炎性坏死物渗出，结合病史，符合治疗后改变，未见癌残留。切缘未见癌，LN 1/10(+)见癌转移。出院诊断为乙状结肠中分化腺癌术后YPT0N1M0 IIIA期。术后9天开始发现腹部伤口渗出暗红色液体，量较多，遂就诊于我院结直肠科，予负压吸引、抗生素抗感染等对症治疗，伤口愈合较前明显改善，排除化疗禁忌症后于2015-07-02、2015-07-28、2015-08-20、2015-09-14、2015-10-12行术后XELOX辅助化疗5程，过程顺利。2程化疗后出现II度转氨酶升高，予护肝治疗后好转。3程化疗后复查未见肿瘤复发、转移征象。现为行第6程XELOX方案辅助化疗入我科。自下次治疗以来，患者无发热、咳嗽、身目黄染，无骶部痛等，精神可，纳眠可，小便无异常，体重无上降。", "entities": [{"end_pos": 22, "label_type": "解剖部位", "overlap": 0, "start_pos": 21}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 97, "label_type": "手术", "overlap": 0, "start_pos": 88}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 100, "end_pos": 102}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"end_pos": 147, "label_type": "手术", "overlap": 0, "start_pos": 140}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 153, "end_pos": 159}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 231, "end_pos": 256}, {"end_pos": 267, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"end_pos": 290, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"end_pos": 423, "label_type": "解剖部位", "overlap": 0, "start_pos": 422}, {"end_pos": 494, "label_type": "解剖部位", "overlap": 0, "start_pos": 492}]}
{"originalText": "，患者2015-12-29于我院在全麻上行\\\"（远端）胃癌根治术\\\"，术程顺利，，术后病理：“（胃大体）镜检为胃中至低分化腺癌（LAUREN分型为混合型），癌组织浸润至胃壁浆膜上层，可见脉管内癌栓及神经束侵犯；送检网膜组织未见癌。淋巴结55枚，8枚见腺癌转移。（近切缘）未见癌。（远切缘）未见癌。，免疫组化：CK（+），HER2（0），VEGF（+）。”，术后病理提示：胃窦癌（PT3N3M0,IIIB期）。现为行术后第四程SOX方案辅助化疗收入我科。起病以来，患者精神尚可，食欲欠佳，大小便正常，无明显变化。", "entities": [{"label_type": "手术", "overlap": 0, "start_pos": 23, "end_pos": 32}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 55, "end_pos": 77}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 84}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 185, "end_pos": 203}]}
{"originalText": "，缘于入院前4月余于我院诊断为直肠癌，于2016-06-22在全麻上行腹腔镜上探查+中转开腹姑息性直肠癌切除+乙状结肠造瘘术。术后病理（201621457），：1、（直肠），：直肠溃疡型黏液腺癌，部分为中分化绒毛状-管状腺癌，侵犯肠壁全层及肠周纤维脂肪组织，未及明确侵犯脉管及神经组织，手术标本双切端均未见癌浸润；找到肠周淋巴结23个均未见癌转移。，免疫组化结果：肿瘤细胞CK20（+），CEA（+），P53（+，野生型），CK7（-），EGFR（+），KI67（40%阳性）。2、（盆壁组织），：送检为增生的纤维及脂肪组织，表面见纤维素样坏死，间质见多量急、慢性炎症细胞浸润。，病理：该病例检测到KRAS基因12号密码子G12D突变。，病理：该病例未检测到BRAF基因V600E突变。术后给予对症、营养支持等治疗，恢复良好，伤口II/甲愈合。2016.07.20、2016.08.10、2016.09.02、2016.09.22、2016.10.14予“奥沙利铂200MGIVGTTD1+卡培他滨1500MGPOBIDD1-14”方案化疗，辅以制酸、保肝、营养支持、增强免疫力等处理。此次为第6次化疗就诊我院，门诊拟直肠癌术后收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，造瘘口排便通畅，小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手术", "overlap": 0, "start_pos": 35, "end_pos": 62}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 82, "end_pos": 97}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 115, "end_pos": 116}, {"end_pos": 126, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 432, "label_type": "药物", "overlap": 0, "start_pos": 428}, {"end_pos": 449, "label_type": "药物", "overlap": 0, "start_pos": 445}, {"end_pos": 478, "label_type": "解剖部位", "overlap": 0, "start_pos": 477}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 509, "end_pos": 514}, {"end_pos": 536, "label_type": "解剖部位", "overlap": 0, "start_pos": 535}, {"end_pos": 539, "label_type": "解剖部位", "overlap": 0, "start_pos": 538}]}
{"originalText": "患者于6月前，因“直肠癌”于2015-12-30在我院行“腹腔镜上直肠癌根治术”，术后病理：（直肠）溃疡型中分化管状乳头状腺癌，浸及肠壁全层，脉管、神经未见癌侵犯，双切端未见癌累及，肠壁脂肪中淋巴结未见癌转移（0/11）。术后患者恢复可，腹泻，不能控制，进食少，无腹痛腹胀，无发热等，为进一步治疗，拟行第2次化疗，门诊以“直肠癌术后”收入院。\\U0004   患者自起病以来，精神可，胃纳略差，大便次数增多，小便如常，体重未见明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 9, "end_pos": 12}, {"end_pos": 39, "label_type": "手术", "overlap": 0, "start_pos": 29}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 46, "end_pos": 63}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 66, "end_pos": 67}, {"end_pos": 99, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"end_pos": 120, "label_type": "解剖部位", "overlap": 0, "start_pos": 119}, {"end_pos": 133, "label_type": "解剖部位", "overlap": 0, "start_pos": 132}, {"end_pos": 135, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 161, "end_pos": 166}]}
{"originalText": "，患者因患“结肠癌并肠梗阻”于2015-11-25在全麻上行右半结肠切除术+横结肠两腔造瘘术，术后给予营养补液、抑酸、抗菌等治疗。，术后病理示：（结肠）腺癌（中度分化），浸润溃疡型，体积4*3.5*0.6CM，部分侵穿浆膜。 双端切线未查见癌。 呈肠壁一站（2/7个）、中间组（1/1个）淋巴结癌转移。 中央组（3个）淋巴结及大网膜组织内未查见癌。，免疫组化染色示：SYN（-）、TS较多（+）。于术后行化疗XELOX方案（奥沙利铂200MG D1+希罗达2G BID D1-14 ）5次。后肿瘤标志物持续下升，改为洛铂50MG D1+亚叶酸钙0.3G D2-6+替加氟1G D2-6。现患者为行复查来我院就诊，门诊以“结肠癌术后”收入院。自下次出院后，患者一般情况保持良好， 无乏力感，无发热，无恶心、呕吐，无反酸、嗳气，无明显进食不适，未现明显 腹痛、腹胀；大小便情况良好。目前患者精神及情绪状态可，食欲、饮食好，夜间睡眠可，大小便正常，近期无明显体重变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 6, "end_pos": 9}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"label_type": "手术", "overlap": 0, "start_pos": 30, "end_pos": 46}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 72, "end_pos": 90}, {"end_pos": 216, "label_type": "药物", "overlap": 0, "start_pos": 212}, {"end_pos": 228, "label_type": "药物", "overlap": 0, "start_pos": 225}, {"end_pos": 260, "label_type": "药物", "overlap": 0, "start_pos": 258}, {"end_pos": 272, "label_type": "药物", "overlap": 0, "start_pos": 268}, {"end_pos": 285, "label_type": "药物", "overlap": 0, "start_pos": 282}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 310, "end_pos": 315}, {"end_pos": 376, "label_type": "解剖部位", "overlap": 0, "start_pos": 375}, {"end_pos": 379, "label_type": "解剖部位", "overlap": 0, "start_pos": 378}]}
{"originalText": "，缘于入院前3月余因“直肠癌”于2016.08.25在我科行“腹腔镜上直肠根治性切除术+预防性回肠造瘘术”，术顺，恢复良好，术后病理（201630447），：（直肠），：肠隆起型中分化管状腺癌，侵及深肌层，未见明确侵犯脉管及神经组织，手术标本双切端及另送（下切端）、（上切端）均未见癌浸润；找到肠周淋巴结13个，及另送（肠系膜上动脉根部）淋巴结3个均未见癌转移。，免疫组化结果：肿瘤细胞示KI67（30%+），P53（30%+），CEA（+），CK7（-），CK20（+），CDX2（+）。因患者要求化疗，后于2016.10.24、2016.11.15予“奥沙利铂（乐沙定）200MGIVGTTD1+卡培他滨1000MGPOBIDD1-D14”方案化疗，辅以水化、保肝、止吐、增强免疫力等处理，未出现明显化疗副反应。此后今为第3次化疗再次就诊我院，门诊拟“直肠癌术后化疗”收入院。自下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，小便正常，造口排便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 11, "end_pos": 14}, {"label_type": "手术", "overlap": 0, "start_pos": 31, "end_pos": 52}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 79, "end_pos": 96}, {"end_pos": 152, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 172, "label_type": "解剖部位", "overlap": 0, "start_pos": 159}, {"end_pos": 282, "label_type": "药物", "overlap": 0, "start_pos": 278}, {"end_pos": 286, "label_type": "药物", "overlap": 0, "start_pos": 283}, {"end_pos": 304, "label_type": "药物", "overlap": 0, "start_pos": 300}, {"end_pos": 334, "label_type": "解剖部位", "overlap": 0, "start_pos": 333}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 378, "end_pos": 383}, {"end_pos": 409, "label_type": "解剖部位", "overlap": 0, "start_pos": 408}, {"end_pos": 412, "label_type": "解剖部位", "overlap": 0, "start_pos": 411}]}
{"originalText": "，患者2008年1月因粘液血便在*****诊断为直肠癌，于2008.1.17行直肠癌切除术，，术后病理：直肠中-高分化腺癌侵及肠壁全层，肠系膜淋巴结3/6见癌转移，分期PT4N1M0.术后于2008.2.13-2008.4.26行FOLFOX方案化疗4程。200.9.10.，19复查CT：直肠壁局部不规则增厚。2009.10.26放疗40GY。2009.12.5、2009.12.25再次行FOLFOX方案化疗2程。2010.8.26行直肠癌根治术，9.21二期缝合，，术后病理：直肠高分化腺癌侵及肠壁全层，肛门切缘及切端均为见癌，肠周淋巴结0/2见癌转移。术后FOLFIRI方案化疗3程，末次化疗时间2010.10.26.2010.11.23出现会阴部脓肿，行脓肿切开引流术，考虑肠穿孔。2011.2.9行回肠末端（穿孔部分）切除端侧吻合术。2011.3.，7复查CT：盆底少许软组织影，局部复发待排，两侧髂血管旁、两侧腹股沟淋巴结，两侧肾盂扩张、积液，考虑输尿管上端受压，肝S4、8转移瘤。2011.3.30，我院会诊病理：直肠中分化腺癌，肌层受侵犯，脉管内见癌栓，K－RAS基因野生型。于2011.3.20-2011.7.20行XELOX＋BEV方案化疗6程。2、4程化疗后评价疗效SD。于2011.8.16开始予XELODA单药维持化疗，至今已化疗5程。2程化疗后评价疗效SD,出现轻度手足麻木。现为进一步治疗入院。患者近期精神食欲可，大小便正常，体力体重无上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 24, "end_pos": 27}, {"end_pos": 45, "label_type": "手术", "overlap": 0, "start_pos": 39}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 52, "end_pos": 61}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 63, "end_pos": 64}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"label_type": "影像检查", "overlap": 0, "start_pos": 142, "end_pos": 144}, {"end_pos": 148, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"end_pos": 225, "label_type": "手术", "overlap": 0, "start_pos": 219}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 241, "end_pos": 248}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 250, "end_pos": 251}, {"end_pos": 257, "label_type": "解剖部位", "overlap": 0, "start_pos": 255}, {"end_pos": 272, "label_type": "解剖部位", "overlap": 0, "start_pos": 267}, {"end_pos": 328, "label_type": "解剖部位", "overlap": 0, "start_pos": 325}, {"end_pos": 339, "label_type": "手术", "overlap": 0, "start_pos": 332}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 342, "end_pos": 345}, {"end_pos": 372, "label_type": "手术", "overlap": 0, "start_pos": 355}, {"label_type": "影像检查", "overlap": 0, "start_pos": 384, "end_pos": 386}, {"end_pos": 389, "label_type": "解剖部位", "overlap": 0, "start_pos": 387}, {"end_pos": 409, "label_type": "解剖部位", "overlap": 0, "start_pos": 403}, {"end_pos": 418, "label_type": "解剖部位", "overlap": 0, "start_pos": 410}, {"end_pos": 423, "label_type": "解剖部位", "overlap": 0, "start_pos": 419}, {"end_pos": 436, "label_type": "解剖部位", "overlap": 0, "start_pos": 431}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 439, "end_pos": 447}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 465, "end_pos": 472}, {"end_pos": 527, "label_type": "药物", "overlap": 0, "start_pos": 524}, {"end_pos": 567, "label_type": "药物", "overlap": 0, "start_pos": 561}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 598, "end_pos": 599}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 599, "end_pos": 600}]}
{"originalText": "，缘于1个月前入院，诊为胃体管状腺癌，于2014年02月07日在全麻上行“腹腔镜辅助上根治性全胃切除术+食管空肠ROUX-Y吻合术（D2）”。手术顺利。，术后病理示：（全胃），：胃体溃疡型管状腺癌（II-III级），浸润深肌层，侵犯神经，手术标本下、上切端及另送（下切端）均未见癌浸润。找到贲门旁淋巴结5个，小弯淋巴结3个，幽门下淋巴结1个，幽门上淋巴结2个，及另送（第7组）淋巴结2个，（第8组）淋巴结4个，（第9组）淋巴结3个，（第12组）淋巴结1个均未见癌转移。，免疫组化：KI67（65%阳性），P53（+），P170（+++），GSTπ（+），EGFR（-），5-FU（+），HER-2（+），CD56（-），CGA（-），SY（-）。术后给予对症、抗感染治疗，恢复良好,伤口愈合II/甲。此次为行术后第1次化疗入院，门诊拟“胃癌术后”收入院，自出院后饮食、夜休可，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 12, "end_pos": 18}, {"label_type": "手术", "overlap": 0, "start_pos": 37, "end_pos": 69}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 83, "end_pos": 107}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 145}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 154}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 162}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 171}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 368, "end_pos": 372}, {"end_pos": 390, "label_type": "解剖部位", "overlap": 0, "start_pos": 389}, {"end_pos": 393, "label_type": "解剖部位", "overlap": 0, "start_pos": 392}]}
{"originalText": "，患者2015-03-31因“黑便半年”就诊于我院结直肠科，2015-03-31，腹盆MR示：升结肠肿物，考虑为升结肠癌；升结肠系膜多发淋巴结，考虑转移，遂2015-04-09行全麻上“腹腔镜左半结肠切除术”，过程顺利，，术后病理示：符合中分化腺癌，浸润至肠壁浆膜上层，可见脉管内癌栓，未见明确神经束侵犯；淋巴结（2/23）可见癌转移，，分期为：PT3N1BM0 IIIB期，术后恢复可。2015-05-13、2015-06-03、2015-06-28起行XELOX方案化疗3程，过程顺利。现为行第4程辅助化疗入我科。患者3周来，无发热，胃纳可，睡眠一般，大小便正常，体重无明显上降。", "entities": [{"end_pos": 28, "label_type": "解剖部位", "overlap": 0, "start_pos": 25}, {"label_type": "影像检查", "overlap": 0, "start_pos": 41, "end_pos": 45}, {"end_pos": 50, "label_type": "解剖部位", "overlap": 0, "start_pos": 47}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 56, "end_pos": 60}, {"end_pos": 66, "label_type": "解剖部位", "overlap": 0, "start_pos": 61}, {"end_pos": 103, "label_type": "手术", "overlap": 0, "start_pos": 93}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 128, "end_pos": 129}, {"end_pos": 270, "label_type": "解剖部位", "overlap": 0, "start_pos": 269}]}
{"originalText": "，患者因“胃窦癌”于2015-6-24在我院全麻上行\\\"（远端）胃癌根治术\\\"，术程顺利，，术后病理回报:“（胃大体）镜检为低分化腺癌，部分为印戒细胞癌（LAUREN，分型：弥漫型），癌组织浸润至胃壁浆膜上层；未见明确脉管内癌栓及神经束侵犯；网膜组织未见癌。淋巴结103枚，10枚见癌。（近、远切缘）未见癌。，免疫组化：CK（+），VEGF（+），HER2（0） ”术后预防感染、抑制分泌、静脉营养等对症支持处理，恢复好，切口甲级愈合。2015.8.6，2015.9.8行术后辅助化疗（替吉奥 60MG BID+奥沙利铂 150MG）双程，化疗耐受可，拟\\\"胃窦癌综合治疗后\\\"收入我科。从下次出院以来，患者精神尚可，食欲一般，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 5, "end_pos": 8}, {"label_type": "手术", "overlap": 0, "start_pos": 28, "end_pos": 37}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 54, "end_pos": 67}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 71, "end_pos": 91}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 98, "end_pos": 99}, {"end_pos": 247, "label_type": "药物", "overlap": 0, "start_pos": 243}, {"end_pos": 260, "label_type": "药物", "overlap": 0, "start_pos": 256}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 279, "end_pos": 287}]}
{"originalText": "，缘于入院前5月余于我院诊为直肠癌，于2014-11-19在全麻上行腹腔镜上直肠癌根治术MILES，，术中见：见腹腔内少许粘连，无明显腹水，子宫及右侧附件缺如，呈术后改变。肿瘤于腹膜返折上不可见，周围可见少许肿大淋巴结。术后病理示（201440196），：（直肠）直肠隆起型管状腺癌II级，侵出外膜层达周边纤维脂肪组织，脉管中见癌栓，侵犯神经组织，齿状线未见癌浸润。手术标本下、上切端及另送（下切端）及环周切缘均未见癌浸润。手术标本肿物周找到淋巴结6个，肠周淋巴结10个及另送（肠系膜上动脉根部）淋巴结1个均未见癌转移。术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。2014-12-24、2015-01-20、2015-02-13、2015-03-10、2015-04-08予以“奥沙利铂150MGIVGTTD1+希罗达1000MGPOBIDD1-14”方案化疗，并辅以制酸、保肝、水化等治疗。化疗过程顺利，无恶心、呕吐、乏力、腹泻等明显化疗副作用。此次为行第6次化疗再次就诊我院，门诊拟直肠癌术后收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 17}, {"label_type": "手术", "overlap": 0, "start_pos": 34, "end_pos": 49}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 56}, {"end_pos": 68, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 89}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 128, "end_pos": 144}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}, {"end_pos": 232, "label_type": "解剖部位", "overlap": 0, "start_pos": 227}, {"end_pos": 251, "label_type": "解剖部位", "overlap": 0, "start_pos": 238}, {"end_pos": 350, "label_type": "药物", "overlap": 0, "start_pos": 346}, {"end_pos": 366, "label_type": "药物", "overlap": 0, "start_pos": 363}, {"end_pos": 396, "label_type": "解剖部位", "overlap": 0, "start_pos": 395}, {"end_pos": 421, "label_type": "解剖部位", "overlap": 0, "start_pos": 420}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 450, "end_pos": 455}, {"end_pos": 477, "label_type": "解剖部位", "overlap": 0, "start_pos": 476}, {"end_pos": 480, "label_type": "解剖部位", "overlap": 0, "start_pos": 479}]}
{"originalText": "，缘于入院前4月余于我院诊断为胃窦癌，于2015年08月25日在全麻上行“腹腔镜辅助上根治性远端胃大部切除+残胃空肠ROUX-Y吻合术（D2）+阑尾切除术”，手术顺利。，术后病理：1、（远端胃），：胃窦小弯侧溃疡型管状腺癌II-III级，少数为肝样腺癌，侵犯神经，脉管内见癌栓，侵及浆膜层。手术标本下切端、上切端及另送（下切端）均未见癌浸润。找到小弯侧淋巴结0/7个，大弯侧淋巴结0/3个，幽门下淋巴结1/1个，幽门上淋巴结1/5个，及另送的（第7组）淋巴结0/1个，（第8组）淋巴结0/3个，（第9组）淋巴结0/4个，（第11组）淋巴结0/2个，（第12A组）淋巴结1/2个，（第12P组）淋巴结0/2个，见癌转移。另送（第10组淋巴结）镜上为脉管、纤维及脂肪组织。急性单纯性阑尾炎。，免疫组化染色结果：CK(PAN)（+++），KI67（60%阳性），CDX-2（+++），CD56（-），CGA（-），SY（-），HER-2（-），HEPACOCYTE（-），GLYPICAN-3（+）。术后予对症、抗感染治疗，恢复良好，伤口愈合II/甲，遂出院。2015.10.10、2015.11.27行“伊立替康240MGIVGTTD1+替吉奥胶囊(艾奕)40MGPOBIDD1-14”方案化疗，现为行术后第3次化疗再入院。门诊拟“胃癌术后化疗”收住入院。自此次发病以来，精神、睡眠、食欲可，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 15, "end_pos": 18}, {"label_type": "手术", "overlap": 0, "start_pos": 37, "end_pos": 77}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 92, "end_pos": 118}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 122, "end_pos": 126}, {"end_pos": 179, "label_type": "解剖部位", "overlap": 0, "start_pos": 173}, {"end_pos": 190, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 195}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 334, "end_pos": 342}, {"end_pos": 504, "label_type": "药物", "overlap": 0, "start_pos": 500}, {"end_pos": 522, "label_type": "药物", "overlap": 0, "start_pos": 517}, {"end_pos": 525, "label_type": "药物", "overlap": 0, "start_pos": 523}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 564, "end_pos": 568}]}
{"originalText": "，患者3月余前（2015-12-24）因“直肠癌”于我院行腹腔镜直肠癌根治术（DIXON术），，术后常规病理示：（直肠）粘液腺癌伴印戒细胞癌成分（40%），肿瘤切面积8.5*1.7CM，侵透浆膜达周围脂肪组织。下上切缘、环周切缘、吻合器切缘均未查见癌，肠周淋巴结21枚，均未查见转移癌（0/21），，病理号：46920.15。术后给予消炎、营养支持治疗，病情好转后出院。后再次入院行XELOX方案化疗3周期，现患者为行化疗治疗来我院，门诊以“直肠癌术后化疗”收入院。自下次出院来，患者饮食睡眠尚可，大小便无明显异常，体重较前无明显改变。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 21, "end_pos": 24}, {"label_type": "手术", "overlap": 0, "start_pos": 29, "end_pos": 46}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 56, "end_pos": 77}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 126}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 221, "end_pos": 226}]}
{"originalText": "缘于入院前3月于我院诊为直肠癌，于2015-07-31在全麻上行腹腔镜上直肠全系膜切除术(TME)预防性回肠造口术。术后病理示肠溃疡型管状腺癌II级，侵及深肌层。手术标本下、上切端及另送（下切端)、(上切端)均未见癌浸润。找到肠周淋巴结21个，未见癌转移。免疫组化结果：KI67（80%+），CK7（-），CK20（+），VILLIN（+++），CDX-2（+++），CEA（++），CD56（-），术后给予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。术后未定期复查化疗，此次入院为造口还纳就诊我院。门诊拟“直肠癌术后回肠造口状态”收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 12, "end_pos": 15}, {"label_type": "手术", "overlap": 0, "start_pos": 32, "end_pos": 57}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 63, "end_pos": 74}, {"end_pos": 118, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 257, "end_pos": 262}, {"end_pos": 291, "label_type": "解剖部位", "overlap": 0, "start_pos": 290}, {"end_pos": 294, "label_type": "解剖部位", "overlap": 0, "start_pos": 293}]}
{"originalText": "，患者1月前因“进食梗阻感伴下腹部隐痛不适2月余”于2016.3.25在全麻上行全胃切除术+淋巴结清扫术，手术顺利，术后患者恢复良好，术后常规病理示（胃）低分化腺癌，弥漫浸润型，肿瘤切面积14*1.8CM，侵及浆膜脂肪组织，吻合器切缘及大网膜均未查见癌。小弯侧淋巴结7枚，其中5枚（5/7）查见转移；贲门周围淋巴结11枚，其中7枚（7/11）查见转移；大弯侧淋巴结2枚（0/2），均未查见转移。，免疫组化：CK（+）、E-CAD（+）、HER-2（0）。，病理号：10987.16。现患者为行进一步治疗来我院就诊，门诊以“胃癌术后”收入院。患者近期饮食睡眠可，大小便无明显异常，体重较前略有减轻。", "entities": [{"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"label_type": "手术", "overlap": 0, "start_pos": 40, "end_pos": 52}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 74, "end_pos": 88}, {"end_pos": 133, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 150}, {"end_pos": 182, "label_type": "解剖部位", "overlap": 0, "start_pos": 176}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 261, "end_pos": 265}]}
{"originalText": "，缘于入院前9天（2016.12.15）因“右卵巢囊肿破裂”急诊于我院全麻上行“腹腔镜上右卵巢囊肿剥除术+盆腔粘连松解术”，，术中见：腹腔内见暗红色血液及凝血块约400ML，右卵巢见一大小约90×70MM的囊肿，表面有破口，可见活动性出血，囊肿内可见大量暗红色凝血块，右卵巢与右侧盆壁膜状粘连，子宫及左侧附件外观未见明显异常。术顺，术后病理（201646465），示：(右卵巢肿物)，：符合卵巢卵黄囊瘤，伴大片出血坏死。期间监测，AFP：（12.14）14235NG/ML、（12.16）9635NG/ML、（12.22）4986NG/ML。术后无特殊不适，切口愈合好。现无腹痛、腹胀、腹泻，无阴道流血、流液，无尿频、尿急、尿急，无胸闷、心悸等不适。为行化疗再次就诊我院，门诊遂拟“右卵巢卵黄囊瘤术后”收入院。下次出院以来，患者精神、睡眠、食欲尚可，大小便正常，体重无明显改变。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 22, "end_pos": 27}, {"label_type": "手术", "overlap": 0, "start_pos": 40, "end_pos": 60}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 67}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 87}, {"end_pos": 137, "label_type": "解剖部位", "overlap": 0, "start_pos": 134}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 138, "end_pos": 142}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 188, "label_type": "解剖部位", "overlap": 0, "start_pos": 185}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 195, "end_pos": 201}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 215, "end_pos": 218}, {"end_pos": 288, "label_type": "解剖部位", "overlap": 0, "start_pos": 287}, {"end_pos": 291, "label_type": "解剖部位", "overlap": 0, "start_pos": 290}, {"end_pos": 294, "label_type": "解剖部位", "overlap": 0, "start_pos": 293}, {"end_pos": 299, "label_type": "解剖部位", "overlap": 0, "start_pos": 297}, {"end_pos": 317, "label_type": "解剖部位", "overlap": 0, "start_pos": 316}, {"end_pos": 320, "label_type": "解剖部位", "overlap": 0, "start_pos": 319}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 341, "end_pos": 350}]}
{"originalText": "，患儿2015年12月16日无明显诱因出现左下腹胀痛，无呕吐、腹泻等症状，家长自行查体可触及左下腹巨大包块，质硬，活动度可，遂于我院就诊，，完善B超发现：腹腔内巨大实性占位（150*90*140MM），肝母细胞瘤可能（侵犯肝右、左叶）。12-25于****行“肝肿瘤切除+胆囊切除术”，术后病理确诊肝母细胞瘤，下皮型（胎儿及胚胎型）。2016.1.9入住我科，评估全身检查后诊断为肝母细胞瘤I期，并入“肝母-SCMC-2011”方案化疗。2016.1.10、2.2、2.25、3.21起予CDDP+VCR+5-FU方案*4次化疗。此次化疗间期已满，拟收治入院按序化疗。   近期患儿无发热，无咳嗽、喘憋，无吐泻，胃纳精神可，二便正常。，初始资料：，诊断日期：2016.1.11，进入方案：肝母（SCMC-2011），初发影像学检查及特殊检查：B，超发现：腹腔内巨大实性占位（150*90*140MM），肝母细胞瘤可能（侵犯肝右、左叶）。，术后病理：肝母细胞瘤，下皮型（胎儿及胚胎型）。，末次化疗时间及方案：2016.3.21予以CDDP+VCR+5-FU，方案化疗末次影像检查：头颅(MRI平扫+增强）(2016-01-11) 脑部MRI平扫＋增强未见明显异常。腹部(CT平扫+增强)(2016-01-07) 肝母细胞瘤术后改变，请结合临床。--胸部(CT平扫)(2016-01-07) 左肺尖条索影，请结合临床。", "entities": [{"end_pos": 24, "label_type": "解剖部位", "overlap": 0, "start_pos": 21}, {"end_pos": 32, "label_type": "解剖部位", "overlap": 0, "start_pos": 31}, {"end_pos": 49, "label_type": "解剖部位", "overlap": 0, "start_pos": 46}, {"label_type": "影像检查", "overlap": 0, "start_pos": 72, "end_pos": 74}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 101, "end_pos": 106}, {"end_pos": 116, "label_type": "解剖部位", "overlap": 0, "start_pos": 111}, {"label_type": "手术", "overlap": 0, "start_pos": 130, "end_pos": 141}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 149, "end_pos": 166}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 190, "end_pos": 197}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 201, "end_pos": 213}, {"end_pos": 248, "label_type": "药物", "overlap": 0, "start_pos": 244}, {"end_pos": 252, "label_type": "药物", "overlap": 0, "start_pos": 249}, {"end_pos": 257, "label_type": "药物", "overlap": 0, "start_pos": 253}, {"end_pos": 307, "label_type": "解剖部位", "overlap": 0, "start_pos": 306}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 344, "end_pos": 357}, {"label_type": "影像检查", "overlap": 0, "start_pos": 371, "end_pos": 374}, {"end_pos": 379, "label_type": "解剖部位", "overlap": 0, "start_pos": 377}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 401, "end_pos": 406}, {"end_pos": 416, "label_type": "解剖部位", "overlap": 0, "start_pos": 411}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 424, "end_pos": 441}, {"end_pos": 472, "label_type": "药物", "overlap": 0, "start_pos": 469}, {"end_pos": 477, "label_type": "药物", "overlap": 0, "start_pos": 473}, {"label_type": "影像检查", "overlap": 0, "start_pos": 489, "end_pos": 501}, {"label_type": "影像检查", "overlap": 0, "start_pos": 514, "end_pos": 519}, {"label_type": "影像检查", "overlap": 0, "start_pos": 531, "end_pos": 542}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 555, "end_pos": 562}, {"label_type": "影像检查", "overlap": 0, "start_pos": 573, "end_pos": 581}, {"end_pos": 597, "label_type": "解剖部位", "overlap": 0, "start_pos": 594}]}
{"originalText": "，患者2015年5月开始无明显诱因出现腹泻、稀烂便为主，1-2次/日，后出现便血，量不多，无黑便、恶心、腹痛、腹胀等，无头晕、乏力、发热等不适。外院肠镜检查提示距肛22-25CM环周肿物，肠镜能通过，活检病理提示粘液腺癌；直肠多发息肉。2015-11-11在我院结直肠科全麻上行“DIXON'S”术，，术后病理回报：1（肠大体）镜检为中至低分化腺癌，部分为粘液腺癌，癌组织侵犯肠壁浆膜上层，未见明确脉管内癌栓及神经束侵犯。2（近切缘）未见癌。3（远切缘）未见癌。4（中央淋巴结）6枚，未见癌。5（中间淋巴结）5枚，未见癌。6（肠旁淋巴结）7枚，1/7见腺癌转移，并浸润至结外脂肪结缔组织。，免疫组化：ER（-），ERCC1（+），KI67（70%+），MSH2（+），MSH6（+），MLH1（+），PMS2（+）。患者术后恢复良好，于2015-12-08、2015-12-30给予XELOX方案（奥沙利铂200MG，D1+希罗达 早2000MG晚1500MG，D1-D14）化疗2程。2016.1.21因考虑患者化疗反应较大，暂停乐沙定化疗，先予希罗达单药化疗1程。现为求上一程化疗入院，患者近来食欲、睡眠及精神尚可，二便正常，体力、体重无明显上降。", "entities": [{"end_pos": 20, "label_type": "解剖部位", "overlap": 0, "start_pos": 19}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 106, "end_pos": 110}, {"end_pos": 113, "label_type": "解剖部位", "overlap": 0, "start_pos": 111}, {"end_pos": 134, "label_type": "解剖部位", "overlap": 0, "start_pos": 131}, {"label_type": "手术", "overlap": 0, "start_pos": 139, "end_pos": 149}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 160, "end_pos": 161}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 167, "end_pos": 174}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 178, "end_pos": 182}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 188, "end_pos": 189}, {"end_pos": 268, "label_type": "解剖部位", "overlap": 0, "start_pos": 263}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 276, "end_pos": 278}, {"end_pos": 403, "label_type": "药物", "overlap": 0, "start_pos": 399}, {"end_pos": 416, "label_type": "药物", "overlap": 0, "start_pos": 412}, {"end_pos": 469, "label_type": "药物", "overlap": 0, "start_pos": 466}, {"end_pos": 477, "label_type": "药物", "overlap": 0, "start_pos": 474}]}
{"originalText": "，缘于入院前2月患者因“升结肠癌”，于2015.1.23全麻上行“腹腔镜上左半结肠根治性切除术”，，术中见：无腹水，肝表面光滑，胃及空肠未见明显病变。升结肠近肝曲可见一大约5*3*3CM菜花型肿物，质硬，可疑侵出浆膜层,肠系膜根部未见肿大淋巴结。术后恢复可，术后病理（201503027），：(左半结肠)，：结肠隆起型管状腺癌II级，部分为粘液腺癌，侵及浆膜层，侵犯神经组织，脉管中见癌栓，手术标本回肠切端、结肠切端及另送（下切端）、（上切端）均未见癌浸润；找到回肠周淋巴结2/6个、结肠周围淋巴结1/10个,及另送(左结肠系膜根根部)淋巴结0/3个，(回结结肠系膜肠系膜根部)淋巴结0/4个，见癌转移。另见阑尾组织。该病例未检测到BRAF基因V600E突变。该病例未检测到KRAS基因12、13号密码子热点突变。于2015.02.26予“奥沙利铂D1150MGIVGTT+卡培他滨1000MGPOD2-15”方案化疗，辅以止吐、制酸保胃、保肝等治疗，无明显化疗反应。此次为第2次化疗再次入院。自下次出院后饮食、夜休可，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 12, "end_pos": 16}, {"end_pos": 47, "label_type": "手术", "overlap": 0, "start_pos": 33}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"end_pos": 59, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"end_pos": 68, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 110, "end_pos": 111}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 146, "end_pos": 166}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 170, "end_pos": 174}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 199}, {"end_pos": 206, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"end_pos": 237, "label_type": "解剖部位", "overlap": 0, "start_pos": 231}, {"end_pos": 249, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 271, "label_type": "解剖部位", "overlap": 0, "start_pos": 258}, {"end_pos": 292, "label_type": "解剖部位", "overlap": 0, "start_pos": 276}, {"end_pos": 306, "label_type": "解剖部位", "overlap": 0, "start_pos": 304}, {"end_pos": 374, "label_type": "药物", "overlap": 0, "start_pos": 370}, {"end_pos": 391, "label_type": "药物", "overlap": 0, "start_pos": 387}, {"end_pos": 419, "label_type": "解剖部位", "overlap": 0, "start_pos": 418}, {"end_pos": 422, "label_type": "解剖部位", "overlap": 0, "start_pos": 421}, {"end_pos": 462, "label_type": "解剖部位", "overlap": 0, "start_pos": 461}, {"end_pos": 465, "label_type": "解剖部位", "overlap": 0, "start_pos": 464}]}
{"originalText": "，患者于2016-6-30在全麻上行\\\"（远端）腹腔镜辅助胃癌根治术\\\"，，术后病理回报:“（胃大体）（肿物）镜检为低分化腺癌，LAUREN，分型：混合型，癌组织累及胃壁浅肌层，可见神经束侵犯，未见明确脉管内癌栓；（溃疡病灶）镜检为低分化腺癌，溃疡病灶浸润情况及免疫组化待待补充报告；网膜组织未见癌。淋巴结81枚，3枚见癌。（远、近切缘）未见癌”。于2016-08-04开始行S-1单药化疗，现为进一步术后辅助化疗收入我科。起病以来，患者精神尚可，食欲欠佳，大小便正常，身体无明显消瘦。", "entities": [{"end_pos": 34, "label_type": "手术", "overlap": 0, "start_pos": 20}, {"end_pos": 48, "label_type": "解剖部位", "overlap": 0, "start_pos": 47}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 83, "end_pos": 84}, {"end_pos": 191, "label_type": "药物", "overlap": 0, "start_pos": 188}]}
{"originalText": "，患者因“直肠癌”于2015-11-24在腰硬联合麻醉上行TEM术，手术过程顺利，，术后病理示：（直肠）腺癌（中度分化），隆起型，体积2.3*2.1*1CM，侵达粘膜上层。未累及周边及另送“底部”切除面。术后给予抗感染及营养支持治疗，患者恢复好。6个月前患者返院复查行结肠镜检查，见手术部位愈合良好，直肠未见明显异常。2016-3-8，腹盆腔强化CT示：胆囊管结石，直肠壁厚，前列腺增生。于2016-3-9开始行直肠局部放疗，共行25次，DT 5000CGY，同时给予局部灌肠及激素、维生素、改善微循环治疗，院外期间患者一般情况好，未再出现便血情况，无恶心，无腹痛腹胀不适，1月前患者查体发现胆囊息肉，直径约6MM，现患者为行手术治疗来院就诊，门诊以“TEM术后、胆囊息肉”收入院。   近期患者精神可，饮食可，大便次数多，小便正常，近期体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 5, "end_pos": 8}, {"label_type": "手术", "overlap": 0, "start_pos": 21, "end_pos": 33}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 48, "end_pos": 64}, {"end_pos": 152, "label_type": "解剖部位", "overlap": 0, "start_pos": 150}, {"label_type": "影像检查", "overlap": 0, "start_pos": 168, "end_pos": 175}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 177, "end_pos": 182}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 188, "end_pos": 193}, {"end_pos": 208, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"end_pos": 238, "label_type": "解剖部位", "overlap": 0, "start_pos": 237}, {"end_pos": 281, "label_type": "解剖部位", "overlap": 0, "start_pos": 280}, {"end_pos": 283, "label_type": "解剖部位", "overlap": 0, "start_pos": 282}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 296, "end_pos": 300}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 326, "end_pos": 331}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 332, "end_pos": 336}]}
{"originalText": "患者于2014.6.23因“下腹部胀痛不适并黑便”来我院胃肠外科就诊，入院后完善必要的化验检查，于2014-6-25行胃镜检查，于贲门部小弯处可见菜花样隆起，大小约5*4CM，周边粘膜不规则，呈结节状，质地脆，易出血。侵犯食道上段约3CM。综合患者病情，转胸外科后于2014.7.1日行贲门癌根治术，术后给予抗生素预防感染、化痰、止酸等治疗。术后病理：胃贲门小弯侧腺癌（中度分化），浸润溃疡型，体积5*5*1.2CM，累及上段食管。侵穿浆膜达脂肪组织。双端切线及底部切除面未查见癌。患者术后恢复顺利，于2014.7.14出院。   患者于2014.8.6第2次入院，入院后完善检查，给予奥沙利铂+多西他赛方案化疗，同时给予保肝、升白细胞、止吐等对症治疗，化疗结束后患者顺利出院。   患者现为求进一步治疗第3次来我院就诊，门诊以“胃底贲门癌术后”收入院。患者自下次出院以来无恶心呕吐，无腹胀腹泻，无胸闷憋气，无咳嗽咳痰等症状，饮食及睡眠可，大小便正常，体重未见明显变化。", "entities": [{"end_pos": 17, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 28, "end_pos": 29}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 29, "end_pos": 30}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 65}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 111}, {"end_pos": 129, "label_type": "解剖部位", "overlap": 0, "start_pos": 128}, {"end_pos": 149, "label_type": "手术", "overlap": 0, "start_pos": 143}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 176, "end_pos": 196}, {"end_pos": 215, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 297, "label_type": "药物", "overlap": 0, "start_pos": 293}, {"end_pos": 302, "label_type": "药物", "overlap": 0, "start_pos": 298}, {"end_pos": 313, "label_type": "解剖部位", "overlap": 0, "start_pos": 312}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 365, "end_pos": 372}, {"end_pos": 394, "label_type": "解剖部位", "overlap": 0, "start_pos": 393}, {"end_pos": 396, "label_type": "解剖部位", "overlap": 0, "start_pos": 395}, {"end_pos": 400, "label_type": "解剖部位", "overlap": 0, "start_pos": 399}]}
{"originalText": "，患者2014年12月22日于我科全麻上行扩大左半结肠切除术，，术中探查：肿瘤前壁与大网膜粘连，肿瘤后壁与胃后壁侵润粘连，病变位于横结肠中段，透浆膜，，术后病理：结肠癌（浆膜上层），溃疡型，中分化腺癌，II级，断端无癌，淋巴结可见癌转移（1/23枚），，浸润深度：浆膜上层，肌间神经节侵犯（+)，脉管癌栓（+），结外肿瘤种植（1+)，PTNM，分期：T4BN1M0,IIIC期，，免疫组化：KI67（50-70%+）,P53(70-90%+),CA199(+)，CEA(++)，CDX2(>90%+)，GSTP1(+)，EGFR(++)，VEGF(+++)。血管内皮细胞CD34（+）其内可见癌栓，淋巴管内皮细胞D2-40(+)其内未见癌栓。，病理号：1446。患者术后恢复良好，已行XELOX方案4次，现为求进一步辅助化疗收入我科，近日无发热，饮食睡眠可，大小便正常，无腹痛，无便血，近来体重未见明显变化。ECOG，评分：1分。", "entities": [{"end_pos": 30, "label_type": "手术", "overlap": 0, "start_pos": 21}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 53, "end_pos": 54}, {"end_pos": 70, "label_type": "解剖部位", "overlap": 0, "start_pos": 65}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 81, "end_pos": 104}, {"end_pos": 387, "label_type": "解剖部位", "overlap": 0, "start_pos": 386}]}
{"originalText": "缘于入院前3月余于我院诊为“胃癌”，于2014.01.02全麻上行“腹腔镜上根治性全胃切除+食管空肠ROUX-Y吻合术（D2）”，术中见：腹腔内无明显腹水，盆腔、腹壁、大网膜无转移结节，肝脏质地大小正常，未及明显转移病灶。术后病理（201400136）示“（全胃）胃体下段小弯侧溃疡型管状腺癌I级，侵出浆膜层，手术标本下、上切端及另送（下切端）均未见癌浸润，找到贲门右淋巴结3个，小弯淋巴结8个，大弯淋巴结12个，幽门下淋巴结6个，幽门上淋巴结15个，及另送（胃右动脉旁）淋巴结13个，（肝总动脉旁）淋巴结2个，均未见癌转移”，术后予对症、营养支持等治疗，恢复良好,伤口愈合II/甲。于2014.2.11、2014.3.4、2014.3.27于我院予行“奥沙利铂200MGIGVTTD1+卡培他滨1000MGPOBIDD1-14”方案化疗3次，化疗后未见明显化疗副反应，此次为入院再次化疗求诊我院，门诊拟“胃癌术后”收入院。下次出院以来精神、睡眠、饮食可，无腹痛、腹胀、发热，大小便正常，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 16}, {"label_type": "手术", "overlap": 0, "start_pos": 34, "end_pos": 63}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 69}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 78}, {"end_pos": 83, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"end_pos": 87, "label_type": "解剖部位", "overlap": 0, "start_pos": 84}, {"end_pos": 95, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 128, "end_pos": 148}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 181}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 190}, {"end_pos": 203, "label_type": "解剖部位", "overlap": 0, "start_pos": 198}, {"end_pos": 213, "label_type": "解剖部位", "overlap": 0, "start_pos": 207}, {"end_pos": 222, "label_type": "解剖部位", "overlap": 0, "start_pos": 216}, {"end_pos": 239, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"end_pos": 253, "label_type": "解剖部位", "overlap": 0, "start_pos": 243}, {"end_pos": 331, "label_type": "药物", "overlap": 0, "start_pos": 327}, {"end_pos": 348, "label_type": "药物", "overlap": 0, "start_pos": 344}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 403, "end_pos": 407}, {"end_pos": 430, "label_type": "解剖部位", "overlap": 0, "start_pos": 429}, {"end_pos": 433, "label_type": "解剖部位", "overlap": 0, "start_pos": 432}]}
{"originalText": "患者因“宫颈癌”于2015-11-30在我院行经腹广泛子宫+两附件切除+盆腔淋巴清扫术，术后病理检查示：宫颈低分化鳞状细胞癌，内生浸润型，肿物切面积9.3*1.8CM,侵达深肌层，（约占宫壁全层3/4处），阴道壁断端及右左宫旁组织均未查见癌，送检右闭孔淋巴结4枚（0/4），左闭孔淋巴结12枚（0/12），右髂血管淋巴结9枚（0/9），左髂血管淋巴结5枚（0/5），均未查见转移癌。（宫腔）子宫内膜息肉，萎缩状态子宫内膜。（两侧）输卵管、卵巢大致正常。术后于2015-12-09应用力朴素+顺铂化疗一次，化疗过程顺利，副反应不重。现患者进食较差，轻度恶心，无呕吐，无腹胀、腹痛，现为求二次化疗入院，门诊以“宫颈癌术后化疗”收住妇科病房。现一般情况可，睡眠可，进食量少，大小便无异常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 4, "end_pos": 7}, {"label_type": "手术", "overlap": 0, "start_pos": 23, "end_pos": 43}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 52, "end_pos": 68}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 93, "end_pos": 94}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 103, "end_pos": 105}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 111, "end_pos": 112}, {"end_pos": 129, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 143, "label_type": "解剖部位", "overlap": 0, "start_pos": 137}, {"end_pos": 160, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"end_pos": 175, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 191, "end_pos": 201}, {"end_pos": 210, "label_type": "解剖部位", "overlap": 0, "start_pos": 206}, {"end_pos": 218, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"end_pos": 244, "label_type": "药物", "overlap": 0, "start_pos": 241}, {"end_pos": 247, "label_type": "药物", "overlap": 0, "start_pos": 245}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 283}, {"end_pos": 287, "label_type": "解剖部位", "overlap": 0, "start_pos": 286}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 303, "end_pos": 308}]}
{"originalText": "，缘于入院前2月余于我院诊断为胃癌，于2015年01月02日在全麻上行远端胃大部切除术（B-II式）,手术顺利。术后病理(201500055)，示:远端胃)，：胃窦小弯侧溃疡型低分化腺癌（双灶），侵出浆膜层，累及神经，手术标本下、上切端未见癌浸润。找到小弯淋巴结12/13个，大弯淋巴结0/1个，幽门上淋巴结1/1个见癌转移。，基因测结果:计数肿瘤细胞20个HER2/CEN17=1.10HER2/CELL=2.3CEN17/CELL=2.1，结论:HER2基因无扩增,17号染色体呈二倍体。术后恢复可，于2015.02.04、2015.02.27行“盐酸伊立替康注射液280MG静滴D1+替吉奥胶囊(艾奕)60.00MG口服BID*D1-14天”方案化疗，辅以保肝、制酸、免疫支持等对症处理后，化疗过程顺利，无特殊化疗副反应。目前患者无进食可，无特殊不适，要求进一步行化疗，拟“胃癌术后”入院。患者出院后饮食、夜休可，无腹痛、腹胀、发热，体重较前无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 15, "end_pos": 17}, {"label_type": "手术", "overlap": 0, "start_pos": 35, "end_pos": 50}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 76, "end_pos": 77}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 80, "end_pos": 93}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 126}, {"end_pos": 143, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 148}, {"label_type": "药物", "overlap": 0, "start_pos": 276, "end_pos": 285}, {"end_pos": 300, "label_type": "药物", "overlap": 0, "start_pos": 295}, {"end_pos": 303, "label_type": "药物", "overlap": 0, "start_pos": 301}, {"end_pos": 333, "label_type": "解剖部位", "overlap": 0, "start_pos": 332}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 390, "end_pos": 394}, {"end_pos": 412, "label_type": "解剖部位", "overlap": 0, "start_pos": 411}, {"end_pos": 415, "label_type": "解剖部位", "overlap": 0, "start_pos": 414}]}
{"originalText": "，入院前9天（2016.10.25）因“宫颈鳞癌IB1期”于我院气静全麻上行“腹式广泛全子宫切除术+右输卵管切除术+盆腔淋巴结清扫术+两侧卵巢移位术+肠粘连松解术+阴道顶悬吊术”。，术中见：腹腔内无腹水，子宫正常大小，表面光滑，右侧输卵管积水，呈腊肠状，右阔韧带前方粘连，左侧输卵管伞部与左卵巢粘连，峡部见一膨出瘤体，大小约1.5CM×1.5CM，表面光滑，质稍硬；两侧卵巢未见明显异常；肝、脾、膈上、肠管、肠系膜、腹膜等未见明显异。术顺，术后病理（201638443），示：（全子宫+右侧输卵管），：宫颈内生浸润性角化性鳞状细胞癌II级（水平浸润约5CM，垂直浸润深度约1.5CM，约＞1/2肌层）。手术标本阴道切端及两侧宫旁组织未见癌浸润。找到左宫旁淋巴结1个，及另送（右盆腔）淋巴结10个，（左盆腔）淋巴结10个，（右髂总）淋巴结2个，（左髂总）淋巴结7个，均未见癌转移。现无发热、咳嗽、咳痰，无腹痛、腹胀、腹泻，无胸闷、心悸，无恶心、呕吐等不适。为行化疗再次就诊于我院，门诊遂拟“宫颈鳞癌IB1期术后”收入院。自下次出院以来，患者精神、饮食、睡眠尚可，留置导尿，尿管通畅，尿色清，大便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 20, "end_pos": 28}, {"label_type": "手术", "overlap": 0, "start_pos": 39, "end_pos": 88}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 102}, {"end_pos": 119, "label_type": "解剖部位", "overlap": 0, "start_pos": 114}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"end_pos": 143, "label_type": "解剖部位", "overlap": 0, "start_pos": 136}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 144}, {"end_pos": 187, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 194}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 196}, {"end_pos": 200, "label_type": "解剖部位", "overlap": 0, "start_pos": 198}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 201, "end_pos": 202}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 204, "end_pos": 205}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 208, "end_pos": 209}, {"end_pos": 242, "label_type": "解剖部位", "overlap": 0, "start_pos": 239}, {"end_pos": 248, "label_type": "解剖部位", "overlap": 0, "start_pos": 243}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 251, "end_pos": 269}, {"end_pos": 307, "label_type": "解剖部位", "overlap": 0, "start_pos": 305}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 312, "end_pos": 313}, {"end_pos": 330, "label_type": "解剖部位", "overlap": 0, "start_pos": 324}, {"end_pos": 344, "label_type": "解剖部位", "overlap": 0, "start_pos": 336}, {"end_pos": 356, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"end_pos": 368, "label_type": "解剖部位", "overlap": 0, "start_pos": 360}, {"end_pos": 379, "label_type": "解剖部位", "overlap": 0, "start_pos": 371}, {"end_pos": 402, "label_type": "解剖部位", "overlap": 0, "start_pos": 401}, {"end_pos": 405, "label_type": "解剖部位", "overlap": 0, "start_pos": 404}, {"end_pos": 408, "label_type": "解剖部位", "overlap": 0, "start_pos": 407}, {"end_pos": 412, "label_type": "解剖部位", "overlap": 0, "start_pos": 411}, {"end_pos": 415, "label_type": "解剖部位", "overlap": 0, "start_pos": 414}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 444, "end_pos": 454}]}
{"originalText": "，缘于入院前2年患者于我院诊断为“胃癌”，于2013年11月22日在全麻上行“腹腔镜根治性远端胃大部切除术（毕I式D2R0）”，，术中见：无腹水，盆底、膀胱、未及结节；肝表面光滑，腹膜后、空回肠未见结节，肿瘤位于胃小弯侧胃角处，大小3×3×1.5CM，浸润溃疡型，侵出浆膜层，侵及邻近脂肪组织，腹腔动脉周围见数个0.8-1CM大小不一肿大淋巴结。术后病理（201336699），：（远端胃）胃角溃疡型低分化腺癌，侵出浆膜层，侵犯神经，脉管内见癌栓，手术标本下、上切端及另送（下切端）、（上切端）均未见癌浸润。找到小弯淋巴结10/15个，大弯淋巴结1/7个，幽门上淋巴结5/5个，及另送（第七组）淋巴结1/2个，（第八组）淋巴结2/7个，（第九组）淋巴结0/4个，（第十二组）淋巴结0/1个，（第十五组）淋巴结0/1个见癌转移。，免疫组化结果：CK7（++），CK20（-），VILLIN（+++），CEA（-），CDX-2（+++），CGA（-），CD56（-），SY（-），KI67（70%+），HER-2（++）。术后恢复良好,于我院行“多柔比星40MGD1+奥沙利铂（艾恒）150MGD2+希罗达1000MGBIDD1-14”方案行术后化疗8次。化疗后出院后，饮食睡眠可，一般情况可。3天前突发腹痛，伴腹胀，肛门停止排气排便，无恶心呕吐，无畏冷寒战，遂就诊我院，门诊拟“胃癌术后化疗后”收住入院，自发病以来，精神欠佳，饮食欠佳，大便未解，小便如常。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 17, "end_pos": 19}, {"label_type": "手术", "overlap": 0, "start_pos": 39, "end_pos": 62}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 75, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"end_pos": 85, "label_type": "解剖部位", "overlap": 0, "start_pos": 84}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 91}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 106, "end_pos": 112}, {"end_pos": 151, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 190, "end_pos": 205}, {"end_pos": 261, "label_type": "解剖部位", "overlap": 0, "start_pos": 256}, {"end_pos": 273, "label_type": "解剖部位", "overlap": 0, "start_pos": 268}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 278}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 292, "end_pos": 300}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 305, "end_pos": 313}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 318, "end_pos": 326}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 331, "end_pos": 340}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 345, "end_pos": 354}, {"end_pos": 475, "label_type": "药物", "overlap": 0, "start_pos": 471}, {"end_pos": 486, "label_type": "药物", "overlap": 0, "start_pos": 482}, {"end_pos": 489, "label_type": "药物", "overlap": 0, "start_pos": 487}, {"end_pos": 501, "label_type": "药物", "overlap": 0, "start_pos": 498}, {"end_pos": 551, "label_type": "解剖部位", "overlap": 0, "start_pos": 550}, {"end_pos": 555, "label_type": "解剖部位", "overlap": 0, "start_pos": 554}, {"end_pos": 559, "label_type": "解剖部位", "overlap": 0, "start_pos": 557}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 588, "end_pos": 592}]}
{"originalText": "缘于入院前2月余于我院诊断“乙状结肠癌”，于2016-7-25行“腹腔镜上乙状结肠切除术”，术顺，术后予营养支持、制酸保胃、增强免疫及维持电解质平衡等治疗，术后恢复良好。术后病理：大肠溃疡型管状腺癌II级，侵及外膜层。手术标本双切端及另送(下切端)、(上切端)均未见癌浸润。找到肠周淋巴结15个，及另送(肠系膜上A根部）淋巴结1个、(中间组）淋巴结2个，未见癌转移。于2016.08.21、2016.09.13予“奥沙利铂200MGIVGTTD1+卡培他滨1500MGPOBIDD1-14”方案化疗2周期，疗程顺利，未出现明显化疗副作用，今为行术后第3次化疗再诊我院，门诊拟“乙状结肠癌术后化疗”收住入院。自下次出院以来，精神、睡眠、食欲尚可，二便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 19}, {"end_pos": 44, "label_type": "手术", "overlap": 0, "start_pos": 33}, {"end_pos": 61, "label_type": "解剖部位", "overlap": 0, "start_pos": 60}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 90, "end_pos": 102}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 139}, {"end_pos": 163, "label_type": "解剖部位", "overlap": 0, "start_pos": 151}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 166, "end_pos": 174}, {"end_pos": 211, "label_type": "药物", "overlap": 0, "start_pos": 207}, {"end_pos": 228, "label_type": "药物", "overlap": 0, "start_pos": 224}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 288, "end_pos": 295}]}
{"originalText": "，患者2016-07-07于我院在全麻上行\\\"腹腔镜探查+（全胃）胃癌根治术\\\"，，术后病理回报:“（大体）镜检为低分化腺癌，部分为印戒细胞癌，LAUREN，分型:弥漫型，浸润至胃壁浆膜上层，可见神经束侵犯，未见明确脉管内癌栓；网膜组织未见癌。淋巴结51枚，10枚见癌。（远、近切缘）未见癌”，诊断“全胃癌（PT3N3M0，IIIB）”。于2016-08-10、2016-09-07、2016-10-08予以SOX方案化疗三程，化疗过程顺利，现患者无返酸、嗳气、恶心、呕吐、黑便等不适，现为行进一步治疗收入我科。起病以来，患者精神尚可，食欲欠佳，大小便正常，近期体重无明显改变。", "entities": [{"label_type": "手术", "overlap": 0, "start_pos": 23, "end_pos": 38}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 57, "end_pos": 62}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 66, "end_pos": 71}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 72, "end_pos": 85}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 89, "end_pos": 91}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 150, "end_pos": 167}]}
{"originalText": "，患者因2013-1-13外院查CA125 623 U/ML CA199 522 U/ML，01-21，盆腔MR平扫示：1.盆腔右侧附件区占位，考虑来源于右侧附件，以囊性成分为主，伴少许实性壁结节 2.盆腔少量积液.后于*****行分段诊刮，该院及我院病理检查均提示腺癌。完善检查后于2013年01月30日在全身麻醉上行广泛性子宫切除、两侧输卵管卵巢切除及盆腔淋巴结清扫术，，术后组织病理检查报告：1、子宫内膜腺癌诊刮术后全子宫标本，内膜未见癌残留，宫颈、颈管、右左宫旁、阴道壁残端及两输卵管未见癌累及，两卵巢见癌累及。2、右髂内（0/2）、右腹股沟（0/1）、右髂总（0/1）、左闭孔（0/2）、左髂外（0/2）、左腹股沟（0/2）、左髂总（0/2）淋巴结未见癌转移。术后予TP方案化疗４周期，有恶心呕吐及骨髓抑制不良反应，对症支持治疗后好转，今患者为求上一周期化疗再来我院我科住院治疗。\\U0004  患者本次发病以来，食欲正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，体重无明显变化。", "entities": [{"label_type": "实验室检验", "overlap": 0, "start_pos": 16, "end_pos": 21}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 31, "end_pos": 36}, {"label_type": "影像检查", "overlap": 0, "start_pos": 52, "end_pos": 56}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 62, "end_pos": 71}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 101, "end_pos": 107}, {"end_pos": 120, "label_type": "手术", "overlap": 0, "start_pos": 116}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 133, "end_pos": 135}, {"label_type": "手术", "overlap": 0, "start_pos": 160, "end_pos": 186}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 201, "end_pos": 211}, {"end_pos": 214, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 227, "label_type": "解剖部位", "overlap": 0, "start_pos": 225}, {"end_pos": 230, "label_type": "解剖部位", "overlap": 0, "start_pos": 228}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 233, "end_pos": 234}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 236, "end_pos": 238}, {"end_pos": 246, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 255, "label_type": "解剖部位", "overlap": 0, "start_pos": 252}, {"end_pos": 265, "label_type": "解剖部位", "overlap": 0, "start_pos": 262}, {"end_pos": 275, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 281}, {"end_pos": 293, "label_type": "解剖部位", "overlap": 0, "start_pos": 290}, {"end_pos": 302, "label_type": "解剖部位", "overlap": 0, "start_pos": 299}, {"end_pos": 312, "label_type": "解剖部位", "overlap": 0, "start_pos": 308}, {"end_pos": 321, "label_type": "解剖部位", "overlap": 0, "start_pos": 318}, {"end_pos": 329, "label_type": "解剖部位", "overlap": 0, "start_pos": 326}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 354, "end_pos": 358}]}
{"originalText": "，患者2月前因“胃癌”于2014-07-01在在全麻上行胃癌根治术，手术过程顺利，术后患者恢复好，切口愈合好，按期拆线。，术后病理：病理诊断 ，:（胃幽门小弯侧）腺癌（中度分化），浸润溃疡型，体积2*2*0.3CM，侵达深肌层。 双端切线及另送“远端”切线未查见癌。 呈五组（1/1个）淋巴结癌转移。 四组（9个）、六组（4个）及另送“1、3、7组”（11个）淋巴结未查见癌。 ，免疫组化染色示癌组织：CERBB-2（2+）、SYN（-）、ERCC1弥漫（+）、β-TUBULIN-III（-）、TS多量（+）、RRM1少量（+）、TOPOII较多（+）。根据患者病情具有化疗指征，于2014-07-15开始第一周期化疗，，方案为：奥沙利铂150MG D1，亚叶酸钙0.3G+替加氟1.0G D2-D6，同时给与升白细胞、护肝、止吐、免疫增强治疗，注意观察患者病情变化,给予升白、止吐等药物，患者化疗耐受可，无明显化疗副反应。   院外期间患者一般情况好，无恶心，无腹痛腹胀不适，现患者为行复查及化疗再次来院就诊，门诊以“胃癌术后”收入院。   近期患者精神可，饮食可，大便次数多，小便正常，近期体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 8, "end_pos": 10}, {"end_pos": 33, "label_type": "手术", "overlap": 0, "start_pos": 28}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 73, "end_pos": 96}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 135, "end_pos": 146}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 151, "end_pos": 183}, {"end_pos": 320, "label_type": "药物", "overlap": 0, "start_pos": 316}, {"end_pos": 333, "label_type": "药物", "overlap": 0, "start_pos": 329}, {"end_pos": 341, "label_type": "药物", "overlap": 0, "start_pos": 338}, {"end_pos": 363, "label_type": "解剖部位", "overlap": 0, "start_pos": 362}, {"end_pos": 434, "label_type": "解剖部位", "overlap": 0, "start_pos": 433}, {"end_pos": 436, "label_type": "解剖部位", "overlap": 0, "start_pos": 435}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 461, "end_pos": 465}]}
{"originalText": "缘于入院前3月余就诊我院行胃镜检查示：“胃癌”，腹部CT提示“胃体局部管壁不规则增厚，符合胃癌，侵犯浆膜面，伴邻近的网膜种植转移可能及胃周、下腹膜后多发淋巴结转移；病变与肝右外叶、胰头间脂肪间隙模糊”。考虑诊断为“胃癌伴腹腔种植转移”并于2015.04.06、2015.04.29、2015.05.26、2015.06.19予行“奥沙利铂(艾恒)150MG静滴D1+紫杉醇注射液(安素泰)180MG静滴D2+卡培他滨片(希罗达)1000.00MG口服BIDD1-14”方案化疗，期间辅以止吐、保肝、营养支持等治疗，化疗后无特殊不适，今为返院复查行第5周期化疗，门诊拟“胃癌”收治入院。自发病以来，精神、睡眠可，食欲一般，大小便如常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 20, "end_pos": 22}, {"label_type": "影像检查", "overlap": 0, "start_pos": 24, "end_pos": 28}, {"end_pos": 33, "label_type": "解剖部位", "overlap": 0, "start_pos": 31}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 45, "end_pos": 47}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 67, "end_pos": 68}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 70, "end_pos": 72}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 85, "end_pos": 89}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 92}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 107, "end_pos": 116}, {"end_pos": 169, "label_type": "药物", "overlap": 0, "start_pos": 165}, {"end_pos": 172, "label_type": "药物", "overlap": 0, "start_pos": 170}, {"end_pos": 186, "label_type": "药物", "overlap": 0, "start_pos": 183}, {"end_pos": 193, "label_type": "药物", "overlap": 0, "start_pos": 190}, {"end_pos": 209, "label_type": "药物", "overlap": 0, "start_pos": 204}, {"end_pos": 213, "label_type": "药物", "overlap": 0, "start_pos": 210}, {"end_pos": 248, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 284, "end_pos": 286}]}
{"originalText": "患者于2011-6月无明显诱因上出现吞咽困难，进行性加重，伴胸骨后烧灼样疼痛，程度轻，至我院就诊，经检查确诊胸中段食管癌，完善准备后于2011-7-7全麻上行“经左胸下腹颈部食管部分切除+胃食管颈部吻合+二野清扫术”，术后恢复良好，病理示鳞癌，PT3N1M0，左喉返神经旁旁淋巴结转移。于2011-8至2011-10行“泰素帝+奈达铂”方案化疗4程，过程顺利。后于2011-11-8至2011-12-12行辅助性放疗（原发灶50GY，25次），过程顺利。后定期复查未见明显肿瘤复发转移征象，末次复查时间为2012-6。2012-8-13起患者在我科行CIK细胞治疗（QW*4），已回输2次，回输后出现发热，体温最高达39.5度，对症治疗后好转。现为继续治疗入我科。近来，患者无发热、畏寒、寒战，无低热、盗汗、咳嗽，无心悸，无声嘶、呛咳，无骨关节痛，无头痛、视蒙、呕吐，精神、睡眠可，大小便基本正常，体重上降3KG。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 30, "end_pos": 32}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 54, "end_pos": 60}, {"label_type": "手术", "overlap": 0, "start_pos": 80, "end_pos": 107}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 119, "end_pos": 129}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"end_pos": 163, "label_type": "药物", "overlap": 0, "start_pos": 160}, {"end_pos": 167, "label_type": "药物", "overlap": 0, "start_pos": 164}, {"end_pos": 359, "label_type": "解剖部位", "overlap": 0, "start_pos": 358}, {"end_pos": 372, "label_type": "解剖部位", "overlap": 0, "start_pos": 369}, {"end_pos": 376, "label_type": "解剖部位", "overlap": 0, "start_pos": 375}]}
{"originalText": "，患者于2013年6月16日因“停经21周中央型前置胎盘在我院引产”，住院期间（6月18日）行子宫动脉造影术及子宫动脉栓塞术及利凡诺羊膜腔穿刺引产术，，6月22日14：50引产分娩一死婴，当时胎盘粘连剥离不完整，于6月24日在Ｂ超监测上行清宫术，因胎盘粘连重，清宫不全，术后患者发热1天，最高38.6℃，胎盘组织送病检，，病检结果：胎盘组织局灶玻变，大量炎细胞浸润；给予“益保世灵”抗感染治疗，口服补佳乐增加子宫内膜等治疗，本拟择日复查B超后清宫；但后患者及家属签字出院，办理出院后，患者突然阴道流血增加，约60ML，伴头晕，乏力，心悸不适，无恶心呕吐，无呼吸困难，无晕厥，无畏寒发热等不适；故再次办理入院，入院时患者一般情况可，生命体征正常；\\U0004   患者本次发病以来，食欲正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 21, "end_pos": 28}, {"label_type": "手术", "overlap": 0, "start_pos": 47, "end_pos": 74}, {"label_type": "影像检查", "overlap": 0, "start_pos": 113, "end_pos": 115}, {"end_pos": 122, "label_type": "手术", "overlap": 0, "start_pos": 119}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 166, "end_pos": 182}, {"end_pos": 190, "label_type": "药物", "overlap": 0, "start_pos": 186}, {"end_pos": 202, "label_type": "药物", "overlap": 0, "start_pos": 199}, {"end_pos": 208, "label_type": "解剖部位", "overlap": 0, "start_pos": 204}, {"label_type": "影像检查", "overlap": 0, "start_pos": 218, "end_pos": 220}, {"end_pos": 248, "label_type": "解剖部位", "overlap": 0, "start_pos": 246}, {"end_pos": 261, "label_type": "解剖部位", "overlap": 0, "start_pos": 260}, {"end_pos": 267, "label_type": "解剖部位", "overlap": 0, "start_pos": 266}]}
{"originalText": "，患者因“肝恶性肿瘤术后11月余，腹胀10余天”于2014-05-31第1次入院。，查体：腹部平坦，下腹部可见一长约25CM“反L”型手术切口，愈合良好。腹软，上腹轻压痛，无反跳痛，肝、脾肋上未触及，MURPHY'S征阴性，肝、肾区无叩痛，肠鸣音无亢进，移动性浊音阴性。两上肢无水肿。患者入院后完善相关检查检验，，腹部彩超：肝硬化部分切除术后；肝硬化；胆囊切除术后；腹腔积液（少量）。，心电图：1.窦性心律2.大致正常心电图。，明确诊断为：1.肝恶性肿瘤术后2.胆囊切除术后状态。给予保肝、降酶、抗病毒、利尿及对症支持治疗。2014.6.5行DSA上选择性肝动脉造影及TACE术，并行CIK体细胞治疗术。患者病情好转出院。   出院后患者继续服用“恩替卡韦分散片、熊去氧胆酸胶囊”，间断服用“螺内酯片、呋塞米片”，病情稳定，偶有两上肢凹陷性水肿。为行CIK细胞治疗术，分别于2014-07-19、2014-08-23第二、三次入院。入院后完善相关辅助检查，给予保肝、抗病毒、调节免疫、CIK体细胞回输及对症支持治疗，病情好转后出院。   患者出院后病情平稳，为复查及进一步诊治分别于2014-12-04、2015-04-16、2015-09-28、2015-10-28、2015-12-13、2016-04-07、2016-05-19、2016-8-16、2016-12-14、2017-03-15第四-十三次住院。入院后完善相关检查，给予抗病毒、调节免疫及对症支持治疗，行DSA上选择性肝动脉造影及TACE术，并行CIK体细胞治疗术及TACE术。经治疗患者病情好转出院。   患者出院后继续服用“恩替卡韦分散片”，病情稳定。因“肝恶性肿瘤术后4年余”于2017-7-10第14次入院。，查体：心肺查体未见明显异常，腹部平坦，下腹部可见一长约25CM“反L”型手术疤痕，愈合良好。腹软，无压痛，无反跳痛。肝、脾肋上未触及，MURPHY'S征阴性，肝、肾区无叩痛，肠鸣音无亢进，移动性浊音阴性。患者入院后完善相关化验检查，下腹部MRI平扫+，增强：肝左叶异常信号，符合肝CA.MR表现，结合病史考虑转移瘤可能，肝右左叶交界处异常信号，考虑肝CA治疗后改变，较前变化不明显，符合肝内多发小囊肿表现，脾大。给予保肝、降酶、抗病毒、调节免疫及对症支持治疗。于2017年7月12日行DSA上选择性肝动脉造影+TACE术。经治疗患者症状好转，因个人原因自动出院，并签署自动出院协议。   患者出院后病情稳定，继续服用“恩替卡韦分散片”，无发热，无腹痛、腹胀、腹泻，无恶心、呕吐，无乏力、纳差，无反酸、烧心，无呕血、黑便，无心悸、胸闷、胸痛，无头晕、头痛、黑朦、晕厥等。现为复查及进一步治疗今来我院，门诊以“PHC”收入院。   患者自本次发病以来，神志清，精神可，饮食睡眠佳，大小便未见异常，近期体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 5, "end_pos": 12}, {"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 17}, {"end_pos": 47, "label_type": "解剖部位", "overlap": 0, "start_pos": 45}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 50}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 92, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"end_pos": 96, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"end_pos": 113, "label_type": "解剖部位", "overlap": 0, "start_pos": 112}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 114}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"label_type": "影像检查", "overlap": 0, "start_pos": 157, "end_pos": 161}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 162, "end_pos": 171}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 172, "end_pos": 175}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 176, "end_pos": 182}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 183, "end_pos": 191}, {"label_type": "影像检查", "overlap": 0, "start_pos": 193, "end_pos": 196}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 199, "end_pos": 203}, {"label_type": "影像检查", "overlap": 0, "start_pos": 209, "end_pos": 212}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 222, "end_pos": 229}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 231, "end_pos": 237}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 243}, {"label_type": "手术", "overlap": 0, "start_pos": 271, "end_pos": 289}, {"end_pos": 331, "label_type": "药物", "overlap": 0, "start_pos": 324}, {"end_pos": 339, "label_type": "药物", "overlap": 0, "start_pos": 332}, {"end_pos": 350, "label_type": "药物", "overlap": 0, "start_pos": 346}, {"end_pos": 355, "label_type": "药物", "overlap": 0, "start_pos": 351}, {"end_pos": 367, "label_type": "解剖部位", "overlap": 0, "start_pos": 364}, {"end_pos": 432, "label_type": "解剖部位", "overlap": 0, "start_pos": 431}, {"label_type": "手术", "overlap": 0, "start_pos": 637, "end_pos": 655}, {"end_pos": 673, "label_type": "手术", "overlap": 0, "start_pos": 668}, {"end_pos": 706, "label_type": "药物", "overlap": 0, "start_pos": 699}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 715, "end_pos": 722}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 747, "end_pos": 748}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 748, "end_pos": 749}, {"end_pos": 760, "label_type": "解剖部位", "overlap": 0, "start_pos": 758}, {"end_pos": 766, "label_type": "解剖部位", "overlap": 0, "start_pos": 763}, {"end_pos": 791, "label_type": "解剖部位", "overlap": 0, "start_pos": 790}, {"end_pos": 803, "label_type": "解剖部位", "overlap": 0, "start_pos": 802}, {"end_pos": 805, "label_type": "解剖部位", "overlap": 0, "start_pos": 804}, {"end_pos": 807, "label_type": "解剖部位", "overlap": 0, "start_pos": 805}, {"end_pos": 824, "label_type": "解剖部位", "overlap": 0, "start_pos": 823}, {"end_pos": 826, "label_type": "解剖部位", "overlap": 0, "start_pos": 825}, {"end_pos": 832, "label_type": "解剖部位", "overlap": 0, "start_pos": 831}, {"label_type": "影像检查", "overlap": 0, "start_pos": 860, "end_pos": 866}, {"end_pos": 876, "label_type": "解剖部位", "overlap": 0, "start_pos": 873}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 883, "end_pos": 886}, {"label_type": "影像检查", "overlap": 0, "start_pos": 887, "end_pos": 889}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 904, "end_pos": 908}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 918, "end_pos": 924}, {"end_pos": 938, "label_type": "解剖部位", "overlap": 0, "start_pos": 937}, {"end_pos": 948, "label_type": "解剖部位", "overlap": 0, "start_pos": 947}, {"end_pos": 954, "label_type": "解剖部位", "overlap": 0, "start_pos": 953}, {"label_type": "手术", "overlap": 0, "start_pos": 986, "end_pos": 1004}, {"end_pos": 1060, "label_type": "药物", "overlap": 0, "start_pos": 1053}, {"end_pos": 1068, "label_type": "解剖部位", "overlap": 0, "start_pos": 1067}, {"end_pos": 1071, "label_type": "解剖部位", "overlap": 0, "start_pos": 1070}, {"end_pos": 1074, "label_type": "解剖部位", "overlap": 0, "start_pos": 1073}, {"end_pos": 1106, "label_type": "解剖部位", "overlap": 0, "start_pos": 1105}, {"end_pos": 1109, "label_type": "解剖部位", "overlap": 0, "start_pos": 1108}, {"end_pos": 1112, "label_type": "解剖部位", "overlap": 0, "start_pos": 1111}, {"end_pos": 1116, "label_type": "解剖部位", "overlap": 0, "start_pos": 1115}, {"end_pos": 1119, "label_type": "解剖部位", "overlap": 0, "start_pos": 1118}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 1147, "end_pos": 1150}]}
{"originalText": "患者于6月前因“解稀烂便”完善检查发现结肠癌伴肝转移，2月2日行结肠癌手术切除，手术顺利，术后行FOLFOX方案化疗2程。2月前复查CT发现肝内病灶较前进展，故于2012-4-17、5-3予以FOLFIRI化疗2程，过程顺利。复查CT提示肝脏病变较前增大，考虑PD。故予FOLFIRI＋AVASTIN方案化疗3程，过程顺利。今日为求进一步诊治来我院。患者发病以来,无症状。精神佳,饮食睡眠佳,大小便正常，体重无减轻。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 19, "end_pos": 26}, {"label_type": "手术", "overlap": 0, "start_pos": 32, "end_pos": 37}, {"label_type": "影像检查", "overlap": 0, "start_pos": 66, "end_pos": 68}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"label_type": "影像检查", "overlap": 0, "start_pos": 115, "end_pos": 117}, {"end_pos": 121, "label_type": "解剖部位", "overlap": 0, "start_pos": 119}, {"end_pos": 150, "label_type": "药物", "overlap": 0, "start_pos": 143}]}
{"originalText": "患儿1年余前无诱因出现体重逐渐上降，由35KG逐渐上降至25KG，无多饮多尿，无低热，无咳嗽，无腹泻，未予治疗，半年前出现反复腹痛，中下腹为主，有夜间痛醒情况，与进食无关，排便后腹痛稍缓解，在我院住院完善检查后诊断为“炎症性肠病”，5.19在我院用第一次类克，现为进一步治疗再次入院。病程中患儿无发热，无咳嗽，无呕吐，无便血，无明显腹痛，患儿目前精神食欲可，睡眠可，大便有少量粘液，日约2次，无便血，小便无殊。患儿近1年余来口水多，近1年内体重上降10KG。                      第一次入院录（2016.4.28-2016.5.12）患儿因“体重上降1年余，腹痛半年”入院，入院后予以低纤维半流质饮食，头孢他啶联合奥硝唑抗感染，于5-4行胃镜、肠镜检查术，术顺安返。内镜上见横结肠弥漫性息肉样隆起，溃疡性改变。考虑炎症性肠病，予以加用常乐康调节肠道菌群。病理报告符合炎症性肠病。患儿无发热，无明显腹痛腹胀，呕血黑便，家属因经济问题，要求出院，待部分血报告回，再次入院考虑行生物制剂治疗原发病。                       第二次入院录（2016.5.17-2016.5.21）。", "entities": [{"end_pos": 49, "label_type": "解剖部位", "overlap": 0, "start_pos": 48}, {"end_pos": 64, "label_type": "解剖部位", "overlap": 0, "start_pos": 63}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 66}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 89, "end_pos": 90}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 109, "end_pos": 114}, {"end_pos": 129, "label_type": "药物", "overlap": 0, "start_pos": 127}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 166}, {"end_pos": 291, "label_type": "解剖部位", "overlap": 0, "start_pos": 290}, {"end_pos": 316, "label_type": "药物", "overlap": 0, "start_pos": 312}, {"end_pos": 321, "label_type": "药物", "overlap": 0, "start_pos": 318}, {"end_pos": 351, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 368, "end_pos": 373}, {"end_pos": 381, "label_type": "药物", "overlap": 0, "start_pos": 378}, {"end_pos": 384, "label_type": "解剖部位", "overlap": 0, "start_pos": 383}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 394, "end_pos": 399}, {"end_pos": 410, "label_type": "解剖部位", "overlap": 0, "start_pos": 409}, {"end_pos": 412, "label_type": "解剖部位", "overlap": 0, "start_pos": 411}]}
{"originalText": "，入院前3月，患者曾因“反复呕吐”于我院住院治疗，并于2016.03.17于我科行腹腔镜上胃癌根治术，手术顺利，，术后病理提示：（胃）溃疡型中分化管状腺癌，浸及胃壁全层，双切端未见癌累及，胃大小弯淋巴结未见癌转移（分别为0/10、0/10），网膜组织未见癌累及。，诊断为：溃疡型中分化管状腺癌（T3N0M0）,术后患者行静脉化疗1次，化疗过程中无恶心、呕吐等不适，今日患者为求第2次化疗入院，门诊遂以“胃癌术后化疗”收住。\\U0004   患者自起病以来，精神可，胃纳可，大便如常，小便如常，体重未见明显上降。", "entities": [{"end_pos": 50, "label_type": "手术", "overlap": 0, "start_pos": 41}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 64, "end_pos": 77}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 101, "label_type": "解剖部位", "overlap": 0, "start_pos": 94}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 136, "end_pos": 154}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 201, "end_pos": 205}]}
{"originalText": "缘于入院前1月余因“胆石症、急性胆囊炎”就诊我院，下腹部CT示：1、胆总管上段多发结石，伴肝内外胆管扩张。2、急性胆囊炎，胆囊多发结石。入院后予抗感染，保肝，抑制胰酶分泌，营养支持等治疗，于2014.01.16在B超定位上行“胆囊穿刺造瘘术”，术顺，术后症状好转，家属要求出院。此次为行进一步治疗再次就诊我院，门诊拟“胆石症PTCD术后”收入院，自发病以来神志清，精神不振，饮食少，睡眠可，二便正常，体重未见明显增减。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 14, "end_pos": 19}, {"label_type": "影像检查", "overlap": 0, "start_pos": 25, "end_pos": 30}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 34, "end_pos": 43}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 45, "end_pos": 52}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 55, "end_pos": 60}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 61, "end_pos": 67}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 82, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"label_type": "影像检查", "overlap": 0, "start_pos": 106, "end_pos": 108}, {"end_pos": 120, "label_type": "手术", "overlap": 0, "start_pos": 113}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 159, "end_pos": 168}]}
{"originalText": "，缘于入院前2月无明显诱因出现便秘，无里急后重、排便不尽感，偶伴有血便，为鲜血便，大便附于大便表面。无腹痛、腹胀，无腹泻，无恶心、呕吐，无呕血、黑便，无肛门停止排气、排便，无畏冷、发热。就诊于我院，，行肠镜：“乙状结肠癌”，，病理：“大肠管状腺瘤下皮呈高级别下皮内瘤变伴癌变”，遂门诊拟乙状结肠癌收入院，发病以来，精神、睡眠、食欲尚可，大便如下述，小便如常，体重无明显变化。", "entities": [{"end_pos": 52, "label_type": "解剖部位", "overlap": 0, "start_pos": 51}, {"end_pos": 55, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"end_pos": 59, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 105, "end_pos": 110}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 117, "end_pos": 137}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 143, "end_pos": 148}]}
{"originalText": "，患者2年前无明显诱因出现大便异常，为青色成形软便，约2-3次/天，无粘液脓血便，无发热，无腹痛、腹泻、腹胀，无反酸、烧心，无恶心、呕吐，无进食阻挡感及哽噎感，无胸骨后疼痛，无乏力、纳差，无呕血、黑便，无停止排便、排气、腹胀，未诊疗。患者下述症状持续存在，未诊治。为明确病情，患者20天前于我院查体中心体检，，查体示：幽门螺旋杆菌抗体阳性。为求进一步治疗就诊于我院门诊，查凝血四项、乙肝五项未见明显异常，，心电图：1.窦性心律2.大致正常心电图，建议行胃肠镜检查。患者今日于内镜室行胃肠镜检查，胃镜提示慢性胃炎，，结肠镜提示：结肠息肉，并行结肠息肉内镜上切除治疗，操作顺利，报告未回，为进一步诊治，门诊以“肠息肉”收住院。   患者自发病以来，神志清，精神可，饮食、睡眠可，大、小便如前所述，体重近期无明显变化。", "entities": [{"end_pos": 47, "label_type": "解剖部位", "overlap": 0, "start_pos": 46}, {"end_pos": 50, "label_type": "解剖部位", "overlap": 0, "start_pos": 49}, {"end_pos": 53, "label_type": "解剖部位", "overlap": 0, "start_pos": 52}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 81, "end_pos": 83}, {"end_pos": 111, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 159, "end_pos": 167}, {"label_type": "影像检查", "overlap": 0, "start_pos": 203, "end_pos": 206}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 209, "end_pos": 213}, {"label_type": "影像检查", "overlap": 0, "start_pos": 219, "end_pos": 222}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 251, "end_pos": 255}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 263, "end_pos": 267}, {"end_pos": 279, "label_type": "手术", "overlap": 0, "start_pos": 270}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 303, "end_pos": 306}]}
{"originalText": "，患者1月前无明显诱因出现腹泻，5-6次/日，量少，不成形，混有粘液，无脓血，伴左上腹痛，无明显放射痛，无发热，无恶心、呕吐，无腹胀，于我院急诊科就诊，，行腹部彩超示：符合急性阑尾炎声像图表现。给予“来立信”、“甲硝唑”治疗1周，患者左上腹痛消失，仍有腹泻，5-6次/日，混有粘液，无脓血，未再系统治疗。1周前于我门诊就诊，，行电子结肠镜示：溃疡性结肠炎；镜上取活检2块，，病理结果示：（直肠）粘膜充血、水肿，急慢性发炎，局部粘膜糜烂。建议其住院治疗，患者因个人原因，未能入院。患者仍有腹泻，为求系统治疗今来我院，门诊以“溃疡性结肠炎”收入院。   患者自发病以来，神志清，精神可，饮食睡眠可，大便同下，小便正常，近期体重无明显变化。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 13}, {"end_pos": 43, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"end_pos": 65, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"label_type": "影像检查", "overlap": 0, "start_pos": 78, "end_pos": 82}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 86, "end_pos": 91}, {"end_pos": 103, "label_type": "药物", "overlap": 0, "start_pos": 100}, {"end_pos": 109, "label_type": "药物", "overlap": 0, "start_pos": 106}, {"end_pos": 120, "label_type": "解剖部位", "overlap": 0, "start_pos": 117}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 126}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 171, "end_pos": 177}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 194, "end_pos": 196}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 205, "end_pos": 210}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 243}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 261, "end_pos": 267}]}
{"originalText": "患者1余年前无明显诱因出现大便排出困难，同时伴有排便不尽感，遂至我院诊治，行纤维结肠镜检查示：结肠息肉，电凝切除，并予“痔疮栓”等治疗（具体不详），效果尚可，回家后大便困难症状复现，症状逐渐加重，未予系统诊治。现为系统治疗，进一步缓解病情，特来我院，门诊以“便秘”收入院患者自发病以来，神志清，精神可，饮食量及夜间睡眠可，小便可，大便每日1次，质软排出欠通畅，无恶心、呕吐，体重无明显减轻。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 47, "end_pos": 51}, {"label_type": "手术", "overlap": 0, "start_pos": 52, "end_pos": 56}]}
{"originalText": "患者于50年前渐出现两上肢浅表蚯蚓状肿物，以久立、劳累后明显，休息并抬高患肢后可减轻。无患肢水肿、皮肤搔痒不适、脱屑、颜色改变。无上肢酸痛、疼痛、发热、头痛、恶心。无特殊治疗。于3年前渐出现两小腿皮肤颜色加深，站立容易疲劳感觉，无上肢疼痛、肿胀，无头晕、头痛、胸闷、气促等不适，于2年前就诊我院门诊，门诊以两侧上肢静脉曲张收入院。入院后行上肢静脉造影，术中见：1.左髂总静脉血栓，中度阻塞，右腘静脉附壁血栓12.87*53.88MM大小，中度阻塞，右髂总静脉下段95%狭窄，右髂外静脉上段后前向75%狭窄，右下下肺动脉栓塞。予行上腔静脉滤器置入、两侧髂静脉支架置入等治疗。术后予抗凝、改善循环等治疗。患者恢复顺利出院，出院后口服华法林抗凝治疗，两上肢浅表蚯蚓状肿物无明显改善，2月前于我科行“左上肢大隐静脉手术”，手术顺利，恢复良好出院，今为进一步治疗，再次就诊我院，门诊拟“右大隐静脉曲张；左大隐静脉曲张术后；两侧髂静脉支架术后；上腔静脉滤器置入术后”收住入院。患者自发病以来无明显胸闷、气短，无发烧，精神状态一般，食欲一般，睡眠良好，体重无明显变化，大便正常，小便正常。", "entities": [{"end_pos": 13, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"end_pos": 67, "label_type": "解剖部位", "overlap": 0, "start_pos": 65}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 95, "end_pos": 98}, {"end_pos": 117, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 124}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 127}, {"end_pos": 131, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 153, "end_pos": 161}, {"label_type": "影像检查", "overlap": 0, "start_pos": 169, "end_pos": 175}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 182, "end_pos": 189}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 195, "end_pos": 203}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 224, "end_pos": 229}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 237, "end_pos": 242}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 253, "end_pos": 261}, {"label_type": "手术", "overlap": 0, "start_pos": 264, "end_pos": 282}, {"end_pos": 317, "label_type": "药物", "overlap": 0, "start_pos": 314}, {"end_pos": 325, "label_type": "解剖部位", "overlap": 0, "start_pos": 322}, {"label_type": "手术", "overlap": 0, "start_pos": 346, "end_pos": 355}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 388, "end_pos": 395}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 396, "end_pos": 405}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 406, "end_pos": 415}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 416, "end_pos": 426}, {"end_pos": 443, "label_type": "解剖部位", "overlap": 0, "start_pos": 442}]}
{"originalText": "入院前55天因“肝内外胆管结石伴急性胆管炎”于我科行“胆囊切除+胆总管切口取石术+T管引流术”，术顺，术后予抗感染、保肝、营养支持等处理。40天前出现左上腹手术切口开裂，并出现黄白色脓性液体流出，量较多，伴切口部位胀痛不适，无畏寒、寒战、发热，无恶心、呕吐，无眼黄、尿黄、皮肤黄等，诊断“术后切口感染”，予行术后伤口切开清创处理，并予营养支持、补液、加强换药等治疗，后腹痛缓解、切口愈合良好，出院后无腹痛、腹胀、切口红肿流脓，无恶心、呕吐、眼黄、尿黄、畏冷、发热等。今为进一步行“胆道镜检查”，门诊拟“胆石症术后”收住院。前次出院以来，精神、睡眠、食欲尚可，大小便如常，体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 8, "end_pos": 21}, {"label_type": "手术", "overlap": 0, "start_pos": 27, "end_pos": 46}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 144, "end_pos": 150}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 184}, {"end_pos": 201, "label_type": "解剖部位", "overlap": 0, "start_pos": 200}, {"end_pos": 204, "label_type": "解剖部位", "overlap": 0, "start_pos": 203}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 251, "end_pos": 256}]}
{"originalText": "，患者因“腹痛2天”于2017-4-6第1次入院，既往“高血压病”病史14年，血压最高达180/110MMHG，在家间断服用保健品（具体不详），血压控制欠佳；14年前有“酒精性脂肪肝、下消化道出血”病史，9年前双次因“急性胰腺炎”入院治疗，7年前及6年前双次因“慢性胰腺炎急性发作”入院治疗，查体发现“2型糖尿病”病史9年，未服用降糖药物，血糖控制欠佳。否认冠心病等慢性病病史，否认肝炎、结核等传染病及其接触史，6年前行“胆囊切除术、胆总管空肠ROUX-EN-Y吻合术”。，查体：T ，: 37.2℃，P ，: 71次/分，R ，: 17次/分，BP ，: 153/88MMHG。心肺查体未见异常。腹部平坦，左侧腹部可见一长约20CM纵行手术疤痕，愈合良好。全腹压痛，无反跳痛，以中下腹为重。肝、脾肋上未触及，MURPHY'S征阴性，肝区无叩痛，肠鸣音无亢进，移动性浊音阴性。脊柱无畸形，四肢无畸形，两上肢无水肿。两上肢足背动脉搏动正常。，患者入院后完善相关辅助检查：C反应蛋白 87 MG/L, 葡萄糖 8.52 MMOL/L,同型半胱氨酸 26.30 UMOL/L,血浆凝血酶原时间活动度 61.50 %,活化部分凝血活酶时间 40.8 秒,活化部分凝血活酶比率 1.54 ,血浆D二聚体测定 0.72 MG/L,降钙素原 0.601NG/ML,中性粒细胞百分比 0.889 ,淋巴细胞计数 0.27× 10^9/L,血小板计数 48 ×10^9/L,HBCAB(ECLIA) 0.008阳性COI,大便潜血阳性 ,，尿常规：粒细胞 +1 ,尿糖 +- ,酮体+2 ,白细胞 80 /UL,鳞状下皮细胞 15 /UL,消化道肿瘤未见明显异常。，心电图诊断：1.窦性心律2.ST-T改变。腹部立位片（20170406），：考虑不完全性肠梗阻，请结合临床。腹部，CT:胰腺异常改变，考虑慢性胰腺炎急性发作，请结合临床；胆囊术后CT所见；脂肪肝、脾大。给予抗感染、抑酸、补液、加强营养、提高免疫力等治疗。经治疗患者病情好转，2017-04-18，行肠镜示：1.结肠多发憩室2.降结肠病变性质？，胃镜示：1.早期食管癌2.慢性萎缩性胃炎3.十二指肠球炎4.十二指肠球部胃黏膜异位。行早期食管癌（癌前病变）内镜上切除术，，病理诊断：（食管距门齿28CM）鳞状下皮高级别下皮内瘤变（中度不典型增生）。（十二指肠球部）粘膜水肿，轻度慢性发炎，腺体轻度增生。（降结肠1、2）粘膜水肿及慢性发炎，局部浅表溃疡形成，肉芽组织增生，另见片状渗出物。继续抑酸、补液、抗感染等治疗。于2017-04-24行食管早期病变内镜上切除术。术后生命体征平稳，给予禁食、胃肠减压3天，并给予抑酸、抗感染、补液及对症支持治疗。，术后病理示：（食管距门齿28CM）鳞状下皮高级别下皮内瘤变（面积0.5×0.4CM），未累及切缘及底部切除面。经治疗患者症状好转，未诉明显不适，予以出院。   患者出院后病情稳定，无腹痛、腹胀，无恶心、呕吐，无反酸、烧心，无头晕、头痛，无发热、畏寒，无心慌、胸闷、胸痛，无肩部及腰背部放射痛，无进食阻挡感及哽噎感，无尿频、尿急、尿痛，尿色、尿量无明显异常，无腹泻、便秘，排便1次/天，为黄色成形软便，肛门未停止排便排气。今为复查，前来我院就诊，门诊以“食管恶性肿瘤ESD术后”收入我科。   患者自发病以来，神志清，精神可，饮食、睡眠尚可，大小便如前所述。近期体重未见明显减轻。", "entities": [{"end_pos": 6, "label_type": "解剖部位", "overlap": 0, "start_pos": 5}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 28, "end_pos": 32}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 85, "end_pos": 91}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 92, "end_pos": 98}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 109, "end_pos": 114}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 131, "end_pos": 140}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 151, "end_pos": 156}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 179, "end_pos": 182}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 191, "end_pos": 193}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 194, "end_pos": 196}, {"label_type": "手术", "overlap": 0, "start_pos": 211, "end_pos": 234}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 290, "end_pos": 291}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 291, "end_pos": 292}, {"end_pos": 301, "label_type": "解剖部位", "overlap": 0, "start_pos": 299}, {"end_pos": 308, "label_type": "解剖部位", "overlap": 0, "start_pos": 304}, {"end_pos": 331, "label_type": "解剖部位", "overlap": 0, "start_pos": 330}, {"end_pos": 343, "label_type": "解剖部位", "overlap": 0, "start_pos": 340}, {"end_pos": 347, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"end_pos": 349, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"end_pos": 351, "label_type": "解剖部位", "overlap": 0, "start_pos": 349}, {"end_pos": 369, "label_type": "解剖部位", "overlap": 0, "start_pos": 367}, {"end_pos": 374, "label_type": "解剖部位", "overlap": 0, "start_pos": 373}, {"end_pos": 390, "label_type": "解剖部位", "overlap": 0, "start_pos": 388}, {"end_pos": 396, "label_type": "解剖部位", "overlap": 0, "start_pos": 394}, {"end_pos": 403, "label_type": "解剖部位", "overlap": 0, "start_pos": 400}, {"end_pos": 414, "label_type": "解剖部位", "overlap": 0, "start_pos": 407}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 434, "end_pos": 439}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 449, "end_pos": 452}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 465, "end_pos": 471}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 485, "end_pos": 496}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 505, "end_pos": 515}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 523, "end_pos": 533}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 540, "end_pos": 548}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 559, "end_pos": 563}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 575, "end_pos": 583}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 591, "end_pos": 597}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 611, "end_pos": 616}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 628, "end_pos": 633}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 652, "end_pos": 656}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 665, "end_pos": 668}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 673, "end_pos": 675}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 680, "end_pos": 682}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 686, "end_pos": 689}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 697, "end_pos": 703}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 711, "end_pos": 716}, {"label_type": "影像检查", "overlap": 0, "start_pos": 724, "end_pos": 727}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 732, "end_pos": 736}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 738, "end_pos": 744}, {"label_type": "影像检查", "overlap": 0, "start_pos": 745, "end_pos": 750}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 764, "end_pos": 771}, {"label_type": "影像检查", "overlap": 0, "start_pos": 778, "end_pos": 783}, {"end_pos": 786, "label_type": "解剖部位", "overlap": 0, "start_pos": 784}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 793, "end_pos": 802}, {"label_type": "影像检查", "overlap": 0, "start_pos": 809, "end_pos": 815}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 818, "end_pos": 821}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 822, "end_pos": 823}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 879, "end_pos": 885}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 887, "end_pos": 892}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 902, "end_pos": 907}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 909, "end_pos": 916}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 918, "end_pos": 924}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 926, "end_pos": 937}, {"end_pos": 956, "label_type": "手术", "overlap": 0, "start_pos": 939}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 964, "end_pos": 966}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 967, "end_pos": 969}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 974, "end_pos": 986}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 997, "end_pos": 1003}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 1009, "end_pos": 1015}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1024, "end_pos": 1027}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 1036, "end_pos": 1040}, {"end_pos": 1104, "label_type": "手术", "overlap": 0, "start_pos": 1092}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1119, "end_pos": 1120}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1120, "end_pos": 1121}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1154, "end_pos": 1156}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1157, "end_pos": 1159}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 1164, "end_pos": 1176}, {"end_pos": 1239, "label_type": "解剖部位", "overlap": 0, "start_pos": 1238}, {"end_pos": 1242, "label_type": "解剖部位", "overlap": 0, "start_pos": 1241}, {"end_pos": 1260, "label_type": "解剖部位", "overlap": 0, "start_pos": 1259}, {"end_pos": 1263, "label_type": "解剖部位", "overlap": 0, "start_pos": 1262}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1273, "end_pos": 1274}, {"end_pos": 1277, "label_type": "解剖部位", "overlap": 0, "start_pos": 1276}, {"end_pos": 1280, "label_type": "解剖部位", "overlap": 0, "start_pos": 1279}, {"end_pos": 1285, "label_type": "解剖部位", "overlap": 0, "start_pos": 1283}, {"end_pos": 1289, "label_type": "解剖部位", "overlap": 0, "start_pos": 1286}, {"end_pos": 1327, "label_type": "解剖部位", "overlap": 0, "start_pos": 1326}, {"end_pos": 1349, "label_type": "解剖部位", "overlap": 0, "start_pos": 1347}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 1373, "end_pos": 1384}]}
{"originalText": "患者无明显诱因出现中下腹隐痛下腹隐痛不适，为阵发性（持续时间不详），进食后加重，无反射痛，与时间及活动无关，伴腹胀、反酸及嗳气，感恶心，无呕吐，无呕血及黑便，无明显咳嗽，有痰，不易咳出，无咯血，时感心悸，无胸闷，院外行冠脉造影、腹部彩超未见异常，给予抑酸、护胃等对症支持治疗后症状无明显好转。后腹痛反复发作（症状同前），院外行胃镜检查示“浅表性胃窦炎”，心电图无异常，现为求进一步诊疗，收入我院。\\U0004   患者本次发病以来，食欲正常， 神志清醒，精神尚可，睡眠尚可，解黄色软便，小便正常，体重无明显变化。", "entities": [{"end_pos": 12, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 14}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"end_pos": 100, "label_type": "解剖部位", "overlap": 0, "start_pos": 99}, {"end_pos": 104, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"label_type": "影像检查", "overlap": 0, "start_pos": 109, "end_pos": 113}, {"label_type": "影像检查", "overlap": 0, "start_pos": 114, "end_pos": 118}, {"end_pos": 130, "label_type": "解剖部位", "overlap": 0, "start_pos": 129}, {"end_pos": 148, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 169, "end_pos": 175}, {"label_type": "影像检查", "overlap": 0, "start_pos": 177, "end_pos": 180}]}
{"originalText": "患者于2012年2月17日因“右上腹阵发性隐痛1月余”入我院就诊，诊断为结肠脾曲MT，并于2012年2月21日行右半结肠根治术。术后患者一般情况好，无腹痛腹胀等不适，生命体征平稳，切口愈合良好，腹部平软，无压痛。患者于2012年2月29日突发腹胀腹痛伴寒战高热，原引流管处可见粪渣样物渗出，认为吻合口瘘明确，予急行横结肠造瘘术，术中伤口粪块感染，术后入外科监护室，于2012年3月5日转入我科。经诊治，患者生命体征平稳，一般情况可，无腹痛腹胀等不适症状，切口愈合良好，腹部平软，无压痛，于2012年4月9日出院。现患者为行造瘘肠段回纳术入院。出院至今，病人精神睡眠佳，胃纳可，大便成形，颜色无殊，小便正常。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 15}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 36, "end_pos": 42}, {"end_pos": 63, "label_type": "手术", "overlap": 0, "start_pos": 56}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 99, "label_type": "解剖部位", "overlap": 0, "start_pos": 97}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 124, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 163, "label_type": "手术", "overlap": 0, "start_pos": 157}, {"end_pos": 218, "label_type": "解剖部位", "overlap": 0, "start_pos": 217}, {"end_pos": 220, "label_type": "解剖部位", "overlap": 0, "start_pos": 219}, {"end_pos": 236, "label_type": "解剖部位", "overlap": 0, "start_pos": 234}, {"end_pos": 268, "label_type": "手术", "overlap": 0, "start_pos": 261}]}
{"originalText": "，缘于入院前2月余前无明显诱因出现中下腹部闷痛不适，为持续性隐，可放射至后背部，与进食无关，无恶心、呕吐、返酸、嗳气、纳差、乏力、消瘦、腹泻、便秘，无呕血、黑便，无发热、咳嗽、咳痰，未予治疗，症状无明显好转。1，周前至我院门诊行胃镜检查示：“胃角溃疡型CA可能，慢性萎缩性胃炎，霉菌性食管炎”，病理（胃角，201418212），：“送检6小块胃黏膜，其中一块胃黏膜见有少量低分化腺癌浸润，其余为浅表胃黏膜呈慢性炎症活动期，增生颈腺呈低级别下皮内瘤变”，遂门诊拟“胃癌”收入院。自发病以来，精神、睡眠可，食欲一般，大小便如常，体重减轻5KG。", "entities": [{"end_pos": 21, "label_type": "解剖部位", "overlap": 0, "start_pos": 17}, {"end_pos": 39, "label_type": "解剖部位", "overlap": 0, "start_pos": 36}, {"end_pos": 69, "label_type": "解剖部位", "overlap": 0, "start_pos": 68}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 121, "end_pos": 128}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 131, "end_pos": 138}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 139, "end_pos": 145}, {"end_pos": 152, "label_type": "解剖部位", "overlap": 0, "start_pos": 150}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 171, "end_pos": 172}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 179, "end_pos": 180}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 186, "end_pos": 191}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 197, "end_pos": 210}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 213, "end_pos": 215}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 216, "end_pos": 224}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 231, "end_pos": 233}]}
{"originalText": "，3+年前，患者绝经后出现同房后阴道流血，量少，无血凝块、腹痛，无头晕、眼花、乏力等不适，伴轻微外阴瘙痒、少量阴道流液，无异味，患者未予重视，未就诊，2月前，患者出现不规则阴道流血，量同月经，无头晕、眼花、乏力、血凝块、腹痛及腹胀，遂至我院门诊就诊，查HPV16型阳性，，阴道镜提示：宫颈重度糜烂，薄的醋酸白色下皮，妇科彩超提示宫颈偏低回声区；建议行宫颈活检术，，宫颈活检术后病检提示：（宫颈）鳞状细胞癌。1月前，患者来我院住院治疗，完善相关检查后于2016.2.22行腹腔镜上广泛性子宫切除术+两侧附件切除+盆腔淋巴结清扫术+盆腔粘连松解术，术后病检（病理号1601341），示：（宫颈）中分化鳞状细胞癌，侵及宫颈壁全层，脉管内见癌栓，颈管内见癌累及，右、左宫旁，骶韧带，阴道壁切缘未见癌累及，（右、左盆腔淋巴结）未见癌转移（0/6、0/10），右、左附件，老年期宫内膜。建议术后化疗，待阴道顶端愈合后放疗。术后予头孢美唑钠抗感染、止血及补液等对症支持治疗，于2016.2.27行TP（紫杉醇270MG+柰达铂140MG）静脉化疗，予护肝、护胃、止吐等对症支持治疗，后复查血常规及电解质无异常予以出院，出院后，患者常感恶心、食欲差，上腹坠胀，。", "entities": [{"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"end_pos": 30, "label_type": "解剖部位", "overlap": 0, "start_pos": 29}, {"end_pos": 34, "label_type": "解剖部位", "overlap": 0, "start_pos": 33}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 36, "end_pos": 37}, {"end_pos": 50, "label_type": "解剖部位", "overlap": 0, "start_pos": 48}, {"end_pos": 57, "label_type": "解剖部位", "overlap": 0, "start_pos": 55}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 97}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 100, "end_pos": 101}, {"end_pos": 111, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"end_pos": 114, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"end_pos": 144, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"label_type": "影像检查", "overlap": 0, "start_pos": 158, "end_pos": 162}, {"end_pos": 166, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 180, "label_type": "手术", "overlap": 0, "start_pos": 175}, {"end_pos": 187, "label_type": "手术", "overlap": 0, "start_pos": 182}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 193, "end_pos": 202}, {"label_type": "手术", "overlap": 0, "start_pos": 235, "end_pos": 271}, {"label_type": "手术", "overlap": 0, "start_pos": 291, "end_pos": 303}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 306, "end_pos": 308}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 319, "end_pos": 320}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 330, "end_pos": 331}, {"end_pos": 336, "label_type": "解剖部位", "overlap": 0, "start_pos": 333}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 337, "end_pos": 339}, {"end_pos": 357, "label_type": "解剖部位", "overlap": 0, "start_pos": 349}, {"end_pos": 379, "label_type": "解剖部位", "overlap": 0, "start_pos": 374}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 383, "end_pos": 384}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 395, "end_pos": 397}, {"end_pos": 413, "label_type": "药物", "overlap": 0, "start_pos": 408}, {"end_pos": 447, "label_type": "药物", "overlap": 0, "start_pos": 444}, {"end_pos": 456, "label_type": "药物", "overlap": 0, "start_pos": 453}, {"end_pos": 464, "label_type": "解剖部位", "overlap": 0, "start_pos": 462}, {"end_pos": 470, "label_type": "解剖部位", "overlap": 0, "start_pos": 469}, {"end_pos": 473, "label_type": "解剖部位", "overlap": 0, "start_pos": 472}, {"end_pos": 519, "label_type": "解剖部位", "overlap": 0, "start_pos": 517}]}
{"originalText": "，患者因“胸闷、憋气2个月，加重1周”于2014.9.9就诊于我院。，入院查体：全身皮肤无黄染、无瘀点、无出血点。全身浅表淋巴结未触及肿大。两肺呼吸音粗糙，有湿性啰音。心界无扩大，心律不规整，心音强弱不等，各瓣膜听诊区未闻及病理性杂音。腹部平坦，腹软，无压痛，无反跳痛。肝、脾肋上未触及，MURPHY'S征阴性，肝、肾区无叩痛，肠鸣音无亢进，移动性浊音阴性。两上肢无水肿。，入院后行腹部CT示：贲门及胃小弯壁增厚，小网膜囊区及胰腺后下方多发大小不等结节。，行胃镜检查示：胃癌；胃窦隆起（腔外压迫）。，病理示：腺癌。给予抑酸、护胃、调节免疫、利尿、抗感染等对症支持治疗后，患者自觉不适好转，家属要求出院，予以出院。   患者出院后仍反复腹痛，为下腹部闷痛，不伴放射痛，偶有进食阻挡感，伴纳差，伴恶心，因“反复下腹痛半年余”于2014.12.2再次入院。，查体：贫血貌，眼睑及口唇苍白。右侧锁骨下窝可触及一花生大小的淋巴结，质地韧，与周围边界清，余身浅表淋巴结未触及肿大。两肺呼吸音粗糙，两上肺可闻及湿性啰音，未闻及干性啰音。心率118次/分，节律规整，各瓣膜听诊区无闻及病理性杂音。腹部平坦，未见胃肠型及蠕动波。腹软，中下腹部部有压痛，无反跳痛，中下腹可触及一包块，质地韧，与周围组织分界不清。肝、脾肋上未触及，MURPHY'S征阴性，肝、肾区无叩痛，肠鸣音无亢进，移动性浊音阴性。两上肢轻度凹陷性水肿。两上肢足背动脉搏动减弱。，辅助检查：（2014-9-18，本院），胃镜：1、胃癌；2、胃窦隆起；病理示腺癌；（2014-9-22，本院）腹部，CT：1、胆囊多发小结石，胆囊炎；2、贲门及胃小弯壁增厚，小网膜囊区及胰后下方多发大小不等结节，建议增强扫描。，患者入院后完善相关化验检查：，血细胞分析:白细胞计数 10.26×10^9/L，中性粒细胞% 0.829，中性粒细胞 8.51×10^9/L，红细胞计数 2.70×10^12/L，血红蛋白 65.0 G/L；，降钙素原: 0.107 NG/ML；，CRP：115.00 MG/L；，大便分析:隐血 +；癌胚抗原 21.44 NG/ML；，肝功:总蛋白 51.2 G/L；胸部CT+腹部，CT：1、两肺上叶炎症、胸腔积液；2、贲门及胃小弯病增厚，小网膜囊区及胰腺后下方多发大小不等结节，符合胃癌并发转移CT表现；3、胆囊多发小结石，胆囊炎；，痰培养：**不动杆菌。患者入院后给予抗感染、抑酸、保护胃粘膜、补充白蛋白、利尿、补钾、止咳化痰、调节免疫及对症支持治疗，并于2014.12.9输注“B型悬浮去白细胞红细胞2U”，咳嗽、咳痰、纳差较前减轻，住院29天出院。   患者出院后继续口服“螺内酯 一次3片，一天3次”，病情相对平稳。1周前患者出现黑便，为柏油样便，量多少不等，次数不详，伴进食明显减少，无呕血、便血，无恶心、呕吐，无反酸、烧心。4天前患者无明显诱因地出现咳嗽、咳痰，为白色粘痰，易咳出，2天前出现发热，体温最高达38.5℃，昨日最高体温达38.0℃。现为求进一步系统诊治，再次就诊，门诊以“胃癌，肺炎”收入院。   患者自本次发病以来，神志清，精神欠佳，饮食差，夜间睡眠尚可，小便量约少（具体不详），近期体重减轻约20KG。", "entities": [{"end_pos": 6, "label_type": "解剖部位", "overlap": 0, "start_pos": 5}, {"end_pos": 64, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 72, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 84, "end_pos": 85}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 91}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 96, "end_pos": 97}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"end_pos": 120, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 124, "label_type": "解剖部位", "overlap": 0, "start_pos": 123}, {"end_pos": 136, "label_type": "解剖部位", "overlap": 0, "start_pos": 135}, {"end_pos": 138, "label_type": "解剖部位", "overlap": 0, "start_pos": 137}, {"end_pos": 140, "label_type": "解剖部位", "overlap": 0, "start_pos": 138}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 156}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 158}, {"end_pos": 165, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"end_pos": 182, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"label_type": "影像检查", "overlap": 0, "start_pos": 191, "end_pos": 195}, {"end_pos": 199, "label_type": "解剖部位", "overlap": 0, "start_pos": 197}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 200, "end_pos": 203}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 213, "end_pos": 215}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 235, "end_pos": 237}, {"end_pos": 240, "label_type": "解剖部位", "overlap": 0, "start_pos": 238}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 254, "end_pos": 256}, {"end_pos": 264, "label_type": "解剖部位", "overlap": 0, "start_pos": 263}, {"end_pos": 318, "label_type": "解剖部位", "overlap": 0, "start_pos": 317}, {"end_pos": 324, "label_type": "解剖部位", "overlap": 0, "start_pos": 321}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 353, "end_pos": 355}, {"end_pos": 385, "label_type": "解剖部位", "overlap": 0, "start_pos": 383}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 386, "end_pos": 388}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 391, "end_pos": 395}, {"end_pos": 428, "label_type": "解剖部位", "overlap": 0, "start_pos": 423}, {"end_pos": 436, "label_type": "解剖部位", "overlap": 0, "start_pos": 434}, {"end_pos": 445, "label_type": "解剖部位", "overlap": 0, "start_pos": 442}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 461, "end_pos": 462}, {"end_pos": 478, "label_type": "解剖部位", "overlap": 0, "start_pos": 476}, {"end_pos": 492, "label_type": "解剖部位", "overlap": 0, "start_pos": 490}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 497, "end_pos": 498}, {"end_pos": 499, "label_type": "解剖部位", "overlap": 0, "start_pos": 498}, {"end_pos": 506, "label_type": "解剖部位", "overlap": 0, "start_pos": 505}, {"end_pos": 512, "label_type": "解剖部位", "overlap": 0, "start_pos": 508}, {"end_pos": 525, "label_type": "解剖部位", "overlap": 0, "start_pos": 522}, {"end_pos": 547, "label_type": "解剖部位", "overlap": 0, "start_pos": 546}, {"end_pos": 549, "label_type": "解剖部位", "overlap": 0, "start_pos": 548}, {"end_pos": 551, "label_type": "解剖部位", "overlap": 0, "start_pos": 549}, {"end_pos": 568, "label_type": "解剖部位", "overlap": 0, "start_pos": 567}, {"end_pos": 570, "label_type": "解剖部位", "overlap": 0, "start_pos": 569}, {"end_pos": 576, "label_type": "解剖部位", "overlap": 0, "start_pos": 575}, {"end_pos": 593, "label_type": "解剖部位", "overlap": 0, "start_pos": 590}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 601, "end_pos": 608}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 639, "end_pos": 641}, {"end_pos": 646, "label_type": "解剖部位", "overlap": 0, "start_pos": 644}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 652, "end_pos": 654}, {"label_type": "影像检查", "overlap": 0, "start_pos": 669, "end_pos": 674}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 677, "end_pos": 684}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 685, "end_pos": 688}, {"end_pos": 693, "label_type": "解剖部位", "overlap": 0, "start_pos": 691}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 694, "end_pos": 697}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 707, "end_pos": 708}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 749, "end_pos": 754}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 768, "end_pos": 773}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 781, "end_pos": 786}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 799, "end_pos": 804}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 818, "end_pos": 821}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 833, "end_pos": 837}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 852, "end_pos": 855}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 874, "end_pos": 876}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 879, "end_pos": 884}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 900, "end_pos": 903}, {"label_type": "影像检查", "overlap": 0, "start_pos": 913, "end_pos": 917}, {"label_type": "影像检查", "overlap": 0, "start_pos": 918, "end_pos": 923}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 926, "end_pos": 932}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 933, "end_pos": 937}, {"end_pos": 942, "label_type": "解剖部位", "overlap": 0, "start_pos": 940}, {"end_pos": 946, "label_type": "解剖部位", "overlap": 0, "start_pos": 943}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 956, "end_pos": 958}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 972, "end_pos": 978}, {"label_type": "影像检查", "overlap": 0, "start_pos": 978, "end_pos": 980}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 985, "end_pos": 992}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 993, "end_pos": 996}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 998, "end_pos": 1001}, {"end_pos": 1028, "label_type": "解剖部位", "overlap": 0, "start_pos": 1025}, {"end_pos": 1124, "label_type": "药物", "overlap": 0, "start_pos": 1121}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 1280, "end_pos": 1282}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 1283, "end_pos": 1285}]}
{"originalText": "患者既往月经规律，13岁，4-5天/28天，45岁绝经，经量中，无痛经病史，绝经后无异常阴道流血。1+月前，患者因“盆腔巨内巨大囊性包块”于我院全麻上行经腹全子宫切除术+两侧附件切除术。术后将子宫及附件送病检。病检报告回：1、子宫平滑肌瘤。 2、萎缩性宫内膜。 3、慢性宫颈炎。 4、（左）附件。5.右附件附件卵巢交界性粘液性囊腺瘤，局灶癌变。同侧输卵管未见癌累及。术后予以TP方案（紫杉醇210MG+顺铂100MG）化疗2日，水化2日，患者化疗过程中呕吐较明显，毛发脱落较明显。余无畏寒、发热、反酸、嗳气，无尿频、尿急、尿痛，无腹痛、腹泻、腹胀不适，完成化疗后予以出院，出院后，患者稍感上腹疼痛不适，毛发脱落较明显，无明显恶心呕吐，无畏寒发热，无头昏乏力等不适，现患者入院要求行第二次化疗，门诊以“卵巢癌术后”收治入院。\\U0004   患者本次发病以来，食欲正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，体重无明显变化。", "entities": [{"end_pos": 46, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 58, "end_pos": 68}, {"label_type": "手术", "overlap": 0, "start_pos": 76, "end_pos": 92}, {"end_pos": 98, "label_type": "解剖部位", "overlap": 0, "start_pos": 96}, {"end_pos": 101, "label_type": "解剖部位", "overlap": 0, "start_pos": 99}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 113, "end_pos": 119}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 123, "end_pos": 129}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 133, "end_pos": 138}, {"end_pos": 147, "label_type": "解剖部位", "overlap": 0, "start_pos": 142}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 150, "end_pos": 171}, {"end_pos": 177, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}, {"end_pos": 195, "label_type": "药物", "overlap": 0, "start_pos": 192}, {"end_pos": 203, "label_type": "药物", "overlap": 0, "start_pos": 201}, {"end_pos": 266, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"end_pos": 269, "label_type": "解剖部位", "overlap": 0, "start_pos": 268}, {"end_pos": 272, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"end_pos": 296, "label_type": "解剖部位", "overlap": 0, "start_pos": 294}, {"end_pos": 325, "label_type": "解剖部位", "overlap": 0, "start_pos": 324}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 350, "end_pos": 355}]}
{"originalText": "患者于2014-12-21起床小便时突发头晕，呈视物旋转，伴恶心、呕吐，呕吐物为非咖啡色胃内容物，随即意识丧失、摔倒在地，被家属发现后急呼120来我院，急诊行脑、肺CT示“1.左基底节区低密度灶2.左肺下叶病变，较前无明显变化3.两肺炎症伴纤维灶4.两肺上叶钙化灶、轻度肺气肿5.心包积液、两侧胸腔积液”，急诊以“晕厥原因待查”收住我科，患者醒后发现右侧肢体活动不灵，2014-12-22在我科做脑DWI示“左侧大脑半球多发急性梗塞灶”，考虑“1.急性脑梗死2.高血压病（2级 很高危）3.冠状动脉粥样硬化性心脏病 心房颤动4.肺炎 两侧胸腔积液5.心包积液6.慢性肾功能不全7.胃CA术后8.直肠CA术后9.胆囊摘除术”，给予“拜阿司匹林、氟伐他汀钠缓释片、低分子肝素钙、神经节苷酯、疏血通、舒普深、沐舒坦”等输液治疗，2014-12-30因呼吸衰竭行气管插管呼吸机辅助呼吸，病情平稳后于2015-01-23转入ICU行气管切开后再转入我科继续治疗后好转出院。   患者出院后病情仍有反复，反复多次入我科治疗，均治疗好转后出院。现患者为气管切开状态，右侧肢体仍活动不灵，为求进一步治疗，我院门诊以“脑梗死、冠状动脉粥样硬化性心脏病、心房颤动、肺部感染”收入我科。   患者自发病以来，神志清，精神尚可，气管切开状态，鼻饲饮食，留置导尿，大便正常。", "entities": [{"end_pos": 21, "label_type": "解剖部位", "overlap": 0, "start_pos": 20}, {"end_pos": 45, "label_type": "解剖部位", "overlap": 0, "start_pos": 44}, {"label_type": "影像检查", "overlap": 0, "start_pos": 79, "end_pos": 84}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 99, "end_pos": 105}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 115, "end_pos": 123}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 125, "end_pos": 132}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 135, "end_pos": 138}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 140, "end_pos": 151}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 157, "end_pos": 163}, {"end_pos": 179, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"label_type": "影像检查", "overlap": 0, "start_pos": 198, "end_pos": 202}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 204, "end_pos": 217}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 224, "end_pos": 229}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 231, "end_pos": 243}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 245, "end_pos": 257}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 258, "end_pos": 262}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 264, "end_pos": 266}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 267, "end_pos": 273}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 275, "end_pos": 279}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 281, "end_pos": 288}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 290, "end_pos": 295}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 297, "end_pos": 303}, {"end_pos": 310, "label_type": "手术", "overlap": 0, "start_pos": 305}, {"end_pos": 320, "label_type": "药物", "overlap": 0, "start_pos": 315}, {"end_pos": 329, "label_type": "药物", "overlap": 0, "start_pos": 321}, {"end_pos": 336, "label_type": "药物", "overlap": 0, "start_pos": 330}, {"end_pos": 342, "label_type": "药物", "overlap": 0, "start_pos": 337}, {"end_pos": 346, "label_type": "药物", "overlap": 0, "start_pos": 343}, {"end_pos": 350, "label_type": "药物", "overlap": 0, "start_pos": 347}, {"label_type": "药物", "overlap": 0, "start_pos": 351, "end_pos": 354}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 372, "end_pos": 376}, {"end_pos": 379, "label_type": "解剖部位", "overlap": 0, "start_pos": 377}, {"end_pos": 415, "label_type": "手术", "overlap": 0, "start_pos": 411}, {"label_type": "手术", "overlap": 0, "start_pos": 469, "end_pos": 473}, {"end_pos": 480, "label_type": "解剖部位", "overlap": 0, "start_pos": 476}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 500, "end_pos": 503}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 504, "end_pos": 516}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 517, "end_pos": 521}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 522, "end_pos": 526}, {"label_type": "手术", "overlap": 0, "start_pos": 552, "end_pos": 556}, {"end_pos": 560, "label_type": "解剖部位", "overlap": 0, "start_pos": 559}]}
{"originalText": "，1年余出现接触性阴道出血，伴轻微腹痛，有少量阴道排液，无异味。，在外院行宫颈活检提示：中分化鳞癌。后转我院妇科于2012-07-09行“宫颈癌根治术+两侧附件切除术+盆腔淋巴结清扫术”，，术后病理提示：宫颈中分化鳞癌，浸润宫颈深肌层，累及宫颈管未见明确脉管癌栓及神经侵犯。遵原主诊教授意见于2012-07-26、2012-8-16、2012-9-11行TP方案辅助化疗3程。2012-9-19开始行放射治疗。现按原主诊教授意见返院继续行TP方案化疗。患者一般情况可，饮食入眠可，大小便正常，体重无明显改变。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 17}, {"end_pos": 25, "label_type": "解剖部位", "overlap": 0, "start_pos": 23}, {"end_pos": 39, "label_type": "解剖部位", "overlap": 0, "start_pos": 37}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 44, "end_pos": 49}, {"label_type": "手术", "overlap": 0, "start_pos": 69, "end_pos": 92}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 102, "end_pos": 109}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 112, "end_pos": 114}, {"end_pos": 123, "label_type": "解剖部位", "overlap": 0, "start_pos": 120}]}
{"originalText": "患者1月余前因“间断下腹部疼痛1年，加重十余天”就诊，1腹痛呈阵发性绞痛，无发热，无恶心、呕吐，当时未作治疗，疼痛间断发作，在来我院行B超及MRI检查提示胆囊泥沙样结石、胆总管末端可疑结石,入院后完善相关化验检查，于2013.4.2在全麻上行胆囊切除、胆总管探查取石、T管引流术。术中见胆囊张力高，胆囊壁充血水肿，周围血管曲张，胆总管粗约2CM，壁厚，术后给予禁食、胃肠减压、抗感染、保肝、止血、抑酸等治疗，病人恢复良好，术后病理回示：急性单纯性胆囊炎，现为进一步治疗今来我院就诊，门诊以\\\"胆石症术后\\\"收入院。   患者自出院以来，饮食睡眠良好，大小便正常，体重无减轻。", "entities": [{"end_pos": 13, "label_type": "解剖部位", "overlap": 0, "start_pos": 10}, {"end_pos": 29, "label_type": "解剖部位", "overlap": 0, "start_pos": 28}, {"label_type": "影像检查", "overlap": 0, "start_pos": 67, "end_pos": 69}, {"label_type": "影像检查", "overlap": 0, "start_pos": 70, "end_pos": 75}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 77, "end_pos": 84}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 85, "end_pos": 94}, {"label_type": "手术", "overlap": 0, "start_pos": 121, "end_pos": 139}, {"end_pos": 145, "label_type": "解剖部位", "overlap": 0, "start_pos": 143}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 149, "end_pos": 151}, {"end_pos": 167, "label_type": "解剖部位", "overlap": 0, "start_pos": 164}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 183, "end_pos": 184}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 184, "end_pos": 185}, {"end_pos": 194, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 218, "end_pos": 226}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 246, "end_pos": 251}]}
{"originalText": "，患者2015-04-26无明显诱因出现肉眼血尿，无腰痛、发热等不适，稍有尿频、尿急、尿痛。，行急诊超声及CT示：\\\"膀胱占位病变，大小37*29MM\\\"。考虑膀胱癌可能。完善相关检查并于2015-4-29行经尿道膀胱肿瘤电切术，，术后病理示：“浸润性高级别尿路下皮癌”，有根治性膀胱切除术指征，遂于2015-5-5于全麻上行根治性膀胱切除术+回肠原位新膀胱术，手术顺利，术后恢复可。2015-06-11在本科行“顺铂+吉西他滨”化疗治疗，化疗过程顺利。现为进一步治疗入住本科。起病以来,患者精神尚可,饮食睡眠尚可,无发冷发热，无咳嗽、咳痰、胸痛及心慌气短，大便正常，小便如下所述，体重无减轻。", "entities": [{"end_pos": 27, "label_type": "解剖部位", "overlap": 0, "start_pos": 26}, {"label_type": "影像检查", "overlap": 0, "start_pos": 50, "end_pos": 52}, {"label_type": "影像检查", "overlap": 0, "start_pos": 53, "end_pos": 55}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 59, "end_pos": 65}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 80, "end_pos": 83}, {"end_pos": 114, "label_type": "手术", "overlap": 0, "start_pos": 104}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 123, "end_pos": 134}, {"end_pos": 145, "label_type": "手术", "overlap": 0, "start_pos": 137}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 163, "end_pos": 180}, {"end_pos": 209, "label_type": "药物", "overlap": 0, "start_pos": 207}, {"end_pos": 214, "label_type": "药物", "overlap": 0, "start_pos": 210}, {"end_pos": 272, "label_type": "解剖部位", "overlap": 0, "start_pos": 271}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 274, "end_pos": 275}]}
{"originalText": "，入院前3年余患者出现左上腹刺痛，伴左侧臀部放射痛，难以忍受，伴腹胀、里急后重不适，月经周期延长，不伴恶心、呕吐、腹泻腹胀等不适，行MRI诊断盆腔内囊实性占位病变，浆液性囊腺癌？累及子宫后壁及直肠左侧壁，，CA125：335.4U/ML，，行腹部CT提示：肝左叶后段病灶，考虑转移可能，遂于2010年6月2日行“全子宫+右附件切除+直肠切除术”，术后病检回示“盆腔中低分化腺癌，卵巢来源性大，直肠外膜中见癌侵润”。术后予以6周期紫杉醇210MG+顺铂100MG化疗，化疗结束时间为2010年11月。2011-12-19患者因复查CA-125 185.4U/ML,盆腔B超未见异常，遂行3周期多西他赛120MG＋奥沙利铂200MG化疗，末次化疗时间2012年3月，化疗期间行腹部CT提示肝左叶转移灶，遂于院外行肝转移灶伽马刀治疗。院外无腹痛等不适。2月余前患者因无明显诱因出现左上腹疼痛，呈持续性刀割样疼痛，坐位或平卧时可稍缓解，无呕心呕吐，无腹泻便秘，无发热寒颤，无全身骨痛等不适，遂于门诊行盆腔彩超示盆腔内混合性包块，腹部CT提示两侧附件区多发囊状占位灶，左输尿管盆腔段与左附件区占位灶关系密切伴管壁增厚，考虑卵巢癌复发伴左输尿管受累可能，肝左叶异常强化影。CA-125、CA-199升高。提示病情进展，遂于我科行一周期吉西他滨+奈达铂化疗，化疗后患者出现骨髓抑制，予以升血小板治疗后好转出院。出院后患者左上腹疼痛较前明显缓解，无恶心呕吐，无咳嗽咳痰，无腹痛腹胀等不适，今为进一步治疗入院。\\U0004   患者本次发病以来，食欲正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，体重无明显变化。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"end_pos": 22, "label_type": "解剖部位", "overlap": 0, "start_pos": 18}, {"end_pos": 33, "label_type": "解剖部位", "overlap": 0, "start_pos": 32}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 59}, {"label_type": "影像检查", "overlap": 0, "start_pos": 66, "end_pos": 69}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 71, "end_pos": 81}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 82, "end_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 91, "end_pos": 93}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 96, "end_pos": 98}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 103, "end_pos": 108}, {"label_type": "影像检查", "overlap": 0, "start_pos": 121, "end_pos": 125}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 128, "end_pos": 142}, {"label_type": "手术", "overlap": 0, "start_pos": 156, "end_pos": 171}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 180, "end_pos": 188}, {"end_pos": 191, "label_type": "解剖部位", "overlap": 0, "start_pos": 189}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 196, "end_pos": 198}, {"end_pos": 217, "label_type": "药物", "overlap": 0, "start_pos": 214}, {"end_pos": 225, "label_type": "药物", "overlap": 0, "start_pos": 223}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 264, "end_pos": 270}, {"label_type": "影像检查", "overlap": 0, "start_pos": 281, "end_pos": 285}, {"end_pos": 299, "label_type": "药物", "overlap": 0, "start_pos": 295}, {"end_pos": 309, "label_type": "药物", "overlap": 0, "start_pos": 305}, {"label_type": "影像检查", "overlap": 0, "start_pos": 336, "end_pos": 340}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 342, "end_pos": 348}, {"end_pos": 355, "label_type": "解剖部位", "overlap": 0, "start_pos": 354}, {"end_pos": 368, "label_type": "解剖部位", "overlap": 0, "start_pos": 367}, {"end_pos": 390, "label_type": "解剖部位", "overlap": 0, "start_pos": 387}, {"end_pos": 422, "label_type": "解剖部位", "overlap": 0, "start_pos": 421}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 435, "end_pos": 436}, {"label_type": "影像检查", "overlap": 0, "start_pos": 446, "end_pos": 450}, {"end_pos": 453, "label_type": "解剖部位", "overlap": 0, "start_pos": 451}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 460, "end_pos": 464}, {"end_pos": 470, "label_type": "解剖部位", "overlap": 0, "start_pos": 466}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 479, "end_pos": 483}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 483, "end_pos": 485}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 487, "end_pos": 490}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 506, "end_pos": 518}, {"end_pos": 524, "label_type": "解剖部位", "overlap": 0, "start_pos": 521}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 530, "end_pos": 536}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 537, "end_pos": 543}, {"end_pos": 565, "label_type": "药物", "overlap": 0, "start_pos": 561}, {"end_pos": 569, "label_type": "药物", "overlap": 0, "start_pos": 566}, {"end_pos": 581, "label_type": "解剖部位", "overlap": 0, "start_pos": 579}, {"end_pos": 606, "label_type": "解剖部位", "overlap": 0, "start_pos": 603}, {"end_pos": 629, "label_type": "解剖部位", "overlap": 0, "start_pos": 628}, {"end_pos": 631, "label_type": "解剖部位", "overlap": 0, "start_pos": 630}]}
{"originalText": "，缘于入院前半月体检查电子肠镜示：肝曲见一宽基息肉样隆起，大小约3×1.5CM，约环1/3周，表面充血，，内镜诊断：结肠侧向发育型肿瘤（LST）；查CEA、AFP、CA199、CA125均正常；无畏冷、寒战、发热，无恶心、呕吐，无腹痛、腹胀、腹泻，无关节肿痛、消瘦。今为进一步行内镜治疗求诊我院，门诊拟以“结肠侧向发育型肿瘤”收治入院。近半年来，精神、睡眠欠佳，食欲尚可，大小便正常，体重无明显变化。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 17, "end_pos": 19}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 58, "end_pos": 72}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 74, "end_pos": 77}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 78, "end_pos": 81}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 82, "end_pos": 87}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 88, "end_pos": 93}, {"end_pos": 116, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 119, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 127, "label_type": "解剖部位", "overlap": 0, "start_pos": 125}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 153, "end_pos": 162}]}
{"originalText": "患者2年前无明显诱因开始出现多食，进食以稀饭为主，每餐约800G，自觉体重上降，具体数值不详，无明显口渴、多饮、多尿，无多汗、心悸、盗汗，无腹痛、腹泻、便秘等不适，未重视，未治疗。1+年前患者因血压升高，在*****住院治疗，发现血糖升高，测指血糖最高达18.0MMOL/L，仍有多食的症状，诊断为“糖尿病”，予以胰岛素降糖（具体剂量不详），好转出院。出院后规律口服药物降糖药（具体药物不详），未监测血糖情况。病程中否认活动后心悸、气促，无四肢麻木、两上肢水肿等不适。5月前患者出现两上肢水肿，伴上肢疼痛，按压时明显。就诊我院，诊断为“2型糖尿病糖尿病周围神经病变 左上肢深静脉血栓形成”，给予抗凝、降糖，利尿等对症治疗后好转出院。出院后长期使用“华法林 2.5MG，QD、阿卡波糖 50MG，TID 阿托伐他汀 20MG，QN”对症治疗。10+天前患者再次出现两上肢水肿，呈凹陷性，左侧为主，伴有疼痛，按压时疼痛明显。病程中无夜间阵发性呼吸困难，无端坐呼吸，无咳嗽、咯痰，无腹痛、腹胀等不适。为进一步诊治，就诊我院。门诊以“水肿待查”收入我科。\\U0004   患者发现血压升高10年余，最高170/？MMHG，长期规律口服“珍菊降压片 1粒 QOD”，未监测血压，否认胸闷、胸痛等不适。5月前患者在我院行心脏彩超提示“右室及两房增大”，心电图提示心房颤动，诊断为“高血压性心脏病 心脏扩大 心房纤颤”，给予“氨氯地平 5MG，QD，美托洛尔缓释片 23.75MG，QD”。平时未正规监测血压。\\U0004   患者本次发病以来， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，食欲及体重同下所述。", "entities": [{"end_pos": 64, "label_type": "解剖部位", "overlap": 0, "start_pos": 63}, {"end_pos": 71, "label_type": "解剖部位", "overlap": 0, "start_pos": 70}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 115, "end_pos": 117}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 122, "end_pos": 124}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 150, "end_pos": 153}, {"end_pos": 160, "label_type": "药物", "overlap": 0, "start_pos": 157}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 200, "end_pos": 202}, {"end_pos": 214, "label_type": "解剖部位", "overlap": 0, "start_pos": 213}, {"end_pos": 222, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"end_pos": 228, "label_type": "解剖部位", "overlap": 0, "start_pos": 225}, {"end_pos": 244, "label_type": "解剖部位", "overlap": 0, "start_pos": 241}, {"end_pos": 250, "label_type": "解剖部位", "overlap": 0, "start_pos": 248}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 268, "end_pos": 293}, {"end_pos": 328, "label_type": "药物", "overlap": 0, "start_pos": 324}, {"end_pos": 342, "label_type": "药物", "overlap": 0, "start_pos": 337}, {"end_pos": 356, "label_type": "药物", "overlap": 0, "start_pos": 351}, {"end_pos": 384, "label_type": "解剖部位", "overlap": 0, "start_pos": 381}, {"end_pos": 439, "label_type": "解剖部位", "overlap": 0, "start_pos": 438}, {"end_pos": 442, "label_type": "解剖部位", "overlap": 0, "start_pos": 441}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 463, "end_pos": 467}, {"end_pos": 519, "label_type": "药物", "overlap": 0, "start_pos": 514}, {"end_pos": 537, "label_type": "解剖部位", "overlap": 0, "start_pos": 536}, {"end_pos": 540, "label_type": "解剖部位", "overlap": 0, "start_pos": 539}, {"label_type": "影像检查", "overlap": 0, "start_pos": 554, "end_pos": 558}, {"end_pos": 563, "label_type": "解剖部位", "overlap": 0, "start_pos": 561}, {"end_pos": 566, "label_type": "解剖部位", "overlap": 0, "start_pos": 564}, {"label_type": "影像检查", "overlap": 0, "start_pos": 570, "end_pos": 573}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 575, "end_pos": 579}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 584, "end_pos": 601}, {"end_pos": 610, "label_type": "药物", "overlap": 0, "start_pos": 606}, {"end_pos": 625, "label_type": "药物", "overlap": 0, "start_pos": 618}]}
{"originalText": "患者半年前无明显诱因发现便中带血，呈鲜红色，大便成形，不伴里急后重感，无腹痛、腹泻，恶心呕吐等不适，此后下述症状持续存在，未系统诊治。10天前我院门诊行肠镜检查示“结肠多发息肉”，行病理检查示：“横结肠增生性腺瘤性息肉 乙状结肠低级别管状腺瘤”，遂入我院要求行结肠镜电切手术治疗。患者病来无发热寒战，无咳嗽咳痰，无腹痛、腹泻，无恶心、呕吐，无尿频、尿急及尿痛等不适，饮食睡眠可，精神体力可，近期体重无明显变化。", "entities": [{"end_pos": 37, "label_type": "解剖部位", "overlap": 0, "start_pos": 36}, {"end_pos": 40, "label_type": "解剖部位", "overlap": 0, "start_pos": 39}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 82, "end_pos": 88}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 98, "end_pos": 121}, {"label_type": "手术", "overlap": 0, "start_pos": 130, "end_pos": 137}, {"end_pos": 158, "label_type": "解剖部位", "overlap": 0, "start_pos": 157}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}]}
{"originalText": "入院前2月患者无明显诱因开始出现吞咽哽咽感，能正常进食，伴有中下腹隐痛下腹隐痛不适，程度轻微，不影响睡眠，进食后加重，可逐渐自行缓解，无反酸、嗳气，无胸骨后烧灼感，无恶心、呕吐，无呕血，无黑便、血便，无里急后重感，无咳嗽、咳痰，无心悸、胸闷、胸痛，无喘累、气促、呼吸困难。入院前半月，患者自觉吞咽哽咽感加重，仍能正常进食，进食时感下腹部及胸骨后胀痛不适，可向左肩背部放射，可自行缓解，无恶心、呕吐，无呕血，无黑便、血便，无心悸、胸闷。未治疗。今日来我院行胃镜检查提示：食管癌？（活检已取），浅表性胃窦炎伴糜烂。今日为进一步治疗收治入院。\\U0004   患者本次发病以来，食欲正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，至患病以来体重减轻约２．５公斤。", "entities": [{"end_pos": 33, "label_type": "解剖部位", "overlap": 0, "start_pos": 30}, {"end_pos": 37, "label_type": "解剖部位", "overlap": 0, "start_pos": 35}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 75, "end_pos": 77}, {"end_pos": 116, "label_type": "解剖部位", "overlap": 0, "start_pos": 115}, {"end_pos": 119, "label_type": "解剖部位", "overlap": 0, "start_pos": 118}, {"end_pos": 122, "label_type": "解剖部位", "overlap": 0, "start_pos": 121}, {"end_pos": 168, "label_type": "解剖部位", "overlap": 0, "start_pos": 165}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 169, "end_pos": 171}, {"end_pos": 183, "label_type": "解剖部位", "overlap": 0, "start_pos": 179}, {"end_pos": 212, "label_type": "解剖部位", "overlap": 0, "start_pos": 211}, {"end_pos": 215, "label_type": "解剖部位", "overlap": 0, "start_pos": 214}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 234, "end_pos": 237}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 245, "end_pos": 254}]}
{"originalText": "入院前1+年，患者无明显诱因出现剑突上疼痛，餐后为甚，呈持续性隐痛，尚可忍受，伴下腹胀、纳差、反酸、嗳气，无进行性吞咽困难，无恶心、呕吐、呕血、黑便、腹泻，无肛门停止排便、排气，无胸痛、胸闷、咯血、呼吸困难，遂于我院就诊，行胃镜检查提示：胃癌可能性大，病检回示胃腺癌，患者家属要求保守治疗，经治疗后，好转出院。病程中下述症状反复发作，性质同前，自购药物服用（具体药物不详）后下述症状可缓解。入院前1+小时，患者无明显诱因出现呕血，为咖啡色样胃内容物，量大，具体不详，有中下腹痛，性质同前，伴头昏、乏力，无晕厥、意识障碍等，无皮肤黏膜、牙龈出血。至我科就诊，以“下消化道出血”收入我科住院治疗。   发病以来，精神欠佳，未进食，睡眠可，大小便正常，体重上降，具体不详。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 16, "end_pos": 18}, {"end_pos": 42, "label_type": "解剖部位", "overlap": 0, "start_pos": 40}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"end_pos": 91, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"end_pos": 94, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 119, "end_pos": 121}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 130, "end_pos": 133}, {"end_pos": 221, "label_type": "解剖部位", "overlap": 0, "start_pos": 220}, {"end_pos": 237, "label_type": "解剖部位", "overlap": 0, "start_pos": 234}, {"end_pos": 246, "label_type": "解剖部位", "overlap": 0, "start_pos": 245}, {"end_pos": 269, "label_type": "解剖部位", "overlap": 0, "start_pos": 267}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 280, "end_pos": 286}]}
{"originalText": "患者因下腹部不适在我院完善相关检查后确诊“胃癌”，于2015-09-23全麻上行\\\"胃癌根治术\\\"（远端胃大部切除），术程顺利，术后预防感染、抑制分泌、静脉营养等对症支持处理，术后第一天上午开始出现心律加快，最高180多次，查心肌损伤项目心衰项目未见明显异常，心电图提示快速房颤，ICU会诊后予可达龙控制心律，效果一般，另患者诉全身皮肤瘙痒，未见皮疹及其他过敏症状，抗过敏治疗效果欠佳。后出现一过性心前区疼痛，程度中等，复查心肌损伤，心电图等未提示有心梗，患者数天来，心律血压有波动，心律在54-140多次每分，仍可达龙维持治疗。血压在100-154/70-100MMHG之间，舌上含服心痛定等可维持在正常血压。9月27日晚出现全身皮疹伴瘙痒，抗过敏治疗欠佳，后停止原有补液后皮疹消退瘙痒改善。术后第六天，一般情况尚可，已进食流质拔除引流管患者。出院时患者生命体征平稳心律64次/分，血压正常，进食半流胃纳可，二便正常。出院至今患者自诉恢复尚可，进食半流质为主，大小便正常，体重上降约4斤。", "entities": [{"end_pos": 6, "label_type": "解剖部位", "overlap": 0, "start_pos": 3}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 21, "end_pos": 23}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 42, "end_pos": 58}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 99, "end_pos": 100}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 113}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 119, "end_pos": 120}, {"label_type": "影像检查", "overlap": 0, "start_pos": 130, "end_pos": 133}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 135, "end_pos": 139}, {"label_type": "药物", "overlap": 0, "start_pos": 147, "end_pos": 150}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 152, "end_pos": 153}, {"end_pos": 202, "label_type": "解剖部位", "overlap": 0, "start_pos": 199}, {"end_pos": 214, "label_type": "解剖部位", "overlap": 0, "start_pos": 212}, {"label_type": "影像检查", "overlap": 0, "start_pos": 217, "end_pos": 220}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 225, "end_pos": 227}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 234, "end_pos": 235}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 242, "end_pos": 243}, {"end_pos": 260, "label_type": "药物", "overlap": 0, "start_pos": 257}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 289, "end_pos": 290}, {"end_pos": 296, "label_type": "药物", "overlap": 0, "start_pos": 293}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 401, "end_pos": 402}]}
{"originalText": "，患者于2011年4月份因\\\"大便次数增多2月余，CT发现盆腔占位10天\\\"入住我院综合科，于5月3日行剖腹探查术，见肿物位于距回盲部150CM回肠处，行肿物及双端5CM空肠切除术，术后恢复可，，术后病理：胃肠间质肿瘤，3个核分裂/50HPF,，免疫组化：CD34-、CD117+，S-100(-)、SAM+/-，DES(-),HHF35-；2011-5-11起口服格列卫400MG QD治疗至今，耐受可。偶有心前区不适，随访心电图、心功酶等均未见明显异常。无颜面水肿及皮肤瘙痒，无恶心、呕吐、腹痛不适。现入院继续格列卫化疗。患者起病以来，无发热、乏力、咳嗽、气促、身目黄染等，精神睡眠可，胃纳欠佳，小便正常，大便1-2次/天，体重无明显上降。", "entities": [{"label_type": "影像检查", "overlap": 0, "start_pos": 25, "end_pos": 27}, {"end_pos": 31, "label_type": "解剖部位", "overlap": 0, "start_pos": 29}, {"end_pos": 57, "label_type": "手术", "overlap": 0, "start_pos": 52}, {"end_pos": 67, "label_type": "解剖部位", "overlap": 0, "start_pos": 64}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 72}, {"end_pos": 90, "label_type": "手术", "overlap": 0, "start_pos": 85}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 103, "end_pos": 109}, {"end_pos": 186, "label_type": "药物", "overlap": 0, "start_pos": 183}, {"end_pos": 208, "label_type": "解剖部位", "overlap": 0, "start_pos": 205}, {"label_type": "影像检查", "overlap": 0, "start_pos": 213, "end_pos": 216}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 231, "end_pos": 232}, {"end_pos": 248, "label_type": "解剖部位", "overlap": 0, "start_pos": 247}, {"end_pos": 260, "label_type": "药物", "overlap": 0, "start_pos": 257}, {"end_pos": 284, "label_type": "解剖部位", "overlap": 0, "start_pos": 283}, {"end_pos": 285, "label_type": "解剖部位", "overlap": 0, "start_pos": 284}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 295, "end_pos": 296}]}
{"originalText": "2016-04患者因确诊胃癌于我院术前检查发现左下肺阴影，患者无自觉症状，无咳嗽、咳痰，无咯血、气促，无呼吸困难、胸闷，无发热、消瘦、午后盗汗，无胸痛、骨痛、头痛、声嘶，无眼睑上垂、颜面浮肿、吞咽困难。患者行胃癌根治术后，今为进一步手术治疗肺部病灶，门诊拟“左下肺肿物”收入我科。起病以来，患者精神、睡眠、食欲尚可，大小便正常，体重近期无明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 12, "end_pos": 14}, {"end_pos": 26, "label_type": "解剖部位", "overlap": 0, "start_pos": 23}, {"end_pos": 58, "label_type": "解剖部位", "overlap": 0, "start_pos": 57}, {"end_pos": 74, "label_type": "解剖部位", "overlap": 0, "start_pos": 73}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 76}, {"end_pos": 80, "label_type": "解剖部位", "overlap": 0, "start_pos": 79}, {"end_pos": 88, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 92, "end_pos": 93}, {"end_pos": 109, "label_type": "手术", "overlap": 0, "start_pos": 104}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 120, "end_pos": 124}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 129, "end_pos": 134}]}
{"originalText": "，患者绝经10年，于2012-12月无明显诱因出现阴道不规则出血，量同月经.在外院行子宫内膜分段诊刮病理示子宫内膜癌.我院病理会诊为恶性苗勒氏混合瘤。为求进一步诊治2013-02-21收入我院，入院后完善相关检查，于2013-02-28在全麻上行全子宫+两附件切除+盆腔淋巴结清扫+大网膜切除+腹主动脉旁淋巴结活检术，，术后病理示：子宫内膜样腺癌（中分化）浸润至浅肌层，未见癌肉瘤成份。未予特殊治疗，于2013-03-15复查既往子宫内物活检组织诊断为癌肉瘤。2013-04-03~06行IAP方案（IFOD1-D3+里葆多D1+DDPD1-D4）化疗一程，行里葆多化疗初始出现一过性心悸、胸闷、气促不适，于抗过敏治疗后缓解。患者自起病以来，精神、胃纳、睡眠可，无头晕头痛，胸闷气促，恶心呕吐，腹胀腹痛，尿频尿急，里急后重等不适，大小便正常，体重无明显改变。`，外院治疗经过：无。", "entities": [{"end_pos": 27, "label_type": "解剖部位", "overlap": 0, "start_pos": 25}, {"label_type": "手术", "overlap": 0, "start_pos": 42, "end_pos": 50}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 53, "end_pos": 58}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 66, "end_pos": 74}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 123, "end_pos": 158}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 166, "end_pos": 178}, {"end_pos": 217, "label_type": "解剖部位", "overlap": 0, "start_pos": 215}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 226, "end_pos": 229}, {"end_pos": 253, "label_type": "药物", "overlap": 0, "start_pos": 250}, {"end_pos": 262, "label_type": "药物", "overlap": 0, "start_pos": 259}, {"end_pos": 268, "label_type": "药物", "overlap": 0, "start_pos": 265}, {"end_pos": 283, "label_type": "药物", "overlap": 0, "start_pos": 280}, {"end_pos": 293, "label_type": "解剖部位", "overlap": 0, "start_pos": 292}, {"end_pos": 296, "label_type": "解剖部位", "overlap": 0, "start_pos": 295}, {"end_pos": 333, "label_type": "解剖部位", "overlap": 0, "start_pos": 332}, {"end_pos": 335, "label_type": "解剖部位", "overlap": 0, "start_pos": 334}, {"end_pos": 338, "label_type": "解剖部位", "overlap": 0, "start_pos": 337}, {"end_pos": 348, "label_type": "解剖部位", "overlap": 0, "start_pos": 347}, {"end_pos": 350, "label_type": "解剖部位", "overlap": 0, "start_pos": 349}]}
{"originalText": "2014-4因肾结石查体，胃镜示胃底占位，病理低分化腺癌。2014-5胃部介入治疗2次（具体不详），家属诉复查无变化，2014-7口服药物治疗（具体不详），2014-10复查胃镜侵及食道，给予含奥沙利铂方案化疗4周期，家属诉复查无变化，末次2015-1。家属诉后口服化疗药至2015-9（具体不详）。2015-9进食哽噎、呕吐，钡餐见食管堵塞大部分，给予放疗20余天。2015-10-2当地查CT发现肝转移。目前进食较前好转，可进普食，无明显哽噎感，无呕吐。近1月自觉右肩部疼痛，口服止痛药物后效果欠佳，口服阿司匹林后疼痛可缓解4-5小时。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 7, "end_pos": 10}, {"end_pos": 18, "label_type": "解剖部位", "overlap": 0, "start_pos": 16}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 23, "end_pos": 28}, {"end_pos": 37, "label_type": "解剖部位", "overlap": 0, "start_pos": 35}, {"end_pos": 93, "label_type": "解剖部位", "overlap": 0, "start_pos": 91}, {"end_pos": 101, "label_type": "药物", "overlap": 0, "start_pos": 97}, {"end_pos": 169, "label_type": "解剖部位", "overlap": 0, "start_pos": 167}, {"label_type": "影像检查", "overlap": 0, "start_pos": 196, "end_pos": 198}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 200, "end_pos": 203}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 234, "end_pos": 237}, {"end_pos": 258, "label_type": "药物", "overlap": 0, "start_pos": 254}]}
{"originalText": "患者2014-05无明显诱因出现粘液血便，量少，伴大便次数增加至4-5次/天，稀烂，偶有里急后重，伴阵发性腹痛。无恶心、发热等不适。外院肠镜检查提示距肛门30CM结肠肿物，肠镜不能通过。活检病理提示腺癌。患者遂来我院，门诊查CT提示：结肠肝曲、乙状结肠肠壁增厚，考虑结肠癌。结肠病灶邻近系膜区域淋巴结肿大，考虑淋巴结转移。腹主动脉旁、肠系膜区淋巴结，转移？右下肺叶斑片影，炎症？患者2014-07-03于我院全麻上行“腹腔镜上全结肠切除术”，术后诊断“多原发结肠癌 PT3N1AM0,IIIB”期,于2014-08-11予XELOX方案化疗1程。现为行上一程化疗收住入院，起病以来无发热，胃纳可，睡眠一般，小便正常，体重上降5公斤。", "entities": [{"end_pos": 54, "label_type": "解剖部位", "overlap": 0, "start_pos": 53}, {"end_pos": 77, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"end_pos": 83, "label_type": "解剖部位", "overlap": 0, "start_pos": 81}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 99, "end_pos": 101}, {"label_type": "影像检查", "overlap": 0, "start_pos": 112, "end_pos": 114}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 117, "end_pos": 119}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 119, "end_pos": 121}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 122, "end_pos": 126}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 133, "end_pos": 136}, {"end_pos": 139, "label_type": "解剖部位", "overlap": 0, "start_pos": 137}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 143, "end_pos": 150}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 155, "end_pos": 160}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 161, "end_pos": 177}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 178, "end_pos": 188}, {"end_pos": 219, "label_type": "手术", "overlap": 0, "start_pos": 209}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 226, "end_pos": 246}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 294, "end_pos": 295}]}
{"originalText": "患者于入院前2月余在我院胃肠外科因“胃底升结肠印戒细胞癌”行化疗期间发现右乳一拳头大小的无痛包块，无红肿压痛，无皮肤破溃，无乳房橘皮样外观，无乳头凹陷，无乳头溢液。转入我科行了右乳包块活检术，病检结果为：（右乳）分泌粘液癌（印戒细胞癌）， ER（－） PR（－） CERBB-2（－）CEA（+++） ，并行“紫杉醇+希罗达”化疗双个疗程，化疗期间乳房皮肤有轻微发红，无明显骨髓抑制及胃肠道反应，化疗后肿块有所缩小，出院后发现乳房肿块又开始缓慢增大，且乳头回缩，今日患者为求进一步治疗入我院，门诊以“右乳印戒细胞癌”收入住院。\\U0004   患者于入院前8月我院行左腹股沟肿大淋巴结活检提示转移性癌，并行胃镜、结肠镜检查并取活检，提示为胃底、升结肠印戒细胞癌，并于胃肠外科行数个疗程化疗，未行胃肠道手术。曾用卡培他滨、奥沙利铂、倍伐单抗等药物治疗。\\U0004   患者自起病以来，精神可，胃纳可，大便如常，小便如常，体重未见明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 18, "end_pos": 28}, {"end_pos": 38, "label_type": "解剖部位", "overlap": 0, "start_pos": 36}, {"end_pos": 64, "label_type": "解剖部位", "overlap": 0, "start_pos": 62}, {"end_pos": 73, "label_type": "解剖部位", "overlap": 0, "start_pos": 71}, {"end_pos": 79, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 95, "label_type": "手术", "overlap": 0, "start_pos": 88}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 102, "end_pos": 118}, {"end_pos": 158, "label_type": "药物", "overlap": 0, "start_pos": 155}, {"end_pos": 162, "label_type": "药物", "overlap": 0, "start_pos": 159}, {"end_pos": 178, "label_type": "解剖部位", "overlap": 0, "start_pos": 174}, {"end_pos": 189, "label_type": "解剖部位", "overlap": 0, "start_pos": 187}, {"end_pos": 195, "label_type": "解剖部位", "overlap": 0, "start_pos": 192}, {"end_pos": 215, "label_type": "解剖部位", "overlap": 0, "start_pos": 213}, {"end_pos": 228, "label_type": "解剖部位", "overlap": 0, "start_pos": 226}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 250, "end_pos": 257}, {"label_type": "手术", "overlap": 0, "start_pos": 283, "end_pos": 294}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 296, "end_pos": 300}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 319, "end_pos": 330}, {"end_pos": 350, "label_type": "解剖部位", "overlap": 0, "start_pos": 347}, {"end_pos": 359, "label_type": "药物", "overlap": 0, "start_pos": 355}, {"end_pos": 364, "label_type": "药物", "overlap": 0, "start_pos": 360}, {"end_pos": 369, "label_type": "药物", "overlap": 0, "start_pos": 365}, {"end_pos": 397, "label_type": "解剖部位", "overlap": 0, "start_pos": 396}]}
{"originalText": "，缘于入院2年前因“呕血、排黑便”就诊于我院，无畏冷、发热，无口干、多饮、多尿，无多食、易饥，查“，末梢血糖：HIGH，，尿常规:尿糖3+，酮体3+，蛋白质1+，，血气分析示：PH7.0，BE-29，LAC3.65MMOL/L，HCO3-1.9MMOL/L，，粪常规：隐血试验阳性(3+)，，胃镜：出血性胃炎，慢性萎缩性胃炎，未见活动性出血”，诊断为“糖尿病糖尿病酮症酸中毒、下消化道出血”，予输血、降糖、补液、制酸保胃、止血等治疗，下述症状好转，复查尿酮体转阴，监测空腹末梢血糖7MMOL/L下上，餐后末梢血糖7-14MMOL/L，出院后予“来得时16U、诺和锐三餐前6U”降糖治疗，规律注射胰岛素，监测空腹末梢血糖7MMOL/L右左，未监测餐后血糖。1年半前无明显诱因出现恶心、呕吐，呕吐物为胃内容物，无头晕、头痛，无畏冷、发热，无咳嗽、咳痰，就诊我院，查“末梢血糖HIGH，，血气分析：PH7.122，PACO219.5MMHG，PAO2110MMHG，BE-23MMOL/L，，尿常规：尿糖3+，酮体3+，，血常规：WBC26.8*10^9/L，NE87.7%，HB138G/L。，糖尿病抗体:谷氨酸脱羧酶抗体阳性(+)。胰岛素、C，肽检查：1.胰岛素（空腹）&LT;0.2MU/L，2.胰岛素（2H）&LT;0.2MU/L,3.C肽（空腹）&LT;0.02UG/L,C肽（2H）0.02UG/L”，诊断为“1型糖尿病糖尿病酮症酸中毒”，予降糖、补液、感染、制酸保胃等治疗，下述症状好转，出院后予“诺和锐特充9U早11U午9U晚+来得时7U睡前”降糖治疗，后规律注射胰岛素，未监测血糖。1年前自测末梢血糖均偏高，餐后2小时末梢血糖16-18MMOL/L，无口干、多饮，无多食、易饥，无多尿、泡沫尿，就诊我院，予“降糖、改善微循环、营养心肌、抗凝”等治疗后，血糖控制稳定后出院，出院后予“诺和锐特充三餐前5U-9U-4U+来得时9U睡前”，未规律监测血糖，偶测空腹末梢血糖10MMOL/L下上。1月前无明显诱因出现泡沫尿，无尿频、尿急、尿痛，无发热、寒战，无多饮、多食，未予重视，未处理。今求进一步诊治，就诊我院，门诊“糖尿病糖尿病性肾病？”收入院。自发病以来，精神、食欲、睡眠尚可，小便如下述，大便正常，体重无明显改变。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 16}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 31, "end_pos": 32}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 50, "end_pos": 54}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 65, "end_pos": 67}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 70, "end_pos": 72}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 75, "end_pos": 78}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 88, "end_pos": 90}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 94, "end_pos": 96}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 100, "end_pos": 103}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 114, "end_pos": 119}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 134, "end_pos": 138}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 149, "end_pos": 154}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 155, "end_pos": 162}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 176, "end_pos": 187}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 188, "end_pos": 194}, {"label_type": "影像检查", "overlap": 0, "start_pos": 226, "end_pos": 229}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 234, "end_pos": 240}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 250, "end_pos": 256}, {"end_pos": 275, "label_type": "药物", "overlap": 0, "start_pos": 272}, {"end_pos": 282, "label_type": "药物", "overlap": 0, "start_pos": 279}, {"label_type": "药物", "overlap": 0, "start_pos": 297, "end_pos": 300}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 303, "end_pos": 309}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 322, "end_pos": 326}, {"end_pos": 349, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"end_pos": 355, "label_type": "解剖部位", "overlap": 0, "start_pos": 354}, {"end_pos": 358, "label_type": "解剖部位", "overlap": 0, "start_pos": 357}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 381, "end_pos": 385}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 396, "end_pos": 398}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 404, "end_pos": 409}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 418, "end_pos": 422}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 430, "end_pos": 432}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 447, "end_pos": 449}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 452, "end_pos": 454}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 462, "end_pos": 465}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 477, "end_pos": 479}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 501, "end_pos": 511}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 527, "end_pos": 534}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 548, "end_pos": 555}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 569, "end_pos": 575}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 588, "end_pos": 594}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 608, "end_pos": 621}, {"end_pos": 637, "label_type": "解剖部位", "overlap": 0, "start_pos": 636}, {"end_pos": 656, "label_type": "药物", "overlap": 0, "start_pos": 653}, {"end_pos": 672, "label_type": "药物", "overlap": 0, "start_pos": 669}, {"label_type": "药物", "overlap": 0, "start_pos": 687, "end_pos": 690}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 694, "end_pos": 696}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 702, "end_pos": 706}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 715, "end_pos": 719}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 732, "end_pos": 733}, {"end_pos": 773, "label_type": "解剖部位", "overlap": 0, "start_pos": 771}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 782, "end_pos": 784}, {"end_pos": 800, "label_type": "药物", "overlap": 0, "start_pos": 797}, {"end_pos": 817, "label_type": "药物", "overlap": 0, "start_pos": 814}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 828, "end_pos": 830}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 833, "end_pos": 839}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 913, "end_pos": 922}]}
{"originalText": "患者2年前无明显诱因出现左上腹隐痛，间断性，无放散，自服止痛药物后可缓解，于外院检查发现子宫肌瘤，行子宫次全切除术，术后切口愈合不良，时有脓性液体流出，半年后切口愈合，仍有左上腹隐痛，间断性，较术前频繁，向腰骶部放散，自服止痛药物可缓解。近4日左上腹隐痛加重，较剧烈，持续性，自服止痛药物未缓解，于外院就诊发现左侧盆腔直径约10CM囊性包块。现为求进一步诊治入院。患者平素便秘，时有尿频、尿急、尿痛等尿路感染症状，白带可，否认合房出血。病来无发热乏力，无头晕头痛，无胸闷气短，无腹胀，饮食睡眠可，体重无减轻。", "entities": [{"end_pos": 15, "label_type": "解剖部位", "overlap": 0, "start_pos": 12}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 44, "end_pos": 48}, {"end_pos": 57, "label_type": "手术", "overlap": 0, "start_pos": 50}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 86}, {"end_pos": 106, "label_type": "解剖部位", "overlap": 0, "start_pos": 103}, {"end_pos": 125, "label_type": "解剖部位", "overlap": 0, "start_pos": 122}, {"end_pos": 159, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"end_pos": 228, "label_type": "解剖部位", "overlap": 0, "start_pos": 227}, {"end_pos": 230, "label_type": "解剖部位", "overlap": 0, "start_pos": 229}, {"end_pos": 234, "label_type": "解剖部位", "overlap": 0, "start_pos": 233}, {"end_pos": 240, "label_type": "解剖部位", "overlap": 0, "start_pos": 239}]}
{"originalText": "缘于3天前无明显诱因感左上肢肿痛，为持续性钝痛，以左小腿为重，久立或久行后症状加重，抬高患肢可略缓解。无患肢发凉、浅表血管曲张、紫绀，伴间歇性跛行，无腰痛、咳嗽、咯血等不适。未行特殊治疗患肢肿胀无明显变化。今来我院就诊，行上肢深静脉彩超检查示左上肢深静脉血栓形成，为进一步治疗，遂收入我科。自发病以来无明显胸闷、气短，无发烧，精神状态一般，食欲一般，睡眠良好，体重无明显变化，大便正常，小便正常。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"end_pos": 28, "label_type": "解剖部位", "overlap": 0, "start_pos": 25}, {"end_pos": 76, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"label_type": "影像检查", "overlap": 0, "start_pos": 111, "end_pos": 118}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 121, "end_pos": 131}, {"end_pos": 154, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}]}
{"originalText": "，患者9月余前于我院行全膀胱切除根治术+回肠导管术，，术后病理提示：膀胱浸润性癌，结合免疫组化结果，符合高级别浸润性尿路下皮癌，左闭孔淋巴结、左髂外淋巴结、左髂内淋巴结见癌转移，并侵出至淋巴结包膜外结缔组织。左髂总淋巴结见癌转移，脉管内见癌栓。左髂总淋巴结见癌转移，脉管内见癌栓。4月前，患者于我院复查，CT:膀胱术后缺如，局部未见明显肿物；左上腹壁见肠管造瘘口。直肠下段前方新增软组织灶与直肠分界不清，增强扫描强化稍明显，大小约41MM×17MM。直肠系膜见多发淋巴结，边界清，较大者约10MM×7MM，密度均匀。2月前患者出现腹部剧烈疼痛，患者为求进一步诊治再次入院，复查CT示膀胱癌根治术后，膀胱术后缺失，直肠下段前方软组织灶，较前明显增大，考虑腹膜种植可能性大，直肠系膜多发小淋巴结，较前增大，腹主动脉旁及小肠系膜根肠系膜根部淋巴结，较前未见明显变化，两侧髂血管旁结节，考虑淋巴结转移，并两肾盂、两输尿管积水，左上上肺内基底段类结节较前变化不明显。遂于2014-11-13、2014.12.03、2014-12-23、2015-01-13行GC方案动脉化疗（吉西他滨1.2GD1，顺铂20MG，D1-D3）双周期，化疗后患者回家休养。今为求进一步治疗再次来我院，门诊以\\\"膀胱癌综合治疗后\\\"收入我科。患者发病以来,精神好,饮食睡眠可,无发冷发热，无咳嗽、咳痰、胸痛及心慌气短，大便正常，小便如下所述，体重无减轻。", "entities": [{"label_type": "手术", "overlap": 0, "start_pos": 11, "end_pos": 25}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 34, "end_pos": 40}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 52, "end_pos": 63}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 64, "end_pos": 70}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 71, "end_pos": 77}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 78, "end_pos": 84}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 104}, {"end_pos": 128, "label_type": "解剖部位", "overlap": 0, "start_pos": 122}, {"label_type": "影像检查", "overlap": 0, "start_pos": 152, "end_pos": 154}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 155, "end_pos": 159}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 171, "end_pos": 174}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 176, "end_pos": 178}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 182, "end_pos": 184}, {"end_pos": 197, "label_type": "解剖部位", "overlap": 0, "start_pos": 195}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 227}, {"end_pos": 267, "label_type": "解剖部位", "overlap": 0, "start_pos": 265}, {"label_type": "影像检查", "overlap": 0, "start_pos": 288, "end_pos": 290}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 291, "end_pos": 298}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 299, "end_pos": 303}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 306, "end_pos": 308}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 326, "end_pos": 330}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 335, "end_pos": 337}, {"end_pos": 356, "label_type": "解剖部位", "overlap": 0, "start_pos": 351}, {"end_pos": 370, "label_type": "解剖部位", "overlap": 0, "start_pos": 357}, {"end_pos": 385, "label_type": "解剖部位", "overlap": 0, "start_pos": 380}, {"end_pos": 401, "label_type": "解剖部位", "overlap": 0, "start_pos": 398}, {"end_pos": 406, "label_type": "解剖部位", "overlap": 0, "start_pos": 402}, {"end_pos": 417, "label_type": "解剖部位", "overlap": 0, "start_pos": 409}, {"end_pos": 487, "label_type": "药物", "overlap": 0, "start_pos": 483}, {"end_pos": 496, "label_type": "药物", "overlap": 0, "start_pos": 494}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 540, "end_pos": 548}, {"end_pos": 586, "label_type": "解剖部位", "overlap": 0, "start_pos": 585}]}
{"originalText": "，缘于入院前[主诉单一时间1月主诉单一时间]前无明显诱因出现中下腹部闷痛部闷痛不适，为持续性隐痛，无其它部位放射，与进食无关，无恶心、呕吐、返酸、嗳气、纳差、乏力、消瘦、腹痛、腹泻、便秘，无呕血、黑便，无发热、咳嗽、咳痰，，此次至我院门诊行胃镜检查示：“吻合口溃疡”，，病理：腺癌，遂门诊拟“残胃癌”收入院。自发病以来，精神、睡眠可，食欲一般，大小便如常，体重无明显变化。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 30, "end_pos": 34}, {"end_pos": 86, "label_type": "解剖部位", "overlap": 0, "start_pos": 85}, {"end_pos": 89, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 127, "end_pos": 132}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 138, "end_pos": 140}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 146, "end_pos": 149}]}
{"originalText": "患者于3月余前因“肛门坠胀伴疼痛5月余，加重1月余。”入院，诊断为直肠腺癌并行腹腔镜上直肠癌根治术（DIXON）+末端回肠造口术，手术顺利，术后病理诊断：1、（直肠）溃疡型中分化管状腺癌，侵及肠壁全层，双切端未见癌累及，肠壁淋巴结见癌转移（4/7），脂肪组织中见癌结节。 2、（吻合口残端）未见癌累及。患者于院外期间未诉腹痛、腹胀，恶心、呕吐，便血、腹泻等不适，胃纳可，今患者为求还纳回肠末端造口遂来我院，门诊以“直肠癌术后”收入我科。\\U0004   患者发病以来，神志 清晰，精神可，胃纳可，大便如常，小便如常，体重未见明显上降。", "entities": [{"end_pos": 11, "label_type": "解剖部位", "overlap": 0, "start_pos": 9}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 33, "end_pos": 37}, {"label_type": "手术", "overlap": 0, "start_pos": 39, "end_pos": 64}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 79, "end_pos": 93}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 96, "end_pos": 97}, {"end_pos": 115, "label_type": "解剖部位", "overlap": 0, "start_pos": 110}, {"end_pos": 161, "label_type": "解剖部位", "overlap": 0, "start_pos": 160}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 163}, {"end_pos": 176, "label_type": "解剖部位", "overlap": 0, "start_pos": 175}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 181, "end_pos": 182}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 192, "end_pos": 194}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 207, "end_pos": 212}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 244, "end_pos": 245}]}
{"originalText": "，患者入院前6年无明显诱因出现腹痛，主要为左下腹及左上腹阵发性隐痛不适，疼痛与进食、活动及体位改变无明显关系，无反酸、嗳气、烧心、恶心、呕吐等不适，无肩背部放射痛，，曾于我院行胃镜示：1.食管浅溃疡；2.浅表性胃窦炎伴糜烂；3.十二指肠球部多发息肉。并行十二指肠球部息肉消融术，，术后活检示：十二指肠球部息肉伴柱状下皮化生。后腹痛反复出现，予对症治疗后缓解，患者入院前3月无明显诱因再发腹痛，部位同前，疼痛程度较前加重，无厌油、纳差、乏力、反酸、嗳气等不适，，于我院行胃镜示：1.慢性非萎缩性胃炎；2.十二指肠球部息肉。今日患者为求进一步诊治收入我科治疗。\\U0004   患者本次发病以来，食欲正常， 神志清醒，精神尚可，睡眠尚可，大便正常，小便正常，体重无明显变化。", "entities": [{"end_pos": 16, "label_type": "解剖部位", "overlap": 0, "start_pos": 15}, {"end_pos": 24, "label_type": "解剖部位", "overlap": 0, "start_pos": 21}, {"end_pos": 28, "label_type": "解剖部位", "overlap": 0, "start_pos": 25}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 75}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 94, "end_pos": 99}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 102, "end_pos": 111}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 114, "end_pos": 124}, {"end_pos": 138, "label_type": "手术", "overlap": 0, "start_pos": 127}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 146, "end_pos": 161}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 163}, {"end_pos": 194, "label_type": "解剖部位", "overlap": 0, "start_pos": 193}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 240, "end_pos": 248}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 251, "end_pos": 259}]}
{"originalText": "患者因\\\"直肠癌同期放化疗后\\\"于2012年5月25日在我院在全麻上行DIXON手术，术后病理显示直肠中分化腺癌，癌组织浸润至肠壁外膜层，淋巴结及切缘未见转移。因术后10余天发现“阴道中有大便排出”于2012年6月25日行“横结肠两腔造瘘术+阴道修补术”。患者术后已于2012年8月3日行XELOX方案化疗一程，过程顺利，患者诉化疗后自觉手麻木3天，现已恢复。患者自发病以来，食欲、睡眠及精神良好，小便正常，体力无上降，体重无明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 5, "end_pos": 14}, {"end_pos": 42, "label_type": "手术", "overlap": 0, "start_pos": 35}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 49, "end_pos": 56}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 63, "end_pos": 64}, {"end_pos": 92, "label_type": "解剖部位", "overlap": 0, "start_pos": 90}, {"label_type": "手术", "overlap": 0, "start_pos": 112, "end_pos": 126}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 169}]}
{"originalText": "，缘于入院前1个月无明显诱因出现食物反流，偶于睡觉时从嘴角流出，为胃内容物，伴咳嗽，乏力，进食后、卧位以及夜间明显，无反酸、烧心，无吞咽困难、进食障碍，无胸闷、胸痛，无发热、畏冷，无咳痰，无腹胀、腹痛，就诊我院，予“世福素、甘草合剂”等治疗后无明显好转。入院前7天就诊我院消化科，，查腹部CT示：1、右下下腹部残胃腔管壁明显增厚伴轻度强化，最厚约24MM，管腔变窄，食管轻度扩张，考虑残胃癌，建议内镜检查，残胃周围未见明显肿大淋巴结。，胃镜检查:食管腔见大量液体残留，影响观察；距门齿40CM处见一隆起性病灶，表面糜烂、出血，质地组织脆,活检易出血，管腔狭窄，内镜不能通过，无法观察全貌。，考虑:胃癌术后复发？，胃镜病理示：（距门齿40CM），：乳头状-管状腺癌。予“右卡尼汀、力素营养心肌，氨基酸、脂肪乳营养支持，胸腺五肽增强免疫力，潘妥洛克制酸保胃、头孢替安抗感染”等处理后症状稍好转。今为求进一步诊治，就诊我院，门诊拟“贲门癌”收住入院。自发病以来，精神、饮食、睡眠一般，大小便正常，体重减轻3KG。", "entities": [{"end_pos": 34, "label_type": "解剖部位", "overlap": 0, "start_pos": 33}, {"end_pos": 78, "label_type": "解剖部位", "overlap": 0, "start_pos": 77}, {"end_pos": 81, "label_type": "解剖部位", "overlap": 0, "start_pos": 80}, {"end_pos": 96, "label_type": "解剖部位", "overlap": 0, "start_pos": 95}, {"end_pos": 99, "label_type": "解剖部位", "overlap": 0, "start_pos": 98}, {"end_pos": 111, "label_type": "药物", "overlap": 0, "start_pos": 108}, {"end_pos": 116, "label_type": "药物", "overlap": 0, "start_pos": 112}, {"label_type": "影像检查", "overlap": 0, "start_pos": 142, "end_pos": 146}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 150, "end_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 156, "end_pos": 157}, {"end_pos": 185, "label_type": "解剖部位", "overlap": 0, "start_pos": 183}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 193, "end_pos": 194}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 204, "end_pos": 205}, {"end_pos": 225, "label_type": "解剖部位", "overlap": 0, "start_pos": 223}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 240, "end_pos": 242}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 298, "end_pos": 304}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 314, "end_pos": 316}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 323, "end_pos": 331}, {"end_pos": 338, "label_type": "药物", "overlap": 0, "start_pos": 334}, {"end_pos": 341, "label_type": "药物", "overlap": 0, "start_pos": 339}, {"end_pos": 349, "label_type": "药物", "overlap": 0, "start_pos": 346}, {"end_pos": 353, "label_type": "药物", "overlap": 0, "start_pos": 350}, {"end_pos": 362, "label_type": "药物", "overlap": 0, "start_pos": 358}, {"end_pos": 372, "label_type": "药物", "overlap": 0, "start_pos": 368}, {"end_pos": 381, "label_type": "药物", "overlap": 0, "start_pos": 377}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 413, "end_pos": 416}]}
{"originalText": "患者4年前因上肢疼痛就诊我院，诊断“上肢动脉粥样硬化闭塞症状”，于2013年于全麻上行“两侧上肢动脉支架置入术+术中溶栓术”，术顺，术后顺利出院。患者1月前无明显诱因于行走100M时出现右侧上肢疼痛，休息后好转，行走后症状反复。患者近日症状加重，行走50M出现右上肢疼痛症状，休息后症状好转。无上肢肿胀，无上肢静脉曲张，无胸腹部疼痛，无腰部疼痛。现患者为进一步治疗就诊我院，门诊拟以“上肢动脉粥样硬化闭塞症”收住入院。患者自发病以来，饮食睡眠可，大小便无明显异常，运动耐量明显上降。", "entities": [{"end_pos": 8, "label_type": "解剖部位", "overlap": 0, "start_pos": 6}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 18, "end_pos": 30}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 44, "end_pos": 61}, {"end_pos": 97, "label_type": "解剖部位", "overlap": 0, "start_pos": 93}, {"end_pos": 133, "label_type": "解剖部位", "overlap": 0, "start_pos": 130}, {"end_pos": 149, "label_type": "解剖部位", "overlap": 0, "start_pos": 147}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 153}, {"end_pos": 164, "label_type": "解剖部位", "overlap": 0, "start_pos": 161}, {"end_pos": 170, "label_type": "解剖部位", "overlap": 0, "start_pos": 168}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 192, "end_pos": 203}]}
{"originalText": "，患者无明显诱因上自觉中下腹疼痛不适，腹痛性质为阵发性绞痛，剧烈难忍，伴大汗淋漓，伴左肩胛部放射痛，进食油腻食物后无加重。有发热、恶心、呕吐史，发热最高度数不详。数年前出现皮肤巩膜黄染史。2010年5月23日，至我院门诊查CT示：肝内外胆管多发结石伴胆管扩张，慢性肝病，脾肿大，，查B超示：肝内胆管及胆总管多发结石伴远端胆管扩张，2010/6/29在肝外科行复杂粘连松解、胆总管切开取石、胆道镜探查、T管引流术，因患者右肝代偿性增大明显，切除右肝患者肝功能无法耐受，故手术未取出嵌顿于右肝管内的结石，术后恢复可。现为求进一步诊治，收入本病房。患者发病以来精神可，胃纳可，双便如常，睡眠可，否认明显体重变化。", "entities": [{"end_pos": 14, "label_type": "解剖部位", "overlap": 0, "start_pos": 11}, {"end_pos": 20, "label_type": "解剖部位", "overlap": 0, "start_pos": 19}, {"end_pos": 45, "label_type": "解剖部位", "overlap": 0, "start_pos": 42}, {"end_pos": 90, "label_type": "解剖部位", "overlap": 0, "start_pos": 88}, {"label_type": "影像检查", "overlap": 0, "start_pos": 111, "end_pos": 113}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 115, "end_pos": 129}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 130, "end_pos": 134}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 135, "end_pos": 136}, {"label_type": "影像检查", "overlap": 0, "start_pos": 141, "end_pos": 143}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 145, "end_pos": 164}, {"label_type": "手术", "overlap": 0, "start_pos": 179, "end_pos": 205}, {"end_pos": 211, "label_type": "解剖部位", "overlap": 0, "start_pos": 209}, {"end_pos": 223, "label_type": "解剖部位", "overlap": 0, "start_pos": 221}, {"end_pos": 245, "label_type": "解剖部位", "overlap": 0, "start_pos": 242}, {"end_pos": 282, "label_type": "解剖部位", "overlap": 0, "start_pos": 281}]}
{"originalText": "患者于2009.7.22因残胃异时性原发癌在全麻上行胃癌根治术（全胃切除+区域淋巴结清扫+ROUX-EN-Y消化道重建术），术后恢复好，病理类型（印戒细胞癌），分期T4、N３、M０。术后18天行全身化疗（FOLFIRI），共1次，有特别化疗反应，轻微恶心呕吐，食欲上降。3天前化疗结束自动要求出院。出院后感反复下腹痛，为阵发性绞痛，可自行缓解。伴有食欲不佳，恶心，未呕吐。今为明确诊治入院。\\U0004   患者自起病以来，精神略差，胃纳略差，大便次数增多，小便如常，体重未见明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 13, "end_pos": 21}, {"end_pos": 61, "label_type": "手术", "overlap": 0, "start_pos": 26}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 72, "end_pos": 90}, {"end_pos": 157, "label_type": "解剖部位", "overlap": 0, "start_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 217, "end_pos": 218}]}
{"originalText": "，患者约于10月前无明显诱因出现消化不良，餐后饱胀，伴嗳气，偶有反酸，无发热，无恶心、呕吐，无腹泻、黑便，无肛门上坠感及里急后重感，未规范治疗。现患者为求明确诊疗来我院就诊，，门诊行胃镜检查示:胃体大弯侧见一直径约0.8CM息肉样隆起，，超声示：隆起为粘膜上层来源等回声光团，并有颗粒感，，检查诊断：1.萎缩性胃炎伴急性活动；2.胃体隆起，SMT?3.十二指肠炎。现为行进一步治疗，门诊以\\\"胃息肉\\\"收入我科。患者自发病以来，精神可，饮食可，睡眠可，二便正常，体重无明显改变。", "entities": [{"end_pos": 48, "label_type": "解剖部位", "overlap": 0, "start_pos": 47}, {"end_pos": 56, "label_type": "解剖部位", "overlap": 0, "start_pos": 54}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 97, "end_pos": 101}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 152, "end_pos": 162}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 164, "end_pos": 169}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 170, "end_pos": 173}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 176, "end_pos": 181}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 196, "end_pos": 199}]}
{"originalText": "入院前10+年患者开始出现咳嗽、咳痰，多于冬春季及受凉后发作，抗感染治疗有效，每年发作超过3个月。入院前6+年开始出现咳嗽咳痰时伴喘累，逐渐出现活动后心累，于下坡时出现。2014年4月患者曾因下诉症状发作在我科住院治疗，当时查“心脏彩超示右房、左房、左室增大，主动脉瓣、二尖瓣轻度反流，三尖瓣重度反流，肺动脉重度高压，心包腔积液，右室舒张功能减退。腹部彩超未见明显异常。胸片示1.右肺中上野团片影，建议CT检查；2.考虑左下肺感染性病变，肺气肿；3.心影增大，主动脉少许钙化；4.考虑左侧水平裂少量包裹性积液或水平裂增厚，右上胸壁条片影，考虑少量胸腔积液或胸膜增厚；5.两膈面粘连，胸椎骨质增生。完善胸部CT示1.考虑左下叶感染，两上肺支气管扩张伴感染，以右上肺为甚；2.右心缘不规则低密度影，考虑囊性病变，支气管囊肿？心包囊肿？心包积液？囊性畸胎瘤？；3.符合慢支炎、肺气肿伴左上肺大泡形成；4.心影增大，主动脉壁钙化；5.右侧胸腔积液及叶间积液，部分包裹”，考虑诊断“1、慢性阻塞性肺病（急性加重期）肺源性心脏病 2、冠心病 缺血性心肌病型 心脏增大 心房纤颤 心衰 心包腔积液 心功能Ⅲ级 3、支气管扩张 4. 右肺中上野团片影原因待查”，予以吸氧、抗感染、平喘、改善循环、调节代谢、对症治疗后好转出院。出院后患者曾间断服用利尿剂，未长期服用止咳化痰药物及家庭氧疗。入院前4天，患者受凉后喘累、气促再发，伴咳嗽、咳痰，自诉痰呈白色丝状，不易咳出，无咯血，感夜间难以平卧位休息，喜高枕卧位，无畏寒发热，无潮热盗汗，无心慌心悸，无胸闷胸痛，无腹胀腹痛，无上肢浮肿等，曾在外诊所输液治疗2天，自觉症状缓解，但昨日夜间再次感咳嗽明显，伴气促，故就诊我院门诊，查“血气分析全套：二氧化碳总量 39mmol/l、酸碱度 7.360、二氧化碳分压 66mmHg、氧分压 163mmHg、碳酸氢根 37.3mmol/l、标准碳酸氢根 31.90mmol/l、细胞外液碱剩余 11.9mmol/l、全血碱剩余 8.90mmol/l、血氧饱和度 99%、乳酸 1.00mmol/l，血常规：白细胞数 8.3 10^9/L、血红蛋白浓度 139g/L、血小板数 181 10^9/L、中性粒细胞百分比 84.21%、淋巴细胞百分比 11.02%，肾功：尿素 9.23mmol/L、肌酐 63.6μmol/l、尿酸 289.2μmol/l，电解质：钾 3.59mmol/l、钠 147.1mmol/、氯 104.9mmol/l。胸片示1.左下肺感染性病变，侧位肺门增大增浓，建议CT或治疗后复查。2.肺气肿征。3.左侧胸膜增厚。4.胸椎骨质增生，部分椎体楔形变”，为进一步诊疗收入我科住院。患者此次起病后精神、食欲、睡眠一般，大小便正常，体力体重无明显变化。", "entities": [{"label_type": "影像检查", "overlap": 0, "start_pos": 114, "end_pos": 118}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 119, "end_pos": 121}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 122, "end_pos": 124}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 125, "end_pos": 127}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 130, "end_pos": 134}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 135, "end_pos": 138}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 143, "end_pos": 146}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 151, "end_pos": 154}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 159, "end_pos": 164}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 165, "end_pos": 167}, {"label_type": "影像检查", "overlap": 0, "start_pos": 174, "end_pos": 178}, {"label_type": "影像检查", "overlap": 0, "start_pos": 185, "end_pos": 187}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 190, "end_pos": 192}, {"label_type": "影像检查", "overlap": 0, "start_pos": 201, "end_pos": 203}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 210, "end_pos": 218}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 219, "end_pos": 222}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 230, "end_pos": 233}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 242, "end_pos": 247}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 255, "end_pos": 258}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 261, "end_pos": 265}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 273, "end_pos": 277}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 278, "end_pos": 282}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 285, "end_pos": 288}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 291, "end_pos": 297}, {"label_type": "影像检查", "overlap": 0, "start_pos": 300, "end_pos": 304}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 309, "end_pos": 314}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 315, "end_pos": 326}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 328, "end_pos": 331}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 336, "end_pos": 339}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 349, "end_pos": 353}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 354, "end_pos": 359}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 360, "end_pos": 364}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 365, "end_pos": 369}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 370, "end_pos": 375}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 381, "end_pos": 384}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 385, "end_pos": 388}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 389, "end_pos": 392}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 399, "end_pos": 400}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 404, "end_pos": 408}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 415, "end_pos": 419}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 438, "end_pos": 452}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 452, "end_pos": 458}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 461, "end_pos": 464}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 465, "end_pos": 472}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 473, "end_pos": 475}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 478, "end_pos": 482}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 483, "end_pos": 485}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 486, "end_pos": 491}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 492, "end_pos": 497}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 500, "end_pos": 505}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 509, "end_pos": 511}, {"label_type": "药物", "overlap": 0, "start_pos": 565, "end_pos": 568}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 660, "end_pos": 661}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 662, "end_pos": 663}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 666, "end_pos": 667}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 668, "end_pos": 669}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 672, "end_pos": 673}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 674, "end_pos": 675}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 678, "end_pos": 680}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 737, "end_pos": 743}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 753, "end_pos": 756}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 763, "end_pos": 769}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 777, "end_pos": 780}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 789, "end_pos": 793}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 805, "end_pos": 811}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 824, "end_pos": 831}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 843, "end_pos": 848}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 860, "end_pos": 865}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 870, "end_pos": 872}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 888, "end_pos": 892}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 904, "end_pos": 910}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 918, "end_pos": 921}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 934, "end_pos": 942}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 950, "end_pos": 957}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 968, "end_pos": 970}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 982, "end_pos": 984}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 996, "end_pos": 998}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 1015, "end_pos": 1016}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 1028, "end_pos": 1029}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 1041, "end_pos": 1042}, {"label_type": "影像检查", "overlap": 0, "start_pos": 1055, "end_pos": 1057}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1060, "end_pos": 1063}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1071, "end_pos": 1073}, {"label_type": "影像检查", "overlap": 0, "start_pos": 1080, "end_pos": 1082}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 1091, "end_pos": 1094}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1098, "end_pos": 1102}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 1107, "end_pos": 1113}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1116, "end_pos": 1118}]}
{"originalText": "入院前3+年患者在院外发现肾功能异常，具体不详，考虑“高血压肾病”，予以控制血压、保护肾功能等治疗，院外随访肾功能不详。反复因黑便多次在我院内二科住院，住院后诊断“尿毒症 肾性贫血，高血压肾病，消化道出血，高血压心脏病、心功能不全，营养不良”，给予输血、止血、抑酸、纠正心衰等治疗后好转，后期患者自动出院后于**医院就诊，查血肌酐 638umol/L，尿素氮 22.92mmol/L，血常规：血红蛋白 89g/L，电解质：血钾 4.70mmol/L等，诊断“慢性肾脏病5期，肾性贫血，消化道出血，高血压3级很高危、高血压心脏病，尿路感染，低蛋白血症”，急诊行深静脉置管，开始行规律血液透析，并给予止血、抑酸、营养支持、稳定血压、抗尿路感染、对症等治疗后好转，并于2016-03-14行右前臂动静脉内瘘吻合术，2016-04-06自动出院转我科行长期维持性血液透析治疗。1-月前受凉后出现咳嗽，家属在药店购买“消炎止咳”等药物给其服用，具体不详，服药后症状无好转，起床后出现面部浮肿，咳嗽时腹部疼痛，伴有腹泻，无腹痛腹胀，无恶心呕吐，无发热、气促，无心悸胸闷，无两上肢水肿，为进一步治疗到我院透析室检查透析后患者症状无好转，后收入我科住院，使用依替米星抗感染（7天），查胸部CT：1、考虑两肺感染性病变，建议治疗后复查。2、两侧少-中量胸腔积液。3、右肺尖条片状及纤维条索状影，右下肺门稍牵拉下移。4、心影增大，主动脉及冠状动脉壁钙化。5、少量心包积液。6、两侧胸膜增厚，左侧少许胸膜钙化。胸椎骨质增生。7、脾脏稍增大。因不除外肺部结核，建议转往******医院就诊，于2017-10-13转入******医院，予以胸腔闭式引流术，莫西沙星抗感染（14天），胎盘多肽增强抵抗力，多索茶碱舒张支气管，厄贝沙坦氢氯噻嗪、氨氯地平降压等治疗，查胸水一般细菌涂片、找抗酸杆菌、腺苷脱氨酶测定、CEA、AFP、CA125无明显异常，T-SPOT弱阳性，复查胸部CT提示：1、气管左移，肺内血管支气管束增多增粗，两侧肺较多散在的斑片状、条索状高密度影，考虑感染性病变可能；2、胸腔内可见明显中量积液，密度不均，邻近胸膜粘连；2、心脏血管及主动脉钙化。*******医院评估，目前暂不考虑肺结核诊断；患者目前间断咳嗽，少许白色粘痰，不易咳出，精神欠佳，食欲差，感活动后心累，气促较前缓解，无意识障碍大小便失禁，无胸闷胸痛，无心悸、恶心呕吐，无腹胀腹痛腹泻，无尿痛尿频等不适，建议患者继续抗感染治疗，但患者家属要求转回我院，今日转入我院继续治疗。病程中患者精神欠佳，饮食差，昨日解黄色稀便2次，小便约400ml，体重无明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 27, "end_pos": 32}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 82, "end_pos": 85}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 86, "end_pos": 90}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 91, "end_pos": 96}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 97, "end_pos": 102}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 103, "end_pos": 109}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 110, "end_pos": 115}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 116, "end_pos": 120}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 162, "end_pos": 165}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 176, "end_pos": 179}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 196, "end_pos": 200}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 211, "end_pos": 213}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 229, "end_pos": 236}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 237, "end_pos": 241}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 242, "end_pos": 247}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 248, "end_pos": 256}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 257, "end_pos": 263}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 264, "end_pos": 268}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 269, "end_pos": 274}, {"label_type": "手术", "overlap": 0, "start_pos": 342, "end_pos": 353}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 436, "end_pos": 438}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 444, "end_pos": 446}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 451, "end_pos": 452}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 455, "end_pos": 456}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 457, "end_pos": 458}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 474, "end_pos": 475}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 480, "end_pos": 483}, {"label_type": "药物", "overlap": 0, "start_pos": 521, "end_pos": 525}, {"label_type": "影像检查", "overlap": 0, "start_pos": 534, "end_pos": 538}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 543, "end_pos": 550}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 567, "end_pos": 571}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 574, "end_pos": 577}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 588, "end_pos": 592}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 600, "end_pos": 601}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 605, "end_pos": 616}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 621, "end_pos": 625}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 628, "end_pos": 632}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 639, "end_pos": 643}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 644, "end_pos": 650}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 653, "end_pos": 655}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 663, "end_pos": 665}, {"label_type": "手术", "overlap": 0, "start_pos": 707, "end_pos": 714}, {"label_type": "药物", "overlap": 0, "start_pos": 715, "end_pos": 719}, {"label_type": "药物", "overlap": 0, "start_pos": 728, "end_pos": 732}, {"label_type": "药物", "overlap": 0, "start_pos": 738, "end_pos": 742}, {"label_type": "药物", "overlap": 0, "start_pos": 748, "end_pos": 756}, {"label_type": "药物", "overlap": 0, "start_pos": 757, "end_pos": 761}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 768, "end_pos": 776}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 778, "end_pos": 782}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 783, "end_pos": 790}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 791, "end_pos": 794}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 795, "end_pos": 798}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 799, "end_pos": 804}, {"label_type": "影像检查", "overlap": 0, "start_pos": 822, "end_pos": 826}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 831, "end_pos": 833}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 836, "end_pos": 844}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 849, "end_pos": 852}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 881, "end_pos": 883}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 900, "end_pos": 902}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 907, "end_pos": 917}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 936, "end_pos": 939}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 998, "end_pos": 999}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1000, "end_pos": 1001}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1004, "end_pos": 1005}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1013, "end_pos": 1014}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1015, "end_pos": 1016}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 1017, "end_pos": 1018}]}
{"originalText": "入院前5+小时，患者被家属发现呼之不应，无恶心、呕吐，无四肢抽搐。家属家中自测血糖3.2mmol/l，家属给予\\\"糖水\\\"口服后，复查血糖6.5mmol/l，但仍然呼之不应，家属拨打120接回。入室后立即予以心电监护，吸氧，建立静脉通道，床旁心电图示：室下性心动过速。急查血常规、肾功、电解质、心肌酶谱、肌钙蛋白、D-二聚体，血气分析，头颅及胸部CT，于14:23接放射科危急值报告血气分析:血氧饱和度83.00 %↓、氧分压45 mmHg↓↓、二氧化碳分压30 mmHg↓、乳酸11.40 mmol/l↑↑，氧饱和度逐渐上降，告诉患者家属患者目前情况需要紧急气管插管，患者家属表示同意，于14:35分行气管插管，但患者牙关紧闭，口中假牙无法取出。行血常规:WBC 7.5 10^9/L、RBC 4.51 10^12/L、HGB 128 g/L↓、PLT 213 10^9/L，肾功:UREA 5.44 mmol/L、CREA 57.5 μmol/l、UA 208.8 μmol/l↓，电解质1:K 5.07 mmol/l、Na 141.4 mmol/、Cl 98.1 mmol/l↓，心肌酶谱:AST 34.0 U/L、CK 360.7 U/L↑、CK-MB 15 U/L、LDH 222.9 U/L，高敏肌钙蛋白:TNT-HSSTT 38.29 pg/ml↑，D_2聚体:D-D 1.90 μg/ml↑，凝血试验:PT 12.3 秒、INR 1.04 、APTT 17.7 秒↓、FIB 3.41 g/L、TT 16.4 秒，血气分析全套:TCO2 21 mmol/l↓、pH 7.440 、PCO2 30 mmHg↓、PO2 45 mmHg↓↓、HCO3 20.4 mmol/l↓、SBC 22.40 mmol/l、BE(ecf) -3.8 mmol/l↓、BE(B) -2.80 mmol/l、sO2% 83.00 %↓、Lac 11.40 mmol/l↑↑、GLU 5.80 mmol/l、Na+ 138 mmol/l、K+ 5.0 mmol/l、Ca++ 1.07 mmol/l↓.头颅CT：考虑右侧基底节区脑梗死；左侧基底节腔隙性脑梗死。2、脑白质脱髓鞘改变；脑萎缩。3、考虑两肺感染性病变，建议治疗后复查。4、两侧少量胸腔积液。5、主动脉及冠状动脉壁钙化。6、胸椎骨质增生。给予补液，营养神经等治疗，请我科会诊，交代患者病情危重，随时有生命危险，家属对病情表示理解，同意转ICU治疗。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 28, "end_pos": 30}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 39, "end_pos": 41}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 67, "end_pos": 69}, {"label_type": "影像检查", "overlap": 0, "start_pos": 104, "end_pos": 108}, {"label_type": "影像检查", "overlap": 0, "start_pos": 121, "end_pos": 124}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 126, "end_pos": 133}, {"label_type": "影像检查", "overlap": 0, "start_pos": 168, "end_pos": 175}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 196, "end_pos": 201}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 210, "end_pos": 213}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 223, "end_pos": 229}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 238, "end_pos": 240}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 255, "end_pos": 259}, {"label_type": "手术", "overlap": 0, "start_pos": 280, "end_pos": 284}, {"label_type": "手术", "overlap": 0, "start_pos": 302, "end_pos": 306}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 329, "end_pos": 332}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 344, "end_pos": 347}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 361, "end_pos": 364}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 374, "end_pos": 377}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 392, "end_pos": 396}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 409, "end_pos": 413}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 426, "end_pos": 428}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 448, "end_pos": 449}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 462, "end_pos": 464}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 477, "end_pos": 479}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 498, "end_pos": 501}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 511, "end_pos": 513}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 525, "end_pos": 530}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 538, "end_pos": 541}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 559, "end_pos": 568}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 588, "end_pos": 591}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 609, "end_pos": 611}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 619, "end_pos": 622}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 629, "end_pos": 633}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 642, "end_pos": 645}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 655, "end_pos": 657}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 672, "end_pos": 676}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 688, "end_pos": 690}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 698, "end_pos": 702}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 712, "end_pos": 715}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 726, "end_pos": 730}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 744, "end_pos": 747}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 761, "end_pos": 768}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 782, "end_pos": 787}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 801, "end_pos": 805}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 815, "end_pos": 818}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 834, "end_pos": 837}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 850, "end_pos": 852}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 865, "end_pos": 866}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 879, "end_pos": 881}, {"label_type": "影像检查", "overlap": 0, "start_pos": 897, "end_pos": 901}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 904, "end_pos": 913}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 914, "end_pos": 925}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 928, "end_pos": 936}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 937, "end_pos": 940}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 945, "end_pos": 952}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 967, "end_pos": 971}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 974, "end_pos": 985}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 988, "end_pos": 994}]}
{"originalText": "入院前1年，患者因咯血于**医院诊断“肺癌”（未见报告、具体不详）。未给予手术、放化疗治疗，间断服用中药治疗。病程中反复咳嗽、咳痰，痰中带鲜红色血液。不伴发热、畏寒、寒战、反酸、烧心、嗳气、呃逆、头昏、头痛、乏力、胸闷、胸痛、心悸、气促、腹痛、腹泻、黑便，无晕厥、黑朦、意识丧失。1月前，患者进食火锅后出现脐周阵发性隐痛，以脐周偏左侧为主，无肩背部放射痛，与进食及体位无关，疼痛持续时间不定。伴恶心、纳差，饮食较前减少约1/2，以流质为主，伴嗳气，无反酸、烧心、呕吐、腹泻、黑便、心悸、气促、胸闷、胸痛，无畏寒、发热，肛门未停止排便排气。于我院消化科住院，复查胸部CT平扫提示“左肺下叶后段团片状影、右肺上叶肿块影及两肺散在多发类圆形影，纵隔及主动脉弓旁多发肿大淋巴结影，考虑肺Ca伴两肺及纵隔淋巴结转移”。全腹部增强CT示“胆总管及胰管轻度扩张，胰头上方及邻近十二指肠腹壶周围见增多软组织影，考虑为淋巴结转移；邻近十二指肠壁肿胀，提示肿瘤受侵，右侧肾下腺稍增大，转移可能大；右侧腹股沟淋巴结转移，两上肺结节考虑肺内转移；胸9椎体及附件骨质破坏、转移，右侧髂骨多发骨质破坏伴周围软组织肿胀，累及邻近骶髂关节面。右侧股骨转子间骨质破坏，考虑骨转移”。遂转入**医院，完善相关检查后诊断考虑为“肺癌伴全身多处转移”（具体不详），并逐渐出现皮肤、巩膜黄染。10+天前，患者无明显诱因出现解黑便，2-3次/天，量少，无粘液、脓血，伴头昏、乏力、纳差，偶有嗳气，无呕血、腹痛、腹胀，无反酸、烧心，未予特殊处理。3+小时前，患者无明显诱因出现恶心、呕吐3次，呕吐物为咖啡色胃内容物，无鲜红色血液及血凝块，不呈喷射状，伴腹痛，为持续性隐痛，脐周为主，伴头昏，如厕时晕厥2次，由家属搀扶，持续约数十秒后意识恢复，无抽搐，无大小便失禁，无肢体活动障碍。呼叫120送入我院急诊科，查指血糖：26.0mmol/L，粪便隐血试验 阳性，血常规：WBC 13.4*109/L，RBC 1.9*1012/L，PLT 507*109/L，Hb 48g/L，N 92.44%，Hct 15.6%。遂以“肺癌伴全身多处转移、消化道出血、重度贫血”收入住院。患者此次患病以来，精神、食欲、睡眠欠佳，大便如下述，小便颜色加深，尿量可。体重上降约5kg。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 19, "end_pos": 21}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 98, "end_pos": 99}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 101, "end_pos": 102}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 107, "end_pos": 108}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 110, "end_pos": 111}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 113, "end_pos": 114}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 119, "end_pos": 120}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 122, "end_pos": 123}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 153, "end_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 162, "end_pos": 164}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 171, "end_pos": 174}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 234, "end_pos": 235}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 240, "end_pos": 241}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 246, "end_pos": 247}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 249, "end_pos": 250}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 259, "end_pos": 261}, {"label_type": "影像检查", "overlap": 0, "start_pos": 280, "end_pos": 284}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 289, "end_pos": 295}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 300, "end_pos": 304}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 308, "end_pos": 310}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 319, "end_pos": 321}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 322, "end_pos": 326}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 338, "end_pos": 352}, {"label_type": "影像检查", "overlap": 0, "start_pos": 354, "end_pos": 361}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 363, "end_pos": 366}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 367, "end_pos": 369}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 374, "end_pos": 378}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 381, "end_pos": 387}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 408, "end_pos": 413}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 423, "end_pos": 428}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 438, "end_pos": 448}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 449, "end_pos": 460}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 461, "end_pos": 475}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 476, "end_pos": 486}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 487, "end_pos": 492}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 499, "end_pos": 504}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 505, "end_pos": 516}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 519, "end_pos": 522}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 545, "end_pos": 554}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 570, "end_pos": 572}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 612, "end_pos": 613}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 630, "end_pos": 631}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 633, "end_pos": 634}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 680, "end_pos": 681}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 703, "end_pos": 704}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 713, "end_pos": 715}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 719, "end_pos": 720}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 760, "end_pos": 762}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 782, "end_pos": 784}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 796, "end_pos": 802}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 810, "end_pos": 813}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 825, "end_pos": 828}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 840, "end_pos": 843}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 854, "end_pos": 856}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 863, "end_pos": 864}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 872, "end_pos": 875}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 885, "end_pos": 894}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 895, "end_pos": 900}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 901, "end_pos": 905}]}
{"originalText": "患者入院前6年余无明显诱因出现心累、气促，起病初多以活动后明显，伴胸闷，无明显胸痛，需胸骨后压榨感，无上肢浮肿，无夜间阵发性呼吸困难，患者休息后症状可减轻，曾于*******医院就诊，考虑“冠状动脉粥样硬化性心脏病”，并办理特病，但平素未行相关治疗。入院前1年患者因心累加重，并全身多处瘀斑，于******医院住院治疗，行心脏彩超提示“右房增大，室间隔、右室后壁增厚，左室流出道增宽，二尖瓣及主动脉瓣狭窄，二尖瓣及三尖瓣重度反流，反流压差增高，肺动脉瓣及主动脉瓣轻度反流，心包积液，右室收缩功能正常”，具体治疗不详，出院后患者长期服用“单硝酸异山梨酯缓释片、阿托伐他汀钙、厄贝沙坦、曲美他嗪”等药物，仍有活动后心累不适。半年前患者因活动后胸闷伴胸痛在我科住院，予以改善循环、降脂稳定斑块、利尿减轻心脏负荷等对症治疗后好转出院。近1周患者诉咳嗽、咳痰，痰中偶有鲜红色血丝，入院前3小时，患者无明显诱因出现心悸、气促，伴右侧胸痛，右下臂及右后背疼痛，无明显上肢浮肿，无畏寒发热，无潮热盗汗，无意识障碍，无恶心呕吐等不适，遂来我院就诊，急诊科查血常规：白细胞数 12.6×10^9/L、血红蛋白浓度 116 g/L、血小板数 103×10^9/L、中性粒细胞百分比 76.74 %，心肌酶谱：肌酸激酶同工酶 41 U/L。肾功、高敏肌钙蛋白、电解质未见明显异常，心电图示快速型房颤，予以强心、利尿、改善心肌血供等对症处理后患者自觉症状稍缓解。现为进一步治疗收入我科住院。患者1年前因全身多处瘀斑，于******医院就诊，完善检查发现血小板减少、贫血，查血常规(2016-03-01)PLT 63×109/L、HB 63g/L；住院期间予以骨髓穿刺，考虑缺铁性贫血、血小板减少性紫癜，予以输红细胞悬液2U，并激素治疗（目前已停用），自诉复查指标好转。并于住院期间检查发现肾功能异常 BUN 19.6mmol/L CREA 223umol/L，原因不明确，因血小板减少未能肾活检，出院诊断考虑慢性肾脏病（CKD3期），急性肾损害不除外。患者自发病以来精神、食欲较差，大小便未诉异常。近期体重无明显减轻。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 33, "end_pos": 34}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 39, "end_pos": 40}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 43, "end_pos": 45}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 51, "end_pos": 53}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 95, "end_pos": 107}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 133, "end_pos": 134}, {"label_type": "影像检查", "overlap": 0, "start_pos": 161, "end_pos": 165}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 168, "end_pos": 170}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 173, "end_pos": 176}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 177, "end_pos": 181}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 184, "end_pos": 186}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 192, "end_pos": 195}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 196, "end_pos": 200}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 203, "end_pos": 206}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 207, "end_pos": 210}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 222, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 227, "end_pos": 231}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 236, "end_pos": 240}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 241, "end_pos": 249}, {"label_type": "药物", "overlap": 0, "start_pos": 268, "end_pos": 278}, {"label_type": "药物", "overlap": 0, "start_pos": 279, "end_pos": 285}, {"label_type": "药物", "overlap": 0, "start_pos": 286, "end_pos": 290}, {"label_type": "药物", "overlap": 0, "start_pos": 291, "end_pos": 295}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 305, "end_pos": 306}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 319, "end_pos": 320}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 322, "end_pos": 323}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 401, "end_pos": 402}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 408, "end_pos": 411}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 413, "end_pos": 416}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 417, "end_pos": 420}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 426, "end_pos": 428}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 473, "end_pos": 476}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 490, "end_pos": 496}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 505, "end_pos": 508}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 521, "end_pos": 529}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 543, "end_pos": 550}, {"label_type": "影像检查", "overlap": 0, "start_pos": 578, "end_pos": 581}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 582, "end_pos": 587}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 663, "end_pos": 668}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 669, "end_pos": 671}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 688, "end_pos": 691}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 701, "end_pos": 703}, {"label_type": "手术", "overlap": 0, "start_pos": 716, "end_pos": 720}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 723, "end_pos": 728}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 729, "end_pos": 737}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 787, "end_pos": 790}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 802, "end_pos": 806}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 824, "end_pos": 829}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 841, "end_pos": 853}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 854, "end_pos": 859}]}
{"originalText": "患者于入院半年前发现两上肢浮肿、尿量减少、喘累，到****医院查血常规： Hb：87g/l，肾功：血肌酐：394umol/L，考虑肾功能不全、肾性贫血，后到**********医院就诊，查肾功：血肌酐：330umol/L，血常规：Hb：89g/l，甲状旁腺激素 55.5pg/ml，内生肌酐清除率：14.49ml/min，腹部彩超：两肾结构欠清，实质回声稍增强，腹腔少量积液；心脏彩超：右室肥厚，少许心包积液；胸部CT平扫：右肺上叶炎症，心脏增大，两侧胸腔积液，给予血液净化治疗、降压、降糖、纠正贫血、改善循环等治疗后好转出院。5月前曾因胸闷心悸于我科住院，考虑诊断“1、慢性肾脏病5期 肾性贫血 2、原发性高血压3级很高危 高血压性心脏病 3、2型糖尿病 糖尿病周围神经病变 糖尿病视网膜病变 4、甲状腺功能减退 5、心包积液”，予以深静脉置管、血液透析，纠正贫血，改善心功能，降糖，降压后症状好转出院。入院前半月患者无明显诱因开始出现咳嗽咳白色粘痰，量少，伴心累气促，活动后加重，伴颜面及两上肢水肿，今于我院血透室行透析治疗，查血常规：白细胞数 8.8 10^9/L、红细胞数 3.17 10^12/L、血红蛋白浓度 91 g/L、血小板数 200 10^9/L、中性粒细胞百分比 86.61 %，肾功：尿素 15.26 mmol/L、肌酐 331.2 μmol/l，电解质2：钾 4.87 mmol/l、钠 137.1 mmol/、氯 107.4 mmol/l，透析后感心累气促减轻，为进一步治疗，门诊收入我科住院治疗。患者自患病以来，精神、睡眠可，食欲差，大便结燥，院外服用泻药，具体不详，后今日解稀便2次，小便偏少，量约500ml/d，体重无明显变化。22年前因手足麻木在当地医院查血糖升高，值不详，诊断为2型糖尿病，先后服用格列齐特、消渴丸降糖，偶测血糖20+mmol/L,曾服用二甲两胍出现恶心、呕吐停用，后开始出现视物模糊、两上肢水肿，2年前开始使用优思林降血糖，血糖控制不详，现改为诺和锐30 16u/早，12u/晚降血糖，血糖控制可。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 37, "end_pos": 39}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 49, "end_pos": 52}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 65, "end_pos": 70}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 71, "end_pos": 75}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 97, "end_pos": 100}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 115, "end_pos": 117}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 124, "end_pos": 130}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 141, "end_pos": 148}, {"label_type": "影像检查", "overlap": 0, "start_pos": 161, "end_pos": 165}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 166, "end_pos": 168}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 181, "end_pos": 183}, {"label_type": "影像检查", "overlap": 0, "start_pos": 188, "end_pos": 192}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 193, "end_pos": 195}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 200, "end_pos": 204}, {"label_type": "影像检查", "overlap": 0, "start_pos": 205, "end_pos": 209}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 212, "end_pos": 218}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 219, "end_pos": 221}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 226, "end_pos": 230}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 269, "end_pos": 270}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 286, "end_pos": 293}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 294, "end_pos": 298}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 301, "end_pos": 312}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 313, "end_pos": 320}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 323, "end_pos": 328}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 329, "end_pos": 338}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 339, "end_pos": 347}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 350, "end_pos": 357}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 360, "end_pos": 364}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 443, "end_pos": 445}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 446, "end_pos": 449}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 470, "end_pos": 473}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 486, "end_pos": 489}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 504, "end_pos": 510}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 518, "end_pos": 521}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 534, "end_pos": 539}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 554, "end_pos": 556}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 570, "end_pos": 572}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 591, "end_pos": 592}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 605, "end_pos": 606}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 619, "end_pos": 620}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 736, "end_pos": 738}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 746, "end_pos": 750}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 758, "end_pos": 763}, {"label_type": "药物", "overlap": 0, "start_pos": 768, "end_pos": 772}, {"label_type": "药物", "overlap": 0, "start_pos": 773, "end_pos": 776}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 781, "end_pos": 783}, {"label_type": "药物", "overlap": 0, "start_pos": 796, "end_pos": 800}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 820, "end_pos": 823}, {"label_type": "药物", "overlap": 0, "start_pos": 833, "end_pos": 836}, {"label_type": "药物", "overlap": 0, "start_pos": 850, "end_pos": 855}]}
{"originalText": "患者10+年前始逐渐出现慢性咳嗽、咳痰，每日均咳白色泡沫痰，受凉后症状加重，偶咳嗽加剧时伴喘累，未特殊治疗。5年前患者感体力耐量明显上降，爬坡及平地快步活动不能耐受，受凉后喘累明显加重，反复住院治疗，最近一次于2017-10-29于我院泌尿外科住院，给予保留导尿，头孢唑肟抗感染、血必净抗炎，抗前列腺增生，止咳祛痰、雾化对症等治疗，11月5日转我科给予哌拉西林他坐巴坦加强抗感染、解痉改善通气、祛痰、改善微循环、改善排尿困难、调脂稳定斑块、抗血小板聚等治疗后好转出院，出院诊断为：1、慢性阻塞性肺疾病急性加重期；2、泌尿道感染；3、感染性休克 代偿期；4、前列腺增生；5、慢性前列腺炎；6、慢性尿潴留；7、冠心病 冠脉支架及起搏器置入术后；8、高血压病；9、轻度贫血；10、电解质紊乱；11、两肾积水；12、慢性膀胱炎 膀胱憩室；13、两肺结节待查；14、肝囊肿。1天前，患者无明显诱因出现发热，自测体温37.9℃，伴有咳嗽，咳白色泡沫痰，痰不易咳出，喘息明显，端坐呼吸，无畏寒、寒战，无恶心、呕吐，无咳嗽、咳痰，无腰痛不适，尿管导尿中，家人发现尿管中无尿，家属遂送入我院急诊，查血气分析：PH 7.42，PaO2 93mmHg，PaCO2 31mmHg，标准碳酸氢根22.1mmol/l，实测碳酸氢根20.1mmol/l，BE3.7mmol/l。血常规：白细胞数 14.2×10^9/L、红细胞数 2.94×10^12/L、血红蛋白浓度 92 g/L、血小板数 194×10^9/L、中性粒细胞百分比 92.74 %，CRP：22 mg/l 。肾功、心肌酶未见明显异常，电解质：钾 3.47 mmol/l、钠 127.2mmol/l、氯 88.2mmol/l，遂以“发热待查：肺部感染？尿路感染？感染性休克？”收入我科。有“高血压”病史7年，口服药物控制，自诉血压控制尚可，有“冠心病”病史，2年前行“冠脉支架置入术及起搏器置入术”，术后心率控制在85次/分右左，患者本次患病来，精神、睡眠、食欲欠佳，大便正常，小便如下述，体重无明显改变。", "entities": [{"label_type": "药物", "overlap": 0, "start_pos": 132, "end_pos": 136}, {"label_type": "药物", "overlap": 0, "start_pos": 140, "end_pos": 143}, {"label_type": "药物", "overlap": 0, "start_pos": 176, "end_pos": 184}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 242, "end_pos": 255}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 258, "end_pos": 263}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 266, "end_pos": 275}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 278, "end_pos": 283}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 286, "end_pos": 292}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 295, "end_pos": 300}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 303, "end_pos": 306}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 307, "end_pos": 319}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 322, "end_pos": 326}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 329, "end_pos": 333}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 337, "end_pos": 342}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 346, "end_pos": 350}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 354, "end_pos": 359}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 360, "end_pos": 364}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 368, "end_pos": 374}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 378, "end_pos": 381}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 458, "end_pos": 459}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 495, "end_pos": 497}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 503, "end_pos": 507}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 515, "end_pos": 520}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 528, "end_pos": 534}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 545, "end_pos": 551}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 562, "end_pos": 564}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 578, "end_pos": 581}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 595, "end_pos": 598}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 613, "end_pos": 619}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 627, "end_pos": 630}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 643, "end_pos": 651}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 660, "end_pos": 663}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 690, "end_pos": 691}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 704, "end_pos": 705}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 718, "end_pos": 719}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 734, "end_pos": 738}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 739, "end_pos": 743}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 744, "end_pos": 748}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 749, "end_pos": 754}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 763, "end_pos": 766}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 790, "end_pos": 793}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 802, "end_pos": 816}]}
{"originalText": "患者30+年前检查发现血压高，最高时收缩压超过200/？mmHg，长期服用降压药物（硝苯地平缓释片、替米沙坦等），自诉血压控制尚可，起初无头昏、头痛，无心悸、无活动后心累、乏力等不适。2016.9.3天患者无明确诱因反复出现头晕，急诊头部CT：两侧基底节区腔隙性脑梗死 2、脑白质轻度脱髓鞘改变，脑萎缩。3、基底动脉钙化，随访。收入内1科行胸片：1.两上肺纹理增多。2.主动脉弓迂曲、钙化。心脏彩超：室间隔增厚（13.5mm）；三尖瓣轻度反流；肺动脉轻度高压；右室舒张功能减退。出院诊断：1、原发性高血压3级极高危，高血压性心脏病 2、脑动脉供血不足 3、腔隙性脑梗死 4、2型糖尿病 5、冠状动脉粥样硬化性心脏病，慢性心衰。院外服药：苯磺酸右旋氨氯地平2.5mg每日一次，厄贝沙坦氢氯噻嗪1片每日一次，二甲两胍缓释片0.5每日双次，阿卡波糖50mg每日三次，氢氯噻嗪25mg每日一次，螺内酯20mg每日一次；1周前患者感头昏阵性发作，无视物旋转、视物模糊，无恶心呕吐，2天前患者头昏症状加重，恶心，纳差，心慌，无偏瘫，无视野缺损，无四肢抽搐，无黑矇晕厥，为求进一步治疗，遂入我院急诊科，查血压190/96mmhg，血糖(静脉血)：葡萄糖 4.2mmol/l ，血常规：白细胞数 6.0×10^9/L、血红蛋白浓度 113 g/L ↓、血小板数 181×10^9/L、CRP：C反应蛋白 <1 mg/l，血气分析：PH 7.36，PCO2 28mmHg，PO2 126mmHg，碳酸氢根：15.8mmol/L，全血碱剩余 -8mmol/L，乳酸：10.3mmol/L，胸片：1，两上肺感染，右上肺可疑环状或结节状稍高密度影，不除外支扩，随访复查或必要时CT进一步检查。2，肺气肿征。3，主动脉球钙化。4，胸椎骨质增生。以“高血压 糖尿病 乳酸酸中毒”收入我科。患者此次患病以来精神食欲差，大便正常，夜尿次数增多，睡眠尚可,体力及体重无明显改变.近来诉咳嗽，少痰。", "entities": [{"label_type": "药物", "overlap": 0, "start_pos": 42, "end_pos": 49}, {"label_type": "药物", "overlap": 0, "start_pos": 50, "end_pos": 54}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 70}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 72, "end_pos": 73}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 76, "end_pos": 77}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 83, "end_pos": 84}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 112, "end_pos": 113}, {"label_type": "影像检查", "overlap": 0, "start_pos": 117, "end_pos": 121}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 122, "end_pos": 134}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 137, "end_pos": 147}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 148, "end_pos": 151}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 154, "end_pos": 160}, {"label_type": "影像检查", "overlap": 0, "start_pos": 170, "end_pos": 172}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 175, "end_pos": 178}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 185, "end_pos": 189}, {"label_type": "影像检查", "overlap": 0, "start_pos": 195, "end_pos": 199}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 200, "end_pos": 203}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 214, "end_pos": 217}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 222, "end_pos": 225}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 230, "end_pos": 238}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 246, "end_pos": 257}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 258, "end_pos": 265}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 268, "end_pos": 275}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 278, "end_pos": 284}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 287, "end_pos": 292}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 295, "end_pos": 307}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 308, "end_pos": 312}, {"label_type": "药物", "overlap": 0, "start_pos": 318, "end_pos": 327}, {"label_type": "药物", "overlap": 0, "start_pos": 337, "end_pos": 345}, {"label_type": "药物", "overlap": 0, "start_pos": 352, "end_pos": 359}, {"label_type": "药物", "overlap": 0, "start_pos": 367, "end_pos": 371}, {"label_type": "药物", "overlap": 0, "start_pos": 380, "end_pos": 384}, {"label_type": "药物", "overlap": 0, "start_pos": 393, "end_pos": 396}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 411, "end_pos": 412}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 440, "end_pos": 441}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 467, "end_pos": 469}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 516, "end_pos": 519}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 535, "end_pos": 538}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 551, "end_pos": 557}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 568, "end_pos": 571}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 588, "end_pos": 593}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 607, "end_pos": 609}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 615, "end_pos": 619}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 627, "end_pos": 630}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 639, "end_pos": 643}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 655, "end_pos": 660}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 670, "end_pos": 672}, {"label_type": "影像检查", "overlap": 0, "start_pos": 684, "end_pos": 686}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 689, "end_pos": 694}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 695, "end_pos": 698}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 715, "end_pos": 717}, {"label_type": "影像检查", "overlap": 0, "start_pos": 726, "end_pos": 728}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 736, "end_pos": 739}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 743, "end_pos": 749}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 752, "end_pos": 758}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 761, "end_pos": 764}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 765, "end_pos": 768}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 769, "end_pos": 774}]}
{"originalText": "入院前1+年无明显诱因逐渐出现活动障碍、反应迟钝、与人交流减少，对周围事物缺乏兴趣、记忆减退，同时有纳差、逐渐消瘦，未述明显腹痛、腹胀、吞咽梗阻，无胸闷、心悸、发热，患者长期卧床、有大小便失禁，5月前因纳差在我院住院，作胸腹部CT：1、考虑左肺中叶及上叶少许慢性感染。2、左肺下叶尖段外侧胸膜上梭形突起，考虑脂肪瘤。3、主动脉及冠状动脉壁钙化。4、肺气肿征。5、胸椎骨质增生，左侧多根肋骨陈旧骨折。6、左侧甲状腺可疑结节影。7、肝右叶内侧段小片状稍低密度影，建议增强扫描。8、两肾多发小结石；左肾囊肿。9、胆囊结石。10、肝左叶上段见两边影，考虑呼吸动度伪影，不除外少许腹腔积液可能。11、腹主动脉壁钙化。腰椎骨质增生。12、骶管内类圆形稍低密度影，考虑良性病变，骶管囊肿可能。建议结合临床。因患者呼吸动度较大，扫描范围内胸腹部部分图像较模糊，建议随访复查。诊断为“1.高渗性脱水 2.急性肾功能不全 3.老年痴呆症 4 .重度营养不良”，予纠正电解质、营养支持治疗好转出院。出院后患者反复有食纳差，无恶心、呕吐，无黄染、厌油，近期患者不愿进食，未述明显腹痛、腹胀，无畏寒、发热、胸痛、呼吸困难、黑便、呕血等，今日患者稍有恶心、呕吐、烦躁不安，无意识障碍，家属将其送入我院，在门诊查血常规：白细胞数 13.0×10^9/L、中性粒细胞百分比 86.04 %，心肌酶谱：谷草转氨酶 49.0 U/L、肌酸激酶 247.7 U/L、乳酸脱氢酶 343.3 U/L，肾功：尿素 27.62 mmol/L、肌酐 309.1 μmol/l、尿酸 592.5 μmol/l，高敏肌钙蛋白：高敏肌钙蛋白T 130.70 pg/ml，电解质1：钠 168.7 mmol/l、氯 128.0 mmol/l。心电图提示：快速性房颤。为进一步就诊，我院急诊科以“老年痴呆、重度营养不良”收入住院。病程中患者精神差，睡眠差，长期大小便失禁，体重减轻不祥。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 62, "end_pos": 63}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 65, "end_pos": 66}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 74, "end_pos": 75}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 77, "end_pos": 78}, {"label_type": "影像检查", "overlap": 0, "start_pos": 110, "end_pos": 115}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 120, "end_pos": 133}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 136, "end_pos": 142}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 144, "end_pos": 146}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 154, "end_pos": 157}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 160, "end_pos": 171}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 174, "end_pos": 177}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 181, "end_pos": 187}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 188, "end_pos": 198}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 201, "end_pos": 206}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 214, "end_pos": 220}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 238, "end_pos": 245}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 246, "end_pos": 250}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 253, "end_pos": 257}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 261, "end_pos": 266}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 285, "end_pos": 289}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 295, "end_pos": 302}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 303, "end_pos": 309}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 313, "end_pos": 315}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 332, "end_pos": 336}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 361, "end_pos": 364}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 385, "end_pos": 390}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 393, "end_pos": 400}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 403, "end_pos": 408}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 412, "end_pos": 418}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 477, "end_pos": 478}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 480, "end_pos": 481}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 490, "end_pos": 491}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 545, "end_pos": 548}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 562, "end_pos": 570}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 584, "end_pos": 589}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 599, "end_pos": 603}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 614, "end_pos": 619}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 633, "end_pos": 635}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 649, "end_pos": 651}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 665, "end_pos": 667}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 688, "end_pos": 695}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 714, "end_pos": 715}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 729, "end_pos": 730}, {"label_type": "影像检查", "overlap": 0, "start_pos": 744, "end_pos": 747}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 750, "end_pos": 755}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 770, "end_pos": 774}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 775, "end_pos": 781}]}
{"originalText": "入院前6+天患者无明显诱因出现咳嗽、咳痰，易咳出大量白色粘痰，感阵发性胸闷，左季肋间断隐痛，休息可缓解，上肢水肿，无头昏、头痛、发热，无胸痛，无腹痛腹泻，今日为进一步治疗，遂来我院，急诊查X线：左上肺可疑类圆形浅淡密度影，建议CT进一步检查。血常规：白细胞数 3.3 10^9/L ↓、红细胞数 2.70 10^12/L ↓、血红蛋白浓度 98 g/L ↓、血小板数 32 10^9/L ↓、淋巴细胞绝对值 0.84 10^9/L ↓、红细胞压积 27.7 % ↓、平均红细胞体积 102.6 fL ↑、平均红细胞血红蛋白量 36.3 pg ↑、红细胞体积分布宽度 56.5 fl ↑、红细胞体积分布宽度百分比 15.4 % ↑，CRP：C反应蛋白 5 mg/l，未予处理，以“咳嗽待查”收入我科住院治疗。2年前在外院及我院确诊“肝癌”，故诉长期闷油、牙龈易出血，易鼻出血，凝血功能异常。2月22日我院肿瘤标志物：甲胎蛋白 16.90 ng/ml ↑，3月12日我院查乙肝三对：乙肝表面抗原定性 阳性、乙肝核心抗体定性 阳性，肝功3：谷草转氨酶 87.5 U/L ↑、碱性磷酸酶 172.5 U/L ↑、总胆红素 44.7 μmol/l ↑、直接胆红素 28.2 μmol/l ↑、总胆汁酸 106.84 μmol/l ↑。2015年2月20日我院查全腹增强CT：1，考虑为肝硬化、脾脏轻度增大，建议结合临床或必要时进一步检查。2，胰头体积稍增大，形态欠规则，不除外肿瘤。3，大量腹水，腹膜后及网膜、系膜内多个小结节影，考虑为增大的淋巴结可能，建议CT增强进一步明确。4，右侧中上腹部分小肠积气，伴小液平形成，提示不全性肠梗阻可能大，结合临床随访或CT增强检查。5，前列腺钙化。6，腰椎骨质增生。7，扫描野右肺底少许慢性炎症或纤维化；右侧胸壁胸膜稍增厚。病程中精神、食欲一般，大小便正常，无明显体重上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 35, "end_pos": 36}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 38, "end_pos": 41}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 52, "end_pos": 54}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 58, "end_pos": 59}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 61, "end_pos": 62}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 72, "end_pos": 73}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 74, "end_pos": 75}, {"label_type": "影像检查", "overlap": 0, "start_pos": 94, "end_pos": 96}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 97, "end_pos": 100}, {"label_type": "影像检查", "overlap": 0, "start_pos": 113, "end_pos": 115}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 125, "end_pos": 128}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 143, "end_pos": 146}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 163, "end_pos": 169}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 179, "end_pos": 182}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 196, "end_pos": 203}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 218, "end_pos": 223}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 233, "end_pos": 240}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 252, "end_pos": 262}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 273, "end_pos": 282}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 293, "end_pos": 305}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 319, "end_pos": 324}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 339, "end_pos": 343}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 365, "end_pos": 367}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 376, "end_pos": 378}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 383, "end_pos": 384}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 407, "end_pos": 411}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 439, "end_pos": 447}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 451, "end_pos": 459}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 467, "end_pos": 472}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 484, "end_pos": 489}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 502, "end_pos": 506}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 521, "end_pos": 526}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 541, "end_pos": 545}, {"label_type": "影像检查", "overlap": 0, "start_pos": 575, "end_pos": 581}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 587, "end_pos": 590}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 591, "end_pos": 593}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 616, "end_pos": 618}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 640, "end_pos": 641}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 643, "end_pos": 645}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 647, "end_pos": 649}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 650, "end_pos": 652}, {"label_type": "影像检查", "overlap": 0, "start_pos": 674, "end_pos": 676}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 686, "end_pos": 691}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 693, "end_pos": 697}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 707, "end_pos": 713}, {"label_type": "影像检查", "overlap": 0, "start_pos": 724, "end_pos": 726}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 733, "end_pos": 738}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 741, "end_pos": 747}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 753, "end_pos": 756}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 767, "end_pos": 773}]}
{"originalText": "入院前3年患者在院外发现肾功能异常，具体不详，考虑“高血压肾病”，予以控制血压、保护肾功能等治疗，院外随访肾功能不详。反复因黑便多次在我院内二科住院，住院后诊断“尿毒症 肾性贫血，高血压肾病，消化道出血，高血压心脏病、心功能不全，营养不良”，给予输血、止血、抑酸、纠正心衰等治疗后好转，后期患者自动出院后于**医院就诊，查血肌酐 638umol/L，尿素氮 22.92mmol/L，血常规：血红蛋白 89g/L，电解质：血钾 4.70mmol/L等，诊断“慢性肾脏病5期，肾性贫血，消化道出血，高血压3级很高危、高血压心脏病，尿路感染，低蛋白血症”，急诊行深静脉置管，开始行规律血液透析，并给予止血、抑酸、营养支持、稳定血压、抗尿路感染、对症等治疗后好转，并于2016-03-14行右前臂动静脉内瘘吻合术，2016-04-06自动出院转我科行长期维持性血液透析治疗，4天前受凉后出现咳嗽，家属在药店购买“消炎止咳”等药物给其服用，具体不详，服药后症状无好转，今日起床后出现面部浮肿，咳嗽时腹部疼痛，伴有腹泻，无腹痛腹胀，无恶心呕吐，无发热、气促，无心悸胸闷，无两上肢水肿，为进一步治疗到我院透析室检查肾功：尿素 9.27 mmol/L、肌酐 540.5 μmol/l、尿酸 313.4 μmol/l，电解质：钾 4.15 mmol/l、钠 140.3 mmol/l、氯 104.1 mmol/l、二氧化碳 22.6 mmol/l、钙 2.11 mmol/l、磷 1.13 mmol/l，血常规：白细胞数 4.1×10^9/L、红细胞数 3.97×10^12/L、血红蛋白浓度 121 g/L、血小板数 101×10^9/L、中性粒细胞百分比 82.91 %，透析后患者症状无好转，门诊以\\\"慢性肾脏病5期，肺炎\\\"收入我科住院治疗。病程中患者精神、饮食一般，大便正常，小便约200ml，体重无明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 26, "end_pos": 31}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 81, "end_pos": 84}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 85, "end_pos": 89}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 90, "end_pos": 95}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 96, "end_pos": 101}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 102, "end_pos": 108}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 109, "end_pos": 114}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 115, "end_pos": 119}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 161, "end_pos": 164}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 175, "end_pos": 178}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 195, "end_pos": 199}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 210, "end_pos": 212}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 228, "end_pos": 235}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 236, "end_pos": 240}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 241, "end_pos": 246}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 247, "end_pos": 255}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 256, "end_pos": 262}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 263, "end_pos": 267}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 268, "end_pos": 273}, {"label_type": "手术", "overlap": 0, "start_pos": 341, "end_pos": 352}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 436, "end_pos": 438}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 444, "end_pos": 446}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 451, "end_pos": 452}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 455, "end_pos": 456}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 457, "end_pos": 458}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 474, "end_pos": 475}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 476, "end_pos": 477}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 480, "end_pos": 483}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 503, "end_pos": 505}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 518, "end_pos": 520}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 534, "end_pos": 536}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 554, "end_pos": 555}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 568, "end_pos": 569}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 583, "end_pos": 584}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 598, "end_pos": 602}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 615, "end_pos": 616}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 629, "end_pos": 630}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 647, "end_pos": 650}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 663, "end_pos": 666}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 681, "end_pos": 687}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 696, "end_pos": 699}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 712, "end_pos": 720}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 745, "end_pos": 752}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 753, "end_pos": 755}]}
{"originalText": "入院前10余天患者无明显诱因出现下腹胀，伴纳差、大便未解，无反酸、嗳气、烧心，无腹痛、腹泻、呕吐，无黑便、呕吐咖啡色物质及胆汁，未予重视治疗。入院前半天患者服用“通便药物”后出现解暗红色稀糊样便，共5次，总量约300g，伴头昏、乏力、冷汗，伴下腹部不适、心悸、胸闷，伴心悸、气促，无黑曚、晕厥、呕吐，为进一步诊治遂至我院急诊，急诊科查心肌酶谱：谷草转氨酶 27.7 U/L、肌酸激酶 175.9 U/L、肌酸激酶同工酶 22 U/L、乳酸脱氢酶 287.8 U/L，肾功：尿素 27.48 mmol/L、肌酐 92.4 μmol/l、尿酸 340.8 μmol/l，凝血试验：凝血酶原时间 14.4 秒、国际标准化比值 1.21、活化部分凝血酶原时间 22.1 秒、纤维蛋白原 2.50 g/L、凝血酶时间 15.3 秒，高敏肌钙蛋白：高敏肌钙蛋白T 77.89 pg/ml，血常规：白细胞数 9.5×10^9/L、红细胞数 2.85×10^12/L、血红蛋白浓度 82 g/L、血小板数 130×10^9/L、中性粒细胞百分比 88.24 %、红细胞压积 25.9 %，腹部彩超提示胆囊壁增厚毛糙，考虑“1.急性下消化道出血2.慢性心力衰竭 房颤3.肺部感染4.肠梗阻？”，给予速尿20mg静推后收入我科。入院前10余年患者反复出现劳力性心累气促，伴间断夜间阵发性呼吸困难、两上肢水肿，在外院诊断“冠状动脉粥样硬化性心脏病 心衰 房颤”，2+年前患者在我院住院诊断“1.冠状动脉粥样硬化性心脏病 缺血性心肌病型 心功能不全 心功能III级 心律失常 心房纤颤伴II°房室传导阻滞 2.原发性高血压2级 极高危 3.肺部感染 4.前列腺增生症”。院外长期服用“单硝酸异山梨酯、利尿剂”等治疗，稳定期时患者仅能耐受轻度体力活动。病程以来患者精神食欲差，大便同前，小便尚可，体重无改变，体力上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 17, "end_pos": 18}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 40, "end_pos": 41}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 43, "end_pos": 44}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 111, "end_pos": 112}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 124}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 127, "end_pos": 128}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 130, "end_pos": 131}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 134, "end_pos": 135}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 172, "end_pos": 177}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 187, "end_pos": 191}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 202, "end_pos": 209}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 217, "end_pos": 222}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 236, "end_pos": 238}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 252, "end_pos": 254}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 267, "end_pos": 269}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 288, "end_pos": 294}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 302, "end_pos": 309}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 315, "end_pos": 325}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 333, "end_pos": 338}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 348, "end_pos": 353}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 368, "end_pos": 374}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 392, "end_pos": 396}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 408, "end_pos": 412}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 426, "end_pos": 432}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 440, "end_pos": 444}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 456, "end_pos": 464}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 473, "end_pos": 478}, {"label_type": "影像检查", "overlap": 0, "start_pos": 486, "end_pos": 490}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 492, "end_pos": 495}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 505, "end_pos": 513}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 515, "end_pos": 521}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 522, "end_pos": 524}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 526, "end_pos": 530}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 532, "end_pos": 535}, {"label_type": "药物", "overlap": 0, "start_pos": 540, "end_pos": 542}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 570, "end_pos": 571}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 588, "end_pos": 591}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 600, "end_pos": 612}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 613, "end_pos": 615}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 616, "end_pos": 618}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 636, "end_pos": 656}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 657, "end_pos": 662}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 663, "end_pos": 670}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 671, "end_pos": 675}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 676, "end_pos": 690}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 693, "end_pos": 705}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 708, "end_pos": 712}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 715, "end_pos": 721}, {"label_type": "药物", "overlap": 0, "start_pos": 730, "end_pos": 737}]}
{"originalText": "患者7+年前开始出现受凉后咳嗽、伴喘累，需输液治疗缓解，缓解后未长期口服药物，每年冬春季及天气变化时易于发病，无胸痛、咯血，多次在外院就诊考虑“慢支炎、肺气肿”。病程中逐渐出现劳力性气促，初为爬坡及重体力劳动时出现，后平地活动亦感气促，受凉后喘累气促明显加重，反复在当地医院输液治疗。近1+年患者先后多次在我院住院治疗，诊断“慢性支气管炎急性发作”，经抗感染、止咳祛痰、平喘等治疗病情稍缓解。入院前10天患者无明显诱因咳嗽咯痰症状加重，咯痰费力，伴有心慌胸闷，喘累气促，在*****医院住院治疗1周后病情好转于昨日出院。入院前4小时患者感咳嗽加重，喉头有痰不能咯出，剧烈咳嗽后感腹痛，喘累气促明显，伴有呼吸困难，大汗淋漓，无畏寒发热，无恶心呕吐，无胸痛咯血，无咯粉红色泡沫痰。家属呼叫120接入我院，接诊途中予以静推“地塞米松10mg”。到达我院急救部后查血气分析全套：二氧化碳总量 38 mmol/l、酸碱度 7.350、二氧化碳分压 65 mmHg、氧分压 231 mmHg、碳酸氢根 35.9 mmol/l、标准碳酸氢根 30.70 mmol/l、全血碱剩余 7.30 mmol/l、血氧饱和度 100.00 %；血常规：白细胞数 8.7 10^9/L、红细胞数 5.34 10^12/L、血红蛋白浓度 148 g/L、血小板数 191 10^9/L、中性粒细胞百分比 82.81 %；肾功：尿素 6.11 mmol/L、肌酐 58.0 μmol/l、尿酸 406.8 μmol/l；电解质1：钾 4.45 mmol/l、钠 142.7 mmol/、氯 101.0 mmol/l；C反应蛋白 <1 mg/l。为进一步诊疗急诊以“慢支炎急发、肺气肿”收我科住院。本次发病以来患者精神食欲较差，大小便如常，睡眠较差，体力上降，体重无明显改变。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 56, "end_pos": 57}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 72, "end_pos": 75}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 76, "end_pos": 79}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 163, "end_pos": 173}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 226}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 227, "end_pos": 228}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 274, "end_pos": 276}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 289, "end_pos": 290}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 324, "end_pos": 325}, {"label_type": "药物", "overlap": 0, "start_pos": 359, "end_pos": 363}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 385, "end_pos": 391}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 402, "end_pos": 405}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 412, "end_pos": 418}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 427, "end_pos": 430}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 440, "end_pos": 444}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 457, "end_pos": 463}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 477, "end_pos": 482}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 495, "end_pos": 500}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 514, "end_pos": 517}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 530, "end_pos": 533}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 548, "end_pos": 554}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 563, "end_pos": 566}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 579, "end_pos": 587}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 599, "end_pos": 601}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 614, "end_pos": 616}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 629, "end_pos": 631}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 650, "end_pos": 651}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 664, "end_pos": 665}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 678, "end_pos": 679}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 693, "end_pos": 698}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 717, "end_pos": 722}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 723, "end_pos": 726}]}
{"originalText": "患者入院前半月患者可能受凉后感咳嗽，咯少许白色粘痰，无痰中带血，并乏力，轻微认知功能障碍，余否认畏寒发热，无潮热盗汗，无胸痛，无呼吸困难，无上肢浮肿。于*****老年科住院治疗，完善辅助检查，2018-01-15血常规 WBC 8.28x10^9/L、RBC 3.65x10^12/L；BNP 875ng/L；2018-01-15CT提示：右侧半卵圆中心及两侧基底节区多发腔隙性脑梗死灶可能。脑萎缩，两侧脑白质脱髓鞘改变。左侧下颌窦及筛窦炎症。甲状腺左叶稍低密度结节；峡部增厚。两肺散在炎症，以两肺上叶为甚，建议治疗后复查，两肺散在纤维灶，左肺下叶后段、右肺下叶及右肺上叶背段小结节状钙化灶，左肺中叶肺大泡形成，两肾囊肿。结肠内较多内容物，随访。主动脉、弓下动脉、右左冠状动脉、腹腔干、肝固有动脉、肝动脉、肠系膜下动脉、两肾动脉、脾动脉及两侧髂总动脉髂内外动脉管壁多发钙化。两上肢血管彩超：两上肢动脉硬化伴粥样斑点形成。两上肢深静脉未见异常。心脏彩超提示：右室肥厚伴顺应性减退、二尖瓣环、主动脉瓣钙化；颈动脉彩超提示：两侧颈动脉斑块形成右侧颈内动脉内膜增厚。头颅MRI提示两侧额顶叶、半卵圆中心、脑室体旁及基底节区、脑桥多发缺血灶及腔梗灶。脑萎缩。考虑诊断“肺部感染”，予以莫西沙星抗感染治疗，并继续改善认知、营养神经、祛痰、冠心病二级预防、控制血糖等处理，治疗近9天，患者咳嗽症状缓解，复查血色素较入院时上降，家属诉其有黑便表现，复查维生素B12 220.0pg/ml，叶酸＞23.9ng/ml。铁生化：血清铁 3.4umol/L 总铁结合力 47.7umol/L。骨髓穿刺提示骨髓增生活跃，内外铁阴性。因患者不配合，家属为方便照顾要求转入我科继续住院治疗。患者此次患病以来精神、食欲、睡眠一般，大便干结，小便正常，体力及体重无明显改变。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 60, "end_pos": 61}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 70, "end_pos": 72}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 110, "end_pos": 113}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 126, "end_pos": 129}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 143, "end_pos": 146}, {"label_type": "影像检查", "overlap": 0, "start_pos": 165, "end_pos": 167}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 170, "end_pos": 193}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 196, "end_pos": 199}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 200, "end_pos": 210}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 211, "end_pos": 221}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 222, "end_pos": 233}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 234, "end_pos": 236}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 239, "end_pos": 245}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 247, "end_pos": 251}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 262, "end_pos": 264}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 270, "end_pos": 276}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 277, "end_pos": 281}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 282, "end_pos": 288}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 296, "end_pos": 300}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 306, "end_pos": 310}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 311, "end_pos": 313}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 323, "end_pos": 326}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 327, "end_pos": 331}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 332, "end_pos": 338}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 339, "end_pos": 342}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 343, "end_pos": 348}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 349, "end_pos": 352}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 353, "end_pos": 359}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 360, "end_pos": 364}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 365, "end_pos": 368}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 369, "end_pos": 375}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 375, "end_pos": 382}, {"label_type": "影像检查", "overlap": 0, "start_pos": 387, "end_pos": 394}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 395, "end_pos": 407}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 410, "end_pos": 413}, {"label_type": "影像检查", "overlap": 0, "start_pos": 421, "end_pos": 425}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 428, "end_pos": 432}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 439, "end_pos": 450}, {"label_type": "影像检查", "overlap": 0, "start_pos": 451, "end_pos": 456}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 459, "end_pos": 464}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 468, "end_pos": 474}, {"label_type": "影像检查", "overlap": 0, "start_pos": 479, "end_pos": 484}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 486, "end_pos": 491}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 492, "end_pos": 497}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 498, "end_pos": 502}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 503, "end_pos": 507}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 508, "end_pos": 510}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 520, "end_pos": 523}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 529, "end_pos": 533}, {"label_type": "药物", "overlap": 0, "start_pos": 537, "end_pos": 541}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 563, "end_pos": 566}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 618, "end_pos": 624}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 636, "end_pos": 638}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 653, "end_pos": 656}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 667, "end_pos": 672}, {"label_type": "手术", "overlap": 0, "start_pos": 684, "end_pos": 688}]}
{"originalText": "入院前30+年，患者常在受凉后出现咳嗽、咳痰，多为白色泡沫痰，并逐渐出现喘累、气促，好发于冬春季节，每年累计发病时间超过3月，外院诊断为“慢支炎、肺气肿”，予以抗感染、止咳平喘等治疗后可好转。患者喘累、气促症状逐年加重，并逐渐出现间断两上肢水肿，外院考虑为“肺源性心脏病”，未利尿、长期低流量吸氧及吸入剂治疗。7+年前，患者喘累、呼吸困难明显，于外院诊断为“支气管哮喘”（具体检查报告及诊治经过不详），开始使用沙丁胺醇气雾剂治疗。后患者下述症状反复发作，反复住院治疗，完善检查：心脏彩超：全心增大；主动脉窦部增宽；室间隔、右室后壁动度降低；主动脉瓣钙化；二尖瓣、三尖瓣重度反流；主动脉瓣中度反流；右室收缩、舒张功能减退；肺动脉收缩轻度高压。EF31%。肺功能检查提示重度阻塞性通气功能障碍，舒张试验阳性（FEV1 41.7%,FEV1%FVC59.14%）。最近一次于2017-12-30于我科住院治疗，给予抗感染、化痰、平喘、改善循环等治疗后于2018-1-6因患者个人原因自动出院，出院诊断为：1、慢性阻塞性肺疾病急性加重期；2、慢性肺源性心脏病；3、支气管哮喘；4、冠状动脉粥样硬化性心脏病 心律失常 心功能Ⅲ-Ⅳ级；5、慢性胃炎急发。出院后用药情况不详。入院前1天，患者再次感下述症状较前加重，咳嗽、咳白色粘痰，喘累明显，不能平卧位休息，夜间阵发性呼吸困难，腹胀纳差，进食量明显上降，轻微下腹部疼痛，无畏寒寒战、发热，无咯血，无潮热盗汗，无恶心呕吐，无胸闷、胸痛，无尿频、尿急、尿痛等不适，自行服用“平喘药”（具体不详），下述症状无明显好转，遂来我院就诊，门诊以“AECOPD”收入我科进一步治疗。患者此次患病以来精神、食欲、睡眠差，大小便正常，体力明显上降，体重无明显改变。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 69, "end_pos": 72}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 73, "end_pos": 76}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 117, "end_pos": 120}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 129, "end_pos": 135}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 179, "end_pos": 184}, {"label_type": "药物", "overlap": 0, "start_pos": 205, "end_pos": 209}, {"label_type": "影像检查", "overlap": 0, "start_pos": 239, "end_pos": 243}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 249, "end_pos": 254}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 257, "end_pos": 260}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 261, "end_pos": 265}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 270, "end_pos": 276}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 277, "end_pos": 280}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 281, "end_pos": 284}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 289, "end_pos": 293}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 298, "end_pos": 300}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 310, "end_pos": 313}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 320, "end_pos": 322}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 333, "end_pos": 344}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 451, "end_pos": 464}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 467, "end_pos": 475}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 478, "end_pos": 483}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 486, "end_pos": 498}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 499, "end_pos": 503}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 504, "end_pos": 511}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 514, "end_pos": 518}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 583, "end_pos": 584}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 598, "end_pos": 601}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 630, "end_pos": 631}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 633, "end_pos": 634}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 686, "end_pos": 692}]}
{"originalText": "入院前5+年，患者因右侧肢体乏力，伴口齿不清，在外院明确诊断“脑梗死”，经治疗后好转出院，出院后遗留右侧肢体活动轻度障碍及口齿稍含糊，生活可自理。入院前半月，患者反复出现头昏，阵发性发作，发作时自觉乏力、站立不稳、心悸，并出现左下肢抽动，伴流涎，在我科住院，诊断：脑梗死后遗症、短暂性脑缺血发作、高血压病、颈动脉多发硬化性斑块形成、高脂血症、2型糖尿病？查糖化血红蛋白：7.1 %。血脂：甘油三酯 3.74 mmol/l、总胆固醇 5.89 mmol/l、低密度脂蛋白胆固醇 3.39 mmol/l，头颈部CTA示1、两侧基底节区及侧脑室体旁腔隙性脑梗死。右侧颞、枕叶慢性脑梗死；右侧顶叶软化灶。脑白质脱髓鞘改变；脑萎缩。右侧下颌窦炎症或息肉。两侧筛窦炎。食道中段壁增厚，食道旁软组织增多，建议胃镜检查。CTA：主动脉壁较多软硬斑块形成，并见多个深大溃疡；头臂干、左侧颈内动脉起始部、右侧锁骨上动脉起始段广泛软、硬斑块形成，局部管腔轻度狭窄；颈内动脉颅内各段、大脑前、中、后动脉各段血管硬化。心脏彩超示右房增大；主动脉窦部增宽；二尖瓣及肺动脉瓣局限性反流；主动脉瓣中度反流，提示右室舒张功能减退。腹部彩超示脂肪肝；胆囊结石 胆囊肿大；左肾结石。颈动脉彩超示颈动脉粥样硬化；左侧颈动脉中段粥样斑块，右侧颈动脉多发粥样斑块；左侧椎动脉流速减慢。予以改善循环、改善头昏等对症治疗后好转出院。入院前1天，患者无明显诱因再次出现头昏，伴肢体乏力，发作时伴站立不稳、头昏加重、眼花，持续1小时右左，无恶心、呕吐，无大小便失禁、意识丧失，无畏寒、无胸闷、胸痛，无喘累、气促，无晕厥等，今晨患者活动后再次发作头昏，故收入我科住院。患者自发病以来精神、食欲一般，大小便未诉异常。近期体重无明显减轻。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 10, "end_pos": 14}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 31, "end_pos": 34}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 50, "end_pos": 54}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 85, "end_pos": 86}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 107, "end_pos": 108}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 113, "end_pos": 116}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 132, "end_pos": 138}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 139, "end_pos": 147}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 148, "end_pos": 152}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 153, "end_pos": 165}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 166, "end_pos": 170}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 171, "end_pos": 176}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 178, "end_pos": 184}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 194, "end_pos": 198}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 211, "end_pos": 215}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 228, "end_pos": 237}, {"label_type": "影像检查", "overlap": 0, "start_pos": 250, "end_pos": 256}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 259, "end_pos": 277}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 278, "end_pos": 289}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 290, "end_pos": 297}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 298, "end_pos": 306}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 307, "end_pos": 310}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 311, "end_pos": 321}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 322, "end_pos": 327}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 328, "end_pos": 332}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 336, "end_pos": 339}, {"label_type": "影像检查", "overlap": 0, "start_pos": 352, "end_pos": 355}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 356, "end_pos": 360}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 378, "end_pos": 381}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 382, "end_pos": 388}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 392, "end_pos": 402}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 421, "end_pos": 425}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 430, "end_pos": 439}, {"label_type": "影像检查", "overlap": 0, "start_pos": 446, "end_pos": 450}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 451, "end_pos": 453}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 456, "end_pos": 461}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 464, "end_pos": 467}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 468, "end_pos": 472}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 478, "end_pos": 482}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 489, "end_pos": 497}, {"label_type": "影像检查", "overlap": 0, "start_pos": 498, "end_pos": 502}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 503, "end_pos": 506}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 507, "end_pos": 511}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 512, "end_pos": 516}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 517, "end_pos": 521}, {"label_type": "影像检查", "overlap": 0, "start_pos": 522, "end_pos": 527}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 528, "end_pos": 535}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 536, "end_pos": 543}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 548, "end_pos": 553}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 560, "end_pos": 565}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 579, "end_pos": 580}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 609, "end_pos": 610}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 613, "end_pos": 615}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 627, "end_pos": 628}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 667, "end_pos": 668}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 670, "end_pos": 671}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 696, "end_pos": 697}]}
{"originalText": "入院8年前患者受凉后出现咳嗽、伴喘累，需输液治疗缓解，缓解后未长期口服药物，每年冬春季及天气变化时易于发病，无胸痛、咯血，多次在外院就诊考虑“慢支炎、肺气肿”。病程中逐渐出现劳力性气促，初为爬坡及重体力劳动时出现，后平地活动亦感气促，受凉后喘累气促明显加重，反复在当地医院输液治疗。近2年患者先后多次在我院住院治疗，诊断“慢性支气管炎急性发作”，经抗感染、止咳祛痰、平喘等治疗病情稍缓解。入院前10天患者受凉后咳嗽咯痰症状加重，咳黄色痰液，咯痰费力。伴有心慌胸闷，喘累气促，夜间不能平卧。伴纳差，饮食较前明显减少，每餐进食3-4口饭，伴活动耐力明显上降，未上床活动。无畏寒、发热、咳血、胸痛、流涕、打喷嚏。未予诊治。入院前5天出现两上肢水肿。今日患者感气促明显，端坐位易气促，家属遂呼120送入我院就诊，查“血气分析：PCO2:66mmhg，PO2:38mmhg，PH：7.35，SO2:68%。心电图示：窦性心动过速，不完全性左束支传导阻滞，左室肥大，右房肥大。血常规：WBC：9.0*10^9/L，N：74.64%，NEUT：6.75*10^9/L。电解质示：K：5.97mmol/L，Na：135.7mmol/L，Cl：94.3mmol/L。肾功、心肌酶谱无异常。胸片示：两肺广发感染，两侧肺门增大增浓，建议结合临床后复查或CT检查除外其它。”诊断“慢性阻塞性肺病急性加重，2型呼吸衰竭。”给予“呋塞米利尿、多索茶碱平喘、地塞米松平喘”对症处理，患者呼吸衰竭明显，需入住ICU行无创呼吸机治疗，但家属拒绝。请内一科会诊后因内一科无床，经沟通后收入我科治疗。本次发病以来患者精神食欲较差，大小便如常，睡眠差，体力上降，体重无明显改变", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 55, "end_pos": 56}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 71, "end_pos": 74}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 75, "end_pos": 78}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 161, "end_pos": 171}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 227, "end_pos": 228}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 229, "end_pos": 230}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 293, "end_pos": 294}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 315, "end_pos": 318}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 359, "end_pos": 363}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 371, "end_pos": 374}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 382, "end_pos": 384}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 390, "end_pos": 393}, {"label_type": "影像检查", "overlap": 0, "start_pos": 398, "end_pos": 401}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 403, "end_pos": 409}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 410, "end_pos": 421}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 422, "end_pos": 426}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 427, "end_pos": 431}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 436, "end_pos": 439}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 451, "end_pos": 452}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 460, "end_pos": 464}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 482, "end_pos": 483}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 495, "end_pos": 497}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 510, "end_pos": 512}, {"label_type": "影像检查", "overlap": 0, "start_pos": 535, "end_pos": 537}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 539, "end_pos": 545}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 546, "end_pos": 550}, {"label_type": "影像检查", "overlap": 0, "start_pos": 565, "end_pos": 567}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 578, "end_pos": 589}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 590, "end_pos": 596}, {"label_type": "药物", "overlap": 0, "start_pos": 601, "end_pos": 604}, {"label_type": "药物", "overlap": 0, "start_pos": 607, "end_pos": 611}, {"label_type": "药物", "overlap": 0, "start_pos": 614, "end_pos": 618}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 628, "end_pos": 632}]}
{"originalText": "入院前3+月，患者无明显诱因出现剑突上阵发性隐痛，无肩背部放射痛，疼痛无规律，与进食及体位无关，持续约数十分钟后可自行缓解，伴嗳气，无反酸烧心、恶心呕吐、纳差、黑便、消瘦、腹胀，无心悸、气促、胸闷胸痛，于我院门诊查胃镜示：贲门肿瘤可能？活检示：贲门腺癌（均未见原报告）。故于我院消化内科住院治疗，完善胸腹部CT：1.贲门及邻近胃壁增厚，增强后轻度强化，周围淋巴结肿大，考虑肿瘤性病变，胃Ca？2.左肺中叶外侧段及两肺上叶少许炎症。3.左肺下叶尖后段少许纤维、钙化灶；右肺上叶胸膜上可疑浅淡小结节影。4.纵隔及左肺门区淋巴结钙化。5.脂肪肝，肝左后缘斑点状钙化。6.主动脉、冠状动脉及两侧髂动脉壁钙化，胸椎、腰椎骨质增生。患方拒绝手术治疗，经对症处理后好转出院，院外患者病情相对稳定。入院前5+天，患者再发下诉腹痛不适，伴恶心欲吐，纳差乏力明显，伴明显头昏，严重时致体位不能维持，卧床休息后好转，否认呕血及便血，无反酸烧心，无心悸、气促、胸闷胸痛，无咳嗽咯痰，无畏寒发热等不适，故于*******医院就诊治疗，完善胸片：1.双肺纹理增多；2.左侧第7肋间腋侧走行皱褶；3.主动脉增宽钙化。心电图：窦性心律，正常心电图。腹部增强CT：胃底及贲门曲占位性性病变，考虑恶性肿瘤（胃癌可能性大），胃及食管远端，伴肝脏及淋巴结多发转移，门静脉左干及主干、脾静脉、胃引流静脉（注入门静脉）多发癌栓。血常规：HB69.2g/L。给予输注红细胞悬液2u，白蛋白纠正低蛋白血症等处理后好转，建议当地治疗，遂来我院，门诊以“胃癌伴转移”收入我科住院治疗。患者自患病以来，精神、睡眠一般，饮食如下，大小便未见明显异常，近期体重未见明显变化。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 16, "end_pos": 18}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 26, "end_pos": 29}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 86, "end_pos": 87}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 91}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 96, "end_pos": 97}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 98, "end_pos": 99}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 111, "end_pos": 118}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 122, "end_pos": 126}, {"label_type": "影像检查", "overlap": 0, "start_pos": 151, "end_pos": 155}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 158, "end_pos": 160}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 163, "end_pos": 164}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 192, "end_pos": 195}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 198, "end_pos": 214}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 217, "end_pos": 224}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 233, "end_pos": 237}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 237, "end_pos": 239}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 251, "end_pos": 263}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 266, "end_pos": 269}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 270, "end_pos": 279}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 282, "end_pos": 299}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 300, "end_pos": 309}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 354, "end_pos": 355}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 375, "end_pos": 376}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 412, "end_pos": 413}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 418, "end_pos": 419}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 420, "end_pos": 421}, {"label_type": "影像检查", "overlap": 0, "start_pos": 456, "end_pos": 458}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 461, "end_pos": 463}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 470, "end_pos": 476}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 485, "end_pos": 492}, {"label_type": "影像检查", "overlap": 0, "start_pos": 493, "end_pos": 496}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 497, "end_pos": 501}, {"label_type": "影像检查", "overlap": 0, "start_pos": 504, "end_pos": 507}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 508, "end_pos": 514}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 515, "end_pos": 517}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 518, "end_pos": 521}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 530, "end_pos": 534}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 543, "end_pos": 544}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 545, "end_pos": 549}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 551, "end_pos": 553}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 554, "end_pos": 557}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 562, "end_pos": 567}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 568, "end_pos": 570}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 571, "end_pos": 574}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 575, "end_pos": 580}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 589, "end_pos": 591}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 596, "end_pos": 598}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 651, "end_pos": 656}]}
{"originalText": "患者入院前6年无明显诱因出现心累、气促，起病初多以活动后明显，伴胸闷，无明显胸痛，需胸骨后压榨感，无上肢浮肿，无夜间阵发性呼吸困难，患者休息后症状可减轻，曾于*******医院就诊，考虑“冠状动脉粥样硬化性心脏病”，并办理特病，但平素未行相关治疗。入院前半年患者因心累加重，并全身多处瘀斑，于******医院住院治疗，行心脏彩超提示“右房增大，室间隔、右室后壁增厚，左室流出道增宽，二尖瓣及主动脉瓣狭窄，二尖瓣及三尖瓣重度反流，反流压差增高，肺动脉瓣及主动脉瓣轻度反流，心包积液，右室收缩功能正常”，具体治疗不详，出院后患者长期服用“单硝酸异山梨酯缓释片、阿托伐他汀钙、厄贝沙坦、曲美他嗪”等药物，仍有活动后心累不适，近1月患者自觉心累加重，平路缓步行走感心累难以忍受，日常一般活动，如做饭等不能从事，夜间需高枕卧位，感胸闷，时有端坐呼吸，活动后伴有咳嗽，气喘，痰中偶有鲜红色血丝，无明显上肢浮肿，无畏寒发热，无潮热盗汗等不适，今日来院就诊，为进一步治疗收入我科住院。患者半年前因全身多处瘀斑，于******医院就诊，完善检查发现血小板减少、贫血，查血常规(2016-03-01)PLT 63×109/L、HB 63g/L；住院期间予以骨髓穿刺，考虑缺铁性贫血、血小板减少性紫癜，予以输红细胞悬液2U，并激素治疗（目前服用甲泼尼龙 2片/日），自诉复查指标好转。另外此次住院期间检查发现肾功能异常 BUN 19.6mmol/L CREA 223umol/L，原因不明确，因血小板减少未能肾活检，出院诊断考虑慢性肾脏病（CKD3期），急性肾损害不除外。患者自发病以来精神、食欲可，大小便未诉异常。近期体重无明显减轻。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 14, "end_pos": 15}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 32, "end_pos": 33}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 38, "end_pos": 39}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 42, "end_pos": 44}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 50, "end_pos": 52}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 94, "end_pos": 106}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 132, "end_pos": 133}, {"label_type": "影像检查", "overlap": 0, "start_pos": 160, "end_pos": 164}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 167, "end_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 172, "end_pos": 175}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 176, "end_pos": 180}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 183, "end_pos": 185}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 191, "end_pos": 201}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 202, "end_pos": 213}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 221, "end_pos": 234}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 235, "end_pos": 239}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 240, "end_pos": 248}, {"label_type": "药物", "overlap": 0, "start_pos": 267, "end_pos": 277}, {"label_type": "药物", "overlap": 0, "start_pos": 278, "end_pos": 284}, {"label_type": "药物", "overlap": 0, "start_pos": 285, "end_pos": 289}, {"label_type": "药物", "overlap": 0, "start_pos": 290, "end_pos": 294}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 304, "end_pos": 305}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 328, "end_pos": 329}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 360, "end_pos": 361}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 394, "end_pos": 396}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 490, "end_pos": 493}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 503, "end_pos": 505}, {"label_type": "手术", "overlap": 0, "start_pos": 518, "end_pos": 522}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 525, "end_pos": 530}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 531, "end_pos": 539}, {"label_type": "药物", "overlap": 0, "start_pos": 561, "end_pos": 565}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 599, "end_pos": 602}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 614, "end_pos": 618}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 653, "end_pos": 665}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 666, "end_pos": 671}]}
{"originalText": "患者入院前1+年因发作性胸闷，于2015年10月9日至10月21日在*******医院住院，冠脉造影检查示：前降支狭窄20-50%，回旋支狭窄80%，行支架植入术；术后给予冠心病二级预防口服药物治疗，出院时胸闷明显缓解。病程中患者未再发作明显胸闷、胸痛等不适，家属诉平素监测心率偏慢，未进一步就诊。入院前3+小时患者于餐后突发感心前区胀痛感，难以忍受，随后意识丧失，两眼凝视，张口呼吸，左手不自主抖动，无大小便失禁，家属立即按压“人中”，并予以舌上含服“速效救心丸”等，同时呼叫120急救，下述症状持续约5min后患者意识恢复，并自主活动，120医师现场查看患者清醒，随机指血糖：7.9mmol/L，接回我院急诊科，急诊查血常规 WBC 8.5x10^9/L HB 117g/L；凝血试验 APTT 21.3秒；高敏肌钙蛋白 23.87pg/ml；电解质 K 3.8mmol/L；肾功能 BUN 11.04mmol/L CREA 152.4umol/L；血气分析 PH 7.47 PO2 122mmHg PCO2 36mmHg；CT提示：1.两侧基底节区腔隙性脑梗死。2.脑白质脱髓鞘改变；脑萎缩。3.左肺下叶尖段及左肺上叶小结节影，考虑炎性肉芽肿可能，建议短期内复查。4.右肺下叶尖后段少许感染，右肺上叶内前基底段少许慢性感染，建议治疗后复查。5.右肺下叶尖后段钙化灶。6.主动脉壁及冠状动脉壁钙化；胸椎骨质增生。7.肝实质内多个类圆形低密度影，考虑为囊肿，部分病灶边界欠清晰，随访或必要时增强检查。请我科会诊后为进一步治疗收入我科住院。本次发病以来患者精神食欲较差，大小便如常，睡眠较差，体重无明显上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 12, "end_pos": 13}, {"label_type": "影像检查", "overlap": 0, "start_pos": 46, "end_pos": 50}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 54, "end_pos": 65}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 66, "end_pos": 74}, {"label_type": "手术", "overlap": 0, "start_pos": 76, "end_pos": 81}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 86, "end_pos": 89}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 103, "end_pos": 104}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 122}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 124, "end_pos": 125}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 164, "end_pos": 167}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 183, "end_pos": 185}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 193, "end_pos": 195}, {"label_type": "药物", "overlap": 0, "start_pos": 227, "end_pos": 232}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 287, "end_pos": 289}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 315, "end_pos": 318}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 330, "end_pos": 332}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 345, "end_pos": 349}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 356, "end_pos": 362}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 378, "end_pos": 379}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 394, "end_pos": 397}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 410, "end_pos": 414}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 432, "end_pos": 434}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 440, "end_pos": 443}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 452, "end_pos": 456}, {"label_type": "影像检查", "overlap": 0, "start_pos": 464, "end_pos": 466}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 471, "end_pos": 483}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 486, "end_pos": 494}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 495, "end_pos": 498}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 501, "end_pos": 507}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 508, "end_pos": 512}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 519, "end_pos": 524}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 537, "end_pos": 544}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 549, "end_pos": 558}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 575, "end_pos": 582}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 588, "end_pos": 600}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 601, "end_pos": 607}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 610, "end_pos": 611}]}
{"originalText": "入院前半天患者被家属发现失语、阵发性大汗淋漓，无大小便失禁，无呕吐，无抽搐，家属遂拨打120，由我院120接回，查血气分析：PH 7.41，PaO2 53mmHg，PaCO2 43mmHg，乳酸1.4mmol/L，肾功：未见明显异常，肝功：白球比 1.2，电解质：氯 110.6 mmol/l，血常规：白细胞数 9.4×10^9/L、红细胞数 4.41×10^12/L、血红蛋白浓度 131 g/L、血小板数 140×10^9/L、中性粒细胞百分比 77.61 %，凝血试验：纤维蛋白原 4.62 g/L，心肌酶正常。高敏肌钙蛋白T 33.10 pg/ml，CRP：69 mg/l，D_2聚体：7.07 μg/ml，胸部CT：1，两侧基底节及侧脑室体旁少许散在小腔隙灶，结合临床随访复查或必要时MRI进一步检查。2，脑白质脱髓鞘，脑萎缩，随访。3，左肺下叶、中叶及两上肺感染，随访复查。4，肺气肿征，右下肺小肺大泡形成。5，主动脉及冠状动脉壁钙化。6，两侧胸膜稍增厚，胸椎骨质增生。心电图：极端的窦性心律不齐，窦性心动过缓，完全性左束支传导阻滞。予以吸氧、心电监护，指脉氧由85%下升至90%，复查血气分析：PH 7.41，PaO2 52mmHg，PaCO2 36mmHg，乳酸2.0mmol/L，请我科会诊后建议转ICU进一步治疗，家属拒绝，急诊以“I型呼吸衰竭，肺部感染，缺血缺氧性脑病？急性脑梗死？”收入我科。与患者家属进一步沟通后同意住院，随后以“肺部感染”收入我科住院治疗。患者自发病以来精神、食欲差，睡眠可，大便，小便未诉异常。近半年患者懒言少语，反应迟钝，但能正确对答。近期体重无明显减轻。", "entities": [{"label_type": "实验室检验", "overlap": 0, "start_pos": 62, "end_pos": 64}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 70, "end_pos": 74}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 82, "end_pos": 87}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 95, "end_pos": 97}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 120, "end_pos": 123}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 132, "end_pos": 133}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 151, "end_pos": 154}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 167, "end_pos": 170}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 185, "end_pos": 191}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 200, "end_pos": 203}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 216, "end_pos": 224}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 238, "end_pos": 243}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 259, "end_pos": 266}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 279, "end_pos": 282}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 291, "end_pos": 296}, {"label_type": "影像检查", "overlap": 0, "start_pos": 308, "end_pos": 312}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 315, "end_pos": 320}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 321, "end_pos": 325}, {"label_type": "影像检查", "overlap": 0, "start_pos": 347, "end_pos": 350}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 358, "end_pos": 364}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 365, "end_pos": 368}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 374, "end_pos": 387}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 395, "end_pos": 398}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 400, "end_pos": 403}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 412, "end_pos": 423}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 426, "end_pos": 430}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 434, "end_pos": 440}, {"label_type": "影像检查", "overlap": 0, "start_pos": 441, "end_pos": 444}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 448, "end_pos": 454}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 455, "end_pos": 461}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 462, "end_pos": 472}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 504, "end_pos": 506}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 512, "end_pos": 516}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 524, "end_pos": 529}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 537, "end_pos": 539}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 576, "end_pos": 582}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 583, "end_pos": 587}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 588, "end_pos": 595}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 596, "end_pos": 601}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 628, "end_pos": 632}]}
{"originalText": "患者于入院10月前发现两上肢浮肿、尿量减少、喘累，到****医院查血常规： Hb：87g/l，肾功：血肌酐：394umol/L，考虑肾功能不全、肾性贫血，后到**********医院就诊，查肾功：血肌酐：330umol/L，血常规：Hb：89g/l，甲状旁腺激素 55.5pg/ml，内生肌酐清除率：14.49ml/min，腹部彩超：两肾结构欠清，实质回声稍增强，腹腔少量积液；心脏彩超：右室肥厚，少许心包积液；胸部CT平扫：右肺上叶炎症，心脏增大，两侧胸腔积液，给予血液净化治疗、降压、降糖、纠正贫血、改善循环等治疗后好转出院。8月前前患者再次出现心悸、胸闷，伴恶心、纳差，无咳嗽、咳痰，无腹痛、腹胀，无肉眼血尿，无头昏、头痛，无皮上出血、牙龈出血等不适。在我科住院规律透析治疗，3月前因个人原因回当地，但未行透析治疗，给予口服药及胰岛素控制血糖等，5天前因活动后气促在*****就医，急诊入院后给予无创呼吸机、西地兰强心、呋塞米利尿、改善循环、持续血液净化，补充蛋白等治疗后，患者生命体征平稳，水肿消退，但仍诉心悸不适、血糖波动较大，家属为进一步诊治，到我院就诊，门诊以\\\"尿毒症、糖尿病、高血压\\\"收入我科住院治疗。患者自患病以来，精神、睡眠可，食欲差，大便正常，小便偏少，量不详，体重无明显变化。22年前因手足麻木在当地医院查血糖升高，值不详，诊断为2型糖尿病，先后服用格列齐特、消渴丸降糖，偶测血糖20+mmol/L,曾服用二甲两胍出现恶心、呕吐停用，后开始出现视物模糊、两上肢水肿，2年前开始使用优思林降血糖，血糖控制不详，现改为诺和锐30 16u/早，12u/晚降血糖，血糖控制可。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 11, "end_pos": 14}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 38, "end_pos": 40}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 50, "end_pos": 53}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 66, "end_pos": 71}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 72, "end_pos": 76}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 98, "end_pos": 101}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 116, "end_pos": 118}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 125, "end_pos": 131}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 142, "end_pos": 149}, {"label_type": "影像检查", "overlap": 0, "start_pos": 162, "end_pos": 166}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 167, "end_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 182, "end_pos": 184}, {"label_type": "影像检查", "overlap": 0, "start_pos": 189, "end_pos": 193}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 194, "end_pos": 196}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 201, "end_pos": 205}, {"label_type": "影像检查", "overlap": 0, "start_pos": 206, "end_pos": 210}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 213, "end_pos": 219}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 220, "end_pos": 222}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 225, "end_pos": 231}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 275, "end_pos": 276}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 278, "end_pos": 279}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 296, "end_pos": 297}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 299, "end_pos": 300}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 309, "end_pos": 310}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 312, "end_pos": 313}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 321, "end_pos": 323}, {"label_type": "药物", "overlap": 0, "start_pos": 367, "end_pos": 370}, {"label_type": "药物", "overlap": 0, "start_pos": 407, "end_pos": 410}, {"label_type": "药物", "overlap": 0, "start_pos": 413, "end_pos": 416}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 457, "end_pos": 458}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 489, "end_pos": 492}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 493, "end_pos": 496}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 497, "end_pos": 500}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 557, "end_pos": 559}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 567, "end_pos": 571}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 579, "end_pos": 584}, {"label_type": "药物", "overlap": 0, "start_pos": 589, "end_pos": 593}, {"label_type": "药物", "overlap": 0, "start_pos": 594, "end_pos": 597}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 602, "end_pos": 604}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 617, "end_pos": 621}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 641, "end_pos": 644}, {"label_type": "药物", "overlap": 0, "start_pos": 654, "end_pos": 657}, {"label_type": "药物", "overlap": 0, "start_pos": 671, "end_pos": 676}]}
{"originalText": "入院前14年患者检查发现血糖升高，血糖具体值不详，有口干、多饮、多尿等症状，伴四肢麻木，并有感觉异常，自觉肢体冰凉，伴视物模糊，于外院诊断为“2型糖尿病 糖尿病周围神经病变 糖尿病眼病”，后长期服用“格列美脲、伏格列波糖、罗格列酮”等降血糖，半年前于我科住院，出院后使用“来得时+阿卡波糖”降糖，但院外患者自行加用“格列美脲”降糖，偶有心慌冒汗症状。1+年前患者因活动后心累心悸，偶有干咳，感肢体麻木冰凉较明显，伴有腰部及上肢疼痛，自觉健忘症状加重，于我院内一科住院，查肾功：尿素 16.00 mmol/L、肌酐 141.7 μmol/l，诊断为“糖尿病肾病、原发性高血压3级极高危 高血压性心脏病”，治疗后好转出院；半年前因腹泻于我科住院，检查肾功：尿素 19.79 mmol/L、肌酐 225.2 μmol/l及其他检查，诊断“1.2型糖尿病 糖尿病周围神经病变 糖尿病眼病 糖尿病肾病 糖尿病植物神经病变 2.原发性高血压3级 很高危 高血压性心脏病 3.重度骨质疏松 4、甲状腺功能减退 5、冠状动脉粥样硬化心脏病”，治疗后好转出院，出院后未定期随访复查，并自行停用相关药物。3+月前患者感活动及爬坡后心累、气促明显，稍休息后能好转，并出现头昏痛，无视物旋转，无耳鸣，无发热，无呕吐，无黑便等，在院外自行服药（具体药名不详），效果欠佳,今为求治疗，来我科要求住院治疗。以“2型糖尿病、糖尿病肾病”收入院。患者此次发病以来精神食欲一般，长期睡眠差，经常服用“安眠药”，大便正常，诉长期解小便色偏黄，尿量不详，体重无明显上降。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 12, "end_pos": 16}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 39, "end_pos": 41}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 53, "end_pos": 55}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 71, "end_pos": 76}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 77, "end_pos": 86}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 87, "end_pos": 92}, {"label_type": "药物", "overlap": 0, "start_pos": 100, "end_pos": 104}, {"label_type": "药物", "overlap": 0, "start_pos": 105, "end_pos": 110}, {"label_type": "药物", "overlap": 0, "start_pos": 111, "end_pos": 115}, {"label_type": "药物", "overlap": 0, "start_pos": 136, "end_pos": 139}, {"label_type": "药物", "overlap": 0, "start_pos": 140, "end_pos": 144}, {"label_type": "药物", "overlap": 0, "start_pos": 158, "end_pos": 162}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 168, "end_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 185, "end_pos": 186}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 187, "end_pos": 188}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 196, "end_pos": 198}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 208, "end_pos": 210}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 211, "end_pos": 213}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 238, "end_pos": 240}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 254, "end_pos": 256}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 274, "end_pos": 279}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 280, "end_pos": 291}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 292, "end_pos": 299}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 313, "end_pos": 315}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 326, "end_pos": 328}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 342, "end_pos": 344}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 368, "end_pos": 373}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 374, "end_pos": 383}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 384, "end_pos": 389}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 390, "end_pos": 395}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 396, "end_pos": 405}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 408, "end_pos": 420}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 421, "end_pos": 428}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 431, "end_pos": 437}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 440, "end_pos": 447}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 450, "end_pos": 461}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 505, "end_pos": 506}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 524, "end_pos": 525}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 535, "end_pos": 536}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 590, "end_pos": 595}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 596, "end_pos": 601}]}
{"originalText": "入院前16年患者因“肝昏迷”（具体不详）在“**********医院”就诊，诊断为“乙肝后肝硬化”，给予血浆置换等对症处理后好转出院。院外未再发作下述疾病，无腹胀、消化道出血等。院外未再口服药物治疗。入院前半年无明显诱因出现肝区持续性隐痛不适，无阵发性加重，无肩背部放射痛，与进食及体位无关，无明显缓解方式。无恶心、呕吐、黑便、反酸、烧心、嗳气、纳差、黄疸、畏寒、发热。在“**********医院”就诊，完善相关检查后诊断“肝癌”，无手术指征，给予“介入术”治疗后腹痛稍缓解，院外口服“抗病毒、保肝、抗肿瘤”药物治疗。病程中出现黄疸、纳差，查肝功异常，总共给予2次介入术，1次海扶刀治疗。入院前10天患者再次出现纳差，饮食较前减少，食欲减退，伴剑突上阵发性隐痛，无肩背部放射痛，与进食无关。伴全身乏力、心悸，皮肤逐渐出现黄染，无恶心、呕吐、黑便。未予诊治。家属发现患者精神变差，乏力明显，遂送来我院就诊，查“血常规：白细胞数 2.9*10^9/L ↓、红细胞数 3.49 *10^12/L ↓、血红蛋白浓度 109 g/L ↓、血小板数 97 *10^9/L ↓、中性粒细胞百分比 87.01 % ↑，肝功1：白球比 1.2 ↓、谷草转氨酶 334.0 U/L ↑、谷氨酰转肽酶 538.2 U/L ↑、总胆红素 67.6 μmol/l ↑、直接胆红素 48.8 μmol/l ↑、间接胆红素 18.80 μmol/l ↑。电解质正常。”，门诊以“肝癌”收入我科。病程中精神、饮食稍差，大便基本正常，小便色黄，体重较前稍减轻。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 10, "end_pos": 13}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 42, "end_pos": 48}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 79, "end_pos": 80}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 112, "end_pos": 114}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 130, "end_pos": 133}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 213, "end_pos": 215}, {"label_type": "手术", "overlap": 0, "start_pos": 226, "end_pos": 229}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 233, "end_pos": 234}, {"label_type": "手术", "overlap": 0, "start_pos": 283, "end_pos": 286}, {"label_type": "手术", "overlap": 0, "start_pos": 289, "end_pos": 292}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 323, "end_pos": 325}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 333, "end_pos": 336}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 352, "end_pos": 353}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 409, "end_pos": 412}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 427, "end_pos": 430}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 448, "end_pos": 454}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 465, "end_pos": 468}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 483, "end_pos": 491}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 506, "end_pos": 509}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 516, "end_pos": 521}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 534, "end_pos": 540}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 553, "end_pos": 557}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 572, "end_pos": 577}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 592, "end_pos": 597}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 625, "end_pos": 627}]}
{"originalText": "患者于入院前40+年，常于受凉后出现咳嗽、咳痰，痰呈白色泡沫痰，下述症状反复发作，多在冬春季节反复发作，常予以抗炎止咳等药物治疗后可缓解。病程中患者逐渐出现喘累气促，活动耐力上降，曾在我院行胸部CT提示肺气肿、肺大泡形成。心脏彩超提示射血分数上降，考虑“慢性阻塞性肺疾病、肺源性心脏病”。院外未使用平喘药物及吸氧。入院前4+月患者因咳嗽、咳痰、喘累复发在我院心内科住院治疗，给予“头孢呋辛抗感染、痰热清及溴己新祛痰、多索茶碱平喘、甲泼尼龙平喘”等对症处理后好转，因心率快未行冠脉CTA检查，给予出院。院外长期口服“阿司匹林肠溶片（100mg/片）每天1次 每次1片、富马酸比索洛尔片（5mg/片）每天1次 每次半片、辛伐他汀 每晚1次 每次1片、螺内酯（20mg/片） 每日1次 每次1片、呋塞米（20mg/片） 每日1次 每次1片”治疗。入院前10+天患者无明显诱因出现中下腹阵发性隐痛，以上午饥饿后明显，无肩背部放射痛，进食后腹痛可稍缓解。伴偶有嗳气、反酸，伴大便改变，每日3次，起始2次解成形黄色大便，后解黄色糊状大便。无粘液脓血便，无黑便、里急后重、腹胀。在外未予处理。入院前5天患者受凉后出现明显喘累、气促，伴咳嗽，咳白色粘液痰，无胸痛咯血，无心慌胸闷，无恶心呕吐，无呼吸困难。在家口服下述药物后无缓解。今日来院就诊，为进一步治疗门诊以“慢性阻塞性肺疾病、腹痛待查”收入我科。患者自发病以来精神稍差，食欲尚可，睡眠一般，大便3次/日，时干时稀，无粘液脓血便，小便正常。近期体力上降，体重无明显减轻。", "entities": [{"label_type": "影像检查", "overlap": 0, "start_pos": 95, "end_pos": 99}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 101, "end_pos": 104}, {"label_type": "影像检查", "overlap": 0, "start_pos": 111, "end_pos": 115}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 117, "end_pos": 121}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 127, "end_pos": 135}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 136, "end_pos": 142}, {"label_type": "药物", "overlap": 0, "start_pos": 190, "end_pos": 194}, {"label_type": "药物", "overlap": 0, "start_pos": 198, "end_pos": 201}, {"label_type": "药物", "overlap": 0, "start_pos": 202, "end_pos": 205}, {"label_type": "药物", "overlap": 0, "start_pos": 208, "end_pos": 212}, {"label_type": "药物", "overlap": 0, "start_pos": 215, "end_pos": 219}, {"label_type": "影像检查", "overlap": 0, "start_pos": 237, "end_pos": 242}, {"label_type": "药物", "overlap": 0, "start_pos": 257, "end_pos": 264}, {"label_type": "药物", "overlap": 0, "start_pos": 283, "end_pos": 291}, {"label_type": "药物", "overlap": 0, "start_pos": 308, "end_pos": 312}, {"label_type": "药物", "overlap": 0, "start_pos": 323, "end_pos": 326}, {"label_type": "药物", "overlap": 0, "start_pos": 345, "end_pos": 348}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 387, "end_pos": 389}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 405, "end_pos": 408}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 415, "end_pos": 416}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 521, "end_pos": 522}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 527, "end_pos": 528}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 529, "end_pos": 530}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 574, "end_pos": 582}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 583, "end_pos": 587}]}
{"originalText": "入院前14年患者检查发现血糖升高，血糖具体值不详，有口干、多饮、多尿等症状，伴四肢麻木，并有感觉异常，自觉肢体冰凉，伴视物模糊，于外院诊断为“2型糖尿病 糖尿病周围神经病变 糖尿病眼病”，后长期服用“格列美脲、伏格列波糖、罗格列酮”等降血糖，半年前于我科住院，出院后使用“来得时+阿卡波糖”降糖，但院外患者自行加用“格列美脲”降糖，偶有心慌冒汗症状。1+年前患者因活动后心累心悸，偶有干咳，感肢体麻木冰凉较明显，伴有腰部及上肢疼痛，自觉健忘症状加重，于我院内一科住院，查肾功：尿素 16.00 mmol/L、肌酐 141.7 μmol/l，诊断为“糖尿病肾病、原发性高血压3级极高危 高血压性心脏病”，治疗后好转出院；半年前因腹泻于我科住院，检查肾功：尿素 19.79 mmol/L、肌酐 225.2 μmol/l及其他检查，诊断“1.2型糖尿病 糖尿病周围神经病变 糖尿病眼病 糖尿病肾病 糖尿病植物神经病变 2.原发性高血压3级 很高危 高血压性心脏病 3.重度骨质疏松 4、甲状腺功能减退 5、冠状动脉粥样硬化心脏病”，治疗后好转出院，出院后未定期随访复查，并自行停用相关药物。半月前患者无明显诱因开始出现咳嗽，几乎无痰，伴有咽痒，咳嗽时有溢尿，无畏寒发热，无胸闷胸痛，无腹胀腹痛，无腹泻黑便，无上肢水肿，于我院就诊，遂门诊以\\\"糖尿病，咳嗽待查\\\"收入我科住院治疗。患者此次发病以来精神食欲可，长期睡眠差，经常服用“安眠药”，大便正常，诉长期解小便色偏黄，伴有尿灼热尿痛，体重无明显上降", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 12, "end_pos": 16}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 39, "end_pos": 41}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 53, "end_pos": 55}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 71, "end_pos": 76}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 77, "end_pos": 86}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 87, "end_pos": 92}, {"label_type": "药物", "overlap": 0, "start_pos": 100, "end_pos": 104}, {"label_type": "药物", "overlap": 0, "start_pos": 105, "end_pos": 110}, {"label_type": "药物", "overlap": 0, "start_pos": 111, "end_pos": 115}, {"label_type": "药物", "overlap": 0, "start_pos": 136, "end_pos": 139}, {"label_type": "药物", "overlap": 0, "start_pos": 140, "end_pos": 144}, {"label_type": "药物", "overlap": 0, "start_pos": 158, "end_pos": 162}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 168, "end_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 185, "end_pos": 186}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 187, "end_pos": 188}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 196, "end_pos": 198}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 208, "end_pos": 210}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 211, "end_pos": 213}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 238, "end_pos": 240}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 254, "end_pos": 256}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 274, "end_pos": 279}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 280, "end_pos": 291}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 292, "end_pos": 299}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 313, "end_pos": 314}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 326, "end_pos": 328}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 342, "end_pos": 344}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 368, "end_pos": 373}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 374, "end_pos": 383}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 384, "end_pos": 389}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 390, "end_pos": 395}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 396, "end_pos": 405}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 408, "end_pos": 420}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 421, "end_pos": 428}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 431, "end_pos": 437}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 440, "end_pos": 447}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 450, "end_pos": 461}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 516, "end_pos": 517}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 533, "end_pos": 534}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 535, "end_pos": 536}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 539, "end_pos": 540}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 541, "end_pos": 542}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 545, "end_pos": 546}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 551, "end_pos": 553}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 568, "end_pos": 571}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 572, "end_pos": 576}]}
{"originalText": "入院前4年患者院外测血压高，最高达230/？mmHg，院外服用坎地沙坦、氨氯地平、卡维地洛药物控制血压（具体剂量不详），院外自测血压约150-160mmHg，平素未感视物模糊，未感头昏。2天前患者骑车时不慎跌倒，至两膝、两手掌、上巴处擦伤，感头昏痛，遂于我院门诊就诊，查血压170/100mmHg，血脂：甘油三酯 3.72 mmol/l ↑、总胆固醇 6.26 mmol/l ↑、载脂蛋白B 1.48 g/l ↑，血糖(静脉血)：葡萄糖 9.27 mmol/l ↑，肝功1：谷丙转氨酶 34.3 U/L、谷草转氨酶 20.9 U/L、谷氨酰转肽酶 112.6 U/L ↑，血常规：白细胞数 4.6×10^9/L、红细胞数 5.24×10^12/L、血红蛋白浓度 160 g/L、血小板数 256×10^9/L、中性粒细胞百分比 57.80 %、淋巴细胞百分比 35.90 %，肾功能未见异常，予以硝苯地平缓释片降压处理后好转。1天前患者感头昏减轻，再次于我院就诊，查糖化血红蛋白：糖化血红蛋白 8.7 %，血糖(静脉血)：葡萄糖 13.90 mmol/l，尿微量白蛋白定量：尿微量白蛋白 451 mg/L，尿常规：酮体 -、尿胆原 +、蛋白 +、葡萄糖 +++。无意识障碍大小便失禁，无肢体活动受限，否认多饮多食，否认多尿消瘦，无胸闷胸痛，无腹胀腹痛，无上肢水肿，为进一步治疗，门诊以“高血压、糖尿病”收入我科住院治疗。病程中患者精神、饮食一般，大小便正常，体重无明显上降。", "entities": [{"label_type": "药物", "overlap": 0, "start_pos": 31, "end_pos": 35}, {"label_type": "药物", "overlap": 0, "start_pos": 36, "end_pos": 40}, {"label_type": "药物", "overlap": 0, "start_pos": 41, "end_pos": 45}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 90, "end_pos": 91}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 107, "end_pos": 109}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 110, "end_pos": 113}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 114, "end_pos": 116}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 122}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 152, "end_pos": 156}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 171, "end_pos": 175}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 190, "end_pos": 195}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 215, "end_pos": 218}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 237, "end_pos": 242}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 252, "end_pos": 257}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 267, "end_pos": 273}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 290, "end_pos": 293}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 306, "end_pos": 309}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 324, "end_pos": 330}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 339, "end_pos": 342}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 355, "end_pos": 363}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 372, "end_pos": 379}, {"label_type": "药物", "overlap": 0, "start_pos": 398, "end_pos": 405}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 419, "end_pos": 420}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 440, "end_pos": 446}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 461, "end_pos": 464}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 487, "end_pos": 493}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 507, "end_pos": 509}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 512, "end_pos": 515}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 518, "end_pos": 520}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 523, "end_pos": 526}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 543, "end_pos": 545}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 565, "end_pos": 566}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 567, "end_pos": 568}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 571, "end_pos": 572}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 573, "end_pos": 574}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 577, "end_pos": 579}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 593, "end_pos": 596}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 597, "end_pos": 600}]}
{"originalText": "患者7年前始出现反复咳、喘，平时咳少许白色泡沫痰，平地活动可耐受，爬坡等活动感气促明显。近2年活动后气促明显加重，检查发现左侧颈部豌豆大小包块，无疼痛感，因同期被诊断为“肺结核”故考虑肿块性质为结核，给予HRZ方案抗结核治疗2年后停药。病程中颈部包块无增大及缩小，持续无疼痛，未进一步检查。半年多前患者因活动后气促加重在***二院住院，完善多项影像学检查后诊断为“左侧肺癌”，家属放弃积极治疗，院外对症治疗。出院后左侧颈部包块进行性增大，间断有隐痛不适。近半年多来，反复因咳喘症状加重多次在我科住院治疗，给予抗肿瘤、抗感染、止咳平喘、对症治疗后症状好转出院。入院前3月患者感颜面部浮肿，程度不重，于我科治疗，考虑为下腔静脉栓塞。给予治疗后可消退，但反复出现。入院前1+月，患者再次感颜面部浮肿及咳嗽、咳痰、气促、纳差较前加重于我科住院，给予抗肿瘤、抗感染、对症治疗，症状部分缓解。出院后仍感纳差、活动后气促，可耐受10余米距离行走。入院前12天，患者促、水肿症状加重，就诊我科，诊断“1、左肺周围型肺癌 2、转移性淋巴癌 3、慢性阻塞性肺疾病急性加重 4、矽肺 5、陈旧性肺结核 6、压疮”，给予抗感染、止咳祛痰、止痛治疗后好转出院。入院前2天，患者再次出现喘累、气促加重，伴有两下肢及左上肢明显水肿，腹胀，腹泻，稀水样大便。无明显咳嗽咳痰，今为求诊治，就诊我院我科。本次发病以来患者精神食欲睡眠差，小便量少色黄，腹泻，稀水样大便，约5-6次/天。体重变化不明显。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 61, "end_pos": 65}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 85, "end_pos": 88}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 121, "end_pos": 123}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 182, "end_pos": 186}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 207, "end_pos": 211}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 287, "end_pos": 290}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 307, "end_pos": 313}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 341, "end_pos": 344}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 444, "end_pos": 451}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 454, "end_pos": 460}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 463, "end_pos": 475}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 478, "end_pos": 480}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 483, "end_pos": 489}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 492, "end_pos": 494}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 539, "end_pos": 542}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 543, "end_pos": 546}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 551, "end_pos": 552}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 554, "end_pos": 555}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 607, "end_pos": 608}]}
{"originalText": "患者入院前3+天患者受凉后感咽痛，并咳嗽，痰液较少，偶咳出少许白色粘痰，无痰中带血，并畏寒发热，体温未测，无胸痛，无胸骨后压榨感，无明显心累，无上肢浮肿，入院前1天患者在乘坐公交车时，突发晕倒一次，起病前感头晕，无黑朦，症状持续1分钟右左，无大小便失禁，无抽搐，醒后无遗留言语、肢体功能障碍，今日为求进一步治疗收入我科住院。入院前3+年，患者无明确诱因反复出现胸闷、心累，活动后加重，发作时伴头晕、肢体麻木、视物模糊，2014年4月在我院查心电图提示“心房纤颤”，住院治疗症状好转。后就诊于“**医院”，冠脉造影检查提示“四支血管病变”，最严重者狭窄85%（具体不详），于**医院行“冠脉搭桥手术及射频消融术”，术后常感伤口疼痛，胸闷、心累好转。院外长期遵瞩服用“阿司匹林肠溶片、氯吡格雷、瑞舒伐他汀、美托洛尔缓释片”，日常平地活动耐受较好，爬楼约4层感胸闷、气短明显，需休息缓解，否认肢体水肿、黑朦、晕厥史。近1月来患者无明显诱因活动后心累气促较前加重，在我院就诊，动态心电图示：偶发房性早搏，室性早搏（两源），加速的室性逸搏，ST-T未见明显改变。胸片：1.两上肺纹理增多，建议结合临床。2.右侧胸膜增厚或右侧胸腔少量积液。3.胸骨区域多个环状金属密度影，考虑术后改变。心脏彩超：右房增大；主动脉窦部增宽；室间隔动度降低；二尖瓣、三尖瓣轻度反流；肺动脉瓣局限性反流；提示右室舒张功能减退。本次发病以来患者精神食欲尚可，大小便如常，睡眠较差，体重无明显上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 14, "end_pos": 15}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 54, "end_pos": 55}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 58, "end_pos": 60}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 72, "end_pos": 74}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 103, "end_pos": 104}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 180, "end_pos": 181}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 183, "end_pos": 184}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 196, "end_pos": 197}, {"label_type": "影像检查", "overlap": 0, "start_pos": 220, "end_pos": 223}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 226, "end_pos": 230}, {"label_type": "影像检查", "overlap": 0, "start_pos": 252, "end_pos": 256}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 261, "end_pos": 267}, {"label_type": "手术", "overlap": 0, "start_pos": 292, "end_pos": 304}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 315, "end_pos": 316}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 318, "end_pos": 319}, {"label_type": "药物", "overlap": 0, "start_pos": 332, "end_pos": 339}, {"label_type": "药物", "overlap": 0, "start_pos": 340, "end_pos": 344}, {"label_type": "药物", "overlap": 0, "start_pos": 345, "end_pos": 350}, {"label_type": "药物", "overlap": 0, "start_pos": 351, "end_pos": 358}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 377, "end_pos": 378}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 419, "end_pos": 420}, {"label_type": "影像检查", "overlap": 0, "start_pos": 434, "end_pos": 439}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 441, "end_pos": 447}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 448, "end_pos": 456}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 457, "end_pos": 464}, {"label_type": "影像检查", "overlap": 0, "start_pos": 476, "end_pos": 478}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 481, "end_pos": 484}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 498, "end_pos": 502}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 505, "end_pos": 509}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 516, "end_pos": 518}, {"label_type": "影像检查", "overlap": 0, "start_pos": 537, "end_pos": 541}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 542, "end_pos": 544}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 547, "end_pos": 552}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 555, "end_pos": 558}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 563, "end_pos": 566}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 567, "end_pos": 570}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 575, "end_pos": 579}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 587, "end_pos": 595}]}
{"originalText": "1年前，患者不明原因出现记忆力减退，主要表现为近事记忆减退明显，远期记忆正常，当时未引起重视，未予以治疗。并进行性加重，半月前出现性格改变，暴躁、易怒，无幻觉、被害妄想；日常基本生活不能自理，且对自己熟悉的家人不认识，不知道何处下厕所；曾到*********神经内科门诊就诊，行头颅CT检查后诊断“老年痴呆”，具体服药情况不详。在回家服药治疗观察过程中出现2次跌倒，无发作先兆，无明显的头昏、视物旋转、恶心、呕吐，无肢体活动障碍及抽搐，无大小便失禁及意识障碍。家属自觉患者病情重，再次到*********就诊，并住入神经内科，住院过程中出现左侧肢体活动障碍，不能行走，进食出现吞咽困难，饮水呛咳，行头颅CT及MRI检查，诊断“急性脑梗死”，予以“阿司匹林”抗血小板聚集、“阿托伐他汀”调脂，“依达拉奉”抗自由基氧化等对症治疗。由于患者不能进食，予以胃管鼻饲，但胃管内抽出暗红色胃液，考虑“消化道出血”，予以“奥美拉唑、凝血酶粉”等对治疗。3天前，患者出现咳嗽、咯痰，咯黄色粘稠痰，且发热，体温38.1℃，并出现意识加深，呼之不应，行血气分析提示呼吸衰竭，转入重症监护室进一步治疗，予以气管插管，呼吸机辅助呼吸，并予以“莫西沙星”抗感染、营养支持治疗。患者病情重，家属要求转入我院进一步治疗，遂由我院120转入，门诊以“急性脑梗死、急性呼吸衰竭、肺部感染、消化道出血”收住我科。患者患病以来，精神差，一直胃管进食流质，小便正常，大便未解。", "entities": [{"label_type": "影像检查", "overlap": 0, "start_pos": 139, "end_pos": 143}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 149, "end_pos": 153}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 193, "end_pos": 194}, {"label_type": "影像检查", "overlap": 0, "start_pos": 299, "end_pos": 303}, {"label_type": "影像检查", "overlap": 0, "start_pos": 304, "end_pos": 307}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 313, "end_pos": 318}, {"label_type": "药物", "overlap": 0, "start_pos": 323, "end_pos": 327}, {"label_type": "药物", "overlap": 0, "start_pos": 336, "end_pos": 341}, {"label_type": "药物", "overlap": 0, "start_pos": 346, "end_pos": 350}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 394, "end_pos": 399}, {"label_type": "药物", "overlap": 0, "start_pos": 404, "end_pos": 408}, {"label_type": "药物", "overlap": 0, "start_pos": 409, "end_pos": 413}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 472, "end_pos": 476}, {"label_type": "手术", "overlap": 0, "start_pos": 492, "end_pos": 496}, {"label_type": "药物", "overlap": 0, "start_pos": 509, "end_pos": 513}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 559, "end_pos": 564}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 565, "end_pos": 571}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 572, "end_pos": 576}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 577, "end_pos": 582}]}
{"originalText": "入院前9月患者无明显诱因出现腹胀，无腹痛、腹泻、黑便，无纳差、厌油，无恶心、呕吐，无反酸、嗳气、烧心。在**医院就诊，完善相关检查后诊断“乙肝后肝硬化失代偿期”，给予“保肝、放腹水、抗病毒”等对症处理后好转。入院前2月因中下腹隐痛及腹胀在我院内四科住院，行“胃镜示：慢性非萎缩性胃炎，轻度食管静脉曲张可能。乙肝三对：乙肝表面抗原定性 阳性，乙肝核心抗体定性 阳性。乙肝DNA＜5E+02，腹部彩超：肝实质回声异常，符合肝硬化超声表现，胆囊壁增厚毛糙，脾大；”，诊断“肝硬化失代偿期”，给予“泮托拉唑抑酸、还原型谷胱甘肽及甘利欣、门冬氨酸鸟氨酸保肝、保护胃黏膜、改善腹胀等对症处理”后好转出院。院外口服“恩替卡韦片”抗病毒治疗。病程中未出现黑便、呕血、黄疸等。于2014-12-02在**医院复诊肝硬化，查“肾功、血脂、电解质、AFP无明显异常。血常规：WBC：3.59*10^9/L，HB：138g/L。肝功：ALT：44IU/L，GGT：134IU/L。ALB：42.9g/L。”。入院前4小时患者劳动时突然出现肝区持续性胀痛，伴阵发性加重，感左侧背部放射痛，无肩膀放射痛，与饮食及体位无关。无畏寒、发热，无嗳气、反酸、烧心，无纳差、乏力。遂来我院就诊，门诊查腹部彩超示“肝硬化，胆囊壁毛糙增厚，脾大，胰腺未见异常。”，为进一步诊治，门诊以“肝硬化失代偿期”收入我科。病程中精神、饮食尚可，大小便正常。体重无明显上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 14, "end_pos": 15}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 18, "end_pos": 19}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 21, "end_pos": 22}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 69, "end_pos": 79}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 111, "end_pos": 113}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 116, "end_pos": 117}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 133, "end_pos": 141}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 142, "end_pos": 150}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 158, "end_pos": 166}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 170, "end_pos": 178}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 182, "end_pos": 187}, {"label_type": "影像检查", "overlap": 0, "start_pos": 194, "end_pos": 198}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 199, "end_pos": 200}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 209, "end_pos": 212}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 217, "end_pos": 220}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 225, "end_pos": 226}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 233, "end_pos": 240}, {"label_type": "药物", "overlap": 0, "start_pos": 245, "end_pos": 249}, {"label_type": "药物", "overlap": 0, "start_pos": 252, "end_pos": 259}, {"label_type": "药物", "overlap": 0, "start_pos": 260, "end_pos": 263}, {"label_type": "药物", "overlap": 0, "start_pos": 264, "end_pos": 271}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 276, "end_pos": 277}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 282, "end_pos": 283}, {"label_type": "药物", "overlap": 0, "start_pos": 301, "end_pos": 306}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 376, "end_pos": 379}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 392, "end_pos": 394}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 405, "end_pos": 408}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 416, "end_pos": 419}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 428, "end_pos": 431}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 457, "end_pos": 458}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 473, "end_pos": 477}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 482, "end_pos": 484}, {"label_type": "影像检查", "overlap": 0, "start_pos": 531, "end_pos": 535}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 537, "end_pos": 540}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 541, "end_pos": 544}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 549, "end_pos": 550}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 552, "end_pos": 554}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 572, "end_pos": 579}]}
{"originalText": "患者入院前4年活动后感心累、气促，不伴明显胸痛，无胸骨后压榨感，无慢性咳嗽咳痰，经******转诊至*****就诊，具体检查及治疗情况不详，自诉诊断“冠心病、房颤、高血压”，经治疗后症状缓解出院。出院当时服药情况不详，否认服用“华法林”，有服用“阿司匹林肠溶片”病史，近期服用“地高辛、依那普利”，但患者依从性差，常有自行停药情况。入院前4天患者受凉后感心累加重，平路缓步走即感心累，夜间不能平卧，需高枕卧位，并心前区闷胀感，食欲不振，无饥饿感，伴咳嗽，咯白色粘痰，无痰中带血，无畏寒发热，无潮热盗汗，无胸痛，无胸骨后压榨感，无明显上肢浮肿，今日来院就诊，门诊查心电图提示快速型房颤。胸片提示1.两上肺肺纹增多、2.主动脉硬化，心脏重度增大，结合临床、3.两侧肋膈角欠锐利。血常规：白细胞数 6.8 10^9/L、中性粒细胞百分比 78.34 %，心肌酶谱：谷草转氨酶 44.8 U/L、肌酸激酶 198.7 U/L、肌酸激酶同工酶 14 U/L、乳酸脱氢酶 241.6 U/L，肾功：尿素 4.48 mmol/L、肌酐 43.0 μmol/l，高敏肌钙蛋白T 11.93 pg/ml，电解质1：钾 3.77 mmol/l，D_2聚体 0.54 μg/ml。门诊予以静推“胺碘酮 150mg”，静滴“丹参川芎嗪5ml”，为进一步治疗收入我科住院。病程中患者精神、饮食一般，大小便正常，体重无明显上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 11, "end_pos": 12}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 21, "end_pos": 22}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 25, "end_pos": 27}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 75, "end_pos": 78}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 79, "end_pos": 81}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 82, "end_pos": 85}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 114, "end_pos": 117}, {"label_type": "药物", "overlap": 0, "start_pos": 123, "end_pos": 130}, {"label_type": "药物", "overlap": 0, "start_pos": 139, "end_pos": 142}, {"label_type": "药物", "overlap": 0, "start_pos": 143, "end_pos": 147}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 177, "end_pos": 178}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 189, "end_pos": 190}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 206, "end_pos": 209}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 252, "end_pos": 253}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 256, "end_pos": 258}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 266, "end_pos": 268}, {"label_type": "影像检查", "overlap": 0, "start_pos": 281, "end_pos": 284}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 286, "end_pos": 291}, {"label_type": "影像检查", "overlap": 0, "start_pos": 292, "end_pos": 294}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 298, "end_pos": 301}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 308, "end_pos": 313}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 314, "end_pos": 316}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 328, "end_pos": 333}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 341, "end_pos": 344}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 357, "end_pos": 365}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 379, "end_pos": 384}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 394, "end_pos": 398}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 409, "end_pos": 416}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 424, "end_pos": 429}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 443, "end_pos": 445}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 458, "end_pos": 460}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 473, "end_pos": 480}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 498, "end_pos": 499}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 512, "end_pos": 517}, {"label_type": "药物", "overlap": 0, "start_pos": 536, "end_pos": 539}, {"label_type": "药物", "overlap": 0, "start_pos": 550, "end_pos": 555}]}
{"originalText": "入院前1+月，患者无明显诱因出现吞咽梗阻，进食固体食物时明显，偶有恶心，呕吐少许白色粘液，不呈喷射状，不含隔夜宿食，无咖啡色物质及血凝块，偶有下腹部隐痛，伴腹胀，伴反酸，伴纳差，饮食较前减少1/2，以流质为主，无烧心、嗳气，无呕血、黑便，无黄疸，无腹泻，无乏力、心悸、头晕、头痛，无胸闷、胸痛、呼吸困难，无畏寒、发热等不适，于1月前就诊于我院，完善腹部彩超提示“两肾结石”，予以口服PPT及曲美布汀治疗，患者症状无明显好转。半月前再次就诊于我院，完善碳14呼气试验阳性，予以“维三联+PPI”抗HP治疗2周，今日于我院完善胃镜检查提示“胃底、胃体巨大溃疡伴出血可能，考虑胃癌可能”（未见报告），为求进一步诊治，遂以“吞咽哽噎原因待查”收入住院。患者此次患病以来精神食欲差，大小便正常，睡眠尚可，体力明显上降，体重无明显改变。入院前10年，患者常在受凉后出现咳嗽、咳痰，并逐渐出现喘累气促，好发于冬春季节，每年累计发病时间超过3月，常就诊于******医院及我院，诊断为“慢支炎、支气管哮喘”，予以抗感染、止咳平喘等治疗后可好转。院外长期服用氨茶碱等药物治疗。半月前，患者于我院行肺功能提示“重度混合性通气功能障碍以阻塞为主（FEV1/FVC 38.28%），舒张试验阳性”。近期患者受凉后感活动后喘累、气促较前加重，有咳嗽，咳白色黏痰，痰不易咯出，无畏寒、寒战、发热，无咯血、胸痛、呼吸困难等不适。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 71, "end_pos": 74}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 78, "end_pos": 79}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 124, "end_pos": 125}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 131, "end_pos": 132}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 134, "end_pos": 135}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 137, "end_pos": 138}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 141, "end_pos": 142}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 144, "end_pos": 145}, {"label_type": "影像检查", "overlap": 0, "start_pos": 174, "end_pos": 178}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 181, "end_pos": 185}, {"label_type": "药物", "overlap": 0, "start_pos": 195, "end_pos": 199}, {"label_type": "药物", "overlap": 0, "start_pos": 238, "end_pos": 245}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 268, "end_pos": 270}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 271, "end_pos": 273}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 285, "end_pos": 287}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 308, "end_pos": 316}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 435, "end_pos": 444}, {"label_type": "药物", "overlap": 0, "start_pos": 470, "end_pos": 473}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 495, "end_pos": 528}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 588, "end_pos": 589}]}
{"originalText": "入院前2天，患者无明显诱因出现纳差、失语，伴发热、流涕，但未测体温，偶有咳痰，无畏寒、寒战，无头昏、头痛，无胸闷、胸痛，无恶心、呕吐，无腹胀、腹痛，无喘累、气促，无端坐呼吸、阵发性呼吸困难，无咯血、黑朦、晕厥，无肢体瘫痪、意识障碍、大小便失禁等。今日未进食，精神较差，故家属送入******，查“血常规示WBC 11.58×10e9/L，RBC 5.30×10e12/L，HGB 144g/L，N 71.1%，L 26.5%。心电图示室下性心动过速”，故转入我院急救部治疗，送入急诊科行床旁心电图示室下性心动过速，心率213次/分，T 37.9℃，立即予以吸氧、心电监护、NS 16ml+维拉帕米10mg缓慢静推，静推约8mg后心律恢复为窦性，心率降至94次/分，同时完善心肌酶谱：谷草转氨酶 17.2 U/L、肌酸激酶 41.5 U/L、肌酸激酶同工酶 8 U/L、乳酸脱氢酶 245.7 U/L ↑，肾功：尿素 8.28 mmol/L ↑、肌酐 66.2 μmol/l、尿酸 251.6 μmol/l，高敏肌钙蛋白：40.75 pg/ml ↑，电解质：钾 3.39 mmol/l ↓、钠 145.2 mmol/l、氯 107.6 mmol/l，凝血功能大致正常。为进一步治疗以“心律失常”收入我科住院。患者自发病以来精神、食欲差，大便干燥，小便未诉异常。近期体重无明显减轻。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 47, "end_pos": 48}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 50, "end_pos": 51}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 54, "end_pos": 55}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 57, "end_pos": 58}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 68, "end_pos": 69}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 71, "end_pos": 72}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 152, "end_pos": 155}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 169, "end_pos": 172}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 186, "end_pos": 189}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 197, "end_pos": 198}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 205, "end_pos": 206}, {"label_type": "影像检查", "overlap": 0, "start_pos": 213, "end_pos": 216}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 217, "end_pos": 224}, {"label_type": "影像检查", "overlap": 0, "start_pos": 243, "end_pos": 248}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 249, "end_pos": 256}, {"label_type": "药物", "overlap": 0, "start_pos": 294, "end_pos": 298}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 341, "end_pos": 346}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 356, "end_pos": 360}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 370, "end_pos": 377}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 384, "end_pos": 389}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 405, "end_pos": 407}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 422, "end_pos": 424}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 437, "end_pos": 439}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 453, "end_pos": 459}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 478, "end_pos": 479}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 494, "end_pos": 495}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 509, "end_pos": 510}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 541, "end_pos": 545}]}
{"originalText": "患者于入院前1年余即开始反复出现胸痛症状，心前区压榨感，均在活动及进食后出现，不能耐受平地快走，发作后含服“速效救心丸”或休息后可逐渐缓解。病程中曾多次出现突发呼吸困难、大汗、濒死感，在****医院等住院治疗好转。9月前，患者进餐后再次突然出现呼吸困难，全身大汗、胸痛，诊断为心力衰竭，于我科住院，给予扩管、抗血小板、降压、控制心室率治疗后好转出院。入院前1天，患者感气促加重，有夜间阵发性呼吸困难，如厕即可诱发喘累，伴有咳嗽、咳痰、中下腹疼痛。无心前区压榨感，无恶心、呕吐，无发热、畏寒，肛门有排气排便。家属拨打120由*****医院120送入我院急诊科，查血气分析PH7.43，PO2 104mmHg，PCO2 35mmHg。血常规：白细胞数 6.2×10^9/L、中性粒细胞百分比 78.51 %，心肌酶谱：谷草转氨酶 38.0 U/L、肌酸激酶同工酶 10 U/L、乳酸脱氢酶 279.5 U/L，肾功：肌酐 115.1 μmol/l，高敏肌钙蛋白：264.30 pg/ml。电解质、CRP无异常。胸片提示两肺中上野感染，以左上肺明显。腹部彩超提示胆总管增宽。给予呋塞米20mg静推利尿、单硝酸异山梨酯25mg静滴后患者症状有所缓解。为进一步治疗收治我科。患者此次患病以来精神食欲睡眠差，大便正常，小便量偏少，体力明显上降，体重无明显改变。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 16, "end_pos": 17}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 21, "end_pos": 24}, {"label_type": "药物", "overlap": 0, "start_pos": 54, "end_pos": 59}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 132, "end_pos": 133}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 138, "end_pos": 142}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 217, "end_pos": 220}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 224, "end_pos": 227}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 245, "end_pos": 247}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 284, "end_pos": 286}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 291, "end_pos": 294}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 303, "end_pos": 307}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 319, "end_pos": 322}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 335, "end_pos": 343}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 357, "end_pos": 362}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 372, "end_pos": 379}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 387, "end_pos": 392}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 406, "end_pos": 408}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 422, "end_pos": 428}, {"label_type": "影像检查", "overlap": 0, "start_pos": 453, "end_pos": 455}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 457, "end_pos": 464}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 466, "end_pos": 469}, {"label_type": "影像检查", "overlap": 0, "start_pos": 472, "end_pos": 476}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 478, "end_pos": 481}, {"label_type": "药物", "overlap": 0, "start_pos": 486, "end_pos": 489}, {"label_type": "药物", "overlap": 0, "start_pos": 498, "end_pos": 505}]}
{"originalText": "入院前9月患者无明显诱因出现腹胀，无腹痛、腹泻、黑便，无纳差、厌油，无恶心、呕吐，无反酸、嗳气、烧心。在**医院就诊，完善相关检查后诊断“乙肝后肝硬化失代偿期”，给予“保肝、放腹水、抗病毒”等对症处理后好转。入院前2月因中下腹隐痛及腹胀在我院内四科住院，行胃镜示：慢性非萎缩性胃炎，轻度食管静脉曲张可能。乙肝三对：乙肝表面抗原定性 阳性，乙肝核心抗体定性 阳性。乙肝DNA＜5E+02，腹部彩超：肝实质回声异常，符合肝硬化超声表现，胆囊壁增厚毛糙，脾大。诊断“肝硬化失代偿期”，给予“泮托拉唑抑酸、还原型谷胱甘肽及甘利欣、门冬氨酸鸟氨酸保肝、保护胃黏膜、改善腹胀等对症处理”后好转出院。院外口服“恩替卡韦片”抗病毒治疗。病程中未出现黑便、呕血、黄疸等。于2014-12-02在**医院复诊，查“肾功、血脂、电解质、AFP无明显异常。血常规：WBC：3.59*10^9/L，HB：138g/L。肝功：ALT：44 IU/L，GGT：134 IU/L。ALB：42.9g/L。”。2天前劳动时出现肝区持续性胀痛，在我院治疗好转后出院，半天前患者再次出现肝区胀痛，无阵发性加重，无放射痛，与饮食及体位无关。无嗳气、反酸、烧心，无纳差、乏力，无皮肤黄染。为进一步诊治，门诊以“肝硬化失代偿期”收入我科。病程中精神、饮食尚可，大小便正常。体重无明显上降。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 14, "end_pos": 15}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 18, "end_pos": 19}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 21, "end_pos": 22}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 69, "end_pos": 79}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 111, "end_pos": 113}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 132, "end_pos": 140}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 141, "end_pos": 151}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 157, "end_pos": 165}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 169, "end_pos": 177}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 181, "end_pos": 186}, {"label_type": "影像检查", "overlap": 0, "start_pos": 193, "end_pos": 197}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 198, "end_pos": 199}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 208, "end_pos": 211}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 216, "end_pos": 219}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 224, "end_pos": 225}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 230, "end_pos": 237}, {"label_type": "药物", "overlap": 0, "start_pos": 242, "end_pos": 246}, {"label_type": "药物", "overlap": 0, "start_pos": 249, "end_pos": 256}, {"label_type": "药物", "overlap": 0, "start_pos": 257, "end_pos": 260}, {"label_type": "药物", "overlap": 0, "start_pos": 261, "end_pos": 268}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 273, "end_pos": 274}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 279, "end_pos": 280}, {"label_type": "药物", "overlap": 0, "start_pos": 298, "end_pos": 303}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 370, "end_pos": 373}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 386, "end_pos": 388}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 399, "end_pos": 402}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 411, "end_pos": 414}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 424, "end_pos": 427}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 446, "end_pos": 448}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 474, "end_pos": 476}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 534, "end_pos": 541}]}
{"originalText": "入院前7年无明显诱因患者感活动后乏力、气促，不伴头昏、头痛、胸闷、心悸、胸痛、晕厥、黑曚、呃逆、反酸、嗳气、烧心、恶心、呕吐、腹痛、腹胀、腹泻、黑便。患者于*****医院诊断“溶血性贫血”，给予输血等处理后病情缓解。病程中如下症状反复发生，多次给予输血治疗后病程好转。2013年4月*****胸片检查：两肺纹理增多，心影轻度增大。心脏彩超：右房、右室稍增大，EF正常。血库：间接Coomb’s试验（+）P，阳性对照（+++），P。骨髓象：增生性骨髓象，红系增生旺盛。2014-4-24（******医院）分钟遗传学检验报告单：未检测到送检样本中G6PD基因G1388A，G1376T，A95G三个常见突变位点，结合临床；新生儿疾病筛查报告单：新生儿G6PD活性试验1.56（正常）。肝功：总胆红素 50umol/L，直接胆红素 10umol/L，ALT 40U/L，AST 18U/L。诊断“G-6-PD酶缺乏症，贫血性心脏病，肝功能不全”明确。经输洗涤红细胞后病情好转。出院后患者反复出现乏力、气促不适，反复经输注洗涤红细胞后缓解。7天前可疑受凉后出现血尿，患者未予处理。今再次出现四肢乏力，活动后气促伴耳鸣。为求进一步治疗今日入我院门诊，门诊以“G-6-PD酶缺乏症”收入我科。患者此次患病以来，精神状态差，大小便正常，体重无明显减轻。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 24, "end_pos": 25}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 27, "end_pos": 28}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 30, "end_pos": 31}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 33, "end_pos": 34}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 36, "end_pos": 37}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 63, "end_pos": 64}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 66, "end_pos": 67}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 69, "end_pos": 70}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 88, "end_pos": 93}, {"label_type": "影像检查", "overlap": 0, "start_pos": 146, "end_pos": 148}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 151, "end_pos": 153}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 158, "end_pos": 159}, {"label_type": "影像检查", "overlap": 0, "start_pos": 165, "end_pos": 169}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 170, "end_pos": 172}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 173, "end_pos": 175}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 179, "end_pos": 181}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 187, "end_pos": 198}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 321, "end_pos": 332}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 344, "end_pos": 348}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 358, "end_pos": 363}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 373, "end_pos": 376}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 383, "end_pos": 386}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 396, "end_pos": 406}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 407, "end_pos": 413}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 414, "end_pos": 419}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 492, "end_pos": 494}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 503, "end_pos": 504}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 525, "end_pos": 535}]}
{"originalText": "患者于入院前40+年，常于受凉后出现咳嗽、咳痰，痰呈白色泡沫痰，下述症状反复发作，多在冬春季节反复发作，常予以抗炎止咳等药物治疗后可缓解。病程中患者逐渐出现喘累气促，活动耐力上降，曾在我院行胸部CT提示肺气肿、肺大泡形成，多次在我院住院治疗，经抗感染等治疗后好转。病程中曾出现上肢浮肿、气促，考虑肺源性心脏病。入院前半年，患者因下诉症状再发于我科住院，行心脏彩超示EF 25%，室间隔、右室后壁增厚；室间隔、右室后壁动度降低；二尖瓣、三尖瓣中度反流；右室舒张、收缩功能减退。考虑“慢性阻塞性肺疾病、肺源性心脏病、冠心病？”，予以抗感染、祛痰、利尿等治疗后好转，建议患者进一步完善冠脉造影，但患者未遵医嘱。患者曾于2017年5月2日在我院行胸部CT提示：1.两肺上叶感染，治疗后复查。2.慢支炎、肺气肿，肺大泡形成。3.两下肺纤维斑块病灶；左肺下叶及右肺上叶支气管局段性扩张。4.左侧肺门及心后软组织块影，建议患者定期复查，患者此后未再复查。入院前2天患者受凉感冒，自觉咳嗽，咯黄痰，并觉畏寒发热，喘累症状加重，无胸痛咯血，无心慌胸闷，无恶心呕吐，无腹痛纳差，无呼吸困难。今日来院就诊，为进一步治疗今日到我科住院。患者自发病以来精神、食欲可，进食好，睡眠一般，大便4-5次/日，时干时稀，无粘液脓血便，小便正常。近期体力上降，体重无明显减轻。", "entities": [{"label_type": "影像检查", "overlap": 0, "start_pos": 95, "end_pos": 99}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 101, "end_pos": 104}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 138, "end_pos": 140}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 148, "end_pos": 154}, {"label_type": "影像检查", "overlap": 0, "start_pos": 177, "end_pos": 181}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 182, "end_pos": 184}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 189, "end_pos": 192}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 193, "end_pos": 197}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 200, "end_pos": 203}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 204, "end_pos": 208}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 213, "end_pos": 216}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 217, "end_pos": 220}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 225, "end_pos": 236}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 240, "end_pos": 248}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 249, "end_pos": 255}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 256, "end_pos": 259}, {"label_type": "影像检查", "overlap": 0, "start_pos": 289, "end_pos": 293}, {"label_type": "影像检查", "overlap": 0, "start_pos": 319, "end_pos": 323}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 328, "end_pos": 334}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 343, "end_pos": 346}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 347, "end_pos": 350}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 359, "end_pos": 362}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 369, "end_pos": 373}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 374, "end_pos": 378}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 378, "end_pos": 381}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 389, "end_pos": 393}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 394, "end_pos": 399}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 456, "end_pos": 457}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 462, "end_pos": 463}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 464, "end_pos": 465}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 474, "end_pos": 475}]}
{"originalText": "入院前30+年，患者常在受凉后出现咳嗽、咳痰，多为白色泡沫痰，并逐渐出现喘累、气促，好发于冬春季节，每年累计发病时间超过3月，外院诊断为“慢支炎、肺气肿”，予以抗感染、止咳平喘等治疗后可好转。患者喘累、气促症状逐年加重，并逐渐出现间断两上肢水肿，外院考虑为“肺源性心脏病”，未利尿、长期低流量吸氧及吸入剂治疗。7+年前，患者喘累、呼吸困难明显，于外院诊断为“支气管哮喘”（具体检查报告及诊治经过不详），开始使用沙丁胺醇气雾剂治疗。后患者下述症状反复发作，反复住院治疗，最近一次于2017-10-29于我科住院治疗，给予抗感染、化痰、平喘、改善循环等治疗后好转出院，出院诊断为：1.慢性阻塞性肺疾病急性加重期;2、慢性肺源性心脏病;3、支气管哮喘 ;4、冠心病 频发多源性房早，频发室早？院外长期平喘化痰对症治疗。入院前2天前，患者受凉后下述症状较前加重，咳嗽、咳黄白色粘痰，喘累明显，不能平卧位休息，夜间阵发性呼吸困难，伴有头昏，偶有头疼，无畏寒、寒战、发热，无咯血，无潮热、盗汗，无恶心、呕吐，无腹胀、腹痛，无胸闷、胸痛，无尿频、尿急、尿痛等不适，自行服用“平喘药”（具体不详），下述症状无明显好转，遂来我院就诊，门诊以“AECOPD”收入我科进一步治疗。患者此次患病以来精神、食欲、睡眠差，大小便正常，体力明显上降，体重无明显改变。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 69, "end_pos": 72}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 73, "end_pos": 76}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 117, "end_pos": 120}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 129, "end_pos": 135}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 179, "end_pos": 184}, {"label_type": "药物", "overlap": 0, "start_pos": 205, "end_pos": 212}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 290, "end_pos": 303}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 306, "end_pos": 314}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 317, "end_pos": 322}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 326, "end_pos": 329}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 330, "end_pos": 337}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 338, "end_pos": 343}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 412, "end_pos": 413}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 417, "end_pos": 418}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 449, "end_pos": 450}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 452, "end_pos": 453}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 456, "end_pos": 457}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 459, "end_pos": 460}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 512, "end_pos": 518}]}
{"originalText": "入院前10余年，患者无明显诱因出现活动后心累、气促，间断出现两上肢水肿、夜间喜高枕卧位，偶有胸闷，于当地医院就诊，考虑为“冠心病”。5年前因“心累、气促”加重，于“**医院”就诊，查“心率30次/分”右左，给予安置“起搏器”，后喘累症状稍所好转，平素缓慢走平路即感气促，无明显胸闷、胸痛等不适。院外长期口服心脏疾病相关药物（具体不详）治疗。近1年来，患者反复因喘累、气促在我院住院治疗，予以改善循环、利尿、营养心肌等对症治疗后好转出院。入院前10+天，患者受凉后诉心累、气促症状加重，夜间明显，夜间高枕卧位，难以平卧，伴心悸、胸闷，伴中下腹部不适，伴咳嗽、咳痰，咳出白色粘痰，否认胸痛、心前区压榨感，无恶心、呕吐，无咯血、腹泻等，遂就诊于我院急诊科，查血常规：WBC 3.9×109/L，HGB 117g/l、N 66.2%。凝血试验、D2聚体、肾功、电解质、心肌酶谱、肌钙蛋白均未见明显异常。腹部彩超示肝胆胰脾肾未见明显异常。胸片示1.两肺中上野感染，建议治疗后复查。2.心影稍增大，主动脉弓少许钙化；心脏人工起搏器术后改变，结合临床。3.胸椎骨质增生。予以平喘、改善循环后症状稍有改善，为进一步治疗，门诊以“高血压、肺部感染”收入我科住院治疗。患者此次患病以来精神食欲欠佳，大小便未诉异常，睡眠尚可，体力明显上降，体重无明显改变。", "entities": [{"label_type": "解剖部位", "overlap": 0, "start_pos": 20, "end_pos": 21}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 30, "end_pos": 33}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 46, "end_pos": 47}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 61, "end_pos": 64}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 71, "end_pos": 72}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 138, "end_pos": 139}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 141, "end_pos": 142}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 232, "end_pos": 233}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 260, "end_pos": 261}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 263, "end_pos": 264}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 267, "end_pos": 271}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 290, "end_pos": 291}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 293, "end_pos": 296}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 311, "end_pos": 312}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 330, "end_pos": 333}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 344, "end_pos": 347}, {"label_type": "实验室检验", "overlap": 0, "start_pos": 355, "end_pos": 356}, {"label_type": "影像检查", "overlap": 0, "start_pos": 397, "end_pos": 401}, {"label_type": "影像检查", "overlap": 0, "start_pos": 414, "end_pos": 416}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 419, "end_pos": 426}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 437, "end_pos": 438}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 443, "end_pos": 447}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 471, "end_pos": 477}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 506, "end_pos": 509}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 510, "end_pos": 514}]}
